PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eysenbach, G				Eysenbach, G			Recent advances - Consumer health informatics	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMMUNICATION APPLICATIONS; MEDICAL INFORMATION; INTERNET; QUALITY; CARE; TECHNOLOGY; RECORDS; SYSTEMS		Heidelberg Univ, Dept Clin Social Med, Unit Cybermed, D-69115 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Eysenbach, G (corresponding author), Heidelberg Univ, Dept Clin Social Med, Unit Cybermed, Bergheimer Str 58, D-69115 Heidelberg, Germany.	ey@yi.com	Eysenbach, Gunther/AAJ-7158-2020	Eysenbach, Gunther/0000-0001-6479-5330				BALDRY M, 1986, BRIT MED J, V292, P596, DOI 10.1136/bmj.292.6520.596; Barry MJ, 1999, JAMA-J AM MED ASSOC, V282, P2356, DOI 10.1001/jama.282.24.2356; Bouhaddou O, 1998, J AM MED INFORM ASSN, P612; Brennan PF, 1998, J AM MED INFORM ASSN, V5, P257, DOI 10.1136/jamia.1998.0050257; Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; COLEMAN V, 1984, J MED ETHICS, V10, P27, DOI 10.1136/jme.10.1.27; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; Eysenbach G, 1999, METHOD INFORM MED, V38, P80; Eysenbach G, 1998, BRIT MED J, V317, P1496, DOI 10.1136/bmj.317.7171.1496; Eysenbach G, 1998, LANCET, V352, P1526, DOI 10.1016/S0140-6736(05)60334-0; EYSENBACH G, 1999, BMJ-BRIT MED J, P319; Ferguson T, 1997, JOINT COMM J QUAL IM, V23, P251, DOI 10.1016/S1070-3241(16)30315-7; Friedman CP, 1999, JAMA-J AM MED ASSOC, V282, P1851, DOI 10.1001/jama.282.19.1851; GILHOOLY MLM, 1991, J MED ETHICS, V17, P138, DOI 10.1136/jme.17.3.138; GREENES RA, 1990, JAMA-J AM MED ASSOC, V263, P1114; Gustafson DH, 1999, AM J PREV MED, V16, P23, DOI 10.1016/S0749-3797(98)00104-4; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; HERSEY JC, 1997, 98M001 AHCPR; Irving L., 1999, FALLING NET DEFINING; Jadad AR, 1999, BMJ-BRIT MED J, V319, P761, DOI 10.1136/bmj.319.7212.761; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P611, DOI 10.1001/jama.279.8.611; Jones R, 1999, BRIT MED J, V319, P1241, DOI 10.1136/bmj.319.7219.1241; KREUTER M, 2000, TAILORING HLTH MESSA; Patrick K, 1999, AM J PREV MED, V16, P35, DOI 10.1016/S0749-3797(98)00103-2; PATRICK K, 2000, CONSUMER HLTH INFORM; Pencheon D, 1998, BRIT MED J, V316, P1665, DOI 10.1136/bmj.316.7145.1665; Pencheon D, 1998, BRIT MED J, V317, P1026; Pies R, 1998, NEW ENGL J MED, V339, P638, DOI 10.1056/NEJM199808273390920; RIND DM, 1999, P AMIA S, P1147; Rippen H, 2000, J MED INTERNET RES, V2, DOI 10.2196/jmir.2.1.e2; Shepperd S, 1999, BMJ-BRIT MED J, V319, P764, DOI 10.1136/bmj.319.7212.764; SHORTLIFFE EH, 1990, MED INFORMATICS COMP; Smith R, 1997, BRIT MED J, V314, P1495, DOI 10.1136/bmj.314.7093.1495; *US GEN ACC OFF, 1996, TAIMD96134; VANBEMMEL JH, 1997, HDB MED INFORMATICS; Wyatt J, 1998, BRIT MED J, V317, P900	36	361	370	5	97	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2000	320	7251					1713	1716		10.1136/bmj.320.7251.1713	http://dx.doi.org/10.1136/bmj.320.7251.1713			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	329UJ	10864552	Green Published			2022-12-28	WOS:000087926400027
J	Smith, KJ; Roberts, MS				Smith, KJ; Roberts, MS			The cost-effectiveness of sildenafil	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ERECTILE DYSFUNCTION; ORAL SILDENAFIL; PROSTATE-CANCER; VIAGRA; MEN; DECISION; PREFERENCES; ALPROSTADIL; EFFICACY	Background: Coverage of sildenafil by health insurance plans is a contentious issue. Objective: To evaluate the cost-effectiveness of sildenafil treatment for erectile dysfunction. Design: A Markov decision model to estimate the incremental cost-effectiveness of sildenafil compared with no drug therapy. Data Sources: Values for the efficacy and safety of sildenafil and quality-of-life utilities were obtained from the published medical literature. Base-case values were chosen to bias against sildenafil use. Target Population: Men 60 years of age with erectile dysfunction. Time Horizon: Lifetime. Perspective: Societal and third-party payer. Intervention: Sildenafil or no treatment in identical hypothetical cohorts. Outcome Measures: Cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: The cost per QALY gained for sildenafil treatment compared with no therapy was $11 290 from the societal perspective and $11 230 from the third-party payer perspective. Results of Sensitivity Analysis: From the societal perspective, the cost per QALY gained associated with sildenafil was less than $50 000 if treatment-related morbidity was less than 0.8% per year, mortality was less than 0.55% per year, treatment was successful in more than 40.2% of patients, or sildenafil cost less than $244 per month. The results were sensitive to variation of erectile dysfunction utilities, but cost per QALY gained was less than $50 000 if successful treatment increased utility values by 0.05 or more on a scale of 0 (death) to 1 (perfect health). Conclusions: In an analysis biased against use of sildenafil, the cost-effectiveness of sildenafil treatment compared favorably with that of accepted therapies for other medical conditions.	Mercy Hosp, Dept Med, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Sch Med, Ctr Res Hlth Care, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smith, KJ (corresponding author), Mercy Hosp, Dept Med, 1400 Locust St, Pittsburgh, PA 15219 USA.	ksmith@pmhs.mercy.org						Aldridge J, 1999, BRIT MED J, V318, P669, DOI 10.1136/bmj.318.7184.669; BARRY MJ, 1988, JAMA-J AM MED ASSOC, V259, P3010, DOI 10.1001/jama.259.20.3010; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Brooks A, 1998, BRIT MED J, V317, P765, DOI 10.1136/bmj.317.7161.765; CHANG CF, 1999, AM J MANAG CARE, V5, pS15; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; Chisholm J, 1999, BMJ-BRIT MED J, V318, P273, DOI 10.1136/bmj.318.7179.273; Dinsmore WW, 1999, UROLOGY, V53, P800, DOI 10.1016/S0090-4295(98)00586-X; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; EISENBERG JM, 1989, JAMA-J AM MED ASSOC, V262, P2879, DOI 10.1001/jama.262.20.2879; Feenstra J, 1998, LANCET, V352, P957, DOI 10.1016/S0140-6736(98)00015-4; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR, 1996, COST EFFECTIVENESS H; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; GORMAN C, 1998, TIME             JUL, V13, P22; Jhaveri FM, 1998, INT J IMPOT RES, V10, P251, DOI 10.1038/sj.ijir.3900359; KRAHN MD, 1994, JAMA-J AM MED ASSOC, V272, P773, DOI 10.1001/jama.272.10.773; La Puma J, 1998, Manag Care, V7, P55; Lamberg L, 1998, JAMA-J AM MED ASSOC, V280, P867, DOI 10.1001/jama.280.10.867; LAPUMA J, 1998, MANAG CARE, V7, P55; Linet OI, 1996, NEW ENGL J MED, V334, P873, DOI 10.1056/NEJM199604043341401; MARK DB, 1995, NEW ENGL J MED, V332, P1418, DOI 10.1056/NEJM199505253322106; MCDOWELL I, 1996, MEASURING HLTH GUIDE, P483; MOLD JW, 1992, J FAM PRACTICE, V34, P561; Montague DK, 1996, J UROLOGY, V156, P2007, DOI 10.1016/S0022-5347(01)65419-3; Montorsi F, 1999, UROLOGY, V53, P1011, DOI 10.1016/S0090-4295(98)00643-8; *NAT CTR HLTH STAT, 1991, 1988 VIT STAT US A, V2; PadmaNathan H, 1997, NEW ENGL J MED, V336, P1, DOI 10.1056/NEJM199701023360101; PARHAM W, 1999, AM J MANAG CARE S, V5, pS23; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; *US FOOD DRUG ADM, 1998, POSTM SAF SLID CITR; Volk RJ, 1997, ARCH FAM MED, V6, P72, DOI 10.1001/archfami.6.1.72; 1998, BMJ, V317, P836	35	54	55	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					933	+		10.7326/0003-4819-132-12-200006200-00002	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858175				2022-12-28	WOS:000087670800001
J	Holt, R; Roberts, G; Scully, C				Holt, R; Roberts, G; Scully, C			ABC of oral health - Oral health and disease	BRITISH MEDICAL JOURNAL			English	Review									Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, London, England	University of London; University College London	Holt, R (corresponding author), Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, London, England.							SCULLY C, 1994, COLOUR ATLAS ORAL DI; SCULLY C, 1996, ORAL DIS	2	12	12	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1652	+		10.1136/bmj.320.7250.1652	http://dx.doi.org/10.1136/bmj.320.7250.1652			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856071	Green Published			2022-12-28	WOS:000087734200026
J	Gottlieb, S				Gottlieb, S			FDA censures NEJM editor	BRITISH MEDICAL JOURNAL			English	News Item																			0	4	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1562	1562		10.1136/bmj.320.7249.1562	http://dx.doi.org/10.1136/bmj.320.7249.1562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845960	Green Published			2022-12-28	WOS:000087631400016
J	Marshall, SF; Hardy, RJ; Kuh, D				Marshall, SF; Hardy, RJ; Kuh, D			Socioeconomic variation in hysterectomy up to age 52: national, population based, prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							UNITED-STATES; EPIDEMIOLOGY		Royal Free & UCL, Dept Epidemiol & Publ Hlth, MRC, Natl Survey Hlth & Dev, London WC1E 6BT, England	University of London; University College London	Kuh, D (corresponding author), Royal Free & UCL, Dept Epidemiol & Publ Hlth, MRC, Natl Survey Hlth & Dev, London WC1E 6BT, England.	d.kuh@ucl.ac.uk	Hardy, Rebecca/AFR-1989-2022; Kuh, Diana/L-6019-2014	Kuh, Diana/0000-0001-7386-2857; Hardy, Rebecca/0000-0001-9949-0799				Brett KM, 1997, J WOMENS HEALTH, V6, P309, DOI 10.1089/jwh.1997.6.309; KJERULFF K, 1993, AM J PUBLIC HEALTH, V83, P106, DOI 10.2105/AJPH.83.1.106; KUH D, 1995, BRIT MED J, V311, P840, DOI 10.1136/bmj.311.7009.840; Settnes A, 1996, ACTA OBSTET GYN SCAN, V75, P274, DOI 10.3109/00016349609047101; VESSEY MP, 1992, BRIT J OBSTET GYNAEC, V99, P402, DOI 10.1111/j.1471-0528.1992.tb13758.x	5	13	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1579	1579		10.1136/bmj.320.7249.1579	http://dx.doi.org/10.1136/bmj.320.7249.1579			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324PW	10845967	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000087631400023
J	Castelo-Branco, M; Goebel, R; Neuenschwander, S; Singer, W				Castelo-Branco, M; Goebel, R; Neuenschwander, S; Singer, W			Neural synchrony correlates with surface segregation rules	NATURE			English	Article							CAT VISUAL-CORTEX; NEURONAL RESPONSES; MOTION PERCEPTION; PLAID PATTERNS; COHERENCE; ORGANIZATION; TRANSPARENCY; ORIENTATION; NUCLEUS	To analyse an image, the visual system must decompose the scene into its relevant parts. Identifying distinct surfaces is a basic operation in such analysis, and is believed to precede object recognition(1,2). Two superimposed gratings moving in different directions (plaid stimuli) may be perceived either as two surfaces, one being transparent and sliding on top of the other (component motion) or as a single pattern whose direction of motion is intermediate to the component vectors (pattern motion)(3-6). The degree of transparency, and hence the perception, can be manipulated by changing only the luminance of the grating intersections(7-12). Here we show that neurons in two visual cortical areas-A18 and PMLS-synchronize their discharges when responding to contours of the same surface but not when responding to contours belonging to different surfaces. The amplitudes of responses correspond to previously described rate predictions(3,13-16) for component and pattern motion, but, in contrast to synchrony, failed to reflect the transition from component to pattern motion induced by manipulating the degree of transparency. Thus, dynamic changes in synchronization could encode, in a context-dependent way, relations among simultaneous responses to spatially superimposed contours and thereby bias their association with distinct surfaces.	Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany	Max Planck Society	Singer, W (corresponding author), Max Planck Inst Hirnforsch, Deutschordenstr 46, D-60528 Frankfurt, Germany.	singer@mpih-frankfurt.mpg.de	Castelo-Branco, Miguel/E-5689-2010; Singer, Wolf/D-6874-2012; Castelo-Branco, Miguel/F-3866-2019	Castelo-Branco, Miguel/0000-0003-4364-6373; NEUENSCHWANDER, Sergio/0000-0001-7493-121X				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; BATSCHELET E, 1993, CIRCULAR STAT BIOL; BECK J, 1988, PERCEPT PSYCHOPHYS, V44, P585, DOI 10.3758/BF03207492; Brecht M., 1997, Society for Neuroscience Abstracts, V23, P843; Brecht M, 1998, J NEUROPHYSIOL, V79, P2394, DOI 10.1152/jn.1998.79.5.2394; Castelo-Branco M., 1997, Society for Neuroscience Abstracts, V23, P460; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Edwards A. L., 1985, MULTIPLE REGRESSION; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Freiwald WA, 1995, NEUROREPORT, V6, P2348, DOI 10.1097/00001756-199511270-00018; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Merabet L, 1998, NATURE, V396, P265, DOI 10.1038/24382; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; MOVSHON JA, 1985, STUDY GROUP PATTERN; PALMER LA, 1978, J COMP NEUROL, V177, P237, DOI 10.1002/cne.901770205; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Scannell JW, 1996, J NEUROPHYSIOL, V76, P895, DOI 10.1152/jn.1996.76.2.895; SHIMOJO S, 1988, NATURE, V333, P265, DOI 10.1038/333265a0; SMITH AT, 1991, EXP BRAIN RES, V86, P324; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Stoner GR, 1998, VISION RES, V38, P387, DOI 10.1016/S0042-6989(97)00132-6; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Stoner GR, 1996, VISION RES, V36, P1291, DOI 10.1016/0042-6989(95)00195-6; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411	29	119	121	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					685	689		10.1038/35015079	http://dx.doi.org/10.1038/35015079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864325				2022-12-28	WOS:000087465800047
J	Fine, J; Duff, J; Chen, R; Hutchison, W; Lozano, AM; Lang, AE				Fine, J; Duff, J; Chen, R; Hutchison, W; Lozano, AM; Lang, AE			Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS; POSTEROVENTRAL PALLIDOTOMY; STEREOTAXIC PALLIDOTOMY; MEDIAL PALLIDOTOMY; GPI PALLIDOTOMY; LOCATION	Background: Although the short-term benefits of posteroventral pallidotomy for patients with advanced Parkinson's disease have been well documented, little is known about the long-term outcome of the procedure. Methods: We conducted a long-term follow-up study of a cohort of 40 patients who had undergone unilateral posteroventral medial pallidotomy between 1993 and 1996. Twenty patients were not evaluated because they had undergone a second surgical procedure (11 patients) or had died (2) or because they had dementia or another debilitating illness (4), lived too far away (1), or had been lost to follow-up (2). We conducted serial postoperative assessments of parkinsonism in the remaining 20 patients while they were taking medications ("on'' period) and after overnight withdrawal of the drugs ("off" period). The mean follow-up time was 52 months (range, 41 to 64). Results: The combined off-period score for activities of daily living and motor function on the Unified Parkinson's Disease Rating Scale was 18.0 percent better at the last evaluation than at base line (95 percent confidence interval, 4.9 to 31.0 percent; P=0.01). Significant improvements were also evident in the off-period scores for contralateral tremor (65.4 percent improvement, P=0.007), rigidity (43.2 percent, P=0.03), and bradykinesia (18.2 percent, P=0.04) and in the on-period score for contralateral dyskinesia (70.6 percent, P<0.001). Changes in medication did not contribute to the sustained improvement. The 20 patients who could not be included in the long-term analysis had similar base-line characteristics but a worse response to surgery at six months. Conclusions: In the group of patients with advanced Parkinson's disease who could be enrolled in our long-term follow-up study of unilateral posteroventral medial pallidotomy (20 patients from the original cohort of 40), significant early improvements in off-period contralateral signs of parkinsonism were sustained for up to 5 1/2 years. There was a sustained significant improvement in on-period contralateral dyskinesia but not in other on-period signs of parkinsonism. (N Engl J Med 2000;342:1708-14.) (C) 2000, Massachusetts Medical Society.	Univ Toronto, Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Dept Med,Div Neurol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lang, AE (corresponding author), Univ Toronto, Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Dept Med,Div Neurol, 399 Bathurst St,MP 11-306, Toronto, ON M5T 2S8, Canada.		Lozano, Andres M/A-5058-2012; Lang, Anthony/ABF-8114-2021; Chen, Robert/B-3899-2009	Chen, Robert/0000-0002-8371-8629; Hutchison, William/0000-0002-3866-4940; Lang, Anthony/0000-0003-1229-3667; Lozano, Andres M./0000-0001-8257-3694				Baron MS, 1996, ANN NEUROL, V40, P355, DOI 10.1002/ana.410400305; Burchiel KJ, 1999, NEUROSURGERY, V45, P1375, DOI 10.1097/00006123-199912000-00024; Fazzini E, 1997, NEUROLOGY, V48, P1273, DOI 10.1212/WNL.48.5.1273; Galvez-Jimenez N, 1998, CAN J NEUROL SCI, V25, P300, DOI 10.1017/S0317167100034314; GALVEZJIMENEZ N, 1996, MOVEMENT DISORD, V11, P242; Goetz CG, 1999, NEUROLOGY, V52, P1227, DOI 10.1212/WNL.52.6.1227; GOETZ CG, 1994, MOVEMENT DISORD, V9, P390, DOI 10.1002/mds.870090403; Gross RE, 1999, BRAIN, V122, P405, DOI 10.1093/brain/122.3.405; Krack P, 1997, ANN NEUROL, V42, P129, DOI 10.1002/ana.410420122; Kumar R, 1998, MOVEMENT DISORD, V13, P73; Kumar R, 1998, NEUROLOGY, V51, P850, DOI 10.1212/WNL.51.3.850; LAITINEN LV, 1992, J NEUROSURG, V76, P53, DOI 10.3171/jns.1992.76.1.0053; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lang AE, 1997, NEW ENGL J MED, V337, P1036, DOI 10.1056/NEJM199710093371503; LANG AE, 1998, MOV DISORD S2, V13, P263; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Limousin P, 1999, J NEUROL NEUROSUR PS, V66, P289, DOI 10.1136/jnnp.66.3.289; Lozano A, 1996, J NEUROSURG, V84, P194, DOI 10.3171/jns.1996.84.2.0194; LOZANO AM, 1995, LANCET, V346, P1383, DOI 10.1016/S0140-6736(95)92404-3; LOZANO AM, 1996, LANCET, V348, P1108; Samii A, 1999, BRAIN, V122, P417, DOI 10.1093/brain/122.3.417; Samuel M, 1998, BRAIN, V121, P59, DOI 10.1093/brain/121.1.59; Shannon KM, 1998, NEUROLOGY, V50, P434, DOI 10.1212/WNL.50.2.434; Uitti RJ, 1997, NEUROLOGY, V49, P1072, DOI 10.1212/WNL.49.4.1072; Verhagen Leo, 1996, Neurology, V46, pA416; Volkmann J, 1998, ANN NEUROL, V44, P953, DOI 10.1002/ana.410440615	27	162	168	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1708	1714		10.1056/NEJM200006083422304	http://dx.doi.org/10.1056/NEJM200006083422304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841873				2022-12-28	WOS:000087449300004
J	Blume, S; Geesink, I				Blume, S; Geesink, I			A brief history of polio vaccines	SCIENCE			English	Article									Univ Amsterdam, Fac Social Sci, Amsterdam, Netherlands	University of Amsterdam	Blume, S (corresponding author), Univ Amsterdam, Fac Social Sci, Amsterdam, Netherlands.								0	38	38	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1593	1594		10.1126/science.288.5471.1593	http://dx.doi.org/10.1126/science.288.5471.1593			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10858138				2022-12-28	WOS:000087382300023
J	Newman, M				Newman, M			Applied mathematics - The power of design	NATURE			English	Editorial Material									Santa Fe Inst, Santa Fe, NM 87501 USA	The Santa Fe Institute	Newman, M (corresponding author), Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA.							BAK P, 1989, NATURE, V342, P780, DOI 10.1038/342780a0; Carlson JM, 1999, PHYS REV E, V60, P1412, DOI 10.1103/PhysRevE.60.1412; Carlson JM, 2000, PHYS REV LETT, V84, P2529, DOI 10.1103/PhysRevLett.84.2529; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Neukum G., 1994, HAZARDS DUE COMETS A, P359; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Willis J.C., 1922, AGE AREA; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	9	31	33	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					412	413		10.1038/35013189	http://dx.doi.org/10.1038/35013189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839524				2022-12-28	WOS:000087212000031
J	Vidale, JE; Dodge, DA; Earle, PS				Vidale, JE; Dodge, DA; Earle, PS			Slow differential rotation of the Earth's inner core indicated by temporal changes in scattering	NATURE			English	Article							MODEL	The finding that the Earth's inner core might be rotating faster than the mantle(1) has important implications for our understanding of core processes, including the generation of the Earth's magnetic field(2,3). But the reported signal is subtle-a change of about 0.01 s per year in the separation of two seismic waves with differing paths through the core. Subsequent studies of such data have generally supported the conclusion that differential rotation exists(4-6), but the difficulty of accurately locating historic earthquakes(7) and possible biases induced by strong lateral variations in structure near the core-mantle boundary(8) have raised doubt regarding the proposed inner-core motion(9). Also, a study of free oscillations(10) constrained the motion to be relatively small compared to previous estimates and it has been proposed that the interaction of inner-core boundary topography and mantle heterogeneity might lock the inner core to the mantle(11). The recent detection of seismic waves scattered in the inner core(12) suggests a simple test of inner-core motion. Here we compare scattered waves recorded in Montana, USA, from two closely located nuclear tests at Novaya Zemlya, USSR, in 1971 and 1974. The data show small but coherent changes in scattering which point toward an inner-core differential rotation rate of 0.15 degrees per year-consistent with constraints imposed by the free-oscillation data(10).	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Lawrence Livermore Natl Lab, Div Geophys, Livermore, CA 94550 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Vidale, JE (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	vidale@ucla.edu	Vidale, John/H-4965-2011	Vidale, John/0000-0002-3658-818X				BHATTACHARYYA J, 1993, GEOPHYS J INT, V114, P1, DOI 10.1111/j.1365-246X.1993.tb01461.x; Breger L, 1998, SCIENCE, V282, P718, DOI 10.1126/science.282.5389.718; Buffett BA, 1997, NATURE, V388, P571, DOI 10.1038/41534; CAPON J, 1970, B SEISMOL SOC AM, V60, P1701; Creager KC, 1997, SCIENCE, V278, P1284, DOI 10.1126/science.278.5341.1284; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Earle PS, 1998, GEOPHYS RES LETT, V25, P405, DOI 10.1029/97GL53365; ENGDAHL ER, 1971, J GEOPHYS RES, V76, P2706, DOI 10.1029/JB076i011p02706; GLATZMAIER GA, 1995, NATURE, V377, P203, DOI 10.1038/377203a0; GREEN PE, 1965, PR INST ELECTR ELECT, V53, P1821, DOI 10.1109/PROC.1965.4453; HADDON RAW, 1977, PHYS EARTH PLANET IN, V14, P41, DOI 10.1016/0031-9201(77)90045-0; Kuang WL, 1997, NATURE, V389, P371, DOI 10.1038/38712; Laske G, 1999, NATURE, V402, P66, DOI 10.1038/47011; MARSHALL PD, 1994, O294 AT WEAP EST; Poupinet G, 2000, PHYS EARTH PLANET IN, V118, P77, DOI 10.1016/S0031-9201(99)00129-6; Song XD, 2000, J GEOPHYS RES-SOL EA, V105, P7931, DOI 10.1029/1999JB900436; Song XD, 2000, J GEOPHYS RES-SOL EA, V105, P623, DOI 10.1029/1999JB900341; Song XD, 1996, NATURE, V382, P221, DOI 10.1038/382221a0; Souriau A, 1997, GEOPHYS RES LETT, V24, P2103, DOI 10.1029/97GL01933; Vidale JE, 2000, NATURE, V404, P273, DOI 10.1038/35005059	20	81	82	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					445	448		10.1038/35013039	http://dx.doi.org/10.1038/35013039			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839537				2022-12-28	WOS:000087212000045
J	Rainey, PB; Moxon, ER				Rainey, PB; Moxon, ER			Microbiology - When being hyper keeps you fit	SCIENCE			English	Editorial Material							PSEUDOMONAS-AERUGINOSA; ADAPTIVE EVOLUTION; CYSTIC-FIBROSIS; BACTERIA		Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England	University of Oxford; University of Oxford	Rainey, PB (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.		Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795				de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; JACOB F, 1989, LOGIC LIFE, P308; MARTIN C, 1995, J CLIN MICROBIOL, V33, P1461, DOI 10.1128/JCM.33.6.1461-1466.1995; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Stearns SC, 1999, EVOLUTION IN HEALTH AND DISEASE, P3; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696	10	12	12	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1186	1187		10.1126/science.288.5469.1186	http://dx.doi.org/10.1126/science.288.5469.1186			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10841739				2022-12-28	WOS:000087112600032
J	Travers, KJ; Patil, CK; Wodicka, L; Lockhart, DJ; Weissman, JS; Walter, P				Travers, KJ; Patil, CK; Wodicka, L; Lockhart, DJ; Weissman, JS; Walter, P			Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; UBIQUITIN-PROTEASOME PATHWAY; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; SECRETORY PATHWAY; YEAST; NUCLEUS; KINASE; EXPRESSION	The unfolded protein response (UPR) regulates gene expression in response to stress in the endoplasmic reticulum (ER). We determined the transcriptional scope of the UPR using DNA microarrays. Rather than regulating only ER-resident chaperones and phospholipid biosynthesis, as anticipated from earlier work, the UPR affects multiple ER and secretory pathway functions. Studies of UPR targets engaged in ER-associated protein degradation (ERAD) reveal an intimate coordination between these responses: efficient ERAD requires an intact UPR, and UPR induction increases ERAD capacity. Conversely, loss of ERAD leads to constitutive UPR induction. Finally, simultaneous loss of ERAD and the UPR greatly decreases cell viability. Thus, the UPR and ERAD are dynamic responses required for the coordinated disposal of misfolded proteins even in the absence of acute stress.	Univ Calif San Francisco, Dept Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Affymetrix Inc, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Affymetrix	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular Pharmacol, San Francisco, CA 94143 USA.	jsw1@itsa.ucsf.edu; walter@cgl.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Boisrame A, 1999, MOL GEN GENET, V261, P601; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Doerrler WT, 1999, P NATL ACAD SCI USA, V96, P13050, DOI 10.1073/pnas.96.23.13050; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	43	1509	1548	6	152	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					249	258		10.1016/S0092-8674(00)80835-1	http://dx.doi.org/10.1016/S0092-8674(00)80835-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847680	Bronze			2022-12-28	WOS:000086741900005
J	Whittle, M				Whittle, M			Is it time to abandon cardiotocographic ECG analysis?	LANCET			English	Editorial Material							ST		Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham B15 2TG, W Midlands, England	Birmingham Women's Hospital	Whittle, M (corresponding author), Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham B15 2TG, W Midlands, England.							GAFFNEY G, 1994, ARCH DIS CHILD-FETAL, V70, pF101, DOI 10.1136/fn.70.2.F101; GREENE KR, 1982, AM J OBSTET GYNECOL, V144, P950, DOI 10.1016/0002-9378(82)90190-9; KEITH RDF, 1995, BRIT J OBSTET GYNAEC, V102, P688, DOI 10.1111/j.1471-0528.1995.tb11425.x; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; *MAT CHILD CONS, 1997, CONF ENQ STILLB DEAT; WESTGATE J, 1993, AM J OBSTET GYNECOL, V169, P1151, DOI 10.1016/0002-9378(93)90273-L	6	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					422	422						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841116				2022-12-28	WOS:000085306800002
J	Andersen, AMN; Wohlfahrt, J; Christens, P; Olsen, J; Melbye, M				Andersen, AMN; Wohlfahrt, J; Christens, P; Olsen, J; Melbye, M			Maternal age and fetal loss: population based register Linkage study	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; ECTOPIC PREGNANCY; RISK-FACTORS; DEATH; RATES	Objective To estimate the association between maternal age and fetal death (spontaneous abortion, ectopic pregnancy, stillbirth), taking into account a woman's reproductive history. Design Prospective register linkage study. Subjects All women with a reproductive outcome (live birth, stillbirth, spontaneous abortion leading to admission to hospital, induced abortion, ectopic pregnancy, or hydatidiform mole) in Denmark from 1978 to 1992; a total of 634 272 women and 1 221 546 pregnancy outcomes. Main outcome measures Age related risk of fetal loss, ectopic pregnancy, and stillbirth, and age related risk of spontaneous abortion stratified according to parity and previous spontaneous abortions. Results Overall, 13.5% of the pregnancies intended to be carried to term ended with fetal loss. At age 42 years, more than half of such pregnancies resulted in fetal loss. The risk of a spontaneous abortion was 8.9% in women aged 20-24 years and 74.7% in those aged 45 years or more. High maternal age was a significant risk factor for spontaneous abortion irrespective of the number of previous miscarriages, parity, or calendar period. The risk of an ectopic pregnancy and stillbirth also increased with increasing maternal age. Conclusions Fetal loss in high in women in their late 30s or older; irrespective of reproductive history. This should be taken into consideration in pregnancy planning and counselling.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; Aarhus Univ, Inst Epidemiol & Social Med, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark	Aarhus University; Statens Serum Institut; Aarhus University	Andersen, AMN (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.		Nybo Andersen, Anne-Marie/AAA-1997-2022; Andersen, Anne-Marie Nybo/E-4993-2013	Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Andersen, Anne-Marie Nybo/0000-0002-4296-8488; melbye, mads/0000-0001-8264-6785				ALBERMAN E, 1987, SPONTANEOUS RECURREN; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; CANO F, 1995, FERTIL STERIL, V64, P584, DOI 10.1016/S0015-0282(16)57797-8; Christiansen OB, 1997, DAN MED BULL, V44, P396; COSTE J, 1991, HUM REPROD, V6, P1332, DOI 10.1093/oxfordjournals.humrep.a137535; Egger M, 1998, BRIT MED J, V316, P1776, DOI 10.1136/bmj.316.7147.1776; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; HAKIM RB, 1995, AM J OBSTET GYNECOL, V172, P1510, DOI 10.1016/0002-9378(95)90489-1; HARLAP S, 1980, HUMAN EMBRYONIC FOCT; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HEIDAM LZ, 1985, SCAND J SOC MED, V13, P159, DOI 10.1177/140349488501300406; Kline J, 1989, CONCEPTION BIRTH EPI, P43; Kline J., 1984, PERINATAL EPIDEMIOLO; Makinen J, 1998, AM J EPIDEMIOL, V148, P369; NAYLOR AF, 1979, FERTIL STERIL, V31, P282; PETITTI DB, 1987, CLIN OBSTET GYNECOL, V30, P253, DOI 10.1097/00003081-198706000-00004; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; RISCH HA, 1988, AM J EPIDEMIOL, V128, P420, DOI 10.1093/oxfordjournals.aje.a114982; SOEGAARD P, 1996, UGESKRIFT LAEGER, V158, P759; SOERENSEN JL, 1992, UGESKRIFT LAEGER, V154, P3053; WARBURTON D, 1964, AM J HUM GENET, V16, P1; Westergaard T, 1997, BMJ-BRIT MED J, V314, P775, DOI 10.1136/bmj.314.7083.775; WILCOX AJ, 1982, EARLY HUM DEV, V7, P165, DOI 10.1016/0378-3782(82)90135-9	24	956	984	1	51	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1708	1712		10.1136/bmj.320.7251.1708	http://dx.doi.org/10.1136/bmj.320.7251.1708			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864550	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000087926400026
J	Smith, R				Smith, R			The BMJ, spin, and the stockmarket	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1737	1737		10.1136/bmj.320.7251.1737	http://dx.doi.org/10.1136/bmj.320.7251.1737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864559	Green Published			2022-12-28	WOS:000087926400056
J	Walba, DM; Korblova, E; Shao, R; Maclennan, JE; Link, DR; Glaser, MA; Clark, NA				Walba, DM; Korblova, E; Shao, R; Maclennan, JE; Link, DR; Glaser, MA; Clark, NA			A ferroelectric liquid crystal conglomerate composed of racemic molecules	SCIENCE			English	Article								We describe the design and synthesis of a ferroelectric liquid crystal composed of racemic molecules. The ferroelectric polarization results from spontaneous polar symmetry breaking in a fluid smectic. The ferroelectric phase is also chiral, resulting in the formation of a mixture of macroscopic domains of either handedness at the isotropic-to-liquid crystal phase transition. This smectic liquid crystal is thus a fluid conglomerate. Detailed investigation of the electrooptic and polarization current behavior within individual domains in liquid crystal cells shows the thermodynamically stable structure to be a uniformly tilted smectic bow-phase (banana phase), with all layer pairs homochiral and ferroelectric (SmCSPF).	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Colorado, Ferroelect Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Walba, DM (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.		Maclennan, Joseph E/A-9836-2013; Clark, Noel A./E-9011-2010; Korblova, Eva/AAC-3502-2021; Walba, David/F-7284-2013; Clark, Noel A/AAP-9116-2020; Glaser, Matthew/H-2345-2016	Maclennan, Joseph E/0000-0002-3587-554X; Clark, Noel A./0000-0001-9301-5540; Korblova, Eva/0000-0002-3818-4373; Glaser, Matthew/0000-0002-8366-5598				Brand HR, 1998, EUR PHYS J B, V6, P347, DOI 10.1007/s100510050560; Bustamante EAS, 1996, LIQ CRYST, V21, P829, DOI 10.1080/02678299608032899; CHANDANI ADL, 1989, JPN J APPL PHYS 2, V28, pL1265, DOI 10.1143/JJAP.28.L1265; CLADIS PE, 1993, LIQ CRYST, V14, P1327, DOI 10.1080/02678299308026446; CLARK NA, 1980, APPL PHYS LETT, V36, P899, DOI 10.1063/1.91359; Heppke G, 1998, SCIENCE, V279, P1872, DOI 10.1126/science.279.5358.1872; HEPPKE G, 1999, 7 INT C FERR LIQ CRY, P202; Jakli A, 1998, PHYS REV E, V57, P6737, DOI 10.1103/PhysRevE.57.6737; Link DR, 1997, SCIENCE, V278, P1924, DOI 10.1126/science.278.5345.1924; Macdonald R, 1998, PHYS REV LETT, V81, P4408, DOI 10.1103/PhysRevLett.81.4408; Meyer R. B., 1975, J PHYS LETT-PARIS, V36, P69; MEYER RB, 1974, 5 INT LIQ CRYST C ST; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; NITO K, 1995, LIQ CRYST, V19, P653, DOI 10.1080/02678299508031080; Pelzl G, 1999, LIQ CRYST, V26, P135, DOI 10.1080/026782999205641; Pelzl G, 1999, ADV MATER, V11, P707, DOI 10.1002/(SICI)1521-4095(199906)11:9<707::AID-ADMA707>3.0.CO;2-D; SATO Y, 1989, JPN J APPL PHYS 2, V28, pL483, DOI 10.1143/JJAP.28.L483	17	320	321	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2181	2184		10.1126/science.288.5474.2181	http://dx.doi.org/10.1126/science.288.5474.2181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864861				2022-12-28	WOS:000087782900065
J	Neumann, PJ; Stone, PW; Chapman, RH; Sandberg, EA; Bell, CM				Neumann, PJ; Stone, PW; Chapman, RH; Sandberg, EA; Bell, CM			The quality of reporting in published cost-utility analyses, 1976-1997	ANNALS OF INTERNAL MEDICINE			English	Article							ECONOMIC-EVALUATION; MEDICAL LITERATURE; CLINICAL-PRACTICE; USERS GUIDES; GUIDELINES; HEALTH; POLICY; RECOMMENDATIONS; INTERVENTIONS; SUBMISSIONS	Purpose: Cost-utility analysis is a type of cost-effectiveness analysis in which health effects are measured in terms of quality-adjusted life-years (QALYs) gained. Such analyses have become popular for examining the health and economic consequences of health and medical interventions, and they have been recommended by leaders in the field. These recommendations emphasize the importance of good reporting practices. This study determined 1) the quality of reporting in published cost-utility analyses through 1997 and 2) whether reporting practices have improved over time. We examined quality of reporting by journal type and number of cost-utility analyses a journal has published. Data Sources: Computerized databases were searched through 1997 for the Medical Subject Headings or text keywords quality-adjusted, QALY, and cost-utility analysis. Published bibliographies of the field were also searched. Study Selection: Original cost-utility analyses written in English were included. Cost-effectiveness analyses that measured health effects in units other than QALYs and review, editorial, or methodologic articles were excluded. Data Extraction: Each of the 228 articles found was audited independently by two trained readers who used a standard data collection form to determine the quality of reporting in several categories: disclosure of funding, framing, reporting of costs, reporting of preference weights, reporting of results, and discussion. Results: The number of cost-utility analyses in the medical literature increased greatly between 1976 and 1997. Analyses covered a wide range of diseases and interventions. Most studies listed modeling assumptions (82%), described the comparator intervention (83%), reported sensitivity analysis (89%), and noted study limitations (84%). Only 52% clearly stated the study perspective; 34% did not disclose the funding source. Methods of reporting costs and preference weights varied widely. The quality of published analyses improved slightly over time and was higher in general clinical journals and in journals that published more of these analyses. Conclusions: The study results reveal an active and evolving field but also underscore the need for more consistency and clarity in reporting. Better peer review and independent, third-party audits may help in this regard. Future investigations should examine the quality of clinical and economic assumptions used in cost-utility analyses, in addition to whether analysts followed recommended protocols for performance and reporting.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Rochester, Rochester, NY USA; Univ Toronto, Toronto, ON, Canada	Harvard University; Harvard T.H. Chan School of Public Health; University of Rochester; University of Toronto	Neumann, PJ (corresponding author), Harvard Univ, Sch Publ Hlth, 718 Huntington Ave,2nd Floor, Boston, MA 02115 USA.	pneumann@hsph.harvard.edu	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469				ADAMS ME, 1992, MED CARE, V30, P231, DOI 10.1097/00005650-199203000-00005; Balas EA, 1998, JAMA-J AM MED ASSOC, V279, P54, DOI 10.1001/jama.279.1.54; Blackmore CC, 1997, RADIOLOGY, V203, P87, DOI 10.1148/radiology.203.1.9122421; BRIGGS A, 1995, HEALTH ECON, V4, P355, DOI 10.1002/hec.4730040502; BROWN ML, 1993, BREAST CANCER RES TR, V25, P113, DOI 10.1007/BF00662136; COX DR, 1992, J ROY STAT SOC A STA, V155, P353, DOI 10.2307/2982889; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 1997, JAMA-J AM MED ASSOC, V277, P1552, DOI 10.1001/jama.277.19.1552; Drummond MF, 2015, METHODS EC EVALUATIO; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; ELIXHAUSER A, 1993, MED CARE, V31, pJS1, DOI 10.1097/00005650-199307001-00001; ELIXHAUSER A, 1998, MED CARE S, V36, p7S1; Elstein AS, 1997, MED DECIS MAKING, V17, P497; EVANS RG, 1995, ANN INTERN MED, V123, P59, DOI 10.7326/0003-4819-123-1-199507010-00010; Gerard K, 1999, HEALTH POLICY, V46, P217, DOI 10.1016/S0168-8510(98)00061-X; GERARD K, 1992, HEALTH POLICY, V21, P249, DOI 10.1016/0168-8510(92)90022-4; Gold MR, 1996, COST EFFECTIVENESS H; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; HILLMAN AL, 1995, ANN INTERN MED, V123, P61; Jefferson T, 1998, JAMA-J AM MED ASSOC, V280, P275, DOI 10.1001/jama.280.3.275; KASSIRER JP, 1994, NEW ENGL J MED, V331, P669, DOI 10.1056/NEJM199409083311009; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luce BR, 1996, HEALTH AFFAIR, V15, P168, DOI 10.1377/hlthaff.15.4.168; MASON JM, 1994, PHARMACOECONOMICS, V5, P472, DOI 10.2165/00019053-199405060-00004; MEHREZ A, 1993, MED DECIS MAKING, V13, P287, DOI 10.1177/0272989X9301300404; Menon D, 1996, MED CARE, V34, pDS77; Mitchell A, 1996, MED CARE, V34, pDS216; Neumann PJ, 1998, MED DECIS MAKING, V18, pS23, DOI 10.1177/0272989X98018002S05; Neumann PJ, 1997, MED DECIS MAKING, V17, P402, DOI 10.1177/0272989X9701700405; Neumann PJ, 1996, HEALTH AFFAIR, V15, P54, DOI 10.1377/hlthaff.15.3.54; Nord E, 1993, Int J Technol Assess Health Care, V9, P37; OBrien BJ, 1997, JAMA-J AM MED ASSOC, V277, P1802; *OHE BRIEF, 1998, HLTH EC EV DAT TREND; Paltiel AD, 1997, PHARMACOECONOMICS, V12, P297, DOI 10.2165/00019053-199712030-00001; Reinhardt UE, 1997, SOC SCI MED, V45, P555, DOI 10.1016/S0277-9536(96)00396-6; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Torrance GW, 1987, METHODS EC EVALUATIO; Ubel PA, 1996, MED DECIS MAKING, V16, P108, DOI 10.1177/0272989X9601600202; UDVARHELYI IS, 1992, ANN INTERN MED, V116, P238, DOI 10.7326/0003-4819-116-3-238; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304	44	162	167	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					964	972		10.7326/0003-4819-132-12-200006200-00007	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	325HU	10858180				2022-12-28	WOS:000087670800006
J	Seto, TB; Taira, DA; Berezin, R; Chauhan, MS; Cutlip, DE; Ho, KKL; Kuntz, RE; Cohen, DJ				Seto, TB; Taira, DA; Berezin, R; Chauhan, MS; Cutlip, DE; Ho, KKL; Kuntz, RE; Cohen, DJ			Percutaneous coronary revascularization in elderly patients: Impact on functional status and quality of life	ANNALS OF INTERNAL MEDICINE			English	Article							ARTERY DISEASE; ANGIOPLASTY; HEALTH	Background: Percutaneous coronary intervention (PCI) is frequently performed in elderly patients, but little is known about its impact on overall health and quality of life. Objective: To examine changes in health-related quality of life among elderly patients after PCI. Design: Observational study. Setting: 75 U.S. hospitals. Patients: Participants in two clinical trials of PCI. Measurements: Health-related quality of life was assessed by using the Medical Outcomes Study Short Form (SF-36) survey and the Seattle Angina Questionnaire at baseline, 6 months, and 1 year. Results: Serial data on health-related quality of life were available for 295 elderly (greater than or equal to 70 years) and 1150 nonelderly (<70 years) patients. At 6 months, physical health had improved in 51% of elderly patients and mental health had improved in 29%. Cardiovascular-specific health status had improved in 58% to 75% of elderly patients. Improvement did not significantly differ between elderly and non-elderly patients at 6 months or 1 year. Conclusions: Elderly patients selected for participation in a trial of PCI had substantial improvements in health-related quality of life after PCI that were similar to those in younger patients.	Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Hawaii Med Serv Assoc, Queens Med Ctr, Honolulu, HI USA; Univ Hawaii, Sch Med, Honolulu, HI 96822 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Rochester; The Queen's Medical Center; University of Hawaii System	Cohen, DJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Cardiovasc, 330 Brookline Ave, Boston, MA 02215 USA.							Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Baim DS, 1998, CIRCULATION, V97, P322; BAIM DS, 1997, CIRCULATION S1, V96, P1; Chamberlain DA, 1997, LANCET, V350, P461; De Gregorio J, 1998, J AM COLL CARDIOL, V32, P577, DOI 10.1016/S0735-1097(98)00287-3; DEMARIS A, 1992, LOGIT MODELING PRACT, P43; Hardin JW, 1999, STATA TECHNICAL B, V50, P21; Krumholz HM, 1996, MED CARE, V34, P754, DOI 10.1097/00005650-199608000-00003; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MOCK MB, 1984, AM J CARDIOL, V53, pC89, DOI 10.1016/0002-9149(84)90754-9; PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102; Phillips R C, 1992, J Heart Valve Dis, V1, P42; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; TSEVAT J, 1991, CIRCULATION, V83, P1194, DOI 10.1161/01.CIR.83.4.1194; Ware J.E, 1994, PHYS MENTAL HLTH SUM	17	60	66	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					955	958		10.7326/0003-4819-132-12-200006200-00005	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858178				2022-12-28	WOS:000087670800004
J	Hammond, CJ; Snieder, H; Spector, TD; Gilbert, CE				Hammond, CJ; Snieder, H; Spector, TD; Gilbert, CE			Genetic and environmental factors in age-related nuclear cataracts in monozygotic and dizygotic twins.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-RESISTANCE SYNDROME; GRADING SYSTEM; CLASSIFICATION; HERITABILITY; WOMEN; EYE	Background: Age-related cataracts are a major public health problem. The relative importance of genes and environment in the causation of nuclear cataracts, the most common form of age-related cataracts, is not known. Methods: We studied 506 pairs of female twins (226 monozygotic and 280 dizygotic) who were 50 to 79 years old (mean, 62). The amount of nuclear cataract in the right and left eyes was determined objectively by analysis of Scheimpflug lens photographs (yielding three measures) and subjectively with use of the Oxford Clinical Cataract Classification and Grading System (yielding one measure). All eight measures (four in each eye) were subsequently combined in one summary measure of nuclear cataract for each woman. A univariate maximum-likelihood model was used to estimate the variance of the genetic and environmental contributions to each of the measures. Results: The different measures of cataract formation were highly correlated (correlation coefficients, 0.71 to 0.94). The mean scores were similar for the right and left eyes and for monozygotic and dizygotic twins. Quantitative genetic modeling of each of the nuclear-cataract scores invariably resulted in a best-fitting model that involved additive genetic effects, unique environmental effects, and age. The common environmental and dominant genetic effects could be removed from the models without significant loss of fit. The overall heritability in the combined nuclear-cataract score (the proportion of the variance explained by genetic factors) was 48 percent (95 percent confidence interval, 42 to 54 percent); age accounted for 38 percent of the variance (95 percent confidence interval, 31 to 44 percent) and unique environmental effects for 14 percent (95 percent confidence interval, 12 to 18 percent). Conclusions: Genetic effects are important even in such a clearly age-related disease as nuclear cataract, explaining almost 50 percent of the variation in the severity of this disease. (N Engl J Med 2000;342:1786-90.) (C)2000, Massachusetts Medical Society.	St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England; Inst Ophthalmol, Dept Prevent Ophthalmol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Hammond, CJ (corresponding author), St Thomas Hosp, Twin Res & Genet Epidemiol Unit, Lambeth Palace Rd, London SE1 7EH, England.		Spector, Tim D/F-6533-2012					BAILEY IL, 1991, INVEST OPHTH VIS SCI, V32, P422; Boomsma D I, 1998, Twin Res, V1, P34, DOI 10.1375/136905298320566465; CHRISTIAN JC, 1999, ADV TWIN SIB PAIR AN, P103; Chylack L T Jr, 1995, Ophthalmic Epidemiol, V2, P59, DOI 10.3109/09286589509057085; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; DATILES MB, 1995, BRIT J OPHTHALMOL, V79, P527, DOI 10.1136/bjo.79.6.527; DOLIN P, 1998, EPIDEMIOLOGY EYE DIS, P103; EDWARDS KL, 1994, ARTERIOSCLER THROMB, V14, P1940, DOI 10.1161/01.ATV.14.12.1940; Edwards KL, 1997, GENET EPIDEMIOL, V14, P241, DOI 10.1002/(SICI)1098-2272(1997)14:3<241::AID-GEPI3>3.0.CO;2-8; Foster A, 1999, EYE, V13, P449, DOI 10.1038/eye.1999.120; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Hall A B, 1997, Ophthalmic Epidemiol, V4, P179; HARRIS M L, 1991, Eye (London), V5, P487; HEIBA IM, 1993, AM J MED GENET, V47, P1208, DOI 10.1002/ajmg.1320470816; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; Klein B E, 1997, Ophthalmic Epidemiol, V4, P175; Klopp N, 1998, GENOMICS, V52, P152, DOI 10.1006/geno.1998.5417; KYVIK KO, 1999, ADV TWIN SIBPAIR ANA, P67; Livingston P M, 1995, Ophthalmic Epidemiol, V2, P151, DOI 10.3109/09286589509057097; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; MARTIN NG, 1975, ANN HUM GENET, V39, P213, DOI 10.1111/j.1469-1809.1975.tb00124.x; MULLERBREITENKAMP U, 1992, OPHTHALMIC RES, V24, P47; Neale MC, 1992, METHODOLOGY GENETIC; NEALE MC, 1997, MX STAT MODELING; Snieder H, 1997, PSYCHOPHYSIOLOGY, V34, P317, DOI 10.1111/j.1469-8986.1997.tb02402.x; SNIEDER H, 1999, ADV TWIN SIBPAIR ANA, P119; SPARROW JM, 1990, EYE, V4, P638, DOI 10.1038/eye.1990.89; SPARROW JM, 1986, INT OPHTHALMOL, V9, P207, DOI 10.1007/BF00137534; SPARROW JM, 1988, INT OPHTHALMOL, V11, P151, DOI 10.1007/BF00130616; *STAT, 1997, INT STAT WIND 95 VER; Steele EC, 1998, CURR EYE RES, V17, P883, DOI 10.1076/ceyr.17.9.883.5144; TABACHNICK BG, 1996, USING MULTIVARIATE S, P635; WHO (World Health Organization), 1998, WORLD HLTH REP 1998; Winchester CL, 1999, HUM MOL GENET, V8, P481, DOI 10.1093/hmg/8.3.481	34	182	187	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1786	1790		10.1056/NEJM200006153422404	http://dx.doi.org/10.1056/NEJM200006153422404			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853001	Bronze			2022-12-28	WOS:000087573700004
J	Davidson, K; Smith, N				Davidson, K; Smith, N			Astronomy - A massive cool dust torus around eta Carinae?	NATURE			English	Article									Univ Minnesota, Dept Astron, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Davidson, K (corresponding author), Univ Minnesota, Dept Astron, 116 Church St SE, Minneapolis, MN 55455 USA.							Davidson K, 1997, ANNU REV ASTRON ASTR, V35, P1, DOI 10.1146/annurev.astro.35.1.1; HACKWELL JA, 1986, ASTROPHYS J, V311, P380, DOI 10.1086/164779; HYLAND AR, 1979, ASTROPHYS J, V233, P145, DOI 10.1086/157376; MITCHELL RM, 1983, ASTROPHYS J, V271, P133, DOI 10.1086/161182; Morris PW, 1999, NATURE, V402, P502, DOI 10.1038/990048; Polomski E, 1999, ASTR SOC P, V179, P41; RIGAUT F, 1995, REV MEX AST ASTR, V2, P27; SMITH CH, 1995, MON NOT R ASTRON SOC, V273, P354, DOI 10.1093/mnras/273.2.354; Smith N, 1998, ASTRON J, V116, P1332, DOI 10.1086/300501	9	10	10	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					532	532		10.1038/35014740	http://dx.doi.org/10.1038/35014740			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850704	Bronze			2022-12-28	WOS:000087449500039
J	Sikes, EL; Samson, CR; Guilderson, TP; Howard, WR				Sikes, EL; Samson, CR; Guilderson, TP; Howard, WR			Old radiocarbon ages in the southwest Pacific Ocean during the last glacial period and deglaciation	NATURE			English	Article							DEEP-WATER; SOUTHERN-OCEAN; YOUNGER DRYAS; NEW-ZEALAND; CIRCULATION; CLIMATE; RECORDS; TEPHRA; EVENT	Marine radiocarbon (C-14) dates are widely used for dating oceanic events and as tracers of ocean circulation, essential components for understanding ocean-climate interactions. Past ocean ventilation rates have been determined by the difference between radiocarbon ages of deep-water and surface-water reservoirs, but the apparent age of surface waters (currently similar to 400 years in the tropics and similar to 1,200 years in Antarctic waters(1)) might not be constant through time(2), as has been assumed in radiocarbon chronologies(3,4) and palaeoclimate studies(5). Here we present independent estimates of surface-water and deep-water reservoir ages in the New Zealand region since the last glacial period, using volcanic ejecta (tephras) deposited in both marine and terrestrial sediments as stratigraphic markers. Compared to present-day values, surface-reservoir ages from 11,900 C-14 years ago were twice as large (800 years) and during glacial times were five times as large (2,000 years), contradicting the assumption of constant surface age. Furthermore, the ages of glacial deepwater reservoirs were much older (3,000-5,000 years). The increase in surface-to-deep water age differences in the glacial Southern Ocean suggests that there was decreased ocean ventilation during this period.	Univ Auckland, Sch Environm & Marine Sci, Auckland 1, New Zealand; Univ Auckland, Dept Geol, Auckland 1, New Zealand; Antarctic Cooperat Res Ctr, Hobart, Tas, Australia; Univ Tasmania, Inst Antarctic & So Ocean Studies, Hobart, Tas 7001, Australia; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	University of Auckland; University of Auckland; University of Tasmania; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Harvard University	Sikes, EL (corresponding author), Univ Auckland, Sch Environm & Marine Sci, Private Bag 92019, Auckland 1, New Zealand.	e.sikes@auckland.ac.nz		Sikes, Elisabeth/0000-0003-2900-3283				Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; Blunier T, 1997, GEOPHYS RES LETT, V24, P2683, DOI 10.1029/97GL02658; Broecker WS, 1990, GLOBAL BIOGEOCHEM CY, V4, P103, DOI 10.1029/GB004i001p00103; CARTER L, 1995, NEW ZEAL J GEOL GEOP, V38, P29, DOI 10.1080/00288306.1995.9514637; CHARLES CD, 1992, NATURE, V355, P416, DOI 10.1038/355416a0; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; EDWARDS RL, 1993, SCIENCE, V260, P962, DOI 10.1126/science.260.5110.962; FAIRBANKS RG, 1980, SCIENCE, V207, P61, DOI 10.1126/science.207.4426.61; Finkel RC, 1997, J GEOPHYS RES-OCEANS, V102, P26699, DOI 10.1029/97JC01282; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; FROGGATT PC, 1990, NEW ZEAL J GEOL GEOP, V33, P89, DOI 10.1080/00288306.1990.10427576; Guyodo Y, 1996, EARTH PLANET SC LETT, V143, P23, DOI 10.1016/0012-821X(96)00121-5; Higham TFG, 1995, RADIOCARBON, V37, P409, DOI 10.1017/S0033822200030885; HOWARD WR, 1994, PALEOCEANOGRAPHY, V9, P453, DOI 10.1029/93PA03524; Hughen KA, 1996, NATURE, V380, P51, DOI 10.1038/380051a0; Kitagawa H, 1998, RADIOCARBON, V40, P505; KOHN BP, 1978, NEW ZEAL J GEOL GEOP, V21, P49, DOI 10.1080/00288306.1978.10420721; LEA DW, 1995, PALEOCEANOGRAPHY, V10, P733, DOI 10.1029/95PA01546; McCorkle DC, 1998, PALEOCEANOGRAPHY, V13, P20, DOI 10.1029/97PA02305; OSTLUND HG, 1980, RADIOCARBON, V22, P25, DOI 10.1017/S0033822200004707; Rosenthal Y, 1997, PALEOCEANOGRAPHY, V12, P787, DOI 10.1029/97PA02508; SHACKLETON NJ, 1988, NATURE, V335, P708, DOI 10.1038/335708a0; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Stocker TF, 1996, PALEOCEANOGRAPHY, V11, P773, DOI 10.1029/96PA02640; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; Weaver PPE, 1997, PALAEOGEOGR PALAEOCL, V131, P241, DOI 10.1016/S0031-0182(97)00005-9; WRIGHT IC, 1995, QUATERNARY RES, V44, P283, DOI 10.1006/qres.1995.1073; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	31	233	236	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					555	559		10.1038/35014581	http://dx.doi.org/10.1038/35014581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850711				2022-12-28	WOS:000087449500046
J	Simmons, NA; Gurrola, H				Simmons, NA; Gurrola, H			Multiple seismic discontinuities near the base of the transition zone in the Earth's mantle	NATURE			English	Article							660 KM DISCONTINUITY; RECEIVER FUNCTIONS; BENEATH; TEMPERATURE; VELOCITY; SLOPES; JOIN	The seismologically defined boundary between the transition zone in the Earth's mantle (410-660 km depth) and the underlying lower mantle is generally interpreted to result from the breakdown of the gamma-spinel phase of olivine(1) to magnesium-perovskite and magnesiowustite(2). Laboratory measurements of these transformations of olivine have determined that the phase boundary has a negative Clapeyron slope and does indeed occur near pressures corresponding to the base of the transition zone(2,3). But a computational study has indicated that, because of the presence of garnet minerals, multiple seismic discontinuities might exist near a depth of 660 km (ref. 4), which would alter the simple negative correlation of changes in temperature with changes in the depth of the phase boundary. In particular, garnet minerals undergo exothermic transformations near this depth, acting to complicate the phase relations(5-9) and possibly effecting mantle convection processes in some regions(9). Here we present seismic evidence that supports the existence of such multiple transitions near a depth of 660 km beneath southern California. The observations are consistent with having been generated by garnet transformations coupling with the dissociation of the gamma-spinel phase of olivine. Temperature anomalies calculated from the imaged discontinuity depths-using Clapeyron slopes determined for the various transformations(4)-generally match those predicted from an independent P-wave velocity model of the region.	Texas Tech Univ, Dept Geosci, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Gurrola, H (corresponding author), Texas Tech Univ, Dept Geosci, Lubbock, TX 79409 USA.		Simmons, Nathan Alan/J-9022-2014	Simmons, Nathan/0000-0002-1560-059X				AMMON CJ, 1991, B SEISMOL SOC AM, V81, P2504; ANDERSON DL, 1989, THEORY EARTH; BINA CR, 1994, J GEOPHYS RES-SOL EA, V99, P15853, DOI 10.1029/94JB00462; Dueker KG, 1998, J GEOPHYS RES-SOL EA, V103, P7153, DOI 10.1029/97JB03509; Gasparik T, 1997, PHYS EARTH PLANET IN, V100, P197, DOI 10.1016/S0031-9201(96)03240-2; GASPARIK T, 1992, CONTRIB MINERAL PETR, V111, P283, DOI 10.1007/BF00311192; Gasparik T, 1996, CONTRIB MINERAL PETR, V124, P139, DOI 10.1007/s004100050181; Gurrola H, 1998, GEOPHYS J INT, V133, P31, DOI 10.1046/j.1365-246X.1998.1331470.x; HERZBERG C, 1991, J GEOPHYS RES-SOL EA, V96, P16263, DOI 10.1029/91JB01481; ITO E, 1990, SCIENCE, V249, P1275, DOI 10.1126/science.249.4974.1275; ITO E, 1989, J GEOPHYS RES-SOLID, V94, P10637, DOI 10.1029/JB094iB08p10637; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; Li AB, 1998, NATURE, V395, P160, DOI 10.1038/25972; Niu FL, 1996, J PHYS EARTH, V44, P701, DOI 10.4294/jpe1952.44.701; Owens TJ, 2000, GEOPHYS RES LETT, V27, P827, DOI 10.1029/1999GL005429; OWENS TJ, 1984, J GEOPHYS RES, V89, P7783, DOI 10.1029/JB089iB09p07783; REVENAUGH J, 1991, J GEOPHYS RES-SOL EA, V96, P19763, DOI 10.1029/91JB01486; Ringerberg QS, 1987, CLIN THER, V9, P1; RINGWOOD AE, 1994, PHYS EARTH PLANET IN, V86, P5, DOI 10.1016/0031-9201(94)05058-9; Shearer PM, 1999, SCIENCE, V285, P1545, DOI 10.1126/science.285.5433.1545; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P14835, DOI 10.1029/97JB00550; Vacher P, 1998, PHYS EARTH PLANET IN, V106, P275, DOI 10.1016/S0031-9201(98)00076-4; vanderLee S, 1997, J GEOPHYS RES-SOL EA, V102, P22815, DOI 10.1029/97JB01168; Weidner DJ, 1998, J GEOPHYS RES-SOL EA, V103, P7431, DOI 10.1029/97JB03511	24	105	107	1	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					559	562		10.1038/35014589	http://dx.doi.org/10.1038/35014589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850712				2022-12-28	WOS:000087449500047
J	Dalmay, T; Hamilton, A; Rudd, S; Angell, S; Baulcombe, DC				Dalmay, T; Hamilton, A; Rudd, S; Angell, S; Baulcombe, DC			An RNA-Dependent RNA polymerase gene in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; NEUROSPORA-CRASSA; CHALCONE SYNTHASE; ANTISENSE RNA; C-ELEGANS; PLANTS; DNA; INTERFERENCE; SUPPRESSION	Posttranscriptional gene silencing is a defense mechanism in plants that is similar to quelling in fungi and RNA interference in animals. Here, we describe four genetic loci that are required for posttranscriptional gene silencing in Arabidopsis. One of these, SDE1, is a plant homolog of QDE-1 in Neurospora crassa that encodes an RNA-dependent RNA polymerase. The sde1 mutation was specific for posttranscriptional gene silencing induced by transgenes rather than by viruses. We propose that the role of SDE1 is to synthesize a double-stranded RNA initiator of posttranscriptional gene silencing. According to this idea, when a virus induces posttranscriptional gene silencing, the virus-encoded RNA polymerase would produce the double-stranded RNA and SDE1 would be redundant.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; John Innes Ctr Plant Sci Res, Dept Virus Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@bbsrc.ac.uk	Dalmay, Tamas/E-1377-2011; Rudd, Stephen A/A-6434-2013	Dalmay, Tamas/0000-0003-1492-5429; Rudd, Stephen A/0000-0002-0344-7487; Baulcombe, David/0000-0003-0780-6878				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; DEHIO C, 1994, P NATL ACAD SCI USA, V91, P5538, DOI 10.1073/pnas.91.12.5538; DOROKHOV YL, 1994, FEBS LETT, V350, P5, DOI 10.1016/0014-5793(94)00721-7; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hamilton AJ, 1998, PLANT J, V15, P737, DOI 10.1046/j.1365-313X.1998.00251.x; HAMILTON WDO, 1989, J GEN VIROL, V70, P963, DOI 10.1099/0022-1317-70-4-963; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stam M, 1998, MOL CELL BIOL, V18, P6165, DOI 10.1128/MCB.18.11.6165; Stam M, 1997, PLANT J, V12, P63, DOI 10.1046/j.1365-313X.1997.12010063.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 1999, TRENDS PLANT SCI, V4, P452, DOI 10.1016/S1360-1385(99)01493-4; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	44	796	914	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					543	553		10.1016/S0092-8674(00)80864-8	http://dx.doi.org/10.1016/S0092-8674(00)80864-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850496	Bronze			2022-12-28	WOS:000087375400011
J	Mori, K				Mori, K			Tripartite management of unfolded proteins in the endoplasmic reticulum	CELL			English	Review							SIGNALING PATHWAY; STRESS; IDENTIFICATION		Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan	Kyoto University	Mori, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan.		Mori, Kazutoshi/K-6106-2015					Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Gething MJ, 2000, NAT CELL BIOL, V2, pE21, DOI 10.1038/35000090; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	20	765	797	3	44	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					451	454		10.1016/S0092-8674(00)80855-7	http://dx.doi.org/10.1016/S0092-8674(00)80855-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850487	Bronze			2022-12-28	WOS:000087375400002
J	Collinson, PO; Premachandram, S; Hashemi, K				Collinson, PO; Premachandram, S; Hashemi, K			Prospective audit of incidence of prognostically important myocardial damage in patients discharged from emergency department	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC TROPONIN-T; CHEST PAIN; RISK STRATIFICATION; UNSTABLE ANGINA; EARLY DIAGNOSIS; INFARCTION; MULTICENTER; ADMISSION; DISEASE	Objective To assess the incidence of prognostically important myocardial damage in patients with chest pain discharged from the emergency department. Design Prospective observational study. Setting District general hospital emergency department. Participants 110 patients presenting with chest pain of unknown cause who were subsequently discharged home after cardiac causes of chest pain were ruled out by clinical and electrocardiographic investigation. Interventions Patients were reviewed 12-48 hours after presentation by repeat electrocardiography and measurement of cardiac troponin T. Main outcome measures Incidence of missed myocardial damage. Results Eight (7%) patients had detectable cardiac troponin T on review and seven had concentrations greater than or equal to 0.1 mu g/l. The repeat electrocardiogram showed no abnormality in any patient. Conclusion 6% of the patients discharged from the emergency department had missed prognostically important myocardial damage. Follow up measurement of cardiac troponin T allows convenient audit of clinical performance in the emergency department.	Mayday Univ Hosp, Dept Chem Pathol, Croydon CR7 7YE, England; Mayday Univ Hosp, Dept Accid & Emergency Med, Croydon, England	Croydon University Hospital; Croydon University Hospital	Collinson, PO (corresponding author), St George Hosp, Dept Clin Biochem, 2nd Floor,Jenner Wing, London SW17 0QT, England.							APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BAKKER AJ, 1993, LANCET, V342, P1220, DOI 10.1016/0140-6736(93)92192-V; BRUSH JE, 1985, NEW ENGL J MED, V312, P1137, DOI 10.1056/NEJM198505023121801; COLLINSON PO, 1993, ANN CLIN BIOCHEM, V30, P11, DOI 10.1177/000456329303000102; COLLINSON PO, 1995, ANN CLIN BIOCHEM, V32, P450, DOI 10.1177/000456329503200503; Collinson PO, 1996, ANN CLIN BIOCHEM, V33, P308, DOI 10.1177/000456329603300405; EMERSON PA, 1989, Q J MED, V70, P213; GIBLER WB, 1995, ANN EMERG MED, V25, P1, DOI 10.1016/S0196-0644(95)70347-0; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; KARCZ A, 1993, ANN EMERG MED, V22, P553, DOI 10.1016/S0196-0644(05)81941-9; LEE TH, 1991, NEW ENGL J MED, V324, P1239, DOI 10.1056/NEJM199105023241803; LEE TH, 1987, AM J CARDIOL, V60, P220; LINDAHL B, 1995, CORONARY ARTERY DIS, V6, P321, DOI 10.1097/00019501-199504000-00009; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; MCCARTHY BD, 1993, ANN EMERG MED, V22, P579, DOI 10.1016/S0196-0644(05)81945-6; MCQUEEN MJ, 1983, AM HEART J, V105, P258, DOI 10.1016/0002-8703(83)90524-0; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Stubbs P, 1996, BRIT MED J, V313, P262, DOI 10.1136/bmj.313.7052.262; SULLIVAN DJ, 1996, ED LEGAL LETT, V7, P45; YUSUF S, 1984, EUR HEART J, V5, P690, DOI 10.1093/oxfordjournals.eurheartj.a061728; ZARLING EJ, 1983, JAMA-J AM MED ASSOC, V250, P1177	24	96	97	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1702	1704		10.1136/bmj.320.7251.1702	http://dx.doi.org/10.1136/bmj.320.7251.1702			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864545	Green Published, Bronze			2022-12-28	WOS:000087926400022
J	Schiff, R; Rajkumar, C; Bulpitt, C				Schiff, R; Rajkumar, C; Bulpitt, C			Views of elderly people on living wills: interview study	BRITISH MEDICAL JOURNAL			English	Article									Hammersmith Hosp, Sch Med, Imperial Coll, London W12 0NN, England	Imperial College London	Schiff, R (corresponding author), Hammersmith Hosp, Sch Med, Imperial Coll, London W12 0NN, England.							ADSHEAD F, 1992, BRIT MED J, V305, P397, DOI 10.1136/bmj.305.6850.397; Elder N C, 1992, J Am Board Fam Pract, V5, P565; GAMBLE ER, 1991, ARCH INTERN MED, V151, P277, DOI 10.1001/archinte.151.2.277; SOMMERVILLE A, 1995, ADV STATEMENTS MED T	4	52	56	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1640	1641		10.1136/bmj.320.7250.1640	http://dx.doi.org/10.1136/bmj.320.7250.1640			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856065	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000087734200023
J	Raftery, J				Raftery, J			Economics notes - Costing in economic evaluation	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Birmingham B15 2RT, W Midlands, England	University of Birmingham	Raftery, J (corresponding author), Univ Birmingham, Hlth Econ Facil, Birmingham B15 2RT, W Midlands, England.							Byford S, 1998, BRIT MED J, V316, P1529, DOI 10.1136/bmj.316.7143.1529; Gold MR, 1996, COST EFFECTIVENESS H; NETTERS AD, UNIT COSTS COMMUNITY; *NHS EX, 1999, NEW NHS 1999 REF COS; *NHS EX, 1999, NHS COST MAN; Raftery J, 1999, J Health Serv Res Policy, V4, P63	6	48	48	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1597	1597		10.1136/bmj.320.7249.1597	http://dx.doi.org/10.1136/bmj.320.7249.1597			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845978	Green Published			2022-12-28	WOS:000087631400030
J	Szabo, R; Short, RV				Szabo, R; Short, RV			How does male circumcision protect against HIV infection?	BRITISH MEDICAL JOURNAL			English	Article							SEXUALLY-TRANSMITTED DISEASES; SIMIAN-IMMUNODEFICIENCY-VIRUS; LANGERHANS CELLS; RHESUS-MACAQUES		Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Melbourne, Vic 3053, Australia; Monash Univ, Fac Med, Melbourne, Vic 3168, Australia	University of Melbourne; Monash University	Short, RV (corresponding author), Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, 132 Grattan St, Melbourne, Vic 3053, Australia.							BARRETO J, 1997, HISTOLOGY PATHOLOGIS; COOK LS, 1994, AM J PUBLIC HEALTH, V84, P197, DOI 10.2105/AJPH.84.2.197; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; *JOINT UN PROGR HI, 1996, HIV AIDS SIT MID 199; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Miller CJ, 1998, J REPROD IMMUNOL, V41, P331, DOI 10.1016/S0165-0378(98)00069-2; Morris Brian, 1999, FAVOUR CIRCUMCISION; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	16	183	188	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1592	1594		10.1136/bmj.320.7249.1592	http://dx.doi.org/10.1136/bmj.320.7249.1592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845974	Green Published			2022-12-28	WOS:000087631400028
J	te Velde, ER; Eijkemans, R; Habbema, HDF				te Velde, ER; Eijkemans, R; Habbema, HDF			Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction	LANCET			English	Editorial Material							QUALITY; SEMEN		Univ Utrecht, Med Ctr, Div Obstet & Gynaecol, Dept Fertil & Endocrinol, NL-3508 TC Utrecht, Netherlands; Erasmus Univ, Dept Publ Hlth, Rotterdam, Netherlands	Utrecht University; Erasmus University Rotterdam	te Velde, ER (corresponding author), Univ Utrecht, Med Ctr, Div Obstet & Gynaecol, Dept Fertil & Endocrinol, NL-3508 TC Utrecht, Netherlands.							AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; BAIRD DD, 1986, AM J EPIDEMIOL, V124, P470, DOI 10.1093/oxfordjournals.aje.a114417; Bonde J.P., 1995, REPROD MED REV, V4, P59; BONGAARTS J, 1975, DEMOGRAPHY, V12, P645, DOI 10.2307/2060719; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; DECOCK J, 1994, OCCUP ENVIRON MED, V51, P693, DOI 10.1136/oem.51.10.693; GREENHALL E, 1990, FERTIL STERIL, V54, P978; LERIDON H, 1984, FERTIL STERIL, V41, P580; Leridon H., 1977, HUMAN FERTILITY BASI; SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E	10	77	78	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1928	1929		10.1016/S0140-6736(00)02320-5	http://dx.doi.org/10.1016/S0140-6736(00)02320-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859034				2022-12-28	WOS:000087381900005
J	Bassing, CH; Alt, FW; Hughes, MM; D'Auteuil, M; Wehrly, TD; Woodman, BB; Gartner, F; White, JM; Davidson, L; Sleckman, BP				Bassing, CH; Alt, FW; Hughes, MM; D'Auteuil, M; Wehrly, TD; Woodman, BB; Gartner, F; White, JM; Davidson, L; Sleckman, BP			Recombination signal sequences restrict chromosomal V(D)J recombination beyond the 12/23 rule	NATURE			English	Article							MEDIATE RECOMBINATION; T-CELLS; BETA; GENE; REARRANGEMENT; CHAIN; DIFFERENTIATION; INITIATION; SEGMENTS; PROMOTER	The genes encoding the variable regions of lymphocyte antigen receptors are assembled from variable (V), diversity (D) and joining (J) gene segments(1), V(D)J recombination is initiated by the recombinase activating gene (RAG)-1 and -2 proteins, which introduce DNA double-strand breaks between the V, D and J segments and their flanking recombination signal sequences (RSSs), Generally expressed DNA repair proteins then carry out the joining reaction(2,3), The conserved heptamer and nonamer sequences of the RSSs are separated by non-conserved spacers of 12 or 23 base pairs (forming 12-RSSs and 23-RSSs). The 12/23 rule, which is mediated at the level of RAG-1/2 recognition and cutting(4,5), specifies that V(D)J recombination occurs only between a gene segment flanked by a 12-RSS and one flanked by a 23-RSS1, V beta segments are appended to DJ beta rearrangements, with little or no direct V beta to J beta joining, despite 12/23 compatibility of V beta 23-RSSs and J beta 12-RSSs(6,7). Here we use embryonic stem cells and mice with a modified T-cell receptor (TCR)beta locus containing only one D beta (D beta 1) gene segment and one J beta (J beta 1) gene cluster to show that the 5' D beta 1 12-RSS, but not the J beta 1 12-RSSs, targets rearrangement of a diverse V beta repertoire, This targeting is precise and position-independent. This additional restriction on V(D)J recombination has important implications for the regulation of variable region gene assembly and repertoire development.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA	Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	sleckman@immunology.WUSTL.edu		White, James Michael/0000-0001-5110-6567				AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CONNOR AM, 1995, J IMMUNOL, V155, P5268; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Doty RT, 1999, BLOOD, V93, P3017; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GAUSS GH, 1992, GENE DEV, V6, P1553, DOI 10.1101/gad.6.8.1553; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; JOUVINMARCHE E, 1990, EMBO J, V9, P2141, DOI 10.1002/j.1460-2075.1990.tb07383.x; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; SLECKMAN BP, IN PRESS P NATL ACAD; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VanDyk LF, 1996, J IMMUNOL, V157, P4005; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; WEAVER DT, 1995, ADV IMMUNOL, V58, P29, DOI 10.1016/S0065-2776(08)60619-7; WEI Z, 1993, J BIOL CHEM, V268, P3180; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	31	131	139	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					583	586		10.1038/35014635	http://dx.doi.org/10.1038/35014635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850719				2022-12-28	WOS:000087449500054
J	Loder, N				Loder, N			UK labs impeded by old equipment	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					496	496		10.1038/35014760	http://dx.doi.org/10.1038/35014760			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850678	Bronze			2022-12-28	WOS:000087449500005
J	Hambrecht, R; Gielen, S; Linke, A; Fiehn, E; Yu, JT; Walther, C; Schoene, N; Schuler, G				Hambrecht, R; Gielen, S; Linke, A; Fiehn, E; Yu, JT; Walther, C; Schoene, N; Schuler, G			Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIUM-DEPENDENT VASODILATION; MYOCARDIAL-INFARCTION; DYSFUNCTION; CAPACITY	Context Exercise training in patients with chronic heart failure improves work capacity by enhancing endothelial function and skeletal muscle aerobic metabolism, but effects on central hemodynamic function are not well established. Objective To evaluate the effects of exercise training on left ventricular (LV) function and hemodynamic response to exercise in patients with stable chronic heart failure. Design Prospective randomized trial conducted in 1994-1999. Setting University department of cardiology/outpatient clinic in Germany. Patients Consecutive sample of 73 men aged 70 years or younger with chronic heart failure (with LV ejection fraction of approximately 0.27). Intervention Patients were randomly assigned to 2 weeks of in-hospital ergometer exercise for 10 minutes 4 to 6 times per day, followed by 6 months of home-based ergometer exercise training for 20 minutes per day at 70% of peak oxygen uptake (n=36) or to no intervention (control group; n=37). Main Outcome Measures Ergospirometry with measurement of central hemodynamics by thermodilution at rest and during exercise; echocardiographic determination of LV diameters and volumes, at baseline and 6-month follow-up, for the exercise training vs control groups. Results After 6 months, patients in the exercise training group had statistically significant improvements compared with controls in New York Heart Association functional class, maximal ventilation, exercise time, and exercise capacity as well as decreased resting heart rate and increased stroke volume at rest. In the exercise training group, an increase from baseline to 6-month follow-up was observed in mean (SD) resting LV ejection fraction (0.30 [0.08] vs 0.35 [0.09]; P=.003). Mean (SD) total peripheral resistance (TPR) during peak exercise was reduced by 157 (306) dyne/s/cm(-5) in the exercise training group vs an increase of 43 (148) dyne/s/cm-5 in the control group (P=.03), with a concomitant increase in mean (SD) stroke volume of 14 (22) mt vs 1 (19) mL in the control group (P=.03). There was a small but significant reduction in mean (SD) LV end diastolic diameter of 4 (6) mm vs an increase of 1 (4) mm in the control group (P<.001). Changes from baseline in resting TPR for both groups were correlated with changes in stroke volume (r=-0.76; P<.001) and in LV end diastolic diameter (r=0.45; P<.001). Conclusions In patients with stable chronic heart failure, exercise training is associated with reduction of peripheral resistance and results in small but significant improvements in stroke volume and reduction in cardiomegaly.	Univ Leipzig, Kardiol Klin, Herzzentrum GmbH, D-7010 Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University	Hambrecht, R (corresponding author), Univ Leipzig, Herzzentrum Gmbh, Klin Innere Med Kardiol, Russenstr 19, D-04289 Leipzig, Germany.							ADAMOPOULOS S, 1993, J AM COLL CARDIOL, V21, P1101, DOI 10.1016/0735-1097(93)90231-O; BELARDINELLI R, 1995, CIRCULATION, V91, P2775, DOI 10.1161/01.CIR.91.11.2775; Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173; COATS AJS, 1992, CIRCULATION, V85, P2119, DOI 10.1161/01.CIR.85.6.2119; COATS AJS, 1990, LANCET, V335, P63, DOI 10.1016/0140-6736(90)90536-E; Demopoulos L, 1997, J AM COLL CARDIOL, V29, P597, DOI 10.1016/S0735-1097(96)00526-8; Dubach P, 1997, CIRCULATION, V95, P2060, DOI 10.1161/01.CIR.95.8.2060; Giannuzzi P, 1997, CIRCULATION, V96, P1790, DOI 10.1161/01.CIR.96.6.1790; Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6; Hambrecht R, 1998, CIRCULATION, V98, P2709, DOI 10.1161/01.CIR.98.24.2709; HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B; Hornig B, 1996, CIRCULATION, V93, P210, DOI 10.1161/01.CIR.93.2.210; JUGDUTT BI, 1988, J AM COLL CARDIOL, V12, P362, DOI 10.1016/0735-1097(88)90407-X; Katz SD, 1997, J APPL PHYSIOL, V82, P1488, DOI 10.1152/jappl.1997.82.5.1488; Katz SD, 1996, J AM COLL CARDIOL, V28, P585, DOI 10.1016/0735-1097(96)00204-5; KUBO SH, 1991, CIRCULATION, V84, P1589, DOI 10.1161/01.CIR.84.4.1589; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SULLIVAN MJ, 1988, CIRCULATION, V78, P506, DOI 10.1161/01.CIR.78.3.506; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; WEICKER H, 1986, LAB MED, V33, P122; Wilson JR, 1996, CIRCULATION, V94, P1567, DOI 10.1161/01.CIR.94.7.1567	21	461	483	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3095	3101		10.1001/jama.283.23.3095	http://dx.doi.org/10.1001/jama.283.23.3095			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865304	Bronze			2022-12-28	WOS:000087574900034
J	Luz, B; Barkan, E				Luz, B; Barkan, E			Assessment of oceanic productivity with the triple-isotope composition of dissolved oxygen	SCIENCE			English	Article							FRACTIONATION; RESPIRATION; MECHANISMS; BALANCE; BERMUDA; CARBON	Plant production in the sea is a primary mechanism of global oxygen formation and carbon fixation, For this reason, and also because the ocean is a major sink for fossil fuel carbon dioxide, much attention has been given to estimating marine primary production. Here, we describe an approach for estimating production of photosynthetic oxygen, based on the isotopic composition of dissolved oxygen of seawater. This method allows the estimation of integrated oceanic productivity on a time scale of weeks.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Luz, B (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.							Barber RT, 1996, DEEP-SEA RES PT II, V43, P933, DOI 10.1016/0967-0645(96)00035-5; BENDER M, 1992, DEEP-SEA RES, V39, P1707, DOI 10.1016/0198-0149(92)90025-O; BENDER M, 1987, LIMNOL OCEANOGR, V32, P1085, DOI 10.4319/lo.1987.32.5.1085; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; BERHENFELD MJ, 1997, LIMNOL OCEANOGR, V42, P1; Clark J.F., 1995, AIR WATER GAS TRANSF, P785, DOI DOI 10.5281/ZENODO.10571; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CRAIG H, 1987, SCIENCE, V235, P199, DOI 10.1126/science.235.4785.199; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Doney SC, 1996, DEEP-SEA RES PT II, V43, P591, DOI 10.1016/0967-0645(95)00104-2; EMERSON S, 1995, J GEOPHYS RES-OCEANS, V100, P15873, DOI 10.1029/95JC01333; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Luz B, 1999, NATURE, V400, P547, DOI 10.1038/22987; MATSUHISA Y, 1978, GEOCHIM COSMOCHIM AC, V42, P173, DOI 10.1016/0016-7037(78)90130-8; McCarthy JJ, 1999, DEEP-SEA RES PT II, V46, P1623, DOI 10.1016/S0967-0645(99)00038-7; Meijer HAJ, 1998, ISOT ENVIRON HEALT S, V34, P349, DOI 10.1080/10256019808234072; Michaels AF, 1996, DEEP-SEA RES PT II, V43, P157, DOI 10.1016/0967-0645(96)00004-5; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; SPITZER WS, 1989, J MAR RES, V47, P169, DOI 10.1357/002224089785076370; THIEMENS MH, 1995, GEOPHYS RES LETT, V22, P255, DOI 10.1029/94GL02996; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Williams PJL, 1998, NATURE, V394, P55	24	172	177	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2028	2031		10.1126/science.288.5473.2028	http://dx.doi.org/10.1126/science.288.5473.2028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856212				2022-12-28	WOS:000087687000045
J	Sillett, TS; Holmes, RT; Sherry, TW				Sillett, TS; Holmes, RT; Sherry, TW			Impacts of a global climate cycle on population dynamics of a migratory songbird	SCIENCE			English	Article							NINO SOUTHERN OSCILLATION; EL; CALIFORNIA; PATTERNS; BIRDS	Progress toward understanding factors that Limit abundances of migratory birds, including climate change, has been difficult because these species move between diverse Locations, often on different continents. For black-throated blue warblers (Dendroica caerulescens), demographic rates in both tropical winter quarters and north temperate breeding grounds varied with fluctuations in the El Nino Southern Oscillation. Adult survival and fecundity were Lower in El Nino years and higher in La Nina years. Fecundity, in turn, was positively correlated with subsequent recruitment of new individuals into winter and breeding populations. These findings demonstrate that migratory birds can be affected by shifts in global climate patterns and emphasize the need to know how events throughout the annual cycle interact to determine population size.	Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA	Dartmouth College; Tulane University	Sillett, TS (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.		Sillett, Scott/N-2240-2017	Sillett, Scott/0000-0002-7486-0076				Ainley DG, 1996, MAR ECOL PROG SER, V137, P1, DOI 10.3354/meps137001; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Grant P.R., 1999, RECOGNITION STATES L, V2; HOLMES RT, 1994, BIRDS N AM, P1; Jaksic FM, 1997, OIKOS, V78, P341, DOI 10.2307/3546302; Kerr RA, 1999, SCIENCE, V283, P1108, DOI 10.1126/science.283.5405.1108; Kiladis GN, 1989, J CLIMATE, V2, P1069, DOI 10.1175/1520-0442(1989)002<1069:GCAAWE>2.0.CO;2; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Malmgren BA, 1998, J CLIMATE, V11, P2713, DOI 10.1175/1520-0442(1998)011<2713:ENOSOA>2.0.CO;2; Marra PP, 1998, OECOLOGIA, V116, P284, DOI 10.1007/s004420050590; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; NEWTON I, 1998, POPULATION LIMITATIO, P149; Polis GA, 1997, ECOLOGY, V78, P1884; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; RODENHOUSE NL, 1992, ECOLOGY, V73, P357, DOI 10.2307/1938747; Rogers JC, 1988, J CLIMATE, V1, P172, DOI 10.1175/1520-0442(1988)001<0172:PVOTCA>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; RUBENSTEIN DR, 1999, THESIS DARTMOUTH COL; STRONG AM, IN PRESS J ANIM ECOL; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552; Wuethrich B, 2000, SCIENCE, V287, P793, DOI 10.1126/science.287.5454.793	23	383	402	1	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2040	2042		10.1126/science.288.5473.2040	http://dx.doi.org/10.1126/science.288.5473.2040			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856216				2022-12-28	WOS:000087687000049
J	Wessells, H				Wessells, H			Another green world	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					741	741		10.1038/35015636	http://dx.doi.org/10.1038/35015636			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866178	Bronze			2022-12-28	WOS:000087620600025
J	Welch, HG; Schwartz, LM; Woloshin, S				Welch, HG; Schwartz, LM; Woloshin, S			Are increasing 5-year survival rates evidence of success against cancer?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Increased 5-year survival for cancer patients is generally inferred to mean that cancer treatment has improved and that fewer patients die of cancer. Increased 5-year survival, however, may also reflect changes in diagnosis: finding more people with early-stage cancer, including some who would never have become symptomatic from their cancer. Objective To determine the relationship over time between 5-year cancer survival and 2 other measures of cancer burden, mortality and incidence. Design and Setting Using population-based statistics reported by the National Cancer Institute Surveillance, Epidemiology, and End Results Program, we calculated the change in 5-year survival from 1950 to 1995 for the 20 most common solid tumor types. Using the tumor as the unit of analysis, we correlated changes in 5-year survival with changes in mortality and incidence. Main outcome Measure The association between changes in 5-year survival and changes in mortality and incidence measured using simple correlation coefficients (Pearson and Spearman). Results From 1950 to 1995, there was an increase in 5-year survival for each of the 20 tumor types. The absolute increase in 5-year survival ranged from 3% (pancreatic cancer) to 50% (prostate cancer). During the same period, mortality rates declined for 12 types of cancer and increased for the remaining 8 types. There was little correlation between the change in 5-year survival for a specific tumor and the change in tumor-related mortality (Pearson r=.00; Spearman r=-.07). On the other hand, the change in 5-year survival was positively correlated with the change in the tumor incidence rate (Pearson r=+.49; Spearman r=+.37). Conclusion Although 5-year survival is a valid measure for comparing cancer therapies in a randomized trial, our analysis shows that changes in 5-year survival over time bear little relationship to changes in cancer mortality. Instead, they appear primarily related to changing patterns of diagnosis.	Vet Adm Hosp, VA Outcomes Grp, White River Junction, VT USA; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA; Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	VA Outcomes Group; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Welch, HG (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Junction, VT 05009 USA.			Welch, H. Gilbert/0000-0002-3448-1207				BAILAR JC, 1986, NEW ENGL J MED, V314, P1226, DOI 10.1056/NEJM198605083141905; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; KOLATA G, 1999, NY TIMES        1027, pA19; *SEER, 2000, SEER CANC STAT REV 1; SONDIK EJ, 1990, J NATL CANCER I, V82, P825; *US DEPT HHS, 1999, CANC SURV	6	314	317	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2975	2978		10.1001/jama.283.22.2975	http://dx.doi.org/10.1001/jama.283.22.2975			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865276				2022-12-28	WOS:000087480600038
J	Palmer, KT; Walsh, K; Bendall, H; Cooper, C; Coggon, D				Palmer, KT; Walsh, K; Bendall, H; Cooper, C; Coggon, D			Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Hinchingbrooke Hosp, Huntingdon PE18 8NT, England	University of Southampton	Coggon, D (corresponding author), Univ Southampton, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.			Cooper, Cyrus/0000-0003-3510-0709				[Anonymous], WHOLE BODY VIBRATION; Chew CA, 1997, FAM PRACT, V14, P461, DOI 10.1093/fampra/14.6.461; Clinical Standards Advisory Group, 1994, EP REV EP COST BACK; WALSH K, 1992, J EPIDEMIOL COMMUN H, V46, P227, DOI 10.1136/jech.46.3.227	4	131	136	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1577	1578		10.1136/bmj.320.7249.1577	http://dx.doi.org/10.1136/bmj.320.7249.1577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845966	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000087631400022
J	Hasan, MZ; Isaacs, ED; Shen, ZX; Miller, LL; Tsutsui, K; Tohyama, T; Maekawa, S				Hasan, MZ; Isaacs, ED; Shen, ZX; Miller, LL; Tsutsui, K; Tohyama, T; Maekawa, S			Electronic structure of Mott insulators studied by inelastic X-ray scattering	SCIENCE			English	Article							CHARGE-TRANSFER EXCITATIONS; TRANSITION; SUPERCONDUCTORS; SR2CUO2CL2; ND2CUO4; SPECTRA; SYSTEMS; OXIDES	The electronic structure of Mott insulators continues to be a major unsolved problem in physics despite more than 50 years of research. Well-developed momentum-resolved spectroscopies such as photoemission or neutron scattering cannot probe the full Mott gap. High-resolution resonant inelastic x-ray scattering revealed dispersive charge excitations across the Mott gap in a high-critical temperature parent cuprate (Ca2CuO2Cl2), shedding Light on the anisotropy of the Mott gap. These charge excitations across the Mott gap can be described within the framework of the Hubbard model.	Stanford Univ, Stanford Synchrotron Radiat Lab, Dept Appl Phys, Stanford, CA 94305 USA; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford, CA 94305 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Iowa State Univ, Dept Phys, Ames, IA 50011 USA; Iowa State Univ, Ames Lab, Ames, IA 50011 USA; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Alcatel-Lucent; Lucent Technologies; AT&T; Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Tohoku University	Hasan, MZ (corresponding author), Stanford Univ, Stanford Synchrotron Radiat Lab, Dept Appl Phys, Stanford, CA 94305 USA.		HASAN, M. Zahid/D-8237-2012; Maekawa, Sadamichi/J-6194-2018; Tohyma, Takami/F-8212-2018	Maekawa, Sadamichi/0000-0002-4237-7741; Tohyma, Takami/0000-0002-4679-7719				Abbamonte P, 1999, PHYS REV LETT, V83, P860, DOI 10.1103/PhysRevLett.83.860; ANDERSON PW, 1959, PHYS REV, V115, P2, DOI 10.1103/PhysRev.115.2; ANDERSON PW, 1987, SCIENCE, V235, P1996; Hill JP, 1996, PHYS REV LETT, V77, P3665, DOI 10.1103/PhysRevLett.77.3665; Hill JP, 1998, PHYS REV LETT, V80, P4967, DOI 10.1103/PhysRevLett.80.4967; HORSCH P, 1989, PHYSICA C, V162, P783, DOI 10.1016/0921-4534(89)91258-6; HUBBARD J, 1964, PROC R SOC LON SER-A, V277, P237, DOI 10.1098/rspa.1964.0019; Ide T, 1999, J PHYS SOC JPN, V68, P3100, DOI 10.1143/JPSJ.68.3100; Isaacs ED, 1996, PHYS TODAY, V49, P40, DOI 10.1063/1.881488; Isaacs ED, 1996, PHYS REV LETT, V76, P4211, DOI 10.1103/PhysRevLett.76.4211; Kao CC, 1996, PHYS REV B, V54, P16361, DOI 10.1103/PhysRevB.54.16361; Kim C, 1998, PHYS REV LETT, V80, P4245, DOI 10.1103/PhysRevLett.80.4245; LaRosa S, 1997, PHYS REV B, V56, pR525, DOI 10.1103/PhysRevB.56.R525; MILLER LL, 1990, PHYS REV B, V41, P1921, DOI 10.1103/PhysRevB.41.1921; MOTT NF, 1949, P PHYS SOC LOND A, V62, P416, DOI 10.1088/0370-1298/62/7/303; Platzman PM, 1998, PHYS REV B, V57, P11107, DOI 10.1103/PhysRevB.57.11107; ROMBERG H, 1990, PHYS REV B, V42, P8768, DOI 10.1103/PhysRevB.42.8768; Ronning F, 1998, SCIENCE, V282, P2067, DOI 10.1126/science.282.5396.2067; Sette F, 1996, PHYS REV LETT, V77, P83, DOI 10.1103/PhysRevLett.77.83; SHEN ZX, 1995, SCIENCE, V267, P343, DOI 10.1126/science.267.5196.343; SHIRLEY EL, 1996, RAMAN EMISSION XRAY, P51; Simon ME, 1996, PHYS REV B, V54, pR3780, DOI 10.1103/PhysRevB.54.R3780; Tsutsui K, 1999, PHYS REV LETT, V83, P3705, DOI 10.1103/PhysRevLett.83.3705; TSUTSUI K, UNPUB; Wang YY, 1996, PHYS REV LETT, V77, P1809, DOI 10.1103/PhysRevLett.77.1809; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759	27	177	178	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1811	1814		10.1126/science.288.5472.1811	http://dx.doi.org/10.1126/science.288.5472.1811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846160	Green Submitted			2022-12-28	WOS:000087503800046
J	Autumn, K; Liang, YA; Hsieh, ST; Zesch, W; Chan, WP; Kenny, TW; Fearing, R; Full, RJ				Autumn, K; Liang, YA; Hsieh, ST; Zesch, W; Chan, WP; Kenny, TW; Fearing, R; Full, RJ			Adhesive force of a single gecko foot-hair	NATURE			English	Article								Geckos are exceptional in their ability to climb rapidly up smooth vertical surfaces(1-3). Microscopy has shown that a gecko's foot has nearly five hundred thousand keratinous hairs or setae. Each 30-130 mu m long seta is only one-tenth the diameter of a human hair and contains hundreds of projections terminating in 0.2-0.5 mu m spatula-shaped structures(2,4). After nearly a century of anatomical description(2,4-6), here we report the first direct measurements of single setal force by using a two-dimensional micro-electromechanical systems force sensor(7) and a wire as a force gauge. Measurements revealed that a seta is ten times more effective at adhesion than predicted from maximal estimates on whole animals. Adhesive force values support the hypothesis that individual seta operate by van der Waals forces(8,9). The gecko's peculiar behaviour of toe uncurling and peeling(2) led us to discover two aspects of setal function which increase their effectiveness. A unique macroscopic orientation and preloading of the seta increased attachment force 600-fold above that of frictional measurements of the material. Suitably orientated setae reduced the forces necessary to peel the toe by simply detaching above a critical angle with the substratum.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; University of California System; University of California Berkeley	Full, RJ (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.			Fearing, Ronald/0000-0001-6242-5379; Hsieh, Shi-Tong/0000-0003-2233-3327				[Anonymous], 1992, INTERMOLECULAR SURFA; Bellairs, 1970, LIFE REPTILES; Cartmill M., 1985, P73; Chui BW, 1998, APPL PHYS LETT, V72, P1388, DOI 10.1063/1.121064; DELLIT WOLF-DIETRICH, 1934, JENAISCHE ZEITSCHR NATURWISS, V68, P613; GADOW H, 1901, CAMBRIDGE NATURAL HI, V8; Gay C, 1999, PHYS REV LETT, V82, P936, DOI 10.1103/PhysRevLett.82.936; Gennaro JGJ, 1969, NAT HIST, V78, P36; HILLER U, 1968, Zeitschrift fuer Morphologie der Tiere, V62, P307, DOI 10.1007/BF00401561; HILLER U, 1971, Forma et Functio, V4, P240; Hora SL., 1923, J ASIAT SOC BEGAL, V19, P137; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Kinloch A.J., 1987, ADHESION ADHESIVES S; MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0; MAHENDRA BENI CHARAN, 1941, PROC INDIAN ACAD SCI SECT B, V13, P288; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x; Schmidt H.R., 1904, JENA Z NATURW, V39, P551; STORK NE, 1980, J EXP BIOL, V88, P91	19	2021	2178	52	1330	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					681	685		10.1038/35015073	http://dx.doi.org/10.1038/35015073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864324				2022-12-28	WOS:000087465800046
J	Keller, RA; Fisk, MR; White, WM				Keller, RA; Fisk, MR; White, WM			Isotopic evidence for Late Cretaceous plume-ridge interaction at the Hawaiian hotspot	NATURE			English	Article							MANTLE PLUME; TRACE-ELEMENT; NORTH PACIFIC; EVOLUTION; GEOCHEMISTRY; CONSTRAINTS; VOLCANO; ORIGIN; SYSTEM; LAVAS	When a mantle plume interacts with a mid-ocean ridge, both are noticeably affected. The mid-ocean ridge can display anomalously shallow bathymetry, excess volcanism, thickened crust, asymmetric sea-floor spreading and a plume component in the composition of the ridge basalts(1-4). The hotspot-related volcanism can be drawn closer to the ridge, and its geochemical composition can also be affected(3,5-7). Here we present Sr-Nd-Pb isotopic analyses of samples from the next-to-oldest seamount in the Hawaiian hotspot track, the Detroit seamount at 51 degrees N, which show that, 81 Myr ago, the Hawaiian hotspot produced volcanism with an isotopic signature indistinguishable from mid-ocean ridge basalt. This composition is unprecedented in the known volcanism from the Hawaiian hotspot, but is consistent with the interpretation from plate reconstructions(8) that the hotspot was located close to a mid-ocean ridge about 80 Myr ago. As the rising mantle plume encountered the hot, low-viscosity asthenosphere and hot, thin lithosphere near the spreading centre, it appears to have entrained enough of the isotopically depleted upper mantle to overwhelm the chemical characteristics of the plume itself. The Hawaiian hotspot thus joins the growing list of hotspots that have interacted with a rift early in their history.	Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Cornell Univ, Dept Geol Sci, Ithaca, NY 14853 USA	Oregon State University; Cornell University	Keller, RA (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.		White, William M/N-3231-2014	White, William M/0000-0001-9024-7039				CHEN CY, 1985, J GEOPHYS RES-SOLID, V90, P8743, DOI 10.1029/JB090iB10p08743; Clague DA, 1987, VOLCANISM HAWAII, V1350, P5; CLASS C, 1993, NATURE, V362, P715, DOI 10.1038/362715a0; Dalrymple G.B., 1980, INITIAL REPORTS DEEP, V55, P659; DALRYMPLE GB, 1980, INITIAL REPORTS DEEP, V55, P677; FARTNETANI DG, 1995, EARTH PLANET SC LETT, V136, P251; Fisk M.R., 1995, PROC OCEAN DRILL SCI, V145, P333; FISK MR, 1989, GEOLOGY, V17, P934, DOI 10.1130/0091-7613(1989)017<0934:RHMCOT>2.3.CO;2; Garcia MO, 1998, J PETROL, V39, P803, DOI 10.1093/petrology/39.5.803; HANAN BB, 1989, J GEOPHYS RES-SOLID, V94, P7432, DOI 10.1029/JB094iB06p07432; HAURI EH, 1994, J GEOPHYS RES-SOL EA, V99, P24275, DOI 10.1029/94JB01257; Hauri EH, 1996, NATURE, V382, P415, DOI 10.1038/382415a0; ITO G, 1995, GEOLOGY, V23, P657, DOI 10.1130/0091-7613(1995)023<0657:OSCHIC>2.3.CO;2; KINCAID C, 1995, NATURE, V376, P758, DOI 10.1038/376758a0; Kingsley RH, 1998, J GEOPHYS RES-SOL EA, V103, P24159, DOI 10.1029/98JB01496; Lanphere M.A., 1980, INITIAL REPORTS DEEP, V55, P695, DOI [10.2973/dsdp.proc.55.131.1980, DOI 10.2973/DSDP.PROC.55.131.1980]; LONSDALE P, 1993, J GEOPHYS RES-SOL EA, V98, P4081, DOI 10.1029/92JB02452; MAMMERICKX J, 1988, J GEOPHYS RES-SOLID, V93, P3009, DOI 10.1029/JB093iB04p03009; Muller RD, 1998, NATURE, V396, P455, DOI 10.1038/24850; RENKIN ML, 1988, J GEOPHYS RES-SOLID, V93, P2919, DOI 10.1029/JB093iB04p02919; SCHILLING JG, 1973, NATURE, V242, P565, DOI 10.1038/242565a0; UNRUH DM, 1987, HAW VOLC WORK, P260; VERMA SP, 1983, NATURE, V306, P654, DOI 10.1038/306654a0; WEAVER BL, 1991, EARTH PLANET SC LETT, V104, P381, DOI 10.1016/0012-821X(91)90217-6; WEIS D, 1992, GEOPHYS MONOGR SER, V70, P57; WHITE WM, 1993, J GEOPHYS RES-SOL EA, V98, P19533, DOI 10.1029/93JB02018; WHITE WM, 1990, P OCEAN DRILLING PRO, V115, P53, DOI DOI 10.2973/0DP.PR0C.SR.115.131.1990; WOOD DA, 1979, EARTH PLANET SC LETT, V45, P326, DOI 10.1016/0012-821X(79)90133-X	28	60	63	1	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					673	676		10.1038/35015057	http://dx.doi.org/10.1038/35015057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864321				2022-12-28	WOS:000087465800043
J	Lively, CM; Dybdahl, MF				Lively, CM; Dybdahl, MF			Parasite adaptation to locally common host genotypes	NATURE			English	Article							COEVOLUTION; POPULATION; SEX; METAPOPULATION; MAINTENANCE; SELECTION; PATHOGEN; SNAIL; MODEL	According to the Red Queen hypothesis-which states that interactions among species (such as hosts and parasites) lead to constant natural selection for adaptation and counter-adaptation-the disproportionate evolutionary success of parasites on common host genotypes leads to correlated selection for sexual reproduction(1-8) and local adaptation by the parasite population(9-14). Here we determined whether local adaptation is due to disproportionate infection of common host genotypes, and, if so, whether infection of common host genotypes is due to commonness per se, or some other aspect of these genotypes. In a reciprocal cross-inoculation experiment parasites occupying the same geographical area (sympatric) infected locally common host genotypes significantly more often than rare host genotypes, whereas parasites occupying separate geographical areas (allopatric) showed no such significant difference. A mixed source of parasites (containing F-1 hybrids) also showed no difference in infection between rare and common host genotypes. These results show that local adaptation results from parasite tracking of locally common host genotypes, and, as such, a necessary condition of the Red Queen hypothesis is met.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Dybdahl, MF (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.		Dybdahl, Mark/B-8649-2012; Lively, Curtis M/A-8057-2011					BREMERMANN HJ, 1980, J THEOR BIOL, V87, P671, DOI 10.1016/0022-5193(80)90111-3; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI [10.1111/j.1558-5646.1998.tb01833.x, 10.2307/2411236]; Dybdahl MF, 1996, EVOLUTION, V50, P2264, DOI [10.1111/j.1558-5646.1996.tb03615.x, 10.2307/2410696]; DYBDAHL MF, 1995, J EVOLUTION BIOL, V8, P385, DOI 10.1046/j.1420-9101.1995.8030385.x; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; JAENIKE J, 1978, Evolutionary Theory, V3, P191; JUDSON OP, 1995, GENET RES, V65, P175, DOI 10.1017/S0016672300033267; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; NEE S, 1989, J THEOR BIOL, V140, P499, DOI 10.1016/S0022-5193(89)80111-0; NORUSIS MJ, 1990, SPSS ADV STAT USERS; PARKER MA, 1985, EVOLUTION, V39, P713, DOI 10.1111/j.1558-5646.1985.tb00414.x; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; SEGER J, 1988, EVOLUTION SEX, P176	18	378	386	1	221	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					679	681		10.1038/35015069	http://dx.doi.org/10.1038/35015069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864323				2022-12-28	WOS:000087465800045
J	Lindsay, S; Ansell, J; Selman, C; Cox, V; Hamilton, K; Walraven, G				Lindsay, S; Ansell, J; Selman, C; Cox, V; Hamilton, K; Walraven, G			Effect of pregnancy on exposure to malaria mosquitoes	LANCET			English	Article							GAMMA; AREA	Pregnant women attracted twice the number of Anopheles gambiae complex-the predominant African malaria-carrying mosquito-than did their non-pregnant counterparts. We postulate that physiological and behavioural changes that occur during pregnancy are responsible for increased attractiveness, which could be important in intervention strategies aimed at protecting this high-risk group against malaria.	Univ Durham, Dept Biol Sci, Sci Lab, Durham DH1 3LE, England; Univ Aberdeen, Dept Zool, Aberdeen, Scotland	Durham University; University of Aberdeen	Lindsay, S (corresponding author), Univ Durham, Dept Biol Sci, Sci Lab, Durham DH1 3LE, England.		Ansell, Juliet/A-7769-2014	Cox, Valerie/0000-0002-7836-6120; Selman, Colin/0000-0002-8727-0593				Fried M, 1998, J IMMUNOL, V160, P2523; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737	4	129	132	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1972	1972		10.1016/S0140-6736(00)02334-5	http://dx.doi.org/10.1016/S0140-6736(00)02334-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859048				2022-12-28	WOS:000087381900019
J	Elderfield, H; Ganssen, G				Elderfield, H; Ganssen, G			Past temperature and delta O-18 of surface ocean waters inferred from foraminiferal Mg/Ca ratios	NATURE			English	Article							MAGNESIUM; PALEOTEMPERATURE; MG; STRONTIUM; ATLANTIC; CALCITE; SHELLS; PROXY	Determining the past record of temperature and salinity of ocean surface waters is essential for understanding past changes in climate, such as those which occur across glacial-interglacial transitions. As a useful proxy, the oxygen isotope composition (delta(18)O) of calcite from planktonic foraminifera has been shown to reflect both surface temperature and seawater delta(18)O, itself an indicator of global ice volume and salinity(1,2). In addition, magnesium/calcium (Mg/Ca) ratios in foraminiferal calcite show a temperature dependence(3-5) due to the partitioning of Mg during calcification. Here we demonstrate, in a field-based calibration experiment, that the variation of Mg/Ca ratios with temperature is similar for eight species of planktonic foraminifera (when accounting for Mg dissolution effects). Using a multi-species record from the Last Glacial Maximum in the North Atlantic Ocean we found that past temperatures reconstructed from Mg/Ca ratios followed the two other palaeotemperature proxies: faunal abundance(6,7) and alkenone saturation(8). Moreover, combining Mg/Ca and delta(18)O data from the same faunal assemblage, we show that reconstructed surface water delta(18)O from all foraminiferal species record the same glacial-interglacial change-representing changing hydrography and global ice volume. This reinforces the potential of this combined technique in probing past ocean-climate interactions.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Free Univ Amsterdam, Inst Earth Sci, NL-1081 HV Amsterdam, Netherlands	University of Cambridge; Vrije Universiteit Amsterdam	Elderfield, H (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.							Bard E, 1999, SCIENCE, V284, P1133, DOI 10.1126/science.284.5417.1133; Brown SJ, 1996, PALEOCEANOGRAPHY, V11, P543, DOI 10.1029/96PA01491; Chapman MR, 1996, PALEOCEANOGRAPHY, V11, P343, DOI 10.1029/96PA00041; *CLIMAP PROJ MEMB, 1981, GEOLOGICAL SOC AM MA; DELANEY ML, 1985, GEOCHIM COSMOCHIM AC, V49, P1327, DOI 10.1016/0016-7037(85)90284-4; GANSSEN GM, IN PRESS SPECIAL PUB; Hastings DW, 1998, PALEOCEANOGRAPHY, V13, P161, DOI 10.1029/97PA03147; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; NURNBERG D, 1995, J FORAMIN RES, V25, P350; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P135, DOI 10.1029/1999PA000415; Rosenthal Y, 1997, GEOCHIM COSMOCHIM AC, V61, P3633, DOI 10.1016/S0016-7037(97)00181-6; ROSENTHAL Y, 1993, GEOCHIM COSMOCHIM AC, V57, P355; ROSTEK F, 1993, NATURE, V364, P319, DOI 10.1038/364319a0; Schrag D. P., 1996, SCIENCE, V272, P637; Shackleton N.J., 1974, Colloques int Cent natn Res Scient, VNo. 219,1974, P203	21	555	580	5	192	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					442	445		10.1038/35013033	http://dx.doi.org/10.1038/35013033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839536				2022-12-28	WOS:000087212000044
J	Pearson, MA; Reczek, D; Bretscher, A; Karplus, PA				Pearson, MA; Reczek, D; Bretscher, A; Karplus, PA			Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain	CELL			English	Article							NEUROFIBROMATOSIS-2 TUMOR-SUPPRESSOR; F-ACTIN; INTRAMOLECULAR ASSOCIATION; TERMINAL DOMAIN; FAMILY MEMBERS; CELL-ADHESION; EZRIN FAMILY; PTB DOMAINS; IN-VIVO; PHOSPHORYLATION	The ezrin-radixin-moesin (ERM) protein family link actin filaments of cell surface structures to the plasma membrane, using a C-terminal F-actin binding segment and an N-terminal FERM domain, a common membrane binding module. ERM proteins are regulated by an intramolecular association of the FERM and C-terminal tail domains that masks their binding sites. The crystal structure of a dormant moesin FERM/tail complex reveals that the FERM domain has three compact lobes including an integrated PTB/PH/ EVH1 fold, with the C-terminal segment bound as an extended peptide masking a large surface of the FERM domain. This extended binding mode suggests a novel mechanism for how different signals could produce varying levels of activation. Sequence conservation suggests a similar regulation of the tumor suppressor merlin.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Cornell University; Oregon State University	Bretscher, A (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	apb5@cornell.edu; karplusp@ucs.orst.edu		Karplus, Paul/0000-0001-8725-6292	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036652, T32GM008500] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-01646] Funding Source: Medline; NIGMS NIH HHS [GM08500, GM36652] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Borg JP, 1998, CURR TOP MICROBIOL, V228, P23; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; BRUNGER AT, 1996, X PLOR VERSION 3 8; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FERSHT A, 1999, STRUCTURE MECH PROTE, P345; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Girault JA, 1998, MOL MED, V4, P751, DOI 10.1007/BF03401769; GOULD KL, 1986, J CELL BIOL, V102, P660, DOI 10.1083/jcb.102.2.660; Gronholm M, 1999, J CELL SCI, V112, P895; Gusella JF, 1999, BBA-REV CANCER, V1423, pM29, DOI 10.1016/S0304-419X(99)00005-0; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Huang LQ, 1998, BIOCHEM BIOPH RES CO, V248, P548, DOI 10.1006/bbrc.1998.9009; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; LESLIE AGW, 1993, P CCP4 STUD WEEK DAT, P44; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; PAKKANEN R, 1989, J CELL BIOCHEM, V41, P1, DOI 10.1002/jcb.240410102; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sack JS, 1997, METHOD ENZYMOL, V277, P158, DOI 10.1016/S0076-6879(97)77011-3; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; SHELDRICK GM, 1993, ACTA CRYSTALLOGR D, V49, P18, DOI 10.1107/S0907444992007364; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TSUKITA S, 1989, J CELL BIOL, V108, P2369, DOI 10.1083/jcb.108.6.2369; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Turunen O, 1998, BBA-PROTEIN STRUCT M, V1387, P1, DOI 10.1016/S0167-4838(98)00103-4; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	74	472	492	4	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					259	270		10.1016/S0092-8674(00)80836-3	http://dx.doi.org/10.1016/S0092-8674(00)80836-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847681	Bronze			2022-12-28	WOS:000086741900006
J	Vichinsky, EP; Neumayr, LD; Earles, AN; Williams, R; Lennette, ET; Dean, D; Nickerson, B; Orringer, E; McKie, V; Bellevue, R; Daeschner, C; Manci, EA				Vichinsky, EP; Neumayr, LD; Earles, AN; Williams, R; Lennette, ET; Dean, D; Nickerson, B; Orringer, E; McKie, V; Bellevue, R; Daeschner, C; Manci, EA		Natl Acute Chest Syndrome Study Gr	Causes and outcomes of the acute chest syndrome in sickle cell disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESPIRATORY-DISTRESS SYNDROME; CHLAMYDIA-PNEUMONIAE; FAT-EMBOLISM; RISK-FACTORS; BRONCHOALVEOLAR LAVAGE; TRANSFUSION; INFECTION; CHILDREN; ENDOTHELIUM; PARVOVIRUS	Background: The acute chest syndrome is the leading cause of death among patients with sickle cell disease. Since its cause is largely unknown, therapy is supportive. Pilot studies with improved diagnostic techniques suggest that infection and fat embolism are underdiagnosed in patients with the syndrome. Methods: In a 30-center study, we analyzed 671 episodes of the acute chest syndrome in 538 patients with sickle cell disease to determine the cause, outcome, and response to therapy. We evaluated a treatment protocol that included matched transfusions, bronchodilators, and bronchoscopy. Samples of blood and respiratory tract secretions were sent to central laboratories for antibody testing, culture, DNA testing, and histopathological analyses. Results: Nearly half the patients were initially admitted for another reason, mainly pain. When the acute chest syndrome was diagnosed, patients had hypoxia, decreasing hemoglobin values, and progressive multilobar pneumonia. The mean length of hospitalization was 10.5 days. Thirteen percent of patients required mechanical ventilation, and 3 percent died. Patients who were 20 or more years of age had a more severe course than those who were younger. Neurologic events occurred in 11 percent of patients, among whom 46 percent had respiratory failure. Treatment with phenotypically matched transfusions improved oxygenation, with a 1 percent rate of alloimmunization. One fifth of the patients who were treated with bronchodilators had clinical improvement. Eighty-one percent of patients who required mechanical ventilation recovered. A specific cause of the acute chest syndrome was identified in 38 percent of all episodes and 70 percent of episodes with complete data. Among the specific causes were pulmonary fat embolism and 27 different infectious pathogens. Eighteen patients died, and the most common causes of death were pulmonary emboli and infectious bronchopneumonia. Infection was a contributing factor in 56 percent of the deaths. Conclusions: Among patients with sickle cell disease, the acute chest syndrome is commonly precipitated by fat embolism and infection, especially community-acquired pneumonia. Among older patients and those with neurologic symptoms, the syndrome often progresses to respiratory failure. Treatment with transfusions and bronchodilators improves oxygenation, and with aggressive treatment, most patients who have respiratory failure recover. (N Engl J Med 2000;342:1855-65.) (C)2000, Massachusetts Medical Society.	Childrens Hosp Oakland, Dept Hematol Oncol, Oakland, CA 94609 USA; Childrens Hosp Oakland, Dept Pathol, Oakland, CA 94609 USA; Virolab, Berkeley, CA USA; Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA; Childrens Hosp Orange Cty, Dept Pediat Pulm Med, Orange, CA 92668 USA; Univ N Carolina, Dept Hematol, Chapel Hill, NC USA; Med Coll Georgia, Dept Pediat Hematol Oncol, Augusta, GA 30912 USA; New York Methodist Hosp, Dept Med, Brooklyn, NY USA; E Carolina Univ, Dept Pediat Hematol Oncol, Greenville, NC USA; Univ So Alabama, Doctors Hosp, Dept Pathol, Mobile, AL USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; Childrens Hospital of Orange County; University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Augusta University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; University of North Carolina; East Carolina University; University of South Alabama	Vichinsky, EP (corresponding author), Childrens Hosp Oakland, Dept Hematol Oncol, 747 52nd St, Oakland, CA 94609 USA.		Vichinsky, Elliott P/F-8541-2011	Vichinsky, Elliott P/0000-0002-0500-9579	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL020985] Funding Source: NIH RePORTER; NCRR NIH HHS [M-01RR01271] Funding Source: Medline; NHLBI NIH HHS [HL-20985, HL-99-016] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aldrich TK, 1996, J APPL PHYSIOL, V80, P531, DOI 10.1152/jappl.1996.80.2.531; BATES JH, 1992, CHEST, V101, P1005, DOI 10.1378/chest.101.4.1005; BELLET PS, 1995, NEW ENGL J MED, V333, P699, DOI 10.1056/NEJM199509143331104; Bernini JC, 1998, BLOOD, V92, P3082, DOI 10.1182/blood.V92.9.3082.421k15_3082_3089; BONE RC, 1992, CHEST, V101, P320, DOI 10.1378/chest.101.2.320; Castro O, 1996, HEMATOL ONCOL CLIN N, V10, P1289, DOI 10.1016/S0889-8588(05)70401-9; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; CHASTRE J, 1990, ANN INTERN MED, V113, P583, DOI 10.7326/0003-4819-113-8-583; CHIRGWIN K, 1991, J INFECT DIS, V163, P757, DOI 10.1093/infdis/163.4.757; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Cook PJ, 1998, STROKE, V29, P404, DOI 10.1161/01.STR.29.2.404; EMRE U, 1995, J PEDIATR-US, V127, P901, DOI 10.1016/S0022-3476(95)70025-0; FRANKEL LR, 1988, PEDIATRICS, V81, P785; Gladwin MT, 1999, AM J RESP CRIT CARE, V159, P1368, DOI 10.1164/ajrccm.159.5.9810094; Godeau B, 1996, AM J RESP CRIT CARE, V153, P1691, DOI 10.1164/ajrccm.153.5.8630622; HEBBEL RP, 1987, J CLIN INVEST, V80, P1503, DOI 10.1172/JCI113233; HUTCHINSON RM, 1973, J CLIN PATHOL, V26, P620, DOI 10.1136/jcp.26.8.620; Ibe BO, 1997, AM J PHYSIOL-LUNG C, V272, pL597, DOI 10.1152/ajplung.1997.272.4.L597; JACOBS ER, 1986, MED CLIN N AM, V70, P921, DOI 10.1016/S0025-7125(16)30932-4; KAJIGAYA S, 1989, P NATL ACAD SCI USA, V86, P7601, DOI 10.1073/pnas.86.19.7601; KIRKPATRICK MB, 1991, AM J MED, V90, P206; KOHELET D, 1990, BIOL NEONATE, V57, P334; LANDRY ML, 1992, CLIN VIROLOGY MANUAL, P43; LENNETTE ET, 1992, CLIN VIROLOGY MANUAL, P251; LENNETTE ET, 1999, MANUAL CLIN MICROBIO, P912; Lietman T, 1998, CLIN INFECT DIS, V26, P1335, DOI 10.1086/516373; Lowenthal EA, 1996, AM J HEMATOL, V51, P207, DOI 10.1002/(SICI)1096-8652(199603)51:3<207::AID-AJH5>3.3.CO;2-B; MALLOUH AA, 1988, AM J DIS CHILD, V142, P178, DOI 10.1001/archpedi.1988.02150020080034; MILLER ST, 1991, J PEDIATR-US, V118, P30, DOI 10.1016/S0022-3476(05)81839-6; NARITA M, 1992, PEDIATRICS, V90, P250; Ohene-Frempong K, 1998, BLOOD, V91, P288; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; PONCZ M, 1985, J PEDIATR-US, V107, P861, DOI 10.1016/S0022-3476(85)80176-1; POWARS D, 1988, MEDICINE, V67, P66, DOI 10.1097/00005792-198801000-00005; PROHOVNIK I, 1989, NEUROLOGY, V39, P344, DOI 10.1212/WNL.39.3.344; Schachter J, 1991, MANUAL CLIN MICROBIO, P1045; SMOLINSKI PA, 1995, BLOOD, V85, P2945, DOI 10.1182/blood.V85.10.2945.bloodjournal85102945; SPRINKLE RH, 1986, AM J PEDIAT HEMATOL, V8, P105; Styles LA, 1996, BLOOD, V87, P2573, DOI 10.1182/blood.V87.6.2573.bloodjournal8762573; TOHGI H, 1991, STROKE, V22, P17, DOI 10.1161/01.STR.22.1.17; VICHINSKY E, 1994, BLOOD, V83, P3107; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402; VICHINSKY EP, 1991, SEMIN HEMATOL, V28, P220; Vichinsky EP, 1997, BLOOD, V89, P1787, DOI 10.1182/blood.V89.5.1787.1787_1787_1792; Waites K. B., 1999, MANUAL CLIN MICROBIO, V7th, P782; Wyncoll DLA, 1999, LANCET, V354, P497, DOI 10.1016/S0140-6736(98)08129-X	46	691	709	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1855	1865		10.1056/NEJM200006223422502	http://dx.doi.org/10.1056/NEJM200006223422502			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861320	Green Published			2022-12-28	WOS:000087704700002
J	Schwartz, LM; Woloshin, S; Sox, HC; Fischhoff, B; Welch, HG				Schwartz, LM; Woloshin, S; Sox, HC; Fischhoff, B; Welch, HG			US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; IN-SITU; SCREENING MAMMOGRAPHY; HEALTH	Objective To determine women's attitudes to and knowledge of both false positive mammography results and the detection of ductal carcinoma in situ after screening mammography. Design Cross sectional survey. Setting United States. Participants 479 women aged 18-97 years who did not report a history of breast cancer. Main outcome measures Attitudes to and knowledge of false positive results and the detection of ductal carcinoma in situ after screening mammography. Results Women were aware that false positive results do occur. Their median estimate of the false positive rate for 10 years of annual screening was 20% (25th percentile estimate, 10%; 75th percentile estimate, 45%). The women were highly tolerant of false positives: 63% thought that 500 or more false positives per life saved was reasonable and 37% would tolerate 10 000 or more. Women who had had a false positive result (n=76) expressed the same high tolerance: 39% would tolerate 10 000 or more false positives. 62% of women did not want to take false positive results into account when deciding about screening. Only 8% of women thought that mammography could harm a woman without breast cancer, and 94% doubted the possibility of non-progressive breast cancers. Few had heard about ductal carcinoma in situ, a cancer that may not progress, but when informed, 60% of women wanted to take into account the possibility of it being detected when deciding about screening. Conclusions Women are aware of false positives and seem to view them as an acceptable consequence of screening mammography. In contrast, most women are unaware that screening can detect cancers that may never progress but feel that such information would be relevant Education should perhaps focus less on false positives and more on the less familiar outcome of detection of ductal carcinoma in situ.	Vet Adm Med Ctr, Vet Adm Outcomes Grp 111B, White River Jct, VT 05009 USA; Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03756 USA; Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Carnegie Mellon University	Schwartz, LM (corresponding author), Vet Adm Med Ctr, Vet Adm Outcomes Grp 111B, White River Jct, VT 05009 USA.	lisa.schwartz@dartmouth.edu	Fischhoff, Baruch/I-9859-2014	Fischhoff, Baruch/0000-0002-3030-6874				*AM CANC SOC, 1988, SUMM CURR GUID CANC; [Anonymous], 1997, STAT ABSTR US; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; BLENDON RJ, 1995, JAMA-J AM MED ASSOC, V273, P341, DOI 10.1001/jama.273.4.341; Burman ML, 1999, ANN INTERN MED, V131, P1, DOI 10.7326/0003-4819-131-1-199907060-00002; ELLMAN R, 1989, BRIT J CANCER, V60, P781, DOI 10.1038/bjc.1989.359; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; ERNSTER VL, 1997, MONOGR NATL CANC I, V22, P151; Fletcher SW, 1999, ANN INTERN MED, V131, P60, DOI 10.7326/0003-4819-131-1-199907060-00011; Fowler FJ., 2013, SURV RES METHODS-GER, V5; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; GRAM IT, 1990, BRIT J CANCER, V62, P1018, DOI 10.1038/bjc.1990.430; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Lidbrink E, 1996, BRIT MED J, V312, P273; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; National Cancer Advisory Board, 1997, NAT CANC ADV BOARD M; *NIH CONS STAT, 1997, BREAST CANC SCREEN W; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; RUGGLES S, 1997, INTEGRATED PUBLIC US; SUTTON S, 1995, J EPIDEMIOL COMMUN H, V49, P413, DOI 10.1136/jech.49.4.413; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; WOLOSHIN S, 2000, IN PRESS MED DECIS M	29	162	165	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2000	320	7250					1635	1640		10.1136/bmj.320.7250.1635	http://dx.doi.org/10.1136/bmj.320.7250.1635			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856064	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000087734200022
J	Guo, ZH; Zhou, DM; Schultz, PG				Guo, ZH; Zhou, DM; Schultz, PG			Designing small-molecule switches for protein-protein interactions	SCIENCE			English	Article							HUMAN GROWTH-HORMONE; RECEPTOR INTERACTIONS; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; PHAGE; MUTAGENESIS; RESOLUTION; INTERFACE; AFFINITY; EPITOPE	Mutations introduced into human growth hormone (hGH) (Thr(175) --> Gly-hGH) and the extracellular domain of the hGH receptor (Trp(104) --> Gly-hGHbp) created a cavity at the protein-protein interface that resulted in binding affinity being reduced by a factor of 10(6). A small Library of indole analogs was screened for small molecules that bind the cavity created by the mutations and restore binding affinity. The ligand 5-chloro-2-trichloromethylimidazole was found to increase the affinity of the mutant hormone for its receptor more than 1000-fold. Cell proliferation and JAK2 phosphorylation assays showed that the mutant hGH activates growth hormone signaling in the presence of added ligand. This approach may allow other protein-protein and protein-nucleic acid interactions to be switched on or off by the addition or depletion of exogenous small molecules.	Scripps Res Inst, Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schultz, PG (corresponding author), Scripps Res Inst, Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Guo, Zhihong/0000-0003-0374-8412				Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; COLOSI P, 1993, J BIOL CHEM, V268, P12617; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; ERIKSSON AE, 1992, NATURE, V355, P371, DOI 10.1038/355371a0; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P510, DOI 10.1038/nsb0696-510; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; LOWMAN HB, 1991, BIOCHEMISTRY-US, V30, P10832, DOI 10.1021/bi00109a004; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P4491, DOI 10.1093/nar/21.19.4491; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; REIDHAAROLSON JF, 1988, SCIENCE, V241, P53, DOI 10.1126/science.3388019; Spencer DM, 1996, CURR BIOL, V6, P839, DOI 10.1016/S0960-9822(02)00607-3; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; ULRICH HD, 1995, P NATL ACAD SCI USA, V92, P11907, DOI 10.1073/pnas.92.25.11907; WANG YD, 1995, MOL ENDOCRINOL, V9, P303, DOI 10.1210/me.9.3.303; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253	21	79	86	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2042	+		10.1126/science.288.5473.2042	http://dx.doi.org/10.1126/science.288.5473.2042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856217				2022-12-28	WOS:000087687000050
J	Winawer, SJ; Stewart, ET; Zauber, AG; Bond, JH; Ansel, H; Waye, JD; Hall, D; Hamlin, JA; Schapiro, M; O'Brien, MJ; Sternberg, SS; Gottlieb, LS				Winawer, SJ; Stewart, ET; Zauber, AG; Bond, JH; Ansel, H; Waye, JD; Hall, D; Hamlin, JA; Schapiro, M; O'Brien, MJ; Sternberg, SS; Gottlieb, LS		Natl Polyp Study Work Grp	A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLORECTAL-CANCER; FOLLOW-UP; POLYPS; ADENOMAS; INTERVALS; DISEASE; REMOVAL; COLON	Background: After patients have undergone colonoscopic polypectomy, it is uncertain whether colonoscopic examination or a barium enema is the better method of surveillance. Methods: As part of the National Polyp Study, we offered colonoscopic examination and double-contrast barium enema for surveillance to patients with newly diagnosed adenomatous polyps. Although barium enema was performed first, the endoscopist did not know the results. Results: A total of 973 patients underwent one or more colonoscopic examinations for surveillance. In the case of 580 of these patients, we performed 862 paired colonoscopic examinations and barium-enema examinations that met the requirements of the protocol. The findings on barium enema were positive in 222 (26 percent) of the paired examinations, including 94 of the 242 colonoscopic examinations in which one or more adenomas were detected (rate of detection of adenomas, 39 percent; 95 percent confidence interval, 33 to 45 percent). The proportion of examinations in which adenomatous polyps were detected by barium enema was significantly related to the size of the adenomas (P=0.009); the rate was 32 percent for colonoscopic examinations in which the largest adenomas detected were 0.5 cm or less, 53 percent for those in which the largest adenomas detected were 0.6 to 1.0 cm, and 48 percent for those in which the largest adenomas detected exceeded 1.0 cm. Among the 139 paired examinations with positive results on barium enema and negative results on colonoscopic examination in the same location, 19 additional polyps, 12 of which were adenomas, were detected on colonoscopic reexamination. Conclusions: In patients who have undergone colonoscopic polypectomy, colonoscopic examination is a more effective method of surveillance than double-contrast barium enema. (N Engl J Med 2000;342:1766-72.) (C)2000, Massachusetts Medical Society.	Mem Sloan Kettering Canc Ctr, Dept Med, Serv Gastroenterol & Nutr, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Froedtert Mem Lutheran Hosp, Milwaukee, WI 53226 USA; Minneapolis Vet Affairs Med Ctr, Dept Med, Minneapolis, MN USA; Minneapolis Vet Affairs Med Ctr, Dept Radiol, Minneapolis, MN USA; Mt Sinai Hosp, Dept Med, New York, NY 10029 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Cedars Sinai Med Ctr, Dept Radiol, Los Angeles, CA 90048 USA; Valley Presbyterian Hosp, Dept Med, Van Nuys, CA USA; Boston Med Ctr, Mallory Inst Pathol, Boston, MA USA; Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; Mt Sinai Hosp, Dept Radiol, New York, NY USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; Valley Presbyterian Hosp, Dept Radiol, Van Nuys, CA USA; Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Medical College of Wisconsin; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Cedars Sinai Medical Center; Boston Medical Center; Medical College of Wisconsin; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Cedars Sinai Medical Center; Memorial Sloan Kettering Cancer Center	Winawer, SJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Serv Gastroenterol & Nutr, 1275 York Ave, New York, NY 10021 USA.	winawers@mskcc.org		O'Brien, Michael J/0000-0003-1124-3537	NATIONAL CANCER INSTITUTE [R01CA026852] Funding Source: NIH RePORTER; NCI NIH HHS [CA-26852] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON ML, 1992, GASTROINTEST ENDOSC, V38, P560, DOI 10.1016/S0016-5107(92)70516-1; Armitage P., 1987, STAT METHODS MED RES; CASS OW, 1993, ANN INTERN MED, V118, P40, DOI 10.7326/0003-4819-118-1-199301010-00008; Godreau C J, 1992, Fam Pract Res J, V12, P313; HIXSON LJ, 1990, JNCI-J NATL CANCER I, V82, P1769, DOI 10.1093/jnci/82.22.1769; HOGAN WJ, 1977, GASTROINTEST ENDOSC, V23, P230; KRONBORG O, 1987, INT J COLORECTAL DIS, V2, P203, DOI 10.1007/BF01649506; LEINICKE JL, 1977, GASTROINTEST RADIOL, V2, P125, DOI 10.1007/BF02256483; MATEK W, 1985, ENDOSCOPY, V17, P175, DOI 10.1055/s-2007-1018494; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Rex DK, 1997, GASTROENTEROLOGY, V112, P17, DOI 10.1016/S0016-5085(97)70213-0; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; SCHROCK TR, 1993, GASTROINTEST ENDOSC, V3, P585, DOI DOI 10.1016/S1052-5157(18)30533-6; THOENI RF, 1977, RADIOLOGY, V124, P631, DOI 10.1148/124.3.631; Wagner JL, 1996, PREVENTION EARLY DET, P321; WAYE JD, 1982, ENDOSCOPY, V14, P79, DOI 10.1055/s-2007-1021585; WILLIAMS CB, 1974, BRIT J SURG, V61, P673, DOI 10.1002/bjs.1800610902; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1992, CANCER, V70, P1236, DOI 10.1002/1097-0142(19920901)70:3+<1236::AID-CNCR2820701508>3.0.CO;2-4; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; Winawer SJ, 1998, GASTROENTEROLOGY, V114, P625; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P1060; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; WOLFF WI, 1973, NEW ENGL J MED, V288, P329, DOI 10.1056/NEJM197302152880701; WOLFF WI, 1975, AM J SURG, V129, P181, DOI 10.1016/0002-9610(75)90295-0	25	389	411	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1766	1772		10.1056/NEJM200006153422401	http://dx.doi.org/10.1056/NEJM200006153422401			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10852998				2022-12-28	WOS:000087573700001
J	Gallagher, RDP; Rivers, JK; Lee, TK; Bajdik, CD; McLean, DI; Coldman, AJ				Gallagher, RDP; Rivers, JK; Lee, TK; Bajdik, CD; McLean, DI; Coldman, AJ			Broad-spectrum sunscreen use and the development of new nevi in white children - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CUTANEOUS MALIGNANT-MELANOMA; 7-YEAR-OLD EUROPEAN CHILDREN; MELANOCYTIC NEVI; SUN EXPOSURE; RISK-FACTORS; HOST FACTORS; WEARING CLOTHES; VANCOUVER MOLE; BENIGN NEVI; NUMBER	Context High nevus density is a risk factor for cutaneous malignant melanoma. Melanocytic nevi originate in childhood and are largely caused by solar exposure. Objective To determine whether use of broad-spectrum, high-sun protection factor (SPF) sunscreen attenuates development of nevi in white children. Design Randomized trial conducted June 1993 to May 1996. Setting and Participants A total of 458 Vancouver, British Columbia, schoolchildren in grades 1 and 4 were randomized in 1993. After exclusion of nonwhite children and those lost to follow-up or with missing data, 309 children remained for analysis. Each child's nevi were enumerated at the start and end of the study in 1996, Intervention Parents of children randomly assigned to the treatment group (n = 222) received a supply of SPF 30 broad-spectrum sunscreen with directions to apply it to exposed sites when the child was expected to be in the sun for 30 minutes or more. Children randomly assigned to the control group (n = 236) received no sunscreen and were given no advice about sunscreen use. Main Outcome Measure Number of new nevi acquired during the 3 years of the study, compared between treatment and control groups. Results Children in the sunscreen group developed fewer nevi than did children in the control group (median counts, 24 vs 28; P = .048). A significant interaction was detected between freckling and study group, indicating that sunscreen use was much more important for children with freckles than for children without. Modeling of the data suggests that freckled children assigned to a broad-spectrum sunscreen intervention would develop 30% to 40% fewer new nevi than freckled children assigned to the control group. Conclusions Our data indicate that broad-spectrum sunscreens may attenuate the number of nevi in white children, especially if they have freckles.	British Columbia Canc Agcy, Canc Control Res Program, Vancouver, BC V5Z 4E6, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V5Z 1M9, Canada; Vancouver Hosp, British Columbia Canc Agcy, Div Dermatol, Vancouver, BC, Canada; Univ British Columbia, Div Dermatol, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Gallagher, RDP (corresponding author), British Columbia Canc Agcy, Canc Control Res Program, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	rickg@bccancer.bc.ca	Rivers, Jason/K-1031-2019	Rivers, Jason/0000-0002-0131-1607				Autier P, 1999, JNCI-J NATL CANCER I, V91, P1304, DOI 10.1093/jnci/91.15.1304; AUTIER P, 1995, INT J CANCER, V61, P749, DOI 10.1002/ijc.2910610602; Autier P, 1998, JNCI-J NATL CANCER I, V90, P1873, DOI 10.1093/jnci/90.24.1873; BEITNER H, 1990, BRIT J DERMATOL, V122, P43, DOI 10.1111/j.1365-2133.1990.tb08238.x; BISHOP JAN, 1994, MELANOMA RES, V4, P199, DOI 10.1097/00008390-199408000-00001; Chen YT, 1996, INT J CANCER, V67, P636, DOI 10.1002/(SICI)1097-0215(19960904)67:5<636::AID-IJC8>3.0.CO;2-V; COOMBS BD, 1992, AM J EPIDEMIOL, V136, P344, DOI 10.1093/oxfordjournals.aje.a116499; Diffey BL., 1994, EPIDEMIOLOGICAL ASPE, V1st edn, P81; ELWOOD JM, 1984, BRIT MED J, V288, P99, DOI 10.1136/bmj.288.6411.99; Elwood JM, 1999, J NATL CANCER I, V91, P1164, DOI 10.1093/jnci/91.13.1164a; ENGLISH DR, 1994, AM J EPIDEMIOL, V139, P390, DOI 10.1093/oxfordjournals.aje.a117011; ENGLISH DR, 1990, 9002 IARC; GALLAGHER RP, 1990, ARCH DERMATOL, V126, P770, DOI 10.1001/archderm.126.6.770; GALLAGHER RP, 1991, J AM ACAD DERMATOL, V25, P507, DOI 10.1016/0190-9622(91)70231-P; GREEN A, 1985, INT J CANCER, V35, P297, DOI 10.1002/ijc.2910350303; GROB JJ, 1990, CANCER, V66, P387, DOI 10.1002/1097-0142(19900715)66:2<387::AID-CNCR2820660232>3.0.CO;2-J; HARRISON SL, 1994, LANCET, V344, P1529, DOI 10.1016/S0140-6736(94)90348-4; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P934, DOI 10.1093/oxfordjournals.aje.a117360; HOLLY EA, 1987, J AM ACAD DERMATOL, V17, P459, DOI 10.1016/S0190-9622(87)70230-8; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; HOLMAN CDJ, 1986, J NATL CANCER I, V76, P403; HOLMAN CDJ, 1984, JNCI-J NATL CANCER I, V72, P257; KELLY JW, 1994, J AM ACAD DERMATOL, V30, P40, DOI 10.1016/S0190-9622(94)70005-2; KROON S, 1987, J AM ACAD DERMATOL, V17, P422, DOI 10.1016/S0190-9622(87)70223-0; KRUGER S, 1992, J AM ACAD DERMATOL, V26, P920, DOI 10.1016/0190-9622(92)70133-Z; Luther H, 1996, ARCH DERMATOL, V132, P1473, DOI 10.1001/archderm.132.12.1473; MACKIE RM, 1993, LANCET, V341, P1618, DOI 10.1016/0140-6736(93)90758-9; MARRETT LD, 1992, CAN MED ASSOC J, V147, P445; MARRETT LD, 1992, CAN MED ASSOC J, V147, P1764; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; OSTERLIND A, 1988, INT J CANCER, V42, P200, DOI 10.1002/ijc.2910420210; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; POPE DJ, 1992, ARCH DERMATOL, V128, P1201, DOI 10.1001/archderm.128.9.1201; RIVERS JK, 1990, J AM ACAD DERMATOL, V23, P77, DOI 10.1016/0190-9622(90)70190-S; SKENDERKALNENAS TM, 1995, J AM ACAD DERMATOL, V33, P1000, DOI 10.1016/0190-9622(95)90294-5; WEINSTOCK MA, 1989, J NATL CANCER I, V81, P948, DOI 10.1093/jnci/81.12.948; WESTERDAHL J, 1995, MELANOMA RES, V5, P59, DOI 10.1097/00008390-199502000-00007; WHITE E, 1994, AM J EPIDEMIOL, V139, P857, DOI 10.1093/oxfordjournals.aje.a117092	38	206	209	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2955	+		10.1001/jama.283.22.2955	http://dx.doi.org/10.1001/jama.283.22.2955			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865273	Bronze			2022-12-28	WOS:000087480600035
J	Gaidos, EJ; Nimmo, F				Gaidos, EJ; Nimmo, F			Planetary science - Tectonics and water on Europa	NATURE			English	Article							GEOLOGICAL EVIDENCE; FRACTURE		CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Cambridge, Dept Earth Sci, Bullard Labs, Cambridge CB3 0EZ, England	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Cambridge	Gaidos, EJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.			Gaidos, Eric/0000-0002-5258-6846				Cottier F, 1999, J GEOPHYS RES-OCEANS, V104, P15859, DOI 10.1029/1999JC900128; Duval P., 1977, IAHS PUBL, V118, P29; Greenberg R, 1998, ICARUS, V135, P64, DOI 10.1006/icar.1998.5986; MCKENZIE D, 1985, EARTH PLANET SC LETT, V74, P81, DOI 10.1016/0012-821X(85)90168-2; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; Rist MA, 1997, J PHYS CHEM B, V101, P6263, DOI 10.1021/jp963175x; STEVENSON D, 1996, EUROPA OCEAN C CAPIS, V5, P69; Sullivan R, 1998, NATURE, V391, P371, DOI 10.1038/34874; Tufts BR, 1999, ICARUS, V141, P53, DOI 10.1006/icar.1999.6168; Turcotte D. L., 1982, GEODYNAMICS APPL CON, DOI 10.1017/CBO9780511843877; Vorobyova E, 1997, FEMS MICROBIOL REV, V20, P277, DOI 10.1111/j.1574-6976.1997.tb00314.x	12	65	66	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					637	+		10.1038/35015170	http://dx.doi.org/10.1038/35015170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864313				2022-12-28	WOS:000087465800035
J	Herouy, Y; Hellstem, MO; Vanscheidt, W; Schopf, E; Norgauer, K				Herouy, Y; Hellstem, MO; Vanscheidt, W; Schopf, E; Norgauer, K			Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers	LANCET			English	Article							UROKINASE	Densitometric analysis shows an accelerated heating rate and a significantly diminished lesional fibrinolytic activity in patients with venous leg ulcers treated tonically with the fibrin-stabilising factor XIII compared with controls.	Univ Hosp, Dept Dermatol, D-79104 Freiburg, Germany	University of Freiburg	Herouy, Y (corresponding author), Univ Hosp, Dept Dermatol, D-79104 Freiburg, Germany.							BROWSE NL, 1982, LANCET, V2, P243; Herouy Y, 1998, J INVEST DERMATOL, V111, P822, DOI 10.1046/j.1523-1747.1998.00369.x; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Noll T, 1999, J EXP MED, V189, P1373, DOI 10.1084/jem.189.9.1373; STACEY MC, 1993, BRIT J SURG, V80, P596, DOI 10.1002/bjs.1800800515	5	30	31	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1970	1971		10.1016/S0140-6736(00)02333-3	http://dx.doi.org/10.1016/S0140-6736(00)02333-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859047				2022-12-28	WOS:000087381900018
J	Hersh, BS; Tambini, G; Nogueira, AC; Carrasco, P; de Quadros, CA				Hersh, BS; Tambini, G; Nogueira, AC; Carrasco, P; de Quadros, CA			Review of regional measles surveillance data in the Americas, 1996-99	LANCET			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ENZYME IMMUNOASSAYS; VIRUS; DIAGNOSIS; ANTIBODY; VACCINATION; ELIMINATION; OUTBREAK; ENGLAND; WALES	Background In 1994, ministers of health of countries of North and South America established the goal of measles eradication from the western hemisphere by 2000. To accomplish this goal, the Pan American Health Organization (PAHO) developed an enhanced measles vaccination strategy. Methods PAHO's measles eradication vaccination strategy has evolved into three principal components; a catch-up measles Vaccination campaign, maintenance of high vaccination coverage (keep-up), and periodic follow-up measles vaccination campaigns. ro monitor progress towards measles eradication, measles surveillance has been strengthened, including the laboratory investigation of suspected measles cases. and periodic follow-up To monitor progress Findings Both the catch-up and follow-up mass campaigns achieved high vaccination coverages in the respective targeted age groups. In 1996, only 2109 confirmed measles cases were reported in the Americas. In 1997, there was a resurgence of measles in the Americas, mostly as a result of a large measles outbreak with over 42000 cases, which occurred mainly among unvaccinated young adults in Sao Paulo State, Brazil. By 1998, there was a reduction in the number of reported confirmed measles cases, with a total of 14474 cases. Reduction of cases continued to the end of 1999, with a total of only 2828 confirmed cases. Interpretation PAHO's measles eradication strategy has been effective in interrupting transmission and maintaining the absence of measles Virus circulation in most parts of the Americas. The PAHO experience provides strong evidence that with full implementation of an appropriate Vaccination strategy, measles transmission can be effectively interrupted.	Pan Amer Hlth Org, Div Vaccines & Immunizat, Washington, DC USA	Pan American Health Organization	de Quadros, CA (corresponding author), Pan Amer Hlth Org, Div Vaccines & Immunizat, Washington, DC USA.	quadrosc@paho.org						[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P429; BABAD HR, 1995, EPIDEMIOL INFECT, V114, P319, DOI 10.1017/S0950268800057976; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P273; CHERRY JD, 1980, HOSP PRACT, V15, P49, DOI 10.1080/21548331.1980.11946629; Cutts FT, 1999, VACCINE, V17, pS47, DOI 10.1016/S0264-410X(99)00309-6; deQuadros CA, 1997, J INFECT DIS, V175, pS37, DOI 10.1093/infdis/175.Supplement_1.S37; ERDMAN DD, 1991, J CLIN MICROBIOL, V29, P1466, DOI 10.1128/JCM.29.7.1466-1471.1991; FERSON MJ, 1995, MED J AUSTRALIA, V163, P364, DOI 10.5694/j.1326-5377.1995.tb124630.x; Galindo M. A., 1998, PAN AM J PUBLIC HLTH, V4, P171; GUSTAFSON TL, 1987, NEW ENGL J MED, V316, P771, DOI 10.1056/NEJM198703263161303; Helfand RF, 1996, J INFECT DIS, V173, P1470, DOI 10.1093/infdis/173.6.1470; HERSH BS, 1991, AM J PUBLIC HEALTH, V81, P360, DOI 10.2105/AJPH.81.3.360; HUMMEL KB, 1992, J CLIN MICROBIOL, V30, P2874, DOI 10.1128/JCM.30.11.2874-2880.1992; Kumate J, 1997, ARCH MED RES, V28, P155; LIEVENS AW, 1986, J CLIN MICROBIOL, V24, P391, DOI 10.1128/JCM.24.3.391-394.1986; LOUTAN L, 1992, B WORLD HEALTH ORGAN, V70, P741; MATZKIN H, 1985, ISRAEL J MED SCI, V21, P351; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nokes DJ, 1997, TRENDS MICROBIOL, V5, P14, DOI 10.1016/S0966-842X(97)81769-6; Oliveira SA, 1998, T ROY SOC TROP MED H, V92, P636, DOI 10.1016/S0035-9203(98)90793-3; OZANNE G, 1992, J CLIN MICROBIOL, V30, P564, DOI 10.1128/JCM.30.3.564-569.1992; Ramsay M, 1996, BRIT MED J, V313, P231, DOI 10.1136/bmj.313.7051.231; Ramsay M, 1997, B WORLD HEALTH ORGAN, V75, P515; Robbins FC, 1997, J INFECT DIS, V175, pS281, DOI 10.1093/infdis/175.Supplement_1.S281; Rota JS, 1996, J INFECT DIS, V173, P32, DOI 10.1093/infdis/173.1.32; Vitek CR, 1997, JAMA-J AM MED ASSOC, V277, P1952, DOI 10.1001/jama.277.24.1952; WILLIAMS PJ, 1983, REV INFECT DIS, V5, P391	29	85	93	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1943	1948		10.1016/S0140-6736(00)02325-4	http://dx.doi.org/10.1016/S0140-6736(00)02325-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859039				2022-12-28	WOS:000087381900010
J	Peters, WS; Herkner, B; Webb, A; Hibberd, J				Peters, WS; Herkner, B; Webb, A; Hibberd, J			Offside researchers score an own goal	NATURE			English	Letter									Goethe Univ Bioctr, Kinemat Cell Res Grp, D-60439 Frankfurt, Germany; State Museum Nat Hist, D-76133 Karlsruhe, Germany; Dept Plant Sci, Cambridge CB2 3EA, England	Goethe University Frankfurt	Peters, WS (corresponding author), Goethe Univ Bioctr, Kinemat Cell Res Grp, Marie Curie Str 9, D-60439 Frankfurt, Germany.		Peters, Winfried S./N-5851-2019; Peters, Winfried/G-5534-2015	Peters, Winfried S./0000-0002-5061-1497; Peters, Winfried/0000-0002-5061-1497				Oudejans RRD, 2000, NATURE, V404, P33, DOI 10.1038/35003639	1	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					508	508		10.1038/35014668	http://dx.doi.org/10.1038/35014668			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850690	Bronze			2022-12-28	WOS:000087449500018
J	Russo, C; Schettini, G; Saido, TC; Hulette, C; Lippall, C; Lannfelt, L; Ghetti, B; Gambetti, P; Tabaton, M; Teller, JK				Russo, C; Schettini, G; Saido, TC; Hulette, C; Lippall, C; Lannfelt, L; Ghetti, B; Gambetti, P; Tabaton, M; Teller, JK			Neurobiology - Presenilin-1 mutations in Alzheimer's disease	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; SENILE PLAQUES; DOWNS-SYNDROME; BETA-PROTEIN; PEPTIDE; INCREASE		Case Western Reserve Univ, Inst Pathol, Div Neuropathol, Cleveland, OH 44106 USA; Univ Genoa, Natl Inst Canc Res, Dept Neurosci, Adv Biotechnol Ctr,Sect Pharmacol, Genoa, Italy; RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama, Japan; Duke Univ, Med Ctr, Kathleen Price Bryan Brain Bank & Neuropathol Cor, Durham, NC 27710 USA; Med Coll Penn & Hahnemann Univ, Dept Neurol, Philadelphia, PA 19129 USA; Karolinska Inst, Huddinge Hosp, Geriatr Lab, S-14146 Huddinge, Sweden; Indiana Univ, Med Ctr, Dept Pathol, Indianapolis, IN 46202 USA	Case Western Reserve University; University of Genoa; IRCCS AOU San Martino IST; RIKEN; Duke University; Drexel University; Karolinska Institutet; Indiana University System; Indiana University-Purdue University Indianapolis	Russo, C (corresponding author), Case Western Reserve Univ, Inst Pathol, Div Neuropathol, Cleveland, OH 44106 USA.		Russo, Claudio/AIA-1429-2022; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; russo, claudio/0000-0002-2520-2958				Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Lippa CF, 1996, NEUROLOGY, V46, P406, DOI 10.1212/WNL.46.2.406; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sudoh S, 1998, J NEUROCHEM, V71, P1535; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	13	135	158	2	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					531	532		10.1038/35014735	http://dx.doi.org/10.1038/35014735			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850703				2022-12-28	WOS:000087449500038
J	Greyson, B				Greyson, B			Dissociation in people who have near-death experiences: out of their bodies or out of their minds?	LANCET			English	Article							PSYCHODYNAMICS; RELIABILITY; VALIDITY; SCALE	Background Some people who come close to death report having experiences in which they transcend the boundaries of the ego and the confines of time and space. Such near-death experiences (NDEs) share some features with the phenomenon of dissociation, in which a person's self identity becomes detached from bodily sensation. This study explored the frequency of dissociative symptoms in people who had come close to death. Methods 96 individuals who had had self-reported NDEs, and 38 individuals who had come close to death but who had not had NDEs completed a mailed questionnaire that included a measure of "depth" of near-death experience (the NDE scale) and a measure of dissociative symptoms (the Dissociative Experiences Scale). Median scores in the two groups were compared with Mann-Whitney U tests. The association between depth of NDE and dissociative symptoms was tested by Spearman's rank-order correlation between scores on the NDE scale and the dissociative experiences scale. Findings People who reported NDEs also reported significantly more dissociative symptoms than did the comparison group. Among those who reported NDEs, the depth of the experience was positively correlated with dissociative symptoms, although the level of symptoms was substantially lower than that of patients with pathological dissociative disorders. Interpretation The pattern of dissociative symptoms reported by people who have had NDEs is consistent with a non-pathological dissociative response to stress, and not with a psychiatric disorder. A greater understanding of the mechanism of dissociation may shed further light on near-death and other mystical or transcendental experiences.	Univ Virginia Hlth Syst, Dept Psychiat Med, Div Personal Studies, Charlottesville, VA 22908 USA	University of Virginia	Greyson, B (corresponding author), Univ Virginia Hlth Syst, Dept Psychiat Med, Div Personal Studies, POB 800152, Charlottesville, VA 22908 USA.			Greyson, Bruce/0000-0002-2192-7898				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1998, MED PSYCHIAT, V1, P92; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Blackmore SJ, 1996, J ROY SOC MED, V89, P73, DOI 10.1177/014107689608900204; Carlson EB, 1993, DISSOCIATION PROGR D, V6, P16, DOI DOI 10.1177/1073191116645904; Cook E. W., 1998, J SCI EXPLORATION, V12, P377; GABBARD GO, 1984, WITH EYES MIND EMPIR; GREYSON B, 1983, J NERV MENT DIS, V171, P376, DOI 10.1097/00005053-198306000-00008; Greyson B, 1998, PERSPECT BIOL MED, V42, P14; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B, 1997, J NERV MENT DIS, V185, P327, DOI 10.1097/00005053-199705000-00007; GREYSON B, 1997, BROKEN IMAGES BROKEN; Heim A., 1892, JB SCHWEIZER ALPENCL, V27, P327; Irwin H., 1985, FLIGHT MIND PSYCHOL; Irwin H. J., 1993, J NEAR DEATH STUDIES, V12, P95; James W., 1983, PRINCIPLES PSYCHOL; Janet P, 1889, AUTOMATISME PSYCHOL; JANSEN KLR, 1990, MED HYPOTHESES, V31, P25, DOI 10.1016/0306-9877(90)90048-J; KELLEHEAR A, 1993, J NERV MENT DIS, V181, P148, DOI 10.1097/00005053-199303000-00002; NOYES R, 1977, COMPR PSYCHIAT, V18, P375, DOI 10.1016/0010-440X(77)90010-4; OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L; Pfister O, 1930, INT Z PSYCHOANAL, V16, P430; Prince M., 1978, DISSOCIATION PERSONA; Ray William J., 1996, P51; Ring K., 1992, OMEGA PROJECT NEAR D; ROBERTS G, 1988, BRIT J PSYCHIAT, V153, P607, DOI 10.1192/bjp.153.5.607; ROSE DS, 1986, AM J PSYCHIAT, V143, P817; SPIEGEL D, 1991, J ABNORM PSYCHOL, V100, P366, DOI 10.1037/0021-843X.100.3.366; Waller NG, 1996, PSYCHOL METHODS, V1, P300, DOI 10.1037/1082-989X.1.3.300; Wiltse A. S., 1889, ST LOUIS MEDICAL SUR, V57, P355; 1894, BMJ, V2, P823	31	69	76	1	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					460	463						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	283ZW	10841127				2022-12-28	WOS:000085306800013
J	Fedorov, AV; Philander, SG				Fedorov, AV; Philander, SG			Is El Nino changing?	SCIENCE			English	Review							OCEAN-ATMOSPHERE INTERACTION; SEA-SURFACE TEMPERATURE; TROPICAL PACIFIC; SOUTHERN OSCILLATION; SEASONAL CYCLE; ENSO; MODEL; VARIABILITY; TOGA; PROGRESS	Recent advances in observational and theoretical studies of El Nino have shed Light on controversies concerning the possible effect of global warming on this phenomenon over the past few decades and in the future. El Nino is now understood to be one phase of a natural mode of oscillation-La Nina is the complementary phase-that results from unstable interactions between the tropical Pacific Ocean and the atmosphere. Random disturbances maintain this neutrally stable mode, whose properties depend on the background (time-averaged) climate state. Apparent changes in the properties of El Nino could reflect the importance of random disturbances, but they could also be a consequence of decadal variations of the background state. The possibility that global warming is affecting those variations cannot be excluded.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Fedorov, AV (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.		fedorov, alexey/F-1879-2010					BATTISTI DS, 1989, J ATMOS SCI, V46, P1687, DOI 10.1175/1520-0469(1989)046<1687:IVIATA>2.0.CO;2; CANE MA, 1986, NATURE, V321, P827, DOI 10.1038/321827a0; CHANG P, 1994, J ATMOS SCI, V51, P3627, DOI 10.1175/1520-0469(1994)051<3627:ACOIOR>2.0.CO;2; Delecluse P, 1998, J GEOPHYS RES-OCEANS, V103, P14357, DOI 10.1029/97JC02546; DIJKSTRA HA, 1995, J CLIMATE, V8, P1343, DOI 10.1175/1520-0442(1995)008<1343:OAIATT>2.0.CO;2; FEDOROV A, IN PRESS GEOPHYS RES; Guilderson TP, 1998, SCIENCE, V281, P240, DOI 10.1126/science.281.5374.240; HALPERN D, 1987, J GEOPHYS RES-OCEANS, V92, P8197, DOI 10.1029/JC092iC08p08197; Harrison DE, 1997, GEOPHYS RES LETT, V24, P1779, DOI 10.1029/97GL01789; HAYES SP, 1991, B AM METEOROL SOC, V72, P339, DOI 10.1175/1520-0477(1991)072<0339:TTAMAF>2.0.CO;2; JI M, 1994, B AM METEOROL SOC, V75, P569, DOI 10.1175/1520-0477(1994)075<0569:AMCFSA>2.0.CO;2; JIN FF, 1993, J ATMOS SCI, V50, P3477, DOI 10.1175/1520-0469(1993)050<3477:MOITOI>2.0.CO;2; Kirtman BP, 1998, J CLIMATE, V11, P2804, DOI 10.1175/1520-0442(1998)011<2804:DVIEPA>2.0.CO;2; Knutson TR, 1997, J CLIMATE, V10, P138, DOI 10.1175/1520-0442(1997)010<0138:SEIAGC>2.0.CO;2; Li TM, 1996, J CLIMATE, V9, P2986, DOI 10.1175/1520-0442(1996)009<2986:OTACOT>2.0.CO;2; LIU ZY, 1993, J PHYS OCEANOGR, V23, P1592, DOI 10.1175/1520-0485(1993)023<1592:OTFOTR>2.0.CO;2; MCCREARY JP, 1994, J PHYS OCEANOGR, V24, P466; McPhaden MJ, 1998, J GEOPHYS RES-OCEANS, V103, P14169, DOI 10.1029/97JC02906; MECHOSO CR, 1995, MON WEATHER REV, V123, P2825, DOI 10.1175/1520-0493(1995)123<2825:TSCOTT>2.0.CO;2; Moore AM, 1999, J CLIMATE, V12, P1199, DOI 10.1175/1520-0442(1999)012<1199:SFOEBT>2.0.CO;2; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; PENLAND C, 1995, J CLIMATE, V8, P1999, DOI 10.1175/1520-0442(1995)008<1999:TOGOTS>2.0.CO;2; Philander SGH, 1996, J CLIMATE, V9, P2958, DOI 10.1175/1520-0442(1996)009<2958:WTIIMN>2.0.CO;2; PICAUT J, 1995, J GEOPHYS RES-OCEANS, V100, P18393, DOI 10.1029/95JC01358; Rajagopalan B, 1997, J CLIMATE, V10, P2351, DOI 10.1175/1520-0442(1997)010<2351:AEOAAV>2.0.CO;2; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; SCHOPF PS, 1988, J ATMOS SCI, V45, P549, DOI 10.1175/1520-0469(1988)045<0549:VIACOM>2.0.CO;2; Stockdale TN, 1998, J GEOPHYS RES-OCEANS, V103, P14325, DOI 10.1029/97JC02440; TETT S, 1995, J CLIMATE, V8, P1473, DOI 10.1175/1520-0442(1995)008<1473:SOENSO>2.0.CO;2; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1998, J GEOPHYS RES-OCEANS, V103, P14291, DOI 10.1029/97JC01444; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Wallace JM, 1998, J GEOPHYS RES-OCEANS, V103, P14241, DOI 10.1029/97JC02905; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; ZEBIAK SE, 1987, MON WEATHER REV, V115, P2262, DOI 10.1175/1520-0493(1987)115<2262:AMENO>2.0.CO;2; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2	37	517	546	3	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					1997	2002		10.1126/science.288.5473.1997	http://dx.doi.org/10.1126/science.288.5473.1997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856205				2022-12-28	WOS:000087687000038
J	Sessler, AM				Sessler, AM			Setbacks don't dampen the energy of US physics	NATURE			English	Letter									Univ Calif Berkeley, Lawrence Berkeley Lab, Neutrino Factory & Muon Collider Collaborat, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Sessler, AM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Neutrino Factory & Muon Collider Collaborat, Berkeley, CA 94720 USA.							MacIlwain C, 2000, NATURE, V404, P909, DOI 10.1038/35010209	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					733	733		10.1038/35015789	http://dx.doi.org/10.1038/35015789			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866175	Bronze			2022-12-28	WOS:000087620600017
J	Sutton, AJ; Duval, SJ; Tweedie, RL; Abrams, KR; Jones, DR				Sutton, AJ; Duval, SJ; Tweedie, RL; Abrams, KR; Jones, DR			Empirical assessment of effect of publication bias on meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article							METAANALYSIS; TRIALS	Objective To assess the effect of publication bias on the results and conclusions of systematic reviews and meta-analyses. Design Analysis of published meta-analyses by trim and fill method, Studies 48 reviews in Cochrane Database of Systematic Reviews that considered a binary endpoint and contained 10 or more individual studies. Main outcome measures Number of reviews with missing studies and effect on conclusions of meta-analyses. Results The trim and fill fixed effects analysis method estimated that 26 (54%) of reviews had missing studies and in 10 the number missing was significant. The corresponding figures with a random effects model were 23 (48%) and eight. In four cases, statistical inferences regarding the effect of the intervention were changed after the overall estimate for publication bias was adjusted for. Conclusions Publication or related biases were common within the sample of meta-analyses assessed. In most cases these biases did not affect the conclusions, Nevertheless, researchers should check routinely whether conclusions of systematic reviews are robust to possible non-random selection mechanisms.	Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Leicester	Sutton, AJ (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England.	ajs22@le.ac.uk	Abrams, Keith/AAA-2557-2020; Duval, Susan/AAI-1874-2020	Sutton, Alexander/0000-0002-8934-9940; Duval, Sue/0000-0003-1025-8665; Abrams, Keith/0000-0002-7557-1567				Begg C., 1994, HDB RES SYNTHESIS, P399; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begg CB, 1997, STAT SCI, V12, P241; DUVAL S, IN PRESS BIOMETRIKA; DUVAL S, IN PRESS J AM STAT A; EASTERBROOK PJ, 1992, STAT MED, V11, P345, DOI 10.1002/sim.4780110307; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Horton R, 1997, LANCET, V350, P756, DOI 10.1016/S0140-6736(05)62564-0; Linde K, 1997, LANCET, V350, P834, DOI 10.1016/S0140-6736(97)02293-9; Petticrew M, 1999, BRIT MED J, V319, P917, DOI 10.1136/bmj.319.7214.917; Sankey SS, 1996, COMMUN STAT SIMULAT, V25, P1031, DOI 10.1080/03610919608813357; SONG F, IN PRESS HDB RES MET; TALLON D, 2000, P 2 S SYST REV BAS O; Taylor S, 1998, AUSTRALASIAN EPIDEMI, V5, P14; 1998, COCHRANE LIB	15	982	999	2	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2000	320	7249					1574	1577		10.1136/bmj.320.7249.1574	http://dx.doi.org/10.1136/bmj.320.7249.1574			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845965	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000087631400021
J	Bortman, H				Bortman, H			Requiem for an observatory	NATURE			English	Article							GAMMA-RAY BURST; 23 JANUARY 1999; OPTICAL AFTERGLOW; GRB-990123; EMISSION; CONSTRAINTS; REDSHIFT											Akerlof C, 1999, NATURE, V398, P400, DOI 10.1038/18837; Andersen MI, 1999, SCIENCE, V283, P2075, DOI 10.1126/science.283.5410.2075; Castro-Tirado AJ, 1999, SCIENCE, V283, P2069, DOI 10.1126/science.283.5410.2069; Galama TJ, 1999, NATURE, V398, P394, DOI 10.1038/18828; Gehrels N, 2000, NATURE, V404, P363, DOI 10.1038/35006001; HARTMAN RC, 1992, ASTROPHYS J, V385, pL1, DOI 10.1086/186263; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Hjorth J, 1999, SCIENCE, V283, P2073, DOI 10.1126/science.283.5410.2073; Kulkarni SR, 1999, NATURE, V398, P389, DOI 10.1038/18821; Mattox JR, 1997, ASTROPHYS J, V476, P692, DOI 10.1086/303639; MEEGAN CA, 1992, NATURE, V355, P143, DOI 10.1038/355143a0; Metzger MR, 1997, NATURE, V387, P878, DOI 10.1038/43132; Mukherjee R, 1997, ASTROPHYS J, V490, P116, DOI 10.1086/304851; Mukherjee R, 1997, AIP CONF PROC, P394, DOI 10.1063/1.54037; vanParadijs J, 1997, NATURE, V386, P686, DOI 10.1038/386686a0	15	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					504	506		10.1038/35014787	http://dx.doi.org/10.1038/35014787			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850686				2022-12-28	WOS:000087449500014
J	Hannon, JB; Hibino, H; Bartelt, NC; Swartzentruber, BS; Ogino, T; Kellogg, GL				Hannon, JB; Hibino, H; Bartelt, NC; Swartzentruber, BS; Ogino, T; Kellogg, GL			Dynamics of the silicon (111) surface phase transition	NATURE			English	Article							ELECTRON-MICROSCOPY; SI(111); RECONSTRUCTIONS	The manner in which phase transformations occur in solids determines important structural and physical properties of many materials. The main problem in characterizing the kinetic processes that occur during phase transformations is the difficulty of observing directly, in real time, the growth of one phase at the expense of another. Here we use low-energy electron microscopy to study the real-time kinetics of a phase transformation confined to the silicon (111) surface. We show that the transformation is governed by the rate at which material is exchanged between the first layer of the crystal and the surface. In bulk phase transformations. the dynamics are usually governed either by the rate of diffusion of material to the phase boundaries or by the structural rearrangement of atoms at the phase boundary(1). The kinetic process that we have identified here has no bulk analogue and leads to domain dynamics that are qualitatively different from these expected for bulk systems.	Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; NTT, Basic Res Labs, Kanagawa 2430198, Japan; Sandia Natl Labs, Livermore, CA 94551 USA; Sandia Natl Labs, Albuquerque, NM 87185 USA	Carnegie Mellon University; Nippon Telegraph & Telephone Corporation; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Hannon, JB (corresponding author), Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA.		Hibino, Hiroki/D-2072-2014; Hibino, Hiroki/E-9443-2016; Ogino, Toshio/M-9600-2014	Hibino, Hiroki/0000-0002-8604-8640; Hibino, Hiroki/0000-0002-8604-8640; Swartzentruber, Brian/0000-0001-6622-382X; Ogino, Toshio/0000-0002-3241-5652				Bartelt MC, 1998, PHYS REV LETT, V81, P1901, DOI 10.1103/PhysRevLett.81.1901; BAUER E, 1994, REP PROG PHYS, V57, P895, DOI 10.1088/0034-4885/57/9/002; BECKER RS, 1986, PHYS REV LETT, V57, P1020, DOI 10.1103/PhysRevLett.57.1020; BENNETT PA, 1981, SURF SCI, V104, P74, DOI 10.1016/0039-6028(81)90125-4; CHRISTIAN JW, 1970, PHYSICAL METALLURGY, P443; Hannon JB, 1998, PHYS REV LETT, V81, P4676, DOI 10.1103/PhysRevLett.81.4676; LANDER JJ, 1964, SURF SCI, V1, P125, DOI 10.1016/0039-6028(64)90024-X; LATYSHEV AV, 1991, SURF SCI, V254, P90, DOI 10.1016/0039-6028(91)90641-5; OSAKABE N, 1980, JPN J APPL PHYS, V19, pL309, DOI 10.1143/JJAP.19.L309; TAKAYANAGI K, 1985, SURF SCI, V164, P367, DOI 10.1016/0039-6028(85)90753-8; TELIEPS W, 1985, SURF SCI, V162, P163, DOI 10.1016/0039-6028(85)90890-8; Yagi K, 1995, PHASE TRANSIT, V53, P197, DOI 10.1080/01411599508200396; YANG YN, 1994, PHYS REV LETT, V72, P1862, DOI 10.1103/PhysRevLett.72.1862	13	48	50	3	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					552	554		10.1038/35014569	http://dx.doi.org/10.1038/35014569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850710				2022-12-28	WOS:000087449500045
J	Reichhardt, T				Reichhardt, T			US astronomers draw up their wish list for a decade of funding	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					381	382		10.1038/35013206	http://dx.doi.org/10.1038/35013206			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839501	Bronze			2022-12-28	WOS:000087212000003
J	[Anonymous]				[Anonymous]			Britain asks to join European Southern Observatory	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					382	383						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839503				2022-12-28	WOS:000087212000005
J	McMaster, P				McMaster, P			Transplantation for alcoholic liver disease in an era of organ shortage	LANCET			English	Editorial Material							CIRRHOSIS		Univ Hosp Birmingham NHS Trust, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England		McMaster, P (corresponding author), Univ Hosp Birmingham NHS Trust, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England.							Anand AC, 1997, HEPATOLOGY, V25, P1478, DOI 10.1002/hep.510250628; BERESFORD TP, 1994, LIVER TRANSPLANTATIO, P90; BERLAKOVICH GA, 1994, TRANSPLANTATION, V58, P560, DOI 10.1097/00007890-199409150-00006; HOWARD L, 1994, Q J MED, V87, P731, DOI 10.1093/oxfordjournals.qjmed.a068890; KNECHTLE SJ, 1993, TRANSPLANT P, V25, P1916; Lucey M R, 1997, Liver Transpl Surg, V3, P628; Neuberger J, 1998, BMJ-BRIT MED J, V317, P172, DOI 10.1136/bmj.317.7152.172; Pageaux GP, 1999, GUT, V45, P421, DOI 10.1136/gut.45.3.421; Poynard T, 1999, J HEPATOL, V30, P1130, DOI 10.1016/S0168-8278(99)80269-4; Roizen R, 1999, BRIT MED J, V319, P666, DOI 10.1136/bmj.319.7211.666; VANLEMMENS C, 1995, HEPATOLOGY, V22, P375	11	36	38	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					424	425						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841118				2022-12-28	WOS:000085306800004
J	Binswanger, HP				Binswanger, HP			Scaling up HIV/AIDS programs to national coverage	SCIENCE			English	Editorial Material								The most important issue in the fight against HIV/AIDS is how to scale up existing programs that are only reaching small numbers of people to the national Level. Here, I present suggestions on how to tackle the daunting challenge of building truly national HIV/AIDS programs, based on insights gained from participatory, decentralized rural development experiences and from HIV/AIDS programs.	World Bank, Rural Dev & Environm Africa, Washington, DC 20005 USA	The World Bank	Binswanger, HP (corresponding author), World Bank, Rural Dev & Environm Africa, Washington, DC 20005 USA.		Binswanger, Hans/M-6883-2013	Binswanger, Hans/0000-0002-6323-1418				Caldwell JC, 2000, POPUL DEV REV, V26, P117, DOI 10.1111/j.1728-4457.2000.00117.x; FOSTER G, 1999, SAFAIDS NEWS, V7, P3; NGWESHEMI J, 1997, HIV PREVENTION AIDS; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; SCHAPNIK D, 2000, STRATEGIC PRINCIPLES; *TANESA PLANN DIST, 1996, COMP COND CONT COSTS; *U ZIMB, 2000, REG PARTN RED HIV IN; *WORLD BANK, 1998, INT RUR DEV WORLD BA; *WORLD BANK, 1997, RUR DEV VIS ACT	9	33	33	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2173	2176		10.1126/science.288.5474.2173	http://dx.doi.org/10.1126/science.288.5474.2173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	327FH	10864859				2022-12-28	WOS:000087782900048
J	Hibino, T; Hashimoto, A; Inoue, T; Tokuno, J; Yoshida, S; Sano, M				Hibino, T; Hashimoto, A; Inoue, T; Tokuno, J; Yoshida, S; Sano, M			A low-operating-temperature solid oxide fuel cell in hydrocarbon-air mixtures	SCIENCE			English	Article							OXIDATION; METHANE; CERIA; ELECTROLYTES; EXCHANGE	The performance of a single-chamber solid oxide fuel cell was studied using a ceria-based solid electrolyte at temperatures below 773 kelvin. Electromotive forces of similar to 900 millivolts were generated from the cell in a flowing mixture of ethane or propane and air, where the solid electrolyte functioned as a purely ionic conductor. The electrode-reaction resistance was negligibly small in the total internal resistances of the cell. The resulting peak power density reached 403 and 101 milliwatts per square centimeter at 773 and 623 kelvin, respectively.	Natl Ind Res Inst Nagoya, Dept Struct Format Proc, Nagoya, Aichi 4628510, Japan; Nagoya Univ, Grad Sch Human Informat, Nagoya, Aichi 4660804, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Nagoya University	Hibino, T (corresponding author), Natl Ind Res Inst Nagoya, Dept Struct Format Proc, Nagoya, Aichi 4628510, Japan.		Hibino, Takashi/D-7838-2011	Hibino, Takashi/0000-0001-5165-6710				ASHCROFT AT, 1990, NATURE, V344, P319, DOI 10.1038/344319a0; CAVALCA CA, 1993, J PHYS CHEM-US, V97, P6115, DOI 10.1021/j100125a005; Ciureanu M, 1999, J ELECTROCHEM SOC, V146, P4031, DOI 10.1149/1.1392588; DYER CK, 1990, NATURE, V343, P547, DOI 10.1038/343547a0; HASHIMOTO N, 1997, CHEM CHEM IND, V50, P1324; Hibino T, 1999, ELECTROCHEM SOLID ST, V2, P317, DOI 10.1149/1.1390822; HIBINO T, 1993, CHEM LETT, P1131, DOI 10.1246/cl.1993.1131; LOUIS GA, 1981, Patent No. 4248941; Milliken C, 1999, J ELECTROCHEM SOC, V146, P872, DOI 10.1149/1.1391695; Mukerjee S, 1999, ELECTROCHEM SOLID ST, V2, P12, DOI 10.1149/1.1390718; Murray EP, 1999, NATURE, V400, P649, DOI 10.1038/23220; Park SD, 2000, NATURE, V404, P265, DOI 10.1038/35005040; RIESS I, 1995, SOLID STATE IONICS, V82, P1, DOI 10.1016/0167-2738(95)00210-W; STEELE BCH, 1994, J POWER SOURCES, V49, P1, DOI 10.1016/0378-7753(93)01789-K; TULLER HL, 1975, J ELECTROCHEM SOC, V122, P255, DOI 10.1149/1.2134190; UCHIDA H, 1995, J PHYS CHEM-US, V99, P3282, DOI 10.1021/j100010a044; VANGOOL W, 1965, PHILIPS RES REP, V20, P81	17	662	689	9	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2031	2033		10.1126/science.288.5473.2031	http://dx.doi.org/10.1126/science.288.5473.2031			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856213				2022-12-28	WOS:000087687000046
J	Chin, DP; Crane, CM; Diul, MY; Sun, SJ; Agraz, R; Taylor, S; Desmond, E; Wise, F				Chin, DP; Crane, CM; Diul, MY; Sun, SJ; Agraz, R; Taylor, S; Desmond, E; Wise, F			Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULMONARY TUBERCULOSIS; SAN-FRANCISCO; TRANSMISSION; OUTBREAK; EPIDEMIOLOGY; DIAGNOSIS; STRAIN; DELAY; CITY	Context Despite improvements in tuberculosis (TB) control during the past decade, Mycobacterium tuberculosis transmission and resulting disease continue to occur in the United States. Objective To determine the primary reasons for disease development from a particular strain of M tuberculosis. Design Population-based, molecular epidemiological study. Setting Urban community in the San Francisco Bay area of California with recommended elements of TB control in place. Patients Seventy-three TB cases were reported in 1996-1997 that resulted from 1 strain of M tuberculosis as identified by TB genotyping and epidemiological linkage. Main Outcome Measures Transmission patterns involving source and secondary case-patients; primary reasons for disease development. Results Seventy-three (33%) of 221 TB case-patients in this community resulted from this strain of M tuberculosis. Thirty-nine (53%) of the 73 case-patients developed TB because they were not identified as contacts of source case-patients; 20 case-patients (27%) developed TB because of delayed diagnosis of their sources; and 13 case-patients (18%) developed TB because of problems associated with the evaluation or treatment of contacts; and 1 case-patient (1%) developed TB because of delay in being elicited as a contact. Of the 51 TB cases identified with sources, 49 (96%) were infected within the 2 years prior to diagnosis. Conclusions Our results indicate that in a community that has implemented the essential elements of TB control, TB from ongoing transmission of M tuberculosis will continue to develop unless patients are diagnosed earlier and contacts are more completely identified.	Calif Dept Hlth Serv, TB Control Branch, Berkeley, CA 94704 USA; Calif Dept Hlth Serv, Microbial Dis Lab, Berkeley, CA 94704 USA; Contra Costa Publ Hlth, TB Programs, Martinez, CA USA; WHO, CH-1211 Geneva, Switzerland	California Department of Health Care Services; California Department of Health Care Services; World Health Organization	Chin, DP (corresponding author), 2151 Berkeley Way,Room 608, Berkeley, CA 94704 USA.	chind@chn.wpro.who.int			PHS HHS [U52/CCU900515-18] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159; Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Bradford WZ, 1998, J INFECT DIS, V177, P1104, DOI 10.1086/517405; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P1140, DOI 10.1164/ajrccm.155.3.9117000; *CA DEP HLTH SERV, 1998, CONT INV GUID; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P39; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P79; Chaves F, 1996, J CLIN MICROBIOL, V34, P1118, DOI 10.1128/JCM.34.5.1118-1123.1996; COUNSELL SR, 1989, ARCH INTERN MED, V149, P1274, DOI 10.1001/archinte.149.6.1274; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; MATHUR P, 1994, ARCH INTERN MED, V154, P306, DOI 10.1001/archinte.154.3.306; MOUDGIL H, 1994, RESP MED, V88, P507, DOI 10.1016/S0954-6111(05)80332-4; Raffalli J, 1996, ARCH INTERN MED, V156, P1053, DOI 10.1001/archinte.156.10.1053; ROTHENBERG RB, 1996, INVESTIGATION CONTAC, P34; RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Woelffer GB, 1996, AM J MED SCI, V311, P17, DOI 10.1097/00000441-199601000-00004	27	60	64	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2968	2974		10.1001/jama.283.22.2968	http://dx.doi.org/10.1001/jama.283.22.2968			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865275	Bronze			2022-12-28	WOS:000087480600037
J	Gavaghan, H				Gavaghan, H			New UK legislation aids fight against discrimination	NATURE			English	Article																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					716	717		10.1038/35015274	http://dx.doi.org/10.1038/35015274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864334				2022-12-28	WOS:000087465800056
J	Keeling, PJ; Palmer, JD				Keeling, PJ; Palmer, JD			Phylogeny - Parabasalian flagellates are ancient eukaryotes	NATURE			English	Article							EVOLUTION; HYDROGENOSOMES		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Keeling, PJ (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC V6T 1Z4, Canada.		Palmer, Jeffrey/P-6747-2014	Palmer, Jeffrey/0000-0002-4626-2220; Keeling, Patrick/0000-0002-7644-0745				BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Embley TM, 1997, TRENDS ECOL EVOL, V12, P437, DOI 10.1016/S0169-5347(97)01208-1; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; Fast NM, 1999, MOL BIOCHEM PARASIT, V99, P275, DOI 10.1016/S0166-6851(99)00017-1; Keeling PJ, 1998, BIOESSAYS, V20, P87, DOI 10.1002/(SICI)1521-1878(199801)20:1<87::AID-BIES12>3.0.CO;2-4; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Muller M, 1997, PARASITOL TODAY, V13, P166, DOI 10.1016/S0169-4758(97)01036-3; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Roger AJ, 1999, MOL BIOL EVOL, V16, P218, DOI 10.1093/oxfordjournals.molbev.a026104; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217	11	62	63	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					635	637		10.1038/35015167	http://dx.doi.org/10.1038/35015167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864312				2022-12-28	WOS:000087465800034
J	Lee, TI; Causton, HC; Holstege, FCP; Shen, WC; Hannett, N; Jennings, EG; Winston, F; Green, NR; Young, RA				Lee, TI; Causton, HC; Holstege, FCP; Shen, WC; Hannett, N; Jennings, EG; Winston, F; Green, NR; Young, RA			Redundant roles for the TFIID and SAGA complexes in global transcription	NATURE			English	Article							POLYMERASE-II TRANSCRIPTION; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VIVO; HISTONE ACETYLTRANSFERASE; NUCLEOSOME ACETYLATION; ADA-COMPLEX; YEAST; GCN5; ACTIVATION	The transcription factors TFIID and SAGA are multi-subunit complexes involved in transcription by RNA polymerase II1,2. TFIID and SAGA contain common TATA-binding protein (TBP)-associated factor (TAF(II)) subunits and each complex contains a subunit with histone acetyltransferase activity(3). These observations have raised questions about whether the functions of the two complexes in vivo are unique or overlapping. Here we use genome-wide expression analysis to investigate how expression of the yeast genome depends on both shared and unique subunits of these two complexes. We find that expression of most genes requires one or more of the common TAF(II) subunits, indicating that the functions of TFIID and SAGA are widely required for gene expression. Among the subunits shared by TFIID and SAGA are three histone-like TAF(II)s, which have been proposed to forma sub-complex and mediate a common function in global transcription. Unexpectedly, we find that the histonelike TAF(II)s have distinct roles in expression of the yeast genome. Most importantly, we show that the histone acetylase components of TFIID and SAGA (TAF(II)145 and Gcn5) are functionally redundant, indicating that expression of a large fraction of yeast genes can be regulated through the action of either complex.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Utrecht, Med Ctr, Dept Med Genet, NL-3584 EA Utrecht, Netherlands; Univ Massachusetts, Med Ctr, Program Mol Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Utrecht University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Holstege, Frank/AAM-9944-2021; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Causton, Helen/0000-0003-4630-6569				Apone LM, 1996, GENE DEV, V10, P2368, DOI 10.1101/gad.10.18.2368; Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Hahn S, 1998, CELL, V95, P579, DOI 10.1016/S0092-8674(00)81625-6; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; Komarnitsky PB, 1999, GENE DEV, V13, P2484, DOI 10.1101/gad.13.19.2484; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Natarajan K, 1998, MOL CELL, V2, P683, DOI 10.1016/S1097-2765(00)80166-5; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Roberts SM, 1997, GENETICS, V147, P451; Sanders SL, 1999, J BIOL CHEM, V274, P18847, DOI 10.1074/jbc.274.27.18847; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; Walker SS, 1997, CELL, V90, P607, DOI 10.1016/S0092-8674(00)80522-X; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	29	297	301	1	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					701	704		10.1038/35015104	http://dx.doi.org/10.1038/35015104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864329				2022-12-28	WOS:000087465800051
J	Levitin, C				Levitin, C			New Russian science head named	NATURE			English	News Item																		KIRPICHNIKOV M, 2000, NATURE, V405, P384	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					601	601		10.1038/35015220	http://dx.doi.org/10.1038/35015220			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864288	Bronze			2022-12-28	WOS:000087465800004
J	Uhlen, P; Laestadius, A; Jahnukainen, T; Soderblom, T; Backhed, F; Celsi, G; Brismar, H; Normark, S; Aperia, A; Richter-Dahlfors, A				Uhlen, P; Laestadius, A; Jahnukainen, T; Soderblom, T; Backhed, F; Celsi, G; Brismar, H; Normark, S; Aperia, A; Richter-Dahlfors, A			alpha-Haemolysin of uropathogenic E-coli induces Ca2+ oscillations in renal epithelial cells	NATURE			English	Article							ESCHERICHIA-COLI; ACUTE PYELONEPHRITIS; HEMOLYSIN; CALCIUM; ACTIVATION; EXPRESSION	Pyelonephritis is one of the most common febrile diseases in children. If not treated appropriately, it causes irreversible renal damage and accounts for a large proportion of end stage renal failures(1). Renal scarring can occur in the absence of inflammatory cells, indicating that bacteria may have a direct signalling effect on renal cells(2). Intracellular calcium ([Ca2+](i)) oscillations can protect cells from the cytotoxic effects of prolonged increases in intracellular calcium(3,4). However, no pathophysiologically relevant protein that induces such oscillations has been identified. Here we show that infection by uropathogenic Escherichia coli induces a constant, low-frequency oscillatory [Ca2+](i) response in target primary rat renal epithelial cells induced by the secreted RTX (repeats-in-toxin) toxin alpha-haemolysin. The response depends on calcium influx through L-type calcium channels as well as from internal stores gated by inositol triphosphate. Internal calcium oscillations induced by alpha-haemolysin in a renal epithelial cell line stimulated production of cytokines interleukin (IL)-6 and IL-8. Our findings indicate a novel role for alpha-haemolysin in pyelonephritis: as an inducer of an oscillating second messenger response in target cells, which fine-tunes gene expression during the inflammatory response.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Women & Child Hlth, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Richter-Dahlfors, A (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.	agneta.richter.dahlfors@mtc.ki.se	Backhed, Fredrik/ABE-6613-2020; Brismar, Hjalmar/E-8524-2011	Backhed, Fredrik/0000-0002-4871-8818; Brismar, Hjalmar/0000-0003-0578-4003; Uhlen, Per/0000-0003-1446-1062; Richter-Dahlfors, Agneta/0000-0002-5479-7591				BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BLUM G, 1994, INFECT IMMUN, V62, P606, DOI 10.1128/IAI.62.2.606-614.1994; BOLSOVER SR, 1993, ELECT LIGHT MICROSCO, P181; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; HACKER J, 1983, INFECT IMMUN, V42, P57, DOI 10.1128/IAI.42.1.57-63.1983; JACOBSON SH, 1994, NEPHRON, V67, P172, DOI 10.1159/000187923; Jenkins G. M., 1969, SPECTRAL ANAL ITS AP, P1; LARSSON S, 1986, AM J PHYSIOL, V251, pC455, DOI 10.1152/ajpcell.1986.251.3.C455; LUDWIG A, 1987, MOL GEN GENET, V206, P238, DOI 10.1007/BF00333579; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATTSBYBALTZER I, 1982, INFECT IMMUN, V35, P639, DOI 10.1128/IAI.35.2.639-646.1982; Meldolesi J, 1998, NATURE, V392, P863, DOI 10.1038/31804; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Serlachius E, 1997, KIDNEY INT, V51, P1855, DOI 10.1038/ki.1997.253; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; TULLUS K, 1984, J INFECT DIS, V150, P728, DOI 10.1093/infdis/150.5.728; VOGEL M, 1988, MOL GEN GENET, V212, P76, DOI 10.1007/BF00322447; WING AJ, 1992, OXFORD TXB CLIN NEPH, V2, P1227	25	190	197	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					694	697		10.1038/35015091	http://dx.doi.org/10.1038/35015091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864327				2022-12-28	WOS:000087465800049
J	Rivara, FP; Koepsell, TD; Grossman, DC; Mock, C				Rivara, FP; Koepsell, TD; Grossman, DC; Mock, C			Effectiveness of automatic shoulder belt systems in motor vehicle crashes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; SEAT-BELT; RATES	Context Approximately 10 million cars with automatic shoulder belt systems are currently in use in the United States. However, reports on the effectiveness of such restraints have yielded conflicting results. Objective To determine the effectiveness of automatic shoulder belt systems in reducing the risk of injury and death among front-seat passenger vehicle occupants. Design, Setting, and Subjects Analysis of data collected from the 1993-1996 National Highway Traffic Safety Administration Crashworthiness Data System on front-seat occupants involved in 25 811 tow-away crashes of passenger cars, light trucks, vans, and sport utility vehicles, Main Outcome Measures Death and serious injury to specific body areas by use of manual lap and shoulder belts, automatic shoulder belts with manual lap belts, or automatic shoulder belts without lap belts, compared with no restraint use. Results Use of automatic shoulder belts without lap belts was associated with a decrease in the risk of death vs no restraint use but was not statistically significant for all crashes (odds ratio [OR], 0.66; 95% confidence interval [CI], 0.42-1.06) or for frontal crashes (OR, 0.71; 95% CI, 0.38-1.35) after adjustment for occupant age, sex, vehicle year, airbag deployment, estimated change in vehicle speed during the crash, and principal direction of force. This association was significantly weaker than the 86% lower risk observed for use of automatic shoulder belts with lap belts (OR, 0.14; 95% CI, 0.07-0.26 vs no restraint; P<.05). Use of automatic shoulder belts without lap belts was associated with an increased risk of serious chest (OR, 2.66; 95% CI, 1.11-6.35) and abdominal (OR, 2.06; 95% CI, 1.004-4.22) injuries for all crashes. Conclusions These data indicate that improperly used automatic restraint systems may be less effective than properly used systems and are associated with an increased risk of serious chest and abdominal injuries. Given the continued widespread use of these automatic systems, educational programs may be warranted.	Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; Univ Washington, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98104 USA; Crash Injury Res & Engn Network, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rivara, FP (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.			Mock, Charles/0000-0002-0564-568X				Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; EVANS L, 1991, ACCIDENT ANAL PREV, V23, P165, DOI 10.1016/0001-4575(91)90046-8; McConnell EJ, 1997, J TRAUMA, V43, P150, DOI 10.1097/00005373-199707000-00038; NASH CE, 1989, ACCIDENT ANAL PREV, V21, P517, DOI 10.1016/0001-4575(89)90067-5; *NAT HIGHW TRAFF S, 1992, HS PUBL; *NAT HIGHW TRAFF S, 1996, HS PUBL; REINFURT DW, 1991, ACCIDENT ANAL PREV, V23, P521, DOI 10.1016/0001-4575(91)90017-Y; ROH LS, 1993, J FORENSIC SCI, V38, P972; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; SALDEEN T, 1967, J TRAUM, V7, P856, DOI 10.1097/00005373-196711000-00007; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; TAYLOR TKF, 1976, J BONE JOINT SURG BR, V58, P328, DOI 10.1302/0301-620X.58B3.956250; Veenema Kenneth R., 1994, Journal of Emergency Medicine, V12, P317, DOI 10.1016/0736-4679(94)90272-0; WILLIAMS AF, 1989, ACCIDENT ANAL PREV, V21, P427, DOI 10.1016/0001-4575(89)90003-1; YARBROUGH BE, 1990, SOUTHERN MED J, V83, P843, DOI 10.1097/00007611-199007000-00029; 1999, NATL VEHICLE POPULAT	17	41	42	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2826	2828		10.1001/jama.283.21.2826	http://dx.doi.org/10.1001/jama.283.21.2826			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320BQ	10838652	Bronze			2022-12-28	WOS:000087381500038
J	Gimeno, JR; Inigo, LA; Lopez-Palop, R; Chavarri, MV				Gimeno, JR; Inigo, LA; Lopez-Palop, R; Chavarri, MV			Atypical angina	LANCET			English	Article									Hosp Virgen de la Arrixca, Murcia, Spain		Gimeno, JR (corresponding author), Avda Miguel Cervantes 56,Esc 2,7B, Murcia 30009, Spain.		Luis Antonio, Íñigo-García/H-6079-2011; Blanes, Juan R Gimeno/I-4269-2015; Palop, Ramon Lopez/I-2162-2014	Blanes, Juan R Gimeno/0000-0001-5818-1754; Palop, Ramon Lopez/0000-0003-4385-7939				FOX JJ, 1992, CATHETER CARDIO DIAG, V26, P127, DOI 10.1002/ccd.1810260210; FREEDBERG RS, 1988, CIRCULATION, V77, P96, DOI 10.1161/01.CIR.77.1.96; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SEMELKA RC, 1992, JMRI-J MAGN RESON IM, V2, P415, DOI 10.1002/jmri.1880020410	5	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1966	1966		10.1016/S0140-6736(00)02329-1	http://dx.doi.org/10.1016/S0140-6736(00)02329-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859043				2022-12-28	WOS:000087381900014
J	Lees, KR; Asplund, K; Carolei, A; Davis, SM; Diener, HC; Kaste, M; Orgogozo, JM; Whitehead, J				Lees, KR; Asplund, K; Carolei, A; Davis, SM; Diener, HC; Kaste, M; Orgogozo, JM; Whitehead, J			Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial	LANCET			English	Article							ACUTE ISCHEMIC STROKE; BARTHEL INDEX; SCALE; LUBELUZOLE; PLACEBO; THERAPY	Background Early treatment may improve acute ischaemic stroke outcome. Gavestinel is a selective antagonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor, and is neuroprotective in animal models of ischaemic stroke. Methods We did a randomised, double-blind, placebo-controlled trial to test whether gavestinel could improve functional outcome after acute stroke in human beings. Conscious patients with Stroke involving limb weakness received either gavestinel at an intravenous loading dose of 800 mg followed by 200 mg every 12 h for five doses, or matching placebo, within 6 h of stroke onset. Stratification variables were age and stroke severity. A computed tomography brain scan within 18 h of stroke onset identified the primary efficacy population with ischaemic stroke. Outcome was assessed by an independent observer with the Barthel index at 3 months. Three outcome categories were applied: good (Barthel index 95-100), moderate (60-90), and poor (0-55 or dead). Analysis was by intention to treat. Findings Of 1804 patients randomised, 16 received no treatment, and 333 bad primary intracranial haemorrhage. 891 patients received gavestinel and 897 received placebo. Outcome in 721 patients who received gavestinel and were analysed for the primary endpoint at 3 months was good in 246 (34.1%), moderate in 136 (18.8%), and poor in 339 (47.0%), compared with 256 (34.9%), 133 (18.1%), and 345 (47.0%), respectively, of 734 patients who received placebo (p=0.8). Mortality at 3 months was 147 (20.4%) in the gavestinel group and 138 (18.8%) in the placebo group. Outcomes within preplanned subgroup and secondary analyses were also neutral. There were no significant differences in serious side-effects between the groups. Interpretation Treatment with gavestinel within 6 h of acute ischaemic stroke did not improve outcome.	Univ Glasgow, Western Infirm, Gardiner Inst, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland; Umea Univ Hosp, Dept Med, S-90185 Umea, Sweden; Osped S Maria di Collemaggio, Neurol Clin, Laquila, Italy; Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic, Australia; Univ Essex, Dept Neurol, Essen, Germany; Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; Grp Hosp Pellegrin, Dept Neurol, Bordeaux, France; Univ Reading, Med & Pharmaceut Res Stat Res Unit, Reading, Berks, England	University of Glasgow; Umea University; Royal Melbourne Hospital; University of Duisburg Essen; University of Helsinki; Helsinki University Central Hospital; CHU Bordeaux; University of Reading	Lees, KR (corresponding author), Univ Glasgow, Western Infirm, Gardiner Inst, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland.	k.r.lees@clinmed.gla.ac.uk	Diener, Hans-Christoph/AAF-7275-2019; Davis, Stephen M/L-5260-2013; Chen, Christopher/E-7023-2013	Davis, Stephen M/0000-0003-0962-2300; Chen, Christopher/0000-0002-1047-9225; Kaste, Markku/0000-0001-6557-6412				Babikian V, 2000, STROKE, V31, P358; Baron JC, 1999, CEREBROVASC DIS, V9, P193, DOI 10.1159/000015955; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; De Keyser J, 1999, TRENDS NEUROSCI, V22, P535, DOI 10.1016/S0166-2236(99)01463-0; Dewar D, 1999, EUR J PHARMACOL, V375, P41, DOI 10.1016/S0014-2999(99)00280-0; Di Fabio Romano, 1998, Drugs of the Future, V23, P61, DOI 10.1358/dof.1998.023.01.442870; Diener HC, 1998, CEREBROVASC DIS, V8, P172, DOI 10.1159/000015847; Dyker AG, 1999, STROKE, V30, P986, DOI 10.1161/01.STR.30.5.986; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Grotta J, 1997, STROKE, V28, P2338, DOI 10.1161/01.STR.28.12.2338; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Heiss WD, 1999, STROKE, V30, P1486, DOI 10.1161/01.STR.30.7.1486; Hiroshi Y, 1997, BRAIN RES, V753, P80, DOI 10.1016/S0006-8993(96)01494-1; Hoke JF, 2000, EUR J CLIN PHARMACOL, V55, P867, DOI 10.1007/s002280050709; LEES KR, 1999, IN PRESS CEREBROVASC; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; MAHONEY F I, 1965, Md State Med J, V14, P61; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MCCULLOCH J, 1991, ARZNEIMITTEL-FORSCH, V41-1, P319; RANKIN J, 1957, Scott Med J, V2, P200; Sacco RL, 2000, NEUROLOGY, V54, pA87; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; The NINDS t-PA Stroke Study Group, 1998, STROKE, V28, P2119; Tilley BC, 1996, STROKE, V27, P2136, DOI 10.1161/01.STR.27.11.2136; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wahlgren NG, 1999, STROKE, V30, P21, DOI 10.1161/01.STR.30.1.21; WARNER DS, 1995, J CEREBR BLOOD F MET, V15, P188, DOI 10.1038/jcbfm.1995.24; WESTER P, 2000, CEREBROVASC DIS, V10, P76; Whitehead J, 1993, DRUG INF J, V27, P733, DOI 10.1177/009286159302700315	32	238	253	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1949	1954		10.1016/S0140-6736(00)02326-6	http://dx.doi.org/10.1016/S0140-6736(00)02326-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859040				2022-12-28	WOS:000087381900011
J	Butler, D				Butler, D			France plans marine research port at Brest	NATURE			English	News Item																		Butler D, 1998, NATURE, V392, P323, DOI 10.1038/32751; 1996, NATURE, V379, P576	2	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					498	498		10.1038/35014767	http://dx.doi.org/10.1038/35014767			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850681	Bronze			2022-12-28	WOS:000087449500008
J	Kuhn, JR; Armstrong, JD; Bush, RI; Scherrer, P				Kuhn, JR; Armstrong, JD; Bush, RI; Scherrer, P			Rossby waves on the Sun as revealed by solar 'hills'	NATURE			English	Article							ROTATING STAR; OSCILLATIONS; SUPERGRANULATION; MODES	It is a long-standing puzzle that the Sun's photosphere-its visible surface-rotates differentially, with the equatorial regions rotating faster than the poles. It has been suggested(1) that waves analogous to terrestrial Rossby waves, and known as r-mode oscillations, could explain the Sun's differential rotation: Rossby waves are seen(2) in the oceans as large-scale (hundreds of kilometres) variations of sea-surface height (5-cm-high waves), which propagate slowly either east or west (they could take tens of years to cross the Pacific Ocean). Calculations show that the solar r-mode oscillations have properties that should be strongly constrained by differential rotation(3). Here we report the detection of 100-m-high 'hills' in the photosphere, spaced uniformly over the Sun's surface with a spacing of (8.7 +/- 0.6) x 10(4) km. If convection under the photosphere is organized by the r-modes, the observed corrugated photosphere is a probable surface manifestation of these solar oscillations.	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Stanford Univ, HEPL 4085, Stanford, CA 94305 USA	University of Hawaii System; Stanford University	Kuhn, JR (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.			Kuhn, Jeff/0000-0003-1361-9104; Scherrer, Philip/0000-0002-6937-6968				Chelton DB, 1996, SCIENCE, V272, P234, DOI 10.1126/science.272.5259.234; Kuhn JR, 1998, NATURE, V392, P155, DOI 10.1038/32361; KUMAR P, 1996, ASTROPHYS J, V458, P83; Lazrek M, 1997, SOL PHYS, V175, P227, DOI 10.1023/A:1004942929956; PAPALOIZOU J, 1978, MON NOT R ASTRON SOC, V182, P423, DOI 10.1093/mnras/182.3.423; Plaskett H.H., 1966, MNRAS, V131, P407; PROVOST J, 1981, ASTRON ASTROPHYS, V94, P126; RICE SO, 1944, BELL SYST TECH J, V23, P1; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Schrijver CJ, 1997, ASTROPHYS J, V475, P328, DOI 10.1086/303528; WOLFF CL, 1995, ASTROPHYS J, V443, P423, DOI 10.1086/175535; WOLFF CL, 1974, ASTROPHYS J, V193, P721, DOI 10.1086/153211; WOLFF CL, 1986, SOL PHYS, V105, P1, DOI 10.1007/BF00156371; Wolff CL, 1998, ASTROPHYS J, V502, P961, DOI 10.1086/305934	14	49	50	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					544	546		10.1038/35014530	http://dx.doi.org/10.1038/35014530			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850707				2022-12-28	WOS:000087449500042
J	Dobson, A; Lyles, A				Dobson, A; Lyles, A			Ecology - Black-footed ferret recovery	SCIENCE			English	Editorial Material									Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Wildlife Conservat Soc, New York, NY 10010 USA	Princeton University; Wildlife Conservation Society	Dobson, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.							Biggins DE, 1999, BIOL CONSERV, V89, P121, DOI 10.1016/S0006-3207(98)00158-X; Vargas A, 1998, CAN J ZOOL, V76, P1696, DOI 10.1139/cjz-76-9-1696; WILCOVE D. S., 1999, CONDORS SHADOW LOSS	3	52	55	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					985	+		10.1126/science.288.5468.985	http://dx.doi.org/10.1126/science.288.5468.985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10841720				2022-12-28	WOS:000086988400024
J	Bass, BL				Bass, BL			Double-stranded RNA as a template for gene silencing	CELL			English	Review							CAENORHABDITIS-ELEGANS; C-ELEGANS; INTERFERENCE		Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bass, BL (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA.	bbass@howard.genetics.utah.edu						Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Elela SA, 1998, EMBO J, V17, P3738, DOI 10.1093/emboj/17.13.3738; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Homann M, 1996, NUCLEIC ACIDS RES, V24, P4395, DOI 10.1093/nar/24.22.4395; HOUGH RF, 1994, J BIOL CHEM, V269, P9933; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; Rotondo G, 1997, RNA, V3, P1182; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	19	311	474	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					235	238		10.1016/S0092-8674(02)71133-1	http://dx.doi.org/10.1016/S0092-8674(02)71133-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847677	Bronze			2022-12-28	WOS:000086741900001
J	Maron, BJ				Maron, BJ			Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy	LANCET			English	Editorial Material							REDUCTION		Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA	Minneapolis Heart Institute Foundation	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA.							Gietzen FH, 1999, EUR HEART J, V20, P1342, DOI 10.1053/euhj.1999.1520; Henein MY, 1999, J AM COLL CARDIOL, V34, P1117, DOI 10.1016/S0735-1097(99)00332-0; Knight C, 1997, CIRCULATION, V95, P2075, DOI 10.1161/01.CIR.95.8.2075; Lakkis NM, 1998, CIRCULATION, V98, P1750, DOI 10.1161/01.CIR.98.17.1750; Maron BJ, 1998, CIRCULATION, V98, P2505, DOI 10.1161/01.CIR.98.23.2505; Maron BJ, 1999, CIRCULATION, V99, P2927, DOI 10.1161/01.CIR.99.22.2927; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; MARON BJ, IN PRESS N ENGL J ME; Nagueh SF, 1999, CIRCULATION, V99, P344, DOI 10.1161/01.CIR.99.3.344; Rubin David N., 1999, Journal of the American College of Cardiology, V33, p502A; Seggewiss H, 1998, J AM COLL CARDIOL, V31, P252, DOI 10.1016/S0735-1097(97)00508-1; SIGWART U, 1995, LANCET, V346, P211, DOI 10.1016/S0140-6736(95)91267-3; Spirito P, 1999, J AM COLL CARDIOL, V33, P1071	13	51	54	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					425	426		10.1016/S0140-6736(00)82005-X	http://dx.doi.org/10.1016/S0140-6736(00)82005-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841119				2022-12-28	WOS:000085306800005
J	Tabar, L; Chen, HH; Duffy, SW; Yen, MF; Chiang, CF; Dean, PB; Smith, RA				Tabar, L; Chen, HH; Duffy, SW; Yen, MF; Chiang, CF; Dean, PB; Smith, RA			A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study	LANCET			English	Article							CARCINOMA-IN-SITU; MAMMOGRAPHIC FEATURES; MUCINOUS CARCINOMA; CLASSIFICATION; TRIAL; PURE	Background Women with small mammographically detected breast cancers generally have good long-term outcomes, but a few with T1a (1-5 mm) and T1b (6-10 mm) tumours will eventually die from breast cancer. We investigated whether Women at high risk of breast-cancer death could be identified with mammographic criteria and differentiated from women with small cancers of the breast and good outcomes. Methods We prospectively applied mammographic classifications of tumour type to a consecutive series of 343 mammograms of invasive breast cancers of size 1-14 mm, Classifications were: stellate (spiculated) mass with no calcifications; circular or oval lesions with no calcifications; spiculated or circular lesions with non-casting-type calcifications; and casting-type calcifications. Findings 20-year survival for women with 1-14 mm invasive tumours with casting-type calcifications was 55%. 14% of 138 women with 1-9 mm tumours had casting-type calcifications-on mammography, which accounted for 73% of ail breast-cancer deaths (p<0.001). T1a, T1b, and 10-14 mm tumours with casting-type calcifications behaved as if they were larger lesions, since the rate of death was similar to that for women with advanced high-grade tumours, Most women who died were node-negative. The long-term survival of women who had tumours of 1-9 mm with no casting-type calcifications was about 95%. Interpretation Mammographic classification seemed to reliably predict good and bad long-term outcomes for survival in tumours of 14 mm or smaller, and especially for those smaller than 10 mm. The implications for therapy are substantial.	Falun Cent Hosp, Dept Mammog, S-79182 Falun, Sweden; Uppsala Univ, Fac Med, Dept Radiol, Uppsala, Sweden; Natl Taiwan Univ, Coll Publ Hlth, Dept Epidemiol, Taipei 10764, Taiwan; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Univ Turku, Turku, Finland; Amer Canc Soc, Dept Canc Control, Atlanta, GA 30329 USA	Falun Hospital; Uppsala University; National Taiwan University; MRC Biostatistics Unit; University of Cambridge; University of Turku; American Cancer Society	Tabar, L (corresponding author), Falun Cent Hosp, Dept Mammog, S-79182 Falun, Sweden.	laszlo@mammographic.com	Tabar, Laszlo Kornel/AGT-3287-2022	Dean, Peter/0000-0003-0757-9054; Chen, Hsiu-Hsi/0000-0002-5799-6705				*AM COLL RAD, 1998, MAMM BREAST IM REP D; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; EVANS AJ, 1994, CLIN RADIOL, V49, P559, DOI 10.1016/S0009-9260(05)82937-X; Evans AJ, 1997, BRIT J CANCER, V75, P542, DOI 10.1038/bjc.1997.94; GOODMAN DNF, 1995, CAN ASSOC RADIOL J, V46, P296; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Hermann G, 1999, CAN ASSOC RADIOL J, V50, P235; HILLEREN DJ, 1991, RADIOLOGY, V178, P149, DOI 10.1148/radiology.178.1.1984294; HOLLAND R, 1990, LANCET, V335, P519, DOI 10.1016/0140-6736(90)90747-S; HOLLAND R, 1994, SEMIN DIAGN PATHOL, V11, P167; Joensuu H, 1999, CANCER-AM CANCER SOC, V85, P2183, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2183::AID-CNCR12>3.0.CO;2-K; LAGIOS MD, 1989, CANCER, V63, P618, DOI 10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J; Lanyi M., 1988, DIAGNOSIS DIFFERENTI; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; Silverstein MJ, 1999, NEW ENGL J MED, V340, P1455, DOI 10.1056/NEJM199905133401902; Simpson JF, 1996, SEMIN ONCOL, V23, P428; Tabar L, 1999, CANCER, V86, P449, DOI 10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; TABAR L, 1999, RSNA CATEGORICAL COU, P9; TABAR L, 1983, TEACHING ATLAS MAMMO; TABAR L, 1997, DUCTAL CARCINOMA IN, P95; TUBIANA M, 1991, BREAST CANCER RES TR, V18, P125, DOI 10.1007/BF01990028; Tubiana M, 1999, ACTA ONCOL, V38, P295; WILSON TE, 1995, AM J ROENTGENOL, V165, P285, DOI 10.2214/ajr.165.2.7618541	28	132	143	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					429	433						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841122				2022-12-28	WOS:000085306800008
J	Leon, DA; Smith, GD				Leon, DA; Smith, GD			Infant mortality, stomach cancer, stroke, and coronary heart disease: ecological analysis	BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.		Davey Smith, George/A-7407-2013; Leon, David A/G-2195-2010	Davey Smith, George/0000-0002-1407-8314; Leon, David A/0000-0001-9747-1762				Elford J, 1997, LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY, P220; Gale CR, 1997, J ROY SOC MED, V90, P138, DOI 10.1177/014107689709000307; Parsonnet J, 1999, MICROBES AND MALIGNANCY, P372; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; *UN, 1948, IUN DEM YB, P70	5	57	59	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1705	1706		10.1136/bmj.320.7251.1705	http://dx.doi.org/10.1136/bmj.320.7251.1705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864546	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000087926400024
J	Li, BY; Yu, H; Zheng, WP; Voll, R; Na, SQ; Roberts, AW; Williams, DA; Davis, RJ; Ghosh, S; Flavell, RA				Li, BY; Yu, H; Zheng, WP; Voll, R; Na, SQ; Roberts, AW; Williams, DA; Davis, RJ; Ghosh, S; Flavell, RA			Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation	SCIENCE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; TRANSGENIC MICE; KAPPA-B; ACTIVATION; PROTEIN; RHO; LYMPHOCYTES; KINASE; REQUIRES	T helper 1 (T(H)1) cells mediate cellular immunity, whereas T(H)2 cells potentiate antiparasite and humoral immunity. We used a complementary DNA subtraction method, representational display analysis, to show that the small guanosine triphosphatase Rac2 is expressed selectively in murine T(H)1 cells. Rac induces the interferon-gamma (IFN-gamma) promoter through cooperative activation of the nuclear factor kappa B and p38 mitogen-activated protein kinase pathways. Tetracycline-regulated transgenic mice expressing constitutively active Rac2 in T cells exhibited enhanced IFN-gamma production. Dominant-negative pac inhibited IFN-gamma production in murine T cells. Moreover, T cells from Rac2(-/-) mice showed decreased IFN-gamma production under T(H)1 conditions in vitro. Thus, Rac2 activates T(H)1-specific signaling and IFN-gamma gene expression.	Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Indiana Univ, Sch Med, Howard Hughes Med Inst, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Univ Massachusetts, Med Ctr, Howard Hughes Med Inst, Worcester, MA 01605 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunol Sect, 310 Cedar St, New Haven, CT 06520 USA.	fran.manzo@yale.edu	Roberts, Andrew W./C-6736-2012	Roberts, Andrew W./0000-0002-7341-5720				Aune TM, 1997, MOL CELL BIOL, V17, P199, DOI 10.1128/MCB.17.1.199; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Kaga S, 1998, J IMMUNOL, V160, P24; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Li B. A., UNPUB; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Phillips RJ, 1996, MOL CELL BIOL, V16, P7089; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Reif K, 1998, IMMUNITY, V8, P395, DOI 10.1016/S1074-7613(00)80545-2; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; YU H, UNPUB; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	24	132	144	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2219	+		10.1126/science.288.5474.2219	http://dx.doi.org/10.1126/science.288.5474.2219			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864872				2022-12-28	WOS:000087782900060
J	Dobson, R				Dobson, R			Mosquitoes prefer pregnant women	BRITISH MEDICAL JOURNAL			English	News Item																		Lindsay S, 2000, LANCET, V355, P1972, DOI 10.1016/S0140-6736(00)02334-5	1	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1558	1558						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845952				2022-12-28	WOS:000087631400009
J	Packham, C; Pearson, J; Robinson, J; Gray, D				Packham, C; Pearson, J; Robinson, J; Gray, D			Use of statins in general practices, 1996-8: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham Hosp, Queens Med Ctr, Div Publ Hlth Med, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Div Epidemiol, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Div Cardiovasc Med, Nottingham NG7 2UH, England; Nottingham Hlth Author, Nottingham NG1 6GN, England	University of Nottingham; University of Nottingham; University of Nottingham	Packham, C (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Publ Hlth Med, Nottingham NG7 2UH, England.	chris.packham@nottingham.ac.uk						BAXTER C, 1998, BMJ-BRIT MED J, V317, P134; Packham C, 1999, J PUBLIC HEALTH MED, V21, P60, DOI 10.1093/pubmed/21.1.60; PEDERSEN TR, 1994, LANCET, V344, P1383; PICKEN DM, 1996, STATIN THERAPY HMG C; TOWNSEND P, 1998, HLTH DEPRIVATION INE	5	32	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2000	320	7249					1583	1584		10.1136/bmj.320.7249.1583	http://dx.doi.org/10.1136/bmj.320.7249.1583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845969	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000087631400025
J	Bosch, X				Bosch, X			Spain in quandary over French synchrotron	NATURE			English	News Item																		1999, NATURE, V400, P393	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					604	604		10.1038/35015230	http://dx.doi.org/10.1038/35015230			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864292	Bronze			2022-12-28	WOS:000087465800008
J	Li, YM; Xu, M; Lai, MT; Huang, Q; Castro, JL; DiMuzio-Mower, J; Harrison, T; Lellis, C; Nadin, JL; Neduvelil, JG; Register, RB; Sardana, MK; Shearman, MS; Smith, AL; Shi, XP; Yin, KC; Shafer, JA; Gardell, SJ				Li, YM; Xu, M; Lai, MT; Huang, Q; Castro, JL; DiMuzio-Mower, J; Harrison, T; Lellis, C; Nadin, JL; Neduvelil, JG; Register, RB; Sardana, MK; Shearman, MS; Smith, AL; Shi, XP; Yin, KC; Shafer, JA; Gardell, SJ			Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1	NATURE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; IN-VIVO; CELL BIOLOGY; ENDOPROTEOLYSIS; MUTATIONS; PEPTIDES; GENE	Cleavage of amyloid precursor protein (APP) by the beta- and gamma-secretases generates the amino and carboxy termini, respectively, of the A beta amyloidogenic peptides A beta 40 and A beta 42-the major constituents of the amyloid plaques in the brain parenchyma of Alzheimer's disease patients(1). There is evidence that the polytopic membrane-spanning proteins, presenilin 1 and 2 (PS1 and PS2), are important determinants of gamma-secretase activity: mutations in PS1 and PS2 that are associated with early-onset familial Alzheimer's disease(2,3) increase the production of A beta 42 (refs 4-6), the more amyloidogenic peptide; gamma-secretase activity is reduced in neuronal cultures derived from PS1-deficient mouse embryos(7); and directed mutagenesis of two conserved aspartates in transmembrane segments of PS1 inactivates the ability of gamma-secretase to catalyse processing of APP within its transmembrane domain(8). It is unknown, however, whether PS1 (which has little or no homology to any known aspartyl protease) is itself a transmembrane aspartyl protease or a gamma-secretase cofactor, or helps to colocalize gamma-secretase and APP. Here we report photoaffinity labelling of PS1 (and PS2) by potent gamma-secretase inhibitors that were designed to function as transition state analogue inhibitors directed to the active site of an aspartyl protease. This observation indicates that PS1 (and PS2) may contain the active site of gamma-secretase. Interestingly, the intact, single-chain form of wild-type PS1 is not labelled by an active-site-directed photoaffinity probe, suggesting that intact wild-type PS1 may be an aspartyl protease zymogen.	Merck Res Labs, Dept Biol Chem, West Point, PA 19486 USA; Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England	Merck & Company; Merck & Company	Li, YM (corresponding author), Merck Res Labs, Dept Biol Chem, West Point, PA 19486 USA.	yueming_li@merck.com; steve_gardell@merck.com						Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; EVANS BE, 1985, J ORG CHEM, V50, P4615, DOI 10.1021/jo00223a037; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Khorkova OE, 1998, J NEUROSCI METH, V82, P159, DOI 10.1016/S0165-0270(98)00053-3; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LI YM, IN PRESS P NATL ACAD; PerezTur J, 1995, NEUROREPORT, V7, P297; RICH DH, 1986, INHIBITORS ASPARTIC, P179; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SHEARMAN MS, IN PRESS BIOCHEMISTR; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; YANG HJ, 1994, BIO-TECHNOL, V12, P193, DOI 10.1038/nbt0294-193	23	830	870	5	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					689	694		10.1038/35015085	http://dx.doi.org/10.1038/35015085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864326				2022-12-28	WOS:000087465800048
J	Whaley, SR; English, DS; Hu, EL; Barbara, PF; Belcher, AM				Whaley, SR; English, DS; Hu, EL; Barbara, PF; Belcher, AM			Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly	NATURE			English	Article							NANOPARTICLES; ORGANIZATION; DNA	In biological systems, organic molecules exert a remarkable level of control over the nucleation and mineral phase of inorganic materials such as calcium carbonate and silica, and over the assembly of crystallites and other nanoscale building blocks into complex structures required for biological function(1-4). This ability to direct the assembly of nanoscale components into controlled and sophisticated structures has motivated intense efforts to develop assembly methods that mimic or exploit the recognition capabilities and interactions found in biological systems(5-10). Of particular value would be methods that could be applied to materials with interesting electronic or optical properties, but natural evolution has not selected for interactions between biomolecules and such materials. However, peptides with limited selectivity for binding to metal surfaces and metal oxide surfaces have been successfully selected(10,11). Here we extend this approach and show that combinatorial phage-display libraries can be used to evolve peptides that bind to a range of semiconductor surfaces with high specificity, depending on the crystallographic orientation and composition of the structurally similar materials we have used. As electronic devices contain structurally related materials in close proximity, such peptides may rnd use for the controlled placement and assembly of a variety of practically important materials, thus broadening the scope for 'bottom-up' fabrication approaches.	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Texas Mat Inst, Austin, TX 78712 USA; Univ Calif Santa Barbara, Ctr Quantized Elect Struct, Santa Barbara, CA 93106 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Barbara	Belcher, AM (corresponding author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.		English, Douglas/B-9382-2009; Bishnoi, Sandra/F-2762-2011					Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651; BRUST M, 1995, ADV MATER, V7, P795, DOI 10.1002/adma.19950070907; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; COLVIN VL, 1992, J AM CHEM SOC, V114, P5221, DOI 10.1021/ja00039a038; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Li M, 1999, CHEM MATER, V11, P23, DOI 10.1021/cm980610m; Meldrum F. C., 1993, P ROY SOC LOND B BIO, V251, P238; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; SWAMINATHAN V, 1991, MAT ASPECTAS GAAS IN	13	1075	1182	6	444	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					665	668		10.1038/35015043	http://dx.doi.org/10.1038/35015043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864319				2022-12-28	WOS:000087465800041
J	Gorelick, PB				Gorelick, PB			Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?	LANCET			English	Editorial Material							ISCHEMIC STROKE; THERAPY		Rush Med Coll, Ctr Stroke Res, Chicago, IL 60612 USA	Rush University	Gorelick, PB (corresponding author), Rush Med Coll, Ctr Stroke Res, Chicago, IL 60612 USA.							Ahmed S H, 2000, Curr Atheroscler Rep, V2, P167, DOI 10.1007/s11883-000-0112-2; DeGraba TJ, 2000, NEUROL CLIN, V18, P475, DOI 10.1016/S0733-8619(05)70203-6; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Fagan S C, 1999, J Stroke Cerebrovasc Dis, V8, P359, DOI 10.1016/S1052-3057(99)80043-3; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Grotta J, 1999, ANN NEUROL, V46, P496; Heiss WD, 1999, STROKE, V30, P1486, DOI 10.1161/01.STR.30.7.1486; Kidwell C S, 2000, Curr Atheroscler Rep, V2, P126, DOI 10.1007/s11883-000-0107-z; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lindsberg PJ, 2000, NEUROL CLIN, V18, P495, DOI 10.1016/S0733-8619(05)70204-8; LYDEN P, 1995, J NEUROTRAUM, V12, P223, DOI 10.1089/neu.1995.12.223; Muir KW, 1999, STROKE, V30, P180, DOI 10.1161/01.STR.30.1.180; Powers WJ, 2000, NEUROLOGY, V54, P1549, DOI 10.1212/WNL.54.8.1549; Wahlgren N G, 1999, J Stroke Cerebrovasc Dis, V8, P231, DOI 10.1016/S1052-3057(99)80072-X; Warach S, 2000, NEUROLOGY, V54, pA87; WARACH S, 2000, 22 PRINC C CER DIS R; Zivin JA, 1999, NEUROLOGY, V53, P14, DOI 10.1212/WNL.53.1.14	17	38	39	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1925	1926		10.1016/S0140-6736(00)02318-7	http://dx.doi.org/10.1016/S0140-6736(00)02318-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859032				2022-12-28	WOS:000087381900003
J	Rust, J				Rust, J			Palaeontology - Fossil record of mass moth migration	NATURE			English	Article									Univ Gottingen, Inst Zool & Anthropol, D-37073 Gottingen, Germany	University of Gottingen	Rust, J (corresponding author), Univ Gottingen, Inst Zool & Anthropol, Berliner Str 28, D-37073 Gottingen, Germany.							Bonde Niels, 1997, Aarhus Geoscience, V6, P33; HEYDEMANN BERNDT, 1967, DEUT ENTOMOL Z, V14, P185; Johnson C.G., 1969, MIGRATION DISPERSAL; KRISTENSEN NP, 1999, HDB ZOOL, V35, P7; LARSSON S G, 1975, Bulletin of the Geological Society of Denmark, V24, P193; MARTINEZDELCLOS X, 1993, DARMSTADTER BEITRAGE, V2, P133; Rust J, 1999, ZOOL J LINN SOC-LOND, V125, P331; Rust J, 1999, ENTOMOL SCAND, V30, P35; Rust Jes, 1998, Palaeontologische Zeitschrift, V72, P41; Williams C. B., 1930, MIGRATION BUTTERFLIE	10	13	13	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					530	531		10.1038/35014733	http://dx.doi.org/10.1038/35014733			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850702				2022-12-28	WOS:000087449500037
J	Gascon, C; Williamson, GB; da Fonseca, GAB				Gascon, C; Williamson, GB; da Fonseca, GAB			Ecology - Receding forest edges and vanishing reserves	SCIENCE			English	Editorial Material							TROPICAL RAIN-FOREST; HABITAT FRAGMENTATION; EASTERN AMAZON; FIRE; DEFORESTATION; RECRUITMENT; RESPONSES; BIOMASS		Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20037 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Inst Nacl Pesquisas Amazonia, Biol Dynam Forest Fragments Project, BR-69011970 Manaus, Amazonas, Brazil; Univ Fed Minas Gerais, Dept Zool, BR-31270 Belo Horizonte, MG, Brazil	Conservation International; Louisiana State University System; Louisiana State University; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Minas Gerais	Gascon, C (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, 2501 M St NW,Suite 200, Washington, DC 20037 USA.							AYRES MJ, 1997, OS CORREDORES ECOLOG; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; DEAN W, 1995, BROADAX FIREBRAND DE; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; Ferrer EJ, 1997, MOD PHYS LETT B, V11, P1, DOI 10.1142/S0217984997000025; Gascon C, 1998, ZOOL-ANAL COMPLEX SY, V101, P273; KAPOS V, 1993, J ECOL, V81, P425, DOI 10.2307/2261521; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Laurance WF, 1997, CONSERV BIOL, V11, P577, DOI 10.1046/j.1523-1739.1997.96385.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; Laurance WF, 1998, FOREST ECOL MANAG, V110, P173, DOI 10.1016/S0378-1127(98)00291-6; LAURANCE WF, 1994, BIOL CONSERV, V69, P23, DOI 10.1016/0006-3207(94)90325-5; Laurance William F., 1997, P502; Leopold A., 1933, GAME MANAGEMENT; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Nichol J. E., 1999, Progress in Environmental Science, V1, P97; PARSONS JJ, 1972, J RANGE MANAGE, V25, P12, DOI 10.2307/3896654; Sizer N, 1999, BIOL CONSERV, V91, P135, DOI 10.1016/S0006-3207(99)00076-2; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Soulu M., 1999, CONTINENTAL CONSERVA; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; Vega A, 1994, CORREDORES CONSERVAC; Viana Virgilio M., 1997, P351; WILLIAMSON BG, LESSONS AMAZONIA ECO; WILLIAMSON GB, 1998, FLORESTA AMAZONICA D, P131; [No title captured]	32	305	330	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2000	288	5470					1356	1358		10.1126/science.288.5470.1356	http://dx.doi.org/10.1126/science.288.5470.1356			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10847849				2022-12-28	WOS:000087270900032
J	Liu, SQJ; Cull-Candy, SG				Liu, SQJ; Cull-Candy, SG			Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype	NATURE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL INTERNEURONS; RECTIFICATION; NEURONS; BLOCK; MODULATION; DETERMINES; ACTIVATION; DEPRESSION; DENDRITES	Activity-dependent change in the efficacy of transmission is a basic feature of many excitatory synapses in the central nervous system. The best understood postsynaptic modification involves a change in responsiveness of AMPAR (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor)-mediated currents following activation of NMDA (N-methyl-D-aspartate) receptors(1,2) or Ca(2+)-permeable AMPARs(3-6). This process is thought to involve alteration in the number and phosphorylation state of postsynaptic AMPARs(2). Here we describe a new form of synaptic plasticity-a rapid and lasting change in the subunit composition and Ca(2+) permeability of AMPARs at cerebellar stellate cell synapses following synaptic activity. AMPARs lacking the edited GluR2 subunit not only exhibit high Ca(2+) permeability(7) but also are blocked by intracellular polyamines(8-11). These properties have allowed us to follow directly the involvement of GluR2 subunits in synaptic transmission. Repetitive synaptic activation of Ca(2+)-permeable AMPARs causes a rapid reduction in Ca(2+) permeability and a change in the amplitude of excitatory postsynaptic currents, owing to the incorporation of GluR2-containing AMPARs. Our experiments show that activity-induced Ca(2+) influx through GluR2-lacking AMPARs controls the targeting of GluR2-containing AMPARs, implying the presence of a self-regulating mechanism.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Cull-Candy, SG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	s.cull-candy@ulc.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326				Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Clark Beverley A., 1999, Journal of Physiology (Cambridge), V518P, p156P; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; YAMKURA T, 1995, FEBS LETT, V374, P412	30	360	367	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					454	458		10.1038/35013064	http://dx.doi.org/10.1038/35013064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839540				2022-12-28	WOS:000087212000048
J	Smahi, A; Courtois, G; Vabres, P; Yamaoka, S; Heuertz, S; Munnich, A; Israel, A; Heiss, NS; Klauck, SM; Kioschis, P; Wiemann, S; Poustka, A; Esposito, T; Bardaro, T; Gianfrancesco, F; Ciccodicola, A; D'Urso, M; Woffendin, H; Jakins, T; Donnai, D; Stewart, H; Kenwrick, SJ; Aradhya, S; Yamagata, T; Levy, M; Lewis, RA; Nelson, DL				Smahi, A; Courtois, G; Vabres, P; Yamaoka, S; Heuertz, S; Munnich, A; Israel, A; Heiss, NS; Klauck, SM; Kioschis, P; Wiemann, S; Poustka, A; Esposito, T; Bardaro, T; Gianfrancesco, F; Ciccodicola, A; D'Urso, M; Woffendin, H; Jakins, T; Donnai, D; Stewart, H; Kenwrick, SJ; Aradhya, S; Yamagata, T; Levy, M; Lewis, RA; Nelson, DL		Int Incontinentia Pigmenti IP Cons	Genomic rearrangement in NEMO impairs NF-KAPPAB activation and is a cause of incontinentia pigmenti	NATURE			English	Article							ALPHA-INDUCED APOPTOSIS; B KINASE COMPLEX; MICE LACKING; EMBRYONIC LETHALITY; LIVER DEGENERATION; RAPID DETECTION; DEFICIENT MICE; IKK COMPLEX; COMPONENT; MODULATOR	Familial incontinentia pigmenti (IP; MIM 308310) is a genodermatosis that segregates as an X-linked dominant disorder and is usually lethal prenatally in males. In affected females it causes highly variable abnormalities of the skin, hair, nails, teeth, eyes and central nervous system. The prominent skin signs occur in four classic cutaneous stages: perinatal inflammatory vesicles, verrucous patches, a distinctive pattern of hyperpigmentation and dermal scarring(1). Cells expressing the mutated X chromosome are eliminated selectively around the time of birth, so females with IP exhibit extremely skewed X-inactivation(2). The reasons for cell death in females and in utero lethality in males are unknown. The locus for IP has been linked genetically to the factor VIII gene in Xq28 (ref. 3). The gene for NEMO (NF-kappa B essential modulator)/IKK gamma (I kappa B kinase-gamma) has been mapped to a position 200 kilobases proximal to the factor VIII locus(4). NEMO is required for the activation of the transcription factor NF-kappa B and is therefore central to many immune, inflammatory and apoptotic pathways(5-9). Here we show that most cases of IP are due to mutations of this locus and that a new genomic rearrangement accounts for 80% of new mutations. As a consequence, NF-kappa B activation is defective in IP cells.	Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, F-75015 Paris, France; Inst Pasteur, CNRS, URA 1773, Unite Biol Mol Express Gen, F-75724 Paris 15, France; Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, D-69120 Heidelberg, Germany; CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy; Addenbrookes Hosp, Wellcome Trust, Ctr Mol Mechanisms Dis, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2XY, England; St Marys Hosp, Manchester M13 0JH, Lancs, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Helmholtz Association; German Cancer Research Center (DKFZ); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Manchester; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kenwrick, SJ (corresponding author), Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, F-75015 Paris, France.	SJK12@mole.bio.cam.ac.uk	Esposito, Teresa/AAA-5488-2019; Smahi, Asma/J-4184-2017; Vabres, Pierre/V-3850-2019; Wiemann, Stefan/E-4424-2013; Gianfrancesco, Fernando/P-6853-2014	Esposito, Teresa/0000-0002-7879-8441; Smahi, Asma/0000-0002-6002-0981; Vabres, Pierre/0000-0001-8693-3183; Wiemann, Stefan/0000-0003-4683-3174; Ciccodicola, Alfredo/0000-0002-9924-1482; ARADHYA, SWAROOP/0000-0001-6219-2931; Gianfrancesco, Fernando/0000-0002-3812-2471; COURTOIS, Gilles/0000-0003-3117-9595	Telethon [E.0927] Funding Source: Medline	Telethon(Fondazione Telethon)		Alonso A, 1996, ELECTROPHORESIS, V17, P1299, DOI 10.1002/elps.1150170804; Attar RM, 1997, SEMIN CANCER BIOL, V8, P93, DOI 10.1006/scbi.1997.0060; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jin DY, 1999, J BIOMED SCI, V6, P115, DOI 10.1007/BF02256442; Jouet M, 1997, EUR J HUM GENET, V5, P168, DOI 10.1159/000484753; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Rothwarf D.M., 1999, SCI SIGNAL TRANSDUCT; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; SMAHI A, 1994, HUM MOL GENET, V3, P273, DOI 10.1093/hmg/3.2.273; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Weil R, 1997, J BIOL CHEM, V272, P9942; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	30	529	553	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					466	472						8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839543				2022-12-28	WOS:000087212000051
J	Dickson, D				Dickson, D			Unesco backs 'science for debt' plan	NATURE			English	News Item																		2000, NATURE, V400, P8	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					911	911		10.1038/35010221	http://dx.doi.org/10.1038/35010221			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10841690	Bronze			2022-12-28	WOS:000086762000007
J	Checkley, W; Epstein, LD; Gilman, RH; Figueroa, D; Cama, RI; Patz, JA; Black, RE				Checkley, W; Epstein, LD; Gilman, RH; Figueroa, D; Cama, RI; Patz, JA; Black, RE			Effects of El Nino and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children	LANCET			English	Article							SOUTHERN OSCILLATION; RURAL BANGLADESH; INFECTION; CLIMATE; GROWTH	Introduction To investigate whether the El Nino phenomenon and ambient temperature had an effect on the epidemiology of childhood diarrhoea, we analysed data on daily number of admissions of children with diarrhoea to the Oral Rehydration Unit of the Institute de Salud del Nino in Lima, Peru, between January, 1993, and November, 1998. Methods We obtained daily data on hospital admissions from the Oral Rehydration Unit, and meteororological data from the Peruvian Weather Service, and used time-series linear regression models to assess the effects of the 1997-98 El Nino event on admissions for diarrhoea. Findings 57 331 children under 10 years old were admitted to the unit during the study. During the 1997-98 El Nino episode, mean ambient temperature in Lima increased up to 5 degrees C above normal, and the number of daily admissions for diarrhoea increased to 200% of the previous rate. 6225 excess admissions were attributable to El Nino, and these cost US$277 000. During the period before the El Nino episode, admissions for diarrhoea increased by 8% per 1 degrees C increase in mean ambient temperature. The effects of El Nino and ambient temperature on the number of admissions for diarrhoea were greatest during the winter months. Interpretation El Nino had an effect on hospital admissions greater than that explained by the regular seasonal variability in ambient temperature. The excess increase in ambient temperature was the main environmental variable affecting admissions. If our findings are reproducible in other regions, diarrhoeal diseases may increase by millions of cases worldwide with each degree of increase in ambient temperature above normal.	Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Proyectos Informat Salud Med & Agr, Lima, Peru; Catholic Univ Chile, Dept Estadist, Santiago, Chile; Inst Natl Salud Nino, Unidad Rehidratac Oral, Lima, Peru	Johns Hopkins University; Johns Hopkins University; Pontificia Universidad Catolica de Chile	Gilman, RH (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Room W3503, Baltimore, MD 21205 USA.			Black, Robert/0000-0001-9926-7984; Checkley, William/0000-0003-1106-8812	NICHD NIH HHS [F31-HD08488] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD008488] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armitage P, 1996, STAT METHODS MED RES; Bell GD, 1998, B AM METEOROL SOC, V79, pS1, DOI 10.1175/1520-0477-79.5s.S1; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; BLACK RE, 1982, AM J EPIDEMIOL, V115, P315, DOI 10.1093/oxfordjournals.aje.a113308; BLACK RE, 1980, J INFECT DIS, V142, P660, DOI 10.1093/infdis/142.5.660; Black Robert E., 1995, P13; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Cama RI, 1999, J INFECT DIS, V179, P1139, DOI 10.1086/314701; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Diggle P. J., 1995, TIME SERIES BIOSTATI; GILLES HM, 1993, BRUCECHWATTS ESSENTI; GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986; GUERRANT RL, 1996, EDGE DEV HLTH CRISIS, P91; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; HALES S, 1996, LANCET, V348, P1665; KONNO T, 1983, J INFECT DIS, V147, P125, DOI 10.1093/infdis/147.1.125; Madico G, 1996, J CLIN MICROBIOL, V34, P2968, DOI 10.1128/JCM.34.12.2968-2972.1996; Madico G, 1997, CLIN INFECT DIS, V24, P977, DOI 10.1093/clinids/24.5.977; NICHOLLS N, 1993, LANCET, V342, P1284, DOI 10.1016/0140-6736(93)92368-4; *PAN HLTH ORG, 1994, HLTH COND AM SCI PUB, V549; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Rice JA, 1988, MATH STAT DATA ANAL; SalazarLindo E, 1997, LANCET, V350, P1597, DOI 10.1016/S0140-6736(05)64013-5; Tibshirani R., 1995, GEN ADDITIVE MODELS; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; *WHO, 1996, CLI CHANG HUM HLTH; World Health Organization, 1995, 854 WHO	29	303	315	3	42	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					442	450						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841124				2022-12-28	WOS:000085306800010
J	Beecham, L				Beecham, L			GPs want self regulation to continue	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1692	1692						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864541				2022-12-28	WOS:000087926400019
J	Bottke, WF; Jedicke, R; Morbidelli, A; Petit, JM; Gladman, B				Bottke, WF; Jedicke, R; Morbidelli, A; Petit, JM; Gladman, B			Understanding the distribution of near-Earth asteroids	SCIENCE			English	Article							MAIN-BELT ASTEROIDS; APPROACHING ASTEROIDS; SIZE DISTRIBUTION; RESONANCES; OBJECTS; ORIGIN; METEORITES; FRAGMENTS; COMETS; MOTION	We have deduced the orbital and size distributions of the near-Earth asteroids (NEAs) by (i) numerically integrating NEAs from their source regions to their observed orbits, (ii) estimating the observational biases and size distribution associated with asteroids on those orbits, and (iii) creating a model population that can be fit to the known NEAs. We predict that there are similar to 900 NEAs with absolute magnitude Less than 18 (that is, kilometer-sized), of which 29, 65, and 6% reside on Amor, Apollo, and Aten orbits, respectively. These results suggest that roughly 40% of the kilometer-sized NEAs have been found. The remainder, on highly eccentric and inclined orbits, are more difficult to detect.	Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Observ Cote Azur, F-06034 Nice, France	Cornell University; University of Arizona; UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Bottke, WF (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.			Jedicke, Robert/0000-0001-7830-028X				Bottke WF, 2000, ICARUS, V145, P301, DOI 10.1006/icar.2000.6361; Bottke WF, 1999, ASTRON J, V117, P1921, DOI 10.1086/300811; Bottke WF, 1996, ICARUS, V122, P406, DOI 10.1006/icar.1996.0133; BOWELL E, 1994, IAU SYMP, P477; Bowell E., 1989, ASTEROIDS, VII, P524; CHAPMAN CR, 1994, NATURE, V367, P33, DOI 10.1038/367033a0; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; Durda DD, 1998, ICARUS, V135, P431, DOI 10.1006/icar.1998.5960; FARINELLA P, 1993, ICARUS, V101, P174, DOI 10.1006/icar.1993.1016; Farinella P, 1999, SCIENCE, V283, P1507, DOI 10.1126/science.283.5407.1507; Farinella P, 1998, ICARUS, V132, P378, DOI 10.1006/icar.1997.5872; GLADMAN B, IN PRESS ICARUS; Gladman BJ, 1997, SCIENCE, V277, P197, DOI 10.1126/science.277.5323.197; Grieve RAF, 1994, HAZARDS DUE COMETS A, P417; HARRIS AW, 2000, DIV DYNAM ASTRON, V31, P16; HARRIS AW, IN PRESS COLLISIONAL; HARTMANN WK, 1987, ICARUS, V69, P33, DOI 10.1016/0019-1035(87)90005-4; Jedicke R, 1998, ICARUS, V131, P245, DOI 10.1006/icar.1997.5876; Jedicke R, 1996, ASTRON J, V111, P970, DOI 10.1086/117844; Lyons L., 1986, STAT NUCL PARTICLE P; MCFADDEN LA, 1989, ASTEROIDS, V2, P442; MICHEL P, IN PRESS ICARUS; Migliorini F, 1998, SCIENCE, V281, P2022, DOI 10.1126/science.281.5385.2022; Morbidelli A, 1998, METEORIT PLANET SCI, V33, P999, DOI 10.1111/j.1945-5100.1998.tb01707.x; Morbidelli A, 1999, ICARUS, V139, P295, DOI 10.1006/icar.1999.6097; MORBIDELLI A, 1993, ICARUS, V105, P48, DOI 10.1006/icar.1993.1110; MORRISON D, 1992, SPACEGUARD SURVEY RE, P1; Murray N, 1998, ASTRON J, V116, P2583, DOI 10.1086/300586; Nesvorny D, 1998, ASTRON J, V116, P3029, DOI 10.1086/300632; Neukum G., 1994, HAZARDS DUE COMETS A, P359; Press W.H., 1992, NUMERICAL RECIPES AR, V2nd; Rabinowitz D, 2000, NATURE, V403, P165, DOI 10.1038/35003128; RABINOWITZ DL, 1993, NATURE, V363, P704, DOI 10.1038/363704a0; RABINOWITZ DL, 1994, ICARUS, V111, P364, DOI 10.1006/icar.1994.1150; Rabinowitz DL, 1997, ICARUS, V130, P287, DOI 10.1006/icar.1997.5823; Richardson DC, 1998, ICARUS, V134, P47, DOI 10.1006/icar.1998.5954; SCHABER GG, 1992, J GEOPHYS RES, V97, P13256; SHOEMAKER EM, 1983, ANNU REV EARTH PL SC, V11, P461, DOI 10.1146/annurev.ea.11.050183.002333; SHOEMAKER EM, GEOLOGICAL SOC AM SP, V247; Strom R.G., 1992, MARS, P383, DOI DOI 10.1016/S0032-0633(99)00016-1; Tanga P, 1999, ICARUS, V141, P65, DOI 10.1006/icar.1999.6148; Tholen D.J., 1989, ASTEROIDS, VII, P298; WEISSMAN PR, 1989, ASTEROIDS, V2, P880; WETHERILL GW, 1988, ICARUS, V76, P1, DOI 10.1016/0019-1035(88)90138-8; WETHERILL GW, 1985, METEORITICS, V20, P1, DOI 10.1111/j.1945-5100.1985.tb00842.x; WETHERILL GW, 1987, PHILOS T R SOC A, V323, P323, DOI 10.1098/rsta.1987.0089; WETHERILL GW, 1979, ORIGIN DISTRIBUTION, P19; WILLIAMS JG, 1973, EOS T AM GEOPHYS UN, V54, P233; [No title captured]	50	131	131	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2190	2194		10.1126/science.288.5474.2190	http://dx.doi.org/10.1126/science.288.5474.2190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864864				2022-12-28	WOS:000087782900052
J	Yeo, AET; Matsumoto, A; Hisada, M; Shih, JW; Alter, HJ; Goedert, JJ				Yeo, AET; Matsumoto, A; Hisada, M; Shih, JW; Alter, HJ; Goedert, JJ		Multictr Hemophilia Cohort Study	Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; CYTOMEGALOVIRUS-INFECTION; DISEASE PROGRESSION; AIDS; COINFECTION; RISK; RNA	Background: Infection with hepatitis G virus (HGV), also known as GB virus C, is prevalent but is not known to be associated with any chronic disease. Infection with HGV may affect the risk for AIDS in HIV-infected persons. Objective: To compare AIDS-free survival in patients with and those without HGV infection during 16 years of followup after HIV seroconversion. Design: Subanalysis of a prospective cohort study. Setting: Comprehensive hemophilia treatment centers in the United States and Europe. Patients: 131 patients with hemophilia who became HIV-positive between 1978 and 1985. Measurements: Age, CCR5 genotype, HIV and HCV viral loads, CD4(+) and CD8(+) lymphocyte counts, and 12-year AIDS-free survival by HGV positivity (viremia [RNA] or anti-E2 antibodies). Results: Compared with HGV-negative patients, the 60 HGV-positive patients (46%), including 22 who were positive for HGV RNA, had higher CD4(+) lymphocyte counts (difference, 211 cells/mm(3) [95% CI, 88 to 333 cells/mm(3)]) and 12-year AIDS-free survival rates (68% compared with 40%; rate difference, 1.9 per 100 person-years [Cl, -0.3 to 4.2 per 100 person-years]), despite similar ages and HIV viral loads. In multivariate proportional hazards models, risk for AIDS was 40% lower for HCV-positive patients independent of age, HIV and HCV viral loads, CD4(+) and CD8(+) lymphocyte counts, and CCR5 genotype. Conclusions: Patients with past or current HGV infection have higher CD4(+) lymphocyte counts and better AIDS-free survival rates. The mechanism of this association is unknown.	NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Goedert, JJ (corresponding author), NCI, Viral Epidemiol Branch, 6120 Execut Blvd,Room 8012 MSC 7248, Rockville, MD 20852 USA.	gocdertj@mail.nih.gov	Yeo, Anthony/AHD-9194-2022		NCI NIH HHS [N01-CP-33002] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [Z01CP005779, Z01CP010115, N01CP033002] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Goedert JJ, 1997, NEW ENGL J MED, V337, P277; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Mellor J, 1998, J GEN VIROL, V79, P705, DOI 10.1099/0022-1317-79-4-705; O'Brien TR, 1998, JAMA-J AM MED ASSOC, V279, P317, DOI 10.1001/jama.279.4.317; OBrien TR, 1996, JAMA-J AM MED ASSOC, V276, P105, DOI 10.1001/jama.276.2.105; RABKIN CS, 1993, J INFECT DIS, V168, P1260, DOI 10.1093/infdis/168.5.1260; ROSENBERG PS, 1991, J ACQ IMMUN DEF SYND, V4, P392; Sabin CA, 1998, J ACQ IMMUN DEF SYND, V19, P546, DOI 10.1097/00042560-199812150-00016; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Woitas RP, 1999, AIDS, V13, P1313, DOI 10.1097/00002030-199907300-00007; Wu JC, 1997, J MED VIROL, V52, P83, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;83::AID-JMV13&gt;3.0.CO;2-1; Yeo AET, 2000, SEX TRANSM DIS, V27, P178, DOI 10.1097/00007435-200003000-00012; Zanetti AR, 1998, J MED VIROL, V54, P107, DOI 10.1002/(SICI)1096-9071(199802)54:2&lt;107::AID-JMV7&gt;3.0.CO;2-A	20	92	96	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					959	963		10.7326/0003-4819-132-12-200006200-00006	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858179				2022-12-28	WOS:000087670800005
J	Oldenborg, PA; Zheleznyak, A; Fang, YF; Lagenaur, CF; Gresham, HD; Lindberg, FP				Oldenborg, PA; Zheleznyak, A; Fang, YF; Lagenaur, CF; Gresham, HD; Lindberg, FP			Role of CD47 as a marker of self on red blood cells	SCIENCE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; SIGNAL-REGULATORY PROTEIN; OVARIAN TUMOR-MARKER; INHIBITORY RECEPTORS; MONOCLONAL-ANTIBODY; MYELOID CELLS; FAMILY MEMBER; MOUSE SPLEEN; ADHESION; MICE	The immune system recognizes invaders as foreign because they express determinants that are absent on host cells or because they lack "markers of self" that are normally present. Here we show that CD47 (integrin-associated protein) functions as a marker of self on murine red blood cells. Red blood cells that lacked CD47 were rapidly cleared from the bloodstream by splenic red pulp macrophages,CD47 on normal rea blood,cells prevented this elimination by binding to the inhibitory receptor signal regulatory protein alpha (SIRP alpha). Thus, macrophages may use a number of nonspecific activating receptors and rely on the presence or absence of CD47 to distinguish self from foreign. CD47-SIRP alpha may represent a potential pathway for the control of hemolytic anemia.	Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Vet Adm Med Ctr, Res Serv, Albuquerque, NM 87108 USA	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lindberg, FP (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, Campus Box 8051, St Louis, MO 63110 USA.				NIGMS NIH HHS [GM57573-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057573] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams S, 1998, J IMMUNOL, V161, P1853; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; CAMPBELL IG, 1992, CANCER RES, V52, P5416; Colonna M, 1999, CURR TOP MICROBIOL, V244, P115; FRIDMAN WH, 1999, J BIOL CHEM, V274, P32493; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Hoglund P, 1998, EUR J IMMUNOL, V28, P370, DOI 10.1002/(SICI)1521-4141(199801)28:01<370::AID-IMMU370>3.0.CO;2-W; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KRAAL G, 1986, IMMUNOLOGY, V58, P665; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; LINDBERG FP, 1994, J BIOL CHEM, V269, P1567; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; LINDBERG FP, UNPUB; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; POELS LG, 1986, JNCI-J NATL CANCER I, V76, P781; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97, DOI 10.1002/jlb.45.2.97; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; YOKOYAMA WM, 1995, CURR OPIN IMMUNOL, V7, P110, DOI 10.1016/0952-7915(95)80036-0	30	1190	1276	17	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2051	+		10.1126/science.288.5473.2051	http://dx.doi.org/10.1126/science.288.5473.2051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856220				2022-12-28	WOS:000087687000053
J	Bednash, G				Bednash, G			The decreasing supply of registered nurses - Inevitable future or call to action?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MAGNET HOSPITALS; CARE; EXCELLENCE; MORTALITY; OUTCOMES		Amer Assoc Coll Nursing, Washington, DC 20036 USA		Bednash, G (corresponding author), Amer Assoc Coll Nursing, 1 Dupont Circle,Suite 530, Washington, DC 20036 USA.	pbednash@aacn.nche.edu						AIKEN LH, 1994, MED CARE, V32, P771, DOI 10.1097/00005650-199408000-00002; Aiken LH, 1999, MED CARE, V37, P760, DOI 10.1097/00005650-199908000-00006; Aiken LH, 1997, MED CARE, V35, P948, DOI 10.1097/00005650-199709000-00007; Aiken LH, 2000, AM J NURS, V100, P26, DOI 10.2307/3522060; Aiken LH, 1997, AM J PUBLIC HEALTH, V87, P103, DOI 10.2105/AJPH.87.1.103; *AM ASS COLL NURS, 1995, MOD DIFF NURS PRACT; *AM ASS COLL NURS, 1999, 990185P AM ASS COLL; *AM ASS COLL NURS, 2000, 1999 2000 ENR GRAD B; *AM HOSP ASS, 1987, REP HOSP NURS PERS S; American Organization of Nurse Executives, 2000, NURS RECR RET STUD; Buerhaus PI, 2000, JAMA-J AM MED ASSOC, V283, P2948, DOI 10.1001/jama.283.22.2948; BURGESS MA, 1928, NURSES PATIENTS POCK, P36; *CHAUNC GROUP INT, 2000, EX SUMM CERT PROF NU; HARTZ AJ, 1989, NEW ENGL J MED, V321, P1720, DOI 10.1056/NEJM198912213212506; Havens DS, 1999, J NURS ADMIN, V29, P14, DOI 10.1097/00005110-199902000-00006; Institute of Medicine, 1996, NURS STAFF HOSP NURS; Kovner C, 1998, Image J Nurs Sch, V30, P315, DOI 10.1111/j.1547-5069.1998.tb01326.x; KRAMER M, 1990, J NURS ADMIN, V20, P35; KRAMER M, 1988, J NURS ADMIN, V18, P13; Ludmerer KM, 1999, TIME HEAL; MONTAG ML, 1959, COMMUNITY COLLEGE ED; MOSES EB, 1996, REGISTERED NURSE POP; *NAT COUNC STAT BO, 1999, PROF MEMB BOARDS 199; *NAT LEAG NURS, 1997, NURS DAT SOURC; University Health System Consortium, 1999, SURV ED PREP NURS	25	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2985	2987		10.1001/jama.283.22.2985	http://dx.doi.org/10.1001/jama.283.22.2985			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	321XL	10865278				2022-12-28	WOS:000087480600040
J	Rogers, S; Humphrey, C; Nazareth, I; Lister, S; Tomlin, Z; Haines, A				Rogers, S; Humphrey, C; Nazareth, I; Lister, S; Tomlin, Z; Haines, A			Designing trials of interventions to change professional practice in primary care: lessons from an exploratory study of two change strategies	BRITISH MEDICAL JOURNAL			English	Article							QUALITY IMPROVEMENT; MEDICAL-EDUCATION; RANDOMIZED TRIAL; HEALTH-CARE; PROGRAM; WILL; SERVICES		UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, Archway Resource Ctr, London N10 3UA, England	University of London; University College London	Rogers, S (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, Archway Resource Ctr, London N10 3UA, England.	s.rogers@ucl.ac.uk	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Haines, Andy/0000-0002-8053-4605; Nazareth, Irwin/0000-0003-2146-9628				Altman D.G., 1991, PRACTICAL STAT MED R; Anderson N, 1994, TEAM CLIMATE INVENTO; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Bradley F, 1999, BMJ-BRIT MED J, V318, P711; BREWIN CR, 1989, BRIT MED J, V299, P313, DOI 10.1136/bmj.299.6694.313; *COCHR COX, 1957, EXP DES; Dawson S, 1997, QUAL HEALTH CARE, V6, P177, DOI 10.1136/qshc.6.4.177; Goldberg H I, 1998, Jt Comm J Qual Improv, V24, P130; Hearnshaw H, 1998, QUAL HEALTH CARE, V7, P200, DOI 10.1136/qshc.7.4.200; Lawrence M, 1996, QUAL HEALTH CARE, V5, P151, DOI 10.1136/qshc.5.3.151; *MED RES COUNC GEN, 1997, NETW GEN PRACT UK MA; MURPHY E, 1992, BRIT J GEN PRACT, V42, P162; NEUFELD VR, 1989, ACAD MED, V64, P423, DOI 10.1097/00001888-198908000-00001; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; PRITCHARD P, 1994, TEAMWORK PRIMARY SHA; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Shortell SM, 1998, MILBANK Q, V76, P593, DOI 10.1111/1468-0009.00107; SIBLEY JC, 1982, NEW ENGL J MED, V306, P511, DOI 10.1056/NEJM198203043060904; Solberg LI, 1998, PREV MED, V27, P623, DOI 10.1006/pmed.1998.0337; Stephens R, 1993, Clin Oncol (R Coll Radiol), V5, P211, DOI 10.1016/S0936-6555(05)80231-6; Tomlin Z, 1999, BMJ-BRIT MED J, V318, P1532, DOI 10.1136/bmj.318.7197.1532; *U YORK, 1999, EFF HLTH CAR GETT EV; Wyatt JC, 1998, BMJ-BRIT MED J, V317, P1041	23	17	17	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1580	1583		10.1136/bmj.320.7249.1580	http://dx.doi.org/10.1136/bmj.320.7249.1580			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845968	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000087631400024
J	Rasmussen, B				Rasmussen, B			Filamentous microfossils in a 3,235-million-year-old volcanogenic massive sulphide deposit	NATURE			English	Article							WESTERN-AUSTRALIA; BACTERIA; LIFE; MINERALIZATION; HYDROCARBONS; PILBARA; VENTS	The record of Archaean microfossils is sparse(1). Of the few bona fide fossil assemblages, most are from shallow-water settings, and they are typically associated with laminated, stromatolitic sedimentary rocks(2-4). Microfossils from deep-sea hydrothermal systems have not been reported in Precambrian rocks (>544 million years old), although thermophilic microbes are ubiquitous in modern sea-floor hydrothermal settings(5,6), and apparently have the most ancient lineages(7,8). Here, I report the discovery of pyritic filaments, the probable fossil remains of thread-like microorganisms, in a 3,235-million-year-old deep-sea volcanogenic massive sulphide deposit from the Pilbara Craton of Australia. From their mode of occurrence, the micro-organisms were probably thermophilic chemotropic prokaryotes, which inhabited sub-sea-floor hydrothermal environments. They represent the first fossil evidence for microbial life in a Precambrian submarine thermal spring system, and extend the known range of submarine hydrothermal biota by more than 2,700 million years(9). Such environments may have hosted the first living systems on Earth, consistent with proposals for a thermophilic origin of life(10-13).	Univ Western Australia, Dept Geol & Geophys, Nedlands, WA 6907, Australia	University of Western Australia	Rasmussen, B (corresponding author), Univ Western Australia, Dept Geol & Geophys, Nedlands, WA 6907, Australia.			Rasmussen, Birger/0000-0002-2745-0904				AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; BAULD J, 1992, PROTEROZOIC BIOSPHER, P261; BAZYLINSKI DA, 1989, APPL ENVIRON MICROB, V55, P2832, DOI 10.1128/AEM.55.11.2832-2836.1989; Brauhart CW, 1998, ECON GEOL BULL SOC, V93, P292, DOI 10.2113/gsecongeo.93.3.292; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; BUICK R, IUNPUB PRECAMBR RES; Corliss J. B., 1981, Oceanologica Acta, V4, P59; DUHIG NC, 1992, GEOLOGY, V20, P511, DOI 10.1130/0091-7613(1992)020<0511:MIITFO>2.3.CO;2; FERRIS FG, 1986, NATURE, V320, P609, DOI 10.1038/320609a0; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jones B, 1997, J SEDIMENT RES, V67, P88; JUNIPER SK, 1988, CAN MINERAL, V26, P859; KANDLER O, 1994, NOBEL S, V84, P152; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KNOLL AH, 1974, P NATL ACAD SCI USA, V71, P2329, DOI 10.1073/pnas.71.6.2329; KNOLL AH, 1988, PRECAMBRIAN RES, V38, P257, DOI 10.1016/0301-9268(88)90005-8; MORANT P, 1995, B AUST I GEOSCI, V16, P75; Nisbet E.G., 1996, Geological Society Special Publication, V118, P239, DOI 10.1144/GSL.SP.1996.118.01.15; RASMUSSEN B, IN PRESS GEOLOGY; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schopf J.W., 1983, P214; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Stetter KO, 1996, CIBA F SYMP, V202, P1; TEWIN NH, 1999, PALAIOS, V14, P288; VEARNCOMBE S, 1995, J GEOL SOC LONDON, V152, P587, DOI 10.1144/gsjgs.152.4.0587; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; Winn C.D., 1995, MICROBIOLOGY DEEP SE, P255	30	269	295	0	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					676	679		10.1038/35015063	http://dx.doi.org/10.1038/35015063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864322				2022-12-28	WOS:000087465800044
J	Smeeth, L				Smeeth, L			Commentary: patients, preferences, and evidence	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED TRIALS		Univ London London Sch Hyg & Trop Med, Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol Unit, Keppel St, London WC1E 7HT, England.		Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022				Kleijnen J, 1997, NONRANDOM REFLECTION, P93; McPherson K, 1997, J ROY SOC MED, V90, P652, DOI 10.1177/014107689709001205; MCPHERSON K, 1994, J EPIDEMIOL COMMUN H, V48, P6, DOI 10.1136/jech.48.1.6; RUCKER G, 1989, STAT MED, V8, P477, DOI 10.1002/sim.4780080411; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360	5	4	4	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 20	2000	320	7246					1384	1384						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317NY	10858048				2022-12-28	WOS:000087232500024
J	McCabe, H				McCabe, H			... as European public remains sceptical	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					5	5		10.1038/35011212	http://dx.doi.org/10.1038/35011212			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10841694	Bronze			2022-12-28	WOS:000086901600008
J	Strachan, BK; van Wijngaarden, WJ; Sahota, D; Chang, A; James, DK				Strachan, BK; van Wijngaarden, WJ; Sahota, D; Chang, A; James, DK		FECG Study Grp	Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial	LANCET			English	Article							CESAREAN-SECTION; CEREBRAL-PALSY; ELECTROCARDIOGRAM; ASPHYXIA	Background There is a need to improve the sensitivity and specificity of fetal monitoring during labour. We compared the gold standard, cardiotocography, with cardiotocography plus time-interval analysis of the fetal electrocardiogram in fetal surveillance. The aim was to find out whether time-interval analysis decreased the need for operative intervention due to fetal distress. Methods We did a randomised, prospective trial in five hospitals in the UK, Hong Kong, the Netherlands, and Singapore. 1038 women undergoing high-risk labours were randomly assigned fetal monitoring by cardiotocography alone, or cardiotocography plus fetal electrocardiography (ECG). Outcomes measured were rates of operative intervention, and neonatal outcome. Analysis was by intention to treat. Analysis was by Findings 515 women were assigned management by cardiotocography, and 523 cardiotocography plus fetal EGG. There was a trend towards fewer operative interventions for presumed fetal distress in the time-interval analysis plus cardiotocography group (63 [13%] vs 78 [16%]), but this was not significant (relative risk 0.80 [95% CI 0.59-1.08], p=0.17). There was no significant difference between groups in the proportion of babies who had an umbilical arterial pH of 7.15 or less (51 [11%] vs 49 [11%]; 1.01 [0.7-1.47]), or in the frequency of unsuspected acidaemia (42 [9%] vs 35 [8%]; 1.17 [0.76-1.79]). Interpretation The addition of time-interval analysis of the fetal electrocardiogram during labour did not show a significant benefit in decreasing operative intervention. There was no significant difference in neonatal outcome.	Queens Med Ctr, Sch Human Dev, Div Obstet & Gynaecol, Nottingham NG7 2UH, England; Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	University of Nottingham; Chinese University of Hong Kong; Prince of Wales Hospital	Strachan, BK (corresponding author), Queens Med Ctr, Sch Human Dev, Div Obstet & Gynaecol, Nottingham NG7 2UH, England.	bryony.strachan@nottingham.ac.uk	Chang, Allan M/B-1882-2009	Sahota, Daljit/0000-0002-3755-2701				*DEP HLTH, 1997, MAT CHILD HLTH RES C; *FIGO, 1987, INT J GYNECOL OBSTET, V75, P159; GAFFNEY G, 1994, BRIT MED J, V308, P743, DOI 10.1136/bmj.308.6931.743; LILFORD RJ, 1990, BRIT J OBSTET GYNAEC, V97, P883, DOI 10.1111/j.1471-0528.1990.tb02442.x; MILLER JM, 1998, OBSTET GYNECOL CLIN, V15, P629; MOHAJER MP, 1994, EUR J OBSTET GYN R B, V55, P65, DOI 10.1016/0028-2243(94)90210-0; Mongelli M, 1997, BRIT J OBSTET GYNAEC, V104, P771, DOI 10.1111/j.1471-0528.1997.tb12018.x; MURPHY KW, 1990, BRIT J OBSTET GYNAEC, V97, P470, DOI 10.1111/j.1471-0528.1990.tb02515.x; MURRAY HG, 1992, THESIS U NOTTINGHAM; Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001; NIELSON JP, 1993, INTRAPARTUM FETAL SU; Reed NN, 1996, EUR J OBSTET GYN R B, V68, P87, DOI 10.1016/0301-2115(96)02496-7; SHEARER EL, 1993, SOC SCI MED, V37, P1223, DOI 10.1016/0277-9536(93)90334-Z; Spencer JAD, 1998, BRIT MED J, V316, P640, DOI 10.1136/bmj.316.7132.640; vanWijngaarden WJ, 1996, AM J OBSTET GYNECOL, V175, P548, DOI 10.1053/ob.1996.v175.a74285; vanWijngaarden WJ, 1996, AM J OBSTET GYNECOL, V174, P1295, DOI 10.1016/S0002-9378(96)70674-9	16	40	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					456	459						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841126				2022-12-28	WOS:000085306800012
J	Smith, J				Smith, J			A register of blunders or botchers?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1738	1738		10.1136/bmj.320.7251.1738	http://dx.doi.org/10.1136/bmj.320.7251.1738			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864560	Green Published			2022-12-28	WOS:000087926400057
J	Wilmshurst, P				Wilmshurst, P			Devaluing clinical skills	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	3	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1739	1739		10.1136/bmj.320.7251.1739	http://dx.doi.org/10.1136/bmj.320.7251.1739			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864562	Green Published			2022-12-28	WOS:000087926400058
J	Bloom, DE				Bloom, DE		River Path Ass	Something to be done: Treating HIV/AIDS	SCIENCE			English	Editorial Material								Largely because of disparities in access to drug treatment and care, AIDS morbidity and mortality have fallen in the developed world but continue to rise among developing countries. Achieving more equitable access to AIDS drugs is hindered by high drug prices, technical complexities related to the provision of health care, and conflict among stakeholders. Recognition that health is vital to the prospects of the emerging global society must be combined with new mechanisms to help all stakeholders work together cooperatively. Tiered drugs pricing should be coupled with investment in health services. An independent "Global Task Force," able to act as an "active think tank," could build consensus about the way forward.	Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bloom, DE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], INV HLTH RES DEV; Binswanger HP, 2000, SCIENCE, V288, P2173, DOI 10.1126/science.288.5474.2173; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; BLOOM DE, IN PRESS AFRICA COMP; BLOOM DE, 1999, MEMENT TIME AIDS BUI; Gellman Barton, 2000, WASH POST, pA01; HARTLEY W, 2000, BUSINESS DAY    0510; LAURENCE J, IN PRESSS AIDS READE; LOVE J, 1999, COMMUNICATION   0801; MALETSKY C, 2000, NAMIBIAN        0511; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; PILLING D, 2000, FINANCIAL TIMES 0519; REICH MR, 2000, NAT MED, V6, P3; *RIV PATH ASS, 1998, YOU  MAD AFR BOR NEW; SACHS J, 1999, ECONOMIST       0814; SCHOOFS M, 1999, VILLAGE VOICE   1229; SIDLEY P, 2000, BUSINESS DAY    0515; WALDHOLZ M, 2000, WALL STREET J   0511; ZUNIGA J, 1998, INT ASS PHYSICIANS A, V4, P23; 2000, PRESIDENTIAL ORDER A	20	11	11	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2171	2173		10.1126/science.288.5474.2171	http://dx.doi.org/10.1126/science.288.5474.2171			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864858				2022-12-28	WOS:000087782900047
J	Pratibha, R; Madhusudana, NV; Sadashiva, BK				Pratibha, R; Madhusudana, NV; Sadashiva, BK			An orientational transition of bent-core molecules in an anisotropic matrix	SCIENCE			English	Article							ACHIRAL MOLECULES; PHASE; MIXTURES	We report the discovery of an orientational transition of bent-core molecules in a background anisotropic medium, in this case a smectic liquid crystal made of rod-like molecules. The resulting director is apolar in nature, and the medium can be described as an orthogonal biaxial smectic. The detailed phase diagram of mixtures of the two types of compounds revealed the induction of two liquid crystalline phases that are specific to compounds with bent-core molecules. The chemical nature of the bounding surface had a marked influence on the observed textures.	Raman Res Inst, Bangalore 560080, Karnataka, India	Department of Science & Technology (India); Raman Research Institute (RRI)	Madhusudana, NV (corresponding author), Raman Res Inst, Bangalore 560080, Karnataka, India.		Nelamangala V, Madhusudana/E-9592-2012; Ramarao, Pratibha/E-5101-2012; Sadashiva, B./E-5135-2012	Ramarao, Pratibha/0000-0001-6666-5417; 				AVERYANOV EM, 1993, LIQ CRYST, V13, P139, DOI 10.1080/02678299308029060; BRAND HR, 1992, MACROMOLECULES, V25, P7223, DOI 10.1021/ma00052a025; Brand HR, 1998, EUR PHYS J B, V6, P347, DOI 10.1007/s100510050560; Brognara A, 2000, J CHEM PHYS, V112, P4836, DOI 10.1063/1.481087; Chandrasekhar S., 1992, LIQ CRYST, DOI 10.1017/CBO9780511622496; DEGENNES PG, 1993, PHYSICS LIQUID CRYST; DOMB C, 1996, CRITICAL POINT, P349; Heppke G, 1998, SCIENCE, V279, P1872, DOI 10.1126/science.279.5358.1872; LEUBE HF, 1991, MAKROMOL CHEM, V192, P1317; Link DR, 1997, SCIENCE, V278, P1924, DOI 10.1126/science.278.5345.1924; NARAYANAN T, 1994, PHYS REP, V249, P135, DOI 10.1016/0370-1573(94)90015-9; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; PALFFYMUHORAY P, 1985, MOL CRYST LIQ CRYST, V127, P301, DOI 10.1080/00268948508080847; Pelzl G, 1999, ADV MATER, V11, P707, DOI 10.1002/(SICI)1521-4095(199906)11:9<707::AID-ADMA707>3.0.CO;2-D; PRATIBHA R, 1985, MOL CRYST LIQ CRYST, V1, P111; ROBINSON C, 1958, DISCUSS FARADAY SOC, P29; Roy A, 1999, PHYS REV LETT, V82, P1466, DOI 10.1103/PhysRevLett.82.1466; SADASHIVA BK, 1979, MOL CRYST LIQ CRYST, V55, P135, DOI 10.1080/00268947908069797; SADASHIVA BK, IN PRESS FERROELECTR; TAKANISHI Y, 1992, PHYS REV B, V45, P7684, DOI 10.1103/PhysRevB.45.7684	20	133	134	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2184	2187		10.1126/science.288.5474.2184	http://dx.doi.org/10.1126/science.288.5474.2184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864862				2022-12-28	WOS:000087782900050
J	Gostin, LO				Gostin, LO			Public health law in a new century - Part III. Public health regulation: A systematic evaluation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Johns Hopkins Univ, Program Law & Publ Hlth, Baltimore, MD USA	Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, Program Law & Publ Hlth, 600 New Jersey Ave NW, Washington, DC 20001 USA.							Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; BREYER S, 1993, BREAK VIC CIRCL EFF; BURRIS S, 1998, ALBANY LAW REV, V61, P831; Davis RM, 1998, JAMA-J AM MED ASSOC, V280, P1947, DOI 10.1001/jama.280.22.1947; Dworkin G., 1999, NEW ETHICS PUBLICS H, P115; Feinberg J., 1986, MORAL LIMITS CRIMINA; Gostin L O, 1997, Emory Law J, V46, P587; Gostin LO, 2000, JAMA-J AM MED ASSOC, V283, P2837, DOI 10.1001/jama.283.21.2837; Gostin LO, 2000, JAMA-J AM MED ASSOC, V283, P2979, DOI 10.1001/jama.283.22.2979; GOSTLIN LO, IN PRESS AM J PUBLIC; *I MED, 1997, IMPR HLTH COMM ROL P; Jolls C, 1998, STANFORD LAW REV, V50, P1471, DOI 10.2307/1229304; LESSIG L, 1995, U CHICAGO LAW REV, V62, P943, DOI 10.2307/1600054; *NAT RES COUNC, 1996, UND RISK INF DEC DEM; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sunstein CR, 1996, U CHICAGO LAW REV, V63, P1533, DOI 10.2307/1600280	16	29	29	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3118	3122		10.1001/jama.283.23.3118	http://dx.doi.org/10.1001/jama.283.23.3118			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323PV	10865307				2022-12-28	WOS:000087574900037
J	Gulcher, JR; Stefansson, K				Gulcher, JR; Stefansson, K			The Icelandic Healthcare Database and informed consent.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENETIC RESEARCH; PRIVACY		deCODE Genet, IS-110 Reykjavik, Iceland		Gulcher, JR (corresponding author), deCODE Genet, IS-110 Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019					ANNAS GJ, 1995, AM J PUBLIC HEALTH, V85, P1196, DOI 10.2105/AJPH.85.9.1196; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Foster MW, 1998, AM J HUM GENET, V63, P696, DOI 10.1086/302013; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; GULCHER J, 1999, MEDSCAPE; *HUGO ETH LEG SOC, 1996, STAT PRINC COND GEN; HUGO Ethics Committee, 1998, STAT DNA SAMPL CONTR; Knoppers BM, 1996, GENOMICS, V34, P272, DOI 10.1006/geno.1996.0287; *MANNVERND, 1999, ASS ICELAND ETH SCI; Miller HI, 2000, SCIENCE, V287, P591; *MIN HLTH SOC SEC, 1998, BILL HLTH SEC DAT; *NAT BIOETH ADV CO, 1999, RES INV HUM BIOL MAT, V1, P63; Strass E, 1996, AM J HUM GENET, V59, P471; World Health Organization (WHO), 1997, PROP INT GUID ETH IS	16	47	49	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1827	1830		10.1056/NEJM200006153422411	http://dx.doi.org/10.1056/NEJM200006153422411			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853008				2022-12-28	WOS:000087573700011
J	Gutierrez, F; Leon, L				Gutierrez, F; Leon, L			Elemental mercury embolism to the lung.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Hosp Sotero Del Rio, Santiago, Chile	Universidad de Chile	Gutierrez, F (corresponding author), Hosp Sotero Del Rio, Santiago, Chile.								0	9	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1791	1791		10.1056/NEJM200006153422405	http://dx.doi.org/10.1056/NEJM200006153422405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853002				2022-12-28	WOS:000087573700005
J	Klein, J				Klein, J			Fluid dynamics - Smart polymer solutions	NATURE			English	Editorial Material							LIQUID-FILMS; SURFACES; THIN		Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Klein, J (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.							[Anonymous], 1987, DYNAMICS POLYM LIQUI; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bergeron V, 2000, NATURE, V405, P772, DOI 10.1038/35015525; Bird RB, 1987, DYNAMICS POLYMERIC L, V1; CHANDRA S, 1991, P R SOC-MATH PHYS SC, V432, P13, DOI 10.1098/rspa.1991.0002; GYR A, 1995, REDUCTION TURBULENT; Mao T, 1997, AICHE J, V43, P2169, DOI 10.1002/aic.690430903; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; WIRTH W, 1991, PESTIC SCI, V33, P411, DOI 10.1002/ps.2780330403; YERUSHALMIROZEN R, 1995, LANGMUIR, V11, P2806, DOI 10.1021/la00007a074; YERUSHALMIROZEN R, 1994, SCIENCE, V263, P793, DOI 10.1126/science.263.5148.793	11	18	18	1	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					745	747		10.1038/35015645	http://dx.doi.org/10.1038/35015645			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866181				2022-12-28	WOS:000087620600028
J	Fenn, P; Diacon, S; Gray, A; Hodges, R; Rickman, N				Fenn, P; Diacon, S; Gray, A; Hodges, R; Rickman, N			Current cost of medical negligence in NHS hospitals: analysis of claims database	BRITISH MEDICAL JOURNAL			English	Article								Objectives To identify trends in the incidence and cost of clinical negligence claims. To determine the current annual cost to the NHS as a whole in terms of cash paid out to patients and their solicitors and the defence costs incur-red. Design Analysis of records on database. Setting A well defined group of hospitals within one health authority which collected information on a consistent basis over many years. Main outcome measures Data on individual claims. Trends in incidence of claims and costs identified independently from organisational reforms and changes in accounting practices. Results The rate of litigation increased from 0.46 to 0.81 dosed claims per 1000 finished consultant episodes between 1990 and 1998. Overall expenditure on clinical negligence by the NHS in England in 1998 was estimated at pound 84 million (95% confidence interval pound 48 million to pound 130 million). Conclusions After adjustment for hospital activity, the rate of closed claims increased during the 1990s by about 7% per annum, a substantial rate of growth but not the uncontrolled explosion sometimes alluded to in the wider media. More coordination and openness are needed in data collection.	Univ Nottingham, Sch Business, Ctr Risk & Insurance Studies, Nottingham NG7 2RD, England; Univ Oxford, Dept Publ Hlth, Hlth Econ Res Ctr, Inst Hlth Sci, Oxford OX3 7LF, England; Univ Surrey, Dept Econ, Guildford GU2 5XH, Surrey, England	University of Nottingham; University of Oxford; University of Surrey	Fenn, P (corresponding author), Univ Nottingham, Sch Business, Ctr Risk & Insurance Studies, Nottingham NG7 2RD, England.							FENN P, 1994, BRIT MED J, V309, P389, DOI 10.1136/bmj.309.6951.389; FENN P, IN PRESS ACCOUNTING; MAWHINNEY B, 1994, HOUSE COMMONS OFFICI, V14, P239; *NAT AUD OFF, 1998, REP COMPT AUD GEN NH; *OFF NAT STAT, 1999, REG TRENDS 34; *OFF NAT STAT, 1998, KEY POPULATION VITAL, V23; Towse A, 1999, HEALTH ECON, V8, P93, DOI 10.1002/(SICI)1099-1050(199903)8:2<93::AID-HEC419>3.3.CO;2-7; TOYNBEE P, 1999, GUARDIAN        0625	8	47	47	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1567	1571		10.1136/bmj.320.7249.1567	http://dx.doi.org/10.1136/bmj.320.7249.1567			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845963	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000087631400019
J	Setou, M; Nakagawa, T; Seog, DH; Hirokawa, N				Setou, M; Nakagawa, T; Seog, DH; Hirokawa, N			Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor - Containing vesicle transport	SCIENCE			English	Article							GLUTAMATE RECEPTORS; NEURONAL POLARITY; LOCALIZATION; COMPLEX; CHANNEL; SUBUNIT; LIN-7; IDENTIFICATION; HOMOLOGS; SYNAPSES	Experiments with vesicles containing N-methyl-D-aspartate (NMDA) receptor 2B (NR2B subunit) show that they are transported along microtubules by KIF17, a neuron-specific molecular motor in neuronal dendrites. Selective transport is accomplished by direct interaction of the KIF17 tail with a PDZ domain of mLin-10 (Mintl1/X11), which is a constituent of a large protein complex including mLin-2 (CASK), mLin-7 (MALS/VeLis), and the NR2B subunit. This interaction, specific for a neurotransmitter receptor critically important for plasticity in the postsynaptic terminal, may be a regulatory point for synaptic plasticity and neuronal morphogenesis.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo, Japan.							Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Foletti DL, 1999, NEURON, V23, P641, DOI 10.1016/S0896-6273(01)80022-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Irie M, 1999, ONCOGENE, V18, P2811, DOI 10.1038/sj.onc.1202652; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Rubio ME, 1999, J NEUROSCI, V19, P5549; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; SETOU M, 1996, J BIOL CHEM, V271, P15669; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 1996, CURR OPIN NEUROBIOL, V6, P602, DOI 10.1016/S0959-4388(96)80091-2; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Smith SJ, 1999, SCIENCE, V283, P1860, DOI 10.1126/science.283.5409.1860; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x	31	571	595	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1796	1802		10.1126/science.288.5472.1796	http://dx.doi.org/10.1126/science.288.5472.1796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846156				2022-12-28	WOS:000087503800042
J	Watzman, H				Watzman, H			Software spend boosts Israeli R&D	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					603	603		10.1038/35015225	http://dx.doi.org/10.1038/35015225			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864291	Bronze			2022-12-28	WOS:000087465800006
J	Wickware, P				Wickware, P			US minorities stake their claim in science and engineering	NATURE			English	Article																			0	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					717	718		10.1038/35015276	http://dx.doi.org/10.1038/35015276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864335				2022-12-28	WOS:000087465800057
J	Chiang, T				Chiang, T			Catching crumbs from the table	NATURE			English	Article																			0	2	2	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					517	517		10.1038/35014679	http://dx.doi.org/10.1038/35014679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850694	Bronze			2022-12-28	WOS:000087449500028
J	Kofman, AG; Kurizki, G				Kofman, AG; Kurizki, G			Acceleration of quantum decay processes by frequent observations	NATURE			English	Article								In theory, the decay of any unstable quantum state can be inhibited by sufficiently frequent measurements-the quantum Zeno effect(1-10). Although this prediction has been tested only for transitions between two coupled, essentially stable states(5-8), the quantum Zeno effect is thought to be a general feature of quantum mechanics, applicable to radioactive(3) or radiative decay processes(6,9). This generality arises from the assumption that, in principle, successive observations can be made at time intervals too short for the system to change appreciably(1-4). Here we show not only that the quantum Zeno effect is fundamentally unattainable in radiative or radioactive decay (because the required measurement rates would cause the system to disintegrate), but also that these processes may be accelerated by frequent measurements. We find that the modification of the decay process is determined by the energy spread incurred by the measurements (as a result of the time-energy uncertainty relation),and the distribution of states to which the decaying state is coupled. Whereas the inhibitory quantum Zeno effect may be feasible in a limited class of systems, the opposite effect-accelerated decay-appears to be much more ubiquitous.	Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Kurizki, G (corresponding author), Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel.		Kofman, Abraham/A-6838-2013	Kofman, Abraham/0000-0001-5816-6415				Beige A, 1997, J PHYS A-MATH GEN, V30, P1323, DOI 10.1088/0305-4470/30/4/031; Cohen-Tannoudji C., 1998, ATOM PHOTON INTERACT; COOK RJ, 1988, PHYS SCRIPTA, VT21, P49, DOI 10.1088/0031-8949/1988/T21/009; Facchi P, 1998, PHYS LETT A, V241, P139, DOI 10.1016/S0375-9601(98)00144-3; FEARN H, 1992, PHYS REV A, V46, P1199, DOI 10.1103/PhysRevA.46.1199; FRERICHS V, 1991, PHYS REV A, V44, P1962, DOI 10.1103/PhysRevA.44.1962; Harel G, 1998, OPT EXPRESS, V2, P355, DOI 10.1364/OE.2.000355; ITANO WM, 1990, PHYS REV A, V41, P2295, DOI 10.1103/PhysRevA.41.2295; JOOS E, 1984, PHYS REV D, V29, P1626, DOI 10.1103/PhysRevD.29.1626; KHALFIN LA, 1968, JETP LETT-USSR, V8, P65; KNIGHT P, 1990, NATURE, V344, P493, DOI 10.1038/344493a0; Kofman AG, 1996, PHYS REV A, V54, pR3750, DOI 10.1103/PhysRevA.54.R3750; MILBURN GJ, 1988, J OPT SOC AM B, V5, P1317, DOI 10.1364/JOSAB.5.001317; MISRA B, 1977, J MATH PHYS, V18, P756, DOI 10.1063/1.523304; MOSES HE, 1972, LETT NUOVO CIMENTO, V4, P51, DOI 10.1007/BF02807551; SAKURAI JJ, 1994, MODERN QUANTUM MECH, P484; Schulman LS, 1998, PHYS REV A, V57, P1509, DOI 10.1103/PhysRevA.57.1509	17	443	447	1	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					546	550		10.1038/35014537	http://dx.doi.org/10.1038/35014537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850708				2022-12-28	WOS:000087449500043
J	De Rosa, C; Park, C; Thomas, EL; Lotz, B				De Rosa, C; Park, C; Thomas, EL; Lotz, B			Microdomain patterns from directional eutectic solidification and epitaxy	NATURE			English	Article							COPOLYMER THIN-FILMS; DIBLOCK COPOLYMER; ELECTRIC-FIELDS; CRYSTALLIZATION; POLYETHYLENE; POLYMERS; ARRAYS	Creating a regular surface pattern on the nanometre scale is important for many technological applications, such as the periodic arrays constructed by optical microlithography that are used as separation media in electrophoresis(1), and island structures used for high-density magnetic recording devices(2). Block copolymer patterns can also be used for lithography on length scales below 30 nanometres (refs 3-5). But for such polymers to prove useful for thin-film technologies, chemically patterned surfaces need to be made substantially defect-free over large areas, and with tailored domain orientation and periodicity. So far, control over domain orientation has been achieved by several routes(6-9), using electric fields, temperature gradients, patterned substrates and neutral confining surfaces. Here we describe an extremely fast process that leads the formation of two-dimensional periodic thin films having large area and uniform thickness, and which possess vertically aligned cylindrical domains each containing precisely one crystalline lamella. The process involves rapid solidification of a semicrystalline block copolymer from a crystallizable solvent between glass substrates using directional solidification and epitaxy. The film is both chemically and structurally periodic, thereby providing new opportunities for more selective and versatile nanopatterned surfaces.	Univ Naples, Dipartimento Chim, I-80134 Naples, Italy; MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; CNRS, Ctr Rech Macromol, F-67083 Strasbourg, France	University of Naples Federico II; Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Thomas, EL (corresponding author), Univ Naples, Dipartimento Chim, Via Mezzocannone 4, I-80134 Naples, Italy.			Thomas, Edwin/0000-0001-5911-6524; De Rosa, Claudio/0000-0002-5375-7475				Bodycomb J, 1999, MACROMOLECULES, V32, P2075, DOI 10.1021/ma981538g; CHOU SY, 1994, J APPL PHYS, V76, P6673, DOI 10.1063/1.358164; DORSET DL, 1989, MACROMOLECULES, V22, P2169, DOI 10.1021/ma00195a029; Fasolka MJ, 1997, PHYS REV LETT, V79, P3018, DOI 10.1103/PhysRevLett.79.3018; Flemings MC., 1974, SOLIDIFICATION PROCE; HASHIMOTO T, 1983, BLOCK COPOLYMERS SCI, P63; Huang E, 1998, NATURE, V395, P757, DOI 10.1038/27358; Kim G, 1998, MACROMOLECULES, V31, P2670, DOI 10.1021/ma9714070; Lammertink RGH, 2000, ADV MATER, V12, P98, DOI 10.1002/(SICI)1521-4095(200001)12:2<98::AID-ADMA98>3.0.CO;2-5; MANSKY P, 1995, J MATER SCI, V30, P1987, DOI 10.1007/BF00353023; Mansky P, 1998, MACROMOLECULES, V31, P4399, DOI 10.1021/ma980299u; Morkved TL, 1996, SCIENCE, V273, P931, DOI 10.1126/science.273.5277.931; Muthukumar M, 1997, SCIENCE, V277, P1225, DOI 10.1126/science.277.5330.1225; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Reiter G, 1999, PHYS REV LETT, V83, P3844, DOI 10.1103/PhysRevLett.83.3844; SMITH P, 1974, POLYMER, V15, P413, DOI 10.1016/0032-3861(74)90103-7; SWEI GS, 1986, ENCY POLYM SCI ENG, V6, P209; THOMAS EL, 1974, POLYMER, V15, P37, DOI 10.1016/0032-3861(74)90072-X; VOLKMUTH WD, 1992, NATURE, V358, P600, DOI 10.1038/358600a0; WITTMANN JC, 1990, PROG POLYM SCI, V15, P909, DOI 10.1016/0079-6700(90)90025-V; WITTMANN JC, 1983, J POLYM SCI POL PHYS, V21, P2495, DOI 10.1002/pol.1983.180211207; Wu S., 1982, POLYM INTERFACE ADHE	22	334	349	2	138	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					433	437		10.1038/35013018	http://dx.doi.org/10.1038/35013018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839533				2022-12-28	WOS:000087212000041
J	Zhao, S; Weng, YC; Yuan, SSF; Lin, YT; Hsu, HC; Lin, SCJ; Gerbino, E; Song, MH; Zdzienicka, MZ; Gatti, RA; Shay, JW; Ziv, Y; Shiloh, Y; Lee, EYHP				Zhao, S; Weng, YC; Yuan, SSF; Lin, YT; Hsu, HC; Lin, SCJ; Gerbino, E; Song, MH; Zdzienicka, MZ; Gatti, RA; Shay, JW; Ziv, Y; Shiloh, Y; Lee, EYHP			Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products	NATURE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; CELL-CYCLE; C-ABL; CHECKPOINT PATHWAYS; IONIZING-RADIATION; PHOSPHORYLATION; COMPLEX; REPAIR; ATM	Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are recessive genetic disorders with susceptibility to cancer and similar cellular phenotypes(1). The protein product of the gene responsible for A-T, designated ATM, is a member of a family of kinases characterized by a carboxy-terminal phosphatidylinositol 3-kinase-like domain(2,3). The NBS1 protein is specifically mutated in patients with Nijmegen breakage syndrome and forms a complex with the DNA repair proteins Rad50 and Mre11(4-7). Here we show that phosphorylation of NBS1, induced by ionizing radiation, requires catalytically active ATM. Complexes containing ATM and NBS1 exist in vivo in both untreated cells and cells treated with ionizing radiation. We have identified two residues of NBS1, Ser 278 and Ser 343 that are phosphorylated in vitro by ATM and whose modification in vivo is essential for the cellular response to DNA damage. This response includes S-phase checkpoint activation, formation of the NBS1/Mre11/Rad50 nuclear foci and rescue of hypersensitivity to ionizing radiation. Together, these results demonstrate a biochemical link between cell-cycle checkpoints activated by DNA damage and DNA repair in two genetic diseases with overlapping phenotypes.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; Leiden Univ, LUMC, MGC Dept Radiat Genet & Chem Mutagenesis, Leiden, Netherlands; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, Tel Aviv, Israel	University of Texas System; University of Texas Health San Antonio; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tel Aviv University; Sackler Faculty of Medicine	Lee, EYHP (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.		Shay, Jerry W/F-7878-2011	yuan, shyng-shiou/0000-0002-4753-788X				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Caspari T, 1999, BIOCHIMIE, V81, P173, DOI 10.1016/S0300-9084(99)80050-9; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Kraakman-van der Zwet M, 1999, MUTAT RES-DNA REPAIR, V434, P17, DOI 10.1016/S0921-8777(99)00009-9; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; ZIV Y, 1999, EXPERSSION ASSAY REC	29	407	420	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					473	477		10.1038/35013083	http://dx.doi.org/10.1038/35013083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839544				2022-12-28	WOS:000087212000052
J	Irwig, L; Armstrong, B				Irwig, L; Armstrong, B			EUROCARE-2: relevance for assessment of quality of cancer services?	LANCET			English	Editorial Material									Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia; New S Wales Canc Council, Canc Res & Registers, Sydney, NSW, Australia	University of Sydney; Cancer Council New South Wales	Irwig, L (corresponding author), Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia.		Armstrong, Bruce K/K-9464-2015	Armstrong, Bruce K/0000-0001-8940-7525				ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; ARMSTRONG BK, 1992, CANCER CAUSE CONTROL, V3, P569, DOI 10.1007/BF00052754; Barratt A, 1999, JAMA-J AM MED ASSOC, V281, P2029, DOI 10.1001/jama.281.21.2029; Berrino F, 1999, IARC SCI PUBLICATION, V51; *BREASTSCR VICT IN, 1999, 1997 ANN STAT REP; *CLIN ONC SOC AUST, 1999, PREV EARL DET MAN CO, P129; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; HAKAMA M, 1982, TRENDS CANCER INCIDE, P279; Hill D., 1999, SURG MANAGEMENT BREA; Irwig L, 1998, B WORLD HEALTH ORGAN, V76, P17; Kricker A, 1999, INT J CANCER, V81, P877, DOI 10.1002/(SICI)1097-0215(19990611)81:6<877::AID-IJC7>3.0.CO;2-F; PEERS F, 1987, INT J CANCER, V39, P545, DOI 10.1002/ijc.2910390502; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559	13	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					427	428						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841121				2022-12-28	WOS:000085306800007
J	Lazzaro, D; Michtchenko, T; Carvano, JM; Binzel, RP; Bus, SJ; Burbine, TH; Mothe-Diniz, T; Florczak, M; Angeli, CA; Harris, AW				Lazzaro, D; Michtchenko, T; Carvano, JM; Binzel, RP; Bus, SJ; Burbine, TH; Mothe-Diniz, T; Florczak, M; Angeli, CA; Harris, AW			Discovery of a basaltic asteroid in the outer main belt	SCIENCE			English	Article							SPACE-TELESCOPE IMAGES; PARENT BODY; RESONANCES; VESTA; METEORITES; ELEMENTS; EUCRITE; 4-VESTA; MOTION	Visible and near-infrared spectroscopic observations of the asteroid 1459 Magnya indicate that it:has a basaltic surface. Magnya is at 3.15 astronomical units (AU) from the sun and has no known dynamical link to any family, to any nearby Large asteroid, or to asteroid 4 Vesta at 2.36 AU, which is the only other known large basaltic asteroid. We show that the region of the belt around Magnya is densely filled by mean-motion resonances, generating slow orbital diffusion processes and providing a potential mechanism for removing other basaltic fragments that may have been created on the same:parent body as Magnya. Magnya may represent a rare surviving fragment from a Larger, differentiated planetesimal that was disrupted long ago.	Observ Nacl, Dept Astrofis, BR-20921400 Rio De Janeiro, Brazil; Univ Sao Paulo, Inst Astron & Geofis, BR-04301904 Sao Paulo, Brazil; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Ctr Fed Educ Tecnol Parana, Dept Fis, BR-80230901 Curitiba, Parana, Brazil; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Universidade de Sao Paulo; Massachusetts Institute of Technology (MIT); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Lazzaro, D (corresponding author), Observ Nacl, Dept Astrofis, Rua Gal Jose Cristino 77, BR-20921400 Rio De Janeiro, Brazil.		Mothe-Diniz, Thais/B-8987-2011; Lazzaro, Daniela/I-3509-2012; Michtchenko, Tatiana/O-4109-2015; Ferreira Carvano, Jorge/I-4039-2016; Michtchenko, Tatiana/M-3963-2019; Florczak, Marcos Antonio/L-4891-2015	Lazzaro, Daniela/0000-0002-4470-6043; Michtchenko, Tatiana/0000-0002-1499-9893; Ferreira Carvano, Jorge/0000-0003-0670-639X; Michtchenko, Tatiana/0000-0002-1499-9893; Florczak, Marcos Antonio/0000-0002-3874-1926; Mothe-Diniz, Thais/0000-0002-2707-5534				Binzel RP, 1997, ICARUS, V128, P95, DOI 10.1006/icar.1997.5734; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; BOWELL E, 1994, IAU SYMP, P477; BURBINE TH, 2000, THESIS MIT CAMBRIDGE; CONSOLMAGNO GJ, 1977, GEOCHIM COSMOCHIM AC, V41, P1271, DOI 10.1016/0016-7037(77)90072-2; Drake M. J., 1979, ASTEROIDS, P765; Farinella P, 1999, SCIENCE, V283, P1507, DOI 10.1126/science.283.5407.1507; Farinella P, 1998, ICARUS, V132, P378, DOI 10.1006/icar.1997.5872; GAFFEY MJ, 1976, J GEOPHYS RES, V81, P905, DOI 10.1029/JB081i005p00905; LAZZARO D, 1997, B AM ASTRON SOC, V29, P975; MCCORD TB, 1970, SCIENCE, V168, P1445, DOI 10.1126/science.168.3938.1445; MCFADDEN LA, 1977, ICARUS, V31, P439, DOI 10.1016/0019-1035(77)90147-6; MICHTCHENKO TA, 1995, ASTRON ASTROPHYS, V303, P945; Migliorini F, 1997, METEORIT PLANET SCI, V32, P903, DOI 10.1111/j.1945-5100.1997.tb01580.x; MILANI A, 1994, ICARUS, V107, P219, DOI 10.1006/icar.1994.1020; Morbidelli A, 1999, ICARUS, V139, P295, DOI 10.1006/icar.1999.6097; Nesvorny D, 1998, ASTRON J, V116, P3029, DOI 10.1086/300632; SCOTT ERD, 1989, ASTEROIDS II, P701; TEDESCO EF, PLANETARY DATA SYSTE; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; Wasson J.T., 1979, ASTEROIDS, P926; WILLIAMS JG, 1989, ASTEROIDS II, P1034; ZAPPALA V, 1995, ICARUS, V116, P291, DOI 10.1006/icar.1995.1127; Zellner BH, 1997, ICARUS, V128, P83, DOI 10.1006/icar.1997.5735; [No title captured]	25	102	102	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2033	2035		10.1126/science.288.5473.2033	http://dx.doi.org/10.1126/science.288.5473.2033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856214				2022-12-28	WOS:000087687000047
J	Murray, M				Murray, M			Modernising the NHS - Patient care: access	BRITISH MEDICAL JOURNAL			English	Article											Murray, M (corresponding author), 2209 Capitol Ave, Sacramento, CA 95816 USA.								0	41	41	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1594	1596		10.1136/bmj.320.7249.1594	http://dx.doi.org/10.1136/bmj.320.7249.1594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845975	Green Published			2022-12-28	WOS:000087631400029
J	Burnett, K				Burnett, K			Laser-matter interactions - It takes two electrons to tango	NATURE			English	Editorial Material							DOUBLE-IONIZATION; HELIUM		Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Burnett, K (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.							Becker A, 1996, J PHYS B-AT MOL OPT, V29, pL197, DOI 10.1088/0953-4075/29/6/005; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Sheehy B, 1998, PHYS REV A, V58, P3942, DOI 10.1103/PhysRevA.58.3942; Taylor KT, 1999, LASER PHYS, V9, P98; WALKER B, 1994, PHYS REV LETT, V73, P1227, DOI 10.1103/PhysRevLett.73.1227; Watson JB, 1997, PHYS REV LETT, V78, P1884, DOI 10.1103/PhysRevLett.78.1884; Weber T, 2000, NATURE, V405, P658, DOI 10.1038/35015033	7	1	1	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					631	633		10.1038/35015201	http://dx.doi.org/10.1038/35015201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864309				2022-12-28	WOS:000087465800030
J	Biering-Sorensen, F; Bendix, AF				Biering-Sorensen, F; Bendix, AF			Working off low back pain	LANCET			English	Editorial Material									Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Dept Med TH, DK-2100 Copenhagen, Denmark; Odense Univ Hosp, Dept Planning & Qual Dev, Odense, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Biering-Sorensen, F (corresponding author), Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Dept Med TH, DK-2100 Copenhagen, Denmark.			Biering-Sorensen, Fin/0000-0002-2186-0144				Abenhaim L, 2000, SPINE, V25, p1S, DOI 10.1097/00007632-200002151-00001; ALTMAIER EM, 1992, PAIN, V49, P329, DOI 10.1016/0304-3959(92)90240-C; BALAGUE F, 1995, SPINE, V20, P1265, DOI 10.1097/00007632-199506000-00012; Carter JT., 2000, OCCUPATIONAL HLTH GU; Feyer AM, 2000, OCCUP ENVIRON MED, V57, P116, DOI 10.1136/oem.57.2.116; FORD WE, 1995, BACK PAIN WORKPLACE; Hansen FR, 1995, SPINE, V20, P2716, DOI 10.1097/00007632-199512150-00013; Schade V, 1999, PAIN, V80, P239, DOI 10.1016/S0304-3959(98)00210-3; TULDER MW, 2000, COCHRANE DATABASE SY; WADDELL G, 1994, EPIDEMIOLOGY REV EPI; Williams RA, 1998, ARCH PHYS MED REHAB, V79, P366, DOI 10.1016/S0003-9993(98)90135-6	11	9	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1929	1930		10.1016/S0140-6736(00)02321-7	http://dx.doi.org/10.1016/S0140-6736(00)02321-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859035				2022-12-28	WOS:000087381900006
J	Plant, PK; Owen, JL; Elliott, MW				Plant, PK; Owen, JL; Elliott, MW			Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial	LANCET			English	Article							POSITIVE PRESSURE VENTILATION; NASAL VENTILATION; FAILURE; RISK	Background Within the intensive-care unit, non-invasive ventilation (NIV) can prevent the need for intubation and the mortality associated with severe episodes of chronic. obstructive pulmonary disease (COPD). The aim of this study was to find whether the introduction of NIV, early after the admission on a general respiratory ward, was effective at reducing the need for intubation and the mortality associated with acute exacerbations of COPD. Methods We did a prospective multicentre randomised controlled study comparing NIV with standard therapy in patients with mild to moderate acidosis. NIV was administered on the ward with a simple non-invasive ventilator and a standardised predefined protocol. Patients were recruited from 14 UK hospitals over 22 months. Findings 236 patients were recruited, 118 received standard therapy alone and 118 additional NIV. The two groups had similar characteristics at enrolment. The use of NIV significantly reduced the need for intubation as defined by the failure criteria. 32/118 (27%) of the standard group failed compared with 18/118 (15%) of the NIV group (p=0.02). in-hospital mortality was also reduced by NIV, 24/118 (20%) died in the standard group compared with 12/118 (10%) in the NIV group (p=0.05). In both groups pH; PaCO2, and respiratory rate improved at 4 h (p<0.01). However, NIV led to a more rapid improvement in pH in the first hour (p=0.02) and a greater fall in respiratory rate at 4 h (p=0.035). The duration of breathlessness was also reduced by NIV (p=0.025). Interpretation The early use of NIV for mildly and moderately acidotic patients with COPD in the general ward setting leads to more rapid improvement of physiological variables, a reduction in the need for invasive mechanical ventilation (with objective criteria), and a reduction in in-hospital mortality.	St James Univ Hosp, Dept Resp Med, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Plant, PK (corresponding author), St James Univ Hosp, Dept Resp Med, Leeds LS9 7TF, W Yorkshire, England.							Angus RM, 1996, THORAX, V51, P1048, DOI 10.1136/thx.51.10.1048; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; BERGSTROM N, 1987, NURS RES, V36, P205, DOI 10.1097/00006199-198707000-00002; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Celikel T, 1998, CHEST, V114, P1636, DOI 10.1378/chest.114.6.1636; CHEVROLET JC, 1991, CHEST, V100, P775, DOI 10.1378/chest.100.3.775; FLENLEY DC, 1971, LANCET, V1, P961; HUDSON L D, 1989, American Review of Respiratory Disease, V140, pS19; JEFFREY AA, 1992, THORAX, V47, P34, DOI 10.1136/thx.47.1.34; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; Nava S, 1997, CHEST, V111, P1631, DOI 10.1378/chest.111.6.1631; SHNEERSON J, 1996, EUR RESPIR J, V19, P393; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339	14	773	848	0	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1931	1935		10.1016/S0140-6736(00)02323-0	http://dx.doi.org/10.1016/S0140-6736(00)02323-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859037				2022-12-28	WOS:000087381900008
J	Burke, D				Burke, D			Time for voices to be raised	NATURE			English	Editorial Material									Univ E Anglia, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Burke, D (corresponding author), 13 Pretoria Rd, Cambridge CB4 1HD, England.							PUSZTAI A, 1999, NATURE, V401, P731; 2000, NATURE, V404, P211; 2000, NATURE, V404, P112; 2000, NATURE, V405, P54	4	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					509	509		10.1038/35014674	http://dx.doi.org/10.1038/35014674			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850692	Bronze			2022-12-28	WOS:000087449500021
J	Arber, S; Ladle, DR; Lin, JH; Frank, E; Jessell, TM				Arber, S; Ladle, DR; Lin, JH; Frank, E; Jessell, TM			ETS gene Er81 controls the formation of functional connections between group Ia sensory afferents and motor neurons	CELL			English	Article							DORSAL-ROOT GANGLIA; SPINAL-CORD; SYNAPTIC CONNECTIONS; NT-3 ACTIVATION; IN-VIVO; MUSCLE; EXPRESSION; MOUSE; CELLS; NEUROTROPHIN	The connections formed between sensory and motor neurons (MNs) play a critical role in the control of motor behavior. During development, the axons of proprioceptive sensory neurons project into the spinal cord and form both direct and indirect connections with MNs. Two ETS transcription factors, ER81 and PEAS, are expressed by developing proprioceptive neurons and MNs, raising the possibility that these genes are involved in the formation of sensory-motor connections. Er81 mutant mice exhibit a severe motor discoordination, yet the specification of MNs and induction of muscle spindles occurs normally. The motor defect in Er81 mutants results from a failure of group la proprioceptive afferents to form a discrete termination zone in the ventral spinal cord. As a consequence there is a dramatic reduction in the formation of direct connections between proprioceptive afferents and MNs. ER81 therefore controls a late step in the establishment of functional sensory-motor circuitry in the developing spinal cord.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA	Columbia University; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.			Arber, Silvia/0000-0002-6261-250X; Lin, Jonathan/0000-0002-7438-6941				ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bang AG, 1996, CURR OPIN NEUROBIOL, V6, P25, DOI 10.1016/S0959-4388(96)80005-5; Brown A. G., 1981, ORG SPINAL CORD, P154; BROWN MC, 1967, J PHYSIOL-LONDON, V192, P773, DOI 10.1113/jphysiol.1967.sp008330; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen HH, 1999, CURR OPIN NEUROBIOL, V9, P405, DOI 10.1016/S0959-4388(99)80061-0; Coutte L, 1999, ONCOGENE, V18, P6278, DOI 10.1038/sj.onc.1203020; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Frank E, 1988, MESSAGE MIND, P180; Goulding M, 1998, NEURON, V21, P943, DOI 10.1016/S0896-6273(00)80612-1; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Huang EJ, 1999, DEVELOPMENT, V126, P2191; JANSEN JKS, 1964, ACTA PHYSIOL SCAND, V62, P364, DOI 10.1111/j.1748-1716.1964.tb10435.x; Kopp DM, 1997, J NEUROSCI, V17, P6697; Kucera J, 1998, NEUROREPORT, V9, P905, DOI 10.1097/00001756-199803300-00026; KUNO M, 1970, J PHYSIOL-LONDON, V210, P823, DOI 10.1113/jphysiol.1970.sp009244; LANCEJONES C, 1979, J MORPHOL, V162, P275; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; LICHTMAN JW, 1984, J NEUROSCI, V4, P1745; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mears SC, 1997, J NEUROSCI, V17, P3128; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; MU XJ, 1993, J NEUROSCI, V13, P4029; O'Donovan KJ, 1998, J NEUROCHEM, V70, P1241; Ozaki S, 1997, J COMP NEUROL, V380, P215; RiveroMelian C, 1996, J COMP NEUROL, V364, P651, DOI 10.1002/(SICI)1096-9861(19960122)364:4<651::AID-CNE4>3.0.CO;2-2; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Saueressig H, 1999, DEVELOPMENT, V126, P4201; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WATT DGD, 1976, J NEUROPHYSIOL, V39, P1375, DOI 10.1152/jn.1976.39.6.1375; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; ZELENA J, 1994, NERVES MECHANORECEPT, P1	43	374	375	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					485	498		10.1016/S0092-8674(00)80859-4	http://dx.doi.org/10.1016/S0092-8674(00)80859-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850491	Bronze			2022-12-28	WOS:000087375400006
J	Andreyev, AN; Huyse, M; Van Duppen, P; Weissman, L; Ackermann, D; Gerl, J; Hessberger, FP; Hofmann, S; Kleinbohl, A; Munzenberg, G; Reshitko, S; Schlegel, C; Schaffner, H; Cagarda, P; Matos, M; Saro, S; Keenan, A; Moore, C; O'Leary, CD; Page, RD; Taylor, M; Kettunen, H; Leino, M; Lavrentiev, A; Wyss, R; Heyde, K				Andreyev, AN; Huyse, M; Van Duppen, P; Weissman, L; Ackermann, D; Gerl, J; Hessberger, FP; Hofmann, S; Kleinbohl, A; Munzenberg, G; Reshitko, S; Schlegel, C; Schaffner, H; Cagarda, P; Matos, M; Saro, S; Keenan, A; Moore, C; O'Leary, CD; Page, RD; Taylor, M; Kettunen, H; Leino, M; Lavrentiev, A; Wyss, R; Heyde, K			A triplet of differently shaped spin-zero states in the atomic nucleus Pb-186	NATURE			English	Article							ALPHA-DECAY; FINE-STRUCTURE; INTRUDER STATES; MASS NUCLEI; SHELL; COEXISTENCE; ISOTOPES; PO-191; IDENTIFICATION; SPECTROSCOPY	Understanding the fundamental excitations of many-fermion systems is of significant current interest. In atomic nuclei with even numbers of neutrons and protons, the low-lying excitation spectrum is generally formed by nucleon pair breaking and nuclear vibrations or rotations. However, for certain numbers of protons and neutrons, a subtle rearrangement of only a few nucleons among the orbitals at the Fermi surface can result in a different elementary mode: a macroscopic shape change(1-3). The first experimental evidence for this phenomenon came from the observation of shape coexistence in O-16 (ref. 4). Other unexpected examples came with the discovery of fission isomers(5) and superdeformed nuclei(6). Here we find experimentally that the lowest three states in the energy spectrum of the neutron deficient nucleus Pb-186 are spherical, oblate and prolate. The states are populated by the alpha-decay of a parent nucleus; to identify them, we combine knowledge of the particular features of this decay(7) with sensitive measurement techniques (a highly efficient velocity filter(8) with strong background reduction, and an extremely selective recoil-alpha-electron coincidence tagging method(8-10)). The existence of this apparently unique shape triplet is permitted only by the specific conditions that are met around this particular nucleus.	Katholieke Univ Leuven, Inst Kern & Stralingsfys, B-3001 Louvain, Belgium; Gesell Schwerionenforsch Inst Darmstadt, D-6100 Darmstadt, Germany; Comenius Univ, Dept Nucl Phys, Bratislava, Slovakia; Univ Liverpool, Oliver Lodge Lab, Dept Phys, Liverpool L69 7ZE, Merseyside, England; Univ Jyvaskyla, Dept Phys, FIN-40351 Jyvaskyla, Finland; Joint Inst Nucl Res, Flerov Lab Nucl React, Dubna 141980, Russia; Royal Inst Technol, Dept Phys, S-10405 Stockholm, Sweden; Kalmar Univ, Dept Technol, S-39129 Kalmar, Sweden; Inst Theoret Phys, Vakgrp Subatomaire & Stralingsfys, B-9000 Ghent, Belgium	KU Leuven; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Comenius University Bratislava; University of Liverpool; University of Jyvaskyla; Joint Institute for Nuclear Research - Russia; Royal Institute of Technology; Linnaeus University; University of Kalmar	Huyse, M (corresponding author), Katholieke Univ Leuven, Inst Kern & Stralingsfys, Celestijnenlaan 200 D, B-3001 Louvain, Belgium.		Wyss, Ramon A./G-4513-2017; Kettunen, Heikki Ilmari/F-4883-2018; Taylor, Michael/N-1725-2015; Ackermann, Dieter/AAW-6913-2021; Huyse, Mark/ABC-7645-2020; Gerl, Juergen/A-3255-2011; Matos, Milan/G-6947-2012	Wyss, Ramon A./0000-0001-6899-2964; Kettunen, Heikki Ilmari/0000-0001-6207-7060; Taylor, Michael/0000-0002-8718-3684; Ackermann, Dieter/0000-0001-6284-1516; Matos, Milan/0000-0003-1722-9509; Van Duppen, Piet/0000-0002-5053-7370				Allatt RG, 1998, PHYS LETT B, V437, P29, DOI 10.1016/S0370-2693(98)00939-3; Andreyev AN, 1999, ACTA PHYS POL B, V30, P1255; Andreyev AN, 1999, EUR PHYS J A, V6, P381, DOI 10.1007/s100500050359; Andreyev AN, 1999, PHYS REV LETT, V82, P1819, DOI 10.1103/PhysRevLett.82.1819; Batchelder JC, 1997, PHYS REV C, V55, pR2142, DOI 10.1103/PhysRevC.55.R2142; BAXTER AM, 1993, PHYS REV C, V48, pR2140, DOI 10.1103/PhysRevC.48.R2140; Bijnens N, 1996, Z PHYS A-HADRON NUCL, V356, P3, DOI 10.1007/s002180050137; BIJNENS N, 1995, PHYS REV LETT, V75, P4571, DOI 10.1103/PhysRevLett.75.4571; BJORNHOLM S, 1980, REV MOD PHYS, V52, P725, DOI 10.1103/RevModPhys.52.725; Cocks JFC, 1998, EUR PHYS J A, V3, P17, DOI 10.1007/s100500050144; CWIOK S, 1987, COMPUT PHYS COMMUN, V46, P379, DOI 10.1016/0010-4655(87)90093-2; Dracoulis GD, 1998, PHYS LETT B, V432, P37, DOI 10.1016/S0370-2693(98)00620-0; HEESE J, 1993, PHYS LETT B, V302, P390, DOI 10.1016/0370-2693(93)90415-E; HEYDE K, 1989, PHYS LETT B, V218, P287, DOI 10.1016/0370-2693(89)91582-7; HEYDE K, 1983, PHYS REP, V102, P291, DOI 10.1016/0370-1573(83)90085-6; Hofmann S, 1998, REP PROG PHYS, V61, P827, DOI 10.1088/0034-4885/61/7/002; Mergel E., 1999, EPJDIRECT, V1, P1; MORINAGA H, 1956, PHYS REV, V101, P254, DOI 10.1103/PhysRev.101.254; NADREYEV AN, 1999, J PHYS G, V25, P835; NAZAREWICZ W, 1993, PHYS LETT B, V305, P195, DOI 10.1016/0370-2693(93)90107-S; NOLAN PJ, 1988, ANNU REV NUCL PART S, V38, P533, DOI 10.1146/annurev.ns.38.120188.002533; TAJIMA N, 1993, NUCL PHYS A, V551, P409, DOI 10.1016/0375-9474(93)90455-7; VANDUPPEN P, 1984, PHYS REV LETT, V52, P1974, DOI 10.1103/PhysRevLett.52.1974; VANDUPPEN P, IN PRESS HYPERFINE I; Walker P, 1999, NATURE, V399, P35, DOI 10.1038/19911; WAUTERS J, 1994, PHYS REV C, V50, P2768, DOI 10.1103/PhysRevC.50.2768; WAUTERS J, 1994, PHYS REV LETT, V72, P1329, DOI 10.1103/PhysRevLett.72.1329; WOOD JL, 1992, PHYS REP, V215, P101, DOI 10.1016/0370-1573(92)90095-H	28	377	384	1	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					430	433		10.1038/35013012	http://dx.doi.org/10.1038/35013012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839532				2022-12-28	WOS:000087212000040
J	Haldeman, J				Haldeman, J			Brochure - The apocalypse: a great day out for the whole family	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					401	401		10.1038/35013165	http://dx.doi.org/10.1038/35013165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839517	Bronze			2022-12-28	WOS:000087212000024
J	[Anonymous]				[Anonymous]			Powerful visions for astronomy	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					379	379						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839499				2022-12-28	WOS:000087212000001
J	de Gans, J; van Westrum, SS; Kuijper, E; Schaap, GR				de Gans, J; van Westrum, SS; Kuijper, E; Schaap, GR			Earache and back pain	LANCET			English	Article									Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; Acad Med Ctr, Dept Microbiol, NL-1100 DD Amsterdam, Netherlands; Acad Med Ctr, Dept Orthopaed, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Gans, J (corresponding author), Acad Med Ctr, Dept Neurol, POB 22660, NL-1100 DD Amsterdam, Netherlands.	J.deGans@amc.uva.nl	Kuijper, ed/AAB-7853-2022	Kuijper, ed/0000-0001-5726-2405				EYKYN SJ, 1989, SCAND J INFECT DIS, P41; FRANK AM, 1990, NEUROSURG REV, V13, P279, DOI 10.1007/BF00346365; Jimenez-Mejias ME, 1999, CLIN INFECT DIS, V29, P339, DOI 10.1086/520212; TORDA AJ, 1995, CLIN INFECT DIS, V20, P320, DOI 10.1093/clinids/20.2.320	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					464	464						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841128				2022-12-28	WOS:000085306800014
J	Teale, GR; Moffitt, DD; Mann, CH; Luesley, DM				Teale, GR; Moffitt, DD; Mann, CH; Luesley, DM			Management guidelines for women with normal colposcopy after low grade cervical abnormalities: population study	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA	Objectives To develop an evidence based protocol for the follow up of women with low grade cervical abnormalities for whom treatment is not immediately indicated. Design Population outcome study. Setting Colposcopy clinic of an inner city teaching hospital. Participants 566 women with low grade cytological abnormalities who were not treated at a first visit to the colposcopy clinic, followed up for a total of 881 years. Main outcome measures Resolution of abnormalities, persistence of disease, and treated disease. Results Abnormalities resolved in 306 (54.1%) women, whereas 138 (24.4%,) had persistent disease and 122 (21.5%) were subsequently treated. Colposcopic opinion, smear test results, as, smoking history, and number of pregnancies were all significantly related to outcome. Logistic regression analysis produced a model that correctly identified 70% of women whose abnormalities resolved. Only 23 of 295 women (7.8%) with a normal cervix on colposcopy and a smear without dyskaryosis at a first visit were treated by the end of the observation period. Conclusions Women referred with low gr-ade cytological abnormalities who have a normal cervix on colposcopy and a negative or borderline repeat smear test result may be discharged from the colposcopy clinic. We propose a follow up protocol that could safely avoid unnecessary visits to a clinic.	Birmingham Womens NHS Trust, Birmingham B15 2TG, W Midlands, England; Univ Birmingham, Sch Med, Inst Canc Studies, Canc Res Campaign Trials Unit, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Div Gynaecol Oncol, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Teale, GR (corresponding author), Birmingham Womens NHS Trust, Birmingham B15 2TG, W Midlands, England.							CAMPION MJ, 1986, LANCET, V2, P237; DUNCAN ID, 1997, NATL HLTH SERVICE CE, V8; MARTEAU TM, 1990, BRIT J OBSTET GYNAEC, V97, P859, DOI 10.1111/j.1471-0528.1990.tb02586.x; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; *NAT AUD OFF, 1998, PERF NHS CERV SCREEN; RICHART RM, 1969, AM J OBSTET GYNECOL, V105, P386, DOI 10.1016/0002-9378(69)90268-3; Shafi MI, 1997, BRIT J OBSTET GYNAEC, V104, P590, DOI 10.1111/j.1471-0528.1997.tb11538.x; Sideri M, 1998, CANCER EPIDEM BIOMAR, V7, P237; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; SPRIGGS AI, 1980, J CLIN PATHOL, V33, P517, DOI 10.1136/jcp.33.6.517; STERN E, 1964, CANCER, V17, P508, DOI 10.1002/1097-0142(196404)17:4<508::AID-CNCR2820170412>3.0.CO;2-S	11	17	17	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1693	1696		10.1136/bmj.320.7251.1693	http://dx.doi.org/10.1136/bmj.320.7251.1693			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864542	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000087926400020
J	Torgerson, DJ; Gosden, T				Torgerson, DJ; Gosden, T			Priority setting in health care: should we ask the tax payer?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ York, York YO1 5DD, N Yorkshire, England; Univ Manchester, Manchester, Lancs, England	University of York - UK; University of Manchester	Torgerson, DJ (corresponding author), Univ York, York YO1 5DD, N Yorkshire, England.		Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275					0	9	9	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1679	1679		10.1136/bmj.320.7250.1679	http://dx.doi.org/10.1136/bmj.320.7250.1679			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856083	Green Published			2022-12-28	WOS:000087734200059
J	Kohler, HP; Grant, PJ				Kohler, HP; Grant, PJ			Mechanisms of disease: Plasminogen-activator inhibitor type 1 and coronary artery disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-ENDOTHELIAL-CELLS; SMOOTH-MUSCLE CELLS; CARDIOVASCULAR RISK-FACTORS; ISCHEMIC-HEART-DISEASE; VON-WILLEBRAND-FACTOR; FACTOR-XIII GENE; MYOCARDIAL-INFARCTION; TISSUE-TYPE; 4G/5G POLYMORPHISM; COMMON POLYMORPHISM		Inselspital, Dept Trauma & Emergency Med, Univ Hosp Bern, CH-3010 Bern, Switzerland; Inselspital, Lab Thrombosis Res, Univ Hosp Bern, Dept Clin Res, CH-3010 Bern, Switzerland; Univ Leeds, Leeds Gen Infirm, Unit Mol Vasc Med, Leeds, W Yorkshire, England	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Leeds General Infirmary; University of Leeds	Kohler, HP (corresponding author), Inselspital, Dept Trauma & Emergency Med, Univ Hosp Bern, CH-3010 Bern, Switzerland.		Grant, Peter/HIR-3733-2022					ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; ANDREOTTI F, 1988, AM J CARDIOL, V62, P635, DOI 10.1016/0002-9149(88)90669-8; ANGLETON P, 1989, CIRCULATION, V79, P101, DOI 10.1161/01.CIR.79.1.101; AUWERX J, 1988, ARTERIOSCLEROSIS, V8, P68, DOI 10.1161/01.ATV.8.1.68; BAVENHOLM P, 1995, CIRCULATION, V92, P1422, DOI 10.1161/01.CIR.92.6.1422; Bavenholm P, 1998, EUR HEART J, V19, P402, DOI 10.1053/euhj.1997.0752; BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4; BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V999, P225; BLOOM AL, 1994, HAEMOSTASIS THROMBOS, V1, P531; Brown NJ, 1999, HYPERTENSION, V34, P285, DOI 10.1161/01.HYP.34.2.285; Carmeliet P, 1997, CIRCULATION, V96, P3180, DOI 10.1161/01.CIR.96.9.3180; Catto AJ, 1997, THROMB HAEMOSTASIS, V77, P730; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; Chen YQ, 1998, J BIOL CHEM, V273, P8225, DOI 10.1074/jbc.273.14.8225; Clark RAF, 1996, AM J PATHOL, V148, P1407; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; DAWSON S, 1991, ARTERIOSCLER THROMB, V11, P183, DOI 10.1161/01.ATV.11.1.183; DAWSON SJ, 1993, J BIOL CHEM, V268, P10739; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Eriksson P, 1998, ARTERIOSCL THROM VAS, V18, P20, DOI 10.1161/01.ATV.18.1.20; FALK E, 1991, AM J CARDIOL, V68, pB28, DOI 10.1016/0002-9149(91)90382-U; Fatah K, 1996, THROMB HAEMOSTASIS, V76, P535; FOLSOM AR, 1991, ATHEROSCLEROSIS, V91, P191, DOI 10.1016/0021-9150(91)90167-2; FRANCIS RB, 1988, AM HEART J, V115, P776, DOI 10.1016/0002-8703(88)90878-2; FULLER JH, 1979, BMJ-BRIT MED J, V2, P964, DOI 10.1136/bmj.2.6196.964; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; GALLICCHIO M, 1994, ARTERIOSCLER THROMB, V14, P815, DOI 10.1161/01.ATV.14.5.815; Gardemann A, 1999, THROMB HAEMOSTASIS, V82, P1121; GEBARA OCE, 1995, CIRCULATION, V91, P1952, DOI 10.1161/01.CIR.91.7.1952; GELEHRTER TD, 1986, J CLIN INVEST, V77, P165, DOI 10.1172/JCI112271; GREEN D, 1994, ARTERIOSCLER THROMB, V14, P686, DOI 10.1161/01.ATV.14.5.686; HAMSTEN A, 1987, LANCET, V2, P3; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; HEINRICH J, 1994, ARTERIOSCLER THROMB, V14, P54, DOI 10.1161/01.ATV.14.1.54; HEINRICH J, 1994, ARTERIOSCLER THROMB, V14, P1392; Held C, 1997, CIRCULATION, V95, P2380, DOI 10.1161/01.CIR.95.10.2380; HIGGINS DL, 1987, BIOCHEMISTRY-US, V26, P7786, DOI 10.1021/bi00398a038; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; HUSAIN SS, 1989, BLOOD, V74, P999; Iacoviello L, 1998, THROMB HAEMOSTASIS, V80, P1029; ICHINOSE A, 1983, FEBS LETT, V153, P369, DOI 10.1016/0014-5793(83)80645-0; Iwai N, 1998, ATHEROSCLEROSIS, V136, P109, DOI 10.1016/S0021-9150(97)00191-3; JAIN SK, 1993, DIABETIC MED, V10, P27, DOI 10.1111/j.1464-5491.1993.tb01992.x; JUHANVAGUE I, 1989, THROMB HAEMOSTASIS, V61, P370; JuhanVague I, 1996, CIRCULATION, V94, P2057, DOI 10.1161/01.CIR.94.9.2057; JUHANVAGUE I, 1991, DIABETOLOGIA, V34, P457, DOI 10.1007/BF00403280; KANNEL WB, 1990, AM HEART J, V120, P672, DOI 10.1016/0002-8703(90)90026-T; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; KEIJER J, 1991, BLOOD, V78, P401; KLINGER KW, 1987, P NATL ACAD SCI USA, V84, P8548, DOI 10.1073/pnas.84.23.8548; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P8, DOI 10.1055/s-0037-1614250; Kohler HP, 1999, THROMB HAEMOSTASIS, V82, P1202, DOI 10.1055/s-0037-1614357; KOOISTRA T, 1986, BIOCHEM J, V239, P497, DOI 10.1042/bj2390497; KRUITHOF EKO, 1987, BLOOD, V70, P1645; KRUITHOF EKO, 1988, ENZYME, V40, P113, DOI 10.1159/000469153; LEVI M, 1992, CIRCULATION, V85, P305, DOI 10.1161/01.CIR.85.1.305; LINDAHL TL, 1990, BIOCHEM J, V265, P109, DOI 10.1042/bj2650109; MAIELLO M, 1992, DIABETES, V41, P1009, DOI 10.2337/diabetes.41.8.1009; MANSFIELD MW, 1995, THROMB HAEMOSTASIS, V74, P842; Mansfield MW, 1996, CIRCULATION, V94, P2171, DOI 10.1161/01.CIR.94.9.2171; MANSFIELD MW, 1995, THROMB HAEMOSTASIS, V74, P1032; Margaglione M, 1998, ARTERIOSCL THROM VAS, V18, P152, DOI 10.1161/01.ATV.18.2.152; MARGAGLIONE M, 1994, ARTERIOSCLER THROMB, V14, P1741, DOI 10.1161/01.ATV.14.11.1741; MEADE TW, 1993, LANCET, V342, P1076, DOI 10.1016/0140-6736(93)92062-X; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MICHAELS L, 1966, BRIT HEART J, V28, P258; MICHALOPOULOS CD, 1993, EUR HEART J, V14, P8; Nilsson L, 1998, ARTERIOSCL THROM VAS, V18, P1679, DOI 10.1161/01.ATV.18.11.1679; Nilsson L, 1999, J LIPID RES, V40, P913; Orbe J, 1999, THROMB RES, V94, P137, DOI 10.1016/S0049-3848(98)00203-5; OsseiGerning N, 1997, ARTERIOSCL THROM VAS, V17, P33, DOI 10.1161/01.ATV.17.1.33; OWENSBY DA, 1991, J BIOL CHEM, V266, P4334; Panahloo A, 1998, METABOLISM, V47, P637, DOI 10.1016/S0026-0495(98)90023-3; Pandolfi A, 1996, DIABETOLOGIA, V39, P1425, DOI 10.1007/s001250050594; PANELL R, 1988, J CLIN INVEST, V81, P853; Preissner KT, 1997, THROMB HAEMOSTASIS, V78, P88; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reed GL, 1999, CIRCULATION, V99, P299, DOI 10.1161/01.CIR.99.2.299; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; RIDKER PM, 1994, CIRCULATION, V90, P2236, DOI 10.1161/01.CIR.90.5.2236; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; SCHNEIDER DJ, 1992, DIABETES, V41, P890, DOI 10.2337/diabetes.41.7.890; SCHNEIDERMAN J, 1992, P NATL ACAD SCI USA, V89, P6998, DOI 10.1073/pnas.89.15.6998; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; SHEBUSKI RJ, 1990, BLOOD, V75, P1455; Siddiqi F, 1998, BLOOD, V91, P2019, DOI 10.1182/blood.V91.6.2019.2019_2019_2025; Sironi L, 1996, ARTERIOSCL THROM VAS, V16, P89, DOI 10.1161/01.ATV.16.1.89; Sobel BE, 1998, CIRCULATION, V97, P2213, DOI 10.1161/01.CIR.97.22.2213; SPRENGERS ED, 1986, THROMB HAEMOSTASIS, V55, P325; SPRENGERS ED, 1987, BLOOD, V69, P381; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; STRANDBERG L, 1988, EUR J BIOCHEM, V176, P609, DOI 10.1111/j.1432-1033.1988.tb14320.x; Svendsen OL, 1996, ARTERIOSCL THROM VAS, V16, P381, DOI 10.1161/01.ATV.16.3.381; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; THOMPSON SG, 1995, NEW ENGL J MED, V332, P635, DOI 10.1056/NEJM199503093321003; THORSEN S, 1992, ANN NY ACAD SCI, V667, P52, DOI 10.1111/j.1749-6632.1992.tb51597.x; VAUGHAN DE, 1995, J CLIN INVEST, V95, P995, DOI 10.1172/JCI117809; WAGNER OF, 1989, J CLIN INVEST, V84, P647, DOI 10.1172/JCI114211; Wartiovaara U, 1999, ATHEROSCLEROSIS, V142, P295, DOI 10.1016/S0021-9150(98)00241-X; WIMAN B, 1985, J LAB CLIN MED, V105, P265; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YE S, 1995, THROMB HAEMOSTASIS, V74, P837; Zhu YH, 1999, CIRCULATION, V99, P3050, DOI 10.1161/01.CIR.99.23.3050	105	635	662	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1792	1801		10.1056/NEJM200006153422406	http://dx.doi.org/10.1056/NEJM200006153422406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853003				2022-12-28	WOS:000087573700006
J	Milonni, PW				Milonni, PW			Quantum decay - A watched pot boils quicker	NATURE			English	Article									Univ Calif Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Milonni, PW (corresponding author), Univ Calif Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.							BALLENTINE LE, 1991, PHYS REV A, V43, P5165, DOI 10.1103/PhysRevA.43.5165; FEARN H, 1992, PHYS REV A, V46, P1199, DOI 10.1103/PhysRevA.46.1199; ITANO WM, 1990, PHYS REV A, V41, P2295, DOI 10.1103/PhysRevA.41.2295; Kaulakys B, 1997, PHYS REV A, V56, P1131, DOI 10.1103/PhysRevA.56.1131; Kofman AG, 2000, NATURE, V405, P546, DOI 10.1038/35014537; KWIAT P, 1995, FUNDAMENTAL PROBLEMS, P383; Kwiat PG, 1999, PHYS REV LETT, V83, P4725, DOI 10.1103/PhysRevLett.83.4725; Lewenstein M, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.022105; MISRA B, 1977, J MATH PHYS, V18, P756, DOI 10.1063/1.523304	9	4	4	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					525	+		10.1038/35014719	http://dx.doi.org/10.1038/35014719			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850699				2022-12-28	WOS:000087449500033
J	Santen, L; Krauth, W				Santen, L; Krauth, W			Absence of thermodynamic phase transition in a model glass former	NATURE			English	Article							CLUSTER ALGORITHM; LIQUIDS; SYSTEMS	The glass transition can be viewed simply as the point at which the viscosity of a structurally disordered liquid reaches a universal threshold value(1). But this is an operational definition that circumvents fundamental issues, such as whether the glass transition is a purely dynamical phenomenon(2). If so, ergodicity gets broken (the system becomes confined to some part of its phase space), but the thermodynamic properties of the liquid remain unchanged across the transition, provided they are determined as thermodynamic equilibrium averages over the whole phase space. The opposite view(3-6) claims that an underlying thermodynamic phase transition is responsible for the pronounced slow-down in the dynamics at the liquid-glass boundary. Such a phase transition would trigger the dynamic standstill, and then he masked by it. Here we perform Monte Carlo simulations of a two-dimensional system of polydisperse hard disks far within its glassy phase. The approach(7) allows for non-local moves in a way that preserves micro-reversibility. We find no evidence for a thermodynamic phase transition up to very high densities; the glass is thus indistinguishable from the liquid on purely thermodynamic grounds.	Ecole Normale Super, CNRS, Lab Phys Stat, F-75231 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Krauth, W (corresponding author), Ecole Normale Super, CNRS, Lab Phys Stat, 24 Rue Lhomond, F-75231 Paris 05, France.		Krauth, Werner/L-5623-2016; Santen, Ludger/K-8110-2015	Krauth, Werner/0000-0003-0183-6726; Santen, Ludger/0000-0001-8478-9667				ADAM G, 1965, J CHEM PHYS, V43, P139, DOI 10.1063/1.1696442; ALDER BJ, 1962, PHYS REV, V127, P359, DOI 10.1103/PhysRev.127.359; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Buhot A, 1999, PHYS REV E, V59, P2939, DOI 10.1103/PhysRevE.59.2939; DOLIWA B, 1999, THESIS U MAINZ; Dress C, 1995, J PHYS A-MATH GEN, V28, pL597, DOI 10.1088/0305-4470/28/23/001; Fuchs M, 1998, PHYS REV E, V58, P3384, DOI 10.1103/PhysRevE.58.3384; GIBBS JH, 1958, J CHEM PHYS, V28, P373, DOI 10.1063/1.1744141; GOTZE W, 1992, REP PROG PHYS, V55, P241, DOI 10.1088/0034-4885/55/3/001; Hansen J.-P., 2013, THEORY SIMPLE LIQUID, V4th; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Malherbe JG, 1999, MOL PHYS, V97, P677, DOI 10.1080/002689799163514; MENON N, 1995, PHYS REV LETT, V74, P1230, DOI 10.1103/PhysRevLett.74.1230; Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146; STILLINGER FH, 1984, SCIENCE, V225, P983, DOI 10.1126/science.225.4666.983	15	138	139	2	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					550	551		10.1038/35014561	http://dx.doi.org/10.1038/35014561			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850709	Green Submitted			2022-12-28	WOS:000087449500044
J	Torquato, S				Torquato, S			Glass transition - Hard knock for thermodynamics	NATURE			English	Article							SYSTEMS		Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Torquato, S (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.							Debenedetti P. G., 1996, METASTABLE LIQUIDS; HOOVER WG, 1968, J CHEM PHYS, V49, P3609, DOI 10.1063/1.1670641; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Kegel WK, 2000, LANGMUIR, V16, P939, DOI 10.1021/la990661d; Rintoul MD, 1996, PHYS REV LETT, V77, P4198, DOI 10.1103/PhysRevLett.77.4198; Santen L, 2000, NATURE, V405, P550, DOI 10.1038/35014561; SPEEDY RJ, 1994, J CHEM PHYS, V100, P6684, DOI 10.1063/1.467028; SWENDSEN RH, 1987, PHYS REV LETT, V58, P86, DOI 10.1103/PhysRevLett.58.86; WOLFF U, 1989, PHYS REV LETT, V62, P361, DOI 10.1103/PhysRevLett.62.361; WOODCOCK LV, 1976, J CHEM SOC FARAD T 2, V72, P1667, DOI 10.1039/f29767201667	10	51	56	4	59	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					521	+		10.1038/35014711	http://dx.doi.org/10.1038/35014711			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850697				2022-12-28	WOS:000087449500031
J	Kmietowicz, Z				Kmietowicz, Z			Ombudsman slams deputising service	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1689	1689						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864533				2022-12-28	WOS:000087926400011
J	Muller, W; Aerden, D; Halliday, AN				Muller, W; Aerden, D; Halliday, AN			Isotopic dating of strain fringe increments: Duration and rates of deformation in shear zones	SCIENCE			English	Article							KINEMATICS; PYRENEES; PLATE; ALPS	The time scales over which deformation in the Earth's crust remains localized in shear zones are poorly known, as are the associated strain rates. We have determined the longevity and rates of deformation using rubidium-strontium (Rb-Sr) microsampling dating of increments of fibrous strain fringes from a Pyrenean shear zone. The fibers grew quasi-continuously through a protracted deformation history between 87 and 50 million years ago, over a period comparable to that of an orogeny. During a short interval between 66 and 62 million years, a rise in strain rate from 1.1 X 10(-15) to 7.7 X 10(-15) seconds(-1) occurred, This acceleration correlates with an abrupt change in fiber-growth direction and a stress-field inversion from gravitational collapse to renewed horizontal crustal shortening.	ETH Zurich, Dept Erdwissensch, Inst Isotopengeol & Mineral Rohstoffe, CH-8092 Zurich, Switzerland; Univ Granada, Dept Geodinam, E-18071 Granada, Spain	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Granada	Muller, W (corresponding author), ETH Zurich, Dept Erdwissensch, Inst Isotopengeol & Mineral Rohstoffe, Sonneggstr 5, CH-8092 Zurich, Switzerland.		Aerden, Domingo GAM/L-3692-2014	Muller, Wolfgang/0000-0001-5368-8011; Aerden, Domingo/0000-0002-9542-5671				Aerden DGAM, 1996, J STRUCT GEOL, V18, P75, DOI 10.1016/0191-8141(95)00084-Q; CHOUKROUNE P, 1992, ANNU REV EARTH PL SC, V20, P143, DOI 10.1146/annurev.ea.20.050192.001043; DIETRICH D, 1989, TECTONOPHYSICS, V170, P183, DOI 10.1016/0040-1951(89)90271-0; FISCHER D, 1992, TECTONICS, V11, P330; Freeman SR, 1997, TECTONICS, V16, P57, DOI 10.1029/96TC02477; GARWIN LJ, 1985, THESIS CAMBRIDGE U; GOLDBERG JM, 1988, CR HEBD ACAD SCI, V306, P429; Muller W, 1999, J GEOL SOC LONDON, V156, P261, DOI 10.1144/gsjgs.156.2.0261; MULLER W, IN PRESS EARTH PLANE; Olivet JL, 1996, B CENT RECH EXPL, V20, P131; PFIFFNER OA, 1982, J GEOPHYS RES, V87, P311, DOI 10.1029/JB087iB01p00311; Ramsay J. G., 1983, TECHNIQUES MODERN ST, V1; RAMSAY JG, 1980, NATURE, V284, P135, DOI 10.1038/284135a0; ROEST WR, 1991, GEOLOGY, V19, P613, DOI 10.1130/0091-7613(1991)019<0613:KOTPBB>2.3.CO;2; Schmid S.M, 1975, ECLOGAE GEOL HELV, V68, P247	15	78	82	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2195	2198		10.1126/science.288.5474.2195	http://dx.doi.org/10.1126/science.288.5474.2195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864865				2022-12-28	WOS:000087782900053
J	Bell, DS; Fonarow, GC; Hays, RD; Mangione, CM				Bell, DS; Fonarow, GC; Hays, RD; Mangione, CM			Self-study from web-based and printed guideline materials - A randomized, controlled trial among resident physicians	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	22nd Annual Meeting of the Society-of-General-Internal-Medicine	APR 29-MAY 01, 1999	SAN FRANCISCO, CA	Soc Gen Internal Med			ACUTE MYOCARDIAL-INFARCTION; EDUCATIONAL INTERVENTIONS; SPECIALIST PHYSICIANS; MULTIMEDIA TEXTBOOK; GENERALIST; KNOWLEDGE; MEDICINE; LECTURE	Background: On-line physician education is increasing, but its efficacy in comparison with existing self-study methods is unknown. Objective: To compare knowledge, learning efficiency, and learner satisfaction produced by self-study of World Wide Web-based and print-based guidelines for care after acute myocardial infarction. Design: Randomized, controlled trial. Setting: 12 family medicine and internal medicine residency programs at four universities. Participants: 162 residents. Interventions: In proctored sessions, participants were randomly assigned to study from printed materials or from SAGE (Self-Study Acceleration with Graphic Evidence), a Web-based tutorial system. Both methods used identical self-assessment questions and answers and guideline text, but SAGE featured hyperlinks to specific guideline passages and graphic evidence animations. Measurements: Scores on multiple-choice knowledge tests, score gain per unit of study time, and ratings on a learner satisfaction scale. Results: Immediate post-test scores on a 20-point scale were similar in the SAGE and control groups (median score, 15.0 compared with 14.5; P > 0.2), but SAGE users spent less time studying (median, 27.0 compared with 38.5 minutes; P < 0.001) and therefore had greater learning efficiency (median score gain, 8.6 compared with 6.7 points per hour; P = 0.04). On a scale of 5 to 20, SAGE users were more satisfied with learning (median rating, 17.0 compared with 15.0; P < 0.001). After 4 to 6 months, knowledge had decreased to the same extent in the SAGE and control groups (median score, 12.0 compared with 11.0; P = 0.12). Conclusions: On-line tutorials may produce greater learning efficiency and satisfaction than print materials do, but one self-study exposure may be insufficient for long-term knowledge retention. Further research is needed to identify instructional features that motivate greater final learning and retention.	Univ Calif Los Angeles, Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Bell, DS (corresponding author), Univ Calif Los Angeles, Sch Med, Div Gen Internal Med & Hlth Serv Res, 911 Broxton Plaza,Room 218, Los Angeles, CA 90095 USA.	sagcqucry@gim.med.ucla.edu	Bell, Douglas S/G-6702-2013; Fonarow, Gregg C/D-5988-2014; Hays, Ronald/D-5629-2013	Bell, Douglas S/0000-0002-5063-8294; Fonarow, Gregg C/0000-0002-3192-8093; Hays, Ronald/0000-0001-6697-907X	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE019001] Funding Source: NIH RePORTER; BHP HRSA HHS [T32 PE19001-09] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); BHP HRSA HHS		*AM AC PED, 1999, PED REV; *AM COLL PHYS, 1999, CLIN PROBL SOLV CAS; *AM MED ASS, 1999, AMA PHYS REC AW BAS; *AM MED ASS, 1999, AMA PHYS REC AW CAT; ATKINSON RC, 1968, SCIENCE, V162, P73, DOI 10.1126/science.162.3849.73; AYANIAN JZ, 1994, NEW ENGL J MED, V331, P1136, DOI 10.1056/NEJM199410273311707; BELL DS, 1998, P AMIA ANN FALL S, P971; Bernstein I. H, 1994, PSYCHOMETRIC THEORY, P264; BURG FD, 1979, ANN INTERN MED, V90, P100, DOI 10.7326/0003-4819-90-1-100; Burnum JF, 1997, ANN INTERN MED, V126, P84, DOI 10.7326/0003-4819-126-1-199701010-00013; Chin MH, 1997, J GEN INTERN MED, V12, P523, DOI 10.1046/j.1525-1497.1997.07105.x; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; D'Alessandro DM, 1997, ACAD RADIOL, V4, P719, DOI 10.1016/S1076-6332(97)80074-8; DAY SC, 1994, J GEN INTERN MED, V9, P167, DOI 10.1007/BF02600036; ENTWISLE G, 1963, J MED EDUC, V38, P803; FREEMANTLE N, 1999, COCHRANE LIB; Gagne R, 1985, COND LEARN, V4th; Grol R, 1998, INT J QUAL HEALTH C, V10, P135, DOI 10.1093/intqhc/10.2.135; HARLESS WG, 1969, J MED EDUC, V44, P670; Healy AF, 1996, ANNU REV PSYCHOL, V47, P143, DOI 10.1146/annurev.psych.47.1.143; HOFFER EP, 1975, ANNU REV BIOPHYS BIO, V4, P103, DOI 10.1146/annurev.bb.04.060175.000535; Kern D, 1998, CURRICULUM DEV MED E; LYON HC, 1992, ACAD MED, V67, P821, DOI 10.1097/00001888-199212000-00005; MATTS JP, 1988, CONTROL CLIN TRIALS, V9, P327, DOI 10.1016/0197-2456(88)90047-5; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Peterson ED, 1997, ANN INTERN MED, V126, P556, DOI 10.7326/0003-4819-126-7-199704010-00012; PIEMME TE, 1988, JAMA-J AM MED ASSOC, V260, P367, DOI 10.1001/jama.260.3.367; Richardson ML, 1997, AM J ROENTGENOL, V168, P1161, DOI 10.2214/ajr.168.5.9129405; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; SANTER DM, 1995, ARCH PEDIAT ADOL MED, V149, P297, DOI 10.1001/archpedi.1995.02170150077014; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sikorski R, 1998, JAMA, V280, P1013, DOI 10.1001/jama.280.11.1013; *STRAT GROUP, 1999, US INT BREAKS 100 MI; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; [No title captured]	37	115	117	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					938	+		10.7326/0003-4819-132-12-200006200-00003	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	325HU	10858176				2022-12-28	WOS:000087670800002
J	Dalton, R				Dalton, R			Los Alamos 'loses' key weapons data	NATURE			English	News Item																		2000, NATURE, V405, P264	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					725	725		10.1038/35015770	http://dx.doi.org/10.1038/35015770			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866170	Bronze			2022-12-28	WOS:000087620600012
J	Friedrich, MJ				Friedrich, MJ			HAART stopping news: Experts examine structured therapy interruption for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2917	2918		10.1001/jama.283.22.2917	http://dx.doi.org/10.1001/jama.283.22.2917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865250				2022-12-28	WOS:000087480600002
J	Scott, PV				Scott, PV			Politically correct references	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1613	1613		10.1136/bmj.320.7249.1613	http://dx.doi.org/10.1136/bmj.320.7249.1613			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845989	Green Published			2022-12-28	WOS:000087631400061
J	Rothwell, NJ				Rothwell, NJ			Show them how it's really done - The public's appetite for science will not be whetted by a diet of dry facts.	NATURE			English	Editorial Material									Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Rothwell, NJ (corresponding author), Univ Manchester, Sch Biol Sci, Stopford Bldg, Manchester M13 9PT, Lancs, England.								0	2	2	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					621	621		10.1038/35015181	http://dx.doi.org/10.1038/35015181			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864303	Bronze			2022-12-28	WOS:000087465800024
J	Buttery, JP; Moxon, ER				Buttery, JP; Moxon, ER			Varicella vaccine in renal failure	LANCET			English	Editorial Material							CHILDREN		Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England	University of Oxford	Buttery, JP (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England.							Broyer M, 1997, PEDIATRICS, V99, P35, DOI 10.1542/peds.99.1.35; Furth S L, 1997, Pediatr Transplant, V1, P37; GERSHON AA, 1986, PEDIATRICS, V78, P757; Kamiya Hitoshi, 1999, Current Opinion in Pediatrics, V11, P3, DOI 10.1097/00008480-199902000-00002; KITAI IC, 1993, CLIN INFECT DIS, V17, P441, DOI 10.1093/clinids/17.3.441; TAKAHASH.M, 1974, LANCET, V2, P1288, DOI 10.1016/S0140-6736(74)90144-5; Watson B, 2000, PEDIATRICS, V105, P84, DOI 10.1542/peds.105.1.84; Webb NJA, 2000, ARCH DIS CHILD, V82, P141, DOI 10.1136/adc.82.2.141; ZAMORA I, 1994, PEDIATR NEPHROL, V8, P190, DOI 10.1007/BF00865476	9	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1930	1930		10.1016/S0140-6736(00)02322-9	http://dx.doi.org/10.1016/S0140-6736(00)02322-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859036				2022-12-28	WOS:000087381900007
J	Einum, S; Fleming, IA				Einum, S; Fleming, IA			Highly fecund mothers sacrifice offspring survival to maximize fitness	NATURE			English	Article							EGG SIZE; ATLANTIC SALMON; NATURAL-SELECTION; CLUTCH SIZE; EVOLUTION; NUMBER; STRATEGIES; QUALITY	Why do highly fecund organisms apparently sacrifice offspring size for increased numbers when offspring survival generally increases with size(1-3)? The theoretical tools for understanding this evolutionary trade-off between number and size of offspring have developed over the past 25 years(1,4-10); however, the absence of data on the relation between offspring size and fitness in highly fecund species, which would control for potentially confounding variables, has caused such models to remain largely hypothetical(11,12). Here we manipulate egg size, controlling for maternal trait interactions, and determine the causal consequences of offspring size in a wild population of Atlantic salmon. The joint effect of egg size on egg number and offspring survival resulted in stabilizing phenotypic selection for an optimal size. The optimal egg size differed only marginally from the mean value observed in the population, suggesting that it had evolved mainly in response to selection on maternal rather than offspring fitness. We conclude that maximization of maternal fitness by sacrificing offspring survival may well be a general phenomenon among highly fecund organisms.	Norwegian Inst Nat Res, N-7485 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Zool, N-7034 Trondheim, Norway	Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU)	Einum, S (corresponding author), Norwegian Inst Nat Res, Tungasletta 2, N-7485 Trondheim, Norway.	sigurd.einum@ninatrd.ninaniku.no	Fleming, Ian/I-7217-2012	Einum, Sigurd/0000-0002-3788-7800				Bernardo J, 1996, AM ZOOL, V36, P216; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; ELGAR MA, 1990, OIKOS, V59, P283, DOI 10.2307/3545546; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; GERITZ SAH, 1995, AM NAT, V146, P685, DOI 10.1086/285820; Jonsson N, 1996, FUNCT ECOL, V10, P89, DOI 10.2307/2390266; Kamler E., 1992, EARLY LIFE HIST FISH; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; LLOYD DG, 1987, AM NAT, V129, P800, DOI 10.1086/284676; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Roff Derek A., 1992; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; SINERVO B, 1991, SCIENCE, V252, P1300, DOI 10.1126/science.252.5010.1300; SINERVO B, 1992, SCIENCE, V258, P1927, DOI 10.1126/science.258.5090.1927; Sinervo B, 1998, OIKOS, V83, P432, DOI 10.2307/3546671; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; WADE MJ, 1990, EVOLUTION, V44, P1947, DOI [10.2307/2409605, 10.1111/j.1558-5646.1990.tb04301.x]	21	323	329	0	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					565	567		10.1038/35014600	http://dx.doi.org/10.1038/35014600			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850714				2022-12-28	WOS:000087449500049
J	Sachs, AB				Sachs, AB			Cell cycle-dependent translation initiation: IRES elements prevail	CELL			English	Review							CAP-BINDING PROTEIN; MESSENGER-RNAS; ENTRY; INHIBITION; RIBOSOMES; MITOSIS		Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sachs, AB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.							BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; Coldwell MJ, 2000, ONCOGENE, V19, P899, DOI 10.1038/sj.onc.1203407; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; FREDLUND JO, 1995, EXP CELL RES, V216, P86, DOI 10.1006/excr.1995.1011; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Honda M, 2000, GASTROENTEROLOGY, V118, P152, DOI 10.1016/S0016-5085(00)70424-0; HUANG J, 1991, CELL, V65, P271, DOI 10.1016/0092-8674(91)90161-Q; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; LIEBIG HD, 1993, BIOCHEMISTRY-US, V32, P7581, DOI 10.1021/bi00080a033; Ohlmann T, 1996, EMBO J, V15, P1371, DOI 10.1002/j.1460-2075.1996.tb00479.x; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8	19	88	93	3	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					243	245		10.1016/S0092-8674(00)80834-X	http://dx.doi.org/10.1016/S0092-8674(00)80834-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847679	Bronze			2022-12-28	WOS:000086741900003
J	Rocha, V; Wagner, JE; Sobocinski, KA; Klein, JP; Zhang, MJ; Horowitz, MM; Gluckman, E				Rocha, V; Wagner, JE; Sobocinski, KA; Klein, JP; Zhang, MJ; Horowitz, MM; Gluckman, E		Eurocord Int Bone Marrow Transplan	Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-Identical sibling.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; UNRELATED DONORS; PLACENTAL-BLOOD; NEWBORN BLOOD; LYMPHOCYTES; LEUKEMIA; RECIPIENTS; CYCLOSPORINE; RESPONSES; ANEMIA	Background: Umbilical-cord blood as an alternative to bone marrow for hematopoietic stem-cell transplantation may lower the risk of graft-versus-host disease (GVHD). Methods: We studied the records of 113 recipients of cord blood from HLA-identical siblings from the period from 1990 through 1997 and compared them with the records of 2052 recipients of bone marrow from HLA-identical siblings during the same period. The study population consisted of children 15 years of age or younger. We compared the rates of GVHD, hematopoietic recovery, and survival using Cox proportional-hazards regression to adjust for potentially confounding factors. Results: Recipients of cord blood were younger than recipients of bone marrow (median age, 5 years vs. 8 years; P<0.001), weighed less (median weight, 17 kg vs. 26 kg; P<0.001), and were less likely to have received methotrexate for prophylaxis against GVHD (28 percent vs. 65 percent, P<0.001). Multivariate analysis demonstrated a lower risk of acute GVHD (relative risk, 0.41; P=0.001) and chronic GVHD (relative risk, 0.35; P=0.02) among recipients of cord-blood transplants. As compared with recovery after bone marrow transplantation, the likelihood of recovery of the neutrophil count and the platelet count was significantly lower in the first month after cord-blood transplantation (relative risk, 0.40 [P<0.001], and relative risk, 0.20 [P<0.001], respectively). Mortality was similar in the two groups (relative risk of death in the recipients of cord blood, 1.15; P=0.43). Conclusions: Recipients of cord-blood transplants from HLA-identical siblings have a lower incidence of acute and chronic GVHD than recipients of bone marrow transplants from HLA-identical siblings. (N Engl J Med 2000;342:1846-54.) (C)2000, Massachusetts Medical Society.	Med Coll Wisconsin, Hlth Policy Inst, IBMTR ABMTR Stat Ctr, Milwaukee, WI 53226 USA; Hop St Louis, Eurocord Cord Blood Transplant Grp, Paris, France; Univ Paris, F-75252 Paris, France; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	Medical College of Wisconsin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Minnesota System; University of Minnesota Twin Cities	Horowitz, MM (corresponding author), Med Coll Wisconsin, Hlth Policy Inst, IBMTR ABMTR Stat Ctr, POB 26509, Milwaukee, WI 53226 USA.	marymh@mcw.edu	Rocha, Vanderson/AAO-1691-2020; horowitz, Mary/ABH-2173-2021		NATIONAL CANCER INSTITUTE [P01CA040053, P01CA065493] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA-65493, P01-CA-40053] Funding Source: Medline; PHS HHS [U24-76518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andersen PK, 1999, STAT MED, V18, P1489, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#; Cairo MS, 1997, BLOOD, V90, P4665, DOI 10.1182/blood.V90.12.4665.4665_4665_4678; Chalmers IMH, 1998, BLOOD, V92, P11, DOI 10.1182/blood.V92.1.11.413a39_11_18; De la Selle V, 1998, BLOOD, V92, P3968, DOI 10.1182/blood.V92.10.3968.422k32_3968_3975; DEEG HJ, 1985, BLOOD, V65, P1325, DOI 10.1182/blood.V65.6.1325.bloodjournal6561325; deLaSelle V, 1996, BLOOD, V87, P3977, DOI 10.1182/blood.V87.9.3977.bloodjournal8793977; Garban F, 1996, BLOOD, V87, P3970, DOI 10.1182/blood.V87.9.3970.bloodjournal8793970; Garderet L, 1998, BLOOD, V91, P340, DOI 10.1182/blood.V91.1.340.340_340_346; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602; Gluckman E, 1998, HEMATOLOGY, P1; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; HARRIS DT, 1992, P NATL ACAD SCI USA, V89, P10006, DOI 10.1073/pnas.89.21.10006; HOROWITZ MM, 1992, BONE MARROW TRANSPL, P367; KLEIN JP, 1997, SURVIVAL ANAL TECHNI, P344; Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303; Locatelli F, 1999, BLOOD, V93, P3662; Madrigal JA, 1997, HUM IMMUNOL, V56, P1, DOI 10.1016/S0198-8859(97)00125-0; RINGDEN O, 1993, BLOOD, V81, P1094; RISDON G, 1994, CELL IMMUNOL, V154, P14, DOI 10.1006/cimm.1994.1053; RONCAROLO MG, 1994, BLOOD CELLS, V20, P573; Rubinstein P, 1998, NEW ENGL J MED, V339, P1565, DOI 10.1056/NEJM199811263392201; STORB R, 1983, ANN INTERN MED, V98, P461, DOI 10.7326/0003-4819-98-4-461; Truman JP, 1996, EXP HEMATOL, V24, P1409; Truman JP, 1997, BLOOD, V89, P1996, DOI 10.1182/blood.V89.6.1996; WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1; Wagner JE, 1996, BLOOD, V88, P795	28	651	679	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1846	1854		10.1056/NEJM200006223422501	http://dx.doi.org/10.1056/NEJM200006223422501			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861319				2022-12-28	WOS:000087704700001
J	James, M; Turner, DA; Broadbent, DM; Vora, J; Harding, SP				James, M; Turner, DA; Broadbent, DM; Vora, J; Harding, SP			Cost effectiveness analysis of screening for sight threatening diabetic eye disease	BRITISH MEDICAL JOURNAL			English	Article							MM COLOR TRANSPARENCIES; RETINAL PHOTOGRAPHY; PRIMARY-CARE; RETINOPATHY; OPHTHALMOSCOPY; DIAGNOSIS	Objective To measure the cost effectiveness of systematic photographic screening for sight threatening diabetic eye disease compared with existing practice. Design Cost effectiveness analysis. Setting Liverpool. Subjects A target population of 5000 diabetic patients invited for screening. Main outcome measures Cost effectiveness (cost per true positive) of systematic and opportunistic programmes; incremental cost effectiveness of replacing opportunistic with systematic screening. Results Baseline prevalence of sight threatening eye disease was 14.1%. The cost effectiveness of the systematic programme was pound 209 (sensitivity 89%, specificity 86%, compliance 80%, annual cost pound 104 996) and of the opportunistic programme was pound 289 (combined sensitivity 63%, specificity 92%, compliance 78%, annual cost pound 99 981). The incremental cost effectiveness of completely replacing the opportunistic programme was pound 32. Absolute values of cost effectiveness were highly sensitive to varying prevalence, sensitivity and specificity, compliance, and programme size. Conclusion Replacing existing programmes with systematic screening for diabetic eye disease is justified.	Univ Keele, Ctr Hlth Planning & Management, Keele ST5 5BG, Staffs, England; Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool L7 8XP, Merseyside, England; Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool, Merseyside, England	Keele University; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	James, M (corresponding author), Univ Keele, Ctr Hlth Planning & Management, Keele ST5 5BG, Staffs, England.		Turner, David A/E-1847-2013	Turner, David A/0000-0002-1689-4147; Harding, Simon/0000-0003-4676-1158				AWH CC, 1993, INVEST OPHTH VIS SCI, V34, P713; BRIGGS MC, 1995, DIABETIC MED S2, V12, pS44; BUXTON MJ, 1991, DIABETIC MED, V8, P371, DOI 10.1111/j.1464-5491.1991.tb01612.x; DASBACH EJ, 1991, MED CARE, V29, P20, DOI 10.1097/00005650-199101000-00003; Davies R, 1996, BRIT J OPHTHALMOL, V80, P945, DOI 10.1136/bjo.80.11.945; Fendrick A M, 1992, Int J Technol Assess Health Care, V8, P694; FINLAY R, 1991, HLTH TRENDS, V23, P104; FORREST RD, 1987, DIABETES RES CLIN EX, V5, P39; Foulds W S, 1983, Health Bull (Edinb), V41, P318; Gardner GG, 1996, BRIT J OPHTHALMOL, V80, P940, DOI 10.1136/bjo.80.11.940; GEHRS KM, 1993, INVEST OPHTH VIS SCI, V34, P1182; George LD, 1998, DIABETIC MED, V15, P250, DOI 10.1002/(SICI)1096-9136(199803)15:3<250::AID-DIA565>3.0.CO;2-G; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; JACOB J, 1995, DIABETIC MED, V12, P419, DOI 10.1111/j.1464-5491.1995.tb00506.x; JAVITT JC, 1989, OPHTHALMOLOGY, V96, P255; KINYOUN JL, 1992, INVEST OPHTH VIS SCI, V33, P1888; LAIRSON DR, 1992, DIABETES CARE, V15, P1369, DOI 10.2337/diacare.15.10.1369; Leese GP, 1997, J ROY COLL PHYS LOND, V31, P65; NETTEN A, 1996, UNIT COSTS COMMUNITY; OHare JP, 1996, BRIT MED J, V312, P679; Owens DR, 1998, DIABETIC MED, V15, P170, DOI 10.1002/(SICI)1096-9136(199802)15:2<170::AID-DIA518>3.0.CO;2-H; ROHAN TE, 1989, BMJ-BRIT MED J, V299, P1198, DOI 10.1136/bmj.299.6709.1198; RYDER B, 1995, BRIT MED J, V311, P207, DOI 10.1136/bmj.311.6999.207; Ryder REJ, 1998, DIABETIC MED, V15, P254; SCOTT JA, 1996, NVEST OPHTHALMOL VI, V37, pS105; Sculpher M J, 1992, Health Econ, V1, P39, DOI 10.1002/hec.4730010107; SCULPHER MJ, 1991, DIABETIC MED, V8, P644, DOI 10.1111/j.1464-5491.1991.tb01671.x; SUSSMAN EJ, 1982, JAMA-J AM MED ASSOC, V247, P3231, DOI 10.1001/jama.247.23.3231	28	125	127	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1627	1631		10.1136/bmj.320.7250.1627	http://dx.doi.org/10.1136/bmj.320.7250.1627			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856062	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000087734200020
J	Josefson, D				Josefson, D			Pallidotomy relieves some symptoms of Parkinson's disease	BRITISH MEDICAL JOURNAL			English	News Item																		Fine J, 2000, NEW ENGL J MED, V342, P1708, DOI 10.1056/NEJM200006083422304	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1622	1622		10.1136/bmj.320.7250.1622	http://dx.doi.org/10.1136/bmj.320.7250.1622			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856049	Green Published			2022-12-28	WOS:000087734200008
J	Korber, B; Muldoon, M; Theiler, J; Gao, F; Gupta, R; Lapedes, A; Hahn, BH; Wolinsky, S; Bhattacharya, T				Korber, B; Muldoon, M; Theiler, J; Gao, F; Gupta, R; Lapedes, A; Hahn, BH; Wolinsky, S; Bhattacharya, T			Timing the ancestor of the HIV-1 pandemic strains	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEFICIENCY SYNDROME AIDS; MAXIMUM-LIKELIHOOD; DNA-SEQUENCES; TRANSMISSION HISTORY; INTERSPECIES TRANSMISSION; ANTIRETROVIRAL THERAPY; PHYLOGENETIC METHODS; POPULATION-DYNAMICS; GENETIC DIVERSITY	HIV-1 sequences were analyzed to estimate the timing of the ancestral sequence of the main group of HIV-1, the strains responsible for the AIDS pandemic. Using parallel supercomputers and assuming a constant rate of evolution, we applied maximum-likelihood phylogenetic methods to unprecedented amounts of data for this calculation. We validated our approach by correctly estimating the timing of two historically documented points. Using a comprehensive full-length envelope sequence alignment, we estimated the date of the Last common ancestor of the main group of HIV-1 to be 1931 (1915-41). Analysis of a gag gene alignment, subregions of envelope including additional sequences, and a method that relaxed the assumption of a strict molecular clock also supported these results.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Manchester, Inst Sci & Technol, Dept Math, Manchester M60 1QD, Lancs, England; Univ Alabama Birmingham, Dept Med & Microbiol, Birmingham, AL 35294 USA; Northwestern Univ, Dept Med, Div Infect Dis, Chicago, IL 60611 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of Manchester; University of Alabama System; University of Alabama Birmingham; Northwestern University	Korber, B (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.		Muldoon, Mark/T-9192-2019; Bhattacharya, Tanmoy/J-8956-2013; Wolinsky, Steven/B-2893-2012; Muldoon, Mark R/C-7505-2009	Bhattacharya, Tanmoy/0000-0002-1060-652X; Wolinsky, Steven/0000-0002-9625-6697; Hahn, Beatrice/0000-0002-9400-9887; Muldoon, Mark/0000-0002-5004-7195; Korber, Bette/0000-0002-2026-5757	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044596, N01AI085338] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 44596, N01 AI 85338] Funding Source: Medline; NICHD NIH HHS [R01-HD37356] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bagnarelli P, 1999, J VIROL, V73, P3764, DOI 10.1128/JVI.73.5.3764-3777.1999; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bollyky PL, 1999, J MOL EVOL, V49, P130, DOI 10.1007/PL00006526; Bunnell RE, 1999, AIDS, V13, P509, DOI 10.1097/00002030-199903110-00010; Carr JK, 1996, J VIROL, V70, P5935, DOI 10.1128/JVI.70.9.5935-5943.1996; Centers for Disease Control (CDC), 1981, MMWR-MORBID MORTAL W, V30, P250; CHARNEAU P, 1994, VIROLOGY, V205, P247, DOI 10.1006/viro.1994.1640; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; Chen ZW, 1996, J VIROL, V70, P3617, DOI 10.1128/JVI.70.6.3617-3627.1996; CHEVRET S, 1992, J EPIDEMIOL COMMUN H, V46, P582, DOI 10.1136/jech.46.6.582; Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; Cohen J, 1997, SCIENCE, V277, P312, DOI 10.1126/science.277.5324.312; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Courgnaud V, 1998, VIROLOGY, V247, P41, DOI 10.1006/viro.1998.9217; DELEYS R, 1990, J VIROL, V64, P1207, DOI 10.1128/JVI.64.3.1207-1216.1990; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FURTADO MR, 1995, J VIROL, V69, P2092, DOI 10.1128/JVI.69.4.2092-2100.1995; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; GAZZOLO L, 1984, NEW ENGL J MED, V311, P1252, DOI 10.1056/NEJM198411083111912; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P4108, DOI 10.1073/pnas.87.11.4108; GOJOBORI T, 1990, P NATL ACAD SCI USA, V340, P1605; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Goudsmit J, 1999, NATURE, V400, P325, DOI 10.1038/22454; Grassly NC, 1999, GENETICS, V151, P427; GRMEK MD, 1990, HIST AIDS EMERGENCE, pCH10; Gunthard HF, 1999, J VIROL, V73, P9404; Gurtler L, 1996, LANCET, V348, P176, DOI 10.1016/S0140-6736(96)01036-7; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000; Hillis David M., 1996, P515; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; HOOPER E, 1999, RIVER, P77; HUELSENBECK JP, 1995, MOL BIOL EVOL, V12, P843; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Jonassen TO, 1997, VIROLOGY, V231, P43, DOI 10.1006/viro.1997.8510; KASPER P, 1995, AIDS RES HUM RETROV, V11, P1197, DOI 10.1089/aid.1995.11.1197; KELLY JK, 1994, GENET RES, V64, P1, DOI 10.1017/S0016672300032481; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; KORBER B, UNPUB; Korber B.T., 1998, HUMAN RETROVIRUSES A; Korber BT, 1999, NATURE, V400, P326; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; KUIKEN C, IN PRESS AM J EPIDEM; Kuiken CL, 1996, AIDS, V10, P31, DOI 10.1097/00002030-199601000-00005; Leitner T, 1999, P NATL ACAD SCI USA, V96, P10752, DOI 10.1073/pnas.96.19.10752; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Leitner T, 1997, J VIROL, V71, P4761, DOI 10.1128/JVI.71.6.4761-4770.1997; LI WH, 1988, MOL BIOL EVOL, V5, P313; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; MASON C, 1996, J ACQ IMMUN DEF SYND, V19, P165; McCutchan FE, 1996, J VIROL, V70, P3331, DOI 10.1128/JVI.70.6.3331-3338.1996; Meyer A, 1991, Med Trop (Mars), V51, P53; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; PAPE JW, 1983, NEW ENGL J MED, V309, P945, DOI 10.1056/NEJM198310203091603; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; PEETERS M, 1992, AIDS, V6, P447, DOI 10.1097/00002030-199205000-00002; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; ROBERTSON DL, IN PRESS HUMAN RETRO; Salemi M, 1999, P NATL ACAD SCI USA, V96, P13253, DOI 10.1073/pnas.96.23.13253; SELIK RM, 1984, AM J MED, V76, P493, DOI 10.1016/0002-9343(84)90669-7; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHARP PM, 1988, NATURE, V336, P315, DOI 10.1038/336315a0; Simmonds P, 1999, J VIROL, V73, P5787, DOI 10.1128/JVI.73.7.5787-5794.1999; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Slattery JP, 1999, GENOME RES, V9, P525; Smith D G, 1990, Lancet, V335, P781, DOI 10.1016/0140-6736(90)90883-7; SMITH TF, 1988, NATURE, V333, P573, DOI 10.1038/333573a0; SOUQUIERE S, 2000, 7 C RETR OPP INF SAN; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Swofford David L., 1996, P407; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; *UN, 1999, REP JOINT UN PROGR H; Voevodin AF, 1997, VIROLOGY, V238, P212, DOI 10.1006/viro.1997.8826; WANGROONGSARB Y, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P517; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; YANG ZB, 1994, J MOL EVOL, V39, P105; YANG ZH, 1995, GENETICS, V139, P993; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	99	639	671	3	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1789	1796		10.1126/science.288.5472.1789	http://dx.doi.org/10.1126/science.288.5472.1789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846155	Green Submitted			2022-12-28	WOS:000087503800041
J	Price, DD				Price, DD			Neuroscience - Psychological and neural mechanisms of the affective dimension of pain	SCIENCE			English	Review							SOMATOSENSORY CORTEX; ANTERIOR CINGULATE; HUMAN BRAIN; BEHAVIOR; PROJECTIONS; NEUROTICISM; PATHWAY; NEURONS; MONKEY	The affective dimension of pain is made up of feelings of unpleasantness and emotions associated with future implications, termed secondary affect. Experimental and clinical studies show serial interactions between pain sensation intensity, pain unpleasantness, and secondary affect. These pain dimensions and their interactions relate to a central network of brain structures that processes nociceptive information both in a parallel and in series. Spinal pathways to limbic structures and medial thalamic nuclei provide direct inputs to brain areas involved in affect. Another source is from spinal pathways to somatosensory thalamic and cortical areas and then through a cortico-limbic pathway. The latter integrates nociceptive input with contextual information and memory to provide cognitive mediation of pain affect. Both direct and cortical-limbic pathways converge on the same anterior cingulate cortical and subcortical structures whose function may be to establish emotional valence and response priorities.	Univ Florida, Hlth Sci Ctr, Dept Oral & Maxillofacial Surg, Gainesville, FL 32610 USA; Univ Florida, Hlth Sci Ctr, Dept Neurosci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Price, DD (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Oral & Maxillofacial Surg, POB 100416, Gainesville, FL 32610 USA.	dprice@dental.ufl.edu	Price, Donald D./A-3094-2008	Price, Donald D./0000-0002-8971-7184	PHS HHS [R01 295527912] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473, DOI 10.1152/jn.1990.63.3.473; BERTHIER M, 1988, ANN NEUROL, V24, P41, DOI 10.1002/ana.410240109; BURSTEIN R, 1987, J NEUROSCI, V7, P4159; Bushnell MC, 1999, P NATL ACAD SCI USA, V96, P7705, DOI 10.1073/pnas.96.14.7705; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; Craig AD, 1995, FRONTIER PAIN RES, P13; DAMASIO AR, 1994, DESCARTES ERROR; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dong WK, 1996, PAIN, V64, P579, DOI 10.1016/0304-3959(95)00215-4; DONG WK, 1994, J NEUROPHYSIOL, V72, P542, DOI 10.1152/jn.1994.72.2.542; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; FRIEDMAN DP, 1986, J COMP NEUROL, V252, P323, DOI 10.1002/cne.902520304; Hardy JD, 1952, PAIN SENSATIONS REAC; HARKINS SW, 1989, PAIN, V36, P209, DOI 10.1016/0304-3959(89)90025-0; MELZACK R, 1968, P423; MUSULAM MM, 1982, J COMP NEUROL, V212, P38; Price D.D., 1987, PAIN, V28, P291; PRICE DD, 1999, PSYCHOL MECHANISMS P; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; RAINVILLE P, 1992, SOMATOSENS MOT RES, V9, P265, DOI 10.3109/08990229209144776; RUBINS JL, 1948, ARCH NEURO PSYCHIATR, V60, P554, DOI 10.1001/archneurpsyc.1948.02310060007002; Tolle TR, 1999, ANN NEUROL, V45, P40, DOI 10.1002/1531-8249(199901)45:1<40::AID-ART8>3.0.CO;2-L; VOGT BA, 1979, SCIENCE, V204, P205, DOI 10.1126/science.107587; WADE JB, 1992, PAIN, V51, P67, DOI 10.1016/0304-3959(92)90010-9; WADE JB, 1996, PAIN, V62, P1; WEINSTEIN EA, 1955, ARCH NEURO PSYCHIATR, V74, P235, DOI 10.1001/archneurpsyc.1955.02330150001001	28	1338	1399	2	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1769	1772		10.1126/science.288.5472.1769	http://dx.doi.org/10.1126/science.288.5472.1769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846154				2022-12-28	WOS:000087503800039
J	Barber, VA; Juday, GP; Finney, BP				Barber, VA; Juday, GP; Finney, BP			Reduced growth of Alaskan white spruce in the twentieth century from temperature-induced drought stress	NATURE			English	Article							TREE-RING WIDTHS; HIGH-LATITUDES; ATMOSPHERIC CO2; NORTH-AMERICA; BOREAL FOREST; CLIMATE; CARBON; DENSITY; RECORD; WOOD	The extension of growing season at high northern latitudes seems increasingly clear from satellite observations of vegetation extent and duration(1,2). This extension is also thought to explain the observed increase in amplitude of seasonal variations in atmospheric CO2 concentration. Increased plant respiration and photosynthesis both correlate well with increases in temperature this century and are therefore the most probable link between the vegetation and CO2 observations(3). From these observations(1,2), it has been suggested that increases in temperature have stimulated carbon uptake in high latitudes(1,2) and for the boreal forest system as a whole(4). Here we present multi-proxy tree-ring data (ring width, maximum late-wood density and carbon-isotope composition) from 20 productive stands of white spruce in the interior of Alaska. The tree-ring records show a strong and consistent relationship over the past 90 years and indicate that, in contrast with earlier predictions, radial growth has decreased with increasing temperature. Our data show that temperature-induced drought stress has disproportionately affected the most rapidly growing white spruce, suggesting that, under recent climate warming, drought may have been an important factor limiting carbon uptake in a large portion of the North American boreal forest. If this limitation in growth due to drought stress is sustained, the future capacity of northern latitudes to sequester carbon may be less than currently expected.	Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA; Univ Alaska, Dept Forest Sci, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Barber, VA (corresponding author), Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA.	barber@ims.uaf.edu						Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Briffa KR, 1999, SCIENCE, V284, P926, DOI 10.1126/science.284.5416.926; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Chapin FS, 1996, NATURE, V383, P585, DOI 10.1038/383585b0; CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; CONKEY LE, 1986, QUATERNARY RES, V26, P232, DOI 10.1016/0033-5894(86)90107-9; Cook E.R., 2013, METHODS DENDROCHRONO; DARRIGO RD, 1992, CAN J FOREST RES, V22, P1290, DOI 10.1139/x92-171; DENNE MP, 1976, ANN BOT-LONDON, V40, P1017, DOI 10.1093/oxfordjournals.aob.a085209; Elliot-Frisk D.L., 1988, N AM TERRESTRIAL VEG, Vfirst ed., P33; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; GARFINKEL HL, 1980, NATURE, V286, P872, DOI 10.1038/286872a0; HOGG EH, 1995, WATER AIR SOIL POLL, V82, P391, DOI 10.1007/BF01182849; JACOBY GC, 1988, PALAEOGEOGR PALAEOCL, V64, P69, DOI 10.1016/0031-0182(88)90143-5; Jacoby GC, 1996, SCIENCE, V273, P771, DOI 10.1126/science.273.5276.771; JACOBY GC, 1995, GLOBAL BIOGEOCHEM CY, V9, P227, DOI 10.1029/95GB00321; JACOBY GC, 1989, CLIMATIC CHANGE, V14, P39, DOI 10.1007/BF00140174; JACOBY GC, 1999, WORLD RES REV, V11, P21; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; KOZLOWSKI TT, 1997, PHYSL WOODY PLANTS, P1; LARSEN CPS, 1995, CAN J FOREST RES, V25, P1746, DOI 10.1139/x95-189; LEAVITT SW, 1984, NATURE, V311, P145, DOI 10.1038/311145a0; LEAVITT SW, 1993, ANAL CHEM, V65, P87, DOI 10.1021/ac00049a017; Livingston NJ, 1996, PLANT CELL ENVIRON, V19, P768, DOI 10.1111/j.1365-3040.1996.tb00413.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Patric J.H., 1968, PNW71 USDA FOR SERV; Ruess RW, 1996, CAN J FOREST RES, V26, P1326, DOI 10.1139/x26-148; THETFORD RD, 1991, CAN J FOREST RES, V21, P1544, DOI 10.1139/x91-215; VANCLEVE K, 1986, FOREST ECOSYSTEMS AL, P230	30	738	789	16	301	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					668	673		10.1038/35015049	http://dx.doi.org/10.1038/35015049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864320				2022-12-28	WOS:000087465800042
J	Huiskes, R; Ruimerman, R; van Lenthe, GH; Janssen, JD				Huiskes, R; Ruimerman, R; van Lenthe, GH; Janssen, JD			Effects of mechanical forces on maintenance and adaptation of form in trabecular bone	NATURE			English	Article							WOLFFS LAW; OSTEOCYTES; ESTROGEN; ARCHITECTURE; DENSITY; HISTORY; TISSUE	The architecture of trabecular bone, the porous bone found in the spine and at articulating joints, provides the requirements for optimal load transfer, by pairing suitable strength and stiffness to minimal weight according to rules of mathematical design(1-6). But, as it is unlikely that the architecture is fully pre-programmed in the genes(7), how are the bone cells informed about these rules, which so obviously dictate architecture? A relationship exists between bone architecture and mechanical usage(8)-while strenuous exercise increases bone mass(9), disuse, as in microgravity and inactivity, reduces it(10). Bone resorption cells (osteoclasts) and bone formation cells (osteoblasts) normally balance bone mass in a coupled homeostatic process of remodelling, which renews some 25% of trabecular bone volume per year. Here we present a computational model of the metabolic process in bone that confirms that cell coupling is governed by feedback from mechanical load transfer(11-13). This model can explain the emergence and maintenance of trabecular architecture as an optimal mechanical structure, as well as its adaptation to alternative external loads.	Univ Nijmegen, Dept Orthopaed, Orthopaed Res Lab, NL-6500 HB Nijmegen, Netherlands; Eindhoven Univ Technol, Fac Biomed Engn, NL-5600 MB Eindhoven, Netherlands	Radboud University Nijmegen; Eindhoven University of Technology	Huiskes, R (corresponding author), Univ Nijmegen, Dept Orthopaed, Orthopaed Res Lab, POB 9101, NL-6500 HB Nijmegen, Netherlands.		van Lenthe, Harry (GH)/C-1030-2008	van Lenthe, Harry (GH)/0000-0001-8303-4959				Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; CARTER DR, 1987, J BIOMECH, V20, P785, DOI 10.1016/0021-9290(87)90058-3; CHAMBERS TJ, 1985, J CELL SCI, V76, P155; CHAMBERS TJ, 1998, ADV ORG BIO A-C, V5, P627; CHOI K, 1992, J BIOMECH, V25, P1371, DOI 10.1016/0021-9290(92)90051-2; Courteix D, 1998, OSTEOPOROSIS INT, V8, P152, DOI 10.1007/BF02672512; COWIN SC, 1986, J BIOMECH ENG-T ASME, V108, P83, DOI 10.1115/1.3138584; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; FROST HM, 1987, CALCIFIED TISSUE INT, V45, P145; Kelly K, 1998, SCIENCE, V279, P992, DOI 10.1126/science.279.5353.992; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Lanyon LE, 1996, BONE, V18, pS37, DOI 10.1016/8756-3282(95)00378-9; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; MULLENDER MG, 1995, J ORTHOPAED RES, V13, P503, DOI 10.1002/jor.1100130405; Noble BS, 1997, BONE, V20, P273, DOI 10.1016/S8756-3282(96)00365-1; Pazzaglia UE, 1997, J BONE JOINT SURG BR, V79-B, P1025; RODAN GA, 1991, J BONE MINER RES, V6, P527; ROESLER H, 1987, J BIOMECH, V20, P1025, DOI 10.1016/0021-9290(87)90020-0; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519; Smit TH, 2000, J BONE MINER RES, V15, P301, DOI 10.1359/jbmr.2000.15.2.301; Stewart I., 1998, LIFES OTHER SECRET; Thompsons DArcy Wentworth, 1919, GROWTH FORM; TURNER CH, 1995, AM J PHYSIOL-ENDOC M, V269, pE438, DOI 10.1152/ajpendo.1995.269.3.E438; Van Rietbergen B, 1999, J BIOMECH, V32, P443; VANRIETBERGEN B, 1995, J BIOMECH, V28, P69, DOI 10.1016/0021-9290(95)80008-5; Vashishth D, 2000, BONE, V26, P147, DOI 10.1016/S8756-3282(99)00253-7; Wolff J, 1892, GESETZ TRANSFORMATIO; Zerwekh JE, 1998, J BONE MINER RES, V13, P1594, DOI 10.1359/jbmr.1998.13.10.1594	30	798	833	5	148	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					704	706		10.1038/35015116	http://dx.doi.org/10.1038/35015116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864330				2022-12-28	WOS:000087465800052
J	Becker, RC				Becker, RC			Heparins in management of acute coronary syndromes without ST-segment elevation	LANCET			English	Editorial Material							WAVE MYOCARDIAL-INFARCTION; MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; ARTERY DISEASE; METAANALYSIS; ENOXAPARIN; TRIAL		Univ Massachusetts, Sch Med, Cardiovasc Trhombosis Res Ctr, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Becker, RC (corresponding author), Univ Massachusetts, Sch Med, Cardiovasc Trhombosis Res Ctr, Worcester, MA 01655 USA.							ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; Becker RC, 1999, AM HEART J, V137, P59, DOI 10.1016/S0002-8703(99)70460-6; Becker RC, 1999, J AM COLL CARDIOL, V34, P1020, DOI 10.1016/S0735-1097(99)00322-8; BECKER RC, 2000, FIBRINOLYTIC ANTITHR, P119; Cohen M, 1999, INT J CARDIOL, V71, P273, DOI 10.1016/S0167-5273(99)00171-0; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; JEWETT B, 1992, DIALOGUES PLATO, V3, P339; Klein W, 1997, CIRCULATION, V96, P61; LI Y, IN PRESS J THROMB TH; O'Brien BJ, 2000, AM HEART J, V139, P423, DOI 10.1016/S0002-8703(00)90085-1; PETIT JL, 1731, MEM ACAD R SCI, V1, P85; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 1996, LANCET, V347, P561	17	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1926	1928		10.1016/S0140-6736(00)02319-9	http://dx.doi.org/10.1016/S0140-6736(00)02319-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859033				2022-12-28	WOS:000087381900004
J	Aubert, C; Vos, MH; Mathis, P; Eker, APM; Brettel, K				Aubert, C; Vos, MH; Mathis, P; Eker, APM; Brettel, K			Intraprotein radical transfer during photoactivation of DNA photolyase	NATURE			English	Article							ELECTRON-TRANSFER; ESCHERICHIA-COLI; ANACYSTIS-NIDULANS; CATALYSIS; PROTEINS; FADH; EPR	Amino-acid radicals play key roles in many enzymatic reactions(1). Catalysis often involves transfer of a radical character within the protein, as in class I ribonucleotide reductase where radical transfer occurs over 35 Angstrom, from a tyrosyl radical to a cysteine(1-3). It is currently debated whether this kind of long-range transfer occurs by electron transfer, followed by proton release to create a neutral radical, or by H-atom transfer, that is, simultaneous transfer of electrons and protons(4-7), The latter mechanism avoids the energetic cost of charge formation in the low dielectric protein(4,5), but it is less robust to structural changes than is electron transfer(7). Available experimental data do not clearly discriminate between these proposals. We have studied the mechanism of photoactivation (light-induced reduction of the flavin adenine dinucleotide cofactor) of Escherichia coli DNA photolyase(8-10) using time-resolved absorption spectroscopy. Here we show that the excited flavin adenine dinucleotide radical abstracts an electron from a nearby tryptophan in 30 ps. After subsequent electron transfer along a chain of three tryptophans, the most remote tryptophan (as a cation radical) releases a proton to the solvent in about 300 ns, showing that electron transfer occurs before proton dissociation. A similar process may take place in photolyase-like blue-light receptors.	CEA Saclay, Sect Bioenerget, CNRS, URA 2096, F-91191 Gif Sur Yvette, France; Ecole Polytech ENSTA, Lab Opt Appl, INSERM, U451, F-91761 Palaiseau, France; Erasmus Univ, Ctr Med Genet, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Erasmus University Rotterdam	Brettel, K (corresponding author), CEA Saclay, Sect Bioenerget, CNRS, URA 2096, F-91191 Gif Sur Yvette, France.	brettel@dsvidf.cea.fr		Vos, Marten/0000-0003-0493-4831				Aubert C, 1999, J AM CHEM SOC, V121, P8659, DOI 10.1021/ja991938z; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cheung MS, 1999, BIOPHYS J, V76, P1241, DOI 10.1016/S0006-3495(99)77287-5; CLELAND WW, 1977, ISOTOPE EFFECTS ENZY; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; EKER APM, 1994, PHOTOCHEM PHOTOBIOL, V60, P125, DOI 10.1111/j.1751-1097.1994.tb05078.x; Gindt YM, 1999, BIOCHEMISTRY-US, V38, P3857, DOI 10.1021/bi981191+; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HEELIS PF, 1990, BIOCHEMISTRY-US, V29, P5694, DOI 10.1021/bi00476a008; HEELIS PF, 1992, INT J RADIAT BIOL, V62, P137, DOI 10.1080/09553009214551941; KIM ST, 1995, METHOD ENZYMOL, V258, P319; KIM ST, 1993, P NATL ACAD SCI USA, V90, P8023, DOI 10.1073/pnas.90.17.8023; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; MARTIN JL, 1994, METHOD ENZYMOL, V232, P416; OKAMURA T, 1989, J AM CHEM SOC, V111, P5967, DOI 10.1021/ja00197a082; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Sancar A, 1996, SCIENCE, V272, P48, DOI 10.1126/science.272.5258.48; Siegbahn PEM, 1998, J PHYS CHEM B, V102, P10622, DOI 10.1021/jp9827835; Siegbahn PEM, 1997, THEOR CHEM ACC, V97, P289, DOI 10.1007/s002140050264; SJOBERG BM, 1994, STRUCTURE, V2, P793, DOI 10.1016/S0969-2126(94)00080-8; SOLAR S, 1991, J PHYS CHEM-US, V95, P3639, DOI 10.1021/j100162a038; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Yasui A, 1998, CONT CANC RES, P9	28	357	361	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					586	590		10.1038/35014644	http://dx.doi.org/10.1038/35014644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850720				2022-12-28	WOS:000087449500055
J	Spotila, JR; Reina, RD; Steyermark, AC; Plotkin, PT; Paladino, FV				Spotila, JR; Reina, RD; Steyermark, AC; Plotkin, PT; Paladino, FV			Pacific leatherback turtles face extinction	NATURE			English	Article									Drexel Univ, Sch Environm Sci Engn & Policy, Philadelphia, PA 19104 USA; Ctr Marine Conservat, Washington, DC 20036 USA; Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA	Drexel University; Purdue University System; Indiana University Purdue University Fort Wayne	Spotila, JR (corresponding author), Drexel Univ, Sch Environm Sci Engn & Policy, Philadelphia, PA 19104 USA.		Reina, Richard/AAC-7017-2019	Plotkin, Pamela/0000-0003-3973-8988				Boulon Ralf H. Jr., 1996, Chelonian Conservation and Biology, V2, P141; Chan Eng-Heng, 1996, Chelonian Conservation and Biology, V2, P196; Deraniyagala PEP., 1939, TETRAPOD REPTILES CE, V1; Eckert Scott A., 1997, Marine Turtle Newsletter, V78, P2; Hughes George R., 1996, Chelonian Conservation and Biology, V2, P153; McDonald Donna L., 1996, Chelonian Conservation and Biology, V2, P148; Pauly D, 2000, AM SCI, V88, P46; Sarti M. Laura, 1996, Marine Turtle Newsletter, V74, P2; Savage J., SOUNDS; Smith M. A., 1931, FAUNA BRIT INDIA INC, VI; Spotila James R., 1996, Chelonian Conservation and Biology, V2, P209; Steyermark Anthony C., 1996, Chelonian Conservation and Biology, V2, P173; Zug George R., 1996, Chelonian Conservation and Biology, V2, P244	13	276	304	2	80	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					529	530		10.1038/35014729	http://dx.doi.org/10.1038/35014729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850701				2022-12-28	WOS:000087449500036
J	[Anonymous]				[Anonymous]			Recognizing hollow strengths in research communities	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					493	493						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850674				2022-12-28	WOS:000087449500001
J	Sait, SM; Liu, WC; Thompson, DJ; Godfray, HCJ; Begon, M				Sait, SM; Liu, WC; Thompson, DJ; Godfray, HCJ; Begon, M			Invasion sequence affects predator-prey dynamics in a multi-species interaction	NATURE			English	Article							INDIAN MEAL MOTH; PLODIA-INTERPUNCTELLA; POPULATION-DYNAMICS; GRANULOSIS-VIRUS; PATHOGEN INTERACTIONS; CYCLES; MODELS; STOCHASTICITY; PERSISTENCE; DISCRETE	Ecologists seek to understand the rules that govern the assembly, coexistence and persistence of communities of interacting species. There is, however, a variety of sequences in which a multi-species community can be assembled-unlike more familiar one- and two-species systems. Ecological systems can exhibit contrasting dynamics depending on initial conditions(1), but studies have been focused on simple communities initiated at different densities, not on multi-species communities constructed in different sequences. Investigations of permanence and convergence in ecological communities(2-4) have been concerned with the flux of whole species (presence or absence)(4) but have not addressed the central issues concerning the dynamics exhibited by individual species in particular interactions. Here we examine data for replicated three-species systems and demonstrate that the dynamic trajectories of both a predator and its prey within the system are determined by the sequence in which it is constructed, and that for one construction-sequence alternative dynamic patterns are possible.	Univ Liverpool, Sch Biol Sci, Populat & Evolut Biol Res Grp, Liverpool L69 3BX, Merseyside, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	University of Liverpool; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Sait, SM (corresponding author), Univ Liverpool, Sch Biol Sci, Populat & Evolut Biol Res Grp, Nicholson Bldg,POB 147, Liverpool L69 3BX, Merseyside, England.		Thompson, David J/C-3520-2008; Liu, Wei-chung/AAP-3893-2021	Begon, Mike/0000-0003-1715-5327				BEGON M, 1995, P ROY SOC B-BIOL SCI, V260, P131, DOI 10.1098/rspb.1995.0070; Begon M, 1996, NATURE, V381, P311, DOI 10.1038/381311a0; Bjornstad ON, 1998, J ANIM ECOL, V67, P110, DOI 10.1046/j.1365-2656.1998.00168.x; BJORNSTAD ON, UNPUB NATURE; Briggs CJ, 2000, J ANIM ECOL, V69, P352, DOI 10.1046/j.1365-2656.2000.00398.x; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; Chatfield C, 1996, ANAL TIME SERIES; Cushing JM, 1998, J ANIM ECOL, V67, P298, DOI 10.1046/j.1365-2656.1998.00194.x; Dennis B, 1997, J ANIM ECOL, V66, P704, DOI 10.2307/5923; GODFRAY HCJ, 1989, J ANIM ECOL, V58, P153, DOI 10.2307/4992; GORDON DM, 1991, J ANIM ECOL, V60, P295, DOI 10.2307/5461; GURNEY WSC, 1983, J ANIM ECOL, V52, P479, DOI 10.2307/4567; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; HASTINGS A, 1994, SCIENCE, V263, P1133, DOI 10.1126/science.263.5150.1133; HOCHBERG ME, 1990, AM NAT, V135, P74, DOI 10.1086/285033; Knell RJ, 1998, J ANIM ECOL, V67, P592, DOI 10.1046/j.1365-2656.1998.00219.x; LAW R, 1999, ADV ECOLOGICAL THEOR, P143; MAY RM, 1981, AM NAT, V117, P234, DOI 10.1086/283704; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; SAIT SM, 1994, J INVERTEBR PATHOL, V63, P107, DOI 10.1006/jipa.1994.1020; SAIT SM, 1994, J ANIM ECOL, V63, P861, DOI 10.2307/5263; Sait SM, 1997, ECOL ENTOMOL, V22, P225, DOI 10.1046/j.1365-2311.1997.t01-1-00051.x; SAIT SM, 1994, J ANIM ECOL, V63, P541, DOI 10.2307/5220; Samuels CL, 1997, TRENDS ECOL EVOL, V12, P427, DOI 10.1016/S0169-5347(97)01182-8	26	54	56	2	41	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					448	450		10.1038/35013045	http://dx.doi.org/10.1038/35013045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839538				2022-12-28	WOS:000087212000046
J	Dickson, R; Awasthi, S; Williamson, P; Demellweek, C; Garner, P				Dickson, R; Awasthi, S; Williamson, P; Demellweek, C; Garner, P			Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASCARIS-LUMBRICOIDES INFECTIONS; TRICHURIS-TRICHIURA INFECTION; JAMAICAN SCHOOL-CHILDREN; NUTRITIONAL-STATUS; PRESCHOOL-CHILDREN; IMPROVES GROWTH; DEWORMING PROGRAM; PHYSICAL-FITNESS; ALBENDAZOLE; SCHOOLCHILDREN	Objective To summarise the effects of anthelmintic drug treatment on growth and cognitive performance in children. Data sources Electronic databases: Cochrane Infectious Diseases Group controlled trial register, Cochrane controlled trials register, Embase, and Medline. Citations of all identified trials. Contact with the World Health Organization and field researchers. Review methods Systematic review of randomised controlled trials in children aged 1-16 that compared anthelmintic treatment with placebo or no treatment. Assessment of validity and data abstraction conducted independently by two reviewers. Main outcome measures Growth and cognitive performance. Results Thirty randomised controlled trials in more than 15 000 children were identified. Effects on mean weight were unremarkable, and heterogeneity was evident in the results. There were some positive effects on mean weight change in the trials reporting this outcome: after a single dose (any anthelmintic) the pooled estimates were 0.24 kg (95% confidence interval 0.15 kg to 0.32 kg; fixed effects model assumed) and 0.38 kg (0.01 kg to 0.77 kg; random effects model assumed). Results from trials of multiple doses showed mean weight change in up to one year of follow up of 0.10 kg (0.04 kg to 0.17 kg; fixed effects) or 0.15 kg (0.00 to 0.30; random effects). At more than one year of follow up, mean weight change was 0.12 kg (-0.02 kg to 0.26 kg; fixed effects) and 0.43 (-0.61 to 1.47; random effects). Results from studies of cognitive performance were inconclusive. Conclusions There is some limited evidence that routine treatment of children in areas where helminths are common has effects on weight gain, but this is not consistent between trials. There is insufficient evidence as to whether this intervention improves cognitive performance.	Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Div, Liverpool L3 5QA, Merseyside, England; King George Med Coll, Dept Paediat & Epidemiol, Lucknow, Uttar Pradesh, India; Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England; Univ Liverpool, Dept Clin Psychol, Liverpool L69 3BX, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool; King George's Medical University; University of Liverpool; University of Liverpool	Dickson, R (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Div, Liverpool L3 5QA, Merseyside, England.	rdickson@liv.ac.uk	Williamson, Paula R/B-6425-2016; Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019	Williamson, Paula R/0000-0001-9802-6636; Garner, Paul/0000-0002-0607-6941				ADAMS EJ, 1994, J NUTR, V124, P1199, DOI 10.1093/jn/124.8.1199; AWASTHI S, 1995, CONTROLLING PARASITI; BADDELEY A, 1995, APPL COGNITIVE PSYCH, V9, pS173, DOI 10.1002/acp.2350090711; Beach MJ, 1999, AM J TROP MED HYG, V60, P479, DOI 10.4269/ajtmh.1999.60.479; Beasley NMR, 1999, TROP MED INT HEALTH, V4, P744, DOI 10.1046/j.1365-3156.1999.00486.x; BOIVIN MJ, 1993, J PEDIATR PSYCHOL, V18, P249, DOI 10.1093/jpepsy/18.2.249; DICKSON R, 2000, COCHRANE LIB, V2; Donnen P, 1998, J NUTR, V128, P1320, DOI 10.1093/jn/128.8.1320; EVANS DB, 1995, PHARMACOECONOMICS, V8, P14, DOI 10.2165/00019053-199508010-00004; EVANS J, 1986, EFFECT PERIODIC DEWO; Fernando M A, 1983, Indian Pediatr, V20, P721; Forrester JE, 1998, LANCET, V352, P1103, DOI 10.1016/S0140-6736(97)08325-6; FREIJ L, 1979, AM J CLIN NUTR, V32, P1545, DOI 10.1093/ajcn/32.7.1545; Gardner JM, 1996, ANN TROP MED PARASIT, V90, P55, DOI 10.1080/00034983.1996.11813026; Grantham-Mcgregor Sally M., 1993, American Journal of Clinical Nutrition, V57, p303S, DOI 10.1093/ajcn/57.2.303S; GREENBERG BL, 1981, AM J CLIN NUTR, V34, P2508, DOI 10.1093/ajcn/34.11.2508; GUPTA MC, 1982, AM J CLIN NUTR, V36, P79, DOI 10.1093/ajcn/36.1.79; Hadidjaja P, 1998, AM J TROP MED HYG, V59, P791, DOI 10.4269/ajtmh.1998.59.791; Hadju V, 1996, PARASITOLOGY, V113, P497, DOI 10.1017/S0031182000081579; Hadju V, 1997, INT J FOOD SCI NUTR, V48, P85, DOI 10.3109/09637489709006966; Hall A, 1997, PARASITOL TODAY, V13, P411, DOI 10.1016/S0169-4758(97)01136-8; KLOETZEL K, 1982, J TROP PEDIATRICS, V28, P41, DOI 10.1093/tropej/28.1.41; Koroma MM, 1996, J TROP PEDIATRICS, V42, P371, DOI 10.1093/tropej/42.6.371; Kruger Marita, 1996, Food and Nutrition Bulletin, V17, P11; KVALSVIG JD, 1991, ANN TROP MED PARASIT, V85, P551, DOI 10.1080/00034983.1991.11812608; Lai Karen P. F., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P322; MICHAELSEN KF, 1985, T ROY SOC TROP MED H, V79, P848, DOI 10.1016/0035-9203(85)90136-1; NOKES C, 1992, PARASITOLOGY, V104, P539, DOI 10.1017/S0031182000063800; NOKES C, 1992, P ROY SOC B-BIOL SCI, V247, P77, DOI 10.1098/rspb.1992.0011; NOKES C, 1994, PARASITOL TODAY, V10, P14, DOI 10.1016/0169-4758(94)90348-4; ROUSHAM EK, 1994, ANN HUM BIOL, V21, P315, DOI 10.1080/03014469400003322; SAVIOLI L, 1992, T ROY SOC TROP MED H, V86, P353, DOI 10.1016/0035-9203(92)90215-X; SIMEON D, 1994, ACTA PAEDIATR, V83, P1188, DOI 10.1111/j.1651-2227.1994.tb18279.x; SIMEON DT, 1995, PARASITOLOGY, V110, P457, DOI 10.1017/S0031182000064799; SIMEON DT, 1995, J NUTR, V125, P1875, DOI 10.1093/jn/125.7.1875; STEPHENSON LS, 1989, AM J TROP MED HYG, V41, P78, DOI 10.4269/ajtmh.1989.41.78; STEPHENSON LS, 1990, T ROY SOC TROP MED H, V84, P277, DOI 10.1016/0035-9203(90)90286-N; STEPHENSON LS, 1993, J NUTR, V123, P656, DOI 10.1093/jn/123.4.656; STEPHENSON LS, 1993, J NUTR, V123, P1036; Stoltzfus RJ, 1998, AM J CLIN NUTR, V68, P179, DOI 10.1093/ajcn/68.1.179; Stoltzfus RJ, 1997, J NUTR, V127, P2187, DOI 10.1093/jn/127.11.2187; THEIN H, 1991, T R SOC TROP MED HYG, V85, P523; Warren K, 1993, DIS CONTROL PRIORITI; Watkins WE, 1996, PEDIATRICS, V97, P871; Watkins WE, 1996, T ROY SOC TROP MED H, V90, P156, DOI 10.1016/S0035-9203(96)90121-2; WHO, 1996, REP WHO INF CONS US; *WHO, 1997, STRENGTH INT RED HEL; *WHO, 1990, INF CONS INT HLM INF; WILLETT WC, 1979, AM J PUBLIC HEALTH, V69, P987, DOI 10.2105/AJPH.69.10.987; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 1998, GUID EV SOIL TRANSM; YOKOGAWA M, 1970, Japanese Journal of Parasitology, V19, P593	52	136	139	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2000	320	7251					1697	1701		10.1136/bmj.320.7251.1697	http://dx.doi.org/10.1136/bmj.320.7251.1697			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864543	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000087926400021
J	Jones, TD; Ruben, JA; Martin, LD; Kurochkin, EN; Feduccia, A; Maderson, PFA; Hillenius, WJ; Geist, NR; Alifanov, V				Jones, TD; Ruben, JA; Martin, LD; Kurochkin, EN; Feduccia, A; Maderson, PFA; Hillenius, WJ; Geist, NR; Alifanov, V			Nonavian feathers in a Late Triassic archosaur	SCIENCE			English	Article								Longisquama insignis was an unusual archosaur from the Late Triassic of central Asia. Along its dorsal axis Longisquama bore a series of paired integumentary appendages that resembled avian feathers in many details, especially in the anatomy of the basal region. The Latter is sufficiently similar to the calamus of modern feathers that each probably represents the culmination of virtually identical morphogenetic processes. The exact relationship of Longisquama to birds is uncertain. Nevertheless, we interpret Longisquama's elongate integumentary appendages as nonavian feathers and suggest that they are probably homologous with avian feathers. If so, they antedate the feathers of Archaeopteryx, the first known bird from the Late Jurassic.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Univ Kansas, Museum Hist Nat, Lawrence, KS 66045 USA; Russian Acad Sci, Inst Paleontol, Moscow 117868, Russia; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; Coll Charleston, Dept Biol, Charleston, SC 29424 USA; Sonoma State Univ, Dept Biol, Rohnert Park, CA 94928 USA	Oregon State University; University of Kansas; University of Kansas; Russian Academy of Sciences; University of North Carolina; University of North Carolina Chapel Hill; City University of New York (CUNY) System; Brooklyn College (CUNY); College of Charleston; California State University System; Sonoma State University	Jones, TD (corresponding author), Stephen F Austin State Univ, Dept Biol, Nacogdoches, TX 75962 USA.							Dobruskina IA, 1980, T GEOL I AKAD NAUK S, V346, P1; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; HAUBOLD H, 1987, CR ACAD SCI II, V305, P65; Lillie F. R., 1941, Physiological Zoology Chicago, V14, P103; LUCAS AM, 1972, AGR HDB USDA, V362; Maderson PFA, 1998, J MORPHOL, V236, P1, DOI 10.1002/(SICI)1097-4687(199804)236:1<1::AID-JMOR1>3.0.CO;2-B; Sharov A.G., 1970, PALEONTOL ZH, V1, P127; Stettenheim P.R., 1976, PROC 16 INT 353 ORNI, P385	8	48	51	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2202	2205		10.1126/science.288.5474.2202	http://dx.doi.org/10.1126/science.288.5474.2202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864867				2022-12-28	WOS:000087782900055
J	Zhuang, XW; Bartley, LE; Babcock, HP; Russell, R; Ha, TJ; Herschlag, D; Chu, S				Zhuang, XW; Bartley, LE; Babcock, HP; Russell, R; Ha, TJ; Herschlag, D; Chu, S			A single-molecule study of RNA catalysis and folding	SCIENCE			English	Article							TETRAHYMENA-THERMOPHILA RIBOZYME; GROUP-I RIBOZYME; ACTIVE-SITE; SUBSTRATE; BINDING; DYNAMICS; TITIN; PATHWAYS; PROTEIN; STEPS	Using fluorescence microscopy, we studied the catalysis by and folding of individual Tetrahymena thermophila ribozyme molecules. The dye-labeled and surface-immobilized ribozymes used were shown to be functionally indistinguishable from the unmodified free ribozyme in solution. A reversible Local folding step in which a duplex docks and undocks from the ribozyme core was observed directly in single-molecule time trajectories, allowing the determination of the rate constants and characterization of the transition state, A rarely populated docked state, not measurable by ensemble methods, was observed. In the overall folding process, intermediate folding states and multiple folding pathways were observed. In addition to observing previously established folding pathways, a pathway with an observed folding rate constant of 1 per second was discovered. These results establish single-molecule fluorescence as a powerful tool for examining RNA folding.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Beckman Ctr B400, Stanford, CA 94305 USA	Stanford University; Stanford University	Herschlag, D (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.		Ha, Taekjip/B-9506-2009; Russell, Rick/A-9256-2012; Bartley, Laura/AAF-2217-2020; Legros, Jean Claude/I-7472-2013	Ha, Taekjip/0000-0003-2195-6258; Bartley, Laura/0000-0001-8610-7551; Babcock, Hazen/0000-0003-4835-3692	NIGMS NIH HHS [GM49423] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEVILACQUA PC, 1992, SCIENCE, V258, P1355, DOI 10.1126/science.1455230; CECH TR, 1996, NUCL ACIDS MOL BIOL, V10, P1; CELANDER DW, 1991, SCIENCE, V251, P401, DOI 10.1126/science.1989074; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Fang XW, 1999, NAT STRUCT BIOL, V6, P1091; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; GESTELAND RF, 1993, RNA WORLD; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HERSCHLAG D, 1992, BIOCHEMISTRY-US, V31, P1386, DOI 10.1021/bi00120a015; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8299, DOI 10.1021/bi00083a034; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Narlikar GJ, 1999, BIOCHEMISTRY-US, V38, P14192, DOI 10.1021/bi9914309; Narlikar GJ, 1996, NAT STRUCT BIOL, V3, P701, DOI 10.1038/nsb0896-701; Neher E., 1976, NATURE, V260, P779; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; PYLE AM, 1992, NATURE, V358, P123, DOI 10.1038/358123a0; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Russell R, 1999, J MOL BIOL, V291, P1155, DOI 10.1006/jmbi.1999.3026; RUSSELL R, UNPUB; Schutz GJ, 1998, BIOPHYS J, V74, P2223, DOI 10.1016/S0006-3495(98)77931-7; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; WANG JF, 1993, SCIENCE, V260, P504, DOI 10.1126/science.7682726; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Zarrinkar PP, 1996, RNA, V2, P564; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848	40	615	644	1	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2048	+		10.1126/science.288.5473.2048	http://dx.doi.org/10.1126/science.288.5473.2048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856219				2022-12-28	WOS:000087687000052
J	Bentley, G; Minas, T				Bentley, G; Minas, T			Science, medicine, and the future - Treating joint damage in young people	BRITISH MEDICAL JOURNAL			English	Review							ARTICULAR-CARTILAGE DEFECTS; IN-VITRO; KNEE; CHONDROCYTES		Royal Natl Orthopaed Hosp, Inst Orthopaed, Stanmore HA7 4LP, Middx, England; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bentley, G (corresponding author), Royal Natl Orthopaed Hosp, Inst Orthopaed, Stanmore HA7 4LP, Middx, England.							BENTLEY G, 1978, J BONE JOINT SURG BR, V60, P74, DOI 10.1302/0301-620X.60B1.627583; BENTLEY G, IN PRESS J SPORTS ME; Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208; Breinan HA, 1998, TISSUE ENG, V4, P101, DOI 10.1089/ten.1998.4.101; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; BUCKWATER JA, 1999, CLIN ORTHOP S, V244, P238; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356; Hangody L, 1998, ORTHOPEDICS, V21, P751, DOI 10.3928/0147-7447-19980701-04; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; MAFFULLI N, 1993, J BONE JOINT SURG BR, V75, P945, DOI 10.1302/0301-620X.75B6.8245089; Meister K, 1998, J BONE JOINT SURG BR, V80B, P965, DOI 10.1302/0301-620X.80B6.8194; Minas T, 1998, Am J Orthop (Belle Mead NJ), V27, P739; MINAS T, 1999, AM AC ORTH SURG 66 A; PETERSON L, 1998, CARTILAGE REGENERATI; SANDBERG R, 1986, ACTA ORTHOP SCAND, V57, P516, DOI 10.3109/17453678609014782; TWYMAN RS, 1991, J BONE JOINT SURG BR, V73, P461, DOI 10.1302/0301-620X.73B3.1670450; WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013; WHITE AE, IN PRESS KNEE; ZAMBER R W, 1989, Arthroscopy, V5, P258, DOI 10.1016/0749-8063(89)90139-4	20	38	42	1	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1585	1588		10.1136/bmj.320.7249.1585	http://dx.doi.org/10.1136/bmj.320.7249.1585			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845971	Green Published			2022-12-28	WOS:000087631400026
J	Jones, JM; Lawson, ML; Daneman, D; Olmsted, MP; Rodin, G				Jones, JM; Lawson, ML; Daneman, D; Olmsted, MP; Rodin, G			Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BULIMIA-NERVOSA; ATTITUDES TEST; WOMEN; IDDM; COMPLICATIONS; BEHAVIORS; VALIDITY; MELLITUS	Objective To determine the prevalence of eating disorders in adolescent females with type 1 diabetes mellitus compared with that in their non-diabetic peers. Design Cross sectional case-controlled study Setting Diabetes clinics and schools in three Canadian cities, Subjects 356 females aged 12-19 with type 1 diabetes and 1098 age matched non-diabetic controls, Main outcome measure Eating disorders meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria. Results Eating disorders that met DSM-IV criteria were more prevalent in diabetic subjects (36, 10%) than in non-diabetic controls (49, 4%) (odds ratio 2.4, 95% confidence interval 1.5 to 3.7; P < 0.001). Subthreshold eating disorders were also more common in those with diabetes (49, 14%) than in controls (84, 8%) (odds ratio 1.9, 95% confidence interval 1.3 to 2.8; P < 0.001). Mean haemoglobin A(1c) concentration was higher in diabetic subjects with an eating disorder (9.4% (1.8)) than in those without (8.6% (1.6)), P = 0.04). Conclusions DSM-IV and subthreshold eating disorders are almost twice as common in adolescent females with type 1 diabetes as in their non-diabetic peers, In diabetic subjects, eating disorders are associated with insulin omission for weight loss and impaired metabolic control.	Univ Hlth Network, Dept Psychiat, Toronto, ON M5G 2CA, Canada; Univ Hlth Network, Ambulatory Care Eating Disorders, Toronto, ON M5G 2CA, Canada; Childrens Hosp Eastern Ontario, Div Endocrinol, Ottawa, ON K1H 8L1, Canada; Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 2CA, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rodin, G (corresponding author), Univ Hlth Network, Dept Psychiat, Toronto, ON M5G 2CA, Canada.	gary.rodin@uhn.on.ca	; Lawson, Margaret/M-6969-2015	Rodin, Gary/0000-0002-6626-6974; Lawson, Margaret/0000-0002-2370-9552				Abraham S, 1996, PSYCHOPATHOLOGY, V29, P223, DOI 10.1159/000284997; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; COLAS C, 1991, DIABETOLOGIA, V34, P288, DOI 10.1007/BF00405092; COOPER Z, 1989, BRIT J PSYCHIAT, V154, P807, DOI 10.1192/bjp.154.6.807; COOPER Z, 1987, INT J EAT DISORDER, V6, P1, DOI 10.1002/1098-108X(198701)6:1<1::AID-EAT2260060102>3.0.CO;2-9; DAVIS C, 1992, INT J SPORT PSYCHOL, V23, P179; DCCT Res Grp, 1988, DIABETES CARE, V11, P567; FAIRBURN CG, 1991, BRIT MED J, V303, P17, DOI 10.1136/bmj.303.6793.17; FAIRBURN CG, 1990, AM J PSYCHIAT, V147, P401; Garner D. M., 1984, EATING DISORDER INVE; GARNER DM, 1980, PSYCHOL MED, V10, P647, DOI 10.1017/S0033291700054945; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; GILLERY P, 1995, CLIN CHEM, V41, P1644; HAMMER LD, 1991, AM J DIS CHILD, V145, P259, DOI 10.1001/archpedi.1991.02160030027015; JOHNSON C, 1985, HDB PSYCHOTHERAPY AN, P19; MANNUCCI E, 1995, DIABETES CARE, V18, P1503, DOI 10.2337/diacare.18.11.1503; OLMSTED M, 1997, DIABETES S1, V46, pA88; PEVELER RC, 1992, DIABETES CARE, V15, P1356, DOI 10.2337/diacare.15.10.1356; POLIVY J, 1990, ONT SYMP P, V6, P87; RODIN G, 1991, PSYCHOSOMATICS, V32, P171, DOI 10.1016/S0033-3182(91)72088-4; RODIN GM, 1992, DIABETES CARE, V15, P1402, DOI 10.2337/diacare.15.10.1402; ROSEN JC, 1990, INT J EAT DISORDER, V9, P519, DOI 10.1002/1098-108X(199009)9:5&lt;519::AID-EAT2260090507&gt;3.0.CO;2-K; Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; STEEL JM, 1987, BRIT MED J, V294, P859, DOI 10.1136/bmj.294.6576.859; STEEL JM, 1989, BRIT J PSYCHIAT, V155, P513; Striegel-Moore Ruth H., 1993, P144; STRIEGELMOORE RH, 1992, DIABETES CARE, V15, P1361, DOI 10.2337/diacare.15.10.1361; VILA G, 1993, CAN J PSYCHIAT, V38, P606, DOI 10.1177/070674379303800908; WILLIAMS RL, 1986, INT J EAT DISORDER, V5, P879, DOI 10.1002/1098-108X(198607)5:5<879::AID-EAT2260050509>3.0.CO;2-8; WILSON GT, 1989, INT J EAT DISORDER, V8, P173	31	320	325	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2000	320	7249					1563	1566		10.1136/bmj.320.7249.1563	http://dx.doi.org/10.1136/bmj.320.7249.1563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324PW	10845962	Bronze, Green Submitted			2022-12-28	WOS:000087631400018
J	Peng, GW; Qiu, F; Ginzburg, VV; Jasnow, D; Balazs, AC				Peng, GW; Qiu, F; Ginzburg, VV; Jasnow, D; Balazs, AC			Forming supramolecular networks from nanoscale rods in binary, phase-separating mixtures	SCIENCE			English	Article							PARTICLES	Simulations show that when low-volume fractions of nanoscale rods are immersed in a binary, phase-separating blend, the rods self-assemble into needle-like, percolating networks. The interconnected network arises through the dynamic interplay of phase-separation between the fluids, through preferential adsorption of the minority component onto the mobile rods, and through rod-rod repulsion. Such cooperative effects provide a means of manipulating the motion of nanoscopic objects and directing their association into supramolecular structures. Increasing the rod concentration beyond the effective percolation threshold drives the system to self-assemble into a Lamellar morphology, with layers of wetted rods alternating with layers of the majority-component fluid. This approach can potentially yield organic/inorganic composites that are ordered on nanometer scales and exhibit electrical or structural integrity.	Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Balazs, AC (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.		Ginzburg, Valeriy/F-2882-2011	Balazs, Anna/0000-0002-5555-2692				Adams M, 1998, NATURE, V393, P349, DOI 10.1038/30700; Balazs AC, 2000, J PHYS CHEM B, V104, P3411, DOI 10.1021/jp993356+; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; Ginzburg VV, 1999, PHYS REV E, V60, P4352, DOI 10.1103/PhysRevE.60.4352; Ginzburg VV, 1999, PHYS REV LETT, V82, P4026, DOI 10.1103/PhysRevLett.82.4026; Karim A, 1999, MACROMOLECULES, V32, P5917, DOI 10.1021/ma990439f; KAWAKATSU T, 1994, J PHYS-CONDENS MAT, V6, P6385, DOI 10.1088/0953-8984/6/32/003; Lapena AM, 1999, PHYS REV E, V60, pR29, DOI 10.1103/PhysRevE.60.R29; QUI F, 1999, LANGMUIR, V15, P4952; TANAKA H, 1994, PHYS REV LETT, V72, P2581, DOI 10.1103/PhysRevLett.72.2581	10	148	156	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1802	1804		10.1126/science.288.5472.1802	http://dx.doi.org/10.1126/science.288.5472.1802			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846157				2022-12-28	WOS:000087503800043
J	Ryan, ET; Kain, KC				Ryan, ET; Kain, KC			Primary care: Health advice and immunizations for travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; DRUG-THERAPY; HEPATITIS-A; MALARIA; PREVENTION; MEFLOQUINE; PROPHYLAXIS; DIARRHEA; EPIDEMIOLOGY		Massachusetts Gen Hosp, Div Infect Dis, Trop & Geog Med Ctr, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Infect Dis, Travelers Advice & Immunizat Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Toronto Gen Hosp, Div Infect Dis, Ctr Travel & Trop Med, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Ryan, ET (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Trop & Geog Med Ctr, Jackson 504,55 Fruit St, Boston, MA 02114 USA.	etryan@partners.org		Kain, Kevin/0000-0001-6068-1272	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001332] Funding Source: NIH RePORTER; NIAID NIH HHS [AI/K0801332] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*ADV COMM IMM PRAC, 1996, MMWR-MORBID MORTAL W, V45, P1; *ADV COMM IMM PRAC, 1994, MMWR-MORBID MORTAL W, V43, P1; *ADV COMM IMM PRAC, 1999, MMWR-MORBID MORTAL W, V48, P16; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 1997, MMWR MORB MORT WKLY, V46, P1; Ansdell VE, 1999, MED CLIN N AM, V83, P945; AUERBACH PS, 1991, NEW ENGL J MED, V325, P486, DOI 10.1056/NEJM199108153250707; Barrett PJ, 1996, BRIT MED J, V313, P525, DOI 10.1136/bmj.313.7056.525; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Brueckner RP, 1998, AM J TROP MED HYG, V58, P645, DOI 10.4269/ajtmh.1998.58.645; Centers for Disease Control and Prevention, 1999, HLTH INF INT TRAV 19; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P33; CLOSEK MA, 1997, TXB TRAVEL MED HLTH, P261; Croft A, 1997, BRIT MED J, V315, P1412, DOI 10.1136/bmj.315.7120.1412; Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195; DUPONT HL, 1993, NEW ENGL J MED, V328, P1821, DOI 10.1056/NEJM199306243282507; DUPONT HL, 1997, TXB TRAVEL MED HLTH, P253; Ericsson CD, 1998, INFECT DIS CLIN N AM, V12, P285, DOI 10.1016/S0891-5520(05)70006-4; Fischer PR, 1998, INFECT DIS CLIN N AM, V12, P355, DOI 10.1016/S0891-5520(05)70009-X; Fradin MS, 1998, ANN INTERN MED, V128, P931, DOI 10.7326/0003-4819-128-11-199806010-00013; FRYAUFF DJ, 1995, LANCET, V346, P1190, DOI 10.1016/S0140-6736(95)92898-7; HARGARTEN SW, 1991, ANN EMERG MED, V20, P622, DOI 10.1016/S0196-0644(05)82379-0; Hill DR, 1996, T ROY SOC TROP MED H, V90, P680, DOI 10.1016/S0035-9203(96)90433-2; HONIGMAN B, 1994, ANN INTERN MED, V120, P698, DOI 10.7326/0003-4819-120-8-199404150-00034; Houweling H, 1991, Int J STD AIDS, V2, P252; Jong EC, 1999, MED CLIN N AM, V83, P903; Kain KC, 1998, INFECT DIS CLIN N AM, V12, P267, DOI 10.1016/S0891-5520(05)70005-2; Khan WA, 1997, ANN INTERN MED, V126, P697, DOI 10.7326/0003-4819-126-9-199705010-00004; Kozarsky PE, 1998, INFECT DIS CLIN N AM, V12, P305, DOI 10.1016/S0891-5520(05)70007-6; LOBEL HO, 1993, LANCET, V341, P848, DOI 10.1016/0140-6736(93)93058-9; Lobel HO, 1997, JAMA-J AM MED ASSOC, V278, P1767, DOI 10.1001/jama.278.21.1767; Mileno MD, 1998, INFECT DIS CLIN N AM, V12, P369, DOI 10.1016/S0891-5520(05)70010-6; MULHALL BP, 1993, BRIT MED BULL, V49, P394, DOI 10.1093/oxfordjournals.bmb.a072617; NEUMANN K, 1997, TXB TRAVEL HLTH, P304; Ohrt C, 1997, ANN INTERN MED, V126, P963, DOI 10.7326/0003-4819-126-12-199706150-00006; Parviz S, 1998, CLIN INFECT DIS, V27, P751, DOI 10.1086/514931; Plotkin SA, 2000, CLIN INFECT DIS, V30, P4, DOI 10.1086/313632; Protection against viral hepatitis, 1990, MMWR RECOMM REP, V39, P1; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; REID D, 1997, TXB TRAVEL MED HLTH, P3; RIED LD, 1994, J WILDERNESS MED, V5, P34; Rigau-Perez, 1997, J Travel Med, V4, P65, DOI 10.1111/j.1708-8305.1997.tb00782.x; Samuel BU, 1998, INFECT DIS CLIN N AM, V12, P325, DOI 10.1016/S0891-5520(05)70008-8; Shanks GD, 1999, CLIN INFECT DIS, V29, P942, DOI 10.1086/520469; Shanks GD, 1999, J TRAVEL MED, V6, pS21; SMIT, 1999, NEW ENGL J MED, V340, P1525; Soto J, 1998, ANN INTERN MED, V129, P241, DOI 10.7326/0003-4819-129-3-199808010-00013; STEFFEN R, 1994, JAMA-J AM MED ASSOC, V272, P885, DOI 10.1001/jama.272.11.885; STEFFEN R, 1983, JAMA-J AM MED ASSOC, V249, P1176; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; Steffen R, 1999, TROPICAL INFECT DIS, P106; STRICKER M, 1990, MUNCHEN MED WOCHEN, V132, P175; Taylor DN, 1999, MED CLIN N AM, V83, P1033; Thanassi WT, 2000, ANN INTERN MED, V132, P661, DOI 10.7326/0003-4819-132-8-200004180-00009; Thoelen S, 1999, VACCINE, V17, P1657, DOI 10.1016/S0264-410X(98)00421-6; WEINKE T, 1991, AM J TROP MED HYG, V45, P86, DOI 10.4269/ajtmh.1991.45.86; *WHO, 1999, INT TRAV HLTH VACC R; Wittlinger, 1995, J Travel Med, V2, P154, DOI 10.1111/j.1708-8305.1995.tb00643.x; World Health Organization, 1997, WORLD HLTH REP 1996, P1; WYLER DJ, 1993, NEW ENGL J MED, V329, P31, DOI 10.1056/NEJM199307013290107; 2000, MMWR MORB MORTAL WKL, V49, P35; 1999, MED LETT DRUGS THER, V41, P39; 2000, MED LETT, V42, P8	65	105	108	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1716	1725		10.1056/NEJM200006083422306	http://dx.doi.org/10.1056/NEJM200006083422306			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841875				2022-12-28	WOS:000087449300006
J	Windsor, JA				Windsor, JA			Search for prognostic markers for acute pancreatitis	LANCET			English	Editorial Material									Auckland Hosp, Dept Surg, Auckland, New Zealand	Auckland City Hospital	Windsor, JA (corresponding author), Auckland Hosp, Dept Surg, Private Bag 92024, Auckland, New Zealand.							Bonham MJD, 1997, BRIT J SURG, V84, P1670, DOI 10.1002/bjs.1800841208; FAN ST, 1993, NEW ENGL J MED, V328, P228, DOI 10.1056/NEJM199301283280402; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Johnson CD, 1996, BRIT J SURG, V83, P883, DOI 10.1002/bjs.1800830703; LEEDER P, 1997, BRIT J SURG, V84, P696; Simovic MO, 1999, CRIT CARE MED, V27, P2662, DOI 10.1097/00003246-199912000-00009; WILSON C, 1990, BRIT J SURG, V77, P1260, DOI 10.1002/bjs.1800771120; Windsor ACJ, 1998, GUT, V42, P431, DOI 10.1136/gut.42.3.431; WINDSOR JA, 1993, BRIT J SURG, V80, P1042, DOI 10.1002/bjs.1800800840	9	55	56	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1924	1925		10.1016/S0140-6736(00)02317-5	http://dx.doi.org/10.1016/S0140-6736(00)02317-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859031				2022-12-28	WOS:000087381900002
J	Osterlund, MT; Hardtke, CS; Wei, N; Deng, XW				Osterlund, MT; Hardtke, CS; Wei, N; Deng, XW			Targeted destabilization of HY5 during light-regulated development of Arabidopsis	NATURE			English	Article							SEEDLING DEVELOPMENT; BZIP PROTEIN; COP9 COMPLEX; GENE; ENCODES; HYPOCOTYL; PHOTOMORPHOGENESIS; UBIQUITINATION; ENHANCEMENT; ELONGATION	Arabidopsis seedlings display contrasting developmental patterns depending on the ambient light. Seedlings grown in the light develop photomorphogenically, characterized by short hypocotyls and expanded green cotyledons. In contrast, seedlings grown in darkness become etiolated, with elongated hypocotyls and closed cotyledons on an apical hook. Light signals, perceived by multiple photoreceptors and transduced to downstream regulators, dictate the extent of photomorphogenic development in a quantitative manner. Two key downstream components, COP1 and HY5, act antagonistically in regulating seedling development(1). HY5 is a bZIP transcription factor that binds directly to the promoters of light-inducible genes, promoting their expression and photomorphogenic development(2,3). COP1 is a RING-finger protein with WD-40 repeats whose nuclear abundance is negatively regulated by light(4,5). COP1 interacts directly with HY5 in the nucleus to regulate its activity negatively(1). Here we show that the abundance of HY5 is directly correlated with the extent of photomorphogenic development, and that the COP1-HY5 interaction may specifically target HY5 for proteasome-mediated degradation in the nucleus.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208104,165 Prospect St,OML 301, New Haven, CT 06520 USA.		Hardtke, Christian S/B-5861-2009; Deng, Xing Wang/ABF-4107-2020	Hardtke, Christian S./0000-0003-3203-1058				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; AHMAD M, 1994, NATURE, V16, P720; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; BOYLAN MT, 1991, P NATL ACAD SCI USA, V88, P10806, DOI 10.1073/pnas.88.23.10806; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Karniol B, 1998, FEBS LETT, V439, P173, DOI 10.1016/S0014-5793(98)01367-2; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kwok SF, 1999, J MOL BIOL, V285, P85, DOI 10.1006/jmbi.1998.2315; Kwok SF, 1996, PLANT PHYSIOL, V110, P731, DOI 10.1104/pp.110.3.731; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; McNellis TW, 1996, PLANT CELL, V8, P1491, DOI 10.1105/tpc.8.9.1491; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; OSERLUND MT, 1999, TRENDS CELL BIOL, V9, P113; Osterlund MT, 1998, PLANT J, V16, P201, DOI 10.1046/j.1365-313x.1998.00290.x; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Staub B, 1996, CD-ROM PROF, V9, P8; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; vonArnim AG, 1997, PLANT PHYSIOL, V114, P779, DOI 10.1104/pp.114.3.779; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; WAGNER D, 1991, PLANT CELL, V3, P1275, DOI 10.1105/tpc.3.12.1275; Wei D, 1998, J VIS COMMUN IMAGE R, V9, P15, DOI 10.1006/jvci.1997.0369; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757	30	926	986	17	264	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					462	466		10.1038/35013076	http://dx.doi.org/10.1038/35013076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839542				2022-12-28	WOS:000087212000050
J	Benlali, A; Draskovic, I; Hazelett, DJ; Treisman, JE				Benlali, A; Draskovic, I; Hazelett, DJ; Treisman, JE			Act up controls actin polymerization to alter cell shape and restrict hedgehog signaling in the Drosophila eye disc	CELL			English	Article							CYCLASE-ASSOCIATED PROTEIN; CUBITUS-INTERRUPTUS PROTEIN; SACCHAROMYCES-CEREVISIAE; PRONEURAL GENE; RETINAL DIFFERENTIATION; MORPHOGENETIC FURROW; NUCLEOTIDE EXCHANGE; IMAGINAL DISKS; TOUT-VELU; PROFILIN	Cells in the morphogenetic furrow of the Drosophila eye disc undergo a striking shape change immediately prior to their neuronal differentiation. We have isolated mutations in a novel gene, act up (acu), that is required for this shape change. acu encodes a homolog of yeast cyclase-associated protein, which sequesters monomeric actin; we show that acu is required to prevent actin filament polymerization in the eye disc. In contrast, profilin promotes actin filament polymerization, acting epistatically to acu. However, both acu and profilin are required to prevent premature Hedgehog-induced photoreceptor differentiation ahead of the morphogenetic furrow. These findings suggest that dynamic changes in actin filaments alter cell shape to control the movement of signals that coordinate a wave of differentiation.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Treisman, JE (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.			Hazelett, Dennis/0000-0003-0749-9935; Treisman, Jessica/0000-0002-7453-107X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056131, R55GM056131] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56131] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Edwards KA, 1996, DEVELOPMENT, V122, P1499; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GLESELMANN R, 1992, FEBS LETT, V298, P149; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; Gottwald U, 1996, MOL BIOL CELL, V7, P261, DOI 10.1091/mbc.7.2.261; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Hassan BA, 1998, GENETICS, V150, P1527; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HEBERLEIN U, 1995, CELL, V81, P987, DOI 10.1016/S0092-8674(05)80003-0; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0; Horsfield J, 1998, DEVELOPMENT, V125, P5069; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; Kimberly EL, 1998, DEV BIOL, V204, P235, DOI 10.1006/dbio.1998.9075; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; MATVIW H, 1992, MOL CELL BIOL, V12, P5033, DOI 10.1128/MCB.12.11.5033; Maurel-Zaffran C, 2000, DEVELOPMENT, V127, P1007; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Newsome TP, 2000, DEVELOPMENT, V127, P851; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; RONCHI E, 1993, CELL, V74, P347, DOI 10.1016/0092-8674(93)90425-P; Royet J, 1997, DEVELOPMENT, V124, P4793; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; STRUTT DI, 1995, NATURE, V373, P705, DOI 10.1038/373705a0; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Thackeray JR, 1998, DEVELOPMENT, V125, P5033; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TREISMAN JE, 1995, DEVELOPMENT, V121, P2835; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VERDERAME M, 1980, P NATL ACAD SCI-BIOL, V77, P6624, DOI 10.1073/pnas.77.11.6624; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; VOJTEK AB, 1993, J CELL SCI, V105, P777; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOLFF T, 1991, DEVELOPMENT, V113, P841; Yang Y, 1999, DEVELOPMENT, V126, P3027; YU G, 1994, J CELL SCI, V107, P1671; Yu J, 1999, J BIOL CHEM, V274, P19985, DOI 10.1074/jbc.274.28.19985; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	76	90	91	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					271	281		10.1016/S0092-8674(00)80837-5	http://dx.doi.org/10.1016/S0092-8674(00)80837-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847682	Bronze			2022-12-28	WOS:000086741900007
J	Benson, K; Hartz, AJ				Benson, K; Hartz, AJ			A comparison of observational studies and randomized, controlled trials.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTMENOPAUSAL BONE LOSS; CALCIUM-CHANNEL BLOCKERS; HORMONE REPLACEMENT THERAPY; CONTROLLED CLINICAL-TRIALS; DESIGN AFFECTS OUTCOMES; SHOCK-WAVE LITHOTRIPSY; ARTERY BYPASS-SURGERY; OPEN APPENDECTOMY; PNEUMATIC RETINOPEXY; LONG-TERM	Background: For many years it has been claimed that observational studies find stronger treatment effects than randomized, controlled trials. We compared the results of observational studies with those of randomized, controlled trials. Methods: We searched the Abridged Index Medicus and Cochrane data bases to identify observational studies reported between 1985 and 1998 that compared two or more treatments or interventions for the same condition. We then searched the Medline and Cochrane data bases to identify all the randomized, controlled trials and observational studies comparing the same treatments for these conditions. For each treatment, the magnitudes of the effects in the various observational studies were combined by the Mantel-Haenszel or weighted analysis-of-variance procedure and then compared with the combined magnitude of the effects in the randomized, controlled trials that evaluated the same treatment. Results: There were 136 reports about 19 diverse treatments, such as calcium-channel-blocker therapy for coronary artery disease, appendectomy, and interventions for subfertility. In most cases, the estimates of the treatment effects from observational studies and randomized, controlled trials were similar. In only 2 of the 19 analyses of treatment effects did the combined magnitude of the effect in observational studies lie outside the 95 percent confidence interval for the combined magnitude in the randomized, controlled trials. Conclusions: We found little evidence that estimates of treatment effects in observational studies reported after 1984 are either consistently larger than or qualitatively different from those obtained in randomized, controlled trials. (N Engl J Med 2000;342:1878-86.) (C)2000, Massachusetts Medical Society.	Univ Iowa, Coll Med, Dept Family Med, Iowa City, IA 52242 USA	University of Iowa	Hartz, AJ (corresponding author), Univ Iowa, Coll Med, Dept Family Med, 01292-D PFP, Iowa City, IA 52242 USA.	arthur-hartz@uiowa.edu			DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [D15PE087007, D32PE010195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007485] Funding Source: NIH RePORTER; NHLBI NIH HHS [2T35HL07485-21] Funding Source: Medline; BHP HRSA HHS [PD15 PE87007, 5D32PE10195-02] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BHP HRSA HHS		ALOIA JF, 1994, ANN INTERN MED, V120, P97, DOI 10.7326/0003-4819-120-2-199401150-00001; BONANNI F, 1994, J AM COLL SURGEONS, V179, P273; Braun S, 1996, J AM COLL CARDIOL, V28, P7, DOI 10.1016/0735-1097(96)00109-X; BREWSTER AC, 1985, INQUIRY-J HEALTH CAR, V22, P377; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, P1; BUCKLEY RC, 1994, AM SURGEON, V60, P30; CARLSSON P, 1992, SCAND J UROL NEPHROL, V26, P257, DOI 10.3109/00365599209180879; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; CHALMERS TC, 1977, NEW ENGL J MED, V297, P1091, DOI 10.1056/NEJM197711172972004; COLDITZ GA, 1989, STAT MED, V8, P441, DOI 10.1002/sim.4780080408; *COR ART SURG STUD, 1984, J AM COLL CARDIOL, V3, P114; COSMAN F, 1995, MATURITAS, V22, P137, DOI 10.1016/0378-5122(95)00923-9; CURTIS RE, 1992, NEW ENGL J MED, V326, P1745, DOI 10.1056/NEJM199206253262605; Detre KM, 1999, CIRCULATION, V99, P633, DOI 10.1161/01.CIR.99.5.633; DOREN M, 1995, AM J OBSTET GYNECOL, V173, P1446, DOI 10.1016/0002-9378(95)90631-2; Emanuel EJ, 1996, JAMA-J AM MED ASSOC, V275, P1907, DOI 10.1001/jama.275.24.1907; ETTINGER B, 1987, ANN INTERN MED, V106, P40, DOI 10.7326/0003-4819-106-1-40; FEINSTEIN AR, 1989, J CLIN EPIDEMIOL, V42, P481, DOI 10.1016/0895-4356(89)90142-X; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; FERGUSON CJ, 1990, NEPHROL DIAL TRANSPL, V5, P816, DOI 10.1093/ndt/5.9.816; FISHER B, 1985, J CLIN ONCOL, V3, P1640, DOI 10.1200/JCO.1985.3.12.1640; FRIBERG TR, 1985, OPHTHALMOLOGY, V92, P1051; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; GAMBACCIANI M, 1995, MATURITAS, V22, P115, DOI 10.1016/0378-5122(95)00931-A; GAYTON D, 1987, J AM GERIATR SOC, V35, P726, DOI 10.1111/j.1532-5415.1987.tb06350.x; GILLMAN MW, 1984, NEW ENGL J MED, V310, P1610; Golub R, 1998, J AM COLL SURGEONS, V186, P545, DOI 10.1016/S1072-7515(98)00080-5; GREEN SB, 1984, STAT MED, V3, P361, DOI 10.1002/sim.4780030413; GREY AB, 1994, CLIN ENDOCRINOL, V40, P671, DOI 10.1111/j.1365-2265.1994.tb03020.x; Han DP, 1998, AM J OPHTHALMOL, V126, P658, DOI 10.1016/S0002-9394(98)00181-0; HARTZ AJ, 1995, NEW ENGL J MED, V332, P888; HARTZ AJ, 1992, AM J CARDIOL, V70, P179, DOI 10.1016/0002-9149(92)91272-6; Heikkinen J, 1997, MATURITAS, V26, P139, DOI 10.1016/S0378-5122(96)01098-5; HILLARD TC, 1994, OSTEOPOROSIS INT, V4, P341, DOI 10.1007/BF01622195; HLATKY MA, 1988, J AM COLL CARDIOL, V11, P237, DOI 10.1016/0735-1097(88)90086-1; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Jadad AR, 1998, MED DECIS MAKING, V18, P2, DOI 10.1177/0272989X9801800102; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; LADEFOGED SD, 1994, CLIN TRANSPLANT, V8, P128; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; MAYS N, 1992, SCAND J UROL NEPHROL, V26, P43, DOI 10.3109/00365599209180395; MCALLISTER IL, 1988, OPHTHALMOLOGY, V95, P877; MCANENA OJ, 1992, BRIT J SURG, V79, P818, DOI 10.1002/bjs.1800790837; MESCHIA M, 1993, CALCIFIED TISSUE INT, V53, P17, DOI 10.1007/BF01352009; MILLER JN, 1989, STAT MED, V8, P455, DOI 10.1002/sim.4780080409; Mizunuma H, 1997, MATURITAS, V27, P69, DOI 10.1016/S0378-5122(97)01110-9; MOMPEAN JAL, 1994, BRIT J SURG, V81, P133, DOI 10.1002/bjs.1800810148; MOSES LE, 1995, MED CARE, V33, pAS8; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P554, DOI 10.1001/jama.275.7.554; NICHOLSON ML, 1993, BRIT J SURG, V80, P1318, DOI 10.1002/bjs.1800801033; NICOLAIDES, 1994, LANCET, V344, P830; NICOLAIDES K, 1994, LANCET, V344, P435, DOI 10.1016/S0140-6736(94)91769-8; OTTENBACHER K, 1992, CONTROL CLIN TRIALS, V13, P50, DOI 10.1016/0197-2456(92)90029-Y; PALMER BF, 1991, TRANSPLANTATION, V52, P640, DOI 10.1097/00007890-199110000-00012; PARADISE JL, 1990, JAMA-J AM MED ASSOC, V263, P2066, DOI 10.1001/jama.263.15.2066; Pruett B, 1994, J Miss State Med Assoc, V35, P347; PUIG JM, 1991, TRANSPLANT P, V23, P2368; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Richards KF, 1996, SURG LAPAROSC ENDOSC, V6, P205, DOI 10.1097/00019509-199606000-00008; ROSENSTOCK J, 1986, AM J MED, V81, P1012, DOI 10.1016/0002-9343(86)90398-0; Sackett D. L., 1997, EVIDENCE BASED MED P; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SCHIRMER BD, 1993, AM J SURG, V165, P670, DOI 10.1016/S0002-9610(05)80785-8; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shapiro C L, 1994, J Natl Cancer Inst Monogr, P101; SOLEZ K, 1988, TRANSPLANT P, V20, P618; Speroff L, 1996, JAMA-J AM MED ASSOC, V276, P1397, DOI 10.1001/jama.276.17.1397; TANGKANAKUL C, 1999, COCHRANE LIB, V2; TEASDALE TA, 1983, J AM GERIATR SOC, V31, P529, DOI 10.1111/j.1532-5415.1983.tb02196.x; TORNAMBE PE, 1989, OPHTHALMOLOGY, V96, P772; VALLINA VL, 1993, ANN SURG, V218, P685, DOI 10.1097/00000658-199321850-00016; VANDEKERCKHOVE P, 1999, COCHRANE LIB, V2; WATSON A, 1999, COCHRANE LIB, V2; Wimalawansa SJ, 1998, AM J MED, V104, P219, DOI 10.1016/S0002-9343(98)00029-1; YAMAMOTO H, 1992, MAYO CLIN PROC, V67, P228, DOI 10.1016/S0025-6196(12)60097-4	79	1626	1668	0	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1878	1886		10.1056/NEJM200006223422506	http://dx.doi.org/10.1056/NEJM200006223422506			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861324	Bronze			2022-12-28	WOS:000087704700006
J	Lobo, RA; Carmina, E				Lobo, RA; Carmina, E			The importance of diagnosing the polycystic ovary syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DEPENDENT DIABETES-MELLITUS; CORONARY-ARTERY DISEASE; INSULIN-RESISTANCE; OBESE WOMEN; COMMON ENDOCRINOPATHY; LUTEINIZING-HORMONE; BLOOD-PRESSURE; NORMAL MENSES; RISK-FACTORS; HYPERANDROGENISM	The polycystic ovary syndrome (PCOS) is an extremely common disorder that occurs in 4% to 7% of women of reproductive age. Although PCOS is known to be associated with reproductive morbidity and increased risk for endometrial cancer, diagnosis is especially important because PCOS is now thought to increase metabolic and cardiovascular risks. These risks are strongly linked to insulin resistance and are compounded by the common occurrence of obesity, although insulin resistance and its associated risks are also present in nonobese women with PCOS. Women with PCOS are at increased risk for impaired glucose tolerance, type 2 diabetes mellitus, and hypertension. Cardiovascular disease is believed to be more prevalent in women with PCOS, and it has been estimated that such women also have a significantly increased risk for myocardial infarction. Many lipid abnormalities (most notably low high-density lipoprotein cholesterol levels and elevated triglyceride levels) and impaired fibrinolysis are seen in women with PCOS. Early diagnosis of the syndrome and close long-term follow-up and screening for diabetes and cardiovascular disease are warranted. An opportunity exists for preventive therapy, which should improve the reproductive, metabolic, and cardiovascular risks.	Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA	Columbia University	Lobo, RA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, 630 W 168th St, New York, NY 10032 USA.	ral35@columbia.edu						ACHARD C, 1932, B ACAD NATL MED, V86, P51; ANDERSEN P, 1995, METABOLISM, V44, P611, DOI 10.1016/0026-0495(95)90118-3; BARBIERI RL, 1983, AM J OBSTET GYNECOL, V147, P90, DOI 10.1016/0002-9378(83)90091-1; BARNES RB, 1989, NEW ENGL J MED, V320, P559, DOI 10.1056/NEJM198903023200904; Birdsall MA, 1997, ANN INTERN MED, V126, P32, DOI 10.7326/0003-4819-126-1-199701010-00005; BURGHEN GA, 1980, J CLIN ENDOCR METAB, V50, P113, DOI 10.1210/jcem-50-1-113; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; Carmina E, 1999, FERTIL STERIL, V71, P319, DOI 10.1016/S0015-0282(98)00455-5; Carmina E, 1999, J CLIN ENDOCR METAB, V84, P1897, DOI 10.1210/jc.84.6.1897; Chang CA, 1997, INT J IND ENG-APPL P, V4, P5; CHANG RJ, 1983, J CLIN ENDOCR METAB, V57, P356, DOI 10.1210/jcem-57-2-356; CONWAY GS, 1992, CLIN ENDOCRINOL, V37, P119, DOI 10.1111/j.1365-2265.1992.tb02295.x; DA Zawadski JK., 1992, POLYCYSTIC OVARY SYN, P377; DAHLGREN E, 1992, ACTA OBSTET GYN SCAN, V71, P599, DOI 10.3109/00016349209006227; DAHLGREN E, 1992, FERTIL STERIL, V57, P505; DUNAIF A, 1995, AM J MED, V98, pS33, DOI 10.1016/S0002-9343(99)80057-6; DUNAIF A, 1995, J CLIN INVEST, V96, P801, DOI 10.1172/JCI118126; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P3299, DOI 10.1210/jc.81.9.3299; Ehrmann DA, 1997, J CLIN ENDOCR METAB, V82, P2108, DOI 10.1210/jc.82.7.2108; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Ek I, 1997, J CLIN ENDOCR METAB, V82, P1147, DOI 10.1210/jc.82.4.1147; FRANKS S, 1992, POLYCYSTIC OVARY SYN, P19; GADIR AA, 1992, HUM REPROD, V7, P453, DOI 10.1093/oxfordjournals.humrep.a137668; GOLDZIEHER JW, 1963, FERTIL STERIL, V14, P631; Govind A, 1999, J CLIN ENDOCR METAB, V84, P38, DOI 10.1210/jc.84.1.38; Guzick DS, 1996, AM J OBSTET GYNECOL, V174, P1224, DOI 10.1016/S0002-9378(96)70665-8; JACKSON RL, 1957, AM J OBSTET GYNECOL, V73, P161, DOI 10.1016/S0002-9378(16)37277-5; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Legro RS, 1999, FERTIL STERIL, V72, P990, DOI 10.1016/S0015-0282(99)00401-X; Lobo RA, 1996, FERTIL STERIL, V65, P1100, DOI 10.1016/S0015-0282(16)58321-6; LOBO RA, 1983, J CLIN ENDOCR METAB, V57, P393, DOI 10.1210/jcem-57-2-393; LOBO RA, 1983, FERTIL STERIL, V39, P674; LOBO RA, 1996, POLYCYSTIC OVARY SYN, P334; Lobo RA, 1997, MISHELLS TXB INFERTI, P363; Mather KJ, 2000, FERTIL STERIL, V73, P150, DOI 10.1016/S0015-0282(99)00468-9; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; Nestler JE, 1998, FERTIL STERIL, V70, P811; Nestler JE, 1999, NEW ENGL J MED, V340, P1314, DOI 10.1056/NEJM199904293401703; POLSON DW, 1988, LANCET, V1, P870; REBAR R, 1976, J CLIN INVEST, V57, P1320, DOI 10.1172/JCI108400; Robinson S, 1996, CLIN ENDOCRINOL, V44, P277, DOI 10.1046/j.1365-2265.1996.674495.x; Sampson M, 1996, CLIN ENDOCRINOL, V45, P623, DOI 10.1046/j.1365-2265.1996.00863.x; SHOUPE D, 1983, AM J OBSTET GYNECOL, V147, P588, DOI 10.1016/0002-9378(83)90023-6; Sobel Burton E., 1999, Thrombosis and Haemostasis, V82, P8; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; TALBOTT E, 1995, ARTERIOSCL THROM VAS, V15, P821, DOI 10.1161/01.ATV.15.7.821; VELAZQUEZ EM, 1994, METABOLISM, V43, P647, DOI 10.1016/0026-0495(94)90209-7; WILD RA, 1992, AM J OBSTET GYNECOL, V166, P1191, DOI 10.1016/S0002-9378(11)90605-X; WONG IL, 1995, HUM REPROD, V10, P524, DOI 10.1093/oxfordjournals.humrep.a135982	52	202	221	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					989	993		10.7326/0003-4819-132-12-200006200-00010	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858183				2022-12-28	WOS:000087670800009
J	Boutros, M; Mihaly, J; Bouwmeester, T; Mlodzik, M				Boutros, M; Mihaly, J; Bouwmeester, T; Mlodzik, M			Signaling specificity by frizzled receptors in Drosophila	SCIENCE			English	Article							PLANAR POLARITY; TISSUE POLARITY; CELL FATES; WINGLESS; WNT; PATHWAYS; EXPRESSION; ACTIVATION; XENOPUS; PROTEIN	Wnt-Frizzled (Fz) signaling pathways play recurring important roles during the development and homeostasis of vertebrates and invertebrates. Fz receptors can signal through beta-catenin-dependent and -independent pathways. In Drosophila, Fr and Fz2 are redundant receptors for Wg. In addition, Fz conveys signals through a distinct pathway to organize planar polarization of epithelial structures. We demonstrate that the cytoplasmic sequences of Fz2 and Fz preferentially activate the beta-catenin and planar polarity cascade, respectively. Both receptors activate either pathway, but with different efficiencies. Intrinsic differences in signaling efficiency in closely related receptors might be a general mechanism for generating signaling specificity in vivo.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mlodzik, M (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	mlodzik@embl-heidelberg.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Mihaly, Jozsef/0000-0003-3399-2424				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BOUTROS M, UNPUB RESULTS; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Fagotto F, 1997, DEVELOPMENT, V124, P453; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Muller HAJ, 1999, DEVELOPMENT, V126, P577; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; Sato A, 1999, DEVELOPMENT, V126, P4421; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Zhang J, 1998, DEVELOPMENT, V125, P3075	31	100	102	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1825	1828		10.1126/science.288.5472.1825	http://dx.doi.org/10.1126/science.288.5472.1825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846164				2022-12-28	WOS:000087503800050
J	Adzick, NS; Nance, ML				Adzick, NS; Nance, ML			Medical progress: Pediatric surgery (second of two parts).	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NATIONAL WILMS-TUMOR; HERNIA IN-UTERO; NONOPERATIVE MANAGEMENT; INTESTINAL TRANSPLANTATION; LIVER-TRANSPLANTATION; FETAL SURGERY; SPLENIC INJURY; SPINA-BIFIDA; HEAD-INJURY; CHILDREN		Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Adzick, NS (corresponding author), Childrens Hosp Philadelphia, Dept Surg, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.							Adzick NS, 1998, LANCET, V352, P1675, DOI 10.1016/S0140-6736(98)00070-1; Adzick NS, 1997, LANCET, V349, P538, DOI 10.1016/S0140-6736(97)80088-8; Adzick NS, 1998, AM J OBSTET GYNECOL, V179, P884, DOI 10.1016/S0002-9378(98)70183-8; ADZICK NS, 1994, CURR PROB SURG, V31, P6; [Anonymous], 1999, Pediatrics, V103, P1061; Bond SJ, 1996, ANN SURG, V223, P286, DOI 10.1097/00000658-199603000-00009; Bruner JP, 1999, JAMA-J AM MED ASSOC, V282, P1819, DOI 10.1001/jama.282.19.1819; Bueno J, 1999, J PEDIATR SURG, V34, P27, DOI 10.1016/S0022-3468(99)90223-3; Busuttil RW, 1999, ANN SURG, V229, P313, DOI 10.1097/00000658-199903000-00003; Chavers BM, 1997, PEDIATR NEPHROL, V11, P399, DOI 10.1007/s004670050304; *COMM TRAUM AM COL, 1998, RES OPT CAR INJ PAT; COPP AJ, 1993, TRENDS NEUROSCI, V16, P381, DOI 10.1016/0166-2236(93)90001-3; Davis I D, 1998, Pediatr Transplant, V2, P117; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; EIN SH, 1978, J PEDIATR SURG, V13, P117, DOI 10.1016/S0022-3468(78)80001-3; Flake A W, 1996, Semin Pediatr Surg, V5, P266; Freedman AL, 1999, LANCET, V354, P374, DOI 10.1016/S0140-6736(98)11006-1; Fujimoto Y, 1998, TRANSPLANT P, V30, P3441, DOI 10.1016/S0041-1345(98)01093-8; Gandhi RR, 1999, J PEDIATR SURG, V34, P55, DOI 10.1016/S0022-3468(99)90228-2; Goss JA, 1998, ANN SURG, V228, P411, DOI 10.1097/00000658-199809000-00014; Graf JL, 1998, J PEDIATR SURG, V33, P177, DOI 10.1016/S0022-3468(98)90427-4; Grant D, 1996, LANCET, V347, P1801, DOI 10.1016/S0140-6736(96)91619-0; Green DM, 1998, J CLIN ONCOL, V16, P237, DOI 10.1200/JCO.1998.16.1.237; Haase GM, 1999, SEMIN SURG ONCOL, V16, P91, DOI 10.1002/(SICI)1098-2388(199903)16:2<91::AID-SSU3>3.0.CO;2-1; Harrison MR, 1997, J PEDIATR SURG, V32, P1637, DOI 10.1016/S0022-3468(97)90472-3; Harrison MR, 1998, J PEDIATR SURG, V33, P1017, DOI 10.1016/S0022-3468(98)90524-3; Horwitz JR, 1996, J PEDIATR SURG, V31, P1020, DOI 10.1016/S0022-3468(96)90077-9; JOHNSON MP, 1994, AM J OBSTET GYNECOL, V170, P1770; JOHNSTON C, 1994, PEDIATRICS, V93, P960; Keller MS, 1997, J TRAUMA, V42, P1097, DOI 10.1097/00005373-199706000-00019; Keller MS, 1996, J TRAUMA, V41, P471, DOI 10.1097/00005373-199609000-00014; Kumar R, 1998, J UROLOGY, V160, P1450, DOI 10.1016/S0022-5347(01)62588-6; Liechty KW, 1997, AM J OBSTET GYNECOL, V177, P870, DOI 10.1016/S0002-9378(97)70285-0; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; MEULI M, 1995, NAT MED, V1, P342, DOI 10.1038/nm0495-342; Nance ML, 1997, J PEDIATR SURG, V32, P949, DOI 10.1016/S0022-3468(97)90375-4; Quinn TM, 1998, J PEDIATR SURG, V33, P553, DOI 10.1016/S0022-3468(98)90315-3; Reyes J, 1998, J PEDIATR SURG, V33, P243, DOI 10.1016/S0022-3468(98)90440-7; Salvatierra O, 1997, ARCH SURG-CHICAGO, V132, P842; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; Shamberger RC, 1999, ANN SURG, V229, P292, DOI 10.1097/00000658-199902000-00019; Shilyansky J, 1998, J PEDIATR SURG, V33, P343, DOI 10.1016/S0022-3468(98)90459-6; Sindhi R, 1999, J PEDIATR SURG, V34, P107, DOI 10.1016/S0022-3468(99)90238-5; Skinner M A, 1997, Semin Pediatr Surg, V6, P134; Smith GA, 1997, PEDIATRICS, V100, P825, DOI 10.1542/peds.100.5.825; SPENCE LJ, 1993, J PEDIATR SURG, V28, P214, DOI 10.1016/S0022-3468(05)80278-7; Sutton LN, 1999, JAMA-J AM MED ASSOC, V282, P1826, DOI 10.1001/jama.282.19.1826; TEJANI AH, 1998, CLIN TRANS, P87; Vacanti JP, 1999, LANCET, V354, pSI32; VILLE Y, 1995, NEW ENGL J MED, V332, P224, DOI 10.1056/NEJM199501263320404; Yang E Y, 1998, Semin Laparosc Surg, V5, P31; 1995, JAMA, V274, P1752	52	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1726	1732		10.1056/NEJM200006083422307	http://dx.doi.org/10.1056/NEJM200006083422307			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841876				2022-12-28	WOS:000087449300007
J	Lerner, BH				Lerner, BH			The illness and death of Eva Peron: cancer, politics, and secrecy	LANCET			English	Review									Columbia Univ Coll Phys & Surg, Ctr Study Soc & Med, New York, NY 10032 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Study Soc & Med, 630 W 168th St, New York, NY 10032 USA.							ALTMAN LK, 1993, NY TIMES        0117, P26; ANNAS GJ, 1995, NEW ENGL J MED, V333, P945, DOI 10.1056/NEJM199510053331420; *ARG LEAG FIGHT CA, 1950, EARL DET CERV CANC P; BLOOM M, 1980, SCIENCE, V207, P282, DOI 10.1126/science.6985748; BRESLOW L, 1979, DHEW PUBL; BRUNO MF, 1991, HIST ONCOLOGIA CLIN; BUNKER E, 1952, COMMUNICATION   0219; BUNKER E, 1952, COMMUNICATION   0103; CANONICO A N, 1951, Dia Med, V23, P3081; CANONICO AN, 1991, NACION          0322, P7; CHILDE CP, 1997, CONTROL SCOURGE; Crassweller R. D., 1987, PERON ENIGMAS ARGENT; Crispell KR, 1988, HIDDEN ILLNESS WHITE; DIPAOLA G, 1958, ANN REPORT RESULTS T; Fraser, 1980, EVA PERON; HUNIS AP, 1999, BREVE HIST QUIMOTERA; Klimovsky E, 1996, Bull Pan Am Health Organ, V30, P313; KUCHARSKI A, 1978, PERSPECT BIOL MED, V22, P115; Lederer Susan E, 1999, AM ETHICS REVOLUTION, P91; MEIGS JV, 1956, AM J OBSTET GYNECOL, V72, P467, DOI 10.1016/0002-9378(56)90368-4; MILLER EG, 1951, COMMUNIATION    1129; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002; PACK GT, 1952, COMMUNICATION   0114; Patterson James T., 1987, DREAD DIS CANC MODER; Post Jerrold M., 1993, ILLNESS STRIKES LEAD; Shawcross William, 1988, SHAHS LAST RIDE; STANDARD D, 1955, SHOULD PATIENT KNOW; TREZANO G, 1947, B SOC OBSTET GYNECOL, V26, P206; VICTORIA MID, 1997, B NY ACAD SCI, V809, P152; 1951, NEWSWEEK        1029, P44	30	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1988	1991		10.1016/S0140-6736(00)02337-0	http://dx.doi.org/10.1016/S0140-6736(00)02337-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859055				2022-12-28	WOS:000087381900038
J	Devlin, PF; Kay, SA				Devlin, PF; Kay, SA			Plant biology - Flower arranging in Arabidopsis	SCIENCE			English	Article									Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Natl Sci Fdn Biol Timing, La Jolla, CA 92037 USA	Scripps Research Institute; National Science Foundation (NSF); Scripps Research Institute	Devlin, PF (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Devlin, Paul/0000-0002-0168-3793				Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Chandler J, 1996, PLANT J, V10, P637, DOI 10.1046/j.1365-313X.1996.10040637.x; Napp-Zinn K., 1987, Manipulation of flowering, P123; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Smith Harry, 1994, P377; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Thomas B., 1997, PHOTOPERIODISM PLANT; YANOFSKY MF, 1995, ANNU REV PLANT PHYS, V46, P167, DOI 10.1146/annurev.pp.46.060195.001123	10	14	16	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1600	1602		10.1126/science.288.5471.1600	http://dx.doi.org/10.1126/science.288.5471.1600			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10858139				2022-12-28	WOS:000087382300029
J	Boyington, JC; Motyka, SA; Schuck, P; Brooks, AG; Sun, PD				Boyington, JC; Motyka, SA; Schuck, P; Brooks, AG; Sun, PD			Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand	NATURE			English	Article							NATURAL-KILLER-CELLS; LEUKOCYTE ANTIGEN (HLA)-CW4; HLA-C MOLECULES; INHIBITORY RECEPTOR; MEDIATED LYSIS; DIRECT BINDING; AMINO-ACID; PEPTIDE; RECOGNITION; SELECTIVITY	Target cell lysis is regulated by natural killer (NK) cell receptors that recognize class I MHC molecules, Here we report the crystal structure of the human immunoglobulin-like NK cell receptor KIR2DL2 in complex with its class I ligand HLA-Cw3 and peptide. KIR binds in a nearly orthogonal orientation across the alpha 1 and alpha 2 helices of Cw3 and directly contacts positions 7 acid 8 of the peptide. No significant conformational changes in KIR occur on complex formation. The receptor footprint on HCB overlaps with but is distinct from that of the T-cell receptor. Charge complementarity dominates the KIR/HLA interface and mutations that disrupt interface salt bridges substantially diminish binding. Most contacts in the complex are between hip and conserved HLA-C residues. but a hydrogen band between Lys 44 of KIR2DL2 and Asn 80 of Cw3 confers the allotype specificity. KIR contact requires position 8 of the peptide to be a residue smaller than valine, A second KIR/HLA interface produced an ordered receptor-ligand aggregation in the crystal which may resemble receptor clustering during immune synapse formation.	NIAAA, Struct Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Program, Bethesda, MD 20205 USA; NIH, Bioengn & Phys Sci Program, Bethesda, MD 20892 USA; Univ Melbourne, Dept Immunol & Microbiol, Parkville, Vic 3052, Australia	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Johns Hopkins University; National Institutes of Health (NIH) - USA; University of Melbourne	Sun, PD (corresponding author), NIAAA, Struct Biol Sect, Immunogenet Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@nih.gov	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Brooks, Andrew/0000-0002-4085-9683	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000697, Z01AI000697] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [Z01OD010485] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Biassoni R, 1997, EUR J IMMUNOL, V27, P3095, DOI 10.1002/eji.1830271203; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *COLL COMP PROJ 4, 1995, ACTA CRYSTALLOGR D, V50, P760; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; FALK K, 1993, P NATL ACAD SCI USA, V90, P12005, DOI 10.1073/pnas.90.24.12005; Fan QR, 1999, J EXP MED, V190, P113, DOI 10.1084/jem.190.1.113; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LITTAUA RA, 1991, J VIROL, V65, P4051, DOI 10.1128/JVI.65.8.4051-4056.1991; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Mandelboim O, 1997, IMMUNITY, V6, P341, DOI 10.1016/S1074-7613(00)80336-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Orihuela M, 1996, P NATL ACAD SCI USA, V93, P11792, DOI 10.1073/pnas.93.21.11792; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pende D, 1998, EUR J IMMUNOL, V28, P2384, DOI 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; RAJAGOPALAN S, 1995, J IMMUNOL, V155, P4143; Rojo S, 1997, EUR J IMMUNOL, V27, P568, DOI 10.1002/eji.1830270231; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vales-Gomez M, 1998, P NATL ACAD SCI USA, V95, P14326, DOI 10.1073/pnas.95.24.14326; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Winter CC, 1997, J IMMUNOL, V158, P4026; Winter CC, 1998, J IMMUNOL, V161, P571; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412; Zappacosta F, 1997, P NATL ACAD SCI USA, V94, P6313, DOI 10.1073/pnas.94.12.6313	43	320	336	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					537	543		10.1038/35014520	http://dx.doi.org/10.1038/35014520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850706				2022-12-28	WOS:000087449500041
J	Blanco, A; Chomski, E; Grabtchak, S; Ibisate, M; John, S; Leonard, SW; Lopez, C; Meseguer, F; Miguez, H; Mondia, JP; Ozin, GA; Toader, O; van Driel, HM				Blanco, A; Chomski, E; Grabtchak, S; Ibisate, M; John, S; Leonard, SW; Lopez, C; Meseguer, F; Miguez, H; Mondia, JP; Ozin, GA; Toader, O; van Driel, HM			Large-scale synthesis of a silicon photonic crystal with a complete three-dimensional bandgap near 1.5 micrometres	NATURE			English	Article							SELF-ORGANIZING SYSTEMS; OPTICAL WAVELENGTHS; DISORDERED MEDIUM; LOCALIZATION; LIGHT; GAP; EXISTENCE; CLUSTERS; SPHERES; LIQUID	Photonic technology, using light instead of electrons as the information carrier, is increasingly replacing electronics in communication and information management systems. Microscopic light manipulation, for this purpose, is achievable through photonic bandgap materials(1,2), a special class of photonic crystals in which three-dimensional, periodic dielectric constant variations controllably prohibit electromagnetic propagation throughout a specified frequency band. This can result in the localization of photons(3-6), thus providing a mechanism for controlling and inhibiting spontaneous light emission that can be exploited for photonic device fabrication. In fact, carefully engineered line defects could act as waveguides connecting photonic devices in all-optical microchips(7), and infiltration of the photonic material with suitable liquid crystals might produce photonic bandgap structures (and hence light-flow patterns) fully tunable by an externally applied voltage(8-10). However, the realization of this technology requires a strategy for the efficient synthesis of high-quality, large-scale photonic crystals with photonic bandgaps at micrometre and sub-micrometre wavelengths, and with rationally designed line and point defects for optical circuitry. Here we describe single crystals of silicon inverse opal with a complete three-dimensional photonic bandgap centred on 1.46 mu m, produced by growing silicon inside the voids of an opal template of close-packed silica spheres that are connected by small 'necks' formed during sintering, followed by removal of the silica template. The synthesis method is simple and inexpensive, yielding photonic crystals of pure silicon that are easily integrated with existing silicon-based microelectronics.	Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; Univ Politecn Valencia, CSIC, Unidad Asociada, Valencia 46022, Spain; CSIC, Inst Ciencia Mat Madrid, Madrid, Spain; Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada	University of Toronto; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); University of Toronto	John, S (corresponding author), Univ Toronto, Dept Phys, 60 St George St, Toronto, ON M5S 1A7, Canada.	john@physics.utoronto.ca	MESEGUER, FRANCISCO J/M-4512-2014; Miguez, Hernan/B-8881-2011; Blanco, Alvaro/B-2074-2010; Lopez, Cefe/B-2397-2010; López, Cefe/GXM-7004-2022; van Driel, Henry M/A-4263-2008	MESEGUER, FRANCISCO J/0000-0002-5541-9912; Miguez, Hernan/0000-0003-2925-6360; Blanco, Alvaro/0000-0002-0015-4873; Lopez, Cefe/0000-0001-5635-4463; López, Cefe/0000-0001-5635-4463; 				ANDERSON PW, 1985, PHILOS MAG B, V52, P505, DOI 10.1080/13642818508240619; ASHCROFT NW, 1976, SOLID STATE PHYS, P161; Bogomolov VN, 1998, TECH PHYS LETT+, V24, P326, DOI 10.1134/1.1262099; Braun PV, 1999, NATURE, V402, P603, DOI 10.1038/45137; Busch K, 1999, PHYS REV LETT, V83, P967, DOI 10.1103/PhysRevLett.83.967; Busch K, 1998, PHYS REV E, V58, P3896, DOI 10.1103/PhysRevE.58.3896; Chomski E, 1996, CHEM VAPOR DEPOS, V2, P8, DOI 10.1002/cvde.19960020103; Dag O, 1999, ADV MATER, V11, P474, DOI 10.1002/(SICI)1521-4095(199904)11:6<474::AID-ADMA474>3.0.CO;2-I; HO KM, 1990, PHYS REV LETT, V65, P3152, DOI 10.1103/PhysRevLett.65.3152; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Joannopoulos JD, 1997, NATURE, V386, P143, DOI 10.1038/386143a0; John S, 1999, J LIGHTWAVE TECHNOL, V17, P1931, DOI 10.1109/50.802976; JOHN S, 1991, PHYS TODAY, V44, P32, DOI 10.1063/1.881300; JOHN S, 1984, PHYS REV LETT, V53, P2169, DOI 10.1103/PhysRevLett.53.2169; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Leonard SW, 2000, PHYS REV B, V61, pR2389, DOI 10.1103/PhysRevB.61.R2389; Lin SY, 1999, J LIGHTWAVE TECHNOL, V17, P1944, DOI 10.1109/50.802977; Miguez H, 1998, ADV MATER, V10, P480, DOI 10.1002/(SICI)1521-4095(199804)10:6<480::AID-ADMA480>3.0.CO;2-Y; Miguez H, 1997, APPL PHYS LETT, V71, P1148, DOI 10.1063/1.119849; Noda S, 1999, J LIGHTWAVE TECHNOL, V17, P1948, DOI 10.1109/50.802979; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Vlasov YA, 1997, PHYS REV B, V55, P13357, DOI 10.1103/PhysRevB.55.R13357; Vlasov YA, 1999, ADV MATER, V11, P165, DOI 10.1002/(SICI)1521-4095(199902)11:2<165::AID-ADMA165>3.0.CO;2-3; Wiersma DS, 1997, NATURE, V390, P671, DOI 10.1038/37757; Wijnhoven JEGJ, 1998, SCIENCE, V281, P802, DOI 10.1126/science.281.5378.802; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yablonovitch E, 1999, NATURE, V401, P539, DOI 10.1038/44038; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Zakhidov AA, 1998, SCIENCE, V282, P897, DOI 10.1126/science.282.5390.897	29	1432	1501	17	659	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					437	440		10.1038/35013024	http://dx.doi.org/10.1038/35013024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839534				2022-12-28	WOS:000087212000042
J	Hyde, WT; Crowley, TJ; Baum, SK; Peltier, WR				Hyde, WT; Crowley, TJ; Baum, SK; Peltier, WR			Neoproterozoic 'snowball Earth' simulations with a coupled climate/ice-sheet model	NATURE			English	Article							GENERAL-CIRCULATION MODEL; ICE-AGE; SNOWLINE INSTABILITY; SEA-LEVEL; GLACIATION; RECORD; GEOGRAPHY; TECTONICS; PARADOX; HISTORY	Ice sheets may have reached the Equator in the late Proterozoic era (600-800 Myr ago), according to geological and palaeomagnetic studies, possibly resulting in a 'snowball Earth'. But this period was a critical time in the evolution of multicellular animals, posing the question of how early life survived under such environmental stress. Here we present computer simulations of this unusual climate stage with a coupled climate/ice-sheet model. To simulate a snowball Earth, we use only a reduction in the solar constant compared to present-day conditions and we keep atmospheric CO2 concentrations near present levels. We rnd rapid transitions into and out of full glaciation that are consistent with the geological evidence. When we combine these results with a general circulation model, some of the simulations result in an equatorial belt of open water that may have provided a refugium for multicellular animals.	Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	Texas A&M University System; Texas A&M University College Station; University of Toronto	Hyde, WT (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	hyde@rossby.tamu.edu	Peltier, William R./A-1102-2008					[Anonymous], 1959, J GLACIOL, DOI DOI 10.3189/S002214300001724X; BAUM SK, 1991, GEOPHYS RES LETT, V18, P1719, DOI 10.1029/91GL01723; BAUM SK, UNPUB J GEOPHYS RES; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; BOND GC, 1984, EARTH PLANET SC LETT, V70, P325, DOI 10.1016/0012-821X(84)90017-7; BREYER JA, 1995, GEOLOGY, V23, P269, DOI 10.1130/0091-7613(1995)023<0269:PNEFTO>2.3.CO;2; Christie-Blick N., 1997, GEOLOGICAL SOC AM FI, V42, P1; CHRISTIEBLICK N, 1982, ICARUS, V50, P423, DOI 10.1016/0019-1035(82)90133-6; CROWLEY TJ, 1993, J GEOPHYS RES-ATMOS, V98, P16723, DOI 10.1029/93JD01415; CROWLEY TJ, 1994, CLIM DYNAM, V10, P363, DOI 10.1007/BF00219476; CROWLEY TJ, 1993, GEOPHYS RES LETT, V20, P1175, DOI 10.1029/93GL01119; CROWLEY TJ, 1999, J GEOPHYS RES-ATMOSP, V5, P619; Dalziel IWD, 1997, GEOL SOC AM BULL, V109, P16, DOI 10.1130/0016-7606(1997)109<0016:ONPGAT>2.3.CO;2; DEBLONDE G, 1991, J GEOPHYS RES-ATMOS, V96, P9189, DOI 10.1029/90JD02606; DEBLONDE G, 1992, GLOBAL PLANET CHANGE, V98, P37, DOI 10.1016/0921-8181(92)90021-2; EYLES N, 1993, EARTH-SCI REV, V35, P1, DOI 10.1016/0012-8252(93)90002-O; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; HAMBREY MJ, 1985, PALAEOGEOGR PALAEOCL, V51, P255, DOI 10.1016/0031-0182(85)90088-4; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOFFMAN PF, 1991, SCIENCE, V252, P1409, DOI 10.1126/science.252.5011.1409; Huybrechts P., 1995, ANN GLACIOL, V21, P111, DOI 10013/epic.12062.d001; Hyde WT, 1989, J CLIMATE, V2, P864, DOI 10.1175/1520-0442(1989)002<0864:COGAEB>2.0.CO;2; HYDE WT, 1990, J GEOPHYS RES-ATMOS, V95, P18653, DOI 10.1029/JD095iD11p18653; Hyde WT, 1999, CLIM DYNAM, V15, P619, DOI 10.1007/s003820050305; Jenkins GS, 1998, GEOPHYS RES LETT, V25, P3525, DOI 10.1029/98GL52588; Jenkins GS, 1999, GEOPHYS RES LETT, V26, P2263, DOI 10.1029/1999GL900538; JENKINS GS, 1993, J GEOPHYS RES-ATMOS, V98, P20803, DOI 10.1029/93JD02056; KAUFMAN AJ, 1993, EARTH PLANET SC LETT, V120, P409, DOI 10.1016/0012-821X(93)90254-7; Kaufman AJ, 1997, P NATL ACAD SCI USA, V94, P6600, DOI 10.1073/pnas.94.13.6600; Kennedy MJ, 1998, GEOLOGY, V26, P1059, DOI 10.1130/0091-7613(1998)026<1059:TOFNG>2.3.CO;2; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; KNOLL AH, 1992, NATURE, V356, P673, DOI 10.1038/356673a0; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; McNamara KJ, 1996, SCIENCE, V274, P1995; NORTH GR, 1975, J ATMOS SCI, V32, P1301, DOI 10.1175/1520-0469(1975)032<1301:ASTASC>2.0.CO;2; NORTH GR, 1975, J ATMOS SCI, V41, P3990; Oglesby R. J., 1998, PALEOCLIMATES DATA M, V2, P293; PATESON WSB, 1981, PHYSICS GLACIERS; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; REEH N, 1991, POLARFORSCHUNG, V0059; SCHMIDT PW, 1995, EARTH PLANET SC LETT, V134, P107, DOI 10.1016/0012-821X(95)00106-M; Scotese C. R., 1992, PALEOGEOGRAPHIC ATLA; Tarasov L, 1999, J GEOPHYS RES-ATMOS, V104, P9517, DOI 10.1029/1998JD200120; Tarasov L, 1997, J GEOPHYS RES-ATMOS, V102, P21665, DOI 10.1029/97JD01766; THOMPSON SL, 1995, J CLIMATE, V8, P732, DOI 10.1175/1520-0442(1995)008<0732:AGCMWA>2.0.CO;2; WILLIAMS GE, 1975, GEOL MAG, V112, P441, DOI 10.1017/S0016756800046185; WILLIAMS GE, 1998, CLIMATIC CHANGE, V13, P117; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	49	335	363	5	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					425	429		10.1038/35013005	http://dx.doi.org/10.1038/35013005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839531				2022-12-28	WOS:000087212000039
J	Newsome, TP; Schmidt, S; Dietzl, G; Keleman, K; Asling, B; Debant, A; Dickson, BJ				Newsome, TP; Schmidt, S; Dietzl, G; Keleman, K; Asling, B; Debant, A; Dickson, BJ			Trio combines with Dock to regulate Pak activity during photoreceptor axon pathfinding in Drosophila	CELL			English	Article							EXCHANGE FACTOR DOMAINS; RHO-FAMILY GTPASES; PROTEIN-KINASE; ADAPTER PROTEIN; CYTOSKELETAL DYNAMICS; P21-ACTIVATED KINASE; TYROSINE-PHOSPHATASE; LIM-KINASE; C-ELEGANS; IN-VIVO	Correct pathfinding by Drosophila photoreceptor axons requires recruitment of p21-activated kinase (Pak) to the membrane by the SH2-SH3 adaptor Dock. Here, we identify the guanine nucleotide exchange factor (GEF) Trio as another essential component in photoreceptor axon guidance. Regulated exchange activity of one of the two Trio GEF domains is critical for accurate pathfinding. This GEF domain activates Rac, which in turn activates Pak. Mutations in trio result in projection defects similar to those observed in both Pak and dock mutants, and trio interacts genetically with Rac, Pak, and dock. These data define a signaling pathway from Trio to Rac to Pak that links guidance receptors to the growth cone cytoskeleton. We propose that distinct signals transduced via Trio and Dock act combinatorially to activate Pak in spatially restricted domains within the growth cone, thereby controlling the direction of axon extension.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Ctr Rech Biochim Macromol, CNRS, UPR1086, F-34293 Montpellier 5, France	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Dickson, Barry/AAE-7632-2019; Newsome, Timothy P/AAB-4033-2019	Dickson, Barry/0000-0003-0715-892X; Newsome, Timothy P/0000-0002-2193-596X				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Deak P, 1997, GENETICS, V147, P1697; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harden N, 1996, MOL CELL BIOL, V16, P1896; HARDEN N, 1995, DEVELOPMENT, V121, P903; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Jin Z, 1997, J NEUROSCI, V17, P6256; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SENTI KA, 2000, IN PRESS DEVELOPMENT; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Settleman J, 1999, Prog Mol Subcell Biol, V22, P201; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	52	247	249	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					283	294		10.1016/S0092-8674(00)80838-7	http://dx.doi.org/10.1016/S0092-8674(00)80838-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847683	Bronze			2022-12-28	WOS:000086741900008
J	Salazar, AM; Warden, DL; Schwab, K; Spector, J; Braverman, S; Walter, J; Cole, R; Rosner, MM; Martin, EM; Ecklund, J; Ellenbogen, RG				Salazar, AM; Warden, DL; Schwab, K; Spector, J; Braverman, S; Walter, J; Cole, R; Rosner, MM; Martin, EM; Ecklund, J; Ellenbogen, RG		Defense Vet Head Injury Program DV	Cognitive rehabilitation for traumatic brain injury - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MILITARY MEDICAL SYSTEM; HEAD-INJURY; BENEFIT	Context Traumatic brain injury (TBI) is a principal cause of death and disability in young adults. Rehabilitation for TBI has not received the same level of scientific scrutiny for efficacy and cost-efficiency that is expected in other medical fields. Objective To evaluate the efficacy of inpatient cognitive rehabilitation for patients with TBI. Design and Setting Single-center, parallel-group, randomized trial conducted from January 1992 through February 1997 at a US military medical referral center. Patients One hundred twenty active-duty military personnel who had sustained a moderate-to-severe closed head injury, manifested by a Glasgow Coma Scale score of 13 or less, or posttraumatic amnesia lasting at least 24 hours, or focal cerebral contusion or hemorrhage on computed tomography or magnetic resonance imaging. Interventions Patients were randomly assigned to an intensive, standardized, 8-week, in-hospital cognitive rehabilitation program (n=67) or a limited home rehabilitation program with weekly telephone support from a psychiatric nurse (n=53). Main Outcome Measures Return to gainful employment and fitness for military duty at 1-year follow-up, compared by intervention group. Results At 1-year follow-up, there was no significant difference between patients who had received the intensive in-hospital cognitive rehabilitation program vs the limited home rehabilitation program in return to employment (90% vs 94%, respectively; P=.51; difference, 4% [95% confidence interval {CI}, -5% to 14%]) or fitness for duty (73% vs 66%,respectively; P=.43; difference, 7% [95% CI, -10% to 24%]). There also were no significant differences in cognitive, behavioral, or quality-of-life measures. In a post-hoc subset analysis of patients who were unconscious for more than 1 hour (n=75) following TBI, the in-hospital group had a greater return-to-duty rate (80% vs 58%; P=.05). Conclusions In this study, the overall benefit of in-hospital cognitive rehabilitation for patients with moderate-to-severe TBI was similar to that of home rehabilitation. These findings emphasize the importance of conducting randomized trials to evaluate TBI rehabilitation interventions.	Walter Reed Army Med Ctr, Def & Vet Head Injury Program, Washington, DC 20307 USA; Henry M Jackson Fdn, Def & Vet Head Injury Program, Rockville, MD USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Uniformed Services University of the Health Sciences - USA	Salazar, AM (corresponding author), Walter Reed Army Med Ctr, Def & Vet Head Injury Program, Bldg 1,Room B210, Washington, DC 20307 USA.							ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Ben-Yishay Y, 1987, J HEAD TRAUMA REHAB, V2, P35, DOI DOI 10.1097/00001199-198703000-00007; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Braverman SE, 1999, BRAIN INJURY, V13, P405; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; CHESNUT R, 1998, EVIDENCE REPORT REHA, P11; CHESNUT R, 1999, EVIDENCE REPORT REHA, P1; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; Fichera, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI [https://doi.org/10.1300/J294v12n02_03, DOI 10.1300/1294V12N02_03]; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; HAGEN C, 1982, COGNITIVE REHABILITA, P131; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; LEVIN HS, 1990, ARCH NEUROL-CHICAGO, V47, P223, DOI 10.1001/archneur.1990.00530020131027; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76, DOI DOI 10.1097/00001199-199106000-00010; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Prigatano G., 1989, TRAUMATIC BRAIN INJU, P175; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RUFF R M, 1990, Brain Injury, V4, P339, DOI 10.3109/02699059009026187; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Sohlberg M.M., 2013, INTRO COGNITIVE REHA; SOHLBERG MM, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; *US ARM, 1995, STAND MED FITN ARM R, P14; VOLPE BT, 1990, ARCH NEUROL-CHICAGO, V47, P220, DOI 10.1001/archneur.1990.00530020128026; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563	33	185	188	0	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3075	3081		10.1001/jama.283.23.3075	http://dx.doi.org/10.1001/jama.283.23.3075			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865301	Bronze			2022-12-28	WOS:000087574900031
J	Spinrad, N				Spinrad, N			New ice age, or just cold feet? Tempers boil over at a heated meeting on global cooling.	NATURE			English	Editorial Material																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					623	623		10.1038/35015184	http://dx.doi.org/10.1038/35015184			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864304	Bronze			2022-12-28	WOS:000087465800025
J	Eikelboom, JW; Anand, SS; Malmberg, K; Weitz, JI; Ginsberg, JS; Yusuf, S				Eikelboom, JW; Anand, SS; Malmberg, K; Weitz, JI; Ginsberg, JS; Yusuf, S			Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without St elevation: a meta-analysis	LANCET			English	Article							WAVE MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; ARTERY DISEASE; ANTITHROMBOTIC THERAPY; THROMBIN GENERATION; INTRAVENOUS HEPARIN; ASPIRIN USERS; COAGULATION; ISCHEMIA; TRIAL	Background In acute coronary syndrome without ST elevation, the role of unfractionated and low-molecular-weight heparin in aspirin-treated patients remains unclear, and there is conflicting evidence regarding the efficacy and safety of low-molecular-weight heparin (LMWH) relative to unfractionated heparin. We did a systematic overview of the randomised trials to assess the effect of unfractionated heparin and LMWH on death, myocardial infarction, and major bleeding. Methods Randomised trials comparing unfractionated heparin or LMWH with placebo or untreated control, or comparing unfractionated heparin with LMWH, far the short-term and long-term management of patients with acute coronary syndrome without ST elevation, were identified by electronic and manual searches and through contact with experts and industry representatives. Odds ratios for death, myocardial infarction, and major bleeding were calculated for each trial, and results for the individual trials were combined by a modification of the Mantel-Haenszel method. Findings 12 trials, involving a total of 17 157 patients, were included. The summary adds ratio (OR) for myocardial infarction or death during short-term (up to 7 days) unfractionated heparin or LMWH compared with placebo or untreated control was 0.53 (95% CI 0.38-0.73; p=0.0001) or 29 events prevented per 1000 patients treated; during shortterm LMWH compared with unfractionated heparin was 0.88 (0.69-1.12; p=0.34); and during long-term LMWH (up to 3 months) compared with placebo or untreated control was 0.98 (0.81-1.17; p=0.80). Long-term LMWH was associated with a significantly increased risk of major bleeding (OR 2.26, [95% CI 1.63-3.14], p<0.0001), which is equivalent to 12 major bleeds per 1000 patients treated. Interpretation In aspirin-treated patients with acute coronary syndrome without ST elevation, short-term unfractionated heparin or LMWH halves the risk of myocardial infarction or death. There is no convincing difference in efficacy or safety between LMWH and unfractionated heparin. Long-term LMWH has not been proven to confer benefit additional to aspirin and there is no evidence to support its use after the first 7 days.	McMaster Univ, HGH McMaster Clin, Prevent Cardiol & Therapeut Program, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; Karolinska Hosp & Inst, Dept Cardiol, Stockholm, Sweden; McMaster Univ, Hamilton Civ Hosp, Res Ctr, Hamilton, ON, Canada	McMaster University; McMaster University; Karolinska Institutet; Karolinska University Hospital; McMaster University	Yusuf, S (corresponding author), McMaster Univ, HGH McMaster Clin, Prevent Cardiol & Therapeut Program, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@fhs.csu.mcmaster.ca	ginsberg, jeffrey s/ABC-1065-2020; Weitz, Jeffrey/AAD-1929-2019; Eikelboom, John/AAG-6117-2019	Weitz, Jeffrey/0000-0002-1092-7550; Eikelboom, John/0000-0003-4126-1285				ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; BARROWCLIFFE TW, 1984, THROMB RES, V34, P125, DOI 10.1016/0049-3848(84)90069-0; Bednarkiewicz Z., 1997, Journal of the American College of Cardiology, V29, p409A; BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P30; Braunwald E, 1997, J AM COLL CARDIOL, V29, P1474; Claudio Correia L C, 1995, Arq Bras Cardiol, V65, P475; COHEN M, 1994, CIRCULATION, V89, P81, DOI 10.1161/01.CIR.89.1.81; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; COHEN M, 1993, J AM COLL CARDIOL, V22, P1338, DOI 10.1016/0735-1097(93)90540-H; COHEN M, 1994, EUR HEART J, V15, P1196, DOI 10.1093/oxfordjournals.eurheartj.a060653; COHEN M, 1990, AM J CARDIOL, V66, P1287, DOI 10.1016/0002-9149(90)91155-Y; Dolovich LR, 2000, ARCH INTERN MED, V160, P181, DOI 10.1001/archinte.160.2.181; Ernofsson M, 1998, THROMB HAEMOSTASIS, V79, P491; Fareed J, 1998, AM J CARDIOL, V82, p3L, DOI 10.1016/S0002-9149(98)00105-2; *FRAXIS STUD GROUP, 1990, EUR HEART J, V20, P1553; FURIE B, 1992, NEW ENGL J MED, V326, P800; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; GOLD HK, 1993, J AM COLL CARDIOL, V21, P1039, DOI 10.1016/0735-1097(93)90222-M; GRANGER CB, 1995, CIRCULATION, V91, P1929, DOI 10.1161/01.CIR.91.7.1929; GURFINKEL EP, 1995, J AM COLL CARDIOL, V26, P313, DOI 10.1016/0735-1097(95)80001-W; Hirsh J, 1998, CHEST, V114, p489S, DOI 10.1378/chest.114.5_Supplement.489S; HOLDRIGHT D, 1994, J AM COLL CARDIOL, V24, P39, DOI 10.1016/0735-1097(94)90539-8; Klein W, 1997, CIRCULATION, V96, P61; MOISE A, 1994, CIRCULATION, V90, P1107, DOI 10.1161/circ.90.2.8044926; OFOSU FA, 1989, BIOCHEM J, V257, P143, DOI 10.1042/bj2570143; SERNERI GGN, 1995, LANCET, V345, P1201; SURVARNA TT, 1997, INDIAN HEART J, V49, P159; THEROUX P, 1992, NEW ENGL J MED, V327, P141, DOI 10.1056/NEJM199207163270301; Theroux P, 1998, CIRCULATION, V97, P1195, DOI 10.1161/01.CIR.97.12.1195; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; THEROUX P, 1993, CIRCULATION, V88, P2045, DOI 10.1161/01.CIR.88.5.2045; Wallentin L, 1996, LANCET, V347, P561; Wallentin L, 1999, LANCET, V354, P701; WALLENTIN L, 1990, LANCET, V336, P827; WALLIS DE, 1991, AM HEART J, V122, P949, DOI 10.1016/0002-8703(91)90456-R; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Weitz JI, 1998, CHEST, V114, p715S, DOI 10.1378/chest.114.5_Supplement.715S; Yusuf S, 1998, LANCET, V352, P507, DOI 10.1016/S0140-6736(97)11162-X; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; ZWERNER PL, 1987, CIRCULATION, V76, P180	43	281	291	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1936	1942		10.1016/S0140-6736(00)02324-2	http://dx.doi.org/10.1016/S0140-6736(00)02324-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859038				2022-12-28	WOS:000087381900009
J	Li, BB; Oestreich, S; de Lange, T				Li, BB; Oestreich, S; de Lange, T			Identification of human Rap1: Implications for telomere evolution	CELL			English	Article							BINDING-PROTEIN RAP1; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME MOVEMENT; FUNCTIONAL-ANALYSIS; CATALYTIC SUBUNIT; LENGTH REGULATION; DNA; DOMAIN	It has been puzzling that mammalian telomeric proteins, including TRF1, TRF2, tankyrase, and TIN2 have no recognized orthologs in budding yeast. Here, we describe a human protein, hRap1, that is an ortholog of the yeast telomeric protein, scRap1p. hRap1 has three conserved sequence motifs in common with scRap1, is located at telomeres, and affects telomere length. However, while scRap1 binds telomeric DNA directly, hRap1 is recruited to telomeres by TRF2. Extending the comparison of telomeric proteins to fission yeast, we identify S. pombe Taz1 as a TRF ortholog, indicating that TRFs are conserved at eukaryotic telomeres. The data suggest that ancestral telomeres, like those of vertebrates, contained a TRF-like protein as well as Rap1. We propose that budding yeast preserved Rap1 at telomeres but lost the TRF component, possibly concomitant with a change in the telomeric repeat sequence.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NCI NIH HHS [CA76027] Funding Source: Medline; NIGMS NIH HHS [GM49046] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; BIANCHI A, 1999, THESIS ROCKEFELLER U; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; BRIGATI C, 1993, MOL CELL BIOL, V13, P1306, DOI 10.1128/MCB.13.2.1306; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; BROCCOLI D, 1994, EXP CELL RES, V212, P308, DOI 10.1006/excr.1994.1148; Brun C, 1997, TRENDS CELL BIOL, V7, P317, DOI 10.1016/S0962-8924(97)01092-1; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P5086, DOI 10.1128/MCB.8.12.5086; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; de Lange T, 1998, NATURE, V392, P753, DOI 10.1038/33790; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Harlow E., 1988, ANTIBODIES LAB MANUA; HENDERSON E, 1995, TELOMERES, P11; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; KOHLI J, 1994, CURR BIOL, V4, P724, DOI 10.1016/S0960-9822(00)00160-3; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1997, TRENDS BIOCHEM SCI, V22, P43, DOI 10.1016/S0968-0004(97)01008-6; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Krauskopf A, 1998, P NATL ACAD SCI USA, V95, P12486, DOI 10.1073/pnas.95.21.12486; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; LARSON GP, 1994, GENE, V150, P35, DOI 10.1016/0378-1119(94)90854-0; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lipsick JS, 1996, ONCOGENE, V13, P223; LIU C, 1994, GENETICS, V138, P1025; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; MCEACHERN MJ, 1993, MOL CELL BIOL, V13, P551, DOI 10.1128/MCB.13.1.551; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Spink KG, 2000, NUCLEIC ACIDS RES, V28, P527, DOI 10.1093/nar/28.2.527; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; WANG SS, 1990, MOL CELL BIOL, V10, P4415, DOI 10.1128/MCB.10.8.4415; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	75	456	467	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					471	483		10.1016/S0092-8674(00)80858-2	http://dx.doi.org/10.1016/S0092-8674(00)80858-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850490	Bronze			2022-12-28	WOS:000087375400005
J	Spudich, JL				Spudich, JL			Structural biology - A chloride pump at atomic resolution	SCIENCE			English	Editorial Material							BACTERIORHODOPSIN; PROTEIN; RHODOPSINS; PROTON		Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System	Spudich, JL (corresponding author), Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.							BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170; DER A, 1991, P NATL ACAD SCI USA, V88, P4751, DOI 10.1073/pnas.88.11.4751; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Kunji ERS, 2000, P NATL ACAD SCI USA, V97, P4637, DOI 10.1073/pnas.080064697; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 1999, FEBS LETT, V464, P103, DOI 10.1016/S0014-5793(99)01685-3; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; SPUDICH JL, 1994, CELL, V79, P747, DOI 10.1016/0092-8674(94)90064-7; Spudich JL, 1998, MOL MICROBIOL, V28, P1051, DOI 10.1046/j.1365-2958.1998.00859.x; SPUDICH JL, IN PRESS ANN REV CEL; Subramaniam S, 1999, CURR OPIN STRUC BIOL, V9, P462, DOI 10.1016/S0959-440X(99)80065-7; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; Zhang XN, 1999, P NATL ACAD SCI USA, V96, P857, DOI 10.1073/pnas.96.3.857	18	9	9	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2000	288	5470					1358	1359		10.1126/science.288.5470.1358	http://dx.doi.org/10.1126/science.288.5470.1358			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10847850				2022-12-28	WOS:000087270900033
J	Hark, AT; Schoenherr, CJ; Katz, DJ; Ingram, RS; Levorse, JM; Tilghman, SM				Hark, AT; Schoenherr, CJ; Katz, DJ; Ingram, RS; Levorse, JM; Tilghman, SM			CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus	NATURE			English	Article							MOUSE H19 GENE; CONTROL ELEMENT; PROTEIN CTCF; CPG ISLAND; CHROMATIN; BOUNDARIES; SEQUENCE; PROMOTER; UPSTREAM; DELETION	The Insulin-like growth factor 2 (Igf2) and H19 genes are imprinted, resulting in silencing of the maternal and paternal alleles, respectively. This event is dependent upon an imprinted-control region two kilobases upstream of H19 (refs 1, 2). On the paternal chromosome this element is methylated and required for the silencing of H19 (refs 2-4). On the maternal chromosome the region is unmethylated and required for silencing of the Igf2 gene 90 kilobases upstream(2). We have proposed that the unmethylated imprinted-control region acts as a chromatin boundary that blocks the interaction of Igf2 with enhancers that lie 3' of H19 (refs 5, 6). This enhancer-blocking activity would then be lost when the region was methylated, thereby allowing expression of Igf2 paternally. Here we show, using transgenic mice and tissue culture, that the unmethylated imprinted-control regions from mouse and human H19 exhibit enhancer-blocking activity. Furthermore, we show that CTCF, a zinc finger protein implicated in vertebrate boundary function(7), binds to several sites in the unmethylated imprinted-control region that are essential for enhancer blocking. Consistent with our model, CTCF binding is abolished by DNA methylation. This is the first example, to our knowledge, of a regulated chromatin boundary in vertebrates.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University	Tilghman, SM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.		Katz, David J/H-4555-2017	Katz, David J/0000-0002-3040-1142				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Elson DA, 1997, MOL CELL BIOL, V17, P309, DOI 10.1128/MCB.17.1.309; Feil R, 1999, TRENDS GENET, V15, P431, DOI 10.1016/S0168-9525(99)01822-3; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; HAGENBUCHLE O, 1992, NUCLEIC ACIDS RES, V20, P3555, DOI 10.1093/nar/20.14.3555; Hark AT, 1998, HUM MOL GENET, V7, P1979, DOI 10.1093/hmg/7.12.1979; Kellum R, 1998, CURR BIOL, V8, pR521, DOI 10.1016/S0960-9822(07)00337-5; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Khosla S, 1999, MOL CELL BIOL, V19, P2556; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Pfeifer K, 1996, P NATL ACAD SCI USA, V93, P13876, DOI 10.1073/pnas.93.24.13876; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Szabo PE, 1998, MOL CELL BIOL, V18, P6767, DOI 10.1128/MCB.18.11.6767; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655	28	1175	1212	0	81	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					486	489		10.1038/35013106	http://dx.doi.org/10.1038/35013106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839547				2022-12-28	WOS:000087212000055
J	Nataf, HC				Nataf, HC			Seismology - Inner core takes another turn	NATURE			English	Editorial Material									Univ Grenoble 1, CNRS, Observ Sci, F-38041 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Nataf, HC (corresponding author), Univ Grenoble 1, CNRS, Observ Sci, BP 53, F-38041 Grenoble, France.		Nataf, Henri-Claude/K-7167-2012	Nataf, Henri-Claude/0000-0001-6737-1314				JAULT D, 1988, NATURE, V333, P353, DOI 10.1038/333353a0; Poupinet G, 2000, PHYS EARTH PLANET IN, V118, P77, DOI 10.1016/S0031-9201(99)00129-6; Song XD, 1996, NATURE, V382, P221, DOI 10.1038/382221a0; Vidale JE, 2000, NATURE, V405, P445, DOI 10.1038/35013039; Vidale JE, 2000, NATURE, V404, P273, DOI 10.1038/35005059	5	1	2	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					411	412		10.1038/35013184	http://dx.doi.org/10.1038/35013184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839522				2022-12-28	WOS:000087212000029
J	Kennedy, AK; Haniford, DB; Mizuuchi, K				Kennedy, AK; Haniford, DB; Mizuuchi, K			Single active site catalysis of the successive phosphoryl transfer steps by DNA transposases: Insights from phosphorothioate stereoselectivity	CELL			English	Article							V(D)J RECOMBINATION; ESCHERICHIA-COLI; HIV-1 INTEGRASE; STRAND TRANSFER; RAG2 PROTEINS; POLYMERASE-I; TARGET SITE; RETROVIRAL INTEGRATION; TN10 TRANSPOSITION; SYNAPTIC COMPLEX	The transposase family of proteins mediate DNA transposition or retroviral DNA integration via multistep phosphoryl transfer reactions. For Tn10 and phage Mu a single active site of one transposase protomer catalyzes the successive transposition reaction steps. We examined phosphorothioate stereoselectivity at the scissile position for all four reaction steps catalyzed by the Tn10 transposase. The results suggest that the first three steps required for double-strand cutting at the transposon end proceed as a succession of pseudo-reverse reaction steps while the 3' end of the transposon remains bound to the same side of the active site. However, the mode of substrate binding to the active site changes for the cut transposon 3' end to target DNA strand joining. The phosphorothioate stereoselectivity of the corresponding steps of phage Mu transposition and HIV DNA integration matches that of Tn10 reaction, indicating a common mode of substrate-active site interactions for this class of DNA transposition reactions.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Western University (University of Western Ontario)	Mizuuchi, K (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033006, Z01DK033006] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BENDER J, 1986, CELL, V45, P801, DOI 10.1016/0092-8674(86)90555-6; BENJAMIN HW, 1989, CELL, V59, P373, DOI 10.1016/0092-8674(89)90298-5; Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; Bolland S, 1996, CELL, V84, P223, DOI 10.1016/S0092-8674(00)80977-0; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Brown P. O., 1997, P161; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BURGERS PMJ, 1979, J BIOL CHEM, V254, P6889; CHALMERS RM, 1994, J BIOL CHEM, V269, P8029; COEN ES, 1989, MOBILE DNA, P413; Craig NL, 1996, CURR TOP MICROBIOL, V204, P27; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Gerton JL, 1999, J BIOL CHEM, V274, P33480, DOI 10.1074/jbc.274.47.33480; HALLING SM, 1982, CELL, V28, P155, DOI 10.1016/0092-8674(82)90385-3; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Junop MS, 1997, EMBO J, V16, P2646, DOI 10.1093/emboj/16.10.2646; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; May EW, 1996, SCIENCE, V272, P401, DOI 10.1126/science.272.5260.401; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; Mizuuchi K, 1999, BIOCHEMISTRY-US, V38, P4640, DOI 10.1021/bi990054p; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; POLARD P, 1995, GENE DEV, V9, P2846, DOI 10.1101/gad.9.22.2846; POTTER BVL, 1983, BIOCHEMISTRY-US, V22, P1369, DOI 10.1021/bi00275a008; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Sakai J, 1997, CELL, V89, P205, DOI 10.1016/S0092-8674(00)80200-7; SAKAI J, 1995, EMBO J, V14, P4374, DOI 10.1002/j.1460-2075.1995.tb00112.x; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	40	68	70	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					295	305		10.1016/S0092-8674(00)80839-9	http://dx.doi.org/10.1016/S0092-8674(00)80839-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847684	Bronze			2022-12-28	WOS:000086741900009
J	Victora, CG; Barros, AJD; Fuchs, SC; de Francisco, A; Morris, J; Hall, AJ; Schellenberg, JRMA; Greenwood, BM; Kirkwood, BR; Arthur, P; Roos, DA; Morris, SS; Zaman, S; Jalil, F; Karlberg, JP; Hanson, LA; Ashraf, R; Black, RE; Becker, S; Yoon, P; Gray, R; Gultiano, SA; Garenne, M; Fontaine, O; Leroy, O; Beau, JP; Sene, I; Martines, JC				Victora, CG; Barros, AJD; Fuchs, SC; de Francisco, A; Morris, J; Hall, AJ; Schellenberg, JRMA; Greenwood, BM; Kirkwood, BR; Arthur, P; Roos, DA; Morris, SS; Zaman, S; Jalil, F; Karlberg, JP; Hanson, LA; Ashraf, R; Black, RE; Becker, S; Yoon, P; Gray, R; Gultiano, SA; Garenne, M; Fontaine, O; Leroy, O; Beau, JP; Sene, I; Martines, JC		WHO Collaborative Study Team Role	Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; UNDER-5 MORTALITY; DIARRHEAL; HEALTH; POLICY; BRAZIL; DETERMINANTS; TRANSMISSION; BANGLADESH; SURVIVAL	Background The debate on breastfeeding in areas of high HIV prevalence has led to the development of simulation models that attempt to assess the risks and benefits associated with breastfeeding. An essential element of these simulations is the extent to which breastfeeding protects against infant and child mortality; however, few studies are available on this topic. We did a pooled analysis of studies that assessed the effect of not breastfeeding on the risk of death due to infectious diseases. Methods Studies were identified through consultations with experts in international health, and from a MEDLINE search for 1980-98. Using meta-analytical techniques, we assessed the protective effect of breastfeeding according to the age and sex of the infant, the cause of death, and the educational status of the mother. Findings We identified eight studies, data from six of which were available (from Brazil, The Gambia, Ghana, Pakistan, the Philippines, and Senegal), These studies provided information on 1223 deaths of children under two years of age. In the African studies, virtually all babies were breastfed well into the second year of life, making it impossible to include them in the analyses of infant mortality. On the basis of the other three studies, protection provided by breastmilk declined steadily with age during infancy (pooled odds ratios: 5.8 [95% CI 3.4-9.8] for infants <2 months of age, 4.1 [2.7-6.4] for 2-3-month-olds, 2.6 [1.6-3.9] for 4-5-month-olds, 1.8 [1.2-2.8] for 6-8-month-olds, and 1.4 [0.8-2.6] for 9-11-month-olds). In the first 6 months of life, protection against diarrhoea was substantially greater (odds ratio 6.1 [4.1-9.0]) than against deaths due to acute respiratory infections (2.4 [1.6-3.5]). However, for infants aged 6-11 months, similar levels of protection were observed (1.9 [1.2-3.1] and 2.5 [1.4-4.6], respectively). For second-year deaths, the pooled odds ratios from five studies ranged between 1.6 and 2.1. Protection was highest when maternal education was low. Interpretation These results may help shape policy decisions about feeding choices in the face of the HIV epidemic. Of particular relevance is the need to account for declining levels of protection with age in infancy, the continued protection afforded during the second year of life, and the question of the safety of breastmilk substitutes in families of low socioeconomic status.	Univ Fed Pelotas, Fac Med, BR-96001970 Pelotas, RS, Brazil; Univ Fed Rio Grande Sul, BR-90046900 Porto Alegre, RS, Brazil; London Sch Hyg & Trop Med, London, England; Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; Gothenburg Univ, S-41124 Gothenburg, Sweden; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD 21218 USA	Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; University of London; London School of Hygiene & Tropical Medicine; University of Hong Kong; University of Gothenburg; Johns Hopkins University	Victora, CG (corresponding author), Univ Fed Pelotas, Fac Med, CP 464, BR-96001970 Pelotas, RS, Brazil.		Victora, Cesar G/D-4476-2013; Fuchs, Sandra C/T-2670-2019; GARENNE, Michel/A-7712-2013; Martines, Jose Carlos/ABE-4082-2020; Karlberg, Johan Petter Einar/C-4290-2009; Barros, Aluisio JD/A-7417-2008; Karlberg, Johan/AAZ-7864-2020; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; GARENNE, Michel/0000-0001-6073-7803; Barros, Aluisio JD/0000-0002-2022-8729; Victora, Cesar Gomes/0000-0002-2465-2180				AHMAD OB, 1991, J BIOSOC SCI, V23, P313, DOI 10.1017/S0021932000019374; BAUCHNER H, 1986, JAMA-J AM MED ASSOC, V256, P887, DOI 10.1001/jama.256.7.887; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; CUNNINGHAM AS, 1991, J PEDIATR-US, V118, P659, DOI 10.1016/S0022-3476(05)80023-X; DEFRANCISCO A, 1993, INT J EPIDEMIOL, V22, P1174, DOI 10.1093/ije/22.6.1174; DELFANTE P, 1993, J TROP MED HYG, V96, P203; FEACHEM RG, 1984, B WORLD HEALTH ORGAN, V62, P271; GARENNE M, 1986, MEASUREMENT ANAL MOR, P123; *GHANA VAST STUD T, 1992, LANCET, V342, P7; GOLDBERG HI, 1984, POP STUD-J DEMOG, V38, P105, DOI 10.2307/2174357; GRAY RH, 1990, USE VERBAL AUTOPSY M; HABICHT JP, 1988, PEDIATRICS, V81, P456; HABICHT JP, 1986, AM J EPIDEMIOL, V123, P279, DOI 10.1093/oxfordjournals.aje.a114236; HANSON LA, 1994, ACTA PAEDIATR, V83, P3, DOI 10.1111/j.1651-2227.1994.tb12942.x; HEMAN SJ, 1990, AM J PUBLIC HEALTH, V80, P1305; HU DJ, 1992, AIDS, V6, P1505, DOI 10.1097/00002030-199212000-00014; JANOWITZ B, 1981, J BIOSOC SCI, V13, P287, DOI 10.1017/S0021932000013493; JASON JM, 1984, PEDIATRICS, V74, P702; Jelliffe D. B., 1978, HUMAN MILK MODERN WO; KALTER HD, 1990, INT J EPIDEMIOL, V19, P380, DOI 10.1093/ije/19.2.380; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; KHUN L, 1997, AM J PUBLIC HEALTH, V87, P926; KOVAR MG, 1984, PEDIATRICS, V74, P615; MAJUMDER AK, 1991, J BIOSOC SCI, V23, P297, DOI 10.1017/S0021932000019362; MOLBAK K, 1994, BMJ-BRIT MED J, V308, P1403, DOI 10.1136/bmj.308.6941.1403; MURRAY CJL, 1996, GLOBAL BURDEN DIS, V1; NARAYANAN I, 1984, LANCET, V2, P1111; NATH DC, 1994, SOC BIOL, V41, P168; Nduati R., 1998, HIV INFANT FEEDING R; NICOLL A, 1995, AIDS, V9, P107, DOI 10.1097/00002030-199509020-00001; Palloni A, 1994, Bull Pan Am Health Organ, V28, P93; PLANK SJ, 1973, B WORLD HEALTH ORGAN, V48, P203; SAULS HS, 1979, PEDIATRICS, V64, P523; SHAHIDULLAH M, 1994, J BIOSCI SCI, V26, P142; SHAMEBO D, 1994, ANN TROP PAEDIATR, V14, P201, DOI 10.1080/02724936.1994.11747718; SIMONON A, 1994, J ACQ IMMUN DEF SYND, V7, P952; TEKCE B, 1982, STUD FAMILY PLANN, V13, P315, DOI 10.2307/1965803; Victora Cesar G., 1996, Food and Nutrition Bulletin, V17, P390; VICTORA CG, 1993, J DIARRHOEAL DIS RES, V11, P25; VICTORA CG, 1987, LANCET, V2, P319; VICTORA CG, 1990, BREASTFEEDING NUTR I, P405; *WHO UNAIDS UNICEF, 1998, HIV INF FEED GUID DE; Yoon PW, 1996, AM J EPIDEMIOL, V143, P1142, DOI 10.1093/oxfordjournals.aje.a008692	44	749	779	0	81	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					451	455						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	283ZW	10841125				2022-12-28	WOS:000085306800011
J	Nishiwaki, K; Hisamoto, N; Matsumoto, K				Nishiwaki, K; Hisamoto, N; Matsumoto, K			A metalloprotease disintegrin that controls cell migration in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; AXON MIGRATIONS; NETRIN CUES; GENE; UNC-6; CLONING; PROTEIN	in Caenorhabditis elegans, the gonad acquires two U-shaped arms by the directed migration of its distal tip cells (DTCs) along the body wall basement membranes. Correct migration of DTCs requires the mig-17 gene, which encodes a member of the metalloprotease-disintegrin protein family. The MIG-17 protein is secreted from muscle cells of the body wall and Localizes in the basement membranes of gonad, This localization is dependent on the disintegrin-like domain of MIG-17 and its catalytic activity, These results suggest that the MIG-17 metalloprotease directs migration of DTCs by remodeling the basement membrane.	NEC Corp Ltd, Japan Sci & Technol Corp, PRESTO, Tsukuba, Ibaraki 3058501, Japan; NEC Corp Ltd, Fundamental Res Labs, Tsukuba, Ibaraki 3058501, Japan; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Japan Science & Technology Agency (JST); NEC Corporation; NEC Corporation; Japan Science & Technology Agency (JST); Nagoya University	Nishiwaki, K (corresponding author), NEC Corp Ltd, Japan Sci & Technol Corp, PRESTO, Tsukuba, Ibaraki 3058501, Japan.							Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P6684, DOI 10.1021/bi00187a039; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; MADURO M, 1995, GENETICS, V141, P977; Nishiwaki K, 1999, GENETICS, V152, P985; OKKEMA PG, 1993, GENETICS, V135, P385; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wolfsberg TG, 1996, DEV BIOL, V180, P389, DOI 10.1006/dbio.1996.0313	16	93	102	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2205	2208		10.1126/science.288.5474.2205	http://dx.doi.org/10.1126/science.288.5474.2205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864868				2022-12-28	WOS:000087782900056
J	Abbott, A; Markl, H				Abbott, A; Markl, H			One for all - and all for one	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					728	728		10.1038/35015775	http://dx.doi.org/10.1038/35015775			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866171	Bronze			2022-12-28	WOS:000087620600013
J	Wunsch, C				Wunsch, C			Moon, tides and climate	NATURE			English	Editorial Material							THERMOHALINE CIRCULATION; OCEAN		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wunsch, C (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	cwunsch@pond.mit.edu						[Anonymous], 1908, LANGSTON OK W AGE MA, P4; BRYDEN HL, 1991, DEEP-SEA RES, V38, P297, DOI 10.1016/0198-0149(91)90070-V; DICKEY JO, 1994, SCIENCE, V265, P482, DOI 10.1126/science.265.5171.482; Egbert GD, 2000, NATURE, V405, P775, DOI 10.1038/35015531; GREGG MC, 1987, J GEOPHYS RES-OCEANS, V92, P5249, DOI 10.1029/JC092iC05p05249; Huang RX, 1999, J PHYS OCEANOGR, V29, P727, DOI 10.1175/1520-0485(1999)029<0727:MAEOTO>2.0.CO;2; Jeffreys H., 1921, PHILOS T R SOC LONDO, V221, P239; Ledwell JR, 2000, NATURE, V403, P179, DOI 10.1038/35003164; Marotzke J, 1999, J PHYS OCEANOGR, V29, P2962, DOI 10.1175/1520-0485(1999)029<2962:CMATTC>2.0.CO;2; Marotzke J, 1997, J PHYS OCEANOGR, V27, P1713, DOI 10.1175/1520-0485(1997)027<1713:BMATDO>2.0.CO;2; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; MUNK W., 1966, DEEP SEA RES OCEANOG, V13, P707, DOI [10.1016/0011-7471(66)90602-4, DOI 10.1016/0011-7471(66)90602-4]; Munk W., 1997, OCEANOGRAPHY, V10, P132, DOI 10.5670/oceanog.1997.06; Osborn T. R., 1972, Geophysical Fluid Dynamics, V3, P321, DOI 10.1080/03091927208236085; Polzin KL, 1997, SCIENCE, V276, P93, DOI 10.1126/science.276.5309.93; Taylor GI, 1919, PHILOS T R SOC LON A, V220, P1, DOI DOI 10.1098/RSTA.1920.0001	16	48	52	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2000	405	6788					743	744		10.1038/35015639	http://dx.doi.org/10.1038/35015639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866179				2022-12-28	WOS:000087620600026
J	Alexander, DA; Klein, S; Gray, NM; Dewar, IG; Eagles, JM				Alexander, DA; Klein, S; Gray, NM; Dewar, IG; Eagles, JM			Suicide by patients: questionnaire study of its effect on consultant psychiatrists	BRITISH MEDICAL JOURNAL			English	Article							STRESS; INPATIENT; IMPACT	Objective To identify the effect of patients' suicide on consultant psychiatrists in Scotland, Design Confidential coded postal questionnaire sun ev. Participants Of 315 eligible consultant psychiatrists, 247 (78%) contributed. Setting Scotland, Main outcome measures Experience of patient suicide; the features and impact of "most distressing" suicide and what helped them to deal with it. Results 167 (68%) consultants had had a patient commit suicide under their care. Fifty four (33%) reported being affected personally in terms of low mood, poor sleep, or irritability. Changes in professional practice were described by 69 (42%) of the psychiatrists-for example, a more structured approach to the management of patients at risk and increased use of mental health legislation, Twenty four (15%) doctors considered taking early retirement because of a patient's suicide. Colleagues and family or friends were the best sources of help, and team and critical incident reviews were also useful. Conclusions Suicide by patients has a substantial emotional and professional effect on consultant psychiatrists. Support from colleagues is helpful, and professional reviews provide opportunities for learning and improved management of suicide and its aftermath.	Royal Cornhill Hosp, Ctr Trauma Res Bennachie, Aberdeen AB25 2ZH, Scotland; Univ Aberdeen, Sch Med, Dept Mental Hlth, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Alexander, DA (corresponding author), Royal Cornhill Hosp, Ctr Trauma Res Bennachie, Aberdeen AB25 2ZH, Scotland.		Gray, Nicola M./B-8012-2015	Gray, Nicola M./0000-0001-8497-394X; Klein, Susan/0000-0002-4955-6187				ALEXANDER DA, 1999, PREHOSPITAL MED PRIN; BARTELS SJ, 1987, GEN HOSP PSYCHIAT, V9, P189, DOI 10.1016/0163-8343(87)90007-7; CHEMTOB CM, 1988, AM J PSYCHIAT, V145, P224; Deary IJ, 1996, INT J SOC PSYCHIATR, V42, P112, DOI 10.1177/002076409604200205; Dewar I, 1999, PSYCHIAT B, V24, P20, DOI 10.1192/pb.24.1.20; Eastman N, 1996, BRIT MED J, V313, P1069; FIRTHCOZENS J, 1989, STRESS MEDICINE, V5, P121, DOI 10.1002/smi.2460050210; GOLDSTEIN LS, 1984, AM J PSYCHOTHER, V38, P392, DOI 10.1176/appi.psychotherapy.1984.38.3.392; GRALNICK A, 1993, CHILD PSYCHIAT HUM D, V24, P3, DOI 10.1007/BF02353713; KAYE NS, 1991, AM J PSYCHIAT, V148, P739; Kendell RE, 1997, PSYCHIAT B, V21, P741; LITMAN RE, 1965, AM J PSYCHOTHER, V19, P570, DOI 10.1176/appi.psychotherapy.1965.19.4.570; LITTLE JD, 1992, AUST NZ J PSYCHIAT, V26, P162, DOI 10.3109/00048679209072023; MENNINGER WW, 1991, B MENNINGER CLIN, V55, P216; Morris M, 1995, Br J Nurs, V4, P205; OREILLY RL, 1990, PSYCHIAT J U OTTAWA, V15, P173; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Reder P, 1996, INQUIRIES HOMICIDE; *ROYAL COLL GEN PR, 1993, 61 RCGP; SCHNEIDMAN ES, 1971, ANN INTERN MED, V75, P441	20	98	101	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1571	1574		10.1136/bmj.320.7249.1571	http://dx.doi.org/10.1136/bmj.320.7249.1571			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	324PW	10845964	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000087631400020
J	Shraiman, BI; Siggia, ED				Shraiman, BI; Siggia, ED			Scalar turbulence	NATURE			English	Review							ADVECTED PASSIVE SCALAR; MEAN GRADIENT; LOCAL ISOTROPY; SHEAR FLOWS; FLUCTUATIONS; ANISOTROPY; INSTANTON; MODEL	The advection of a passive substance by a turbulent flow is important in many natural and engineering settings. The concentration of such a substance can exhibit complex dynamic behaviour that shows many phenomenological parallels with the behaviour of the turbulent velocity field. Yet the statistical properties of this so-called 'passive scalar' turbulence are decoupled from those of the underlying velocity field. Passive scalar turbulence has recently yielded to mathematical analysis, and such progress may ultimately lead to a better understanding of the still intractable problem of fluid turbulence itself.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Rockefeller Univ, Ctr Phys & Biol, New York, NY 10021 USA	Alcatel-Lucent; Lucent Technologies; AT&T; Rockefeller University	Shraiman, BI (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.							ANTONIA RA, 1978, J FLUID MECH, V84, P561, DOI 10.1017/S0022112078000336; ATEMA J, 1995, P NATL ACAD SCI USA, V92, P62, DOI 10.1073/pnas.92.1.62; Balkovsky E, 1998, PHYS REV E, V58, P5776, DOI 10.1103/PhysRevE.58.5776; BALKOVSKY E, 1995, JETP LETT+, V61, P1049; BERG HC, 1990, COLD SPRING HARB SYM, V55, P539; Bernard D, 1998, J STAT PHYS, V90, P519, DOI 10.1023/A:1023212600779; Buch KA, 1996, J FLUID MECH, V317, P21, DOI 10.1017/S0022112096000651; Celani A, 2000, PHYS REV LETT, V84, P2385, DOI 10.1103/PhysRevLett.84.2385; Chen SY, 1998, PHYS FLUIDS, V10, P2867, DOI 10.1063/1.869808; Chertkov M, 1999, PHYS REV LETT, V83, P4065, DOI 10.1103/PhysRevLett.83.4065; Chertkov M, 1998, PHYS REV LETT, V80, P512, DOI 10.1103/PhysRevLett.80.512; Chertkov M, 1998, PHYS REV LETT, V80, P2121, DOI 10.1103/PhysRevLett.80.2121; Chertkov M, 1997, PHYS REV E, V55, P2722, DOI 10.1103/PhysRevE.55.2722; CHERTKOV M, 1995, PHYS REV E, V52, P4924, DOI 10.1103/PhysRevE.52.4924; DIBBLE RW, 1996, COMBUSTION PHYSICAL; DRUMMOND IT, 1982, J FLUID MECH, V123, P59, DOI 10.1017/S002211208200295X; Edouard S, 1996, NATURE, V384, P444, DOI 10.1038/384444a0; Fairhall AL, 1996, PHYS REV E, V53, P3518, DOI 10.1103/PhysRevE.53.3518; Feynman R.P., 1965, QUANTUM MECH PATH IN; FOURNIER JD, 1978, J PHYS A-MATH GEN, V11, P187, DOI 10.1088/0305-4470/11/1/020; Frisch U, 1999, PHYS FLUIDS, V11, P2178, DOI 10.1063/1.870079; FRISCH U., 1995, TURBULENCE LEGACY AN; Garg S, 1998, PHYS FLUIDS, V10, P662, DOI 10.1063/1.869592; GAWCEDZKI K, 1995, PHYS REV LETT, V75, P3834; GIBSON CH, 1977, PHYS FLUIDS, V20, pS156, DOI 10.1063/1.861725; GOLLUB JP, 1991, PHYS REV LETT, V67, P3507, DOI 10.1103/PhysRevLett.67.3507; HOLZER M, 1994, PHYS FLUIDS, V6, P1820, DOI 10.1063/1.868243; JAYESH, 1991, PHYS REV LETT, V67, P3503, DOI 10.1103/PhysRevLett.67.3503; Kraichnan R. H., 1974, Journal of Fluid Mechanics, V64, P737, DOI 10.1017/S0022112074001881; KRAICHNAN RH, 1994, PHYS REV LETT, V72, P1016, DOI 10.1103/PhysRevLett.72.1016; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; MESTAYER P, 1982, J FLUID MECH, V125, P475, DOI 10.1017/S0022112082003450; Miller PL, 1996, J FLUID MECH, V308, P129, DOI 10.1017/S0022112096001425; Molchanov S. A., 1985, Soviet Physics - Uspekhi, V28, P307, DOI 10.1070/PU1985v028n04ABEH003869; Monin A.S., 1971, STAT FLUID MECH MECH, P769; Mydlarski L, 1998, PHYS REV LETT, V81, P4373, DOI 10.1103/PhysRevLett.81.4373; Ott E, 1994, CHAOS DYNAMICAL SYST; Ottino JM., 1989, KINEMATICS MIXING ST; Pasquill F., 1983, ATMOSPHERIC DIFFUSIO, V3rd; PROCTOR MREF, 1994, LECT SOLAR PLANETARY, V117; PUMIR A, 1995, PHYS REV LETT, V75, P3114, DOI 10.1103/PhysRevLett.75.3114; Pumir A, 1997, PHYS REV E, V55, pR1263, DOI 10.1103/PhysRevE.55.R1263; Pumir A, 1996, EUROPHYS LETT, V34, P25, DOI 10.1209/epl/i1996-00410-4; Pumir A, 1998, PHYS REV E, V57, P2914, DOI 10.1103/PhysRevE.57.2914; PUMIR A, 1994, PHYS FLUIDS, V6, P2118, DOI 10.1063/1.868216; SHRAIMAN BI, 1994, PHYS REV E, V49, P2912, DOI 10.1103/PhysRevE.49.2912; Shraiman BI, 1996, PHYS REV LETT, V77, P2463, DOI 10.1103/PhysRevLett.77.2463; SHRAIMAN BI, 1995, CR ACAD SCI II B, V321, P279; Sreenivasan KR, 1997, ANNU REV FLUID MECH, V29, P435, DOI 10.1146/annurev.fluid.29.1.435; SREENIVASAN KR, 1991, P ROY SOC LOND A MAT, V434, P165, DOI 10.1098/rspa.1991.0087; Tennekes H., 1972, 1 COURSE TURBULENCE; Warhaft Z, 2000, ANNU REV FLUID MECH, V32, P203, DOI 10.1146/annurev.fluid.32.1.203; Williams BS, 1997, PHYS FLUIDS, V9, P2061, DOI 10.1063/1.869326; WILSON KG, 1983, REV MOD PHYS, V55, P583, DOI 10.1103/RevModPhys.55.583	54	566	581	7	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					639	646		10.1038/35015000	http://dx.doi.org/10.1038/35015000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864314				2022-12-28	WOS:000087465800036
J	Turner, GC; Du, FY; Varshavsky, A				Turner, GC; Du, FY; Varshavsky, A			Peptides accelerate their uptake by activating a ubiquitin-dependent proteolytic pathway	NATURE			English	Article							N-END RULE; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPONENT; PROTEIN; DEGRADATION; TRANSPORT; RESIDUE; SYSTEM	Protein degradation by the ubiquitin system controls the intracellular concentrations of many regulatory proteins. A protein substrate of the ubiquitin system is conjugated to ubiquitin through the action of three enzymes, E1, E2 and E3, with the degradation signal (degron) of the substrate recognized by E3 (refs 1-3). The resulting multi-ubiquitylated substrate is degraded by the 26S proteasome(4). Here we describe the physiological regulation of a ubiquitin-dependent pathway through allosteric modulation of its E3 activity by small compounds. Ubr1, the E3 enzyme of the N-end rule pathway (a ubiquitin-dependent proteolytic system) in Saccharomyces cerevisiae mediates the degradation of Cup9, a transcriptional repressor of the peptide transporter Ptr2 (ref. 5). Ubr1 also targets proteins that have destabilizing amino-terminal residues(6). We show that the degradation of Cup9 is allosterically activated by dipeptides with destabilizing N-terminal residues. In the resulting positive feedback circuit, imported dipeptides bind to Ubr1 and accelerate the Ubr1-dependent degradation of Cup9, thereby de-repressing the expression of Ptr2 and increasing the cell's capacity to import peptides. These findings identify the physiological rationale for the targeting of Cup9 by Ubr1, and indicate that small compounds may regulate other ubiquitin-dependent pathways.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Turner, Glenn/0000-0002-5341-2784				ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V87, P2374; Barnes D, 1998, MOL MICROBIOL, V29, P297, DOI 10.1046/j.1365-2958.1998.00931.x; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KNIGHT SAB, 1994, MOL CELL BIOL, V14, P7792, DOI 10.1128/MCB.14.12.7792; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; REISS Y, 1988, J BIOL CHEM, V263, P2693; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832	29	155	161	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					579	583		10.1038/35014629	http://dx.doi.org/10.1038/35014629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850718				2022-12-28	WOS:000087449500053
J	Ehrlich, PR				Ehrlich, PR			Donald Kennedy - The next Editor-in-Chief of Science	SCIENCE			English	Biographical-Item									Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Ehrlich, PR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.								0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2000	288	5470					1349	1349		10.1126/science.288.5470.1349	http://dx.doi.org/10.1126/science.288.5470.1349			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10847848				2022-12-28	WOS:000087270900027
J	McCabe, H				McCabe, H			France sets up elite Internet school	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					381	381		10.1038/35013210	http://dx.doi.org/10.1038/35013210			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839502	Bronze			2022-12-28	WOS:000087212000004
J	Seelert, H; Poetsch, A; Dencher, NA; Engel, A; Stahlberg, H; Muller, DJ				Seelert, H; Poetsch, A; Dencher, NA; Engel, A; Stahlberg, H; Muller, DJ			Structural biology - Proton-powered turbine of a plant motor	NATURE			English	Article							ATP-SYNTHASE; SUBUNIT-C; STOICHIOMETRY; ENERGY; F0F1		Tech Univ Darmstadt, Dept Chem, D-64287 Darmstadt, Germany; Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technical University of Darmstadt; University of Basel; Max Planck Society	Seelert, H (corresponding author), Tech Univ Darmstadt, Dept Chem, Petersenstr 30, D-64287 Darmstadt, Germany.		Müller, Daniel J./A-5967-2010; Stahlberg, Henning/H-1868-2011; Poetsch, Ansgar/A-1862-2013; Dencher, Norbert/G-6640-2014	Müller, Daniel J./0000-0003-3075-0665; Stahlberg, Henning/0000-0002-1185-4592; Poetsch, Ansgar/0000-0002-7540-3475; 				Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; FROMME P, 1987, Z NATURFORSCH C, V42, P1239; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; Junge W, 1999, P NATL ACAD SCI USA, V96, P4735, DOI 10.1073/pnas.96.9.4735; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Neff D, 1997, J STRUCT BIOL, V119, P139, DOI 10.1006/jsbi.1997.3891; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Schemidt RA, 1998, J BACTERIOL, V180, P3205, DOI 10.1128/JB.180.12.3205-3208.1998; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700	11	401	418	2	49	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					418	419		10.1038/35013148	http://dx.doi.org/10.1038/35013148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839529				2022-12-28	WOS:000087212000037
J	Shear, WA				Shear, WA			Jane Gray (1929-2000) - Obituary	NATURE			English	Biographical-Item									Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23948 USA		Shear, WA (corresponding author), Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23948 USA.								0	2	2	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					34	34		10.1038/35011189	http://dx.doi.org/10.1038/35011189			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10841693	Bronze			2022-12-28	WOS:000086901600037
J	Somers, DE; Schultz, TF; Milnamow, M; Kay, SA				Somers, DE; Schultz, TF; Milnamow, M; Kay, SA			ZEITLUPE encodes a novel clock-associated PAS protein from Arabidopsis	CELL			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; UBIQUITIN-DEPENDENT PROTEOLYSIS; REGULATED GENE-EXPRESSION; F-BOX PROTEINS; DROSOPHILA CLOCK; PHYTOCHROME-B; PHOTOTRANSDUCTION PATHWAYS; SIGNAL-TRANSDUCTION; PERIOD PROTEIN; DOUBLE-TIME	We have conducted genetic screens for period length mutants in Arabidopsis using a transgenic bioluminescence phenotype. This screen identified mutations at a locus, ZEITLUPE (ZTL), that lengthen the free-running period of clock-controlled gene transcription and cell expansion, and alter the timing of the daylength-dependent transition from vegetative to floral development. Map-based cloning of ZTL identified a novel 609 amino acid polypeptide consisting of an aminoterminal PAS domain, an F box and six carboxy-terminal kelch repeats. The PAS region is highly similar to the PAS domain of the Arabidopsis blue-light receptor NPH1, and the Neurospora circadian-associated protein WHITE COLLAR-1 (WC-1). The striking fluence rate-dependent effect of the ztl mutations suggests that ZTL plays a primary role in the photocontrol of circadian period in higher plants.	Scripps Res Inst, Res Inst, Dept Cell Biol, Div Plant Biol, La Jolla, CA 92037 USA; Novartis Agr Discovery Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Kay, SA (corresponding author), Scripps Res Inst, Res Inst, Dept Cell Biol, Div Plant Biol, 11055 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Somers, David E/A-9209-2010; Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Schultz, Thomas/0000-0001-9694-9920	NIGMS NIH HHS [GM 56006] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Anderson SL, 1997, PLANT CELL, V9, P1727, DOI 10.1105/tpc.9.10.1727; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; ENGELMANN W, 1998, BIOL RHYTHMS PHOTOPE, P35; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kreps JA, 1997, PLANT CELL, V9, P297, DOI 10.1105/tpc.9.3.297; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mohr Hans, 1994, P353; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Regan-Reimann JD, 1999, CURR BIOL, V9, pR762, DOI 10.1016/S0960-9822(00)80006-8; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Samach A, 1999, PLANT J, V20, P433, DOI 10.1046/j.1365-313x.1999.00617.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thomas B., 1997, PHOTOPERIODISM PLANT; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	61	471	506	1	57	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					319	329		10.1016/S0092-8674(00)80841-7	http://dx.doi.org/10.1016/S0092-8674(00)80841-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847686	Bronze			2022-12-28	WOS:000086741900011
J	Gelenberg, AJ; Lydiard, RB; Rudolph, RL; Aguiar, L; Haskins, JT; Salinas, E				Gelenberg, AJ; Lydiard, RB; Rudolph, RL; Aguiar, L; Haskins, JT; Salinas, E			Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder - A 6-month randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPIDEMIOLOGY	Context Generalized anxiety disorder (GAD) is a chronic disorder that is associated with debilitating psychic and somatic symptoms. Venlafaxine extended-release (XR) capsules have been shown to be effective in short-term treatment of patients with GAD without major depressive disorder (MDD), but long-term data are needed to establish whether this agent confers persistent benefits. Objective To compare the 6-month efficacy and safety of a flexible dosage of venlafaxine XR in outpatients with GAD without associated MDD. Design Six-month, randomized, double-blind, placebo-controlled, parallel-group trial conducted May 1996 to October 1997. Setting Fourteen outpatient clinics and private psychiatric practices in the United States. Participants A total of 251 outpatients aged 18 years or older who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for GAD, had sufficient symptoms to require treatment, and did not have coexisting MDD. Interventions Participants were randomly assigned to receive either placebo (n=127) or venlafaxine XR (75, 150, or 225 mg/d, as required to control symptoms; n=124) for 28 weeks. Main Outcome Measures Changes from baseline in the Hamilton Rating Scale for Anxiety (HAM-A) total score, the HAM-A psychic anxiety factor score, and the Clinical Global Impressions (CGI) scale Severity of Illness and Global Improvement scores, compared by intervention group. Results During weeks 6 through 28, response rates in the venlafaxine XR group were 69% or higher compared with rates of 42% to 46% in the placebo group (P<.001). By an evaluable-patient analysis, venlafaxine XR compared with placebo significantly improved anxiety scores from week 1 or 2 through week 28 on all primary efficacy measures, including the HAM-A total (P<.001), the HAM-A psychic anxiety factor (P<.001), and the CGI scale scores (P<.001). Adjusted mean changes from baseline to week 28 using last-observation-carried-forward methods were for HAM-A, venlafaxine XR -13.4, placebo -8.7 (P<.001); for HAM-A psychic anxiety score, venlafaxine XR -7.4, placebo -4.2 (P<.001); and for CGI-Improvement, venlafaxine XR 2,2, placebo 3.0 (P<.001). The most common treatment-emergent adverse event was nausea, followed by somnolence and dry mouth. Conclusions This study is the first placebo-controlled demonstration of the longterm efficacy of any drug class in treating outpatients with DSM-IV-diagnosed GAD. Venlafaxine XR is an effective, rapidly acting, safe, once-daily agent for both the short-and long-term treatment of anxiety and may provide an important alternative to currently available anxiolytics.	Univ Arizona, Arizona Hlth Sci Ctr, Med Ctr, Tucson, AZ 85724 USA; Med Univ S Carolina, Charleston, SC 29425 USA; Wyeth Ayerst Res, Philadelphia, PA USA	University of Arizona; University of Arizona Health Sciences; Medical University of South Carolina; Pfizer	Gelenberg, AJ (corresponding author), Univ Arizona, Arizona Hlth Sci Ctr, Med Ctr, Tucson, AZ 85724 USA.							*AM PSYCH ASS, 1987, DIAGN STAT MAN MENT, P251; AM. PSYCHIATRIC Assoc, 1994, DIAGN STAT MAN MENT, P432; BARLOW DH, 1986, AM J PSYCHIAT, V143, P40; Blazer DG, 1991, PSYCHIAT DISORDERS A, P180; BrawmanMintzer O, 1996, J CLIN PSYCHIAT, V57, P3; Brown TA, 1997, CAN J PSYCHIAT, V42, P817, DOI 10.1177/070674379704200803; Davidson JRT, 1999, J CLIN PSYCHIAT, V60, P528, DOI 10.4088/JCP.v60n0805; Feighner JP, 1998, J AFFECT DISORDERS, V47, P55, DOI 10.1016/S0165-0327(97)00109-2; FLINT AJ, 1994, AM J PSYCHIAT, V151, P640; Kessler RC, 1999, AM J PSYCHIAT, V156, P1915; Kirkwood CK, 1997, PHARMACOTHERAPY PATH, P1443; MASSION AO, 1993, AM J PSYCHIAT, V150, P600; Olfson M, 1997, AM J PSYCHIAT, V154, P1734, DOI 10.1176/ajp.154.12.1734; RICKELS K, 1993, ARCH GEN PSYCHIAT, V50, P884; RICKELS K, IN PRESS AM J PSYCHI; ROCCA P, 1997, ACTA PSYCHIAT SCAND, V95, P44; ROYBYRNE P, 1993, PSYCHIAT CLIN N AM, V16, P719; Schweizer E, 1995, PSYCHIAT CLIN N AM, V18, P843, DOI 10.1016/S0193-953X(18)30026-1; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stoudemire A, 1996, J CLIN PSYCHIAT, V57, P64; Woodman CL, 1998, PSYCHOSOMATICS, V39, P45, DOI 10.1016/S0033-3182(98)71380-5; Yonkers KA, 1996, BRIT J PSYCHIAT, V168, P308, DOI 10.1192/bjp.168.3.308; Zajecka J, 1997, J CLIN PSYCHIAT, V58, P9	23	213	223	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3082	3088		10.1001/jama.283.23.3082	http://dx.doi.org/10.1001/jama.283.23.3082			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323PV	10865302				2022-12-28	WOS:000087574900032
J	Latham, MC; Preble, EA				Latham, MC; Preble, EA			Appropriate feeding methods for infants of HIV infected mothers in sub-Saharan Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; MILK		Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Latham, MC (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	MCL6@cornell.edu						Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Filteau SM, 1999, IMMUNOLOGY, V97, P595, DOI 10.1046/j.1365-2567.1999.00834.x; Latham MC, 1999, BRIT MED J, V318, P1303, DOI 10.1136/bmj.318.7194.1303; LATHAM MC, 1998, IND J NUTR DIET, V36, P131; Morrison P, 1999, Breastfeed Rev, V7, P5; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NEWBURG DS, 1992, PEDIATR RES, V31, P22, DOI 10.1203/00006450-199201000-00004; PIWOZ EG, 2000, HIV AIDS INFANT FEED; PREBLE EA, 1998, HIV INFANT FEEDING C; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Stecklov G, 1999, AM J PUBLIC HEALTH, V89, P780, DOI 10.2105/AJPH.89.5.780-a; UNAIDS, 1998, MOTH TO CHILD TRANSM; VICTORA CG, 1987, LANCET, V2, P319; WAHL SM, 1997, ORAL DIS, V3, P564; *WHO, 1998, GUID DEC MAK; *WHO COLL STUD TEA, 1999, LANCET, V355, P451; *WHO UN CONS STAT, 1992, WHO UN CONS HIV TRAN; *ZAMB NAT FOOD NUT, 2000, HIV INF FEED SUMM FO	19	30	30	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2000	320	7250					1656	1659		10.1136/bmj.320.7250.1656	http://dx.doi.org/10.1136/bmj.320.7250.1656			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856073	Green Published			2022-12-28	WOS:000087734200027
J	Tackley, PJ				Tackley, PJ			Mantle convection and plate tectonics: Toward an integrated physical and chemical theory	SCIENCE			English	Review							TEMPERATURE-DEPENDENT VISCOSITY; STAGNANT LID CONVECTION; CONTINENTAL LITHOSPHERE; VOLATILE EVOLUTION; SELF-LUBRICATION; EARTHS MANTLE; DEEP MANTLE; GENERATION; MODELS; DYNAMICS	Plate tectonics and convection of the solid, rocky mantle are responsible for transporting heat out of Earth. However, the physics of plate tectonics is poorly understood; other planets do not exhibit it. Recent seismic evidence for convection and mixing throughout the mantle seems at odds with the chemical composition of erupted magmas requiring the presence of several chemically distinct reservoirs within the mantle. There has been rapid progress on these two problems, with the emergence of the first self-consistent models of plate tectonics and mantle convection, along with new geochemical models that may be consistent with seismic and dynamical constraints on mantle structure.	Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Tackley, PJ (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.		Tackley, Paul J/D-8155-2016	Tackley, Paul J/0000-0003-4878-621X				Albarede F, 1998, CHEM GEOL, V145, P413, DOI 10.1016/S0009-2541(97)00152-6; Becker TW, 1999, EARTH PLANET SC LETT, V171, P351, DOI 10.1016/S0012-821X(99)00160-0; Bercovici D, 1998, EARTH PLANET SC LETT, V154, P139, DOI 10.1016/S0012-821X(97)00182-9; Bercovici D, 1996, EARTH PLANET SC LETT, V144, P41, DOI 10.1016/0012-821X(96)00140-9; BERCOVICI D, UNPUB; BERCOVICI D, IN PRESS HIST DYNAMI; Braun J, 1999, J GEOPHYS RES-SOL EA, V104, P25167, DOI 10.1029/1999JB900214; Bunge HP, 1998, SCIENCE, V280, P91, DOI 10.1126/science.280.5360.91; Christensen UR, 1996, EARTH PLANET SC LETT, V140, P27, DOI 10.1016/0012-821X(96)00023-4; CHRISTENSEN UR, 1994, J GEOPHYS RES-SOL EA, V99, P19867, DOI 10.1029/93JB03403; Christensen UR, 1997, J GEOPHYS RES-SOL EA, V102, P22435, DOI 10.1029/97JB01342; Coltice N, 1999, EARTH PLANET SC LETT, V174, P125, DOI 10.1016/S0012-821X(99)00258-7; Davaille A, 1999, NATURE, V402, P756, DOI 10.1038/45461; DAVIES GF, 1992, J GEOL, V100, P151, DOI 10.1086/629582; Doin MP, 1997, J GEOPHYS RES-SOL EA, V102, P2771, DOI 10.1029/96JB03271; Dumoulin C, 1999, J GEOPHYS RES-SOL EA, V104, P12759, DOI 10.1029/1999JB900110; Ferrachat S, 1998, EARTH PLANET SC LETT, V155, P75, DOI 10.1016/S0012-821X(97)00200-8; FORTE AM, 1995, GEOPHYS RES LETT, V22, P1013, DOI 10.1029/95GL01065; Grand SP., 1997, GSA TODAY, V7, P1; Grasset O, 1998, J GEOPHYS RES-SOL EA, V103, P18171, DOI 10.1029/98JB01492; GURNIS M, 1988, NATURE, V332, P695, DOI 10.1038/332695a0; Gurnis M, 1998, SCIENCE, V279, P1499, DOI 10.1126/science.279.5356.1499; GURNIS M, 1986, GEOPHYS RES LETT, V13, P541, DOI 10.1029/GL013i006p00541; GURNIS M, IN PRESS HIST DYNAMI; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Hofmeister AM, 1999, SCIENCE, V283, P1699, DOI 10.1126/science.283.5408.1699; Ishii M, 1999, SCIENCE, V285, P1231, DOI 10.1126/science.285.5431.1231; Jin DH, 1998, J STRUCT GEOL, V20, P195, DOI 10.1016/S0191-8141(97)00059-X; Kameyama M, 1997, GEOPHYS RES LETT, V24, P2523, DOI 10.1029/97GL02648; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kennett BLN, 1998, J GEOPHYS RES-SOL EA, V103, P12469, DOI 10.1029/98JB00150; KING SD, 1992, GEOPHYS J INT, V109, P481, DOI 10.1111/j.1365-246X.1992.tb00111.x; KIRBY SH, 1983, REV GEOPHYS, V21, P1458, DOI 10.1029/RG021i006p01458; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Larsen TB, 1997, EARTH PLANET SC LETT, V146, P393, DOI 10.1016/S0012-821X(96)00247-6; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Lenardic A, 1999, J GEOPHYS RES-SOL EA, V104, P12747, DOI 10.1029/1999JB900035; Lenardic A, 1998, GEOPHYS J INT, V134, P706, DOI 10.1046/j.1365-246x.1998.00604.x; LENARDIC A, 1995, NATURE, V378, P709, DOI 10.1038/378709a0; Lithgow-Bertelloni C, 1998, NATURE, V395, P269, DOI 10.1038/26212; Liu XF, 1998, EARTH PLANET SC LETT, V160, P343, DOI 10.1016/S0012-821X(98)00095-8; Lowman JP, 1996, J GEOPHYS RES-SOL EA, V101, P25485, DOI 10.1029/96JB02568; Lowman JP, 1999, J GEOPHYS RES-SOL EA, V104, P12733, DOI 10.1029/1999JB900108; Manga M, 1996, GEOPHYS RES LETT, V23, P403, DOI 10.1029/96GL00242; MASTERS G, 2000, MINERAL PHYS TOMOGRA, P63; Moore WB, 1998, SCIENCE, V279, P1008, DOI 10.1126/science.279.5353.1008; Moresi L, 1998, GEOPHYS J INT, V133, P669, DOI 10.1046/j.1365-246X.1998.00521.x; Ranalli G., 1995, RHEOLOGY EARTH; Reese CC, 1999, ICARUS, V139, P67, DOI 10.1006/icar.1999.6088; Regenauer-Lieb K, 1998, GEOPHYS RES LETT, V25, P2737, DOI 10.1029/98GL02056; Ribe NM, 1999, EARTH PLANET SC LETT, V171, P517, DOI 10.1016/S0012-821X(99)00179-X; Ritsema J, 1998, GEOPHYS RES LETT, V25, P4245, DOI 10.1029/1998GL900127; Schubert G, 1997, SPACE SCI S, P1245; SCHUBERT G, IN PRESS MANTLE CONV; Shapiro SS, 1999, LITHOS, V48, P115, DOI 10.1016/S0024-4937(99)00025-0; Sidorin I, 1999, J GEOPHYS RES-SOL EA, V104, P15005, DOI 10.1029/1999JB900065; Silver PG, 1998, SCIENCE, V279, P60, DOI 10.1126/science.279.5347.60; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; Tackley PJ, 1998, GEODYNAMICS, V28, P231; Tackley PJ, 1998, EARTH PLANET SC LETT, V157, P9, DOI 10.1016/S0012-821X(98)00029-6; TACKLEY PJ, 1994, J GEOPHYS RES-SOL EA, V99, P15877, DOI 10.1029/94JB00853; TACKLEY PJ, IN PRESS GEOCHEM GEO; TACKLEY PJ, IN PRESS HIST DYNAMI; TACKLEY PJ, 1985, US NATL REPORT IUGG, P275; Ten AA, 1998, GEOPHYS RES LETT, V25, P3205, DOI 10.1029/98GL51991; Thompson PF, 1998, GEOPHYS RES LETT, V25, P1999, DOI 10.1029/98GL01228; Trompert R, 1998, NATURE, V395, P686, DOI 10.1038/27185; TURCOTTE DL, 1993, J GEOPHYS RES-PLANET, V98, P17061, DOI 10.1029/93JE01775; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; van Keken P, 1999, EARTH PLANET SC LETT, V171, P533, DOI 10.1016/S0012-821X(99)00181-8; van Keken PE, 1999, J GEOPHYS RES-SOL EA, V104, P7137, DOI 10.1029/1999JB900003; van Keken PE, 1998, EARTH PLANET SC LETT, V156, P19, DOI 10.1016/S0012-821X(98)00023-5; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; vanKeken P, 1997, EARTH PLANET SC LETT, V148, P1, DOI 10.1016/S0012-821X(97)00042-3; Weinstein SA, 1998, EARTH PLANET SC LETT, V155, P87, DOI 10.1016/S0012-821X(97)00208-2; Yoshida M, 1999, GEOPHYS RES LETT, V26, P947, DOI 10.1029/1999GL900147; YUEN DA, 1993, GEOPHYS RES LETT, V20, P899, DOI 10.1029/93GL00867	78	317	342	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2002	2007		10.1126/science.288.5473.2002	http://dx.doi.org/10.1126/science.288.5473.2002			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856206				2022-12-28	WOS:000087687000039
J	Bennett, CL; Connors, JM; Carwile, JM; Moake, JL; Bell, WR; Tarantolo, SR; McCarthy, LJ; Sarode, R; Hatfield, AJ; Feldman, MD; Davidson, CJ; Tsai, HM				Bennett, CL; Connors, JM; Carwile, JM; Moake, JL; Bell, WR; Tarantolo, SR; McCarthy, LJ; Sarode, R; Hatfield, AJ; Feldman, MD; Davidson, CJ; Tsai, HM			Thrombotic thrombocytopenic purpura associated with clopidogrel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-UREMIC SYNDROME; FACTOR-CLEAVING PROTEASE; TICLOPIDINE	Background: The antiplatelet drug clopidogrel is a new thienopyridine derivative whose mechanism of action and chemical structure are similar to those of ticlopidine. The estimated incidence of ticlopidine-associated thrombotic thrombocytopenic purpura is 1 per 1600 to 5000 patients treated, whereas no clopidogrel-associated cases were observed among 20,000 closely monitored patients treated in phase 3 clinical trials and cohort studies. Because of the association between ticlopidine use and thrombotic thrombocytopenic purpura and other adverse effects, clopidogrel has largely replaced ticlopidine in clinical practice. More than 3 million patients have received clopidogrel. We report the clinical and laboratory findings in 11 patients in whom thrombotic thrombocytopenic purpura developed during or soon after treatment with clopidogrel. Methods: The 11 patients were identified by active surveillance by the medical directors of blood banks (3 patients), hematologists (6), and the manufacturers of clopidogrel (2). Results: Ten of the 11 patients received clopidogrel for 14 days or less before the onset of thrombotic thrombocytopenic purpura. Although 10 of the 11 patients had a response to plasma exchange, 2 required 20 or more exchanges before clinical improvement occurred, and 2 had relapses while not receiving clopidogrel. One patient died despite undergoing plasma exchange soon after diagnosis. Conclusions: Thrombotic thrombocytopenic purpura can occur after the initiation of clopidogrel therapy, often within the first two weeks of treatment. Physicians should be aware of the possibility of this syndrome when initiating clopidogrel treatment. (N Engl J Med 2000;342:1773-7.) (C)2000, Massachusetts Medical Society.	Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA; Northwestern Univ, Div Cardiol, Chicago, IL 60611 USA; Northwestern Univ, Dept Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Northwestern Univ, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Brigham & Womens Hosp, Dept Pathol, Clin Labs, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Div Hematol, Boston, MA USA; Baylor Coll Med, Dept Med, Div Hematol Oncol, Houston, TX 77030 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA; Univ Nebraska, Med Ctr, Dept Med, Omaha, NE 68105 USA; Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Mission St Josephs Hlth Syst, Asheville, NC USA; Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; Univ Texas, Hlth Sci Ctr, Dept Med, Div Cardiol, San Antonio, TX 78284 USA; Montefiore Med Ctr, Dept Med, Div Hematol, Bronx, NY 10467 USA; VA Chicago Healthcare Syst, Lakeside Div, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Johns Hopkins University; University of Nebraska System; University of Nebraska Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; University Hospitals of Cleveland; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health San Antonio; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Bennett, CL (corresponding author), VA Chicago Healthcare Syst, Lakeside Div, Chicago, IL 60611 USA.		Connors, Joseph/AAF-5284-2019; Bennett, Charles L/C-2050-2008	Connors, Joseph/0000-0002-1361-7531; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL018584, R37HL018584] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54169, HL18584, HL62131] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Bennett CL, 1999, ARCH INTERN MED, V159, P2524, DOI 10.1001/archinte.159.21.2524; Bennett CL, 1998, ANN INTERN MED, V128, P541, DOI 10.7326/0003-4819-128-7-199804010-00004; Bennett CL, 1998, LANCET, V352, P1036, DOI 10.1016/S0140-6736(05)60079-7; Carwile JM, 1999, BLOOD, V94, p78B; Connors JM, 1999, TRANSFUSION, V39, p56S; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gordon LI, 1997, SEMIN HEMATOL, V34, P140; Klein LW, 1999, J AM COLL CARDIOL, V34, P1895, DOI 10.1016/S0735-1097(99)00457-X; Mauro M, 1999, BLOOD, V94, p646A; McCarthy LJ, 1998, LANCET, V352, P1284, DOI 10.1016/S0140-6736(05)70492-X; Moake JL, 1998, NEW ENGL J MED, V339, P1629, DOI 10.1056/NEJM199811263392210; Moussa I, 1999, CIRCULATION, V99, P2364, DOI 10.1161/01.CIR.99.18.2364; PAGE Y, 1991, LANCET, V337, P774, DOI 10.1016/0140-6736(91)91383-6; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; ROSE M, 1987, AM J MED, V83, P437, DOI 10.1016/0002-9343(87)90753-4; Sarode R, 1997, AM J HEMATOL, V54, P102, DOI 10.1002/(SICI)1096-8652(199702)54:2<102::AID-AJH2>3.0.CO;2-0; Sharis PJ, 1998, ANN INTERN MED, V129, P394, DOI 10.7326/0003-4819-129-5-199809010-00009; Steinhubl SR, 1999, JAMA-J AM MED ASSOC, V281, P806, DOI 10.1001/jama.281.9.806; TOROK TJ, 1995, AM J HEMATOL, V50, P84, DOI 10.1002/ajh.2830500203; Tsai HM, 2000, ANN INTERN MED, V132, P794, DOI 10.7326/0003-4819-132-10-200005160-00005; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Wysowksi DK, 1996, JAMA-J AM MED ASSOC, V276, P952, DOI 10.1001/jama.1996.03540120030022	25	422	431	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1773	1777		10.1056/NEJM200006153422402	http://dx.doi.org/10.1056/NEJM200006153422402			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10852999	Green Published			2022-12-28	WOS:000087573700002
J	Woolf, CJ; Salter, MW				Woolf, CJ; Salter, MW			Neuroscience - Neuronal plasticity: Increasing the gain in pain	SCIENCE			English	Review							RAT SPINAL-CORD; PRIMARY SENSORY NEURONS; DORSAL HORN NEURONS; RESISTANT SODIUM CURRENT; PERIPHERAL-NERVE INJURY; PRIMARY AFFERENT-FIBERS; LONG-TERM POTENTIATION; ROOT GANGLION NEURONS; INFLAMMATORY PAIN; MESSENGER-RNA	We describe those sensations that are unpleasant, intense, or distressing as painful. Pain is not homogeneous, however, and comprises three categories: physiological, inflammatory, and neuropathic pain. Multiple mechanisms contribute, each of which is subject to or an expression of neural plasticity-the capacity of neurons to change their function, chemical profile, or structure. Here, we develop a conceptual frame- work for the contribution of plasticity in primary sensory and dorsal horn neurons to the pathogenesis of pain, identifying distinct forms of plasticity, which we term activation, modulation, and modification, that by increasing gain, elicit pain hypersensitivity.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp East, Sch Med, Charlestown, MA 02129 USA; Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Univ Toronto, Ctr Study Pain, Toronto, ON M5G 1X8, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Charlestown, MA 02129 USA.		Woolf, Clifford/A-9784-2010					Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Aley KO, 1999, J NEUROSCI, V19, P2181; Ali Z, 1996, PAIN, V68, P401, DOI 10.1016/S0304-3959(96)03199-5; Andrew D, 1999, J NEUROPHYSIOL, V82, P2649, DOI 10.1152/jn.1999.82.5.2649; Azkue JJ, 1998, EUR J NEUROSCI, V10, P2204, DOI 10.1046/j.1460-9568.1998.00260.x; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; CASTROLOPES JM, 1993, BRAIN RES, V620, P287, DOI 10.1016/0006-8993(93)90167-L; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Coggeshall RE, 1997, NEUROSCIENCE, V77, P1115, DOI 10.1016/S0306-4522(96)00528-3; deGroot JF, 1997, NEUROSCI LETT, V233, P113, DOI 10.1016/S0304-3940(97)00642-3; DUGGAN AW, 1990, NEUROSCIENCE, V35, P195, DOI 10.1016/0306-4522(90)90134-P; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Fitzgerald EM, 1999, J PHYSIOL-LONDON, V516, P433, DOI 10.1111/j.1469-7793.1999.0433v.x; Fukuoka T, 1998, PAIN, V78, P13, DOI 10.1016/S0304-3959(98)00111-0; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Guenther S, 1999, EUR J NEUROSCI, V11, P3143, DOI 10.1046/j.1460-9568.1999.00734.x; Hay C, 1997, NEUROREPORT, V8, P1249, DOI 10.1097/00001756-199703240-00038; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; KILO S, 1994, BRAIN, V117, P385, DOI 10.1093/brain/117.2.385; Koerber HR, 1999, J NEUROPHYSIOL, V81, P1636, DOI 10.1152/jn.1999.81.4.1636; Kohama I, 2000, J NEUROSCI, V20, P1538; Koltzenburg M., 1992, PFLUGERS ARCH, V420, pR52; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; MA QP, 1995, J PHYSIOL-LONDON, V486, P769, DOI 10.1113/jphysiol.1995.sp020852; Ma QP, 1996, PAIN, V67, P97, DOI 10.1016/0304-3959(96)03105-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCCARSON KE, 1994, J NEUROSCI, V14, P712; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; Michael GJ, 1999, J NEUROSCI, V19, P1844; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; MIZUMURA K, 1996, POLYMODAL RECEPTOR G, P115; Morisset V, 1999, J NEUROSCI, V19, P7309, DOI 10.1523/JNEUROSCI.19-17-07309.1999; Neumann S, 1996, NATURE, V384, P360, DOI 10.1038/384360a0; NOGUCHI K, 1992, NEUROSCIENCE, V46, P561, DOI 10.1016/0306-4522(92)90144-Q; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; RANDIC M, 1993, J NEUROSCI, V13, P5228, DOI 10.1523/JNEUROSCI.13-12-05228.1993; Reeh PW, 1994, NATO ADV SCI INST SE, V79, P119; Salter MW, 1998, BIOCHEM PHARMACOL, V56, P789, DOI 10.1016/S0006-2952(98)00124-5; Sandkuhler J, 1997, J NEUROSCI, V17, P6483; Shu XQ, 1999, NEUROSCI LETT, V274, P159, DOI 10.1016/S0304-3940(99)00701-6; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; SIMONE DA, 1989, BRAIN RES, V486, P185, DOI 10.1016/0006-8993(89)91293-6; SIVILOTTI LG, 1993, J NEUROPHYSIOL, V69, P1621, DOI 10.1152/jn.1993.69.5.1621; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Stubhaug A, 1997, ACTA ANAESTH SCAND, V41, P1124, DOI 10.1111/j.1399-6576.1997.tb04854.x; SUGIMOTO T, 1990, PAIN, V42, P205, DOI 10.1016/0304-3959(90)91164-E; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; THOMPSON SWN, 1993, J NEUROPHYSIOL, V69, P2116, DOI 10.1152/jn.1993.69.6.2116; THOMPSON SWN, 1990, EUR J NEUROSCI, V2, P638, DOI 10.1111/j.1460-9568.1990.tb00453.x; Traub RJ, 1996, PAIN, V67, P151, DOI 10.1016/0304-3959(96)03076-X; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; WOOLF CJ, 1990, J NEUROSCI, V10, P2717; WOOLF CJ, 1994, PAIN, V58, P141, DOI 10.1016/0304-3959(94)90195-3; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; YAMAMOTO T, 1992, ANESTHESIOLOGY, V77, P757, DOI 10.1097/00000542-199210000-00021; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5	73	2541	2726	8	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1765	1768		10.1126/science.288.5472.1765	http://dx.doi.org/10.1126/science.288.5472.1765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846153				2022-12-28	WOS:000087503800038
J	Knauth, DC; Federman, SR; Lambert, DL; Crane, P				Knauth, DC; Federman, SR; Lambert, DL; Crane, P			Newly synthesized lithium in the interstellar medium	NATURE			English	Article							GALACTIC COSMIC-RAYS; LI-7/LI-6 RATIO; DIFFUSE CLOUDS; ISOTOPE RATIO; ZETA-OPHIUCHI; ELEMENTS; STARS; ABUNDANCES; CARBON; LINES	Astronomical observations of elemental and isotopic abundances provide the means to determine the source of elements and to reveal their evolutionary pathways since the formation of the Galaxy some 15 billion years ago. The abundance of lithium is particularly interesting because, although some of it is thought to be primordial, most results from spallation reactions (in which Galactic cosmic rays break apart larger nuclei in the interstellar medium). Spallation reactions are crucial for the production of other light elements(1), such as beryllium and boron, so observations of lithium isotopic abundances can be used to test model predictions(2-5) for light-element synthesis in general. Here we report observations of Li-7 and Li-6 abundances in several interstellar clouds lying in the direction of the star o Persei. We rnd the abundance ratio Li-7/Li-6 to be about 2, which is significantly lower than the average Solar System value of 12.3 (refs 6, 7). An abundance ratio of 2 is clear evidence that the observed lithium must have resulted entirely from spallation, confirming a basic tenet of light-element synthesis(2-5). The total lithium abundance, however, is not enhanced as expected.	Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; Univ Texas, Dept Astron, Austin, TX 78712 USA; Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; NASA Headquarters, Washington, DC 20546 USA	University System of Ohio; University of Toledo; University of Texas System; University of Texas Austin; Dartmouth College; National Aeronautics & Space Administration (NASA)	Federman, SR (corresponding author), Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA.		Federman, Steven/R-8557-2019	Federman, Steven/0000-0002-8433-9663				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ANDERSEN J, 1984, ASTRON ASTROPHYS, V136, P65; Chaussidon M, 1998, EARTH PLANET SC LETT, V164, P577, DOI 10.1016/S0012-821X(98)00250-7; CRANE P, 1995, ASTROPHYS J SUPPL S, V99, P107, DOI 10.1086/192180; DIPLAS A, 1994, ASTROPHYS J SUPPL S, V93, P211, DOI 10.1086/192052; Federman SR, 1996, ASTROPHYS J, V463, P181, DOI 10.1086/177233; FEDERMAN SR, 1994, ASTROPHYS J, V424, P772, DOI 10.1086/173930; Federman SR, 1996, NATURE, V381, P764, DOI 10.1038/381764a0; Hobbs LM, 1999, ASTROPHYS J, V523, P797, DOI 10.1086/307757; Lambert DL, 1998, ASTROPHYS J, V494, P614, DOI 10.1086/305235; Lemoine M, 1998, ASTROPHYS J, V499, P735, DOI 10.1086/305650; LEMOINE M, 1995, ASTRON ASTROPHYS, V298, P879; LEMOINE M, 1993, ASTRON ASTROPHYS, V269, P469; MENEGUZZI M, 1971, ASTRON ASTROPHYS, V15, P337; MENEGUZZI M, 1975, ASTRON ASTROPHYS, V40, P99; MEYER DM, 1993, ASTROPHYS J, V409, pL61, DOI 10.1086/186860; MORTON DC, 1991, ASTROPHYS J SUPPL S, V77, P119, DOI 10.1086/191601; Parizot E, 1999, ASTRON ASTROPHYS, V349, P673; Ramaty R, 1996, ASTROPHYS J, V456, P525, DOI 10.1086/176677; REEVES H, 1970, NATURE, V226, P727, DOI 10.1038/226727a0; SANSONETTI CJ, 1995, PHYS REV A, V52, P2682, DOI 10.1103/PhysRevA.52.2682; SAVAGE BD, 1977, ASTROPHYS J, V216, P291, DOI 10.1086/155471; SNOW TP, 1975, ASTROPHYS J, V201, pL21, DOI 10.1086/181931; Sofia UJ, 1997, ASTROPHYS J, V482, pL105, DOI 10.1086/310681; TULL RG, 1995, PUBL ASTRON SOC PAC, V107, P251, DOI 10.1086/133548; VANDISHOECK EF, 1986, ASTROPHYS J SUPPL S, V62, P109, DOI 10.1086/191135; WHITE RE, 1986, ASTROPHYS J, V307, P777, DOI 10.1086/164463	28	36	37	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					656	658		10.1038/35015028	http://dx.doi.org/10.1038/35015028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864316				2022-12-28	WOS:000087465800038
J	Loder, N				Loder, N			US science shocked by revelations of sexual discrimination	NATURE			English	Article							WOMEN; BATTLE											Lawler A, 1999, SCIENCE, V286, P1272, DOI 10.1126/science.286.5443.1272; Loder N, 1999, NATURE, V402, P337, DOI 10.1038/46379; Loder N, 1999, NATURE, V400, P202, DOI 10.1038/22184; Nadis S, 1999, NATURE, V398, P361, DOI 10.1038/18746; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; WILSON R, 1999, CHRONICLE HIGHE 1203; ZERNIKE K, 1999, BOSTON GLOBE    0321; 1999, MIT FACULTY NEWSLETT, P4	9	5	5	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					713	714		10.1038/35015266	http://dx.doi.org/10.1038/35015266			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864332				2022-12-28	WOS:000087465800054
J	Dalton, R				Dalton, R			Deep thoughts - North America is about to come under intense geophysical scrutiny	NATURE			English	News Item																			0	4	4	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					390	392		10.1038/35013242	http://dx.doi.org/10.1038/35013242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839512	Bronze			2022-12-28	WOS:000087212000014
J	Levitin, C				Levitin, C			Russian PM supports science	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					384	384		10.1038/35013221	http://dx.doi.org/10.1038/35013221			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839506	Bronze			2022-12-28	WOS:000087212000008
J	Pockley, P				Pockley, P			Tax blow leaves Australian science reeling	NATURE			English	News Item																		1999, NATURE, V399, P94; 1996, NATURE, V382, P659	2	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					387	387		10.1038/35013232	http://dx.doi.org/10.1038/35013232			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839510	Bronze			2022-12-28	WOS:000087212000012
J	Wu, XH; Ranganathan, V; Weisman, DS; Heine, WF; Ciccone, DN; O'Neill, TB; Crick, KE; Pierce, KA; Lane, WS; Rathbum, G; Livingston, DM; Weaver, DT				Wu, XH; Ranganathan, V; Weisman, DS; Heine, WF; Ciccone, DN; O'Neill, TB; Crick, KE; Pierce, KA; Lane, WS; Rathbum, G; Livingston, DM; Weaver, DT			ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response	NATURE			English	Article							ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; BRCA1; COMPLEX; KINASE; REPAIR; HETEROZYGOTES; ASSOCIATION; LINKAGE; RAD51	Nijmegen breakage syndrome (NBS) is characterized by extreme radiation sensitivity, chromosomal instability and cancer(1). The phenotypes are similar to those of ataxia telangiectasia mutated (ATM) disease, where there is a deficiency in a protein kinase that is activated by DNA damage, indicating that the Nbs and Atm proteins may participate in common pathways. Here we report that Nbs is specifically phosphorylated in response to g-radiation, ultraviolet light and exposure to hydroxyurea. Phosphorylation of Nbs mediated by g-radiation, but not that induced by hydroxyurea or ultraviolet light, was markedly reduced in ATM cells. In vivo, Nbs was phosphorylated on many serine residues, of which S343, S397 and S615 were phosphorylated by Atm in vitro. At least two of these sites were underphosphorylated in ATM cells. Inactivation of these serines by mutation partially abrogated Atm-dependent phosphorylation. Reconstituting NBS cells with a mutant form of Nbs that cannot be phosphorylated at selected, ATM-dependent serine residues led to a specific reduction in clonogenic survival after g-radiation. Thus, phosphorylation of Nbs by Atm is critical for certain responses of human cells to DNA damage.	Ctr Blood Res, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Harvard Microchem Facil, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Livingston, DM (corresponding author), Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.							Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; CICCONE DN, UNPUB NATURE GENET; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; ONEILL T, IN PRESS J BIOL CHEM; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; SEEMANOVA E, 1990, MUTAT RES, V238, P321, DOI 10.1016/0165-1110(90)90024-6; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; WU XL, IN PRESS SCIENCE; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	28	366	385	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					477	482		10.1038/35013089	http://dx.doi.org/10.1038/35013089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839545				2022-12-28	WOS:000087212000053
J	White, C				White, C			NICE approves taxanes for breast cancer	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1688	1688						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864529				2022-12-28	WOS:000087926400008
J	Myllykallio, H; Lopez, P; Lopez-Garcia, P; Heilig, R; Saurin, W; Zivanovic, Y; Philippe, H; Forterre, P				Myllykallio, H; Lopez, P; Lopez-Garcia, P; Heilig, R; Saurin, W; Zivanovic, Y; Philippe, H; Forterre, P			Bacterial mode of replication with eukaryotic-like machinery in a hyperthermophilic archaeon	SCIENCE			English	Article							STRAND COMPOSITIONAL ASYMMETRY; DNA-REPLICATION; METHANOCOCCUS-JANNASCHII; IDENTIFICATION; CHROMOSOME; GENOMES; PROTEIN	Despite a rapid increase in the amount of available archaeal sequence information, little is known about the duplication of genetic material in the third domain of life. We identified a single origin of bidirectional replication in Pyrococcus abyssi by means of in silico analyses of cumulative oligomer skew and the identification of an early replicating chromosomal segment. The replication origin in three Pyrococcus species was found to be highly conserved, and several eukaryotic-like DNA replication genes were clustered around it. As in Bacteria, the chromosomal region containing the replication terminus was a hot spot of genome shuffling. Thus, although bacterial and archaeal replication proteins differ profoundly, they are used to replicate chromosomes in a similar manner in both prokaryotic domains.	Univ Paris Sud, Inst Genet & Microbiol, F-91405 Orsay, France; Univ Paris Sud, Biol Cellulaire Lab, F-91405 Orsay, France; Genoscope, Ctr Natl Sequencage, Evry, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Forterre, P (corresponding author), Univ Paris Sud, Inst Genet & Microbiol, F-91405 Orsay, France.	forterre@igmors.u-psud.fr	Myllykallio, Hannu/Y-5462-2019; Lopez-Garcia, Purificacion/B-6775-2012	Lopez-Garcia, Purificacion/0000-0002-0927-0651; Myllykallio, Hannu/0000-0002-0541-1197				Bernander R, 1998, MOL MICROBIOL, V29, P955, DOI 10.1046/j.1365-2958.1998.00956.x; BIERNE H, 1994, MOL MICROBIOL, V13, P17, DOI 10.1111/j.1365-2958.1994.tb00398.x; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Cann IKO, 1999, J BACTERIOL, V181, P6591, DOI 10.1128/JB.181.21.6591-6599.1999; Cann IKO, 1999, GENETICS, V152, P1249; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Desogus G, 1999, NUCLEIC ACIDS RES, V27, P4444, DOI 10.1093/nar/27.22.4444; DINGWALL A, 1989, P NATL ACAD SCI USA, V86, P119, DOI 10.1073/pnas.86.1.119; Forterre P, 1999, MOL MICROBIOL, V33, P457, DOI 10.1046/j.1365-2958.1999.01497.x; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Karlin S, 1999, TRENDS MICROBIOL, V7, P305, DOI 10.1016/S0966-842X(99)01541-3; Kelly TJ, 1998, P NATL ACAD SCI USA, V95, P14634, DOI 10.1073/pnas.95.25.14634; Kelman Z, 1999, J BIOL CHEM, V274, P28751, DOI 10.1074/jbc.274.40.28751; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Leatherwood J, 1998, CURR OPIN CELL BIOL, V10, P742, DOI 10.1016/S0955-0674(98)80117-8; Leipe DD, 1999, NUCLEIC ACIDS RES, V27, P3389, DOI 10.1093/nar/27.17.3389; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lopez P, 1999, MOL MICROBIOL, V32, P883, DOI 10.1046/j.1365-2958.1999.01370.x; Lopez P., UNPUB; LOUARN JM, 1991, J BACTERIOL, V173, P5097, DOI 10.1128/jb.173.16.5097-5104.1991; Maeder DL, 1999, GENETICS, V152, P1299; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; Neuwald AF, 1999, GENOME RES, V9, P27; OGASAWARA N, 1990, BACTERIAL CHROMOSOME, P287; Olsen GJ, 1997, CELL, V89, P991, DOI 10.1016/S0092-8674(00)80284-6; Rocha EPC, 1999, MOL MICROBIOL, V32, P11, DOI 10.1046/j.1365-2958.1999.01334.x; STILLMAN B, 1996, DNA REPLICATION EUKA, P435	27	193	199	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2212	2215		10.1126/science.288.5474.2212	http://dx.doi.org/10.1126/science.288.5474.2212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864870				2022-12-28	WOS:000087782900058
J	Baker, M				Baker, M			Modernising the NHS - Patient care (empowerment): the view from a national society	BRITISH MEDICAL JOURNAL			English	Article									Parkinsons Dis Soc, London SW1V 1EJ, England		Baker, M (corresponding author), Parkinsons Dis Soc, London SW1V 1EJ, England.								0	6	6	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1660	1662		10.1136/bmj.320.7250.1660	http://dx.doi.org/10.1136/bmj.320.7250.1660			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856074	Green Published			2022-12-28	WOS:000087734200029
J	Wong, GCL; Tang, JX; Lin, A; Li, YL; Janmey, PA; Safinya, CR				Wong, GCL; Tang, JX; Lin, A; Li, YL; Janmey, PA; Safinya, CR			Hierarchical self-assembly of F-actin and cationic lipid complexes: Stacked three-layer tubule networks	SCIENCE			English	Article							POSITIVELY CHARGED LIPOSOMES; DNA COMPLEXES; MEMBRANES; PHASE; POLYMERIZATION; VESICLES; SURFACE; PARACRYSTALS	We describe a distinct type of spontaneous hierarchical self-assembly of cytoskeletal filamentous actin (F-actin), a highly charged polyelectrolyte, and cationic Lipid membranes. On the mesoscopic length scale,confocal microscopy reveals ribbonlike tubule structures that connect to form a network of tubules on the macroscopic scale (more than 100 micrometers). Within the tubules, on the 0.5- to 50-nanometer length scale, x-ray diffraction reveals an unusual structure consisting of osmotically swollen stacks of composite membranes with no direct analog in simple amphiphilic systems. The composite membrane is composed of three layers, a lipid bilayer sandwiched between two layers of actin, and is reminiscent of multilayered bacterial cell walls that exist far from equilibrium. Electron microscopy reveals that the actin layer consists of Laterally locked F-actin filaments forming an anisotropic two-dimensional tethered crystal that appears to be the origin of the tubule formation.	Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Biochem & Mol Biol Program, Santa Barbara, CA 93106 USA; Harvard Univ, Brigham & Womens Hosp, Div Expt Med, Boston, MA 02115 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University; Brigham & Women's Hospital	Safinya, CR (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	safinya@mrl.ucsb.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038910, R29AR038910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059288] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR38910] Funding Source: Medline; NIGMS NIH HHS [GM59288] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM FF, 1990, SCIENCE, V249, P393, DOI 10.1126/science.249.4967.393; ARONOVITZ JA, 1988, PHYS REV LETT, V60, P2634, DOI 10.1103/PhysRevLett.60.2634; Bandyopadhyay S, 1999, J PHYS CHEM B, V103, P10075, DOI 10.1021/jp9927496; BLAUROCK AE, 1971, J MOL BIOL, V56, P35, DOI 10.1016/0022-2836(71)90082-9; Bowick M, 1999, PHYS REV E, V59, P5659, DOI 10.1103/PhysRevE.59.5659; Bowick M, 1997, PHYS REV LETT, V79, P885, DOI 10.1103/PhysRevLett.79.885; Bruinsma R, 1998, EUR PHYS J B, V4, P75, DOI 10.1007/s100510050353; CHIRUVOLU S, 1994, SCIENCE, V266, P1222, DOI 10.1126/science.7973704; Dan N, 1996, BIOPHYS J, V71, P1267, DOI 10.1016/S0006-3495(96)79326-8; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; FRANKS NP, 1978, NATURE, V276, P530, DOI 10.1038/276530a0; Gelbart WM, 1994, MICELLES MEMBRANES M; Hackl W, 1998, PHYS REV LETT, V80, P1786, DOI 10.1103/PhysRevLett.80.1786; HANSON J, 1973, PROC R SOC SER B-BIO, V183, P39, DOI 10.1098/rspb.1973.0003; Harries D, 1998, BIOPHYS J, V75, P159, DOI 10.1016/S0006-3495(98)77503-4; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; KANTOR Y, 1986, PHYS REV LETT, V57, P791, DOI 10.1103/PhysRevLett.57.791; KLOSGEN B, 1993, EUR BIOPHYS J, V22, P340; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; LALIBERTE A, 1988, J CELL BIOL, V106, P1221, DOI 10.1083/jcb.106.4.1221; Lasic DD., 1997, LIPOSOMES GENE DELIV; Lipowsky R., 1995, P521; Lodish H., 1999, MOL CELL BIOL; Miyata H, 1999, P NATL ACAD SCI USA, V96, P2048, DOI 10.1073/pnas.96.5.2048; Nelson D, 1989, STAT MECH MEMBRANES; O'Hern CS, 1999, PHYS REV LETT, V83, P2745, DOI 10.1103/PhysRevLett.83.2745; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V394, P483, DOI 10.1016/0005-2736(75)90299-0; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Radzihovsky L, 1995, PHYS REV LETT, V75, P4752, DOI 10.1103/PhysRevLett.75.4752; Renault A, 1999, BIOPHYS J, V76, P1580, DOI 10.1016/S0006-3495(99)77317-0; RIOUX L, 1985, J ULTRA MOL STRUCT R, V93, P42, DOI 10.1016/0889-1605(85)90084-9; Safran S. A., 1994, STAT THERMODYNAMICS; Sara M, 1996, PROG BIOPHYS MOL BIO, V65, P83, DOI 10.1016/S0079-6107(96)00007-7; SCHMIDT CF, 1993, SCIENCE, V259, P952, DOI 10.1126/science.8438153; SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669; Spector MS, 1999, ADV MATER, V11, P337, DOI 10.1002/(SICI)1521-4095(199903)11:4<337::AID-ADMA337>3.0.CO;2-V; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; TAYLOR KA, 1992, J STRUCT BIOL, V108, P140, DOI 10.1016/1047-8477(92)90013-Z; Thomas BN, 1999, PHYS REV E, V59, P3040, DOI 10.1103/PhysRevE.59.3040; THOMAS BN, 1995, SCIENCE, V267, P1635, DOI 10.1126/science.267.5204.1635; Thomas BN, 1998, J AM CHEM SOC, V120, P12178, DOI 10.1021/ja973933c	42	194	197	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2035	+		10.1126/science.288.5473.2035	http://dx.doi.org/10.1126/science.288.5473.2035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856215				2022-12-28	WOS:000087687000048
J	Annas, GJ				Annas, GJ			Rules for research on human genetic variation - Lessons from Iceland.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							POPULATION; CONSENT; DISEASE; BANKS		Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University; Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.			Annas, George/0000-0001-5836-7831				Annas George J., 1992, NAZI DOCTORS NUREMBU; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; Berenson A., 2000, NY TIMES        0315, pA1; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; *COMM GEN DIV COMM, 1997, EV HUM GEN DIV; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Enserink M, 2000, SCIENCE, V287, P951, DOI 10.1126/science.287.5455.951; Fears R, 1999, SCIENCE, V284, P267, DOI 10.1126/science.284.5412.267; Frank L, 1999, SCIENCE, V286, P1262, DOI 10.1126/science.286.5443.1262; Glantz LH, 1998, HASTINGS CENT REP, V28, P38, DOI 10.2307/3528268; Greely H T, 2000, Jurimetrics, V40, P153; *GUDR, 1992, HAV SAYINGS VIK, P71; *I MED, 1993, ASS GEN RISKS; Jonatansson H, 2000, AM J LAW MED, V26, P31; Juengst ET, 1998, AM J HUM GENET, V63, P673, DOI 10.1086/302032; *MANNV, 1999, NANNV ASS IC ETH SCI; National Bioethics Advisory Commission, 1999, RES INV HUM BIOL MAT; NICKERSON C, 2000, BOSTON GLOBE    0102, pA17; Nilsson A, 1999, SCIENCE, V286, P894, DOI 10.1126/science.286.5441.894; Reilly PR, 1998, AM J HUM GENET, V63, P682, DOI 10.1086/302028; RIDLEY M, 1999, GENOME AUTOBIOGRAPHY, P190; Roche PA, 1996, JURIMETRICS, V37, P1; Shuster E, 1997, NEW ENGL J MED, V337, P1436, DOI 10.1056/NEJM199711133372006	23	54	56	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1830	1833		10.1056/NEJM200006153422412	http://dx.doi.org/10.1056/NEJM200006153422412			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853009	Green Published			2022-12-28	WOS:000087573700012
J	Kanfoush, SL; Hodell, DA; Charles, CD; Guilderson, TP; Mortyn, PG; Ninnemann, US				Kanfoush, SL; Hodell, DA; Charles, CD; Guilderson, TP; Mortyn, PG; Ninnemann, US			Millennial-scale instability of the antarctic ice sheet during the last glaciation	SCIENCE			English	Article							YOUNGER DRYAS EVENT; NORTH-ATLANTIC; SEA-LEVEL; HEINRICH EVENTS; ICEBERG DISCHARGES; CLIMATE OSCILLATIONS; GLOBAL CLIMATE; GREENLAND ICE; RECORD; OCEAN	Records of ice-rafted detritus (IRD) concentration in deep-sea cores from the southeast Atlantic Ocean reveal millennial-scale pulses of IRD delivery between 20,000 and 74,000 years ago. Prominent IRD Layers correlate across the Polar Frontal Zone, suggesting episodes of Antarctic Ice Sheet instability. Carbon isotopes (delta(13)C) of benthic foraminifers, a proxy of deepwater circulation, reveal that South Atlantic IRD events coincided with strong increases in North Atlantic Deep Water (NADW) production and inferred warming (interstadials) in the high-latitude North Atlantic. Sea level rise or increased NADW production associated with strong interstadials may have resulted in destabilization of grounded ice shelves and possible surging in the Weddell Sea region of West Antarctica.	Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Calif Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	State University System of Florida; University of Florida; University of California System; University of California San Diego; Scripps Institution of Oceanography; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; Harvard University	Kanfoush, SL (corresponding author), Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA.		Mortyn, P. Graham/I-3860-2015	Mortyn, P. Graham/0000-0002-9473-4309; Hodell, David/0000-0001-8537-1588				ALLEN CP, 1991, P OC DRILL PROGR SCI, V0114; ANDERSON JB, 1991, SEDIMENT GEOL, V70, P87, DOI 10.1016/0037-0738(91)90136-2; ANDREWS JT, 1992, GEOLOGY, V20, P1087, DOI 10.1130/0091-7613(1992)020<1087:DCRSNL>2.3.CO;2; Bard E, 1998, RADIOCARBON, V40, P1085, DOI 10.1017/S0033822200019135; BEHL LRJ, 1996, NATURE, V379, P379; BENDER M, 1994, NATURE, V372, P663, DOI 10.1038/372663a0; Benson LV, 1998, QUATERNARY RES, V49, P1, DOI 10.1006/qres.1997.1940; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; Brathauer U, 1999, PALEOCEANOGRAPHY, V14, P135, DOI 10.1029/1998PA900020; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Channell JET, 2000, EARTH PLANET SC LETT, V175, P145, DOI 10.1016/S0012-821X(99)00285-X; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Charles CD, 1996, EARTH PLANET SC LETT, V142, P19, DOI 10.1016/0012-821X(96)00083-0; CONOLLY JR, 1965, SCIENCE, V150, P1822, DOI 10.1126/science.150.3705.1822; Cooke D. W., 1982, ANTARCT GEOSCI, P1017; Crosta X, 1998, PALEOCEANOGRAPHY, V13, P284, DOI 10.1029/98PA00339; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; DENTON GH, 1986, QUATERNARY RES, V26, P3, DOI 10.1016/0033-5894(86)90081-5; DENTON GH, 1983, QUATERNARY RES, V20, P125, DOI 10.1016/0033-5894(83)90073-X; Elliot M, 1998, PALEOCEANOGRAPHY, V13, P433, DOI 10.1029/98PA01792; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; FRONVAL T, 1995, NATURE, V374, P443, DOI 10.1038/374443a0; GLOERSON P, 1993, NASA; GORDON AL, 1981, J GEOPHYS RES-OCEANS, V86, P4193, DOI 10.1029/JC086iC05p04193; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; GROBE H, 1992, ANTARCT RES SER, V0056; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Hulbe CL, 1997, PALEOCEANOGRAPHY, V12, P711, DOI 10.1029/97PA02014; Jacobs SS, 1985, OCEANOLOGY ANTARCTIC, V43, P59, DOI DOI 10.1029/AR043P0059; JOUZEL J, 1995, CLIM DYNAM, V11, P151, DOI 10.1007/BF00223498; KEANY J, 1976, GEOL SOC AM BULL, V87, P873, DOI 10.1130/0016-7606(1976)87<873:DDOIDI>2.0.CO;2; LABEYRIE LD, 1986, NATURE, V322, P701, DOI 10.1038/322701a0; Linsley BK, 1996, NATURE, V380, P234, DOI 10.1038/380234a0; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; Manabe S, 1997, PALEOCEANOGRAPHY, V12, P321, DOI 10.1029/96PA03932; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; NESHYBA S, 1977, NATURE, V267, P507, DOI 10.1038/267507a0; Ninnemann US, 1999, GEOPH MONOG SERIES, V112, P99; RUDDIMAN WF, 1977, GEOL SOC AM BULL, V88, P1813, DOI 10.1130/0016-7606(1977)88<1813:LQDOIS>2.0.CO;2; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; *SHIP SCI PART, 1999, P OCEAN DRILLING PRO, V177, P35; SMITH DG, 1983, MAR GEOL, V53, P291, DOI 10.1016/0025-3227(83)90047-6; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; WARNKE DA, 1970, AM J SCI, V269, P276, DOI 10.2475/ajs.269.3.276; [No title captured]	49	145	149	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1815	1818		10.1126/science.288.5472.1815	http://dx.doi.org/10.1126/science.288.5472.1815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846161				2022-12-28	WOS:000087503800047
J	Chalandon, Y; Kocher, A				Chalandon, Y; Kocher, A			Severe malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland	University of Geneva	Chalandon, Y (corresponding author), Univ Hosp Geneva, CH-1211 Geneva 14, Switzerland.		Chalandon, Yves/AAF-5125-2019	Chalandon, Yves/0000-0001-9341-8104					0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1715	1715		10.1056/NEJM200006083422305	http://dx.doi.org/10.1056/NEJM200006083422305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841874				2022-12-28	WOS:000087449300005
J	Lasne, F; de Ceaurriz, J				Lasne, F; de Ceaurriz, J			Recombinant erythropoietin in urine - An artificial hormone taken to boost athletic performance can now be detected.	NATURE			English	Article									Natl Antidoping Lab, F-92290 Chatenay Malabry, France		Lasne, F (corresponding author), Natl Antidoping Lab, F-92290 Chatenay Malabry, France.							CASONI I, 1993, INT J SPORTS MED, V14, P307, DOI 10.1055/s-2007-1021183; Gareau R, 1996, NATURE, V380, P113, DOI 10.1038/380113a0; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; WIDE L, 1995, MED SCI SPORT EXER, V27, P1569	4	309	321	2	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					635	635		10.1038/35015164	http://dx.doi.org/10.1038/35015164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864311				2022-12-28	WOS:000087465800033
J	Spurgeon, D				Spurgeon, D			Immigrants help offset Canada's brain-drain crisis	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					604	604		10.1038/35015234	http://dx.doi.org/10.1038/35015234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864293	Bronze			2022-12-28	WOS:000087465800009
J	Helariutta, Y; Fukaki, H; Wysocka-Diller, J; Nakajima, K; Jung, J; Sena, G; Hauser, MT; Benfey, PN				Helariutta, Y; Fukaki, H; Wysocka-Diller, J; Nakajima, K; Jung, J; Sena, G; Hauser, MT; Benfey, PN			The SHORT-ROOT gene controls radial patterning of the Arabidopsis root through radial signaling	CELL			English	Article							CELL-DIFFERENTIATION; DNA-SEQUENCES; THALIANA; MERISTEM; PROTEIN; IDENTIFICATION; ORGANIZATION; PATHWAY; ENCODES; SEARCH	Asymmetric cell divisions play an important role in the establishment and propagation of the cellular pattern of plant tissues. The SHORT-ROOT (SHR) gene is required for the asymmetric cell division responsible for formation of ground tissue (endodermis and cortex) as well as specification of endodermis in the Arabidopsis root. We show that SHR encodes a putative transcription factor with homology to SCARECROW (SCR). From analyses of gene expression and cell identity in genetically stable and unstable alleles of shr, we conclude that SHR functions upstream of SCR and participates in a radial signaling pathway. Consistent with a regulatory role in radial patterning, ectopic expression of SHR results in supernumerary cell divisions and abnormal cell specification in the root meristem.	NYU, Dept Biol, New York, NY 10003 USA; Univ Bodenkultur Wien, Ctr Appl Genet, A-1190 Vienna, Austria	New York University; University of Natural Resources & Life Sciences, Vienna	Benfey, PN (corresponding author), NYU, Dept Biol, 1009 Main Bldg, New York, NY 10003 USA.	philip.benfey@nyu.edu	Sena, Giovanni/C-3297-2012; Helariutta, Yrjo/AAE-8149-2020; Hauser, Marie-Theres/J-6029-2013	Sena, Giovanni/0000-0003-3626-5038; Helariutta, Yrjo/0000-0002-7287-8459; Hauser, Marie-Theres/0000-0001-8938-2460; Nakajima, Keiji/0000-0002-1580-3354	NIGMS NIH HHS [R01-GM43778] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DIETRICH RA, 1992, PLANT CELL, V4, P1371, DOI 10.1105/tpc.4.11.1371; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Freshour G, 1996, PLANT PHYSIOL, V110, P1413, DOI 10.1104/pp.110.4.1413; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; LONG D, 1993, P NATL ACAD SCI USA, V90, P10370, DOI 10.1073/pnas.90.21.10370; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MAYER U, 1993, DEVELOPMENT, V117, P149; MeloOliveira R, 1996, P NATL ACAD SCI USA, V93, P4718, DOI 10.1073/pnas.93.10.4718; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	35	751	806	4	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					555	567		10.1016/S0092-8674(00)80865-X	http://dx.doi.org/10.1016/S0092-8674(00)80865-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850497	Bronze			2022-12-28	WOS:000087375400012
J	Mata, J; Curado, S; Ephrussi, A; Rorth, P				Mata, J; Curado, S; Ephrussi, A; Rorth, P			Tribbles coordinates mitosis and morphogenesis in Drosophila by regulating string/CDC25 proteolysis	CELL			English	Article							CELL-CYCLE REGULATORS; BAG-OF-MARBLES; CHECKPOINT MONITORS; FEMALE GERMLINE; GENE-EXPRESSION; CYST FORMATION; FISSION YEAST; PROTEIN; CDC25; DIVISION	Morphogenesis and cell differentiation in multicellular organisms often require accurate control of cell divisions. We show that a novel cell cycle regulator, tribbles, is critical for this control during Drosophila development. During oogenesis, the level of tribbles affects the number of germ cell divisions as well as oocyte determination. The mesoderm anlage enters mitosis prematurely in tribbles mutant embryos, leading to gastrulation defects. We show that Tribbles acts by specifically inducing degradation of the CDC25 mitotic activators String and Twine via the proteosome pathway. By regulating CDC25, Tribbles serves to coordinate entry into mitosis with morphogenesis and cell fate determination.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Rorth, P (corresponding author), European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany.		Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021; Rørth, Pernille/H-3020-2011	Ephrussi, Anne/0000-0002-5061-4620; Mata, Juan/0000-0002-5514-3653				ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; BRAND AH, 1993, DEVELOPMENT, V118, P401; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; deCuevas M, 1996, DEVELOPMENT, V122, P3959; DUCOMMUN B, 1990, BIOCHEM BIOPH RES CO, V167, P301, DOI 10.1016/0006-291X(90)91765-K; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; EDGAR BA, 1994, DEVELOPMENT, V120, P3131; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Foe Victoria E., 1993, P149; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Hawkins NC, 1996, DEVELOPMENT, V122, P281; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lehner CF, 1997, J CELL SCI, V110, P523; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Lilly MA, 2000, DEV BIOL, V218, P53, DOI 10.1006/dbio.1999.9570; LIN HF, 1994, DEVELOPMENT, V120, P947; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; MORENO S, 1990, NATURE, V344, P549, DOI 10.1038/344549a0; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Pines J, 1998, Results Probl Cell Differ, V22, P57; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 1998, DEVELOPMENT, V125, P1049; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Spradling Allan C., 1993, P1; Van Doren M, 1998, CURR BIOL, V8, P243; Wilkin F, 1997, EUR J BIOCHEM, V248, P660, DOI 10.1111/j.1432-1033.1997.t01-1-00660.x; Wilkin F, 1996, J BIOL CHEM, V271, P28451, DOI 10.1074/jbc.271.45.28451; YUE L, 1992, GENE DEV, V6, P2443, DOI 10.1101/gad.6.12b.2443	43	301	314	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					511	522		10.1016/S0092-8674(00)80861-2	http://dx.doi.org/10.1016/S0092-8674(00)80861-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850493	Bronze			2022-12-28	WOS:000087375400008
J	Dickson, D				Dickson, D			Mathematicians chase the seven million-dollar proofs	NATURE			English	News Item																		1999, NATURE, V400, P115	1	4	4	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					383	383		10.1038/35013216	http://dx.doi.org/10.1038/35013216			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839504	Bronze			2022-12-28	WOS:000087212000006
J	Macilwain, C				Macilwain, C			Congress wakes up to climate change	NATURE			English	News Item																			0	2	2	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					385	385		10.1038/35013224	http://dx.doi.org/10.1038/35013224			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839507	Bronze			2022-12-28	WOS:000087212000009
J	Keavney, B; McKenzie, C; Parish, S; Palmer, A; Clark, S; Youngman, L; Delepine, M; Lathrop, M; Peto, R; Collins, R				Keavney, B; McKenzie, C; Parish, S; Palmer, A; Clark, S; Youngman, L; Delepine, M; Lathrop, M; Peto, R; Collins, R		Int Studies Infarct Survival ISIS	Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls	LANCET			English	Article							CORONARY-ARTERY DISEASE; RECEPTOR GENE POLYMORPHISMS; ISCHEMIC-HEART-DISEASE; DELETION I/D POLYMORPHISM; INCREASED RISK; ESSENTIAL-HYPERTENSION; GENOTYPE DISTRIBUTION; APOLIPOPROTEIN-E; DD-GENOTYPE; ACE	Background The original report of a possible association between myocardial infarction and the insertion/deletion (VD) polymorphism of the gene for the angiotensin-1-converting enzyme (ACE) indicated a risk ratio for myocardial infarction with the DD genotype of 1.34 (95% CI 1.05-1.70), and the association was claimed to be particularly strong in a retrospectively defined low-risk subgroup (3.2 [95% CI 1.7-5.9). Subsequent investigations reached varying conclusions, but ail were small, and much larger studies were needed. Methods 4629 myocardial infarction cases and 5934 controls were compared. Cases were UK men aged 30-54 years and women aged 30-64 years recruited on presentation to hospital with confirmed myocardial infarction. Controls were aged 30-64 years with no history of cardiovascular disease, but were siblings or children of myocardial infarction survivors, or spouses of such relatives. All risk-ratio calculations allow for this relatedness of some of the controls. An updated meta-analysis of previous studies was also conducted. Findings The ACE DD genotype was found in 1359 (29.4%) of the myocardial infarction cases and in 1637 (27.6%) of the controls (risk ratio 1.10 [95% CI 1.00-1.21]). The association between myocardial infarction and the DD genotype did not seem to be stronger in the subgroup defined as low risk by previously used criteria (234 [28%] of 836 cases and 911 [28%] of 3253 controls: risk ratio 1.04 [95% CI 0.87-1.24]), or in any other subgroup. Nor was the ACE I/D genotype predictive of subsequent survival. Interpretation This study involved many more cases than any previously reported study of this question, but did not confirm the existence of any substantial association. In an updated meta-analysis of these results with those of previously published studies, the risk ratio for myocardial infarction with the DD genotype seems to lie in the range 1.0 to about 1.1. Although an increase in risk of up to about 10-15% cannot be ruled out, substantially more extreme risks can be. Moreover, there are not especially strong associations in the subgroups previously selected for emphasis. These findings illustrate the need for some studies of candidate genes to involve much larger populations than is customary, without undue emphasis on retrospectively defined subgroups.	Univ Oxford, Radcliffe Infirm, Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford OX2 6HE, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX2 6HE, England; Univ Oxford, Radcliffe Infirm, Nuffield Dept Clin Med, Epidemiol Studies Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Radcliffe Infirmary; University of Oxford	Collins, R (corresponding author), Univ Oxford, Radcliffe Infirm, Nuffield Dept Clin Med, Clin Trial Serv Unit, Oxford OX2 6HE, England.			Keavney, Bernard/0000-0001-9573-0812				AgerholmLarsen B, 1997, CIRCULATION, V95, P2358, DOI 10.1161/01.CIR.95.10.2358; AHNVE S, 1995, J AM COLL CARDIOL, V25, pA276; Akar N, 1998, SCAND J CLIN LAB INV, V58, P491, DOI 10.1080/00365519850186292; Altshuler D, 1998, NEW ENGL J MED, V338, P1626, DOI 10.1056/NEJM199805283382214; Anderson JL, 1998, J AM COLL CARDIOL, V31, P790, DOI 10.1016/S0735-1097(98)00007-2; ARBUSTINI E, 1995, BRIT HEART J, V74, P584; Arca M, 1998, EUR J CLIN INVEST, V28, P485; BEOHAR N, 1995, J INVEST MED, V43, P275; Biggart S, 1998, CLIN CARDIOL, V21, P831, DOI 10.1002/clc.4960211109; Bogaty P, 1998, AM HEART J, V136, P884, DOI 10.1016/S0002-8703(98)70135-8; BOHN M, 1993, CLIN GENET, V44, P292; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Cambien F, 1995, EUR HEART J, V16, P13, DOI 10.1093/eurheartj/16.suppl_K.13; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Chiang FT, 1997, JPN HEART J, V38, P227; CHOWDHURY TA, 1994, LANCET, V344, P1502, DOI 10.1016/S0140-6736(94)90318-2; COLLINS R, 1996, OXFORD TXB MED, V1, P21; COSTEROUSSE O, 1993, BIOCHEM J, V290, P33, DOI 10.1042/bj2900033; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; Espinosa JS, 1998, MED CLIN-BARCELONA, V110, P488; EVANS AE, 1994, Q J MED, V87, P211; Ferrieres J, 1999, ATHEROSCLEROSIS, V142, P211, DOI 10.1016/S0021-9150(98)00204-4; FRIEDL W, 1995, ATHEROSCLEROSIS, V112, P137, DOI 10.1016/0021-9150(94)05406-9; Fujimura T, 1997, AM J HYPERTENS, V10, P1384, DOI 10.1016/S0895-7061(97)00323-3; FUJISAWA T, 1995, DIABETES CARE, V18, P983, DOI 10.2337/diacare.18.7.983; Gardemann A, 1998, EUR HEART J, V19, P1657, DOI 10.1053/euhj.1998.1097; Gardemann A, 1998, ATHEROSCLEROSIS, V139, P153, DOI 10.1016/S0021-9150(98)00040-9; Gukova S P, 1997, Klin Med (Mosk), V75, P36; Holmer S. R., 1999, European Heart Journal, V20, P143; HUNT D, 1992, LANCET, V339, P753; Iwai N, 1997, ARTERIOSCL THROM VAS, V17, P1730, DOI 10.1161/01.ATV.17.9.1730; JAMIESON A, 1995, BR HEART J S3, V73, pP186; KAMITANI A, 1995, HYPERTENSION, V25, P950, DOI 10.1161/01.HYP.25.5.950; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; KEAVNEY BD, 1995, DIABETOLOGIA, V38, P948, DOI 10.1007/s001250050376; Ko YL, 1997, HUM GENET, V100, P210, DOI 10.1007/s004390050492; Krizanova O, 1997, PHYSIOL RES, V46, P357; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATINI R, 1995, CIRCULATION, V92, P3132, DOI 10.1161/01.CIR.92.10.3132; LEATHAM E, 1994, J HUM HYPERTENS, V8, P635; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; LUDWIG E, 1995, CIRCULATION, V91, P2120, DOI 10.1161/01.CIR.91.8.2120; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moiseev VS, 1997, TERAPEVT ARKH, V69, P18; NAKAI K, 1994, CIRCULATION, V90, P2199, DOI 10.1161/01.CIR.90.5.2199; Nakai K, 1998, CORONARY ARTERY DIS, V9, P329, DOI 10.1097/00019501-199809060-00002; Nakauchi Y, 1996, ATHEROSCLEROSIS, V125, P161; O'Malley JP, 1998, CIRCULATION, V97, P1780, DOI 10.1161/01.CIR.97.18.1780; OSHIMA T, 1997, JPN J CLIN PATHOL, V45, P115; PARISH S, 1995, BMJ-BRIT MED J, V311, P471, DOI 10.1136/bmj.311.7003.471; Park Hyun-Young, 1997, Journal of Korean Medical Science, V12, P391; PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701, DOI 10.1161/01.ATV.12.6.701; Pfohl M, 1999, EUR HEART J, V20, P1318, DOI 10.1053/euhj.1999.1543; Ramasawmy R, 1996, CLIN GENET, V50, P551; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROBITAILLE NM, 1994, CIRCULATION, V90, P110; RUIZ J, 1994, P NATL ACAD SCI USA, V91, P3662, DOI 10.1073/pnas.91.9.3662; Samani NJ, 1996, J AM COLL CARDIOL, V28, P338, DOI 10.1016/0735-1097(96)00139-8; Samani NJ, 1996, CIRCULATION, V94, P708, DOI 10.1161/01.CIR.94.4.708; SCHUSTER H, 1995, AM J CARDIOL, V76, P601, DOI 10.1016/S0002-9149(99)80164-7; SHANMUGAM V, 1993, PCR METH APPL, V3, P120; Sigusch HH, 1997, SCAND J CLIN LAB INV, V57, P127, DOI 10.1080/00365519709056380; Staessen JA, 1997, J HYPERTENS, V15, P1579, DOI 10.1097/00004872-199715120-00059; TAKAHASHI K, 1995, JPN HEART J, V36, P557; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; TIRET L, 1994, LANCET, V344, P910, DOI 10.1016/S0140-6736(94)92268-3; TIRET L, 1992, AM J HUM GENET, V51, P197; VANBOCKXMEER FM, 1995, CIRCULATION, V92, P2066, DOI 10.1161/01.CIR.92.8.2066; Wang XL, 1996, ARTERIOSCL THROM VAS, V16, P115, DOI 10.1161/01.ATV.16.1.115; Winkelmann BR, 1996, ANN INTERN MED, V125, P19, DOI 10.7326/0003-4819-125-1-199607010-00004; YOUNGMAN LD, 1993, FASEB J, V1, P377; Zhao Y, 1994, HYPERTENS RES, V17, P55	74	286	299	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					434	442						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841123				2022-12-28	WOS:000085306800009
J	Macpherson, AJ; Gatto, D; Sainsbury, E; Harriman, GR; Hengartner, H; Zinkernagel, RM				Macpherson, AJ; Gatto, D; Sainsbury, E; Harriman, GR; Hengartner, H; Zinkernagel, RM			A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria	SCIENCE			English	Article							CHOLERA-TOXIN; AFFINITY MATURATION; GERMINAL-CENTERS; DEFICIENT MICE; MUTANT MICE; LYMPHOCYTES; IMMUNITY; GUT; DIFFERENTIATION; IMMUNIZATION	The immunoglobulin A (IgA) is produced to defend mucosal surfaces from environmental organisms, but host defenses against the very heavy load of intestinal commensal microorganisms are poorly understood. The IgA against intestinal commensal bacterial antigens was analyzed; it was not simply "natural antibody" but was specifically induced and responded to antigenic changes within an established gut flora. In contrast to IgA responses against exotoxins, a significant proportion of this specific anti-commensal IgA induction was through a pathway that was independent of T cell help and of follicular lymphoid tissue organization, which may reflect an evolutionarily primitive form of specific immune defense.	Univ Spital Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; GKT Sch Med, London SE5 9PJ, England; Centocor Inc, Malvern, PA 19355 USA	University of Zurich; University Zurich Hospital; University of London; King's College London; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Macpherson, AJ (corresponding author), Univ Spital Zurich, Inst Expt Immunol, Schmetzbergstr 12, CH-8091 Zurich, Switzerland.							Bos NA, 1996, INFECT IMMUN, V64, P616, DOI 10.1128/IAI.64.2.616-623.1996; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; ELSON CO, 1984, J IMMUNOL, V132, P2736; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Gardby E, 1998, J IMMUNOL, V161, P49; Harriman GR, 1999, J IMMUNOL, V162, P2521; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; Londono LP, 1996, VACCINE, V14, P545; LYCKE N, 1987, SCAND J IMMUNOL, V25, P413, DOI 10.1111/j.1365-3083.1987.tb02208.x; MACPHERSON AJ, UNPUB; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Medaglini D, 1997, VACCINE, V15, P1330, DOI 10.1016/S0264-410X(97)00026-1; MEGA J, 1991, INT IMMUNOL, V3, P793, DOI 10.1093/intimm/3.8.793; MOMBAERTS P, 1994, INT IMMUNOL, V6, P1061, DOI 10.1093/intimm/6.7.1061; NANNO M, 1994, J IMMUNOL, V153, P2014; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Snider DP, 1999, INT IMMUNOL, V11, P191, DOI 10.1093/intimm/11.2.191; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; WESTPHAL O, 1966, ADV CARBOHYD CHEM, V25, P83	25	794	833	11	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2222	+		10.1126/science.288.5474.2222	http://dx.doi.org/10.1126/science.288.5474.2222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864873				2022-12-28	WOS:000087782900061
J	Takahashi, K; Chen, ES; Yanagida, M				Takahashi, K; Chen, ES; Yanagida, M			Requirement of Mis6 centromere connector for localizing a CENP-A-like protein in fission yeast	SCIENCE			English	Article							CHROMOSOME SEGREGATION; GENE; DIVISION; MUTATION; SEQUENCE; MITOSIS	Mammalian kinetochores contain the centromere-specific histone H3 Variant CENP-A, whose incorporation into limited chromosomal regions may be important for centromere function and chromosome segregation during mitosis. However, regulation of CENP-A localization and its role have not been clear. Here we report that the fission yeast homolog SpCENP-A is essential for establishing centromere chromatin associated with equal chromosome segregation. SpCENP-A binding to the nonrepetitious inner centromeres depended on Mis6, an essential centromere connector protein acting during G(1)-S phase of the cell cycle. Mis6 is likely required for recruiting SpCENP-A to form proper connection of sister centromeres.	Kyoto Univ, Grad Sch Biostudies, Japan Sci & Technol Corp, CREST Res Project,Sakyo Ku, Kyoto, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Biophys, Sakyo Ku, Kyoto, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto, Japan	Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Japan Sci & Technol Corp, CREST Res Project,Sakyo Ku, Kyoto, Japan.							Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; MATSUMOTO S, 1985, EMBO J, V4, P3531, DOI 10.1002/j.1460-2075.1985.tb04113.x; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tatebayashi K, 1998, GENETICS, V148, P49	17	325	331	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2215	2219		10.1126/science.288.5474.2215	http://dx.doi.org/10.1126/science.288.5474.2215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864871				2022-12-28	WOS:000087782900059
J	Grassl, H				Grassl, H			Status and improvements of coupled general circulation models	SCIENCE			English	Review							CLIMATE-CHANGE; OCEAN; SIMULATION; PROJECT; ATTRIBUTION; FEEDBACKS; MONSOON; SURFACE	Coupled general circulation models (CGCMs) integrate our knowledge about atmospheric and oceanic circulation, Different versions of CGCMs are used to provide a better understanding of natural climate variability on interannual and decadal time scales, for extended weather forecasting, and for making seasonal climate scenario projections. They also help to reconstruct past climates, especially abrupt climate change processes. Model intercomparisons, new test data (mainly from satellites), more powerful computers, and parameterizations of atmospheric and oceanic processes have improved CGCM performance to such a degree that the model results are now used by many decision-makers, including governments. They are also fundamental for the detection and attribution of climate change.	Max Planck Inst Meteorol, D-20146 Hamburg, Germany	Max Planck Society	Grassl, H (corresponding author), Max Planck Inst Meteorol, Bundesstr 55, D-20146 Hamburg, Germany.	grassl@dkrz.de						BARNETT TP, IN PRESS B AM METEOR; Bengtsson L, 1999, J GEOPHYS RES-ATMOS, V104, P3865, DOI 10.1029/1998JD200046; BERGER A, 1988, REV GEOPHYS, V26, P624, DOI 10.1029/RG026i004p00624; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; Brovkin V, 1999, GLOBAL ECOL BIOGEOGR, V8, P509, DOI 10.1046/j.1365-2699.1999.00169.x; Charney JG, 1950, TELLUS, V2, P237, DOI DOI 10.1111/J.2153-3490.1950.TB00336.X; Cubasch U, 1997, CLIM DYNAM, V13, P757, DOI 10.1007/s003820050196; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Gibson J.K., 1997, EUR CENT MED RANG WE; Giorgi F, 1999, J GEOPHYS RES-ATMOS, V104, P6335, DOI 10.1029/98JD02072; GIORGI F, 1991, REV GEOPHYS, V29, P191, DOI 10.1029/90RG02636; GRASSL H, 1978, HAMBURGER GEOPHYSI B; Hasselmann K, 1998, Q J ROY METEOR SOC, V124, P2541, DOI 10.1002/qj.49712455202; Hasselmann K, 1997, CLIM DYNAM, V13, P601, DOI 10.1007/s003820050185; HASSELMANN K, 1993, J CLIMATE, V6, P1957, DOI 10.1175/1520-0442(1993)006<1957:OFFTDO>2.0.CO;2; HEGERL GC, IN PRESS CLIM DYN; Hewitt CD, 1998, GEOPHYS RES LETT, V25, P361, DOI 10.1029/97GL03721; Huffman GJ, 1997, B AM METEOROL SOC, V78, P5, DOI 10.1175/1520-0477(1997)078<0005:TGPCPG>2.0.CO;2; IPCC, 1996, SCI CLIM CHANG; Joussaume S, 1999, GEOPHYS RES LETT, V26, P859, DOI 10.1029/1999GL900126; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kutzbach JE, 1997, SCIENCE, V278, P440, DOI 10.1126/science.278.5337.440; Latif M, 1998, J CLIMATE, V11, P602, DOI 10.1175/1520-0442(1998)011<0602:DOIVIC>2.0.CO;2; LATIF M, IN PRESS J CLIM; LETREUT H, 2000, COMMUNICATION; MANABE S, 1995, NATURE, V378, P165, DOI 10.1038/378165a0; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Meehl GA, 2000, B AM METEOROL SOC, V81, P427, DOI 10.1175/1520-0477(2000)081<0427:TIEWAC>2.3.CO;2; MEEHL GA, IN PRESS B AM METEOR; OERLEMANS J, IN PRESS J GLACIOL; PETOUKHOV V, IN PRESS CLIM DYN; PHILLIPS NA, 1956, Q J ROY METEOR SOC, V82, P123, DOI 10.1002/qj.49708235202; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Reichert BK, 1999, J GEOPHYS RES-ATMOS, V104, P19071, DOI 10.1029/1999JD900264; ROECKNER E, IN PRESS J CLIM; ROWLAND FS, 1988, CHANGING ATMOSPHERE, pCH11; Stockdale TN, 1998, NATURE, V392, P370, DOI 10.1038/32861; Stocker TF, 2000, P NATL ACAD SCI USA, V97, P1362, DOI 10.1073/pnas.97.4.1362; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; STOUFFER RJ, IN PRESS J CLIM; Tett SFB, 1999, NATURE, V399, P569, DOI 10.1038/21164; Texier D, 1997, CLIM DYNAM, V13, P865, DOI 10.1007/s003820050202; Wetherald RT, 1999, CLIMATIC CHANGE, V43, P495, DOI 10.1023/A:1005499220385; WMO (World Meteorological Organization), 1998, 44 WMO GLOB OZ RES M; Zwiers FW, 1998, J CLIMATE, V11, P2200, DOI 10.1175/1520-0442(1998)011<2200:CITEOT>2.0.CO;2	45	40	46	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					1991	1997		10.1126/science.288.5473.1991	http://dx.doi.org/10.1126/science.288.5473.1991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856204				2022-12-28	WOS:000087687000037
J	Ichise, T; Kano, M; Hashimoto, K; Yanagihara, D; Nakao, K; Shigemoto, R; Katsuki, M; Aiba, A				Ichise, T; Kano, M; Hashimoto, K; Yanagihara, D; Nakao, K; Shigemoto, R; Katsuki, M; Aiba, A			mGLuR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination	SCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CLIMBING FIBER INNERVATION; MICE LACKING MGLUR1; MUTANT MICE; TRANSGENE EXPRESSION; FUNCTIONAL SYNAPSES; NERVOUS-SYSTEM; IMPAIRMENT; PLASTICITY; REGRESSION	Targeted deletion of metabotropic glutamate receptor-subtype 1 (mGluR1) gene can cause defects in development and function in the Cerebellum, We introduced the mGluR1 alpha transgene into mGluR1-null mutant [mGluR1 (-/-)] mice with a Purkinje cell (PC)-specific promoter, mGluR1-rescue mice showed normal cerebellar long-term depression and regression of multiple climbing fiber innervation, events significantly impaired in mGluR1 (-/-) mice. The impaired motor coordination was rescued by this transgene, in a dose-dependent manner. We propose that mGluR1 in PCs is a key molecule for normal synapse formation, synaptic plasticity, and motor control in the cerebellum.	Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab DNA Biol & Embryo Engn, Tokyo 1088639, Japan; Kanazawa Univ, CREST, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan; Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Natl Inst Physiol Sci, Lab Cerebral Struct, Okazaki, Aichi 4448585, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kanazawa University; Kanazawa University; Toyohashi University of Technology; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Aiba, A (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab DNA Biol & Embryo Engn, Tokyo 1088639, Japan.	aiba@ims.u-tokyo.ac.jp	Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444; zhong wei, he gui/0000-0002-3066-3564; Hashimoto, Kouichi/0000-0002-3884-8213; Kano, Masanobu/0000-0002-0725-3292; Ichise, Taeko/0000-0002-1441-1463; Aiba, Atsu/0000-0002-8192-0778				AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; CHANGEUX JP, 1973, P NATL ACAD SCI USA, V70, P2974, DOI 10.1073/pnas.70.10.2974; Chen L, 1996, J NEUROSCI, V16, P2829; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FORTIER PA, 1987, EXP BRAIN RES, V66, P271, DOI 10.1007/bf00243304; GRUNER JA, 1980, EXP BRAIN RES, V40, P361; Ito M, 1984, CEREBELLUM NEURAL CO; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Levenes C, 1997, NEUROREPORT, V8, P571, DOI 10.1097/00001756-199701200-00038; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MARIANI J, 1987, NEWS PHYSIOL SCI, V2, P93; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; ORLOVSKII G. N., 1966, BIOFIZIKA, V11, P509; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; UDO M, 1980, J NEUROPHYSIOL, V44, P119, DOI 10.1152/jn.1980.44.1.119	29	318	321	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1832	1835		10.1126/science.288.5472.1832	http://dx.doi.org/10.1126/science.288.5472.1832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846166				2022-12-28	WOS:000087503800052
J	MacDonald, AW; Cohen, JD; Stenger, VA; Carter, CS				MacDonald, AW; Cohen, JD; Stenger, VA; Carter, CS			Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control	SCIENCE			English	Article							ERROR-DETECTION; WORKING-MEMORY; NEURAL SYSTEM; STROOP TASK; ATTENTION; COMPENSATION; PERFORMANCE; ACTIVATION; SELECTION; BEHAVIOR	Theories of the regulation of cognition suggest a system with two necessary components: one to implement control and another to monitor performance and signal when adjustments in control are needed. Event-related functional magnetic resonance imaging and a task-switching version of the Stroop task were used to examine whether these components of cognitive control have distinct neural bases in the human brain. A double dissociation was found. During task preparation, the left dorsolateral prefrontal cortex (Brodmann's area 9) was more active for color naming than for word reading, consistent with a role in the implementation of control. In contrast, the anterior cingulate cortex (Brodmann's areas 24 and 32) was more active when responding to incongruent stimuli, consistent with a role in performance monitoring.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University	Carter, CS (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	cartercs@msx.upmc.edu	MacDonald, Angus/M-9855-2016	MacDonald, Angus/0000-0003-4588-931X				Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Baker SC, 1996, CEREB CORTEX, V6, P612, DOI 10.1093/cercor/6.4.612; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; George M S, 1994, Hum Brain Mapp, V1, P194, DOI 10.1002/hbm.460010305; GOLDMANRAKIC PS, 1991, AM PSYCHOP, P1; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; MCLEOD CM, 1991, PSYCHOL BULL, V109, P163; NOLL DC, 1995, JMRI-J MAGN RESON IM, V5, P49, DOI 10.1002/jmri.1880050112; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; PETRIDES M, 1995, J NEUROSCI, V15, P359; POWERS WT, 1973, SCIENCE, V179, P351, DOI 10.1126/science.179.4071.351; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Weiner N., 1948, CYBERNETICS; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	34	2718	2771	12	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1835	1838		10.1126/science.288.5472.1835	http://dx.doi.org/10.1126/science.288.5472.1835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	322HH	10846167				2022-12-28	WOS:000087503800053
J	Xu, RX; Hassell, AM; Vanderwall, D; Lambert, MH; Holmes, WD; Luther, MA; Rocque, WJ; Milburn, MV; Zhao, YD; Ke, HM; Nolte, RT				Xu, RX; Hassell, AM; Vanderwall, D; Lambert, MH; Holmes, WD; Luther, MA; Rocque, WJ; Milburn, MV; Zhao, YD; Ke, HM; Nolte, RT			Atomic structure of PDE4: Insights into phosphodiesterase mechanism and specificity	SCIENCE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; AMP PHOSPHODIESTERASE; DEPENDENT ACTIVATION; CATALYTIC DOMAIN; BINDING; (R)-ROLIPRAM; EXPRESSION; INHIBITORS	Cyclic nucleotides are second messengers that are essential in vision, muscle contraction, neurotransmission, exocytosis, cell growth, and differentiation. These molecules are degraded by a family of enzymes known as phosphodiesterases, which serve a critical function by regulating the intracellular concentration of cyclic nucleotides. We have determined the three-dimensional structure of the catalytic domain of phosphodiesterase 4B2B to 1.77 angstrom resolution. The active site has been identified and contains a cluster of two metal atoms. The structure suggests the mechanism of action and basis for specificity and will provide a framework for structure-assisted drug design for members of the phosphodiesterase family.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Glaxo Wellcome Res & Dev Ltd, Dept Struct Chem, Res Triangle Pk, NC 27709 USA; Glaxo Wellcome Res & Dev Ltd, Dept Mol Sci, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline; GlaxoSmithKline	Nolte, RT (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		ID, IMCACAT/D-5867-2014	Vanderwall, Dana/0000-0003-1076-8788	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI133072, R01AI033072] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33072] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atienza JM, 1999, J BIOL CHEM, V274, P4839, DOI 10.1074/jbc.274.8.4839; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTT E, 1995, MOL PHARMACOL, V47, P340; CALLAHAN SM, 1995, J BIOL CHEM, V270, P17627, DOI 10.1074/jbc.270.29.17627; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; CONTI M, 1991, ENDOCR REV, V12, P218, DOI 10.1210/edrv-12-3-218; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Houslay MD, 1998, SEMIN CELL DEV BIOL, V9, P161, DOI 10.1006/scdb.1997.0221; JIN SLC, 1992, J BIOL CHEM, V267, P18929; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LIVI GP, 1990, MOL CELL BIOL, V10, P2678, DOI 10.1128/MCB.10.6.2678; LONDESBOROUGH J, 1985, BIOCHEM J, V225, P143, DOI 10.1042/bj2250143; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; MANGANIELLO VC, 1995, ARCH BIOCHEM BIOPHYS, V322, P1, DOI 10.1006/abbi.1995.1429; MARCEL MM, 1981, INVAS METAST, V1, P195; MARCHMONT RJ, 1980, NATURE, V286, P904, DOI 10.1038/286904a0; Omburo GA, 1998, CELL SIGNAL, V10, P491, DOI 10.1016/S0898-6568(97)00175-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Percival MD, 1997, BIOCHEM BIOPH RES CO, V241, P175, DOI 10.1006/bbrc.1997.7542; Rocque WJ, 1997, BIOCHEMISTRY-US, V36, P14250, DOI 10.1021/bi971112e; Rocque WJ, 1997, PROTEIN EXPRES PURIF, V9, P191, DOI 10.1006/prep.1996.0683; Teixeira MM, 1997, TRENDS PHARMACOL SCI, V18, P164, DOI 10.1016/S0165-6147(97)90613-1; TORPHY TJ, 1997, ASTHMA, V2, P1755; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; WEISHAAR RE, 1985, J MED CHEM, V28, P537, DOI 10.1021/jm50001a001; WILKINSON I, 1997, PHARM REV COMMUN, V9, P215; Zhao AZ, 1997, ADV SEC MESS PHOSPH, V31, P237	33	283	300	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1822	1825		10.1126/science.288.5472.1822	http://dx.doi.org/10.1126/science.288.5472.1822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846163				2022-12-28	WOS:000087503800049
J	Weber, T; Giessen, H; Weckenbrock, M; Urbasch, G; Staudte, A; Spielberger, L; Jagutzki, O; Mergel, V; Vollmer, M; Dorner, R				Weber, T; Giessen, H; Weckenbrock, M; Urbasch, G; Staudte, A; Spielberger, L; Jagutzki, O; Mergel, V; Vollmer, M; Dorner, R			Correlated electron emission in multiphoton double ionization	NATURE			English	Article							NONSEQUENTIAL DOUBLE-IONIZATION; THRESHOLD IONIZATION; GAS ATOMS; HELIUM; FIELD; DYNAMICS; PULSES; NEON; HE	Electronic correlations govern the dynamics of many phenomena in nature, such as chemical reactions and solid state effects, including superconductivity. Such correlation effects can be most clearly investigated in processes involving single atoms. In particular, the emission of two electrons from an atom-induced by the impact of a single photon(1), a charged particle(2) or by a short laser pulse(3)-has become the standard process for studies of dynamical electron correlations. Atoms and molecules exposed to laser fields that are comparable in intensity to the nuclear fields have extremely high probabilities for double ionization(4,5); this has been attributed to electron-electron interaction(3). Here we report a strong correlation between the magnitude and the direction of the momentum of two electrons that are emitted from an argon atom, driven by a femtosecond laser pulse (at 38 TW cm(-2)). Increasing the laser intensity causes the momentum correlation between the electrons to be lost, implying that a transition in the laser-atom coupling mechanism takes place.	Goethe Univ Frankfurt, Inst Kernphys, D-60486 Frankfurt, Germany; Univ Marburg, Fachbereich Phys, D-35032 Marburg, Germany	Goethe University Frankfurt; Philipps University Marburg	Dorner, R (corresponding author), Goethe Univ Frankfurt, Inst Kernphys, August Euler Str 6, D-60486 Frankfurt, Germany.	doerner@hsb.uni-frankfurt.de	Weber, Thorsten/K-2586-2013; Giessen, Harald/AAG-7586-2019; Doerner, Reinhard/A-5340-2008	Weber, Thorsten/0000-0003-3756-2704; Giessen, Harald/0000-0002-4270-3850; Doerner, Reinhard/0000-0002-3728-4268; Staudte, Andre/0000-0002-8284-3831				Becker A, 2000, PHYS REV LETT, V84, P3546, DOI 10.1103/PhysRevLett.84.3546; Becker A, 1999, PHYS REV A, V59, pR1742, DOI 10.1103/PhysRevA.59.R1742; Becker A, 1999, J PHYS B-AT MOL OPT, V32, pL335, DOI 10.1088/0953-4075/32/14/101; Becker A, 1996, J PHYS B-AT MOL OPT, V29, pL197, DOI 10.1088/0953-4075/29/6/005; Briggs JS, 2000, J PHYS B-AT MOL OPT, V33, pR1, DOI 10.1088/0953-4075/33/1/201; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; DiMauro LF, 1995, ADV ATOM MOL OPT <D>, V35, P79; Dorner R, 1996, PHYS REV LETT, V77, P1024, DOI 10.1103/PhysRevLett.77.1024; Dorner R, 1998, PHYS REV A, V57, P1074, DOI 10.1103/PhysRevA.57.1074; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; Dorr M, 2000, OPT EXPRESS, V6, P111, DOI 10.1364/OE.6.000111; FITTINGHOFF DN, 1994, PHYS REV A, V49, P2174, DOI 10.1103/PhysRevA.49.2174; FITTINGHOFF DN, 1992, PHYS REV LETT, V69, P2642, DOI 10.1103/PhysRevLett.69.2642; KULANDER KC, 1995, PHYS REV A, V51, P561, DOI 10.1103/PhysRevA.51.561; LaGattuta KJ, 1998, J PHYS B-AT MOL OPT, V31, P5281, DOI 10.1088/0953-4075/31/24/010; Lambropoulos P, 1998, PHYS REP, V305, P203, DOI 10.1016/S0370-1573(98)00027-1; Lappas DG, 1998, J PHYS B-AT MOL OPT, V31, pL249, DOI 10.1088/0953-4075/31/6/001; Larochelle S, 1998, J PHYS B-AT MOL OPT, V31, P1201, DOI 10.1088/0953-4075/31/6/008; Lein M, 2000, J PHYS B-AT MOL OPT, V33, P433, DOI 10.1088/0953-4075/33/3/312; Liu WC, 1999, PHYS REV LETT, V83, P520, DOI 10.1103/PhysRevLett.83.520; Moshammer R, 1996, PHYS REV LETT, V77, P1242, DOI 10.1103/PhysRevLett.77.1242; Moshammer R, 2000, PHYS REV LETT, V84, P447, DOI 10.1103/PhysRevLett.84.447; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; Sheehy B, 1998, PHYS REV A, V58, P3942, DOI 10.1103/PhysRevA.58.3942; Taylor KT, 1999, LASER PHYS, V9, P98; Ullrich J, 1997, J PHYS B-AT MOL OPT, V30, P2917, DOI 10.1088/0953-4075/30/13/006; WALKER B, 1994, PHYS REV LETT, V73, P1227, DOI 10.1103/PhysRevLett.73.1227; Watson JB, 1997, PHYS REV LETT, V78, P1884, DOI 10.1103/PhysRevLett.78.1884; Weber T, 2000, PHYS REV LETT, V84, P443, DOI 10.1103/PhysRevLett.84.443; WEBER T, 2000, J PHYS B ATOM MOL PH, V33, pL128	30	437	445	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					658	661		10.1038/35015033	http://dx.doi.org/10.1038/35015033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864317				2022-12-28	WOS:000087465800039
J	Gottfried, K				Gottfried, K			Inferring the statistical interpretation of quantum mechanics from the classical limit	NATURE			English	Article							STATES	It is widely believed that the statistical interpretation of quantum mechanics cannot be inferred from the Schrodinger equation itself, and must be stated as an additional independent axiom. Here I propose that the situation is not so stark. For systems that have both continuous and discrete degrees of freedom (such as coordinates and spin respectively), the statistical interpretation for the discrete variables is implied by requiring that the system's gross motion can be classically described under circumstances specified by the Schrodinger equation. However, this is not a full-fledged derivation of the statistical interpretation because it does not apply to the continuous variables of classical mechanics.	Cornell Univ, Nucl Studies Lab, Ithaca, NY 14853 USA	Cornell University	Gottfried, K (corresponding author), Cornell Univ, Nucl Studies Lab, Ithaca, NY 14853 USA.							Bell J S, 1987, SPEAKABLE UNSPEAKABL, P111; BELL JS, 1990, PHYS WORLD       AUG, P33; BIRKHOFF GD, 1933, AM MATH SOC B, V39, P681; Gottfried K., 1991, PHYS WORLD       OCT, P34; GOTTFRIED K, 1966, QUANTUM MECH SEC, V20; PERELOMOV AM, 1972, COMMUN MATH PHYS, V26, P222, DOI 10.1007/BF01645091; RADCLIFFE JM, 1971, J PHYS PT A GEN, V4, P313, DOI 10.1088/0305-4470/4/3/009; Schrodinger E, 1928, COLLECTED PAPERS WAV, P1; Zurek WH, 1998, PHILOS T R SOC A, V356, P1793, DOI 10.1098/rsta.1998.0250	9	6	6	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					533	536		10.1038/35014500	http://dx.doi.org/10.1038/35014500			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850705				2022-12-28	WOS:000087449500040
J	Mourrain, P; Beclin, C; Elmayan, T; Feuerbach, F; Godon, C; Morel, JB; Jouette, D; Lacombe, AM; Nikic, S; Picault, N; Remoue, K; Sanial, M; Vo, TA; Vaucheret, H				Mourrain, P; Beclin, C; Elmayan, T; Feuerbach, F; Godon, C; Morel, JB; Jouette, D; Lacombe, AM; Nikic, S; Picault, N; Remoue, K; Sanial, M; Vo, TA; Vaucheret, H			Arabidopsis SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural virus resistance	CELL			English	Article							DEPENDENT RNA-POLYMERASE; DOUBLE-STRANDED-RNA; CHALCONE SYNTHASE; DNA METHYLATION; CO-SUPPRESSION; ANTISENSE RNA; TOMATO LEAVES; TRANSGENE; PLANTS; EXPRESSION	Posttranscriptional gene silencing (PTGS) in plants results from the degradation of mRNAs and shows phenomenological similarities with quelling in fungi and RNAi in animals. Here, we report the isolation of sgs2 and sgs3 Arabidopsis mutants impaired in PTGS. We establish a mechanistic link between PTGS, quelling, and RNAi since the Arabidopsis SGS2 protein is similar to an RNA-dependent RNA polymerase like N. crassa QDE-1, controlling quelling, and C. elegans EGO-1, controlling RNAi. In contrast, SGS3 shows no significant similarity with any known or putative protein, thus defining a specific step of PTGS in plants. Both sgs2 and sgs3 mutants show enhanced susceptibility to virus, definitively proving that PTGS is an antiviral defense mechanism that can also target transgene RNA for degradation.	INRA, Biol Cellulaire Lab, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Beclin, C (corresponding author), INRA, Biol Cellulaire Lab, F-78026 Versailles, France.	beclin@versailles.inra.fr	PICAULT, Nathalie N/M-1476-2015; PICAULT, Nathalie/ABB-1755-2021; Mourrain, Philippe/N-4671-2017	PICAULT, Nathalie N/0000-0003-2770-9688; PICAULT, Nathalie/0000-0003-2770-9688; beclin, christophe/0000-0003-1923-7238; feuerbach, frank/0000-0002-8631-5120; sanial, matthieu/0000-0002-0301-4710; VAUCHERET, HERVE/0000-0002-9986-0988				Al-Kaff NS, 1998, SCIENCE, V279, P2113, DOI 10.1126/science.279.5359.2113; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; ASTIERMA.S, 1971, BIOCHIM BIOPHYS ACTA, V232, P484, DOI 10.1016/0005-2787(71)90602-2; Baulcombe DC, 1996, PLANT MOL BIOL, V32, P79, DOI 10.1007/BF00039378; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Beclin C, 1998, VIROLOGY, V252, P313, DOI 10.1006/viro.1998.9457; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; CHOI S, 1995, PLANT MOL BIOL REP, V13, P124, DOI 10.1007/BF02668782; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hamilton AJ, 1998, PLANT J, V15, P737, DOI 10.1046/j.1365-313X.1998.00251.x; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; Matallana E., 1992, Methods in Arabidopsis research., P144; Metzlaff M, 1997, CELL, V88, P845, DOI 10.1016/S0092-8674(00)81930-3; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1996, PLANT PHYSIOL, V112, P1447, DOI 10.1104/pp.112.4.1447; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Que QD, 1997, PLANT CELL, V9, P1357, DOI 10.1105/tpc.9.8.1357; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stam M, 1997, PLANT J, V12, P63, DOI 10.1046/j.1365-313X.1997.12010063.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; VANDERMEER J, 1984, VIROLOGY, V132, P413, DOI 10.1016/0042-6822(84)90046-1; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016	57	807	903	1	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					533	542		10.1016/S0092-8674(00)80863-6	http://dx.doi.org/10.1016/S0092-8674(00)80863-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850495	Bronze			2022-12-28	WOS:000087375400010
J	Borovikova, LV; Ivanova, S; Zhang, MH; Yang, H; Botchkina, GI; Watkins, LR; Wang, HC; Abumrad, N; Eaton, JW; Tracey, KJ				Borovikova, LV; Ivanova, S; Zhang, MH; Yang, H; Botchkina, GI; Watkins, LR; Wang, HC; Abumrad, N; Eaton, JW; Tracey, KJ			Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; SUBDIAPHRAGMATIC VAGOTOMY; TRANSDERMAL NICOTINE; BRAIN COMMUNICATION; ULCERATIVE-COLITIS; MONONUCLEAR-CELLS; ACTIVATION; ALPHA; INTERLEUKIN-1; MEDIATION	Vertebrates achieve internal homeostasis during infection or injury by balancing the activities of proinflammatory and anti-inflammatory pathways. Endotoxin (lipopolysaccharide), produced by all gram-negative bacteria, activates macrophages to release cytokines that are potentially lethal(1-4). The central nervous system regulates systemic inflammatory responses to endotoxin through humoral mechanisms(5-8). Activation of afferent vagus nerve fibres by endotoxin or cytokines stimulates hypothalamic-pituitary-adrenal anti-inflammatory responses(9-11). However, comparatively little is known about the role of efferent vagus nerve signalling in modulating inflammation. Here, we describe a previously unrecognized, parasympathetic anti-inflammatory pathway by which the brain modulates systemic inflammatory responses to endotoxin. Acetylcholine, the principle vagal neurotransmitter, significantly attenuated the release of cytokines (tumour necrosis factor (TNF), interleukin (IL)-1 beta, IL-6 and IL-18), but not the anti-inflammatory cytokine IL-10, in lipopolysaccharide-stimulated human macrophage cultures. Direct electrical stimulation of the peripheral vagus nerve in vivo during lethal endotoxaemia in rats inhibited TNF synthesis in liver, attenuated peak serum TNF amounts, and prevented the development of shock.	Picower Inst Med Res, Manhasset, NY 11030 USA; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA; N Shore Univ Hosp, Dept Surg, Manhasset, NY 11030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Northwell Health; University of Colorado System; University of Colorado Boulder; Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital; Baylor College of Medicine	Borovikova, LV (corresponding author), Picower Inst Med Res, Manhasset, NY 11030 USA.	lborovikova@mindspring.com; kjtracey@sprynet.com	Wang, Haichao/AAU-2237-2021; Wang, Haichao/K-6310-2012	Wang, Haichao/0000-0002-0211-9000; Wang, Haichao/0000-0002-0211-9000; Tracey, Kevin J/0000-0003-1884-6314				ANTONICA A, 1994, J AUTONOM NERV SYST, V48, P187, DOI 10.1016/0165-1838(94)90047-7; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Fleshner M, 1998, J NEUROIMMUNOL, V86, P134, DOI 10.1016/S0165-5728(98)00026-5; GAYKEMA RPA, 1995, ENDOCRINOLOGY, V136, P4717, DOI 10.1210/en.136.10.4717; Gregory SH, 1998, IMMUNOL TODAY, V19, P507, DOI 10.1016/S0167-5699(98)01319-X; Guslandi M, 1999, BRIT J CLIN PHARMACO, V48, P481; HU XX, 1991, J NEUROIMMUNOL, V31, P35, DOI 10.1016/0165-5728(91)90084-K; Kumins NH, 1996, SHOCK, V5, P385, DOI 10.1097/00024382-199605000-00012; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; Madretsma GS, 1996, IMMUNOPHARMACOLOGY, V35, P47, DOI 10.1016/0162-3109(96)00122-1; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Romanovsky AA, 1997, AM J PHYSIOL-REG I, V273, pR407, DOI 10.1152/ajpregu.1997.273.1.R407; Sandborn WJ, 1997, ANN INTERN MED, V126, P364, DOI 10.7326/0003-4819-126-5-199703010-00004; Sato E, 1998, AM J PHYSIOL-LUNG C, V274, pL970, DOI 10.1152/ajplung.1998.274.6.L970; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Sher ME, 1999, INFLAMM BOWEL DIS, V5, P73, DOI 10.1097/00054725-199905000-00001; Sternberg EM, 1997, J CLIN INVEST, V100, P2641, DOI 10.1172/JCI119807; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; van Dijk APM, 1998, EUR J CLIN INVEST, V28, P664; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R; Watkins LR, 1999, P NATL ACAD SCI USA, V96, P7710, DOI 10.1073/pnas.96.14.7710; WHALEY K, 1981, NATURE, V293, P580, DOI 10.1038/293580a0; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	28	2645	3001	25	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					458	462		10.1038/35013070	http://dx.doi.org/10.1038/35013070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839541				2022-12-28	WOS:000087212000049
J	de Pomerai, D; Daniells, C; David, H; Allan, J; Duce, I; Mutwakil, M; Thomas, D; Sewell, P; Tattersall, J; Jones, D; Candido, P				de Pomerai, D; Daniells, C; David, H; Allan, J; Duce, I; Mutwakil, M; Thomas, D; Sewell, P; Tattersall, J; Jones, D; Candido, P			RETRACTED: Cell biology - Non-thermal heat-shock response to microwaves (Retracted Article. See vol 440, pg 437, 2006)	NATURE			English	Article; Retracted Publication							CAENORHABDITIS-ELEGANS; NEMATODE; STRESS		Univ Nottingham, Sch Biol Sci, Mol Toxicol Div, Nottingham NG7 2RD, England; Univ Nottingham, Sch Elect & Elect Engn, Nottingham NG7 2RD, England; Med Countermeasures, Salisbury SP4 0JQ, Wilts, England; Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Nottingham; University of Nottingham; University of British Columbia	de Pomerai, D (corresponding author), Univ Nottingham, Sch Biol Sci, Mol Toxicol Div, Nottingham NG7 2RD, England.							*ANSI IEEE, 1992, C9511992 ANSI IEEE; CANDIDO E, 1996, TRENDS BIOTECHNOL, V40, P125; Daniells C, 1998, MUTAT RES-FUND MOL M, V399, P55, DOI 10.1016/S0027-5107(97)00266-2; Dennis JL, 1997, AQUAT TOXICOL, V40, P37, DOI 10.1016/S0166-445X(97)00043-X; Gandhi OP, 1996, IEEE T MICROW THEORY, V44, P1884, DOI 10.1109/22.539947; Jewitt N, 1999, ENZYME MICROB TECH, V25, P349, DOI 10.1016/S0141-0229(99)00052-6; Nishizawa J, 1999, CIRCULATION, V99, P934, DOI 10.1161/01.CIR.99.7.934; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; SNUTCH TP, 1983, CAN J BIOCHEM CELL B, V61, P480, DOI 10.1139/o83-064; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]	10	164	171	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					417	418		10.1038/35013144	http://dx.doi.org/10.1038/35013144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839528				2022-12-28	WOS:000087212000036
J	Ricci, E; Parazzini, F; Pardi, G				Ricci, E; Parazzini, F; Pardi, G		Italian Trial Mode Delivery HIV Po	Caesarean section and antiretroviral treatment	LANCET			English	Letter									Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; Osped S Paolo, Clin Ostetr Ginecol, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Parazzini, F (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.			Ricci, Elena/0000-0001-5279-0444; parazzini, fabio/0000-0001-5624-4854				Grubert TA, 1999, LANCET, V354, P1612, DOI 10.1016/S0140-6736(99)03141-4; Parazzini F, 1999, LANCET, V353, P1035, DOI 10.1016/S0140-6736(98)08084-2	2	8	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					496	496		10.1016/S0140-6736(00)82051-6	http://dx.doi.org/10.1016/S0140-6736(00)82051-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841153				2022-12-28	WOS:000085306800051
J	Holt, R; Roberts, G; Scully, C				Holt, R; Roberts, G; Scully, C			ABC of oral health - Dental damage, sequelae, and prevention	BRITISH MEDICAL JOURNAL			English	Review									Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, London WC1E 7HU, England	University of London; University College London	Holt, R (corresponding author), Univ London, Univ Coll London, Eastman Dent Inst Oral Hlth Care Sci, London WC1E 7HU, England.							MURRAY JJ, 1996, PREVENTION ORAL DIS; Ohrn R, 1999, EUR J ORAL SCI, V107, P157; SCULLY C, 1994, COLOUR ATLAS ORAL DI; SCULLY C, 1996, ORAL DIS; Tomar SL, 1999, J AM DENT ASSOC, V130, P1601, DOI 10.14219/jada.archive.1999.0099; Watt R, 1999, BRIT DENT J, V187, P6, DOI 10.1038/sj.bdj.4800191a	6	13	14	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1717	1719		10.1136/bmj.320.7251.1717	http://dx.doi.org/10.1136/bmj.320.7251.1717			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864553	Green Published			2022-12-28	WOS:000087926400028
J	Salonen, JT; Tuomainen, TP; Kontula, K				Salonen, JT; Tuomainen, TP; Kontula, K			Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							INCREASED RISK; HEMOCHROMATOSIS		Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland	University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital	Salonen, JT (corresponding author), Univ Kuopio, Publ Hlth Res Inst, POB 1627, FIN-70211 Kuopio, Finland.				NHLBI NIH HHS [HL44199] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; SALONEN JT, 1995, BRIT MED J, V311, P1124, DOI 10.1136/bmj.311.7013.1124; Tuomainen TP, 1999, CIRCULATION, V100, P1274, DOI 10.1161/01.CIR.100.12.1274; Yaouanq JM, 1995, DIABETES METAB, V21, P319	5	32	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1706	1707		10.1136/bmj.320.7251.1706	http://dx.doi.org/10.1136/bmj.320.7251.1706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864547	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000087926400025
J	Bosch, X				Bosch, X			Spanish postgrads push for better employment rights	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					723	723		10.1038/35015758	http://dx.doi.org/10.1038/35015758			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866165	Bronze			2022-12-28	WOS:000087620600007
J	Cannon, CP; Gibson, CM; Lambrew, CT; Shoultz, DA; Levy, D; French, WJ; Gore, JM; Weaver, WD; Rogers, WJ; Tiefenbrunn, AJ				Cannon, CP; Gibson, CM; Lambrew, CT; Shoultz, DA; Levy, D; French, WJ; Gore, JM; Weaver, WD; Rogers, WJ; Tiefenbrunn, AJ			Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSLUMINAL CORONARY ANGIOPLASTY; COOPERATIVE CARDIOVASCULAR PROJECT; PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; 2ND NATIONAL REGISTRY; THROMBOLYTIC THERAPY; PLASMINOGEN-ACTIVATOR; ACC/AHA GUIDELINES; PROPENSITY SCORES; OPERATOR VOLUME	Context Rapid time to treatment with thrombolytic therapy is associated with lower mortality in patients with acute myocardial infarction (MI). However, data on time to primary angioplasty and its relationship to mortality are inconclusive. Objective To test the hypothesis that more rapid time to reperfusion results in lower mortality in the strategy of primary angioplasty. Design Prospective observational study of data collected from the Second National Registry of Myocardial Infarction between June 1994 and March 1998. Setting A total of 661 community and tertiary care hospitals in the United States. Subjects A cohort of 27 080 consecutive patients with acute MI associated with ST-segment elevation or left bundle-branch block who were treated with primary angioplasty. Main Outcome Measure In-hospital mortality, compared by time from acute MI symptom onset to first balloon inflation and by time from hospital arrival to first balloon inflation (door-to-balloon time). Results Using a multivariate logistic regression model, the adjusted odds of in-hospital mortality did not increase significantly with increasing delay from MI symptom onset to first balloon inflation. However, for door-to-balloon time (median time 1 hour 56 minutes), the adjusted odds of mortality were significantly increased by 41 % to 62 % for patients with door-to-balloon times longer than 2 hours (for 121-150 minutes: odds ratio [OR], 1.41; 95% confidence interval [CI], 1.08-1.84; P = .01; for 151- 180 minutes: OR, 1.62, 95 % CI, 1.2 3 -2.14; P < .001; and for >180 minutes, OR, 1.61; 95% CI, 1.25-2.08; P < .001). Conclusions The relationship in our study between increased mortality and delay in door-to-balloon time longer than 2 hours (present in nearly 50% of this cohort) suggests that physicians and health care systems should work to minimize door-to-balloon times and that door-to-balloon time should be considered when choosing a reperfusion strategy. Door-to-balloon time also appears to be a valid quality-of-care indicator.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Maine Med Ctr, Portland, ME 04102 USA; STATPROBE Inc, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA; Harbor UCLA Med Ctr, Torrance, CA 90509 USA; Univ Massachusetts, Med Ctr, Worcester, MA USA; Henry Ford Heart & Vasc Inst, Detroit, MI USA; Univ Alabama Birmingham, Birmingham, AL USA; Washington Univ, Sch Med, St Louis, MO USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Maine Medical Center; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Henry Ford Health System; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL)	Cannon, CP (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	ccannon@rics.bwh.harvard.edu	Gibson, C. Michael/AAE-8212-2019					Anderson JL, 1996, AM J CARDIOL, V78, P934; [Anonymous], 1986, LANCET, V1, P397; Antman EM, 1999, CIRCULATION, V99, P2720, DOI 10.1161/01.CIR.99.21.2720; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Betriu A, 1997, NEW ENGL J MED, V336, P1621; BRAUNWALD E, 1993, NEW ENGL J MED, V329, P1650, DOI 10.1056/NEJM199311253292211; BRESLOW NE, 1980, STAT METH CANC RES, V1; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Cannon CP, 1996, J THROMB THROMBOLYS, V3, P249; CANNON CP, 1994, J AM COLL CARDIOL, V24, P1602, DOI 10.1016/0735-1097(94)90163-5; Cannon CP, 1999, AM HEART J, V137, P1, DOI 10.1016/S0002-8703(99)70452-7; CANNON CP, 1995, J AM COLL CARDIOL, pA231; CANNON CP, 1994, J THROMB THROMBOLYS, V1, P27; Caputo RP, 1997, AM J CARDIOL, V79, P1159, DOI 10.1016/S0002-9149(97)00074-X; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Danchin N, 1999, CIRCULATION, V99, P2639, DOI 10.1161/01.CIR.99.20.2639; Doorey A, 1998, AM J CARDIOL, V81, P1173, DOI 10.1016/S0002-9149(98)00160-X; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Every NR, 1996, NEW ENGL J MED, V335, P1253, DOI 10.1056/NEJM199610243351701; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Goldberg RJ, 1998, AM J CARDIOL, V82, P259, DOI 10.1016/S0002-9149(98)00342-7; Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; HAND MM, 1994, ANN EMERG MED, V23, P311; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Jollis JG, 1997, CIRCULATION, V95, P2485, DOI 10.1161/01.CIR.95.11.2485; JOLLIS JG, 1994, NEW ENGL J MED, V331, P1625, DOI 10.1056/NEJM199412153312406; Kastrati A, 1998, J AM COLL CARDIOL, V32, P970, DOI 10.1016/S0735-1097(98)00334-9; KIMMEL SE, 1995, JAMA-J AM MED ASSOC, V274, P1137, DOI 10.1001/jama.274.14.1137; Littell R, 1991, SAS SYSTEM LINEAR MO; McGrath P, 1998, J AM COLL CARDIOL, V31, P570, DOI 10.1016/S0735-1097(97)00541-X; MERCHO N, 1996, J AM COLL CARDIOL  S, V27, pA62; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Ohman EM, 1998, CIRCULATION, V98, P504; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; ROGERS WJ, 1994, AM J CARDIOL, V74, P111, DOI 10.1016/0002-9149(94)90082-5; Ross AM, 1999, J AM COLL CARDIOL, V34, P1954, DOI 10.1016/S0735-1097(99)00444-1; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; *SAS I INC, 1996, SAS STAT VERS 6 12; Tiefenbrunn AJ, 1998, J AM COLL CARDIOL, V31, P1240, DOI 10.1016/S0735-1097(98)00094-1; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; van den Merkhof LFM, 1999, J AM COLL CARDIOL, V33, P1528, DOI 10.1016/S0735-1097(99)00038-8; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; Weaver WD, 2000, J AM COLL CARDIOL, V35, p376A; Zahn R, 1997, AM J CARDIOL, V79, P264, DOI 10.1016/S0002-9149(96)00745-X; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002	54	895	946	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2941	+		10.1001/jama.283.22.2941	http://dx.doi.org/10.1001/jama.283.22.2941			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865271	Bronze			2022-12-28	WOS:000087480600033
J	Rossle, M; Ochs, A; Gulberg, V; Siegerstetter, V; Holl, J; Deibert, P; Olschewski, M; Reiser, M; Gerbes, AL				Rossle, M; Ochs, A; Gulberg, V; Siegerstetter, V; Holl, J; Deibert, P; Olschewski, M; Reiser, M; Gerbes, AL			A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REFRACTORY ASCITES; RANDOMIZED TRIAL; CIRRHOSIS; STENT; ALBUMIN; TIPS	Background: In patients with cirrhosis and ascites, creation of a transjugular intrahepatic portosystemic shunt may reduce the ascites and improve renal function. However, the benefit of this procedure as compared with that of large-volume paracentesis is uncertain. Methods: We randomly assigned 60 patients with cirrhosis and refractory or recurrent ascites (Child-Pugh class B in 42 patients and class C in 18 patients) to treatment with a transjugular shunt (29 patients) or large-volume paracentesis (31 patients). The mean (+/-SD) duration of follow-up was 45+/-16 months among those assigned to shunting and 44+/-18 months among those assigned to paracentesis. The primary outcome was survival without liver transplantation. Results: Among the patients in the shunt group, 15 died and 1 underwent liver transplantation during the study period, as compared with 23 patients and 2 patients, respectively, in the paracentesis group. The probability of survival without liver transplantation was 69 percent at one year and 58 percent at two years in the shunt group, as compared with 52 percent and 32 percent in the paracentesis group (P=0.11 for the overall comparison, by the log-rank test). In a multivariate analysis, treatment with transjugular shunting was independently associated with survival without the need for transplantation (P=0.02). At three months, 61 percent of the patients in the shunt group and 18 percent of those in the paracentesis group had no ascites (P=0.006). The frequency of hepatic encephalopathy was similar in the two groups. Of the patients assigned to paracentesis in whom this procedure was unsuccessful, 10 received a transjugular shunt a mean of 5.5+/-4 months after randomization; 4 had a response to this rescue treatment. Conclusions: In comparison with large-volume paracentesis, the creation of a transjugular intrahepatic portosystemic shunt can improve the chance of survival without liver transplantation in patients with refractory or recurrent ascites. (N Engl J Med 2000;342:1701-7.) (C) 2000, Massachusetts Medical Society.	Univ Freiburg, Med Klin 2, Dept Gastroenterol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Med Biometry, D-79106 Freiburg, Germany; Univ Munich, Klinikum Grosshadern, Med Klin 2, D-8000 Munich, Germany; Univ Munich, Klinikum Grosshadern, Inst Diagnost Radiol, D-8000 Munich, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Munich	Rossle, M (corresponding author), Univ Freiburg, Med Klin 2, Dept Gastroenterol, Hugstetter Str 55, D-79106 Freiburg, Germany.	roessle@mm21.ukl.uni-freiburg.de	Deibert, Peter/AAE-4623-2020	Gerbes, Alexander L./0000-0003-0440-7417				Altman D.G., 1991, PRACTICAL STAT MED R; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Benner K. G., 1996, Hepatology, V24, p449A; BORIES P, 1986, J HEPATOL, V3, P212, DOI 10.1016/S0168-8278(86)80028-9; BURCHELL AR, 1968, ANN SURG, V168, P655, DOI 10.1097/00000658-196810000-00012; CAPONE RR, 1978, DIGEST DIS SCI, V23, P867; Conn HO, 1979, HEPATIC COMA SYNDROM, P46; Crenshaw WB, 1996, RADIOLOGY, V200, P185, DOI 10.1148/radiology.200.1.8657908; EPSTEIN M, 1989, NEW ENGL J MED, V321, P1675, DOI 10.1056/NEJM198912143212410; FERRO D, 1992, SCAND J GASTROENTERO, V27, P852, DOI 10.3109/00365529209000153; Forrest EH, 1996, ALIMENT PHARM THERAP, V10, P801, DOI 10.1046/j.1365-2036.1996.60202000.x; FRANCO D, 1988, ARCH SURG-CHICAGO, V123, P987; Gerbes AL, 1998, HEPATOLOGY, V28, P683, DOI 10.1002/hep.510280313; Gerbes AL, 1997, FALK SYMP, V92, P134; GINES P, 1988, GASTROENTEROLOGY, V94, P1493, DOI 10.1016/0016-5085(88)90691-9; GINES P, 1991, NEW ENGL J MED, V325, P829, DOI 10.1056/NEJM199109193251201; HAUENSTEIN KH, 1995, RADIOLOGY, V194, P175, DOI 10.1148/radiology.194.1.7997547; Le Moine O., 1996, Hepatology, V24, p445A; Lebrec D, 1996, J HEPATOL, V25, P135, DOI 10.1016/S0168-8278(96)80065-1; Martinet JP, 1997, DIGEST DIS SCI, V42, P161; Nazarian GK, 1997, RADIOLOGY, V205, P173, DOI 10.1148/radiology.205.1.9314981; OCHS A, 1995, NEW ENGL J MED, V332, P1587; ORLOFF MJ, 1970, ANN NY ACAD SCI, V170, P213, DOI 10.1111/j.1749-6632.1970.tb37015.x; QUIROGA J, 1995, HEPATOLOGY, V21, P986, DOI 10.1016/0270-9139(95)90245-7; Rossle M, 1998, LIVER, V18, P73; Rossle M, 1997, LANCET, V349, P1043, DOI 10.1016/S0140-6736(96)08189-5; ROSSLE M, 1994, NEW ENGL J MED, V330, P165, DOI 10.1056/NEJM199401203300303; RUNYON BA, 1994, NEW ENGL J MED, V330, P337, DOI 10.1056/NEJM199402033300508; SALERNO F, 1993, AM J GASTROENTEROL, V88, P514; SOMBERG KA, 1995, HEPATOLOGY, V21, P709, DOI 10.1016/0270-9139(95)90522-7; STANLEY MM, 1989, NEW ENGL J MED, V321, P1632, DOI 10.1056/NEJM198912143212403	31	395	405	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1701	1707		10.1056/NEJM200006083422303	http://dx.doi.org/10.1056/NEJM200006083422303			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841872				2022-12-28	WOS:000087449300003
J	Yamamoto, Y				Yamamoto, Y			Semiconductor physics - Half-matter, half-light amplifier	NATURE			English	Editorial Material							MICROCAVITY		Stanford Univ, Edward L Ginzton Lab, Quantum Entanglement Project, Stanford, CA 94305 USA; NTT, Basic Res Labs, Kanagawa, Japan	Stanford University; Nippon Telegraph & Telephone Corporation	Yamamoto, Y (corresponding author), Stanford Univ, Edward L Ginzton Lab, Quantum Entanglement Project, Stanford, CA 94305 USA.		Yamamoto, Yoshihisa/A-2811-2012	Yamamoto, Yoshihisa/0000-0002-4150-6804				Dang LS, 1998, PHYS REV LETT, V81, P3920, DOI 10.1103/PhysRevLett.81.3920; Helmerson K, 1999, NATURE, V402, P587, DOI 10.1038/45092; Huang R, 2000, PHYS REV B, V61, pR7854, DOI 10.1103/PhysRevB.61.R7854; Imamoglu A, 1996, PHYS REV A, V53, P4250, DOI 10.1103/PhysRevA.53.4250; Inouye S, 1999, NATURE, V402, P641, DOI 10.1038/45194; Savvidis PG, 2000, PHYS REV LETT, V84, P1547, DOI 10.1103/PhysRevLett.84.1547; Senellart P, 1999, PHYS REV LETT, V82, P1233, DOI 10.1103/PhysRevLett.82.1233	7	37	37	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					629	630		10.1038/35015196	http://dx.doi.org/10.1038/35015196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864308				2022-12-28	WOS:000087465800029
J	Morrison, SJ; Perez, SE; Qiao, Z; Verdi, JM; Hicks, C; Weinmaster, G; Anderson, DJ				Morrison, SJ; Perez, SE; Qiao, Z; Verdi, JM; Hicks, C; Weinmaster, G; Anderson, DJ			Transient notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells	CELL			English	Article							INTRACELLULAR DOMAIN; NERVOUS-SYSTEM; C-ELEGANS; IN-VIVO; EXPRESSION; DIFFERENTIATION; DROSOPHILA; FATE; RECEPTOR; DELTA	The genesis of vertebrate peripheral ganglia poses the problem of how multipotent neural crest stem cells (NCSCs) can sequentially generate neurons and then glia in a local environment containing strong instructive neurogenic factors, such as BMP2. Here we show that Notch ligands, which are normally expressed on differentiating neuroblasts, can inhibit neurogenesis in NCSCs in a manner that is completely dominant to BMP2. Contrary to expectation, Notch activation did not maintain these stem cells in an uncommitted state or promote their self-renewal. Rather, even a transient activation of Notch was sufficient to cause a rapid and irreversible loss of neurogenic capacity accompanied by accelerated glial differentiation. These data suggest that Notch ligands expressed by neuroblasts may act positively to instruct a cell-heritable switch to gliogenesis in neighboring stem cells.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Western Ontario, Dept Physiol, Program Neurosci, Robarts Res Inst,Howard Hughes Med Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol, Program Neurosci, Robarts Res Inst,Neurodegenerat Grp, London, ON N6A 5K8, Canada; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	California Institute of Technology; Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Anderson, DJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.		Morrison, Sean/ABD-5326-2021	Zhou, Qiao/0000-0002-0099-3909; Morrison, Sean/0000-0003-1587-8329	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bao ZZ, 1997, J NEUROSCI, V17, P1425; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; MORGAN BA, 1996, METHODS AVIAN EMBRYO, P185; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; NYE JS, 1994, DEVELOPMENT, V120, P2421; Perez SE, 1999, DEVELOPMENT, V126, P1715; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROHRER H, 1986, J NEUROSCI, V6, P2616; RUDEL C, 1992, DEVELOPMENT, V115, P519; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Topilko P, 1996, MOL CELL NEUROSCI, V8, P71, DOI 10.1006/mcne.1996.0045; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; von Boehmer H, 1999, CURR BIOL, V9, pR186, DOI 10.1016/S0960-9822(99)80110-9; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang MQ, 1999, DEV BIOL, V212, P12, DOI 10.1006/dbio.1999.9357; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wettstein DA, 1997, DEVELOPMENT, V124, P693; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhong WM, 1997, DEVELOPMENT, V124, P1887	60	562	601	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					499	510		10.1016/S0092-8674(00)80860-0	http://dx.doi.org/10.1016/S0092-8674(00)80860-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850492	Bronze			2022-12-28	WOS:000087375400007
J	Goonatilake, S				Goonatilake, S			Many paths to enlightenment - Modern physics bears the imprint of Western and Asian philosophies	NATURE			English	Editorial Material									New Sch Social Res, Ctr Study Social Change, New York, NY 10011 USA	The New School	Goonatilake, S (corresponding author), New Sch Social Res, Ctr Study Social Change, 5th Ave, New York, NY 10011 USA.								0	2	2	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					399	399		10.1038/35013162	http://dx.doi.org/10.1038/35013162			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839516	Bronze			2022-12-28	WOS:000087212000023
J	[Anonymous]				[Anonymous]			Values of the abstract	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					379	379						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839500				2022-12-28	WOS:000087212000002
J	Schiermeier, Q				Schiermeier, Q			German research agency 'doesn't stifle creativity', say 1,600 scientists	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					915	915		10.1038/35010237	http://dx.doi.org/10.1038/35010237			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10841691	Bronze			2022-12-28	WOS:000086762000013
J	O'Donnell, M				O'Donnell, M			Evidence-based illiteracy: time to rescue "the literature"	LANCET			English	Editorial Material									Handon Cottage, Surrey GU8 4BD, England		O'Donnell, M (corresponding author), Handon Cottage, Markwick Lane, Surrey GU8 4BD, England.							BOSELEY S, 1998, GUARDIAN        0624; Delamothe T, 1999, BRIT MED J, V318, P754, DOI 10.1136/bmj.318.7186.754a; Feder G, 1999, BRIT MED J, V318, P728; Forster EM, 1989, HOWARDS END, P270; HEALY JB, 1976, LANCET, V1, P204; Lamers HJ, 1998, BRIT J GEN PRACT, V48, P1819; MADDOX J, 1991, COMMUNICTING SCI HDB, P51; Murphy E, 1999, BMJ-BRIT MED J, V318, P681; NAUGHTON J, 1995, OBSERVER        0709; ODONNELL M, 1971, WORLD MED, V7, P101; ORWELL G, 1957, INSIDE WHALE OTHER A, P154; *ROYAL COLL GEN PR, 1972, FUT GEN PRACT LEARN, P9; SANDWITH F, 1960, SURG COMPASSIONATE, P210	13	25	25	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					489	491						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841145				2022-12-28	WOS:000085306800040
J	Beuschlein, F; Strasburger, CJ; Siegerstetter, V; Moradpour, D; Lichter, P; Bidlingmaier, M; Blum, HE; Reincke, M				Beuschlein, F; Strasburger, CJ; Siegerstetter, V; Moradpour, D; Lichter, P; Bidlingmaier, M; Blum, HE; Reincke, M			Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MESSENGER-RIBONUCLEIC-ACID; FACTOR-I; IMMUNE-SYSTEM; MONONUCLEAR-CELLS; BINDING-PROTEIN; FULL-LENGTH; EXPRESSION; RECEPTORS; CANCER; MANIFESTATIONS		Univ Freiburg Klinikum, Dept Med 2, Freiburg, Germany; Univ Munich, Klinikum Innenstadt, Dept Med, D-8000 Munich, Germany; German Canc Res Ctr, D-6900 Heidelberg, Germany	University of Freiburg; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Reincke, M (corresponding author), Univ Freiburg Klinikum, Innere Med Abt 2, Hugstetter Str 55, D-79106 Freiburg, Germany.		Moradpour, Darius/G-7918-2017	Moradpour, Darius/0000-0003-1977-6792				Auernhammer CJ, 1995, EUR J ENDOCRINOL, V133, P635, DOI 10.1530/eje.0.1330635; BAUMANN G, 1991, ENDOCR REV, V12, P424, DOI 10.1210/edrv-12-4-424; CAMERON DP, 1969, AUSTRALAS ANN MED, V18, P143; Clark R, 1997, ENDOCR REV, V18, P157, DOI 10.1210/er.18.2.157; DABEK JT, 1974, J CLIN ENDOCR METAB, V38, P329, DOI 10.1210/jcem-38-2-329; EZZAT S, 1994, MEDICINE, V73, P233, DOI 10.1097/00005792-199409000-00001; EZZAT S, 1993, CANCER, V71, P66, DOI 10.1002/1097-0142(19930101)71:1<66::AID-CNCR2820710112>3.0.CO;2-U; GREENBERG PB, 1972, LANCET, V1, P350; Harris NL, 1999, J CLIN ONCOL, V17, P3835, DOI 10.1200/JCO.1999.17.12.3835; Harvey S, 1997, ENDOCRINE, V7, P267, DOI 10.1007/BF02801319; HATTORI N, 1994, J CLIN ENDOCR METAB, V79, P1678, DOI 10.1210/jc.79.6.1678; KAGANOWICZ A, 1979, J CLIN ENDOCR METAB, V48, P5, DOI 10.1210/jcem-48-1-5; Kahan Z, 1999, J CLIN ENDOCR METAB, V84, P582, DOI 10.1210/jc.84.2.582; Kayano K, 1995, Nihon Kyobu Geka Gakkai Zasshi, V43, P538; KELLEY KW, 1986, P NATL ACAD SCI USA, V83, P5663, DOI 10.1073/pnas.83.15.5663; KIESS W, 1985, J CLIN ENDOCR METAB, V60, P740, DOI 10.1210/jcem-60-4-740; KRENNING EP, 1992, METABOLISM, V41, P83, DOI 10.1016/0026-0495(92)90038-C; LeRoith D, 1996, ENDOCRINOLOGY, V137, P1071, DOI 10.1210/en.137.3.1071; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LEVESTON SA, 1981, J CLIN ENDOCR METAB, V53, P682, DOI 10.1210/jcem-53-4-682; LI YM, 1992, ENDOCRINOLOGY, V130, P2703, DOI 10.1210/en.130.5.2703; LIPP RW, 1995, J NUCL MED, V36, P13; LOSA M, 1990, J CLIN ENDOCR METAB, V70, P62, DOI 10.1210/jcem-70-1-62; MELMED S, 1995, J CLIN ENDOCR METAB, V80, P3395, DOI 10.1210/jc.80.12.3395; MELMED S, 1995, NEW ENGL J MED, V312, P9; MOLITCH ME, 1992, ENDOCRIN METAB CLIN, V21, P597, DOI 10.1016/S0889-8529(18)30204-4; Odell WD, 1997, SEMIN ONCOL, V24, P299; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; SANO T, 1988, ENDOCR REV, V9, P357, DOI 10.1210/edrv-9-3-357; Shen XY, 1998, J CLIN ENDOCR METAB, V83, P2532, DOI 10.1210/jc.83.7.2532; SPARAGANA M, 1971, METABOLISM, V20, P730, DOI 10.1016/S0026-0495(71)80002-1; Strasburger CJ, 1996, J CLIN ENDOCR METAB, V81, P2613, DOI 10.1210/jc.81.7.2613; TIMSIT J, 1992, J CLIN ENDOCR METAB, V75, P183, DOI 10.1210/jc.75.1.183; VARMA S, 1993, J CLIN ENDOCR METAB, V76, P49, DOI 10.1210/jc.76.1.49; WEIGENT DA, 1988, FASEB J, V2, P2812, DOI 10.1096/fasebj.2.12.3044906; WEIGENT DA, 1991, P SOC EXP BIOL MED, V198, P643; WILSON JD, 1998, WILLIAMS TXB ENDOCRI, P300; Wu H, 1996, J CLIN ENDOCR METAB, V81, P1278, DOI 10.1210/jc.81.3.1278; WU Z, 1998, ENDOCR SOC, V80, P291	39	42	45	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1871	1876		10.1056/NEJM200006223422504	http://dx.doi.org/10.1056/NEJM200006223422504			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861322				2022-12-28	WOS:000087704700004
J	White, B; Moore, WC; Wigley, FM; Xiao, HQ; Wise, RA				White, B; Moore, WC; Wigley, FM; Xiao, HQ; Wise, RA			Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis	ANNALS OF INTERNAL MEDICINE			English	Article							INTERSTITIAL LUNG-DISEASE; SYSTEMIC-SCLEROSIS SCLERODERMA; COLLAGEN-VASCULAR DISEASES; BRONCHOALVEOLAR LAVAGE; PULSE CYCLOPHOSPHAMIDE; FIBROSING ALVEOLITIS; INVOLVEMENT; MANAGEMENT; COMPONENT; THERAPY	Background: Lung inflammation (alveolitis) may cause lung fibrosis in scleroderma. Objective: To determine whether cyclophosphamide treatment is associated with retention of lung function and improved survival in scleroderma patients with alveolitis. Design: Retrospective cohort study, Setting: Johns Hopkins and University of Maryland Scleroderma Center. Patients: 103 patients with scleroderma who had bronchoalveolar lavage or lung biopsy. Intervention: Cyclophosphamide therapy. Measurements: 1) Serial measurement of forced vital capacity (FVC)and carbon monoxide diffusing capacity and 2) survival. Results: During a median follow-up of 13 months after bronchoalveolar ravage or biopsy, patients with alveolitis who did not receive cyclophosphamide therapy experienced a decrease in FVC (mean difference, -0.28 L [95% Cl, -0.41 to -0.16 L] and -7.1% of the predicted value [CI, -10.9% to -4.0%]). Carbon monoxide diffusing capacity also decreased in these patients (mean difference, -3.3 mmol min(-1).kPa(-1) [Cl, -4.6 to -2.1 mmol.min(-1).kPa(-1)] and -9.6% of the predicted value [CI, -16.7% to -2.4%]). During a median follow-up of 16 months, patients with alveolitis who received cyclophosphamide we re more likely to have a good outcome (stabilization or improvement) in FVC (relative risk, 2.5 [CI, 1.5 to 4.1]) and diffusing rapacity (relative risk, 1.5 [CI, 1.0 to 2.2]). These patients also had improved survival; the median survival rate was 89% (25th, 75th percentiles, 84%, 94%) compared with 71% (25th, 75th percentiles, 55%, 86%) in untreated patients (P = 0.01, log-rank test). Conclusions: The presence of lung inflammation identifies patients with scleroderma who are more likely to have worsening lung function. Lung function outcomes and survival are improved in patients with alveolitis who receive cyclophosphamide.	Univ Maryland, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; Johns Hopkins Univ, Inst Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	White, B (corresponding author), Baltimore Vet Affairs Med Ctr, Res Serv, Stop 151,Room 325-A,10 N Greene, Baltimore, MD 21201 USA.			Wise, Robert/0000-0002-8353-2349	NHLBI NIH HHS [1RO1HL54163] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054163] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKESSON A, 1994, ARTHRITIS RHEUM, V37, P729, DOI 10.1002/art.1780370518; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L; Behr J, 1996, AM J RESP CRIT CARE, V154, P400, DOI 10.1164/ajrccm.154.2.8756813; BURROWS B, 1961, AM REV RESPIR DIS, V84, P789; CHANEZ P, 1993, AM REV RESPIR DIS, V147, P1497, DOI 10.1164/ajrccm/147.6_Pt_1.1497; COX DR, 1972, J R STAT SOC B, V34, P187; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; HARRISON NK, 1991, AM REV RESPIR DIS, V144, P706, DOI 10.1164/ajrccm/144.3_Pt_1.706; Lacki Jan K., 1994, Archivum Immunologiae et Therapiae Experimentalis, V42, P291; LEROY EC, 1988, J RHEUMATOL, V15, P202; MERCHANT RK, 1992, AM REV RESPIR DIS, V146, P448, DOI 10.1164/ajrccm/146.2.448; ODONNELL K, 1987, AM REV RESPIR DIS, V136, P288, DOI 10.1164/ajrccm/136.2.288; PETERSGOLDEN M, 1984, AM J MED, V77, P1027, DOI 10.1016/0002-9343(84)90183-9; ROSSI GA, 1985, AM REV RESPIR DIS, V131, P612, DOI 10.1164/arrd.1985.131.4.612; Schnabel A, 1998, ARTHRITIS RHEUM-US, V41, P1215, DOI 10.1002/1529-0131(199807)41:7<1215::AID-ART11>3.0.CO;2-Y; SILVER RM, 1990, AM J MED, V88, P470, DOI 10.1016/0002-9343(90)90425-D; SILVER RM, 1993, J RHEUMATOL, V20, P838; SILVER RM, 1984, ARTHRITIS RHEUM, V27, P1254, DOI 10.1002/art.1780271107; STEEN VD, 1994, ARTHRITIS RHEUM-US, V37, P1290, DOI 10.1002/art.1780370904; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; STRUCK RF, 1987, CANCER RES, V47, P2723; TASHKIN DP, 1994, CHEST, V105, P489, DOI 10.1378/chest.105.2.489; WALLAERT B, 1986, AM REV RESPIR DIS, V133, P574; WELLS AU, 1994, AM J RESP CRIT CARE, V150, P462, DOI 10.1164/ajrccm.150.2.8049830; WHITE B, 1995, ARTHRITIS RHEUM, V38, P351, DOI 10.1002/art.1780380309; [No title captured]	31	276	294	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					947	+		10.7326/0003-4819-132-12-200006200-00004	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858177				2022-12-28	WOS:000087670800003
J	London, NJM; Donnelly, R				London, NJM; Donnelly, R			ABC of arterial and venous disease - Ulcerated lower limb	BRITISH MEDICAL JOURNAL			English	Review																		Browse NL, 1999, DIS VEINS; Fletcher A, 1997, BRIT MED J, V315, P576; Ruckley CV, 1998, BRIT MED J, V316, P407, DOI 10.1136/bmj.316.7129.407; RUCKLEY CV, 1998, VENOUS DIS; *SCOTT INT GUID NE, 1998, SIGN, V26; Scriven JM, 1997, BRIT J SURG, V84, P334, DOI 10.1002/bjs.1800840319; *TASK FORC CHRON V, 1999, PHLEBOLOGY S1, V14; TIBBS DJ, 1997, VARICOSE VEINS VENOU	8	57	59	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 10	2000	320	7249					1589	1591		10.1136/bmj.320.7249.1589	http://dx.doi.org/10.1136/bmj.320.7249.1589			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845973	Green Published			2022-12-28	WOS:000087631400027
J	Nortier, JL; Martinez, MM; Schmeiser, HH; Arlt, VM; Bieler, CA; Petein, M; Depierreux, MF; De Pauw, L; Abramowicz, D; Vereerstraeten, P; Vanherweghem, JL				Nortier, JL; Martinez, MM; Schmeiser, HH; Arlt, VM; Bieler, CA; Petein, M; Depierreux, MF; De Pauw, L; Abramowicz, D; Vereerstraeten, P; Vanherweghem, JL			Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERSTITIAL RENAL FIBROSIS; DNA-ADDUCTS; ANALGESIC NEPHROPATHY; SLIMMING REGIMEN; ACID; RATS; IDENTIFICATION; DISEASE; TUMORS	Background: Chinese-herb nephropathy is a progressive form of renal fibrosis that develops in some patients who take weight-reducing pills containing Chinese herbs. Because of a manufacturing error, one of the herbs in these pills (Stephania tetrandra) was inadvertently replaced by Aristolochia fangchi, which is nephrotoxic and carcinogenic. Methods: The diagnosis of a neoplastic lesion in the native urinary tract of a renal-transplant recipient who had Chinese-herb nephropathy prompted us to propose regular cystoscopic examinations and the prophylactic removal of the native kidneys and ureters in all our patients with end-stage Chinese-herb nephropathy who were being treated with either transplantation or dialysis. Surgical specimens were examined histologically and analyzed for the presence of DNA adducts formed by aristolochic acid. All prescriptions written for weight-reducing compounds during the period of exposure (1990 to 1992) in these patients were obtained, and the cumulative doses were calculated. Results: Among 39 patients who agreed to undergo prophylactic surgery, there were 18 cases of urothelial carcinoma (prevalence, 46 percent; 95 percent confidence interval, 29 to 62 percent): 17 cases of carcinoma of the ureter, renal pelvis, or both and 1 papillary bladder tumor. Nineteen of the remaining patients had mild-to-moderate urothelial dysplasia, and two had normal urothelium. All tissue samples analyzed contained aristolochic acid-related DNA adducts. The cumulative dose of aristolochia was a significant risk factor for urothelial carcinoma, with total doses of more than 200 g associated with a higher risk of urothelial carcinoma. Conclusions: The prevalence of urothelial carcinoma among patients with end-stage Chinese-herb nephropathy (caused by aristolochia species) is high. (N Engl J Med 2000;342:1686-92.) (C) 2000, Massachusetts Medical Society.	Free Univ Brussels, Hop Erasme, Dept Nephrol, B-1070 Brussels, Belgium; Free Univ Brussels, Hop Erasme, Dept Pathol, B-1070 Brussels, Belgium; German Canc Res Ctr, Div Mol Toxicol, D-6900 Heidelberg, Germany	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Helmholtz Association; German Cancer Research Center (DKFZ)	Nortier, JL (corresponding author), Free Univ Brussels, Hop Erasme, Dept Nephrol, 808 Route Lennik, B-1070 Brussels, Belgium.	jnortier@ulb.ac.be	Abramowicz, Daniel/F-7578-2017	Abramowicz, Daniel/0000-0002-6556-9199; Arlt, Volker Manfred/0000-0003-4314-9318; Nortier, Joelle/0000-0003-3609-8217				Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; [Anonymous], 1997, J CLIN PATHOL; Bieler CA, 1997, CARCINOGENESIS, V18, P1063, DOI 10.1093/carcin/18.5.1063; BOSTWICK DG, 1997, UROLOGIC SURG PATHOL, P246; CABANNE F, 1992, PATHOLOGIE GENITALE, P354; Castegnaro M, 1998, INT J CANCER, V77, P70, DOI 10.1002/(SICI)1097-0215(19980703)77:1&lt;70::AID-IJC12&gt;3.0.CO;2-D; COSYNS JP, 1994, LANCET, V344, P188, DOI 10.1016/S0140-6736(94)92786-3; COSYNS JP, 1994, KIDNEY INT, V45, P1680, DOI 10.1038/ki.1994.220; Cosyns JP, 1999, AM J KIDNEY DIS, V33, P1011, DOI 10.1016/S0272-6386(99)70136-8; De Broe ME, 1999, AM J KIDNEY DIS, V33, P1171, DOI 10.1016/S0272-6386(99)70159-9; De Broe ME, 1998, NEW ENGL J MED, V338, P446, DOI 10.1056/NEJM199802123380707; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; EVERSON RB, 1986, SCIENCE, V231, P54, DOI 10.1126/science.3941892; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P489; JACKSON L, 1964, CANCER CHEMOTH REP, P35; Kliem V, 1996, TRANSPLANT INT, V9, P231, DOI 10.1111/j.1432-2277.1996.tb00885.x; Lord GM, 1999, LANCET, V354, P481, DOI 10.1016/S0140-6736(99)03380-2; Malak J, 1998, J ALTERN COMPLEM MED, V4, P131, DOI 10.1089/acm.1998.4.131; McIntyre M, 1998, J ALTERN COMPLEM MED, V4, P15, DOI 10.1089/acm.1998.4.1-15; MENGS U, 1993, ARCH TOXICOL, V67, P307, DOI 10.1007/BF01973700; MENGS U, 1982, ARCH TOXICOL, V51, P107, DOI 10.1007/BF00302751; MURPHY WM, 1982, J UROLOGY, V127, P849, DOI 10.1016/S0022-5347(17)54105-1; Nortier J., 1998, Journal of the American Society of Nephrology, V9, p164A; Pena JM, 1996, NEPHROL DIAL TRANSPL, V11, P1359, DOI 10.1093/ndt/11.7.1359; PEZZUTO JM, 1988, MUTAT RES, V206, P447, DOI 10.1016/0165-1218(88)90052-3; Pfohl-Leszkowicz A, 1993, IARC Sci Publ, P141; POURRAT J, 1994, PRESSE MED, V23, P1669; RICHARDS B, 1991, BRIT J UROL, V67, P369, DOI 10.1111/j.1464-410X.1991.tb15164.x; SCHMEISER HH, 1985, BIOCHEM PHARMACOL, V34, P455, DOI 10.1016/0006-2952(85)90085-1; SCHMEISER HH, 1986, CARCINOGENESIS, V7, P59, DOI 10.1093/carcin/7.1.59; SCHMEISER HH, 1990, CANCER RES, V50, P5464; Schmeiser HH, 1996, CANCER RES, V56, P2025; STEFANOVIC V, 1991, AM J NEPHROL, V11, P1, DOI 10.1159/000168264; TANAKA A, 1997, JPN J NEPHROL, V39, P794; TANAKA A, 1997, JPN J NEPHROL, V39, P438; VANHAELEN M, 1994, LANCET, V343, P174, DOI 10.1016/S0140-6736(94)90964-4; VANHERWEGHEM JL, 1995, NEPHROL DIAL TRANSPL, V10, P270; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Yang CS, 2000, AM J KIDNEY DIS, V35, P313, DOI 10.1016/S0272-6386(00)70343-X	39	744	805	4	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1686	1692		10.1056/NEJM200006083422301	http://dx.doi.org/10.1056/NEJM200006083422301			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841870				2022-12-28	WOS:000087449300001
J	Durieux, P; Nizard, R; Ravaud, P; Mounier, N; Lepage, E				Durieux, P; Nizard, R; Ravaud, P; Mounier, N; Lepage, E			A clinical decision support system for prevention of venous thromboembolism - Effect on physician behavior	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTINUING MEDICAL-EDUCATION; PULMONARY-EMBOLISM; QUALITY ASSURANCE; HEALTH-CARE; PERFORMANCE; GUIDELINES; TRIALS; IMPLEMENTATION; PROPHYLAXIS; OUTCOMES	Context Computer-based clinical decision support systems (CDSSs) have been promoted for their potential to improve quality of health care. However, given the limited range of clinical settings in which they have been tested, such systems must be evaluated rigorously before widespread introduction into clinical practice. Objective To determine whether presentation of venous thromboembolism prophylaxis guidelines using a CDSS increases the proportion of appropriate clinical practice decisions made. Design Time-series study conducted between December 1997 and July 1999. Setting Orthopedic surgery department of a teaching hospital in Paris, France. Participants A total of 1971 patients who underwent orthopedic surgery. Intervention A CDSS designed to provide immediate information pertaining to venous thromboembolism prevention among surgical patients was integrated into daily medical practice during three 10-week intervention periods, alternated with four 10-week control periods, with a 4-week washout between each period. Main Outcome Measure Proportion of appropriate prescriptions ordered for anticoagulation, according to preestablished clinical guidelines, during intervention vs control periods. Results Physicians complied with guidelines in 82.8% (95% confidence interval [CI], 77.6%-87.1%) of cases during control periods and in 94.9% (95% CI, 92.5%-96.6%) of cases during intervention periods. During each intervention period, the appropriateness of prescription increased significantly (P<.001). Each time the CDSS was removed, physician practice reverted to that observed before initiation of the intervention. The relative risk of inappropriate practice decisions during control periods vs intervention periods was 3.8 (95% CI, 2.7-5.4). Conclusions In our study, implementation of clinical guidelines for venous thromboembolism prophylaxis through a CDSS used routinely in an orthopedic surgery department and integrated into the hospital information system changed physician behavior and improved compliance with guidelines.	Fac Med Broussais Hotel Dieu, Dept Publ Hlth, F-75006 Paris, France; Assistance Publ Hop Paris, Lariboisiere Hosp, Dept Orthoped, Paris, France; Assistance Publ Hop Paris, Bichat Hosp, Epidemiol Unit, Paris, France; Assistance Publ Hop Paris, Henri Mondor Hosp, Dept Biostat & Med Informat, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Durieux, P (corresponding author), Fac Med Broussais Hotel Dieu, Dept Publ Hlth, 15 Rue Ecole Med, F-75006 Paris, France.	pierre.kurieux@egp.ap-hop-paris.fr	Mounier, Nicolas/X-2964-2018; Nizard, Remy/R-5845-2019; ravaud, philippe/C-1694-2009	Mounier, Nicolas/0000-0002-0707-426X; Ravaud, Philippe/0000-0001-8264-9206				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; ANDERSON FA, 1994, ARCH INTERN MED, V154, P669, DOI 10.1001/archinte.154.6.669; Auleley GR, 1997, JAMA-J AM MED ASSOC, V277, P1935; Balas EA, 1996, ARCH FAM MED, V5, P271, DOI 10.1001/archfami.5.5.271; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; CLAGETT GP, 1995, CHEST, V108, pS312, DOI 10.1378/chest.108.4_Supplement.312S; DAVIES HTO, 1995, BRIT MED J, V311, P766, DOI 10.1136/bmj.311.7008.766; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Durieux P, 1997, INT J QUAL HEALTH C, V9, P215, DOI 10.1093/intqhc/9.3.215; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; GOLDHABER SZ, 1992, JAMA-J AM MED ASSOC, V268, P1727, DOI 10.1001/jama.268.13.1727; HAMMERMEISTER KE, 1994, ANN THORAC SURG, V58, P1815, DOI 10.1016/0003-4975(94)91720-5; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; LOWE GDO, 1992, BMJ-BRIT MED J, V305, P567; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McKee M, 1997, BRIT MED J, V315, P142, DOI 10.1136/bmj.315.7101.142; MCNALLY E, 1995, BRIT MED J, V310, P640, DOI 10.1136/bmj.310.6980.640; NHS Centre for Reviews and Dissemination, 1994, EFFECTIVE HLTH CARE, V8, P1; NICOLAIDES AN, 1992, INT ANGIOL, V11, P151; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Patterson R, 1998, J AM MED INFORM ASSN, P573; Randolph AG, 1999, JAMA-J AM MED ASSOC, V282, P67, DOI 10.1001/jama.282.1.67; Ravaud P, 1995, SANG THROMB VAISS, V7, P119; Ryskamp RP, 1998, CHEST, V113, P162, DOI 10.1378/chest.113.1.162; Schiff GD, 1998, JAMA-J AM MED ASSOC, V279, P1024, DOI 10.1001/jama.279.13.1024; Schriger DL, 1997, JAMA-J AM MED ASSOC, V278, P1585, DOI 10.1001/jama.278.19.1585; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; Weed LL, 1999, BRIT MED J, V319, P1279, DOI 10.1136/bmj.319.7220.1279; WEINGARTEN SR, 1994, ANN INTERN MED, V120, P257, DOI 10.7326/0003-4819-120-4-199402150-00001; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; 1991, ANN FR ANESTH REANIM, V10, P417	32	176	180	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2816	2821		10.1001/jama.283.21.2816	http://dx.doi.org/10.1001/jama.283.21.2816			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10838650	Bronze			2022-12-28	WOS:000087381500036
J	Gostin, LO				Gostin, LO			Public health law in a new century - Part I: Law as a tool to advance the community's health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE	Statutes, regulations, and litigation are pivotal tools for creating conditions for people to lead healthier and safer lives. Law can educate, create incentives, and deter; mandate safer product design and use of property; and alter the informational, physical, or economic environment, This article defines public health law as the power and duty of the state to ensure conditions for people to be healthy and limitations on the state's power to constrain autonomy, privacy, liberty, and Proprietary interests of individuals and businesses, The 5 essential characteristics of public health law discussed are (1) the government's responsibility to defend against health risks and promote the public's health; (2) the population-based perspective of public health, emphasizing prevention; (3) the relationship between government and the populace; (4) the mission, core functions, and services of the public health system; and (5) the power to coerce individuals, professionals, and businesses for the community's protection.	Georgetown Johns Hopkins Univ, Program Law & Publ Hlth, Washington, DC USA; Georgetown Johns Hopkins Univ, Program Law & Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.							[Anonymous], 1988, FUT PUBL HLTH; [Anonymous], 1989, PRIVATE ACTS SOCIAL; BAUCHAMP DE, 1988, HLTH REPUBLIC EPIDEM; Bowser R, 1999, SOUTH CALIF LAW REV, V72, P1209; Brandt Allan M, 1985, NO MAGIC BULLET SOCI; BROCK DW, 1994, JAMA-J AM MED ASSOC, V271, P1189, DOI 10.1001/jama.271.15.1189; Burris S, 1997, AM J PUBLIC HEALTH, V87, P1607, DOI 10.2105/AJPH.87.10.1607; Burris Scott, 1989, Villanova Law Rev, V34, P933; CHAPIN CV, 1926, PUBLIC HLTH LAW MANU; CHRISTOFFEL T, 1993, PROTECTING PUBLIC LE; *DEP HLTH HUM SERV, 2000, HLTH PEOPL 2010 UND; Fee Elizabeth, 1987, DIS DISCOVERY HIST J; Garner B. A, 1999, BLACKS LAW DICT; GEBBIE KM, 1997, IDENTIFICATION HLTH; GRAD FP, 1990, PUBLIC HLTH LAW MANU; Lasker RD., 1997, MED PUBLIC HLTH POWE; MAUSNER JS, 1994, MAUSNER BAHN EPIDEMI; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Parmet Wendy E, 1993, Hastings Constit Law Q, V20, P267; *PUBL HLTH FUNCT S, 1995, PUBL HLTH AM; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; STEINBOCK B, 1999, NEW ETHICS PUBLICS H; Tobey JA, 1927, NEW YORK U LAW REV, V4, P126; Turnock BJ, 1997, PUBLIC HLTH WHAT IT; Walzer M., 1983, SPHERES JUSTICE DEFE; WING KR, 1995, LAW PUBLICS HLTH	26	47	48	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2837	2841		10.1001/jama.283.21.2837	http://dx.doi.org/10.1001/jama.283.21.2837			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320BQ	10838654				2022-12-28	WOS:000087381500040
J	Lev-Yadun, S; Gopher, A; Abbo, S				Lev-Yadun, S; Gopher, A; Abbo, S			Archaeology - Che cradle of agriculture	SCIENCE			English	Article							WHEAT DOMESTICATION		Agr Res Org, Volcani Ctr, Dept Agron & Nat Resources, IL-50250 Bet Dagan, Israel; Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Dept Field Crops, IL-76100 Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Tel Aviv University; Hebrew University of Jerusalem	Lev-Yadun, S (corresponding author), Agr Res Org, Volcani Ctr, Dept Agron & Nat Resources, IL-50250 Bet Dagan, Israel.	vcfield@agri.gov.il; agopher@post.tau.ac.il; abbo@agri.huji.ac.il						BarYosef O, 1995, SCH AM RES, V354, P39; Binford L.R., 1968, NEW PERSPECTIVES ARC, P313; GARFINKEL Y, 1988, ISRAEL J BOT, V37, P49; Gopher A., 1994, ARROWHEADS NEOLITHIC; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; HILLMAN G, 1998, INT WORKSH GRON NETH; HYDEN B, 1990, J ANTHROPOL ARCHAEOL, P31; Jones MK, 1998, SCIENCE, V279, P302; KISLEV M, 1992, MONOGRAPHIE CRA, V6, P87; Ladizinsky G, 1999, GENET RESOUR CROP EV, V46, P115, DOI 10.1023/A:1008626128871; Ladizinsky G, 1998, PLANT EVOLUTION DOME, P123; Nesbitt M, 1998, SCIENCE, V279, P1433; NESBITT M, 1998, INT WORKSH GRON NETH; Ozdogan M., 1997, J EUROPEAN ARCHAEOLO, V5, P1; Van Zeist W, 1984, PALAEOHISTORIA, V24, P165; Zohary D, 1996, ORIGINS SPREAD AGR P, P142; Zohary D., 1993, DOMESTICATION PLANTS	17	352	380	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2000	288	5471					1602	1603		10.1126/science.288.5471.1602	http://dx.doi.org/10.1126/science.288.5471.1602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10858140				2022-12-28	WOS:000087382300030
J	Gershon, D				Gershon, D			US Congress encouraged to lay out the welcome mat for skilled foreigners	NATURE			English	Article																			0	1	1	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					597	598		10.1038/35014685	http://dx.doi.org/10.1038/35014685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850722	Bronze			2022-12-28	WOS:000087449500057
J	Sakaguchi, S				Sakaguchi, S			Regulatory T cells: Key controllers of immunologic self-tolerance	CELL			English	Review							GROWTH-FACTOR-BETA; TRANSPLANTATION TOLERANCE; AUTOIMMUNE-DISEASES; MICE; RESPONSES; SUBSET		Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Kyoto University	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; HALL BM, 1990, J EXP MED, V171, P141, DOI 10.1084/jem.171.1.141; Itoh M, 1999, J IMMUNOL, V162, P5317; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; O'Garra A, 1997, CURR OPIN IMMUNOL, V9, P872, DOI 10.1016/S0952-7915(97)80192-6; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Seddon B, 2000, IMMUNOL TODAY, V21, P95, DOI 10.1016/S0167-5699(99)01559-5; Seddon B, 1999, J EXP MED, V189, P279, DOI 10.1084/jem.189.2.279; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Van de Keere F, 1998, J EXP MED, V188, P1875, DOI 10.1084/jem.188.10.1875; Zhai Y, 1999, CURR OPIN IMMUNOL, V11, P497, DOI 10.1016/S0952-7915(99)00007-2	20	1329	1461	2	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					455	458		10.1016/S0092-8674(00)80856-9	http://dx.doi.org/10.1016/S0092-8674(00)80856-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850488	Bronze			2022-12-28	WOS:000087375400003
J	Toulouse, G				Toulouse, G			Community groups could show Unesco the way	NATURE			English	Letter									Ecole Normale Super, Phys Lab, UNESCO, French Natl Commiss,Comm Exact & Nat Sci, F-75231 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Toulouse, G (corresponding author), Ecole Normale Super, Phys Lab, UNESCO, French Natl Commiss,Comm Exact & Nat Sci, 24 Rue Lhomond, F-75231 Paris, France.							2000, NATURE, V404, P109	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					394	394		10.1038/35013252	http://dx.doi.org/10.1038/35013252			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839515	Bronze			2022-12-28	WOS:000087212000018
J	Judson, OP; Normark, BB				Judson, OP; Normark, BB			Evolutionary genetics - Sinless originals	SCIENCE			English	Editorial Material							ANCIENT ASEXUALS; DNA		Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Imperial College London; Harvard University	Judson, OP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.			Judson, Olivia/0000-0002-1829-5973				BARRON GL, 1985, CAN J BOT, V63, P211, DOI 10.1139/b85-024; Darlington CD, 1939, EVOLUTION GENETIC SY; HICKEY DA, 1982, GENETICS, V101, P519; HURST LD, 1992, TRENDS ECOL EVOL, V7, P144, DOI 10.1016/0169-5347(92)90205-P; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Little TJ, 1996, TRENDS ECOL EVOL, V11, P296, DOI 10.1016/S0169-5347(96)91640-7; MAYNARD SMITH J., 1978, EVOLUTION SEX; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Schon I, 1998, J NAT HIST, V32, P943, DOI 10.1080/00222939800770481; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211	13	10	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1185	1186		10.1126/science.288.5469.1185	http://dx.doi.org/10.1126/science.288.5469.1185			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10841738				2022-12-28	WOS:000087112600031
J	McKeigue, PM; Reynard, JM				McKeigue, PM; Reynard, JM			Relation of nocturnal polyuria of the elderly to essential hypertension	LANCET			English	Article							URINARY-TRACT SYMPTOMS; ATRIAL-NATRIURETIC-PEPTIDE; NITRIC-OXIDE SYNTHESIS; URODILATIN; INFUSION; HUMANS; PROSTATECTOMY; COMMUNITY; EXCRETION; QUALITY	Nocturnal polyuria is common in the elderly. In this condition the normal circadian rhythm of urine production is reversed so that urine flow is higher at night than during the day. Elderly men with nocturnal polyuria are commonly referred for prostate surgery, which, not surprisingly, fails to relieve their symptoms. Compared with controls, patients with nocturnal polyuria have higher nocturnal sodium excretion but not higher nocturnal free-water clearance. Similar results have been obtained in children with nocturnal enuresis. Use of vasopressin analogues to induce water retention in elderly patients with nocturnal polyuria is illogical and potentially hazardous; nocturia can be more safely alleviated by diuretic therapy. Nocturnal polyuria in the elderly is associated with hypertension: this is consistent with studies in younger age groups that show that essential hypertension is associated with nocturia and with increased night/day ratios for sodium excretion. We propose that nocturnal polyuria and essential hypertension share some of the same pathophysiological determinants. Specifically, we suggest that a defect in the nitric-oxide pathway may lead to resetting of the pressure-natriuresis relation in the kidney, sodium retention, and compensatory nocturnal natriuresis. This suggestion is consistent with evidence that ageing and essential hypertension are both associated with defects in the nitric-oxide pathway. Our hypothesis has obvious therapeutic implications. More generally, studying the pathogenesis of nocturnal polyuria in the elderly may advance our understanding of the pathogenesis of essential hypertension.	Univ London London Sch Hyg & Trop Med, Epidemiol Unit, London WC1E 7HT, England; Churchill Hosp, Dept Urol, Oxford OX3 7LJ, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	McKeigue, PM (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol Unit, Keppel St, London WC1E 7HT, England.							Asplund R, 1999, BJU INT, V84, P297; ASPLUND R, 1996, BR J UROL INT, V83, P591; Bech JN, 1998, AM J PHYSIOL-RENAL, V274, pF914, DOI 10.1152/ajprenal.1998.274.5.F914; *BRIT NAT FORM, 1999, BRIT MED ASS ROYAL P, P340; BULPITT CJ, 1976, BRIT HEART J, V38, P121; CAMPO C, 1996, KIDNEY INT S, V55, pS126; Cannon A, 1999, BJU INT, V84, P20; Carstens J, 1997, CLIN SCI, V92, P397, DOI 10.1042/cs0920397; Carter PG, 1999, EUR UROL, V36, P213, DOI 10.1159/000068000; Debruyne FMJ, 1996, EUR UROL, V30, P369; Dijkhorst-Oei LT, 1998, NEPHROL DIAL TRANSPL, V13, P587, DOI 10.1093/ndt/13.3.587; DRUMMER C, 1991, J AM SOC NEPHROL, V1, P1109; Drummer C, 1996, AM J PHYSIOL-RENAL, V270, pF301, DOI 10.1152/ajprenal.1996.270.2.F301; Emberton M, 1996, BRIT J UROL, V77, P233, DOI 10.1046/j.1464-410X.1996.88213.x; Forte P, 1997, LANCET, V349, P837, DOI 10.1016/S0140-6736(96)07631-3; FOWLER FJ, 1988, JAMA-J AM MED ASSOC, V259, P3018, DOI 10.1001/jama.259.20.3018; Fujii T, 1999, AM J KIDNEY DIS, V33, P29, DOI 10.1016/S0272-6386(99)70254-4; Gerhard M, 1996, HYPERTENSION, V27, P849, DOI 10.1161/01.HYP.27.4.849; JOLLEYS JV, 1994, BRIT J UROL, V74, P551, DOI 10.1111/j.1464-410X.1994.tb09182.x; KANNO K, 1992, CLIN EXP PHARMACOL P, V19, P619, DOI 10.1111/j.1440-1681.1992.tb00514.x; KENTSCH M, 1992, EUR J CLIN INVEST, V22, P319, DOI 10.1111/j.1365-2362.1992.tb01469.x; KIRKLAND JL, 1983, BRIT MED J, V287, P1665, DOI 10.1136/bmj.287.6406.1665; LEPOR H, 1993, UROLOGY, V42, P36, DOI 10.1016/0090-4295(93)90332-5; Lyons D, 1997, CLIN SCI, V93, P519, DOI 10.1042/cs0930519; Matthiesen TB, 1999, BJU INT, V83, P1017; Matthiesen TB, 1996, J UROLOGY, V156, P1292, DOI 10.1016/S0022-5347(01)65572-1; Meyer M, 1996, AM J PHYSIOL-RENAL, V271, pF489, DOI 10.1152/ajprenal.1996.271.3.F489; PEDERSEN PA, 1988, BRIT J UROL, V62, P145, DOI 10.1111/j.1464-410X.1988.tb04294.x; Pinnock CB, 1997, MED J AUSTRALIA, V167, P72, DOI 10.5694/j.1326-5377.1997.tb138783.x; Reynard JM, 1998, BRIT J UROL, V81, P215; Reynard JM, 1998, BRIT J UROL, V82, P619; RICHARDS AM, 1987, CLIN SCI, V73, P489, DOI 10.1042/cs0730489; RITTIG S, 1991, SCAND J CLIN LAB INV, V51, P209, DOI 10.3109/00365519109091109; Robson WLM, 1996, EUR J PEDIATR, V155, P959, DOI 10.1007/BF02282887; SAITO M, 1993, BRIT J UROL, V72, P38, DOI 10.1111/j.1464-410X.1993.tb06453.x; SIRAGY HM, 1992, HYPERTENSION, V19, P775, DOI 10.1161/01.HYP.19.6.775; STAESSEN J, 1991, J HYPERTENS, V9, P1035, DOI 10.1097/00004872-199111000-00009; STEWART RB, 1992, J AM GERIATR SOC, V40, P1217, DOI 10.1111/j.1532-5415.1992.tb03645.x; WILCOX CS, 1974, J NEUROL NEUROSUR PS, V37, P677, DOI 10.1136/jnnp.37.6.677; WILLIAMS G, 1986, LANCET, V1, P738	40	64	67	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					486	488						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841144				2022-12-28	WOS:000085306800039
J	Hoeper, MM; Schwarze, M; Ehlerding, S; Adler-Schuermeyer, A; Spiekerkoetter, E; Niedermeyer, J; Hamm, M; Fabel, H				Hoeper, MM; Schwarze, M; Ehlerding, S; Adler-Schuermeyer, A; Spiekerkoetter, E; Niedermeyer, J; Hamm, M; Fabel, H			Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVENOUS EPOPROSTENOL PROSTACYCLIN; THERAPY; SURVIVAL; INFUSION	Background: Continuous intravenous infusion of epoprostenol (prostacyclin) is an effective treatment for primary pulmonary hypertension. This approach requires the insertion of a permanent central venous catheter, with the associated risk of serious complications. Recently, aerosolized iloprost, a stable prostacyclin analogue, has been introduced as an alternative therapy for severe pulmonary hypertension. Methods: We evaluated the effects of aerosolized iloprost on exercise capacity and hemodynamic variables over a one-year period in patients with primary pulmonary hypertension. Results: Twenty-four patients with primary pulmonary hypertension received aerosolized iloprost at a daily dose of 100 or 150 mu-g for at least one year. The mean (+/-SD) distance covered in the six-minute walk test increased from 278+/-96 m at base line to 363+/-135 m after 12 months (P<0.001). During the same period, the mean pulmonary arterial pressure before the inhalation of iloprost declined from 59+/-10 mm Hg to 52+/-15 mm Hg (P=0.006), cardiac output increased from 3.8+/-1.4 liters per minute to 4.4+/-1.3 liters per minute (P=0.02), and pulmonary vascular resistance declined from 1205+/-467 dyn.sec.cm(-5) to 925+/-469 dyn.sec.cm(-5) (P<0.001). The treatment was generally well tolerated, except for mild coughing, minor headache, and jaw pain in some patients. Conclusions: Long-term treatment with aerosolized iloprost is safe and has sustained effects on exercise capacity and pulmonary hemodynamics in patients with primary pulmonary hypertension. (N Engl J Med 2000;342:1866-70.) (C)2000, Massachusetts Medical Society.	Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany	Hannover Medical School	Hoeper, MM (corresponding author), Hannover Med Sch, Dept Resp Med, D-30623 Hannover, Germany.		Hoeper, Marius C/Z-1546-2019	Hoeper, Marius C/0000-0001-9086-2293				Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BARST RJ, 1994, ANN INTERN MED, V121, P409, DOI 10.7326/0003-4819-121-6-199409150-00003; Fishman AP, 1998, NEW ENGL J MED, V338, P321, DOI 10.1056/NEJM199801293380609; Gessler T, 1999, AM J RESP CRIT CARE, V159, pA159; GRANT SM, 1992, DRUGS, V43, P889, DOI 10.2165/00003495-199243060-00008; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HIGENBOTTAM T, 1984, LANCET, V1, P1046; Hinderliter AL, 1997, CIRCULATION, V95, P1479; Hoeper MM, 1999, AM J RESP CRIT CARE, V160, P535, DOI 10.1164/ajrccm.160.2.9811062; Hoeper MM, 2000, J AM COLL CARDIOL, V35, P176, DOI 10.1016/S0735-1097(99)00494-5; HOEPER MM, 2000, ANN INTERN MED, V132, P500; HOEPER MM, 1997, AM J RESP CELL MOL B, V17, P748; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; Olschewski H, 2000, ANN INTERN MED, V132, P435, DOI 10.7326/0003-4819-132-6-200003210-00003; Olschewski H, 1999, AM J RESP CRIT CARE, V160, P600, DOI 10.1164/ajrccm.160.2.9810008; Olschewski H, 1996, ANN INTERN MED, V124, P820, DOI 10.7326/0003-4819-124-9-199605010-00006; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th; RUBIN LJ, 1990, ANN INTERN MED, V112, P485, DOI 10.7326/0003-4819-112-7-485; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Shapiro SM, 1997, J AM COLL CARDIOL, V30, P343, DOI 10.1016/S0735-1097(97)00187-3	21	387	418	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1866	1870		10.1056/NEJM200006223422503	http://dx.doi.org/10.1056/NEJM200006223422503			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861321				2022-12-28	WOS:000087704700003
J	Taylor, M				Taylor, M			Patient care (empowerment): a local view	BRITISH MEDICAL JOURNAL			English	Article									Peoples Advocacy & Support Serv, Dumfries DG1 2AT, Scotland		Taylor, M (corresponding author), Peoples Advocacy & Support Serv, Dumfries DG1 2AT, Scotland.							*SECR STAT SCOTL, 1998, DES CAR REV NAT HLTH; Slowie DF, 1999, BRIT MED J, V319, P784, DOI 10.1136/bmj.319.7212.784; *TAYS HLTH COUNC, 1999, PAT RIGHTS RESP GUID, P2; 2000, AVMA NEWSLETTER, V153, P3; 2000, AVMA NEWSLETTER, V153, P8	5	4	4	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1663	1664		10.1136/bmj.320.7250.1663	http://dx.doi.org/10.1136/bmj.320.7250.1663			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856076	Green Published			2022-12-28	WOS:000087734200030
J	Thornhill, S; Teasdale, GM; Murray, GD; McEwen, J; Roy, CW; Penny, KI				Thornhill, S; Teasdale, GM; Murray, GD; McEwen, J; Roy, CW; Penny, KI			Disability in young people and adults one year after head injury: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							GLASGOW OUTCOME SCALE; TRAUMATIC BRAIN INJURY; CONTROLLED TRIAL; MODERATE; MILD	Objective To determine the frequency of disability in young people and adults admitted to hospital with a head injury and to estimate the annual incidence in the community. Design Prospective, hospital based cohort study, with one year follow up of sample stratified by coma score. Setting Five acute hospitals in Glasgow. Subjects 2962 patients (aged 14 years or more) with head injury; 549 (71%) of the 769 patients selected for follow up participated. Main outcome measures Glasgow outcome scale and problem orientated questionnaire. Results Survival with moderate or severe disability was common after mild head injury (47%, 95% confidence interval 42% to 52%) and similar to that after moderate (45%, 35% to 56%) or severe injury (48%, 36% to 60%). By extrapolation from the population identified (90% of whom had mild injuries), it was estimated that annually in Glasgow (population 909 498) 1400 young people and adults are still disabled one year after head injury. Conclusion The incidence of disability in young people and adults admitted with a head injury is higher than expected. This reflects die high rate of sequelae previously unrecognised in the large number of patients admitted to hospital with an apparently mild head injury.	Univ Glasgow, So Gen NHS Trust, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; So Gen NHS Trust, Glasgow G51 4TF, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Edinburgh; University of Glasgow; University of Edinburgh	Teasdale, GM (corresponding author), Univ Glasgow, So Gen NHS Trust, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland.			Murray, Gordon/0000-0001-9866-4734	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Bryden J, 1989, MODELS BRAIN INJURY, P17; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; FIELD JH, 1975, EPIDEMIOLOGY HEAD IN; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1975, LANCET, V2, P81; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Kraus JF, 1993, HEAD INJURY, P1; MacMillan R, 1979, Health Bull (Edinb), V37, P75; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; *ROYAL COLL SURG E, 1999, WORK PART MAN PAT HE; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tellier A, 1999, BRAIN INJURY, V13, P463; Wade D T, 1987, Int Rehabil Med, V8, P129; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	24	407	412	1	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1631	1635		10.1136/bmj.320.7250.1631	http://dx.doi.org/10.1136/bmj.320.7250.1631			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856063	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-28	WOS:000087734200021
J	Volarevic, S; Stewart, MJ; Ledermann, B; Zilberman, F; Terracciano, L; Montini, E; Grompe, M; Kozma, SC; Thomas, G				Volarevic, S; Stewart, MJ; Ledermann, B; Zilberman, F; Terracciano, L; Montini, E; Grompe, M; Kozma, SC; Thomas, G			Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6	SCIENCE			English	Article							LIVER-REGENERATION; C-MYC; TRANSCRIPTION; MICE; FIBROBLASTS; PROGRESSION; IDENTITY; KINASE; MODEL	Because ribosome biogenesis plays an essential role in cell proliferation, control mechanisms may have evolved to recognize Lesions in this critical anabolic process. To test this possibility, we conditionally deleted the gene encoding 40S ribosomal protein S6 in the Liver of adult mice. Unexpectedly, Livers from fasted animals deficient in S6 grew in response to nutrients even though biogenesis of 40S ribosomes was abolished. However, Liver cells failed to proliferate or induce cyclin E expression after partial hepatectomy, despite formation of active cyclin D-CDK4 complexes. These results imply that abrogation of 40S ribosome biogenesis may induce a checkpoint control that prevents cell cycle progression.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; Univ Basel, Inst Pathol, Basel, Switzerland; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	Friedrich Miescher Institute for Biomedical Research; University of Zurich; University of Basel; Oregon Health & Science University	Thomas, G (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Terracciano, Luigi M./AAB-5335-2022; Volarevic, Sinisa/O-4349-2018; Montini, Eugenio/L-1152-2016; Thomas, George/K-9235-2014	Terracciano, Luigi M./0000-0002-9393-9660; Volarevic, Sinisa/0000-0003-4893-389X; Montini, Eugenio/0000-0003-1771-6067; Thomas, George/0000-0003-3518-8149; Grompe, Markus/0000-0002-6616-4345				BOWMAN LH, 1983, MOL CELL BIOL, V3, P1501, DOI 10.1128/MCB.3.8.1501; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CONDE RD, 1980, BIOCHEM J, V192, P935, DOI 10.1042/bj1920935; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; HUTSON NJ, 1982, J BIOL CHEM, V257, P9548; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; KOZMA SC, 1989, EMBO J, V8, P4125, DOI 10.1002/j.1460-2075.1989.tb08597.x; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MONTINI E, UNPUB; Nasmyth K, 1996, NATURE, V382, P28, DOI 10.1038/382028a0; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Sambrook J., 2002, MOL CLONING LAB MANU; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Su TT, 1998, CURR BIOL, V8, pR687, DOI 10.1016/S0960-9822(98)70436-1; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; VOLAREVIC S, UNPUB; Wool I. G., 1996, TRANSLATIONAL CONTRO, P685	28	301	317	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2045	+		10.1126/science.288.5473.2045	http://dx.doi.org/10.1126/science.288.5473.2045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856218				2022-12-28	WOS:000087687000051
J	Kremen, C; Niles, JO; Dalton, MG; Daily, GC; Ehrlich, PR; Fay, JP; Grewal, D; Guillery, RP				Kremen, C; Niles, JO; Dalton, MG; Daily, GC; Ehrlich, PR; Fay, JP; Grewal, D; Guillery, RP			Economic incentives for rain forest conservation across scales	SCIENCE			English	Article							GREENHOUSE GASES; BIODIVERSITY; MADAGASCAR; AMAZONIA; TOOL	Globally, tropical deforestation releases 20 to 30% of anthropogenic green-house gases. Conserving forests could reduce emissions, but the cost-effectiveness of this mechanism for mitigation depends on the associated opportunity costs. We estimated these costs from local, national, and global perspectives using a case study from Madagascar, Conservation generated significant benefits over logging and agriculture Locally and globally. Nationally, however, financial benefits from industrial logging were Larger than conservation benefits. Such differing economic signals across scales may exacerbate tropical deforestation. The Kyoto Protocol could potentially overcome this obstacle to conservation by creating markers for protection of tropical forests to mitigate climate change.	Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA; CSU Monterey Bay, Inst Earth Syst Sci & Policy, Seaside, CA 93955 USA; Yale Univ, Sch Law, New Haven, CT 06511 USA; Inst Agr & Trade Policy, Minneapolis, MN 55404 USA	Stanford University; California State University System; California State University Monterey Bay; Yale University	Kremen, C (corresponding author), Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA.	ckremen@stanford.edu						*AS PAC ACT GROUP, 1990, BARN REP; *AS PAC FOR SECT, 1998, AS PAC FOR 2000; Barbier E, 1994, CAUSES TROPICAL DEFO, P271; Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; Bowles IA, 1998, SCIENCE, V280, P1899, DOI 10.1126/science.280.5371.1899; BROWN S, 1996, CLIMATE CHANGE 1995, P774; Brunner J, 1998, LOGGING BURMAS FRONT; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Fankhauser S, 1995, VALUING CLIMATE CHAN; FAO, 1999, STAT WORLDS FOR; Fearnside PM, 1997, CLIMATIC CHANGE, V35, P321, DOI 10.1023/A:1005336724350; GOLDBERG DC, 1998, CARBON CONSERVATION; HARDNER J, 1999, ASSESSMENT EC OPPORT; HARDNER JJ, IN PRESS MITIGATION; HATCHWELL MC, COMMUNICATION; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Johns AG., 1997, TIMBER PRODUCTION BI; Kramer R, 1997, LAST STAND PROTECTED; Kramer RA, 1997, J ENVIRON MANAGE, V49, P277, DOI 10.1006/jema.1995.0085; Kremen C, 1998, CONSERV BIOL, V12, P549, DOI 10.1046/j.1523-1739.1998.96374.x; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; LEMARAINA R, UNPUB; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; NILES JO, 2000, P IEA BIOEN TASK25 W; NORDHAUS WD, 1992, SCIENCE, V258, P1315, DOI 10.1126/science.258.5086.1315; Pearce D., 1994, CAUSES TROPICAL DEFO, P2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; *POP REF BUR, 1997, WORLD POP DAT SHEET; RAKOTOARISOA JN, 1997, THESIS U ANTANANARIV; RAMILISON C, 1997, COMMUNICATION    DEC; RAYMOND I, 1995, THESIS U ANTANANARIV; ROBINSON JG, 1993, CONSERV BIOL, V7, P20, DOI 10.1046/j.1523-1739.1993.07010020.x; Roughgarden T, 1999, ENERG POLICY, V27, P415, DOI 10.1016/S0301-4215(99)00030-0; Ruitenbeek H.J., 1992, ECOL ECON, V6, P5778, DOI 10.1016/0921-8009(92)90038-T; Schneider SH, 1998, CLIMATIC CHANGE, V39, P1, DOI 10.1023/A:1005374030204; Schwarze R, 2000, ECOL ECON, V32, P255, DOI 10.1016/S0921-8009(99)00095-6; Trenberth KE, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P51; Walker B. H., 1999, ENVIRON DEV ECON, V4, P204; Wolfire D., 1998, FORESTS DEMOCRATIC R; *WORLD BANK, 1993, 1993 EV RES WORLD BA; *WORLD BANK, 1996, WORLD DEV REP 1996	41	185	198	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1828	1832		10.1126/science.288.5472.1828	http://dx.doi.org/10.1126/science.288.5472.1828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	322HH	10846165				2022-12-28	WOS:000087503800051
J	Whitby, J; Burgess, R; Turner, G; Gilmour, J; Bridges, J				Whitby, J; Burgess, R; Turner, G; Gilmour, J; Bridges, J			Extinct I-129 in halite from a primitive meteorite: Evidence for evaporite formation in the early solar system	SCIENCE			English	Article							ORDINARY CHONDRITES; FLUID	Halite crystals from the Zag H3-6 chondrite contain essentially pure (monoisotopic) xenon-129 (Xe-129) produced in the early history of the solar system by the decay of short-lived iodine-129 (I-129) (half-Life = 15.7 million years). Correlated release of Xe-129 and Xe-128, produced artificially from I-127 by neutron irradiation, corresponds to an initial (I-129/I-127) ratio of (1.35 +/- 0.05) x 10(-4), close to the most primitive early solar system value. If the Xe-129 was produced by in situ decay. then the halite formed from an aqueous fluid within 2 million years of the oldest known solar system minerals.	Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England; Nat Hist Museum, Dept Mineral, London SW7 5BD, England	University of Manchester; Natural History Museum London	Whitby, J (corresponding author), Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England.		Whitby, James A/J-4559-2012; Burgess, Ray/A-5767-2009; Gilmour, Jamie/G-7515-2011	Whitby, James A/0000-0002-5716-6875; Burgess, Ray/0000-0001-7674-8718; Gilmour, Jamie/0000-0003-1990-8636				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BOGARD DD, 1995, J GEOPHYS RES-PLANET, V100, P9401, DOI 10.1029/95JE00663; CROZAZ G, 1977, PHYS CHEM EARTH, V10, P197; GILMOUR JD, 1994, REV SCI INSTRUM, V65, P617, DOI 10.1063/1.1145127; Grossman JN, 1999, METEORIT PLANET SCI, V34, pA169, DOI 10.1111/j.1945-5100.1999.tb01762.x; HOHENBERG CM, 1981, GEOCHIM COSMOCHIM AC, V45, P251, DOI 10.1016/0016-7037(81)90170-8; HOHENBERG CM, 2000, LUNAR PLANET SCI C, V31; HOLSER WT, 1979, REV MINERAL, V6, pCH9; Johnson LH, 2000, GEOCHIM COSMOCHIM AC, V64, P717, DOI 10.1016/S0016-7037(99)00336-1; KELLEY S, 1986, EARTH PLANET SC LETT, V79, P303, DOI 10.1016/0012-821X(86)90187-1; LEWIS RS, 1975, P NATL ACAD SCI USA, V72, P268, DOI 10.1073/pnas.72.1.268; MARTI K, 1992, ANNU REV EARTH PL SC, V20, P221, DOI 10.1146/annurev.ea.20.050192.001253; STOFFLER D, 1991, GEOCHIM COSMOCHIM AC, V55, P3845, DOI 10.1016/0016-7037(91)90078-J; TURNER G, 1965, J GEOPHYS RES, V70, P5433, DOI 10.1029/JZ070i021p05433; TURNER G, 1971, EARTH PLANET SC LETT, V12, P19, DOI 10.1016/0012-821X(71)90051-3; TURNER G, 1974, GEOCHIM COSMOCHIM  S, V5, P1601; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331; Zolensky ME, 1999, METEORIT PLANET SCI, V34, pA124; Zolensky ME, 1999, SCIENCE, V285, P1377, DOI 10.1126/science.285.5432.1377	19	59	61	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1819	1821		10.1126/science.288.5472.1819	http://dx.doi.org/10.1126/science.288.5472.1819			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846162				2022-12-28	WOS:000087503800048
J	Toyoshima, C; Nakasako, M; Nomura, H; Ogawa, H				Toyoshima, C; Nakasako, M; Nomura, H; Ogawa, H			Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 angstrom resolution	NATURE			English	Article							CA2+ TRANSPORT ATPASE; NUCLEOTIDE-BINDING; ACTIVE-SITE; L-2-HALOACID DEHALOGENASE; FUNCTIONAL CONSEQUENCES; SKELETAL-MUSCLE; CA2+-ATPASE; CA-2+-ATPASE; DOMAIN; MECHANISM	Calcium ATPase is a member of the P-type ATPases that transport ions across the membrane against a concentration gradient. Here we have solved the crystal structure of the calcium ATPase of skeletal muscle sarcoplasmic reticulum (SERCA1a) at 2.6 Angstrom resolution with two calcium ions bound in the transmembrane domain, which comprises ten alpha-helices. The two calcium ions are located side by side and are surrounded by four transmembrane helices, two of which are unwound for efficient coordination geometry. The cytoplasmic region consists of three well separated domains, with the phosphorylation site in the central catalytic domain and the adenosine-binding site on another domain. The phosphorylation domain has the same fold as haloacid dehalogenase. Comparison with a low-resolution electron density map of the enzyme in the absence of calcium and with biochemical data suggests that large domain movements take place during active transport.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Inst Phys & Chem Res, Harima Inst, Hyogo 6795143, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi 3320012, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778				ADACHI S, 1996, SPRING 8 ANN REPORT, V1, P239; ANDERSEN JP, 1986, J MEMBRANE BIOL, V93, P85, DOI 10.1007/BF01871021; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUX L, 1987, J BIOL CHEM, V262, P6439; DUX L, 1983, J BIOL CHEM, V258, P2599; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Falson P, 1997, J BIOL CHEM, V272, P17258, DOI 10.1074/jbc.272.28.17258; Goldshleger R, 1997, P NATL ACAD SCI USA, V94, P9596, DOI 10.1073/pnas.94.18.9596; Hisano T, 1996, J BIOL CHEM, V271, P20322, DOI 10.1074/jbc.271.34.20322; Huang SH, 1998, BIOCHEMISTRY-US, V37, P18064, DOI 10.1021/bi981997+; INESI G, 1980, J BIOL CHEM, V255, P3025; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMIYA N, 1995, REV SCI INSTRUM, V66, P1703, DOI 10.1063/1.1145888; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1998, CCP4 NEWSLETTER PROT, V35, P18; Li YF, 1998, J BIOL CHEM, V273, P15035, DOI 10.1074/jbc.273.24.15035; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; MCINTOSH DB, 1992, J BIOL CHEM, V267, P22328; MCINTOSH DB, 1992, J BIOL CHEM, V267, P5301; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; MISRA M, 1991, BIOCHIM BIOPHYS ACTA, V1077, P107, DOI 10.1016/0167-4838(91)90532-5; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NAKAMOTO RK, 1984, J BIOL CHEM, V259, P2961; NAYAL M, 1994, P NATL ACAD SCI USA, V91, P817, DOI 10.1073/pnas.91.2.817; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ogawa H, 1998, BIOPHYS J, V75, P41, DOI 10.1016/S0006-3495(98)77493-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVCHINNIKOV YA, 1987, FEBS LETT, V217, P111, DOI 10.1016/0014-5793(87)81253-X; PICK U, 1981, EUR J BIOCHEM, V121, P187, DOI 10.1111/j.1432-1033.1981.tb06448.x; Rice WJ, 1997, J BIOL CHEM, V272, P31412, DOI 10.1074/jbc.272.50.31412; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Soulie S, 1999, BIOCHEMISTRY-US, V38, P5813, DOI 10.1021/bi983039d; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; YAMAMOTO H, 1989, J BIOCHEM-TOKYO, V106, P1121, DOI 10.1093/oxfordjournals.jbchem.a122976; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	50	1535	1571	6	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					647	655		10.1038/35015017	http://dx.doi.org/10.1038/35015017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864315				2022-12-28	WOS:000087465800037
J	Singh, N; Singh, PN; Hershman, JM				Singh, N; Singh, PN; Hershman, JM			Effect of calcium carbonate on the absorption of levothyroxine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTESTINAL-ABSORPTION; ALUMINUM HYDROXIDE; THYROXINE; HYPOTHYROIDISM; SUCRALFATE; EFFICACY; THERAPY	Context The effect of calcium carbonate on the absorption of levothyroxine has not been studied systematically. Such a potential drug interaction merits investigation because concurrent treatment with both drugs is common, particularly in postmenopausal women. Objective To investigate the potential interference of calcium carbonate in the absorption of levothyroxine. Design Prospective cohort study conducted from November 1998 to June 1999, supplemented with an in vitro study of thyroxine (T-4) binding to calcium carbonate. Setting Veterans Affairs Medical Center in West Los Angeles, Calif. Patients Twenty patients (age range, 27-78 years; n=11 men) with hypothyroidism who were taking a stable long-term regimen of levothyroxine were included in the study. All patients had serum free T-4 and thyrotropin values in the normal range before beginning the study. Intervention Subjects were instructed to take 1200 mg/d of elemental calcium as calcium carbonate, ingested with their levothyroxine, for 3 months. Main Outcome Measures Levels of free T-4, total T-4, total triiodothyronine (T-3), and thyrotropin, measured in all subjects at baseline (while taking levothyroxine alone), at 2 and 3 months (while taking calcium carbonate and levothyroxine), and 2 months after calcium carbonate discontinuation (while continuing to take levothyroxine). Results Mean free T-4 and total T-4 levels were significantly reduced during the calcium period and increased after calcium discontinuation. Mean free T-4 levels were 17 pmol/L (1.3 ng/dL) at baseline, 15 pmol/L (1.2 ng/dL) during the calcium period, and 18 pmol/L (1.4 ng/dL) after calcium discontinuation (overall P<.001); mean total T-4 levels were 118 nmol/L (9.2 mu g/dL) at baseline, 111 nmol/L (8.6 mu g/dL) during the calcium period, and 120 nmol/L (9.3 mu g/dL) after calcium discontinuation (overall P=.03), Mean thyrotropin levels increased significantly, from 1.6 mIU/L at baseline to 2.7 mIU/L during the calcium period, and decreased to 1.4 mIU/L after calcium discontinuation (P=.008). Twenty percent of patients had serum thyrotropin levels higher than the normal range during the calcium period; the highest observed level was 7.8 mIU/L. Mean T-3 levels did not change du ring the calcium period. The in vitro study of T-4 binding to calcium showed that adsorption of T-4 to calcium carbonate occurs at acidic pH levels. Conclusions This study of 20 patients receiving long-term levothyroxine replacement therapy indicates that calcium carbonate reduces T-4 absorption and increases serum thyrotropin levels. Levothyroxine adsorbs to calcium carbonate in an acidic environment, which may reduce its bioavailability.	Univ Calif Los Angeles, Sch Med, VA Greater Los Angeles Healthcare Syst, Div Endocrinol & Metab, Los Angeles, CA 90073 USA; Loma Linda Med Ctr, Div Epidemiol, Loma Linda, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Loma Linda University	Singh, N (corresponding author), Univ Calif Los Angeles, Sch Med, VA Greater Los Angeles Healthcare Syst, Div Endocrinol & Metab, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.		Singh, Pramil/C-5285-2012	Singh, Pramil/0000-0002-9820-2887				BENVENGA S, 1995, THYROID, V5, P249, DOI 10.1089/thy.1995.5.249; CAMPBELL NRC, 1992, ANN INTERN MED, V117, P1010, DOI 10.7326/0003-4819-117-12-1010; HAVRANKOVA J, 1992, ANN INTERN MED, V117, P445, DOI 10.7326/0003-4819-117-5-445_3; Hays M T, 1991, Thyroid, V1, P241, DOI 10.1089/thy.1991.1.241; HAYS MT, 1968, J CLIN ENDOCR METAB, V28, P749, DOI 10.1210/jcem-28-6-749; Kung AWC, 1996, J CLIN ENDOCR METAB, V81, P1232, DOI 10.1210/jc.81.3.1232; LIEL Y, 1994, AM J MED, V97, P363, DOI 10.1016/0002-9343(94)90303-4; Liel Y, 1996, J CLIN ENDOCR METAB, V81, P857, DOI 10.1210/jc.81.2.857; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; McCowen KC, 1997, NEW ENGL J MED, V337, P1010; NORTHCUTT RC, 1969, J AMER MED ASSOC, V208, P1857; READ DG, 1970, J CLIN ENDOCR METAB, V30, P798, DOI 10.1210/jcem-30-6-798; Ross Douglas S., 1996, P1010; Schneyer CR, 1998, JAMA-J AM MED ASSOC, V279, P750, DOI 10.1001/jama.279.10.750-b; SHERMAN SI, 1994, AM J MED, V96, P531, DOI 10.1016/0002-9343(94)90093-0; SPERBER AD, 1992, ARCH INTERN MED, V152, P183, DOI 10.1001/archinte.152.1.183; Tanis BC, 1996, CLIN ENDOCRINOL, V44, P643, DOI 10.1046/j.1365-2265.1996.739560.x	17	115	122	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2822	2825		10.1001/jama.283.21.2822	http://dx.doi.org/10.1001/jama.283.21.2822			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10838651	Bronze			2022-12-28	WOS:000087381500037
J	Grosshans, J; Wieschaus, E				Grosshans, J; Wieschaus, E			A genetic link between morphogenesis and cell division during formation of the ventral furrow in Drosophila	CELL			English	Article							SHAPE CHANGES; FISSION YEAST; MITOTIC INHIBITOR; KINASE; PROTEIN; GASTRULATION; EMBRYOS; INDUCER; MITOSIS; CYCLE	Stages in development with rapid transitions between mitosis and morphogenesis may require specific mechanisms to coordinate cell shape change. Here we describe a novel mitotic inhibitor that acts during Drosophila gastrulation to counteract String/Cdc25, specifically in the cells that invaginate to form the mesoderm. We have identified two genes, fruhstart and tribbles, that are required for this ventral inhibition. tribbles encodes a kinase-related protein whose RNA, however, is also present outside of the ventral region. Effective inhibition of mitosis in the cells of the ventral furrow depends on the transcription factor Snail that triggers the ventral cell shape changes. When overexpressed in a microinjection assay, Tribbles directly inhibits mitosis. We propose that Fruhstart and Tribbles form a link between the morphogenetic movements and mitotic control.	Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08540 USA	Howard Hughes Medical Institute; Princeton University	Grosshans, J (corresponding author), Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08540 USA.	jgrosshans@molbia.princeton.edu	Großhans, Jörg/AAE-9387-2020	Großhans, Jörg/0000-0003-1114-9233	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; NICHD NIH HHS [5R37HD15587] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARORA K, 1992, DEVELOPMENT, V114, P1003; Ashburner M., 1989, DROSOPHILA LAB HDB; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; CAMPBELL SD, 1995, MOL BIOL CELL, V6, P1333, DOI 10.1091/mbc.6.10.1333; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Costa Michael, 1993, P425; EDGAR BA, 1994, DEVELOPMENT, V120, P3131; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; FOE VE, 1989, DEVELOPMENT, V107, P1; Foe Victoria E., 1993, P149; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Leptin M, 1995, ANNU REV CELL DEV BI, V11, P189; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MILLAR JBA, 1992, CELL, V68, P407, DOI 10.1016/0092-8674(92)90177-E; Morize P, 1998, DEVELOPMENT, V125, P589; Muller HAJ, 1999, DEVELOPMENT, V126, P577; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Robert D. G., 1998, DROSOPHILA PRACTICAL; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rose RE, 1997, GENETICS, V146, P595; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0	37	273	284	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					523	531		10.1016/S0092-8674(00)80862-4	http://dx.doi.org/10.1016/S0092-8674(00)80862-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850494	Bronze			2022-12-28	WOS:000087375400009
J	Fischer, G; James, SA; Roberts, IN; Oliver, SG; Louis, EJ				Fischer, G; James, SA; Roberts, IN; Oliver, SG; Louis, EJ			Chromosomal evolution in Saccharomyces	NATURE			English	Article							SENSU-STRICTO COMPLEX; MISMATCH REPAIR; YEAST GENOME; CEREVISIAE; POPULATIONS; REORGANIZATION; RECOMBINATION; TRANSLOCATION; DUPLICATION; ELEMENTS	The chromosomal speciation model invokes chromosomal rearrangements as the primary cause of reproductive isolation(1). In a heterozygous carrier, chromosomes bearing reciprocal translocations mis-segregate at meiosis, resulting in reduced fertility or complete sterility. Thus, chromosomal rearrangements act as a post-zygotic isolating mechanism. Reproductive isolation in yeast is due to post-zygotic barriers, as many species mate successfully but the hybrids are sterile(2,3). Reciprocal translocations are thought to be the main form of large-scale rearrangement since the hypothesized duplication of the whole yeast genome 10(8) years ago(4,5). To test the chromosomal speciation model in yeast, we have characterized chromosomal translocations among the genomes of six closely related species in the Saccharomyces 'sensu stricto' complex(6). Here we show that rearrangements have occurred between closely related species, whereas more distant ones have colinear genomes. Thus, chromosomal rearrangements are not a prerequisite for speciation in yeast and the rate of formation of translocations is not constant. These rearrangements appear to result from ectopic recombination between Ty elements or other repeated sequences.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Manchester	Louis, EJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	elouis@molbiol.ox.ac.uk	Roberts, Ian N/B-9743-2008; Fischer, Gilles/Q-4603-2019; Louis, Edward/B-7920-2008; Fischer, Gilles/G-6654-2016	Fischer, Gilles/0000-0001-5732-2682; Louis, Edward/0000-0003-1157-3608; 				ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; ADAMS J, 1986, P NATL ACAD SCI USA, V83, P7124, DOI 10.1073/pnas.83.18.7124; BAILIS AM, 1990, GENETICS, V126, P535; BOEKE JD, 1991, GENETICS, V129, P1043; Codon AC, 1997, CURR GENET, V32, P247; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; James SA, 1996, INT J SYST BACTERIOL, V46, P189, DOI 10.1099/00207713-46-1-189; James SA, 1997, INT J SYST BACTERIOL, V47, P453, DOI 10.1099/00207713-47-2-453; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Loidl J, 1998, CHROMOSOMA, V107, P247, DOI 10.1007/s004120050304; Louis Edward J., 1998, V26, P15; NAUMOV G I, 1987, Studies in Mycology, P469; NAUMOV GI, 1995, ANTON LEEUW INT J G, V67, P351, DOI 10.1007/BF00872934; Naumov GI, 1995, J GEN APPL MICROBIOL, V41, P499, DOI 10.2323/jgam.41.499; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Ryu SL, 1998, CURR GENET, V33, P345, DOI 10.1007/s002940050346; Ryu SL, 1996, YEAST, V12, P757, DOI 10.1002/(SICI)1097-0061(19960630)12:8<757::AID-YEA970>3.0.CO;2-H; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seoighe C, 1998, P NATL ACAD SCI USA, V95, P4447, DOI 10.1073/pnas.95.8.4447; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tamai Y, 1998, YEAST, V14, P923, DOI 10.1002/(SICI)1097-0061(199807)14:10<923::AID-YEA298>3.3.CO;2-9; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	27	244	254	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					451	454		10.1038/35013058	http://dx.doi.org/10.1038/35013058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839539				2022-12-28	WOS:000087212000047
J	Stern, S; Altkorn, D; Levinson, W				Stern, S; Altkorn, D; Levinson, W			Anticoagulation for chronic atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STROKE; WARFARIN; PREVENTION; THERAPY; ASPIRIN; RISK		Univ Chicago, Dept Internal Med, Chicago, IL 60637 USA	University of Chicago	Stern, S (corresponding author), Univ Chicago, Dept Internal Med, 5841 S Maryland,MC 5023, Chicago, IL 60637 USA.	sstern@smtp.mcis.uchicago.edu						Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Ezekowitz MD, 1999, JAMA-J AM MED ASSOC, V281, P1830, DOI 10.1001/jama.281.19.1830; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LAUPACIS A, 1995, CHEST, V108, pS352, DOI 10.1378/chest.108.4_Supplement.352S; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; PETERSEN P, 1989, LANCET, V1, P175; Stollberger C, 1998, ANN INTERN MED, V128, P630, DOI 10.7326/0003-4819-128-8-199804150-00004; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639, DOI 10.7326/0003-4819-128-8-199804150-00005	14	10	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2901	2903		10.1001/jama.283.22.2901	http://dx.doi.org/10.1001/jama.283.22.2901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865248				2022-12-28	WOS:000087480600001
J	Weaver, JC; Vaughan, TE; Astumian, RD				Weaver, JC; Vaughan, TE; Astumian, RD			Biological sensing of small field differences by magnetically sensitive chemical reactions	NATURE			English	Article							BEHAVIORAL EVIDENCE; MIGRATORY BIRD; MAGNETORECEPTION; ORIENTATION; VERTEBRATE; MECHANISM; ANIMALS	There is evidence that animals can detect small changes in the Earth's magnetic field by two distinct mechanisms, one using the mineral magnetite as the primary sensor and one using magnetically sensitive chemical reactions(1-14). Magnetite responds by physically twisting(2,15), or even reorienting the whole organism in the case of some bacteria(16), but the magnetic dipoles of individual molecules are too small to respond in the same way. Here we assess whether reactions whose rates are affected by the orientation of reactants in magnetic fields could form the basis of a biological compass. We use a general model, incorporating biological components and design criteria, to calculate realistic constraints for such a compass. This model compares a chemical signal produced owing to magnetic field effects with stochastic noise and with changes due to physiological temperature variation(17). Our analysis shows that a chemically based biological compass is feasible with its size, for any given detection limit, being dependent on the magnetic sensitivity of the rate constant of the chemical reaction.	MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Univ Chicago, Dept Surg, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Harvard University; Massachusetts Institute of Technology (MIT); University of Chicago; University of Chicago	Weaver, JC (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Rm 16-319, Cambridge, MA 02139 USA.		Astumian, Raymond Dean/H-7440-2013	Astumian, Raymond Dean/0000-0001-7472-187X				ABLE KP, 1995, NATURE, V375, P320; BEASON RC, 1984, NATURE, V309, P151, DOI 10.1038/309151a0; BEASON RC, 1995, J EXP BIOL, V198, P141; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; Deutschlander ME, 1999, NATURE, V400, P324, DOI 10.1038/22450; Deutschlander ME, 1999, J EXP BIOL, V202, P891; Kandel E.R., 1991, PRINC NEUROSCI, V3rd ed.; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; PHILLIPS JB, 1986, SCIENCE, V233, P765, DOI 10.1126/science.3738508; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; SCHULTEN K, 1982, FESTKOR-ADV SOLID ST, V22, P61, DOI 10.1007/BFb0107935; Schulten K, 1986, BIOPHYSICAL EFFECTS, P99; SCHULTEN Z, 1977, J CHEM PHYS, V66, P4616, DOI 10.1063/1.433719; van Kampen N. G., 1981, STOCHASTIC PROCESSES; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Weaver JC, 1999, BIOPHYS J, V76, P3026, DOI 10.1016/S0006-3495(99)77455-2; Wiltschko W., 1995, MAGNETIC ORIENTATION; YORKE ED, 1979, J THEOR BIOL, V77, P101, DOI 10.1016/0022-5193(79)90140-1	22	73	74	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					707	709		10.1038/35015128	http://dx.doi.org/10.1038/35015128			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864331				2022-12-28	WOS:000087465800053
J	Joffe, M				Joffe, M			Time trends in biological fertility in Britain	LANCET			English	Article							LONG-TERM RECALL; SEMEN QUALITY; CIGARETTE-SMOKING; TO-PREGNANCY; MEN; QUESTIONNAIRE; FECUNDABILITY; DETERIORATION; CONCEPTION; VALIDITY	Background There is evidence of a decline in semen quality in some countries, including Britain, in recent decades. This retrospective cohort study examined the hypothesis that biological fertility had also declined. The trend in couple fertility was assessed by means of time to pregnancy (TTP)-a sensitive and validated measure of fertility. Methods A representative sample of the British population aged 16-59 years was surveyed. TTP was obtained for all births conceived after unprotected intercourse that began during 1961-93, excluding contraceptive failures. The sample size was 1540. Findings in contrast to the original hypothesis, this study found that fertility has increased; the rising trend was accompanied by slight dips during 1976-80 and 1986-90. These results were consistent between male and female respondents, and undiminished by adjustment for possible confounding factors. A stronger and more consistent relation was found with the year when unprotected intercourse started (a period effect) than with the year of birth of either partner (a birth cohort effect). Interpretation The findings could not be explained by trends in age at first birth, increased treatment of subfertility, or changes in oral contraceptive use. If a decline in male fertility has occurred, it has been more than compensated for by a countervailing increase in couple fertility.	Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Imperial College London	Joffe, M (corresponding author), Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, St Marys Campus, London W2 1PG, England.	m.joffe@ic.ac.uk						ADAMI HO, 1994, INT J CANCER, V59, P33, DOI 10.1002/ijc.2910590108; AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; BAIRD DD, 1991, AM J EPIDEMIOL, V133, P1282, DOI 10.1093/oxfordjournals.aje.a115840; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; Botting Beverley, 1991, Popul Trends, V64, P19; Bujan L, 1996, BRIT MED J, V312, P471, DOI 10.1136/bmj.312.7029.471; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; DECOCK J, 1994, OCCUP ENVIRON MED, V51, P693, DOI 10.1136/oem.51.10.693; FILAKTI H, 1997, POPUL TRENDS, V87, P11; Fisch H, 1996, FERTIL STERIL, V65, P1009, DOI 10.1016/S0015-0282(16)58278-8; HOWE G, 1985, BRIT MED J, V290, P1697, DOI 10.1136/bmj.290.6483.1697; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; JOESOEF MR, 1990, LANCET, V335, P136, DOI 10.1016/0140-6736(90)90005-P; JOFFE M, 1994, AM J EPIDEMIOL, V140, P921, DOI 10.1093/oxfordjournals.aje.a117180; JOFFE M, 1989, J EPIDEMIOL COMMUN H, V43, P268, DOI 10.1136/jech.43.3.268; Joffe M, 1997, OCCUP ENVIRON MED, V54, P289, DOI 10.1136/oem.54.5.289; Joffe M, 1996, LANCET, V347, P1519, DOI 10.1016/S0140-6736(96)90673-X; JOFFE M, 1993, FERTIL STERIL, V60, P99; JOFFE M, 1995, J EPIDEMIOL COMMUN H, V49, P314, DOI 10.1136/jech.49.3.314; MOLLER H, 1993, EUR UROL, V23, P8; OLSEN J, 1991, AM J EPIDEMIOL, V133, P734, DOI 10.1093/oxfordjournals.aje.a115948; Paulsen CA, 1996, FERTIL STERIL, V65, P1015; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, pCH29; SALLMEN M, 1995, AM J IND MED, V27, P699, DOI 10.1002/ajim.4700270506; VanWaeleghem K, 1996, HUM REPROD, V11, P325, DOI 10.1093/HUMREP/11.2.325; VESSEY MP, 1978, BRIT MED J, V1, P265, DOI 10.1136/bmj.1.6108.265; Vierula M, 1996, INT J ANDROL, V19, P11, DOI 10.1111/j.1365-2605.1996.tb00427.x; WEINBERG CR, 1994, STAT MED, V13, P671, DOI 10.1002/sim.4780130528; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wittmaack F M, 1992, Wis Med J, V91, P477; ZIELHUIS GA, 1992, INT J EPIDEMIOL, V21, P1151, DOI 10.1093/ije/21.6.1151	31	96	100	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1961	1965		10.1016/S0140-6736(00)02328-X	http://dx.doi.org/10.1016/S0140-6736(00)02328-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859042				2022-12-28	WOS:000087381900013
J	Becskei, A; Serrano, L				Becskei, A; Serrano, L			Engineering stability in gene networks by autoregulation	NATURE			English	Article							ESCHERICHIA-COLI; TET REPRESSOR; ROBUSTNESS; EXPRESSION; RECOGNITION; PROMOTER; BINDING; NUMBER; DOSAGE	The genetic and biochemical networks which underlie such things as homeostasis in metabolism and the developmental programs of living cells, must withstand considerable variations and random perturbations of biochemical parameters(1-3). These occur as transient changes in, for example, transcription, translation, and RNA and protein degradation. The intensity and duration of these perturbations differ between cells in a population(4). The unique state of cells, and thus the diversity in a population, is owing to the different environmental stimuli the individual cells experience and the inherent stochastic nature of biochemical processes (for example, refs 5 and 6). It has been proposed, but not demonstrated, that autoregulatory, negative feedback loops in gene circuits provide stability(7), thereby limiting the range over which the concentrations of net-work components fluctuate. Here we have designed and constructed simple gene circuits consisting of a regulator and transcriptional repressor modules in Escherichia coli and we show the gain of stability produced by negative feedback.	European Mol Biol Lab, D-69012 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Becskei, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.		Smith, Barry/A-9525-2011; Yang, Chen/G-1379-2010	Smith, Barry/0000-0003-1384-116X; Becskei, Attila/0000-0002-9462-0934				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Backes H, 1997, BIOCHEMISTRY-US, V36, P5311, DOI 10.1021/bi961527k; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BAUMEISTER R, 1992, J MOL BIOL, V226, P1257, DOI 10.1016/0022-2836(92)91065-W; Blau HM, 1999, P NATL ACAD SCI USA, V96, P797, DOI 10.1073/pnas.96.3.797; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; LANZER M, 1988, P NATL ACAD SCI USA, V85, P8973, DOI 10.1073/pnas.85.23.8973; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MORAN L, 1990, GENE DEV, V4, P752, DOI 10.1101/gad.4.5.752; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; OSLEY MA, 1981, CELL, V24, P377, DOI 10.1016/0092-8674(81)90327-5; RECORD J, 1996, ESCHERICHIA COLI SAL, P792; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Wolf DM, 1998, J THEOR BIOL, V195, P167, DOI 10.1006/jtbi.1998.0790	24	1110	1137	4	110	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					590	593		10.1038/35014651	http://dx.doi.org/10.1038/35014651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850721				2022-12-28	WOS:000087449500056
J	Turchin, P; Oksanen, L; Ekerholm, P; Oksanen, T; Henttonen, H				Turchin, P; Oksanen, L; Ekerholm, P; Oksanen, T; Henttonen, H			Are lemmings prey or predators?	NATURE			English	Article							POPULATION-DYNAMICS; EXPLOITATION ECOSYSTEMS; NORWEGIAN LEMMINGS; SMALL RODENTS; PHASE; CHAOS; GRADIENTS; CYCLES	Large oscillations in the populations of Norwegian lemmings have mystified both professional ecologists and lay public(1-3). Ecologists suspect that these oscillations are driven by a trophic mechanism(4,5): either an interaction between lemmings and their food supply, or an interaction between lemmings and their predators. If lemming cycles are indeed driven by a trophic interaction, can we tell whether lemmings act as the resource ('prey') or the consumer ('predator')? In trophic interaction models, peaks of resource density generally have a blunt, rounded shape, whereas peaks of consumer density are sharp and angular. Here we have applied several statistical tests to three lemming datasets and contrasted them with comparable data for cyclic voles, We find that vole peaks are blunt, consistent with their cycles being driven by the interaction with predators. In contrast, the shape of lemming peaks is consistent with the hypothesis that lemmings are functional predators, that is, their cycles are driven by their interaction with food plants. Our findings suggest that a single mechanism, such as interaction between rodents and predators, is unlikely to provide the 'universal' explanation of all cyclic rodent dynamics.	Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; Umea Univ, Dept Ecol Bot, S-90187 Umea, Sweden; Umea Univ, Dept Anim Ecol, S-90187 Umea, Sweden; Vantaa Res Ctr, Finnish Forest Res Inst, FIN-01301 Vantaa, Finland	University of Connecticut; Umea University; Umea University; Natural Resources Institute Finland (Luke)	Turchin, P (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.							Batzli G.O., 1980, ARCTIC ECOSYSTEM COA, P335, DOI DOI 10.1575/1912/222; BAZYKIN AD, 1981, ECOL MODEL, V14, P39, DOI 10.1016/0304-3800(81)90013-2; BEDDINGTON JR, 1976, NATURE, V225, P58; CHERNYAVSKY FB, 1982, CYCLES LEMMINGS ARCT; Chitty D., 1996, LEMMINGS COMMIT SUIC; Chitty D, 1996, LEMMINGS COMMIT SUIC; EKERHOLM P, IN PRESS ECOGRAPHY; Elton CS, 1924, BR J EXP BIOL, V2, P119; Framstad E, 1997, P ROY SOC B-BIOL SCI, V264, P31, DOI 10.1098/rspb.1997.0005; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; HANSKI I, IN PRESS ECOLOGY; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; HENTTONEN H, 1977, OIKOS, V29, P581, DOI 10.2307/3543596; HENTTONEN H, 1993, BIOL LEMMINGS, P157; HENTTONEN H, 2000, CHAOS REAL DATA ANAL, P73; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; May R. M., 1981, THEOR ECOL-NETH, P78; MOEN J, 1993, ARCTIC ALPINE RES, V25, P130, DOI 10.2307/1551549; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; OKSANEN L, 1990, OIKOS, V57, P14, DOI 10.2307/3565732; OKSANEN L, 1992, ECOGRAPHY, V15, P226, DOI 10.1111/j.1600-0587.1992.tb00029.x; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; STENSETH N. C., 1993, BIOL LEMMINGS, P61; Stenseth NC, 1998, P ROY SOC B-BIOL SCI, V265, P1957, DOI 10.1098/rspb.1998.0526; STENSETH NC, 1993, BIOL LEMMINGS, P3; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; TURCHIN P, 1993, OIKOS, V68, P167, DOI 10.2307/3545323; TURCHIN P, IN PRESS ECOLOGY; Virtanen R, 1997, OIKOS, V79, P155, DOI 10.2307/3546100	31	149	155	0	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					562	565		10.1038/35014595	http://dx.doi.org/10.1038/35014595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850713				2022-12-28	WOS:000087449500048
J	Bell, AC; Felsenfeld, G				Bell, AC; Felsenfeld, G			Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene	NATURE			English	Article							MOUSE H19 GENE; BECKWITH-WIEDEMANN-SYNDROME; WILMS-TUMOR; EPIGENETIC CHANGES; CONTROL ELEMENT; REGION; INSULATOR; UPSTREAM; DOMAIN; LOCUS	The expression of the insulin-like growth factor 2 (Igf2) and H19 genes is imprinted. Although these neighbouring genes share an enhancer(1), H19 is expressed only from the maternal allele, and Igf2 only from the paternally inherited allele(2,3). A region of paternal-specific methylation upstream of H19 appears to be the site of an epigenetic mark that is required for the imprinting of these genes(4,5). A deletion within this region results in loss of imprinting of both H19 and Igf2 (ref. 5). Here we show that this methylated region contains an element that blocks enhancer activity. The activity of this element is dependent upon the vertebrate enhancer-blocking protein CTCF. Methylation of CpGs within the CTCF-binding sites eliminates binding of CTCF in vitro, and deletion of these sites results in loss of enhancer-blocking activity in vivo, thereby allowing gene expression. This CTCF-dependent enhancer-blocking element acts as an insulator. We suggest that it controls imprinting of Igf 2. The activity of this insulator is restricted to the maternal allele by specific DNA methylation of the paternal allele. Our results reveal that DNA methylation can control gene expression by modulating enhancer access to the gene promoter through regulation of an enhancer boundary.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		jia, xu/A-8386-2016					BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Frevel MAE, 1999, J BIOL CHEM, V274, P29331, DOI 10.1074/jbc.274.41.29331; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hark AT, 1998, HUM MOL GENET, V7, P1979, DOI 10.1093/hmg/7.12.1979; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; Khosla S, 1999, MOL CELL BIOL, V19, P2556; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Szabo PE, 1998, MOL CELL BIOL, V18, P6767, DOI 10.1128/MCB.18.11.6767; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	30	1316	1359	3	125	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					482	485		10.1038/35013100	http://dx.doi.org/10.1038/35013100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839546				2022-12-28	WOS:000087212000054
J	Denning, DW				Denning, DW			Early diagnosis of invasive aspergillosis	LANCET			English	Editorial Material							LATEX AGGLUTINATION-TEST; PULMONARY ASPERGILLOSIS; FUNGAL-INFECTIONS; GALACTOMANNAN		Univ Manchester, N Manchester Gen Hosp, Dept Trop Med & Infect Dis, Manchester M8 6RB, Lancs, England	University of Manchester	Denning, DW (corresponding author), Univ Manchester, N Manchester Gen Hosp, Dept Trop Med & Infect Dis, Manchester M8 6RB, Lancs, England.		Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251				ASCIOGLU S, 1999, INT C ANT AG CHEM SA; BLUM U, 1994, CHEST, V106, P1156, DOI 10.1378/chest.106.4.1156; Caillot D, 1997, J CLIN ONCOL, V15, P139, DOI 10.1200/JCO.1997.15.1.139; Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Horvath JA, 1996, AM J MED, V100, P171, DOI 10.1016/S0002-9343(97)89455-7; Maertens J, 1999, J CLIN MICROBIOL, V37, P3223, DOI 10.1128/JCM.37.10.3223-3228.1999; Rohrlich P, 1996, PEDIATR INFECT DIS J, V15, P232, DOI 10.1097/00006454-199603000-00011; Sulahian A, 1996, EUR J CLIN MICROBIOL, V15, P139, DOI 10.1007/BF01591487; VERWEIJ PE, 1995, J CLIN PATHOL, V48, P474, DOI 10.1136/jcp.48.5.474; Verweij PE, 1997, INT J INFECT DIS, V2, P61; Vogeser M, 1999, EUR J CLIN MICROBIOL, V18, P42, DOI 10.1007/s100960050224; VONEIFF M, 1995, ANN HEMATOL, V70, P135, DOI 10.1007/BF01682033	13	74	83	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					423	424						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841117				2022-12-28	WOS:000085306800003
J	Borhan, B; Souto, ML; Imai, H; Shichida, Y; Nakanishi, K				Borhan, B; Souto, ML; Imai, H; Shichida, Y; Nakanishi, K			Movement of retinal along the visual transduction path	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSMEMBRANE HELICES; RESONANCE RAMAN; RHODOPSIN ACTIVATION; PRIMARY PHOTOPRODUCT; LOW-TEMPERATURE; FROG RHODOPSIN; ENERGY-STORAGE; 1ST STEP; CHROMOPHORE	Movement of the ligand/receptor complex in rhodopsin (Rh) has been traced. Bleaching of diazoketo rhodopsin (DK-Rh) containing 11-cis-3-diazo-4-oxo-retinal yields batho-, lumi-, meta-I-, and meta-II-Rh intermediates corresponding to those of native kh but at lower temperatures. Photoaffinity labeling of DK-Rh and these bleaching intermediates shows that the ionone ring cross-links to tryptophan-265 on helix F in DK-Rh and batho-Rh, and to alanine-169 on helix D in lumi-, meta-I-, and meta-II-Rh intermediates, It is likely that these movements involving a flip-over of the chromophoric ring trigger changes in cytoplasmic membrane loops resulting in heterotrimeric guanine nucleotide-binding protein (G protein) activation.	Columbia Univ, Dept Chem, New York, NY 10027 USA; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Columbia University; Kyoto University	Nakanishi, K (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	kn5@columbia.edu	Souto, Maria L/L-5911-2014	Souto, Maria L/0000-0001-9123-0749; Imai, Hiroo/0000-0003-0729-0322	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034509, R37GM034509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBECK A, 1989, BIOPHYS J, V55, P233, DOI 10.1016/S0006-3495(89)82798-5; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; BAGLEY KA, 1985, BIOCHEMISTRY-US, V24, P6055, DOI 10.1021/bi00343a006; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Borhan B, 1999, CHEM-EUR J, V5, P1172, DOI 10.1002/(SICI)1521-3765(19990401)5:4<1172::AID-CHEM1172>3.0.CO;2-Q; CALLENDER RH, 1976, BIOCHEMISTRY-US, V15, P1621, DOI 10.1021/bi00653a005; Chosrowjan H, 1998, J AM CHEM SOC, V120, P9706, DOI 10.1021/ja981659w; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; DENG H, 1991, BIOCHEMISTRY-US, V30, P4495, DOI 10.1021/bi00232a018; EYRING G, 1982, BIOCHEMISTRY-US, V21, P384, DOI 10.1021/bi00531a028; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Han M, 1997, P NATL ACAD SCI USA, V94, P13442, DOI 10.1073/pnas.94.25.13442; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Han M, 1997, J BIOL CHEM, V272, P23081, DOI 10.1074/jbc.272.37.23081; Herzyk P, 1998, J MOL BIOL, V281, P741, DOI 10.1006/jmbi.1998.1981; HUG SJ, 1990, BIOCHEMISTRY-US, V29, P1475, DOI 10.1021/bi00458a019; ITO M, 1992, PHOTOCHEM PHOTOBIOL, V56, P915, DOI 10.1111/j.1751-1097.1992.tb09713.x; Kliger DS, 1995, ISR J CHEM, V35, P289; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; NAKAYAMA TA, 1990, J BIOL CHEM, V265, P15762; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; OLIVEIRA L, 1994, TRENDS PHARMACOL SCI, V15, P170, DOI 10.1016/0165-6147(94)90137-6; PALINGS I, 1989, BIOCHEMISTRY-US, V28, P1498, DOI 10.1021/bi00430a012; PETEANU LA, 1993, P NATL ACAD SCI USA, V90, P11762, DOI 10.1073/pnas.90.24.11762; Pogozheva ID, 1997, BIOPHYS J, V72, P1963, DOI 10.1016/S0006-3495(97)78842-8; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578; SCHICK GA, 1987, BIOCHEMISTRY-US, V26, P2556, DOI 10.1021/bi00383a022; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; SHICHIDA Y, 1987, BIOCHEMISTRY-US, V26, P4422, DOI 10.1021/bi00388a035; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; SMITH SO, 1991, BIOCHEMISTRY-US, V30, P7409, DOI 10.1021/bi00244a007; Souto M., UNPUB; Tan Q, 1997, ANGEW CHEM INT EDIT, V36, P2089, DOI 10.1002/anie.199720891; YOSHIZAWA T, 1982, METHOD ENZYMOL, V81, P333; YOSHIZAWA T, 1973, BIOCH PHYSL VISUAL P; ZHANG HZ, 1994, J AM CHEM SOC, V116, P10165, DOI 10.1021/ja00101a040	38	205	208	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2209	2212		10.1126/science.288.5474.2209	http://dx.doi.org/10.1126/science.288.5474.2209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864869				2022-12-28	WOS:000087782900057
J	Chaffin, KA; Knutsen, JS; Brant, P; Bates, FS				Chaffin, KA; Knutsen, JS; Brant, P; Bates, FS			High-strength welds in metallocene polypropylene/polyethylene laminates	SCIENCE			English	Article							MOLECULAR-WEIGHT DEPENDENCE; POLYMER-POLYMER INTERFACES; COPOLYMER; POLYETHYLENE; CATALYSTS; ADHESION; DENSITY; BLENDS	Spectacular advances in organometallic chemistry over the past two decades have resulted in single-site catalysts that are revolutionizing Production of polyethylene (PE) and isotactic polypropylene (iPP). This report describes an unanticipated benefit of metallocene-catalyzed semicrystalline polyolefins, namely welded joint strengths in PE/iPP laminates that can exceed the cohesive strength of the constituents. We propose that interfacial polymer entanglements, established in the molten state and subsequently anchored in chain-folded Lamellae upon crystallization, are responsible for this intrinsic property. The poor adhesion exhibited by traditional Ziegler-Natta-catalyzed polyolefins is shown to derive from the accumulation of amorphous polymer, a by-product of the polymerization reactions, at the interface. These results should facilitate fabrication and improve the properties of composites based on materials that dominate the plastics industry.	Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; Exxon Chem Co, Baytown Polymers Ctr, Baytown, TX 77522 USA	University of Minnesota System; University of Minnesota Twin Cities; Exxon Mobil Corporation	Bates, FS (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.			Bates, Frank/0000-0003-3977-1278				ADOLF D, 1985, J POLYM SCI POL PHYS, V23, P413, DOI 10.1002/pol.1985.180230214; ANASTASIADIS SH, 1988, MACROMOLECULES, V21, P2980, DOI 10.1021/ma00188a015; Bassett D. C., 1981, PRINCIPLES POLYM MOR; Beckman EJ, 1999, SCIENCE, V283, P946, DOI 10.1126/science.283.5404.946; BROSETA D, 1990, MACROMOLECULES, V23, P132, DOI 10.1021/ma00203a023; Brown GM, 1997, POLYMER, V38, P3937, DOI 10.1016/S0032-3861(96)00962-7; BROWN HR, 1989, MACROMOLECULES, V22, P2859, DOI 10.1021/ma00196a059; BROWN HR, 1989, NATURE, V341, P3221; Chaffin KA, 2000, J POLYM SCI POL PHYS, V38, P108, DOI 10.1002/(SICI)1099-0488(20000101)38:1<108::AID-POLB14>3.0.CO;2-9; COATES GW, 1995, SCIENCE, V267, P217, DOI 10.1126/science.267.5195.217; CRETON C, 1991, MACROMOLECULES, V24, P1846, DOI 10.1021/ma00008a023; FETTERS LJ, 1994, MACROMOLECULES, V27, P4639, DOI 10.1021/ma00095a001; HELFAND E, 1975, J CHEM PHYS, V62, P1327, DOI 10.1063/1.430632; JEBENS A, 1999, HIGH DENSITY POLYETH; JEBENS A, 1997, POLYPROPYLENE RESINS; KAMINSKY W, 1983, MAKROMOL CHEM-RAPID, V4, P417; KIM YH, 1983, MACROMOLECULES, V16, P1115, DOI 10.1021/ma00241a013; KRAUSCH HH, 1989, ANNU REV MATER SCI, V26, P651; Lin GX, 1998, ANGEW MAKROMOL CHEM, V255, P33; MARASCHIN NJ, 1997, MOD PLAST, V74, P33; Roscoe SB, 1998, SCIENCE, V280, P270, DOI 10.1126/science.280.5361.270; Service RF, 1997, SCIENCE, V278, P33, DOI 10.1126/science.278.5335.33; Shih HH, 1999, J APPL POLYM SCI, V73, P1769, DOI 10.1002/(SICI)1097-4628(19990829)73:9<1769::AID-APP19>3.0.CO;2-Q; STEHLING FC, 1991, Patent No. 5008204; Stevens J. C., 1991, U.S. Patent, Patent No. [5,064,802, 5064802]; Stevens JC, 1996, STUD SURF SCI CATAL, V101, P11; WHITTMANN JC, 1990, PROG POLYM SCI, V15, P909; WILD L, 1982, J POLYM SCI POL PHYS, V20, P441, DOI 10.1002/pol.1982.180200307; Younkin TR, 2000, SCIENCE, V287, P460, DOI 10.1126/science.287.5452.460	29	72	72	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2187	2190		10.1126/science.288.5474.2187	http://dx.doi.org/10.1126/science.288.5474.2187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864863				2022-12-28	WOS:000087782900051
J	deMenocal, P; Ortiz, J; Guilderson, T; Sarnthein, M				deMenocal, P; Ortiz, J; Guilderson, T; Sarnthein, M			Coherent high- and low-latitude climate variability during the holocene warm period	SCIENCE			English	Article							GREENLAND ICE; SEA; TEMPERATURES; INSTABILITY; MIDHOLOCENE; AFRICA; EVENT; CORE; AGE; BP	A faunal record of sea-surface temperature (SST) variations off West Africa documents a series of abrupt, millennial-scale cooling events, which punctuated the Holocene warm period. These events evidently resulted from increased southward advection of cooler temperate or subpolar waters to this subtropical location or from enhanced regional upwelling. The most recent of these events was the Little Ice Age, which occurred between 1300 to 1850 A.D., when subtropical SSTs were reduced by 3 degrees to 4 degrees C. These events were synchronous with Holocene changes in subpolar North Atlantic SSTs, documenting a strong, in-phase link between millennial-scale variations in high- and Low-latitude climate during the Holocene.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; Univ Kiel, Inst Geowissensch, Kiel, Germany	Columbia University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Kiel	deMenocal, P (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	peter@ldeo.columbia.edu	demenocal, peter/B-1386-2013; Ortiz, Joseph/E-1144-2011	demenocal, peter/0000-0002-7191-717X; Ortiz, Joseph/0000-0002-6583-3850				Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Bianchi GG, 1999, NATURE, V397, P515, DOI 10.1038/17362; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Bond GC, 1999, GEOPH MONOG SERIES, V112, P35; BROECKER WS, 1994, NATURE, V372, P421, DOI 10.1038/372421a0; Chapman MR, 1996, PALEOCEANOGRAPHY, V11, P343, DOI 10.1029/96PA00041; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; DahlJensen D, 1998, SCIENCE, V282, P268, DOI 10.1126/science.282.5387.268; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DENTON G H, 1973, Quaternary Research (Orlando), V3, P155, DOI 10.1016/0033-5894(73)90040-9; Fischer G, 1996, J MAR RES, V54, P73, DOI 10.1357/0022240963213484; GASSE F, 1994, EARTH PLANET SC LETT, V126, P435, DOI 10.1016/0012-821X(94)90123-6; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Jones P. D., 1995, CLIMATE AD 1500; Keigwin LD, 1999, SCIENCE, V286, P520, DOI 10.1126/science.286.5439.520; Keigwin LD, 1996, SCIENCE, V274, P1504, DOI 10.1126/science.274.5292.1504; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P339, DOI 10.1029/PA001i003p00339; OBRIEN SR, 1995, SCIENCE, V270, P1962, DOI 10.1126/science.270.5244.1962; PRELL WL, 1987, J GEOPHYS RES-ATMOS, V92, P8411, DOI 10.1029/JD092iD07p08411; RUDDIMAN W, 1988, P OC DRILL PROGR LEG, VA; RUDDIMAN WF, 1975, QUATERNARY RES, V5, P361, DOI 10.1016/0033-5894(75)90038-1; SAMTHEIN M, 1983, COASTAL UPWELLING IT, P99; Schultz L., 1981, GEOLOGICAL SOC AM SP, V186, P87, DOI DOI 10.1130/SPE186-P87; Steig EJ, 1999, SCIENCE, V286, P1485, DOI 10.1126/science.286.5444.1485; STREET FA, 1979, QUATERNARY RES, V12, P83, DOI 10.1016/0033-5894(79)90092-9; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; ZHAO M, 1995, PALEOCEANOGRAPHY, V10, P661, DOI 10.1029/94PA03354; [No title captured]; [No title captured]	34	521	546	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2198	2202		10.1126/science.288.5474.2198	http://dx.doi.org/10.1126/science.288.5474.2198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864866				2022-12-28	WOS:000087782900054
J	Sloan, RP; Bagiella, E; VandeCreek, L; Hover, M; Casalone, C; Hirsch, TJ; Hasan, Y; Kreger, R; Poulos, P				Sloan, RP; Bagiella, E; VandeCreek, L; Hover, M; Casalone, C; Hirsch, TJ; Hasan, Y; Kreger, R; Poulos, P			Should physicians prescribe religious activities?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FAMILY MEDICINE; HEALTH; MORTALITY; SPIRITUALITY; ATTITUDES; BELIEFS; PRAYER; RISK		Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Sch Publ Hlth, New York, NY 10032 USA; HealthCare Chaplaincy, New York, NY 10022 USA; New York Methodist Hosp, Brooklyn, NY 11215 USA	Columbia University; Columbia University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital	Sloan, RP (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.							ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; BEAUCHAMP TL, MEANING MED READER P; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Ehman JW, 1999, ARCH INTERN MED, V159, P1803, DOI 10.1001/archinte.159.15.1803; Ellis MR, 1999, J FAM PRACTICE, V48, P105; Goldberg Steven, 1999, SEDUCED SCI AM RELIG; Gundersen L, 2000, ANN INTERN MED, V133, P161, DOI 10.7326/0003-4819-133-2-200007180-00102; Hummer RA, 1999, DEMOGRAPHY, V36, P273, DOI 10.2307/2648114; KAPLAN M, 1996, TIME            0624, P62; KING DE, 1994, J FAM PRACTICE, V39, P349; Koenig H G, 1991, J Pastoral Care, V45, P254; Koenig HG, 1999, INT J PSYCHIAT MED, V29, P123, DOI 10.2190/C2FB-95VW-FKYD-C8RV; Lambe M, 1996, MELANOMA RES, V6, P147, DOI 10.1097/00008390-199604000-00010; Larson S S, 1992, Christ Med Dent Soc J, V23, P14; Levin J S, 1997, JAMA, V278, P792, DOI 10.1001/jama.278.9.792; LEVIN JS, 1994, SOC SCI MED, V38, P1475, DOI 10.1016/0277-9536(94)90109-0; LINDNER EW, 1998, YB AM CANADIAN CHURC; MARWICK C, 1995, JAMA-J AM MED ASSOC, V273, P1561, DOI 10.1001/jama.273.20.1561; Matthews DA, 1998, ARCH FAM MED, V7, P118, DOI 10.1001/archfami.7.2.118; Matthews DA, 1997, MIND BODY MED, V2, P3; MAUGANS TA, 1991, J FAM PRACTICE, V32, P210; McNicol T., 1996, US WEEKEND      0405, P4; Oman D, 1998, AM J PUBLIC HEALTH, V88, P1469, DOI 10.2105/AJPH.88.10.1469; Ramon JM, 1996, EUR J EPIDEMIOL, V12, P449, DOI 10.1007/BF00143995; Sides H, 1997, NY TIMES MAGAZINE, P92; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; SLOMSKI AJ, 2000, MED ECON, V77, P145; VANBIEMA D, 1997, TIME            0324, P70; *YANK PARTN INC, 1996, 050304 J TEMPL FDN Y	29	205	206	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1913	1916		10.1056/NEJM200006223422513	http://dx.doi.org/10.1056/NEJM200006223422513			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	325YK	10861331				2022-12-28	WOS:000087704700013
J	Rosene-Montella, K; Keely, E; Laifer, SA; Lee, RV				Rosene-Montella, K; Keely, E; Laifer, SA; Lee, RV			Evaluation and management of infertility in women: The internists' role	ANNALS OF INTERNAL MEDICINE			English	Review							POLYCYSTIC-OVARY-SYNDROME; IN-VITRO FERTILIZATION; HYPERSTIMULATION SYNDROME; ASSISTED-REPRODUCTION; INSULIN-RESISTANCE; DIABETES-INSIPIDUS; TURNERS-SYNDROME; OOCYTE DONATION; UNITED-STATES; GROWTH-FACTOR	Interventions for infertility have greatly increased in number and sophistication. Women with multiple medical problems and women near or beyond menopause are now able to conceive. The internist will be called on to assess the risk that infertility interventions pose and to counsel patients accordingly. Knowledge of the medical illnesses associated with infertility, the types of infertility treatments available, and the medical complications of these interventions a re required to properly assess th is risk, Medical complications of infertility interventions can be direct effects of related drugs and technologies and indirect consequences of the induced pregnancy, multiple gestation, or associated medical conditions. This article reviews the definitions and scope of infertility, the interventions used for treatment of infertility, the medical complications of these interventions, the potential risks of fertility treatment in women unable to conceive spontaneously, and important issues for preconception counseling.	Brown Univ, Sch Med, Providence, RI 02905 USA; Yale Univ, Sch Med, New Haven, CT USA; Univ Ottawa, Ottawa, ON, Canada; SUNY Buffalo, Buffalo, NY 14260 USA	Brown University; Yale University; University of Ottawa; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Rosene-Montella, K (corresponding author), Brown Univ, Women & Infants Hosp, Sch Med, 101 Dudley St,Suite 3356, Providence, RI 02905 USA.							Abramov Y, 1998, FERTIL STERIL, V70, P1070, DOI 10.1016/S0015-0282(98)00350-1; Adashi EY, 1999, NEW ENGL J MED, V340, P709, DOI 10.1056/NEJM199903043400907; Amowitz LL, 1999, ENDOCRIN METAB CLIN, V28, P439, DOI 10.1016/S0889-8529(05)70079-7; Anasti JN, 1998, FERTIL STERIL, V70, P1, DOI 10.1016/S0015-0282(98)00099-5; Annas GJ, 1998, NEW ENGL J MED, V339, P935, DOI 10.1056/NEJM199809243391325; BAMFORD PN, 1982, BRIT J OBSTET GYNAEC, V89, P962, DOI 10.1111/j.1471-0528.1982.tb05067.x; Beerendonk C C, 1998, Obstet Gynecol Surv, V53, P439, DOI 10.1097/00006254-199807000-00024; Birdsall M, 1996, HUM REPROD, V11, P1587; BORINI A, 1995, FERTIL STERIL, V63, P258; Buyalos RP, 1996, FERTIL STERIL, V65, P1; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; DAHLGREN E, 1992, FERTIL STERIL, V57, P505; Dale PO, 1998, HUM REPROD, V13, P567, DOI 10.1093/humrep/13.3.567; DELGADOESCUETA AV, 1992, NEUROLOGY, V42, P149; Dunaif A, 1999, ENDOCRIN METAB CLIN, V28, P341, DOI 10.1016/S0889-8529(05)70073-6; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Ehrmann DA, 1999, ENDOCRIN METAB CLIN, V28, P423, DOI 10.1016/S0889-8529(05)70078-5; Ellis MH, 1998, FERTIL STERIL, V69, P140, DOI 10.1016/S0015-0282(97)00459-7; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Gilbert WM, 1999, OBSTET GYNECOL, V93, P9, DOI 10.1016/S0029-7844(98)00382-2; Govaerts I, 1998, EUR J OBSTET GYN R B, V77, P239, DOI 10.1016/S0301-2115(97)00263-7; GREENE MF, 1989, TERATOLOGY, V39, P225, DOI 10.1002/tera.1420390303; Hanson RS, 1997, OBSTET GYNECOL, V89, P816; HEALY DL, 1994, LANCET, V343, P1539, DOI 10.1016/S0140-6736(94)92941-6; Hoxsey R, 1997, CLIN PERINATOL, V24, P321, DOI 10.1016/S0095-5108(18)30169-6; Hwang WJ, 1998, J FORMOS MED ASSOC, V97, P503; KALLEN BAJ, 1995, EUR J ENDOCRINOL, V132, P144, DOI 10.1530/eje.0.1320144; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lesser K B, 1997, J Matern Fetal Med, V6, P303, DOI 10.1002/(SICI)1520-6661(199709/10)6:5<303::AID-MFM14>3.0.CO;2-L; Levin ER, 1998, J CLIN INVEST, V102, P1978, DOI 10.1172/JCI4814; Lukse MP, 1999, OBSTET GYNECOL, V93, P245, DOI 10.1016/S0029-7844(98)00432-3; MANDEL SJ, 1990, NEW ENGL J MED, V323, P91, DOI 10.1056/NEJM199007123230204; MARSH M, 1996, EMPTY CRADLE INFERTI, P1; MARSHALL LA, 1994, IM INTERNAL MED, V15, P18; NAVOT D, 1994, FERTIL STERIL, V61, P97; NELSON LM, 1994, J CLIN ENDOCR METAB, V79, P1470, DOI 10.1210/jc.79.5.1470; Parikh FR, 1997, FERTIL STERIL, V67, P497, DOI 10.1016/S0015-0282(97)80076-3; Paulson RJ, 1997, FERTIL STERIL, V67, P949, DOI 10.1016/S0015-0282(97)81413-6; Pellicer A, 1999, FERTIL STERIL, V71, P482, DOI 10.1016/S0015-0282(98)00484-1; PIPER JM, 1992, OBSTET GYNECOL, V80, P429; PRESS F, 1995, FERTIL STERIL, V64, P995, DOI 10.1016/S0015-0282(16)57917-5; PRICE WH, 1986, J EPIDEMIOL COMMUN H, V40, P97, DOI 10.1136/jech.40.2.97; RON E, 1987, AM J EPIDEMIOL, V125, P780, DOI 10.1093/oxfordjournals.aje.a114595; ROSSING MA, 1994, NEW ENGL J MED, V331, P771, DOI 10.1056/NEJM199409223311204; SAUER MV, 1995, FERTIL STERIL, V64, P111, DOI 10.1016/S0015-0282(16)57665-1; Shahin MS, 1998, OBSTET GYN CLIN N AM, V25, P423, DOI 10.1016/S0889-8545(05)70016-4; Shushan A, 1996, FERTIL STERIL, V65, P13, DOI 10.1016/S0015-0282(16)58020-0; Simon A, 1998, J ASSIST REPROD GEN, V15, P202, DOI 10.1023/A:1023052419627; SIMPSON JL, 1983, SEMIN REPROD ENDOCR, V1, P93, DOI 10.1055/s-2007-1022579; Speroff L., 1999, CLIN GYNECOLOGIC END, P1013; STEPTOE PC, 1980, BRIT J OBSTET GYNAEC, V87, P757, DOI 10.1111/j.1471-0528.1980.tb04611.x; Stewart JA, 1997, HUM REPROD, V12, P2167, DOI 10.1093/humrep/12.10.2167; TIETZE C, 1957, FERTIL STERIL, V8, P89; van de Vrie W, 1997, NETH J MED, V51, P232, DOI 10.1016/S0300-2977(97)00065-X; VISSCHER RD, 1994, NEW ENGL J MED, V331, P1588; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; WILCOX LS, 1993, OBSTET GYNECOL, V82, P122; WOLFE HM, 1994, CLIN OBSTET GYNECOL, V37, P596, DOI 10.1097/00003081-199409000-00012; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	60	15	15	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					973	981		10.7326/0003-4819-132-12-200006200-00008	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858181				2022-12-28	WOS:000087670800007
J	Baughman, RH; Dantas, SO; Stafstrom, S; Zakhidov, AA; Mitchell, TB; Dubin, DHE				Baughman, RH; Dantas, SO; Stafstrom, S; Zakhidov, AA; Mitchell, TB; Dubin, DHE			Negative Poisson's ratios for extreme states of matter	SCIENCE			English	Article							CRYSTALLIZED ION PLASMAS; COLLOIDAL CRYSTALS; PHASE-DIAGRAMS; DUSTY PLASMAS; SUSPENSIONS; DIFFRACTION; SYSTEMS	Negative Poisson's ratios are predicted for body-centered-cubic phases that Likely exist in white dwarf cores and neutron star outer crusts, as well as those found for vacuumlike ion crystals, plasma dust crystals, and colloidal crystals (including certain virus crystals). The existence of this counterintuitive property, which means that a material laterally expands when stretched, is experimentally demonstrated for very low density crystals of trapped ions. At very high densities, the large predicted negative and positive Poisson's ratios might be important for understanding the asteroseismology of neutron stars and white dwarfs and the effect of stellar stresses on nuclear reaction rates. Giant Poisson's ratios are both predicted and observed for highly strained coulombic photonic crystals, suggesting possible applications of large, tunable Poisson's ratios for photonic crystal devices.	Honeywell Int, Honeywell Technol Ctr, Morristown, NJ 07962 USA; Univ Fed Juiz de Fora, Dept Fis, BR-36036330 Juiz De Fora, MG, Brazil; Linkoping Univ, Dept Phys & Measurement Technol, S-58183 Linkoping, Sweden; Natl Inst Stand & Technol, Boulder, CO 80303 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Honeywell; Universidade Federal de Juiz de Fora; Linkoping University; National Institute of Standards & Technology (NIST) - USA; University of California System; University of California San Diego	Baughman, RH (corresponding author), Honeywell Int, Honeywell Technol Ctr, Morristown, NJ 07962 USA.		Stafstrom, Sven/G-2982-2011; Baughman, Ray Henry/A-8628-2018	Stafstrom, Sven/0000-0001-6555-239X; Baughman, Ray Henry/0000-0001-5845-5137; Zakhidov, Anvar/0000-0003-3983-2229				Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; Baughman RH, 1998, NATURE, V392, P362, DOI 10.1038/32842; BAUGHMAN RH, 1993, NATURE, V365, P735, DOI 10.1038/365735a0; BAYM G, 1971, ANN PHYS-NEW YORK, V66, P816, DOI 10.1016/0003-4916(71)90084-4; CHU JH, 1994, PHYS REV LETT, V72, P4009, DOI 10.1103/PhysRevLett.72.4009; CLARK NA, 1979, NATURE, V281, P57, DOI 10.1038/281057a0; CRANDALL RS, 1977, SCIENCE, V198, P293, DOI 10.1126/science.198.4314.293; EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0; EVERY AG, 1992, LANDOLTBORNSTEIN, P11; GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087; GUNTON DJ, 1972, J MATER SCI, V7, P1061, DOI 10.1007/BF00550070; HONE D, 1983, J CHEM PHYS, V79, P1474, DOI 10.1063/1.445937; Itano WM, 1998, SCIENCE, V279, P686, DOI 10.1126/science.279.5351.686; LAKES R, 1991, J MATER SCI, V26, P2287, DOI 10.1007/BF01130170; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Larsen AE, 1997, NATURE, V385, P230, DOI 10.1038/385230a0; MILSTEIN F, 1979, PHYS REV B, V19, P2030, DOI 10.1103/PhysRevB.19.2030; MILTON GW, 1992, J MECH PHYS SOLIDS, V40, P1105, DOI 10.1016/0022-5096(92)90063-8; Mitchell TB, 1998, SCIENCE, V282, P1290, DOI 10.1126/science.282.5392.1290; Murray CA, 1996, ANNU REV PHYS CHEM, V47, P421, DOI 10.1146/annurev.physchem.47.1.421; OGATA S, 1993, PHYS REV E, V48, P1344, DOI 10.1103/PhysRevE.48.1344; OGATA S, 1990, PHYS REV A, V8, P4867; PIPER JB, 1996, PHYS REV E, V54, P5636; ROBBINS MO, 1988, J CHEM PHYS, V88, P3286, DOI 10.1063/1.453924; Rosenberg M, 1997, PHYS REV E, V56, P7166, DOI 10.1103/PhysRevE.56.7166; RUDMAN MA, 1971, SCI AM, V224, P24; Schiffer J, 1998, SCIENCE, V279, P675, DOI 10.1126/science.279.5351.675; SHIH WY, 1987, J CHEM PHYS, V86, P5127, DOI 10.1063/1.452631; THOMAS JF, 1971, SCRIPTA METALL MATER, V5, P787, DOI 10.1016/0036-9748(71)90164-5; TIMMINS PA, 1988, MAKROMOL CHEM-M SYMP, V15, P311, DOI 10.1002/masy.19880150124; vanBlaaderen A, 1997, ADV MATER, V9, P833, DOI 10.1002/adma.19970091015; VANHORN HM, 1991, SCIENCE, V252, P384, DOI 10.1126/science.252.5004.384; Weissman JM, 1996, SCIENCE, V274, P959, DOI 10.1126/science.274.5289.959; Winget DE, 1998, J PHYS-CONDENS MAT, V10, P11247, DOI 10.1088/0953-8984/10/49/014; Yamanaka J, 1998, PHYS REV LETT, V80, P5806, DOI 10.1103/PhysRevLett.80.5806; YEGANEHHAERI A, 1992, SCIENCE, V257, P650, DOI 10.1126/science.257.5070.650	36	65	87	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2018	+		10.1126/science.288.5473.2018	http://dx.doi.org/10.1126/science.288.5473.2018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856209				2022-12-28	WOS:000087687000042
J	Janssen, P; Vogels, R; Orban, CA				Janssen, P; Vogels, R; Orban, CA			Selectivity for 3D shape that reveals distinct areas within macaque inferior temporal cortex	SCIENCE			English	Article							INFEROTEMPORAL CORTEX; CORTICAL CONNECTIONS; VISUAL IMAGES; RHESUS-MONKEY; ARCHITECTONICS; OBJECTS; NEURONS; SULCUS	The anterior part of the macaque inferior temporal cortex, area TE, occupies a Large portion of the temporal Lobe and is critical for object recognition. Thus far, no relation between anatomical subdivisions of TE and neuronal selectivity has been described. Here, we present evidence that neurons selective for three-dimensional (3D) shape are concentrated in the lower bank of the superior temporal sulcus, whereas neurons in lateral TE are generally unselective for 3D shape, though equally selective for 2D shape. These findings reveal that TE consists of at Least two distinct areas, one of which processes a specific object property.	Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium	KU Leuven	Vogels, R (corresponding author), Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium.			Orban, Guy/0000-0002-8179-9584				BAIZER JS, 1991, J NEUROSCI, V11, P168; BAYLIS GC, 1987, J NEUROSCI, V7, P330; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; ITO M, 1994, CEREB CORTEX, V4, P499, DOI 10.1093/cercor/4.5.499; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Saleem KS, 1996, J NEUROSCI, V16, P4757; SALEEM KS, IN PRESS J NEUROSCI; SELTZER B, 1989, J COMP NEUROL, V290, P451, DOI 10.1002/cne.902900402; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204	16	166	169	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2054	+		10.1126/science.288.5473.2054	http://dx.doi.org/10.1126/science.288.5473.2054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856221	Green Accepted			2022-12-28	WOS:000087687000054
J	Rauschenbeutel, A; Nogues, G; Osnaghi, S; Bertet, P; Brune, M; Raimond, JM; Haroche, S				Rauschenbeutel, A; Nogues, G; Osnaghi, S; Bertet, P; Brune, M; Raimond, JM; Haroche, S			Step-by-step engineered multiparticle entanglement	SCIENCE			English	Article							PODOLSKY-ROSEN CHANNELS; QUANTUM STATE; SINGLE-PHOTON; CAVITY; TELEPORTATION; GENERATION; ATOMS; GATE	After quantum particles have interacted, they generally remain in an entangled state and are correlated at a distance by quantum-mechanical Links that can be used to transmit and process information in nonclassical ways. This implies programmable sequences of operations to generate and analyze the entanglement of complex systems. We have demonstrated such a procedure for two atoms and a single-photon cavity mode, engineering and analyzing a three-particle entangled state by a succession of controlled steps that address the particles individually. This entangling procedure can, in principle, operate on larger numbers of particles, opening new perspectives for fundamental tests of quantum theory.	Ecole Normale Super, Dept Phys, Lab Kastler Brossel, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Raimond, JM (corresponding author), Ecole Normale Super, Dept Phys, Lab Kastler Brossel, 24 Rue Lhomond, F-75231 Paris 05, France.	jmr@lkb.ens.fr	Rauschenbeutel, Arno/C-1472-2013	Rauschenbeutel, Arno/0000-0003-2467-4029; RAIMOND, Jean-Michel/0000-0002-4289-3455				BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bennett CH, 2000, NATURE, V404, P247, DOI 10.1038/35005001; BENNETT CH, 1992, SCI AM, V267, P50, DOI 10.1038/scientificamerican1092-50; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Braunstein SL, 1999, PHYS REV LETT, V83, P1054, DOI 10.1103/PhysRevLett.83.1054; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; DAVIDOVICH L, 1994, PHYS REV A, V50, pR895, DOI 10.1103/PhysRevA.50.R895; DOMOKOS P, 1995, PHYS REV A, V52, P3554, DOI 10.1103/PhysRevA.52.3554; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Hagley E, 1997, PHYS REV LETT, V79, P1, DOI 10.1103/PhysRevLett.79.1; Haroche S., 1999, Laser Spectroscopy. 14th International Conference. ICOLS99, P140; HAROCHE S, 1995, ANN NY ACAD SCI, V755, P73, DOI 10.1111/j.1749-6632.1995.tb38957.x; Maitre X, 1997, PHYS REV LETT, V79, P769, DOI 10.1103/PhysRevLett.79.769; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; NUSSENZVEIG P, 1993, PHYS REV A, V48, P3991, DOI 10.1103/PhysRevA.48.3991; RARITY JG, 1994, J MOD OPTIC, V41, P2435, DOI 10.1080/09500349414552281; Rauschenbeutel A, 1999, PHYS REV LETT, V83, P5166, DOI 10.1103/PhysRevLett.83.5166; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Turchette QA, 1998, PHYS REV LETT, V81, P3631, DOI 10.1103/PhysRevLett.81.3631; Varcoe BTH, 2000, NATURE, V403, P743, DOI 10.1038/35001526; VARCOE BTH, 1999, LASER SPECTROSCOPY, V14, P130; Zeilinger A, 1999, REV MOD PHYS, V71, pS288, DOI 10.1103/RevModPhys.71.S288; Zheng SB, 1999, J OPT B-QUANTUM S O, V1, P534, DOI 10.1088/1464-4266/1/5/307	29	623	660	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2024	2028		10.1126/science.288.5473.2024	http://dx.doi.org/10.1126/science.288.5473.2024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856211				2022-12-28	WOS:000087687000044
J	Ekeland, I				Ekeland, I			Mathematics - Curves and numbers	NATURE			English	Editorial Material							LAST THEOREM		Univ Paris 09, Inst Finance, F-75775 Paris 16, France	UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	Ekeland, I (corresponding author), Univ Paris 09, Inst Finance, F-75775 Paris 16, France.							Conrad B, 1999, J AM MATH SOC, V12, P521, DOI 10.1090/S0894-0347-99-00287-8; DARMON H, 1999, NOT AM MATH SOC, V46, P1397; SWINNERTONDYER P, 1993, NATURE, V364, P13, DOI 10.1038/364013a0; WILES A, 1995, ANN MATH, V141, P443, DOI 10.2307/2118559	4	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					748	749		10.1038/35015651	http://dx.doi.org/10.1038/35015651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866183				2022-12-28	WOS:000087620600030
J	Spirito, P; Bellone, P; Harris, KM; Bernabo, P; Bruzzi, P; Maron, BJ				Spirito, P; Bellone, P; Harris, KM; Bernabo, P; Bruzzi, P; Maron, BJ			Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL COURSE; PROGNOSIS; POPULATION; TACHYCARDIA; PREVALENCE; MUTATIONS; FEATURES; EXTENT; AGE	Background: Sudden death is a possible consequence of hypertrophic cardiomyopathy. Quantification of the risk of sudden death, however, remains imprecise for most patients with this disease. Methods: We assessed the relation between the magnitude of left ventricular hypertrophy and mortality in 480 consecutive patients with hypertrophic cardiomyopathy. The patients were categorized into five subgroups according to maximal wall thickness: 15 mm or less, 16 to 19 mm, 20 to 24 mm, 25 to 29 mm, and 30 mm or more. Their ages ranged from 1 to 89 years (median, 47). Results: Over a mean follow-up period of 6.5 years, 65 of the 480 patients (14 percent) died: 23 suddenly, 15 of heart failure, and 27 of noncardiac causes or stroke. The risk of sudden death increased progressively and in direct relation to wall thickness (P=0.001), ranging from 0 per 1000 person-years (95 percent confidence interval, 0 to 14.4) for a wall thickness of 15 mm or less to 18.2 per 1000 person-years (95 percent confidence interval, 7.3 to 37.6) for a wall thickness of 30 mm or more and almost doubling from each wall-thickness subgroup to the next. The cumulative risk 20 years after the initial evaluation was close to zero for patients with a wall thickness of 19 mm or less but almost 40 percent for wall thicknesses of 30 mm or more. As compared with the other subgroups, patients with extreme hypertrophy were the youngest (mean age, 31 years), and most (41 of 43) had mild symptoms or no symptoms; of the 12 patients who were less than 18 years old at the initial evaluation, 5 died suddenly. Conclusions: In hypertrophic cardiomyopathy, the magnitude of hypertrophy is directly related to the risk of sudden death and is a strong and independent predictor of prognosis. Young patients with extreme hypertrophy, even those with few or no symptoms, appear to be at substantial long-term risk and deserve consideration for interventions to prevent sudden death. The majority of patients with mild hypertrophy are at low risk and can be reassured regarding their prognosis. (N Engl J Med 2000;342:1778-85.) (C)2000, Massachusetts Medical Society.	Ente Osped Osped Galliera, Div Cardiol, I-16128 Genoa, Italy; Osped Santa Corona, Div Cardiol, Pietra Ligure, Savona, Italy; Ist Nazl Ric Canc, Serv Epidemiol Clin, I-16132 Genoa, Italy; Minneapolis Heart Inst Fdn, Minneapolis, MN USA	Ente Ospedaliero Ospedali Galliera; University of Genoa; IRCCS AOU San Martino IST; Minneapolis Heart Institute Foundation	Spirito, P (corresponding author), Ente Osped Osped Galliera, Div Cardiol, Via Volta 8, I-16128 Genoa, Italy.		Bruzzi, Paolo/AAU-3363-2021	Bruzzi, Paolo/0000-0002-7874-2077	Telethon [0860C] Funding Source: Medline	Telethon(Fondazione Telethon)		BRAUNWALD E, 1964, CIRCULATION, V30, P3; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; FRANK S, 1968, CIRCULATION, V37, P759, DOI 10.1161/01.CIR.37.5.759; JOSEPH S, 1972, BRIT HEART J, V34, P974; Knight C, 1997, CIRCULATION, V95, P2075, DOI 10.1161/01.CIR.95.8.2075; KOFFLARD MJ, 1993, AM J CARDIOL, V72, P939, DOI 10.1016/0002-9149(93)91111-T; LOUIE EK, 1986, J AM COLL CARDIOL, V8, P57, DOI 10.1016/S0735-1097(86)80092-4; Maron BJ, 1997, LANCET, V350, P1330; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 1999, CIRCULATION, V99, P2927, DOI 10.1161/01.CIR.99.22.2927; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; MARON BJ, 1986, NEW ENGL J MED, V315, P610, DOI 10.1056/NEJM198609043151003; MARON BJ, 1999, JAMA-J AM MED ASSOC, V281, P2288; MCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X; MCKENNA WJ, 1985, BRIT HEART J, V53, P412; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; PANZA JA, 1992, J AM COLL CARDIOL, V19, P91, DOI 10.1016/0735-1097(92)90057-T; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; SCHWARTZ K, 1995, CIRCULATION, V91, P532, DOI 10.1161/01.CIR.91.2.532; SPIRITO P, 1994, CIRCULATION, V90, P2743, DOI 10.1161/01.CIR.90.6.2743; Spirito P, 1999, CIRCULATION, V99, P2132, DOI 10.1161/01.CIR.99.16.2132; SPIRITO P, 1987, AM J CARDIOL, V60, P123, DOI 10.1016/0002-9149(87)90998-2; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; SPIRITO P, 1989, J AM COLL CARDIOL, V13, P820, DOI 10.1016/0735-1097(89)90222-2; SPIRITO P, 1990, J AM COLL CARDIOL, V15, P1521, DOI 10.1016/0735-1097(90)92820-R; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; TEARE D, 1958, BRIT HEART J, V20, P1; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680	32	718	757	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1778	1785		10.1056/NEJM200006153422403	http://dx.doi.org/10.1056/NEJM200006153422403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853000				2022-12-28	WOS:000087573700003
J	Buerhaus, PI; Staiger, D; Auerbach, DI				Buerhaus, PI; Staiger, D; Auerbach, DI			Implications of an aging registered nurse workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context The average age of registered nurses (RNs), the largest group of health care professionals in the United States, increased substantially from 1983 to 1998, No empirically based analysis of the causes and implications of this aging workforce exists. Objectives To identify and assess key sources of changes in the age distribution and total supply of RNs and to project the future age distribution and total RN workforce up to the year 2020. Design and Setting Retrospective cohort analysis of employment trends of recent RN cohorts over their lifetimes based on US Bureau of the Census Current Population Surveys between 1973 and 1998. Recent workforce trends were used to forecast longterm age and employment of RNs. Participants Employed RNs aged 23 to 64 years (N = 60 386). Main Outcome Measures Annual full-time equivalent employment of RNs in total and by single year of age. Results The average age of working RNs increased by 4.5 years between 1983 and 1998. The number of full-time equivalent RNs observed in recent cohorts has been approximately 35% lower than that observed at similar ages for cohorts that entered the labor market 20 years earlier. Over the next 2 decades, this trend will lead to a further aging of the RN workforce because the largest cohorts of RNs will be between age 50 and 69 years. Within the next 10 years, the average age of RNs is forecast to be 45.4 years, an increase of 3.5 years over the current age, with more than 40% of the RN workforce expected to be older than 50 years. The total number of full-time equivalent RNs per capita is forecast to peak around the year 2007 and decline steadily thereafter as the largest cohorts of RNs retire. By the year 2020, the RN workforce is forecast to be roughly the same size as it is today, declining nearly 20% below projected RN workforce requirements. Conclusions The primary factor that has led to the aging of the RN workforce appears to be the decline in younger women choosing nursing as a career during the last 2 decades. Unless this trend is reversed, the RN workforce will continue to age, and eventually shrink, and will not meet projected long-term workforce requirements.	Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA; Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; Harvard Univ, Program Hlth Policy, Cambridge, MA 02138 USA; Harvard Univ, Natl Bur Econ Res, Cambridge, MA 02138 USA	Vanderbilt University; Dartmouth College; Harvard University; Harvard University; National Bureau of Economic Research	Buerhaus, PI (corresponding author), Vanderbilt Univ, Sch Nursing, Godchaux Hall,Room 512,21st Ave S, Nashville, TN 37240 USA.		Winwood, Peter/A-6363-2008					Aiken LH, 1996, HEALTH AFFAIR, V15, P88, DOI 10.1377/hlthaff.15.4.88; BLAU FD, 1992, EC WOMEN MEN WORK; BOGNANNO MF, 1974, J HUM RESOUR, V9, P80, DOI 10.2307/145046; BUERHAUS P, IN PRESS NURS EC; Buerhaus P I, 1997, Image J Nurs Sch, V29, P313; Buerhaus PI, 1996, JAMA-J AM MED ASSOC, V276, P1487, DOI 10.1001/jama.276.18.1487; BUERHAUS PI, 1991, MED CARE, V29, P1181, DOI 10.1097/00005650-199112000-00002; Buerhaus PI, 1999, HEALTH AFFAIR, V18, P214, DOI 10.1377/hlthaff.18.1.214; *BUR LAB STAT, 2000, 63 US BUR CENS BUR L; DEATON A, 1997, ANAL HOUSEHOLD SURVE, pCH2; *DIV NURS BUR HLTH, 1991, HLTH PERS US 8 REP C; *DIV NURS BUR HLTH, 1996, BAS WORKF REP NAT AD; GILLILAN M, 1997, NURS EC, V6, P320; Greene J, 1998, HOSP HEALTH NETWORK, V72, P78; *KAIS FAM FDN HARV, 2000, 1999 SURV PHYS NURS; LINK CR, 1979, J HUM RESOUR, V14, P256, DOI 10.2307/145647; McBride A. B., 1996, NURSING STAFF HOSP N, P333; MOSES E, 1996, REGISTERED NURS POPU; PETER D, 1998, HLTH PROFESSIONS VIE; Pew Health Professions Commission, 1995, CRIT CHALL REV HLTH; ROGERS B, 1996, NURSING STAFF HOSP N, P503; *US BUR CENS, 1996, POP PROJ US AG SEX R; *US CENS BUR, 1999, US POP EST AG SEX RA; WUNDERLICH G, 1996, NURSING TAFF HOSP NU, P72	25	335	337	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2948	+		10.1001/jama.283.22.2948	http://dx.doi.org/10.1001/jama.283.22.2948			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	321XL	10865272	Bronze			2022-12-28	WOS:000087480600034
J	Choi, I; Aalkjaer, C; Boulpaep, EL; Boron, WF				Choi, I; Aalkjaer, C; Boulpaep, EL; Boron, WF			An electroneutral sodium/bicarbonate cotransporter NBCn1 and associated sodium channel	NATURE			English	Article							INTRACELLULAR PH; TISSUE DISTRIBUTION; BICARBONATE COTRANSPORTER; SMOOTH-MUSCLE; CLONING; TRANSPORT; EXCHANGE; PROTEIN; FAMILY; EXPRESSION	Two electroneutral, Na+-driven HCO3- transporters, the Na+-driven Cl-/HCO3- exchanger and the electroneutral Na+/HCO3- cotransporter, have crucial roles in regulating intracellular pH in a variety of cells, including cardiac myocytes(1,2), vascular smooth-muscle(3,4), neurons(5) and fibroblasts(6); however, it is difficult to distinguish their CT dependence in mammalian cells. Here we report the cloning of three variants of an electroneutral Na+/HCO3- cotransporter, NBCn1, from rat smooth muscle. They are 89-92% identical to a human skeletal muscle clone(7), 55-57% identical to the electrogenic NBCs and 33-43% identical to the anion exchangers(8). When expressed in Xenopus oocytes, NBCn1-B (which encodes 1,218 amino acids) is electroneutral, Na+-dependent and HCO3--dependent, but not Cl--dependent. Oocytes injected with low levels of NBCn1-B complementary RNA exhibit a Na+ conductance that 4,4-diisothiocyanatostilbene-2,2'-disulphonate stimulates slowly and irreversibly.	Yale Univ, Sch Med, Dept Cellular & Mol Biol, New Haven, CT 06520 USA; Aarhus Univ, Dept Physiol, DK-8000 Aarhus, Denmark; Aarhus Univ, Danish Biomembrane Res Ctr, DK-8000 Aarhus, Denmark	Yale University; Aarhus University; Aarhus University	Boron, WF (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Biol, 333 Cedar St, New Haven, CT 06520 USA.		Boron, Walter/ABI-1564-2020; choi, inyeong/AAM-4826-2021	Aalkjaer, Christian/0000-0003-2618-4015; Boron, Walter/0000-0003-4741-7287				AALKJAER C, 1991, J PHYSIOL-LONDON, V436, P57, DOI 10.1113/jphysiol.1991.sp018539; Aalkjaer C, 1996, J VASC RES, V33, P347, DOI 10.1159/000159163; Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; AICKIN CC, 1994, J PHYSIOL-LONDON, V479, P301, DOI 10.1113/jphysiol.1994.sp020297; Bielfeld-Ackermann A, 1998, PFLUG ARCH EUR J PHY, V436, P329, DOI 10.1007/PL00008085; CABANTCHIK ZI, 1978, BIOCHIM BIOPHYS ACTA, V515, P239; Choi I, 1999, AM J PHYSIOL-CELL PH, V276, pC576, DOI 10.1152/ajpcell.1999.276.3.C576; DART C, 1992, J PHYSIOL-LONDON, V451, P365, DOI 10.1113/jphysiol.1992.sp019169; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; LAGADICGOSSMANN D, 1992, J PHYSIOL-LONDON, V458, P361, DOI 10.1113/jphysiol.1992.sp019422; LALLEMAIN G, 1985, J BIOL CHEM, V260, P4877; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; SIEBENS AW, 1987, J GEN PHYSIOL, V90, P799, DOI 10.1085/jgp.90.6.799; Smith GL, 1998, CARDIOVASC RES, V38, P316, DOI 10.1016/S0008-6363(98)00020-0; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yu M, 1998, HYPERTENSION, V32, P807; ZHAO JH, 1995, NATURE, V374, P636, DOI 10.1038/374636a0	28	199	202	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					571	575		10.1038/35014615	http://dx.doi.org/10.1038/35014615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850716				2022-12-28	WOS:000087449500051
J	Iddan, G; Meron, G; Glukhovsky, A; Swain, P				Iddan, G; Meron, G; Glukhovsky, A; Swain, P			Wireless capsule endoscopy	NATURE			English	Article									Given Imageing Ltd, IL-20692 Yoqneam, Israel; Royal London Hosp, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Iddan, G (corresponding author), Given Imageing Ltd, Bldg 7,New Ind Pk, IL-20692 Yoqneam, Israel.							FOSSUM ER, 1993, P SOC PHOTO-OPT INS, V1900, P2, DOI 10.1117/12.148585; HOPKINS HH, 1954, NATURE, V173, P39, DOI 10.1038/173039b0; MACKAY RS, 1957, NATURE, V179, P1239, DOI 10.1038/1791239a0; NOLLER HG, 1960, DEUT MED WOCHENSCHR, V85, P1707, DOI 10.1055/s-0028-1112642; Zworykin V.K., 1957, NATURE, V179, P898, DOI 10.1038/179898a0	5	2042	2217	13	187	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					417	417		10.1038/35013140	http://dx.doi.org/10.1038/35013140			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839527				2022-12-28	WOS:000087212000035
J	Rosenfeld, D; Woodley, WL				Rosenfeld, D; Woodley, WL			Deep convective clouds with sustained supercooled liquid water down to-37.5 degrees C	NATURE			English	Article							HOMOGENEOUS ICE NUCLEATION	In cirrus(1) and orographic wave clouds(2), highly supercooled water has been observed in small quantities (less than 0.15 g m(-3)). This high degree of supercooling was attributed to the small droplet size and the lack of ice nuclei at the heights of these clouds(1,2). For deep convective clouds, which have much larger droplets near their tops and which take in aerosols from near the ground, no such measurements have hitherto been reported. However, satellite data suggest that highly supercooled water (down to -38 degrees C) frequently occurs in vigorous continental convective storms(3). Here we report in situ measurements in deep convective clouds from an aircraft, showing that most of the condensed water remains liquid down to -37.5 degrees C. The droplets reach a median volume diameter of 17 mu m and amount to 1.8 g m(-3), one order of magnitude more than previously reported 2. At slightly colder temperatures only ice was found, suggesting homogeneous freezing. Because of the poor knowledge of mixed-phase cloud processes(4), the simulation of clouds using numerical models is difficult at present. Our observations will help to understand these cloud processes, such as rainfall, hail, and cloud electrification, together with their implications for the climate system.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; Woodley White Consultants, Littleton, CO 80127 USA	Hebrew University of Jerusalem	Rosenfeld, D (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.		Rosenfeld, Daniel/AAJ-4617-2021; Rosenfeld, Daniel/F-6077-2016	Rosenfeld, Daniel/0000-0002-0784-7656; Rosenfeld, Daniel/0000-0002-0784-7656				Heymsfield A. J., 1989, Journal of Atmospheric and Oceanic Technology, V6, P378, DOI 10.1175/1520-0426(1989)006<0378:EOLWMI>2.0.CO;2; HEYMSFIELD AJ, 1993, J ATMOS SCI, V50, P2335, DOI 10.1175/1520-0469(1993)050<2335:HINASL>2.0.CO;2; Jeffery CA, 1997, J GEOPHYS RES-ATMOS, V102, P25269, DOI 10.1029/97JD02243; Petersen WA, 1998, J GEOPHYS RES-ATMOS, V103, P14025, DOI 10.1029/97JD02064; PRUPPACHER HR, 1995, J ATMOS SCI, V52, P1924, DOI 10.1175/1520-0469(1995)052<1924:ANLAHI>2.0.CO;2; Pruppacher HR, 1997, MICROPHYSICS CLOUDS; Rosenfeld D, 1998, B AM METEOROL SOC, V79, P2457, DOI 10.1175/1520-0477(1998)079<2457:SBIIPF>2.0.CO;2; SASSEN K, 1985, SCIENCE, V227, P411, DOI 10.1126/science.227.4685.411; Sukarnjanaset W, 1998, CONFERENCE ON CLOUD PHYSICS, pJ24; WILLIAMS ER, 1991, J ATMOS SCI, V48, P2195, DOI 10.1175/1520-0469(1991)048<2195:MPMACE>2.0.CO;2; [No title captured]; [No title captured]	12	357	375	0	76	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					440	442		10.1038/35013030	http://dx.doi.org/10.1038/35013030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839535				2022-12-28	WOS:000087212000043
J	Indiveri, G; Douglas, F				Indiveri, G; Douglas, F			Robotic vision - Neuromorphic vision sensors	SCIENCE			English	Article							ANALOG VLSI; VISUAL TRACKING; ATTENTION; CIRCUITS; SYSTEM		Univ Zurich, Swiss Fed Inst Technol, Inst Neuroinformat, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Indiveri, G (corresponding author), Univ Zurich, Swiss Fed Inst Technol, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Indiveri, Giacomo/AAX-3310-2020; Indiveri, Giacomo/A-4282-2010	Indiveri, Giacomo/0000-0002-7109-1689; Indiveri, Giacomo/0000-0002-7109-1689				Blanchard M, 2000, ROBOT AUTON SYST, V30, P17, DOI 10.1016/S0921-8890(99)00063-9; Brajovic V, 1998, IEEE J SOLID-ST CIRC, V33, P1199, DOI 10.1109/4.705358; DOUGLAS R, 1995, ANNU REV NEUROSCI, V18, P255, DOI 10.1146/annurev.ne.18.030195.001351; EtienneCummings R, 1997, ISSCC DIG TECH PAP I, V40, P38; Faugeras O, 1993, 3 DIMENSIONAL COMPUT; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; Harrison RR, 1999, AUTON ROBOT, V7, P211, DOI 10.1023/A:1008916202887; Horiuchi TK, 1997, ADV NEUR IN, V9, P706; Horn BK, 1986, ROBOT VISION, V1st; Huber SA, 1999, ROBOT AUTON SYST, V29, P227, DOI 10.1016/S0921-8890(99)00055-X; Indiveri GC, 1999, IEEE T CIRCUITS-II, V46, P1337, DOI 10.1109/82.803473; Koch C, 1996, IEEE SPECTRUM, V33, P38, DOI 10.1109/6.490055; LIU SC, 2000, 2 INT ECSC S NEUR CO; MAHOWALD M, 1994, VLSI SYSTEM STEREOSC; MAURER M, 1997, P IEE C INT TRANSP S, P578; MEAD C, 1989, ANAL VLSI NEURAL SYS; MEAD CA, 1988, NEURAL NETWORKS, V1, P91, DOI 10.1016/0893-6080(88)90024-X; MOLLER R, 2000, IN PRESS BIOL CYBERN; Sarpeshkar R, 1996, P IEEE, V84, P969, DOI 10.1109/5.503298; Webb B, 1998, NEURAL NETWORKS, V11, P1479, DOI 10.1016/S0893-6080(98)00063-X; Weber K, 1997, FROM LIVING EYES TO SEEING MACHINES, P226	21	81	82	5	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1189	1190		10.1126/science.288.5469.1189	http://dx.doi.org/10.1126/science.288.5469.1189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10841740				2022-12-28	WOS:000087112600033
J	Garcia, JA; Zhang, D; Estill, SJ; Michnoff, C; Rutter, J; Reick, M; Scott, K; Diaz-Arrastia, R; McKnight, SL				Garcia, JA; Zhang, D; Estill, SJ; Michnoff, C; Rutter, J; Reick, M; Scott, K; Diaz-Arrastia, R; McKnight, SL			Impaired cued and contextual memory in NPAS2-deficient mice	SCIENCE			English	Article							CLOCK GENE CLOCK; LONG-TERM-MEMORY; SUPRACHIASMATIC NUCLEUS; CONDITIONED FEAR; CIRCADIAN CLOCK; AMYGDALA; BMAL1; ORGANIZATION; HIPPOCAMPUS; EXPRESSION	Neuronal PAS domain protein 2 (NPAS2) is a basic helix-loop-helix (bHLH) PAS domain transcription factor expressed in multiple regions of the vertebrate brain. Targeted insertion of a beta-galactosidase reporter gene (lacZ) resulted in the production of an NPAS2-LacZ fusion protein and an altered form of NPAS2 Lacking the bHLH domain. The neuroanatomical expression pattern of NPAS2-lacZ was temporally and spatially coincident with formation of the mature frontal association/limbic forebrain pathway. NPAS2-deficient mice were subjected to a series of behavioral tests and were found to exhibit deficits in the Long-term memory arm of the cued and contextual fear task. Thus, NPAS2 may serve a dedicated regulatory role in the acquisition of specific types of memory.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Mol Cardiol Div, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594; Garcia, Joseph/0000-0002-5621-7538	NIA NIH HHS [AG16450, AG12297] Funding Source: Medline; NINDS NIH HHS [NS01763] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001763, F31NS101763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG016450, R01AG012297] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abe H, 1998, NEUROSCI LETT, V258, P93, DOI 10.1016/S0304-3940(98)00877-5; Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Amir S, 1998, NEUROSCIENCE, V86, P345, DOI 10.1016/S0306-4522(98)00172-9; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; CAMPBELL BA, 1972, PSYCHOL REV, V79, P215, DOI 10.1037/h0032690; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; GREEN RJ, 1989, BEHAV NEUROSCI, V103, P98, DOI 10.1037/0735-7044.103.1.98; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; ROMANSKI LM, 1993, CEREB CORTEX, V3, P499, DOI 10.1093/cercor/3.6.499; Rosenzweig MR, 1996, ANNU REV PSYCHOL, V47, P1, DOI 10.1146/annurev.psych.47.1.1; RUDY JW, 1993, BEHAV NEUROSCI, V107, P887, DOI 10.1037/0735-7044.107.5.887; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; SPEAR NE, 1990, ANNU REV PSYCHOL, V41, P169, DOI 10.1146/annurev.psych.41.1.169; TRULLAS R, 1993, PSYCHOPHARMACOLOGY, V111, P323, DOI 10.1007/BF02244948; WILSON DA, 1984, DEV BRAIN RES, V16, P61, DOI 10.1016/0165-3806(84)90063-4; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	40	173	176	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2226	2230		10.1126/science.288.5474.2226	http://dx.doi.org/10.1126/science.288.5474.2226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	327FH	10864874				2022-12-28	WOS:000087782900062
J	Hebbel, RP				Hebbel, RP			Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hebbel, RP (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.							Embury Stephen H., 1994, P311; Hebbel RP, 1997, J LAB CLIN MED, V129, P288, DOI 10.1016/S0022-2143(97)90176-1; Hebbel RP, 1997, J CLIN INVEST, V99, P2561, DOI 10.1172/JCI119442; KAUL DK, 1989, ANN NY ACAD SCI, V565, P316, DOI 10.1111/j.1749-6632.1989.tb24179.x; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368	5	55	68	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1910	1912		10.1056/NEJM200006223422512	http://dx.doi.org/10.1056/NEJM200006223422512			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861330				2022-12-28	WOS:000087704700012
J	Peltola, H				Peltola, H			Bacterial perianal dermatitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Helsinki, FIN-00290 Helsinki, Finland	University of Helsinki	Peltola, H (corresponding author), Univ Helsinki, FIN-00290 Helsinki, Finland.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1877	1877		10.1056/NEJM200006223422505	http://dx.doi.org/10.1056/NEJM200006223422505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861323				2022-12-28	WOS:000087704700005
J	Alberts, MJ; Hademenos, G; Latchaw, RE; Jagoda, A; Marler, JR; Mayberg, MR; Starke, RD; Todd, HW; Viste, KM; Girgus, M; Shephard, T; Emr, M; Shwayder, P; Walker, MD				Alberts, MJ; Hademenos, G; Latchaw, RE; Jagoda, A; Marler, JR; Mayberg, MR; Starke, RD; Todd, HW; Viste, KM; Girgus, M; Shephard, T; Emr, M; Shwayder, P; Walker, MD		Brain Attack Coalition	Recommendations for the establishment of primary stroke centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE ISCHEMIC STROKE; TISSUE-PLASMINOGEN ACTIVATOR; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE-PROFESSIONALS; SPECIAL-WRITING-GROUP; UNITED-STATES; TRAUMA CENTER; COST-EFFECTIVENESS; FIRST-EVER; MANAGEMENT	Objective To develop recommendations for the establishment and operation of primary stroke centers as an approach to improve the medical care of patients with stroke. Participants Members of the Brain Attack Coalition (BAC), a multidisciplinary group of representatives from major professional organizations involved with delivering stroke care. Supplemental input was obtained from other experts involved in acute stroke care. Evidence A review of literature published from 1966 to March 2000 was performed using MEDLINE. More than 600 English-language articles that had evidence from randomized clinical trials, meta-analyses, care guidelines, or other appropriate methods supporting specific care recommendations for patients with acute stroke that could be incorporated into a stroke center model were selected. Consensus Process Articles were reviewed initially by 1 author (M.J.A.). Members of the BAC reviewed each recommendation in the context of current practice parameters, with special attention to improving the delivery of care to patients with acute stroke, cost-effectiveness, and logistical issues related to the establishment of primary stroke centers. Consensus was reached among all BAC participants before an element was added to the list of recommendations. Conclusions Randomized clinical trials and observational studies suggest that several elements of a stroke center would improve patient care and outcomes. Key elements of primary stroke centers include acute stroke teams, stroke units, written care protocols, and an integrated emergency response system. Important support services include availability and interpretation of computed tomography scans 24 hours everyday and rapid laboratory testing. Administrative support, strong leadership, and continuing education are also important elements for stroke centers. Adoption of these recommendations may increase the use of appropriate diagnostic and therapeutic modalities and reduce peristroke complications. The establishment of primary stroke centers has the potential to improve the care of patients with stroke.	Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA; Amer Heart Assoc, Dallas, TX USA; Univ Miami, Sch Med, Dept Radiol, Miami, FL USA; Mt Sinai Med Ctr, Dept Emergency Med, New York, NY 10029 USA; NINDS, NIH, Rockville, MD USA; Cleveland Clin Fdn, Dept Neurol, Cleveland, OH 44195 USA; Natl Stroke Assoc, Englewood, CO USA; Lakeside Neurocare, Oshkosh, WI USA; Virginia Commonwealth Univ, Ctr Neurosci, Richmond, VA USA; Med Coll Virginia Hosp, Richmond, VA USA	Duke University; University of Miami; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Cleveland Clinic Foundation; Virginia Commonwealth University; Virginia Commonwealth University	Alberts, MJ (corresponding author), Duke Univ, Med Ctr, Div Neurol, POB 3392,Bryan Res Bldg,Room 227E, Durham, NC 27710 USA.	alber002@mc.duke.edu		Mayberg, Marc/0000-0002-6718-7143				Adams HP, 1996, STROKE, V27, P1711; ADAMS HP, 1994, STROKE, V25, P1901, DOI 10.1161/01.STR.25.9.1901; Adams HP, 1996, NEUROLOGY, V47, P835; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; ALBERTS MJ, 1995, ANN INTERN MED, V122, P622, DOI 10.7326/0003-4819-122-8-199504150-00013; ALBERTS MJ, 1992, STROKE, V23, P352, DOI 10.1161/01.STR.23.3.352; Alberts MJ, 1998, STROKE, V29, P2318, DOI 10.1161/01.STR.29.11.2318; Alberts MJ, 1998, NEUROLOGY, V51, pS53, DOI 10.1212/WNL.51.3_Suppl_3.S53; Alberts MJ, 1997, AM J CARDIOL, V80, pD29, DOI 10.1016/S0002-9149(97)00582-1; APRAHAMIAN C, 1989, J TRAUMA, V29, P566, DOI 10.1097/00005373-198905000-00004; ARROYO JS, 1995, CLIN ORTHOP RELAT R, P11; Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; BARSAN WG, 1993, ARCH INTERN MED, V153, P2558, DOI 10.1001/archinte.153.22.2558; Bazzoli GJ, 1998, SOC SCI MED, V46, P1137, DOI 10.1016/S0277-9536(97)10053-3; BRATINA P, 1995, STROKE, V26, P409, DOI 10.1161/01.STR.26.3.409; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Broderick JP, 1997, DRUGS, V54, P109, DOI 10.2165/00003495-199700543-00015; BRONNER LL, 1995, NEW ENGL J MED, V333, P1392, DOI 10.1056/NEJM199511233332106; Brott T, 1997, STROKE, V28, P1530, DOI 10.1161/01.STR.28.8.1530; CAMARATA PJ, 1994, NEUROSURGERY, V34, P144, DOI 10.1227/00006123-199401000-00021; Champion HR, 1999, BRIT J SURG, V86, P721, DOI 10.1046/j.1365-2168.1999.01125.x; Chiu D, 1998, STROKE, V29, P18, DOI 10.1161/01.STR.29.1.18; Clark W, 1999, J Stroke Cerebrovasc Dis, V8, P111, DOI 10.1016/S1052-3057(99)80015-9; *COMM TRAUM, 1998, RES OPT CAR IN PAT 1; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Fagan SC, 1998, NEUROLOGY, V50, P883, DOI 10.1212/WNL.50.4.883; FELDMANN E, 1993, STROKE, V24, P1805, DOI 10.1161/01.STR.24.12.1805; FURLAN A, 1997, J STROKE CEREBROVASC, V6, P299; Goldstein LB, 2000, STROKE, V31, P66, DOI 10.1161/01.STR.31.1.66; GOMEZ CR, 1994, STROKE, V25, P1920, DOI 10.1161/01.STR.25.10.1920; Gordon DL, 2000, NEUROEPIDEMIOLOGY, V19, P1, DOI 10.1159/000026232; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; GROTTA J, 1996, IMPORTANCE TIME RAPI, P5; GROTTA J, 1997, P NAT S RAP ID TREAT, P87; Hainsworth D S, 1997, J Neurosci Nurs, V29, P156; HARPER GD, 1992, STROKE, V23, P835, DOI 10.1161/01.STR.23.6.835; Holloway RG, 1999, STROKE, V30, P1340, DOI 10.1161/01.STR.30.7.1340; Holloway RG, 1996, NEUROLOGY, V46, P854; Jurkovich GJ, 1999, J TRAUMA, V47, pS46, DOI 10.1097/00005373-199909001-00011; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; KOTHARI R, 1995, STROKE, V26, P937, DOI 10.1161/01.STR.26.6.937; Levine SR, 1999, STROKE, V30, P464, DOI 10.1161/01.STR.30.2.464; Mann NC, 1999, J TRAUMA, V47, pS69, DOI 10.1097/00005373-199909001-00015; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MARTIN GD, 1990, J TRAUMA, V30, P1014, DOI 10.1097/00005373-199008000-00011; Matchar DB, 1998, NEUROLOGY, V51, pS31, DOI 10.1212/WNL.51.3_Suppl_3.S31; Mitchell JB, 1996, STROKE, V27, P1937, DOI 10.1161/01.STR.27.11.1937; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Mullins RJ, 1999, J TRAUMA, V47, pS8, DOI 10.1097/00005373-199909001-00004; Munschauer FE, 1997, STROKE, V28, P72, DOI 10.1161/01.STR.28.1.72; Newell SD, 1998, STROKE, V29, P1092, DOI 10.1161/01.STR.29.6.1092; Pepe P E, 1998, Prehosp Emerg Care, V2, P89, DOI 10.1080/10903129808958849; Pepe PE, 1998, ACAD EMERG MED, V5, P352, DOI 10.1111/j.1553-2712.1998.tb02721.x; PEREDNIA DA, 1995, JAMA-J AM MED ASSOC, V273, P483, DOI 10.1001/jama.273.6.483; Sariego J, 2000, SOUTHERN MED J, V93, P182; Skolnick B E, 1999, Phys Med Rehabil Clin N Am, V10, P801; SPEACH DP, 1995, BAILLIERE CLIN NEUR, V4, P317; Summers D, 1998, J Cardiovasc Nurs, V13, P69; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Thorvaldsen P, 1997, STROKE, V28, P500, DOI 10.1161/01.STR.28.3.500; Tilley BC, 1997, ARCH NEUROL-CHICAGO, V54, P1466, DOI 10.1001/archneur.1997.00550240020008; WEBB DJ, 1995, STROKE, V26, P1353, DOI 10.1161/01.STR.26.8.1353; WENNEKER WW, 1990, AM J SURG, V160, P655, DOI 10.1016/S0002-9610(05)80768-8; Wentworth DA, 1996, STROKE, V27, P1040, DOI 10.1161/01.STR.27.6.1040; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Wolf PA, 1999, STROKE, V30, P1991, DOI 10.1161/01.STR.30.9.1991; Wolfe CDA, 1997, J EPIDEMIOL COMMUN H, V51, P520, DOI 10.1136/jech.51.5.520; Wood VA, 1996, J PUBLIC HEALTH MED, V18, P423, DOI 10.1093/oxfordjournals.pubmed.a024540	68	503	515	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3102	3109		10.1001/jama.283.23.3102	http://dx.doi.org/10.1001/jama.283.23.3102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865305				2022-12-28	WOS:000087574900035
J	D'Arcy, CA; McGee, S				D'Arcy, CA; McGee, S			Does this patient have carpal tunnel syndrome?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDIAN NERVE COMPRESSION; HAND SYMPTOM DIAGRAM; PHYSICAL-EXAMINATION; TINEL SIGN; PROVOCATIVE TESTS; DIAGNOSIS; CONDUCTION; ELECTROMYOGRAPHY; SENSITIVITY; SPECIFICITY	Context History taking and physical examination maneuvers, including Tinel and Phalen signs, are widely used for the diagnosis of carpal tunnel syndrome (CTS). Objective To systematically review the precision and accuracy of history taking and physical examination in diagnosing CTS in adults. Data Sources English-language literature was searched using MEDLINE (January 1966-February 2000) as well as bibliographies of relevant articles. Study Selection Studies of patients presenting to clinicians with symptoms suggestive of CTS in which findings from clearly described physical examination maneuvers were independently compared with electrodiagnostic testing. Twelve of 42 initially identified articles met these criteria and were included in the review. Data Extraction Two authors independently reviewed and abstracted data from all of the articles and reached consensus about any discrepancies. Data Synthesis In patients presenting with hand dysesthesias, the Findings that best distinguish between patients with electrodiagnostic evidence of CTS and patients without it are hypalgesia in the median nerve territory (likelihood ratio [LR], 3.1, 95% confidence interval [CI], 2.0-5.1), classic or probable Katz hand diagram results (LR, 2.4; 95% CI, 1.6-3.5), and weak thumb abduction strength (LR, 1.8; 95% CI, 1.4-2.3). Findings that argue against the diagnosis of carpal tunnel syndrome are unlikely Katz hand diagram results (LR, 0.2; 95 % CI, 0.0-0.7) and normal thumb abduction strength (LR, 0.5; 95% CI, 0.4-0.7). Several traditional findings of CTS have little or no diagnostic value, including nocturnal paresthesias; Phalen and Tinel signs; thenar atrophy; and 2-point, vibratory, and monofilament sensory testing. Other less commonly used maneuvers, including the square wrist sign, flick sign, and closed fist sign, require validation by other studies before they can be recommended. Conclusions Hand symptom diagrams, hypalgesia, and thumb abduction strength testing are helpful in the establishing electrodiagnosis of CTS. The utility of these results is limited, however, by problems inherent in using nerve conduction studies as a criterion standard.	Univ Washington, Hlth Sci Ctr, Div Rheumatol, Seattle, WA 98195 USA; Univ Washington, Seattle Puget Sound Vet Affairs Hlth Care Syst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	D'Arcy, CA (corresponding author), Univ Washington, Hlth Sci Ctr, Div Rheumatol, 1959 NE Pacific St,Box 356428, Seattle, WA 98195 USA.							ALTROCCHI PH, 1993, NEUROLOGY, V43, P2406; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; BANDE S, 1994, J HAND SURG-BRIT EUR, V19B, P14, DOI 10.1016/0266-7681(94)90039-6; Bessette L, 1997, J RHEUMATOL, V24, P726; Boeckstyns MEH, 1999, J HAND SURG-BRIT EUR, V24B, P9, DOI 10.1016/S0266-7681(99)90009-8; BORG K, 1988, ACTA NEUROL SCAND, V78, P537, DOI 10.1111/j.1600-0404.1988.tb03698.x; BOWLES AP, 1983, ANN NEUROL, V13, P689, DOI 10.1002/ana.410130627; BROWN RA, 1993, J BONE JOINT SURG AM, V75A, P1265, DOI 10.2106/00004623-199309000-00002; BUCHJAEGER N, 1994, J HAND SURG-BRIT EUR, V19B, P720, DOI 10.1016/0266-7681(94)90244-5; Burke DT, 1999, AM J PHYS MED REHAB, V78, P504, DOI 10.1097/00002060-199911000-00002; Cantatore FP, 1997, CLIN RHEUMATOL, V16, P596, DOI 10.1007/BF02247800; Concannon MJ, 1997, PLAST RECONSTR SURG, V100, P1452, DOI 10.1097/00006534-199711000-00011; CSEUZ KA, 1966, MAYO CLIN PROC, V41, P232; Dammers JWHH, 1999, BRIT MED J, V319, P884, DOI 10.1136/bmj.319.7214.884; DAWSON DM, 1999, ENTRAPMENT NEUROPATH, P20; DEKROM MCTFM, 1990, LANCET, V335, P393, DOI 10.1016/0140-6736(90)90218-T; delPino JG, 1997, J HAND SURG-BRIT EUR, V22B, P38, DOI 10.1016/S0266-7681(97)80012-5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESMET L, 1995, ACTA ORTHOP BELG, V61, P1772; DOYLE JR, 1968, CALIF MED, V108, P263; DURKAN JA, 1991, J BONE JOINT SURG AM, V73A, P535, DOI 10.2106/00004623-199173040-00009; Ferry S, 1998, ARTHRITIS RHEUM, V41, P720, DOI 10.1002/1529-0131(199804)41:4<720::AID-ART20>3.0.CO;2-6; Fertl E, 1998, ACTA NEUROL SCAND, V98, P328; GAINER JV, 1977, SOUTHERN MED J, V70, P325, DOI 10.1097/00007611-197703000-00021; GELBERMAN RH, 1980, J BONE JOINT SURG AM, V62, P1181, DOI 10.2106/00004623-198062070-00020; GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P632, DOI 10.2106/00004623-198365050-00008; GELBERMAN RH, 1981, J BONE JOINT SURG AM, V63, P380, DOI 10.2106/00004623-198163030-00009; GELBERMAN RH, 1988, ORTHOP CLIN N AM, V19, P115; GELLMAN H, 1986, J BONE JOINT SURG AM, V68A, P735, DOI 10.2106/00004623-198668050-00015; GELMERS HJ, 1979, ACTA NEUROCHIR, V49, P255, DOI 10.1007/BF01808965; GERR F, 1995, J OCCUP ENVIRON MED, V37, P1108, DOI 10.1097/00043764-199509000-00012; Ghavanini M R, 1998, Electromyogr Clin Neurophysiol, V38, P437; GILLIATT RW, 1958, J NEUROL NEUROSUR PS, V21, P109, DOI 10.1136/jnnp.21.2.109; GILLIATT RW, 1953, LANCET, V2, P595; GOLDING DN, 1986, BRIT J RHEUMATOL, V25, P388; GOODGOLD J, 1994, MUSCLE NERVE, V17, P1490; GREEN DP, 1984, J HAND SURG-AM, V9A, P850, DOI 10.1016/S0363-5023(84)80065-9; GRUNDBERG AB, 1983, J HAND SURG-AM, V8, P348, DOI 10.1016/S0363-5023(83)80179-8; Gupta SK, 1997, CAN J NEUROL SCI, V24, P338, DOI 10.1017/S0317167100033023; Haig AJ, 1999, ARCH PHYS MED REHAB, V80, P1273, DOI 10.1016/S0003-9993(99)90029-1; HARRIS CM, 1979, J BONE JOINT SURG AM, V61, P93, DOI 10.2106/00004623-197961010-00017; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; HELLER L, 1986, EUR NEUROL, V25, P40, DOI 10.1159/000115985; Homan MM, 1999, SCAND J WORK ENV HEA, V25, P115, DOI 10.5271/sjweh.413; JABLECKI CK, 1993, MUSCLE NERVE, V16, P1392; JACKSON DA, 1989, ARCH PHYS MED REHAB, V70, P199; KATZ JN, 1990, J RHEUMATOL, V17, P1495; KATZ JN, 1990, ANN INTERN MED, V112, P321, DOI 10.7326/0003-4819-112-5-321; Kaufman MA, 1996, ORTHOP CLIN N AM, V27, P245; KENDALL D, 1960, BRIT MED J, V2, P1633, DOI 10.1136/bmj.2.5213.1633; KERR CD, 1992, J HAND SURG-AM, V17A, P1028, DOI 10.1016/S0363-5023(09)91053-X; KIMURA J, 1979, BRAIN, V102, P619, DOI 10.1093/brain/102.3.619; KORIS M, 1990, CLIN ORTHOP RELAT R, P157; KRENDEL DA, 1986, J NEUROL NEUROSUR PS, V49, P220, DOI 10.1136/jnnp.49.2.220-a; Kuhlman KA, 1997, AM J PHYS MED REHAB, V76, P451, DOI 10.1097/00002060-199711000-00004; KUSCHNER SH, 1992, ORTHOPEDICS, V15, P1287; Lee D, 1999, RADIOL CLIN N AM, V37, P859, DOI 10.1016/S0033-8389(05)70132-9; LUM PB, 1986, ARCH PHYS MED REHAB, V67, P805; LUNDBORG G, 1982, J HAND SURG-AM, V7, P252, DOI 10.1016/S0363-5023(82)80175-5; Mainous AG, 1996, MUSCLE NERVE, V19, P256; Marx RG, 1998, J HAND SURG-BRIT EUR, V23B, P499, DOI 10.1016/S0266-7681(98)80132-0; MOSSMAN SS, 1987, BRIT MED J, V294, P680, DOI 10.1136/bmj.294.6573.680; MUHLAU G, 1984, J NEUROL, V231, P83, DOI 10.1007/BF00313722; Nakamichi K, 1998, J HAND SURG-AM, V23A, P1015, DOI 10.1016/S0363-5023(98)80009-9; NATHAN PA, 1988, ARCH PHYS MED REHAB, V69, P499; NOVAK CB, 1992, J HAND SURG-BRIT EUR, V17B, P204, DOI 10.1016/0266-7681(92)90090-O; PATIALA H, 1985, ARCH ORTHOP TRAUM SU, V104, P69, DOI 10.1007/BF00454239; PHALEN GS, 1972, CLIN ORTHOP RELAT R, P29; PHALEN GS, 1981, J HAND SURG-AM, V6, P109, DOI 10.1016/S0363-5023(81)80163-3; PHALEN GS, 1966, J BONE JOINT SURG AM, VA 48, P211, DOI 10.2106/00004623-196648020-00001; PRYSEPHILLIPS WEM, 1984, J NEUROL NEUROSUR PS, V47, P870, DOI 10.1136/jnnp.47.8.870; RADECKI P, 1994, AM J PHYS MED REHAB, V73, P157, DOI 10.1097/00002060-199406000-00003; REDMOND MD, 1988, MUSCLE NERVE, V11, P511, DOI 10.1002/mus.880110515; ROBINSON LR, 1991, MUSCLE NERVE, V14, P1084, DOI 10.1002/mus.880141108; ROQUER J, 1988, ACTA NEUROL SCAND, V78, P351, DOI 10.1111/j.1600-0404.1988.tb03669.x; ROSENBAUM RB, 1993, INVEST RADIOL, V28, P1059, DOI 10.1097/00004424-199311000-00019; ROSENBERG JH, 1993, NEUROLOGY, V43, P2404; SEROR P, 1987, J HAND SURG-BRIT EUR, V12B, P364, DOI 10.1016/0266-7681(87)90190-2; SEROR P, 1988, J HAND SURG-BRIT EUR, V13B, P383, DOI 10.1016/0266-7681(88)90160-X; SEYFERT S, 1994, J NEUROL, V242, P41, DOI 10.1007/BF00920573; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; SPINDLER HA, 1982, J HAND SURG-AM, V7, P260, DOI 10.1016/S0363-5023(82)80176-7; SPINNER RJ, 1989, MAYO CLIN PROC, V64, P829, DOI 10.1016/S0025-6196(12)61756-X; Stevens JC, 1999, MUSCLE NERVE, V22, P1448, DOI 10.1002/(SICI)1097-4598(199910)22:10<1448::AID-MUS17>3.3.CO;2-P; STEVENS JC, 1992, MAYO CLIN PROC, V67, P541, DOI 10.1016/S0025-6196(12)60461-3; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; STEWART JD, 1978, BRIT MED J, V2, P1125, DOI 10.1136/bmj.2.6145.1125-a; Szabo RM, 1999, J HAND SURG-AM, V24A, P704, DOI 10.1053/jhsu.1999.0704; TANAKA S, 1994, AM J PUBLIC HEALTH, V84, P1846, DOI 10.2105/AJPH.84.11.1846; Tetro AM, 1998, J BONE JOINT SURG BR, V80B, P493, DOI 10.1302/0301-620X.80B3.8208; THOMAS JE, 1967, ARCH NEUROL-CHICAGO, V16, P635, DOI 10.1001/archneur.1967.00470240073010; TOUNTAS CP, 1983, MINN MED, V66, P479; WEISS APC, 1994, J HAND SURG-AM, V19A, P410, DOI 10.1016/0363-5023(94)90054-X; WILLIAMS TM, 1992, ANN PLAS SURG, V29, P8, DOI 10.1097/00000637-199207000-00003; WINN FJ, 1990, MUSCLE NERVE, V13, P254, DOI 10.1002/mus.880130313; YII NW, 1994, J HAND SURG-BRIT EUR, V19B, P439, DOI 10.1016/0266-7681(94)90207-0	96	169	169	4	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3110	3117		10.1001/jama.283.23.3110	http://dx.doi.org/10.1001/jama.283.23.3110			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865306				2022-12-28	WOS:000087574900036
J	Perdue, DG; Bulkow, LR; Gellin, BG; Davidson, M; Petersen, KM; Singleton, RJ; Parkinson, AJ				Perdue, DG; Bulkow, LR; Gellin, BG; Davidson, M; Petersen, KM; Singleton, RJ; Parkinson, AJ			Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCES OROPHARYNGEAL CARRIAGE; HEMOPHILUS-INFLUENZAE; CONJUGATE VACCINE; B DISEASE; ADULTS; INFECTIONS; CHILDREN; EPIDEMIOLOGY; SPECTRUM; BACTEREMIA	Context The introduction of Haemophilus influenzae type b (Hib) vaccination of children has led to a decline in incidence of Hib disease in young Alaskan children, How ever, the impact of vaccination on unimmunized Alaskan adolescents and adults has not been studied. Objective To characterize trends in incidence of and mortality due to invasive H influenzae disease in Alaskan residents aged 10 years and older prior to and after the introduction of a statewide Hib infant vaccination program. Design and Setting Population-based, descriptive correlational study conducted 1980-1996 in Alaska, Subjects One hundred twenty-nine individuals (31 Alaska Natives and 98 nonnative Alaska residents) aged 10 years and older in whom H influenzae was cultured from a normally sterile site. Main Outcome Measures Incidence of H influenzae infection before (1980-1990) vs after (1991-1996) vaccination program initiation; serotype, biotype, and p-lactamase production of isolates. Results The overall annual incidence of invasive H influenzae in those aged 10 years and older declined 33%, from 2.1 per 100000 persons per year to 1.4 per 100000 persons per year (P=.03) after initiation of statewide infant Hib vaccination programs in 1991. This reduction appeared to be the result of a decrease in serotype b disease (82%; P<.001). Infection with other H influenzae serotypes and nontypeable strains increased from 0.5 per 100000 persons per year to 1.1 per 100000 persons per year (P =.01). Incidence declined from 4.2 per 100000 persons per year to 1.2 per 100000 persons per year in Alaska Natives (P=.005) and from 1.7 per 100000 persons per year to 1.4 per 100000 persons per year in non native Alaska residents (P =.37). Pneumonia (43%), sepsis (26%), and meningitis (16%) were the most common clinical presentations. Alcohol/drug abuse was comorbid in 15% of patients, while 13% of patients were pregnant women. beta-Lactamase production occurred in 35% of isolates and was stable throughout the surveillance. The overall case-fatality rate was 15%. Conclusion The overall statewide incidence of invasive H influenzae infections in unimmunized persons aged 10 years and older decreased after the initiation of an infant Hib vaccine program, perhaps by decreasing Hib carriage in child reservoirs. An increase in non-serotype b strains was observed. This trend justifies the need for continued surveillance of invasive disease caused by H influenzas.	Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, Anchorage, AK 99508 USA; Univ Washington, Sch Med, Seattle, WA USA; Alaska Native Med Ctr, Anchorage, AK USA; Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA	Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; Alaska Native Medical Center; Alaska Native Tribal Health Consortium; Vanderbilt University	Parkinson, AJ (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	ajp1@cdc.gov						Adegbola RA, 1998, J INFECT DIS, V177, P1758, DOI 10.1086/517440; BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; CASADEVALL A, 1992, AM J MED, V92, P587, DOI 10.1016/0002-9343(92)90774-6; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P657; CROWE HM, 1987, ARCH INTERN MED, V147, P241, DOI 10.1001/archinte.147.2.241; DEULOFEU F, 1994, EUR J CLIN MICROBIOL, V13, P633, DOI 10.1007/BF01973988; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; Galil K, 1999, J INFECT DIS, V179, P101, DOI 10.1086/314569; HIRSCHMANN JV, 1979, MEDICINE, V58, P80, DOI 10.1097/00005792-197901000-00005; HOWARD AJ, 1991, BRIT MED J, V303, P441, DOI 10.1136/bmj.303.6800.441; HUGOSSON S, 1995, SCAND J INFECT DIS, V27, P63, DOI 10.3109/00365549509018974; KOSTMAN JR, 1993, CLIN INFECT DIS, V17, P389, DOI 10.1093/clinids/17.3.389; LEVIN DC, 1977, AM J MED, V62, P219, DOI 10.1016/0002-9343(77)90317-5; MOHLEBOETANI JC, 1993, PEDIATR INFECT DIS J, V12, P589, DOI 10.1097/00006454-199307000-00009; MUSHER DM, 1983, ANN INTERN MED, V99, P444, DOI 10.7326/0003-4819-99-4-444; NAJM WI, 1995, CLIN INFECT DIS, V21, P213, DOI 10.1093/clinids/21.1.213; NORDEN CW, 1978, MED CLIN N AM, V62, P1037, DOI 10.1016/S0025-7125(16)31753-9; Peltola H, 1999, J INFECT DIS, V179, P223, DOI 10.1086/314535; QUENTIN R, 1989, J CLIN MICROBIOL, V27, P2286, DOI 10.1128/JCM.27.10.2286-2294.1989; SINGLETON R, IN PRESS J PEDIAT; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; SPAGNUOLO PJ, 1982, MEDICINE, V61, P74, DOI 10.1097/00005792-198203000-00002; STEINHART R, 1992, JAMA-J AM MED ASSOC, V268, P3350; TAKALA AK, 1990, ARCH INTERN MED, V150, P2573, DOI 10.1001/archinte.150.12.2573; TAKALA AK, 1993, PEDIATR INFECT DIS J, V12, P593, DOI 10.1097/00006454-199307000-00010; TAKALA AK, 1991, J INFECT DIS, V164, P982, DOI 10.1093/infdis/164.5.982; Urwin G, 1996, CLIN INFECT DIS, V22, P1069, DOI 10.1093/clinids/22.6.1069; WALLACE RJ, 1983, REV INFECT DIS, V5, P123; WALLACE RJ, 1981, J INFECT DIS, V144, P101, DOI 10.1093/infdis/144.2.101; WARD JI, 1986, J INFECT DIS, V153, P17, DOI 10.1093/infdis/153.1.17	30	72	73	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3089	3094		10.1001/jama.283.23.3089	http://dx.doi.org/10.1001/jama.283.23.3089			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865303	Bronze			2022-12-28	WOS:000087574900033
J	Rong, YS; Golic, KG				Rong, YS; Golic, KG			Gene targeting by homologous recombination in Drosophila	SCIENCE			English	Article							INDUCED GAP REPAIR; STRAND; YEAST; MELANOGASTER; REPLACEMENT; EFFICIENT; SITE; TRANSFORMATION; INSERTION; GENOME	Drosophila offers many advantages as an experimental organism. However, in comparison with yeast and mouse, two other widely used eukaryotic model systems, Drosophila suffers from an inability to perform homologous recombination between introduced DNA and the corresponding chromosomal loci. The ability to specifically modify the genomes of yeast and mouse provides a quick and easy way to generate or rescue mutations in genes for which a DNA clone or sequence is available. A method is described that enables analogous manipulations of the Drosophila genome. This technique may also be applicable to other organisms for which gene-targeting procedures do not yet exist.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Golic, KG (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	golic@bioscience.utah.edu	rong, yikang/G-6179-2011		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM057792] Funding Source: NIH RePORTER; NIGMS NIH HHS [R21GM57792] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bellaiche Y, 1999, GENETICS, V152, P1037; Cherbas L, 1997, GENETICS, V145, P349; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Dray T, 1997, GENETICS, V147, P689; FRIDELL YWC, 1991, NUCLEIC ACIDS RES, V19, P5082, DOI 10.1093/nar/19.18.5082; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Golic KG, 1996, GENETICS, V144, P1693; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; Gray YHM, 1996, GENETICS, V144, P1601; HASTINGS PJ, 1993, GENETICS, V135, P973; HASTY P, 1994, MOL CELL BIOL, V14, P8385, DOI 10.1128/MCB.14.12.8385; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009; JASON M, 1988, GENE DEV, V2, P1353; Keeler KJ, 1997, MOL CELL BIOL, V17, P627, DOI 10.1128/MCB.17.2.627; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Leung WY, 1997, P NATL ACAD SCI USA, V94, P6851, DOI 10.1073/pnas.94.13.6851; MARYON E, 1991, MOL CELL BIOL, V11, P3268, DOI 10.1128/MCB.11.6.3268; NASSIF N, 1993, P NATL ACAD SCI USA, V90, P1262, DOI 10.1073/pnas.90.4.1262; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; Preston CR, 1996, GENETICS, V144, P1611; Preston CR, 1996, GENETICS, V144, P1623; RONG YS, UNPUB; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; SALZ HK, 1987, GENETICS, V117, P221; SCHEERER JB, 1994, MOL CELL BIOL, V14, P6663, DOI 10.1128/MCB.14.10.6663; SHULMAN MJ, 1990, MOL CELL BIOL, V10, P466; Spradling AC, 1999, GENETICS, V153, P135; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TOWER J, 1993, GENETICS, V133, P347; ZHANG P, 1993, GENETICS, V133, P361	40	445	486	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2013	2018		10.1126/science.288.5473.2013	http://dx.doi.org/10.1126/science.288.5473.2013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856208				2022-12-28	WOS:000087687000041
J	Judd, LL				Judd, LL			Medical treatment of opiate addiction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									Univ Calif San Diego, Natl Consensus Dev Panel Effect Med Treatment Opi, San Diego, CA 92103 USA	University of California System; University of California San Diego	Judd, LL (corresponding author), Univ Calif San Diego, Natl Consensus Dev Panel Effect Med Treatment Opi, San Diego, CA 92103 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2931	2932						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865259				2022-12-28	WOS:000087480600021
J	Heinze, S; Bode, M; Kubetzka, A; Pietzsch, O; Nie, X; Blugel, S; Wiesendanger, R				Heinze, S; Bode, M; Kubetzka, A; Pietzsch, O; Nie, X; Blugel, S; Wiesendanger, R			Real-space imaging of two-dimensional antiferromagnetism on the atomic scale	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; GD(0001); SURFACES; GROWTH; W(110); IMAGES; FILMS; BIAS	A two-dimensional antiferromagnetic structure within a pseudomorphic monolayer film of chemically identical manganese atoms on tungsten(110) was observed with atomic resolution by spin-polarized scanning tunneling microscopy at 16 kelvin. A magnetic superstructure changes the translational symmetry of the surface Lattice with respect to the chemical unit cell. It is shown, with the aid of first-principles calculations, that as a result of this, spin-polarized tunneling electrons give rise to an image corresponding to the magnetic superstructure and not to the chemical unit cell. These investigations demonstrate a powerful technique for the understanding of complicated magnetic configurations of nanomagnets and thin films engineered from ferromagnetic and antiferromagnetic materials used for magnetoelectronics.	Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany; Univ Hamburg, Microstruct Res Ctr, D-20355 Hamburg, Germany; Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany	University of Hamburg; University of Hamburg; Helmholtz Association; Research Center Julich	Bode, M (corresponding author), Univ Hamburg, Inst Appl Phys, Jungiusstr 11, D-20355 Hamburg, Germany.	bode@physnet.uni-hamburg.de	Bode, Matthias/S-3249-2016; Wiesendanger, Roland/P-9726-2016; Blügel, Stefan/J-8323-2013	Bode, Matthias/0000-0001-7514-5560; Wiesendanger, Roland/0000-0002-0472-4183; Blügel, Stefan/0000-0001-9987-4733; Wortmann, Daniel/0000-0002-2248-1904; Heinze, Stefan/0000-0001-5852-0082				BLUGEL S, 1988, PHYS REV LETT, V60, P1077, DOI 10.1103/PhysRevLett.60.1077; Bode M, 1999, SURF SCI, V432, P8, DOI 10.1016/S0039-6028(99)00447-1; Bode M, 1999, J VAC SCI TECHNOL A, V17, P2228, DOI 10.1116/1.581752; Bode M, 1998, PHYS REV LETT, V81, P4256, DOI 10.1103/PhysRevLett.81.4256; Durr HA, 1999, SCIENCE, V284, P2166, DOI 10.1126/science.284.5423.2166; Heinze S, 1999, PHYS REV LETT, V83, P4808, DOI 10.1103/PhysRevLett.83.4808; Heinze S, 1998, PHYS REV B, V58, P16432, DOI 10.1103/PhysRevB.58.16432; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Kortright JB, 1999, J MAGN MAGN MATER, V207, P7, DOI 10.1016/S0304-8853(99)00485-0; KREMBEL C, 1991, J MAGN MAGN MATER, V93, P529, DOI 10.1016/0304-8853(91)90398-T; LaBella VP, 1999, PHYS REV LETT, V83, P2989, DOI 10.1103/PhysRevLett.83.2989; Moruzzi V.L., 1978, CALCULATED ELECT PRO; Nogues J, 1999, J MAGN MAGN MATER, V192, P203, DOI 10.1016/S0304-8853(98)00266-2; Pietzsch O, 2000, REV SCI INSTRUM, V71, P424, DOI 10.1063/1.1150218; PLETZSCH O, 2000, PHYS REV LETT, V84, P5212; Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660; Scholl A, 2000, SCIENCE, V287, P1014, DOI 10.1126/science.287.5455.1014; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; WIESENDANGER R, 1992, SCIENCE, V255, P583, DOI 10.1126/science.255.5044.583; WIESENDANGER R, 1990, PHYS REV LETT, V65, P247, DOI 10.1103/PhysRevLett.65.247	20	276	282	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1805	1808		10.1126/science.288.5472.1805	http://dx.doi.org/10.1126/science.288.5472.1805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846158				2022-12-28	WOS:000087503800044
J	Hong, SH; Mirkin, CA				Hong, SH; Mirkin, CA			A nanoplotter with both parallel and serial writing capabilities	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPE; NANOMETER-SCALE; PROBE LITHOGRAPHY; THIN-FILMS; NANOLITHOGRAPHY; FABRICATION; ALKANETHIOLS	The development of an eight-pen nanoplotter capable of doing parallel dip-pen nanolithography (DPN) is reported. Because line width and patterning speed in DPN are independent of contact force, only one of the tips in the parallel writing mode (the "imaging" tip) has a feedback system to monitor tip position and to write the pattern; all other tips reproduce what occurs at the imaging tip in a passive fashion. Proof-of-concept experiments that demonstrate eight-pen parallel writing, ink and rinsing wells, and "molecular corralling" via a nanoplotter-generated structure are reported.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Ctr Nanofabricat & Mol Self Assembly, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	camirkin@chem.nwu.edu	Mirkin, Chad A/E-3911-2010; Hong, Seunghun/B-2545-2012	Mirkin, Chad/0000-0002-6634-7627				Amro NA, 2000, LANGMUIR, V16, P3006, DOI 10.1021/la000079l; Bottomley LA, 1998, ANAL CHEM, V70, p425R; CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851; Delamarche E, 1998, J PHYS CHEM B, V102, P3324, DOI 10.1021/jp980556x; Hong SH, 1999, LANGMUIR, V15, P7897, DOI 10.1021/la991095p; Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523; JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795; JASCHKE M, 1995, LANGMUIR, V11, P1061, DOI 10.1021/la00004a004; KIM Y, 1992, SCIENCE, V257, P375, DOI 10.1126/science.257.5068.375; Luthi R, 1999, APPL PHYS LETT, V75, P1314, DOI 10.1063/1.124679; Lutwyche M, 1999, SENSOR ACTUAT A-PHYS, V73, P89, DOI 10.1016/S0924-4247(98)00259-3; Minne SC, 1998, APPL PHYS LETT, V73, P1742, DOI 10.1063/1.122263; Mirkin CA, 2000, MRS BULL, V25, P43, DOI 10.1557/S0883769400065015; Muller HU, 1995, J VAC SCI TECHNOL B, V13, P2846, DOI 10.1116/1.588302; Nyffenegger RM, 1997, CHEM REV, V97, P1195, DOI 10.1021/cr960069i; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Piner RD, 1997, LANGMUIR, V13, P6864, DOI 10.1021/la970921w; Schoer JK, 1997, LANGMUIR, V13, P2323, DOI 10.1021/la960369v; Snow ES, 1999, APPL PHYS LETT, V75, P1476, DOI 10.1063/1.124730; Sugimura H, 1996, J VAC SCI TECHNOL A, V14, P1223, DOI 10.1116/1.580271; TSUKAMOTO S, 1991, REV SCI INSTRUM, V62, P1767, DOI 10.4304/jcp.6.11.2267-2271; Vettiger P, 1999, MICROELECTRON ENG, V46, P11, DOI 10.1016/S0167-9317(99)00006-4; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q; Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f	24	300	330	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1808	1811		10.1126/science.288.5472.1808	http://dx.doi.org/10.1126/science.288.5472.1808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846159				2022-12-28	WOS:000087503800045
J	Gavaghan, H				Gavaghan, H			Making moves to redress the gender imbalance	NATURE			English	Article																			0	1	1	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					715	716		10.1038/35015270	http://dx.doi.org/10.1038/35015270			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864333				2022-12-28	WOS:000087465800055
J	von Storch, H; Stehr, N				von Storch, H; Stehr, N			Climate change in perspective	NATURE			English	Editorial Material									GKSS Forschungszentrum Geesthacht GmbH, Inst Gewasserphys, D-21502 Geesthacht, Germany; Univ British Columbia, Sustainable Dev Res Inst, Vancouver, BC V6T 1Z1, Canada; Univ Duisburg, Fachbereich Soziol, D-47057 Duisburg, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of British Columbia; University of Duisburg Essen	von Storch, H (corresponding author), GKSS Forschungszentrum Geesthacht GmbH, Inst Gewasserphys, Max Planck Str 1, D-21502 Geesthacht, Germany.		von Storch, Hans/J-4165-2012	von Storch, Hans/0000-0002-5825-8069				BRUCKNER E, 1990, KLIMASCHWANKUNGEN SE; FLEMING JR, 1998, HIST PERSPECTIVES CL; Funtowicz S.O., 1985, RISK ANAL PRIVATE SE, P217; Glacken Clarence J., 1967, TRACES RHODIAN SHORE; Kempton W., 1995, ENV VALUES AM CULTUR; Lamb H.H., 1982, CLIMATE HIST MODERN; PONTE L, 1976, COOLING; STEHR N, 2000, SOURCES CONSEQUENCE; WILLIAMSON H, 1771, T AM PHIL SOC, V1	9	18	19	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					615	615		10.1038/35015179	http://dx.doi.org/10.1038/35015179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864302	Bronze			2022-12-28	WOS:000087465800019
J	Neoptolemos, JP; Kemppainen, EA; Mayer, JM; Fitzpatrick, JM; Raraty, MGT; Slavin, J; Beger, HG; Hietaranta, AJ; Puolakkainen, PA				Neoptolemos, JP; Kemppainen, EA; Mayer, JM; Fitzpatrick, JM; Raraty, MGT; Slavin, J; Beger, HG; Hietaranta, AJ; Puolakkainen, PA			Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study	LANCET			English	Article							C-REACTIVE PROTEIN; NECROSIS; TAP	Background There is a pressing clinical requirement for an early simple test of severity in acute pancreatitis. We investigated the use of an assay of trypsinogen activation peptide (TAP). Methods We undertook a multicentre study in 246 patients (172 with acute pancreatitis [35 with severe disease], 74 controls). We assessed the predictive value of urinary TAP concentrations measured by a validated competitive immunoassay. We compared the results with those for plasma C-reactive protein and three clinicobiochemical scoring systems. TAP and C-reactive protein concentrations were analysed at set times after symptom onset and compared with the clinicobiochemical systems scores at key times during hospital stay. Findings At 24 h after symptom onset, the median urinary TAP concentration was 37 nmol/L (IQR 17-110) for severe and 15 nmoI/L (5-35) for mild disease (p<0.001). The respective values for plasma C-reactive protein were 24 mg/L (3-34) and 25 mg/L (6-75; p=0.208). The sensitivity, specificity, positive predictive, and negative predictive values of the test to show severe acute pancreatitis compared with mild acute pancreatitis at 24 h were: for TAP (>35 nmol/L), 58%, 73%, 39%, and 86%, respectively, and for C-reactive protein (>150 mg/L), 0%, 90%, 0%, and 75%. 48 h after admission the values for the clinicobiochemical scoring systems were: APACHE II (greater than or equal to 8), 56%, 64%, 30%, and 85%; Ranson score (greater than or equal to 3), 89%, 64%, 38%, and 96%; and Glasgow score (greater than or equal to 3), 77%, 75%, 44%, and 93%. At 48 h, the Values for C-reactive protein were 86%, 61%, 37%, and 94% and for TAP were 83%, 72%, 44%, and 94%. Combined testing of C-reactive protein and TAP was not superior to TAP alone for accuracy. Interpretation Urinary TAP provided accurate severity prediction 24 h after onset of symptoms. This single marker of severity in acute pancreatitis deserves routine clinical application.	Royal Liverpool Univ Hosp, Dept Surg, Liverpool L69 3GA, Merseyside, England; Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; Univ Hosp Ulm, Dept Gen Surg, Ulm, Germany; Univ Coll Dublin, Dept Surg, Dublin 2, Ireland; Mater Misericordiae Hosp, Dublin 7, Ireland	Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Helsinki; Helsinki University Central Hospital; Ulm University; University College Dublin; Mater Misericordiae University Hospital; University College Dublin	Neoptolemos, JP (corresponding author), Royal Liverpool Univ Hosp, Dept Surg, 5th Floor UCD, Liverpool L69 3GA, Merseyside, England.		Neoptolemos, John/HGU-7742-2022; Neoptolemos, John P/G-4488-2010; Raraty, Michael GT/B-5328-2013	Neoptolemos, John/0000-0002-6201-7399				BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DOMINGUEZMUNOZ JE, 1991, BRIT J SURG, V78, P1230, DOI 10.1002/bjs.1800781027; FAN ST, 1993, NEW ENGL J MED, V328, P228, DOI 10.1056/NEJM199301283280402; Farthing MJG, 1998, GUT, V42, P1, DOI 10.1136/gut.42.1.1; GUDGEON AM, 1990, LANCET, V335, P4, DOI 10.1016/0140-6736(90)90135-R; HEATH DI, 1993, GUT, V34, P41, DOI 10.1136/gut.34.1.41; Hedstrom J, 1996, BRIT MED J, V313, P333, DOI 10.1136/bmj.313.7053.333; HURLEY PR, 1988, J IMMUNOL METHODS, V111, P195, DOI 10.1016/0022-1759(88)90127-5; LARVIN M, 1989, LANCET, V2, P201; LEESE T, 1988, BRIT J SURG, V75, P460, DOI 10.1002/bjs.1800750519; McKay CJ, 1999, BRIT J SURG, V86, P1302, DOI 10.1046/j.1365-2168.1999.01246.x; Messmann H, 1998, EUR J GASTROEN HEPAT, V10, P611, DOI 10.1097/00042737-199807000-00016; Neoptolemos JP, 1998, GUT, V42, P886, DOI 10.1136/gut.42.6.886; NEOPTOLEMOS JP, 1988, LANCET, V2, P979, DOI 10.1016/S0140-6736(88)90740-4; PAAJANEN H, 1995, BRIT J SURG, V82, P271, DOI 10.1002/bjs.1800820244; PUOLAKKAINEN P, 1987, GUT, V28, P764, DOI 10.1136/gut.28.6.764; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Rau B, 1997, GUT, V41, P832, DOI 10.1136/gut.41.6.832; SAINIO V, 1995, LANCET, V346, P663, DOI 10.1016/S0140-6736(95)92280-6; SIMPSON KW, 1995, DIGEST DIS SCI, V40, P2152, DOI 10.1007/BF02208999; Tenner S, 1997, INT J PANCREATOL, V21, P105; Toh SKC, 2000, GUT, V46, P239, DOI 10.1136/gut.46.2.239; WILSON PG, 1997, J ANTIMICROB CHEM SA, V40, P51	24	307	319	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1955	1960		10.1016/S0140-6736(00)02327-8	http://dx.doi.org/10.1016/S0140-6736(00)02327-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859041				2022-12-28	WOS:000087381900012
J	Hovnanian, JS				Hovnanian, JS			Let Armenia show why it's the place for Sesame	NATURE			English	Letter									JS Hovnanian & Sons, Mt Laurel, NJ 08054 USA		Hovnanian, JS (corresponding author), JS Hovnanian & Sons, Mt Laurel, NJ 08054 USA.							2000, NATURE, V404, P798	1	0	0	1	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					508	508		10.1038/35014670	http://dx.doi.org/10.1038/35014670			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850691	Bronze			2022-12-28	WOS:000087449500019
J	Kersten, S; Desvergne, B; Wahli, W				Kersten, S; Desvergne, B; Wahli, W			Roles of PPARs in health and disease	NATURE			English	Article							ACTIVATED RECEPTOR-ALPHA; GENE-EXPRESSION; GAMMA; DIFFERENTIATION; LIGAND; TROGLITAZONE; METABOLISM; NUCLEAR; OBESE; DELTA	In developed societies, chronic diseases such as diabetes, obesity, atherosclerosis and cancer are responsible for most deaths. These ailments have complex causes involving genetic, environmental and nutritional factors. There is evidence that a group of closely related nuclear receptors, called peroxisome proliferator-activated receptors (PPARs), may be involved in these diseases. This, together with the fact that PPAR activity can be modulated by drugs such as thiazolidinediones and fibrates, has instigated a huge research effort into PPARs(1). Here we present the latest developments in the PPAR field, with particular emphasis on the physiological function of PPARs during various nutritional states, and the possible role of PPARs in several chronic diseases.	Univ Lausanne, Inst Biol Anim, CH-1015 Lausanne, Switzerland	University of Lausanne	Wahli, W (corresponding author), Univ Lausanne, Inst Biol Anim, Batiment Biol, CH-1015 Lausanne, Switzerland.	walter.wahli@iba.unil.ch	Wahli, Walter/B-1398-2009; Wahli, Walter/I-3194-2019; Kersten, Sander/A-1116-2011; Desvergne, Beatrice/C-8892-2016	Wahli, Walter/0000-0002-5966-9089; Kersten, Sander/0000-0003-4488-7734; Desvergne, Beatrice/0000-0001-5483-288X				Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Basu-Modak S, 1999, J BIOL CHEM, V274, P35881, DOI 10.1074/jbc.274.50.35881; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Devchand PR, 1999, J BIOL CHEM, V274, P23341, DOI 10.1074/jbc.274.33.23341; Ek J, 1999, DIABETOLOGIA, V42, P892, DOI 10.1007/s001250051243; Ellinghaus P, 1999, J BIOL CHEM, V274, P2766, DOI 10.1074/jbc.274.5.2766; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Foretz M, 1999, MOL CELL BIOL, V19, P3760; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hill MR, 1999, INFECT IMMUN, V67, P3488, DOI 10.1128/IAI.67.7.3488-3493.1999; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kockx M, 1999, BLOOD, V93, P2991; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; Mancini FP, 1999, DIABETES, V48, P1466, DOI 10.2337/diabetes.48.7.1466; Moya-Camarena SY, 1999, J LIPID RES, V40, P1426; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Suh N, 1999, CANCER RES, V59, P5671; Thieringer R, 2000, J IMMUNOL, V164, P1046, DOI 10.4049/jimmunol.164.2.1046; Valve R, 1999, J CLIN ENDOCR METAB, V84, P3708, DOI 10.1210/jc.84.10.3708; Wang MH, 1999, DIABETES, V48, P254, DOI 10.2337/diabetes.48.2.254; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541	30	1546	1660	3	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					421	424		10.1038/35013000	http://dx.doi.org/10.1038/35013000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839530				2022-12-28	WOS:000087212000038
J	Foster, KR; Vecchia, P; Repacholi, MH				Foster, KR; Vecchia, P; Repacholi, MH			Risk management - Science and the precautionary principle	SCIENCE			English	Article									Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Ist Super Sanita, Phys Lab, Natl Inst Hlth, I-00161 Rome, Italy; WHO, Dept Protect Human Environm, CH-1211 Geneva, Switzerland	University of Pennsylvania; Istituto Superiore di Sanita (ISS); World Health Organization	Foster, KR (corresponding author), WHO, CH-1211 Geneva, Switzerland.	kfoster@seas.upenn.edu						Ahlbom A, 1998, HEALTH PHYS, V74, P494; *EEE, 1999, C951 IEEE; ELWOOD JM, 1999, ENV HLTH PERSPECT S1, V107, P145; FREESTONE D, 1996, INTL ENV LAW POLICY, V31; GEE D, 1999, FINANCIAL TIMES 1216, P14; National Research Council, 1983, RISK ASS FED GOV MAN; Vanderzwaag D., 1999, J ENV LAW PRACT, V8, P355	7	264	268	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2000	288	5468					979	+		10.1126/science.288.5468.979	http://dx.doi.org/10.1126/science.288.5468.979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10841718				2022-12-28	WOS:000086988400020
J	Stavnezer, J				Stavnezer, J			Immunology - A touch of antibody class	SCIENCE			English	Editorial Material							CLASS SWITCH RECOMBINATION; TRANSCRIPTION; REGION		Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Stavnezer, J (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, 55 Lake Ave N, Worcester, MA 01655 USA.							BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Hein K, 1998, J EXP MED, V188, P2369, DOI 10.1084/jem.188.12.2369; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; LORENZ M, 1995, SCIENCE, V267, P1825, DOI 10.1126/science.7892607; Mussmann R, 1997, EUR J IMMUNOL, V27, P2610, DOI 10.1002/eji.1830271021; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Snapper CM, 1998, FUNDAMENTAL IMMUNOLO, P831; STAVNEZER J, 1991, NATURE, V351, P447, DOI 10.1038/351447b0; Stavnezer J, 1996, CURR OPIN IMMUNOL, V8, P199, DOI 10.1016/S0952-7915(96)80058-6; Tracy RB, 2000, SCIENCE, V288, P1058, DOI 10.1126/science.288.5468.1058; Tracy RB, 2000, EMBO J, V19, P1055, DOI 10.1093/emboj/19.5.1055; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	14	15	15	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					984	985		10.1126/science.288.5468.984	http://dx.doi.org/10.1126/science.288.5468.984			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10841719				2022-12-28	WOS:000086988400023
J	Smaglik, P				Smaglik, P			Shareholder sues Celera over loss	NATURE			English	News Item																		CLINTON B, 2000, NATURE, V404, P324	1	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					3	3		10.1038/35011202	http://dx.doi.org/10.1038/35011202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10841692	Bronze			2022-12-28	WOS:000086901600004
J	Lin, MZ; Greenberg, ME				Lin, MZ; Greenberg, ME			Orchestral maneuvers in the axon: Trio and the control of axon guidance	CELL			English	Review							DROSOPHILA; RHO; GTPASES; RAC; PROTEIN; ELEGANS; CELL		Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.			Lin, Michael/0000-0002-0492-1961				Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hu S, 1999, NEURON, V22, P419, DOI 10.1016/S0896-6273(00)80696-0; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 1999, CURR BIOL, V9, pR797; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	18	42	42	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					239	242		10.1016/S0092-8674(00)80833-8	http://dx.doi.org/10.1016/S0092-8674(00)80833-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847678	Bronze			2022-12-28	WOS:000086741900002
J	Dobson, R				Dobson, R			Access to investigations is needed 7 days a week	BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1692	1692						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864540				2022-12-28	WOS:000087926400018
J	Langman, MJS; Cheng, KK; Gilman, EA; Lancashire, RJ				Langman, MJS; Cheng, KK; Gilman, EA; Lancashire, RJ			Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database	BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ASPIRIN USE; BREAST-CANCER; RHEUMATOID-ARTHRITIS; COLORECTAL-CANCER; CYCLOOXYGENASE-2; EXPRESSION; ADENOCARCINOMAS; RATS; CARCINOGENESIS	Objective To examine whether anti-inflammatory drug treatment protects against the commoner cancers in the United Kingdom. Design Case-control study using the general practice research database. Setting Practices throughout United Kingdom providing data to the database. Subjects Patients who had a first diagnosis of five gastrointestinal (oesophagus, stomach, colon, rectum, and pancreas) cancers and four non-gastrointestinal (bladder, breast, lung, and prostate) cancers in 1993-5 for whom prescription data were available for the at least the previous 36 months. Each case was matched for age, sex, and general practice with three controls. Main outcome measure Risk of cancer. Results In 12 174 cancer cases and 34 934 controls overall risk of the nine cancers was not significantly reduced among those who had received at least seven prescriptions in the 13-36 months before cancer diagnosis (odds ratio 0.98, 95% confidence interval 0.89 to 1.07). Findings were nevertheless compatible with protective effects from anti-inflammatory drugs against cancers of the oesophagus (0.64, 0.41 to 0.98), stomach (0.51, 0.33 to 0.79), colon (0.76, 0.58 to 1.00), and rectum (0.75, 0.49 to 1.14) with dose related trends. The risk of pancreatic cancer (1.49, 1.02 to 2.18) and prostatic cancer (1.33, 1.07 to 1.64) was increased among patients who had received at least seven prescriptions, but the trend was dose related for only pancreatic cancer. Conclusions Anti-inflammatory drugs may protect against oesophageal and gastric cancer as well as colon and rectal cancer. The increased risks of pancreatic and prostatic cancer could be due to chance or to undetected biases and wan-ant further investigation.	Univ Birmingham, Dept Med, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Langman, MJS (corresponding author), Univ Birmingham, Dept Med, Birmingham B15 2TT, W Midlands, England.		Cheng, Kar/AAL-8899-2021	Cheng, Kar/0000-0002-1516-1857				EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Egan KM, 1996, J NATL CANCER I, V88, P988, DOI 10.1093/jnci/88.14.988; Farrow DC, 1998, CANCER EPIDEM BIOMAR, V7, P97; FRIEDMAN GD, 1983, J NATL CANCER I, V71, P1165; FUNKHOUSER GM, 1995, CANCER, V76, P116; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GRIDLEY G, 1993, JNCI-J NATL CANCER I, V85, P307, DOI 10.1093/jnci/85.4.307; GustafsonSvard C, 1996, GUT, V38, P79, DOI 10.1136/gut.38.1.79; Harris RE, 1996, EPIDEMIOLOGY, V7, P203, DOI 10.1097/00001648-199603000-00017; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; ISOMAKI HA, 1978, J CHRON DIS, V31, P691, DOI 10.1016/0021-9681(78)90071-1; KLAN R, 1993, J CANCER RES CLIN, V119, P482, DOI 10.1007/BF01215929; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; Norrish AE, 1998, INT J CANCER, V77, P511; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; PAGANINIHILL A, 1991, J NATL CANCER I, V83, P1182, DOI 10.1093/jnci/83.16.1182-a; REDDY BS, 1993, CARCINOGENESIS, V14, P1493, DOI 10.1093/carcin/14.8.1493; Ristimaki A, 1997, CANCER RES, V57, P1276; Robertson FM, 1998, CANCER LETT, V122, P165, DOI 10.1016/S0304-3835(97)00387-X; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; THUN MJ, 1993, CANCER RES, V53, P1322; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; Wilson KT, 1998, CANCER RES, V58, P2929	24	348	365	1	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1642	1646		10.1136/bmj.320.7250.1642	http://dx.doi.org/10.1136/bmj.320.7250.1642			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856067	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000087734200024
J	Thadani, H; Deacon, A; Peters, T				Thadani, H; Deacon, A; Peters, T			Regular review: Diagnosis and management of porphyria	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE INTERMITTENT PORPHYRIA; ACUTE HEPATIC PORPHYRIA; ERYTHROPOIETIC PROTOPORPHYRIA; VARIEGATE PORPHYRIA; HEME ARGINATE; PORPHOBILINOGEN; ATTACKS; IDENTIFICATION; GABAPENTIN; DISEASES		Guys & St Thomass Trust, Dept Chem Pathol & Endocrinol, London SE1 7EH, England; Kings Coll Hosp London, Dept Clin Chem, London SE5 9RS, England; Kings Coll Hosp London, Guys Kings & St Thomass Med Sch, Dept Clin Biochem, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Peters, T (corresponding author), Kings Coll Hosp London, Guys Kings & St Thomass Med Sch, Dept Chem Pathol, London SE5 9RS, England.	timothy.peters@kcl.ac.uk						ASHTON RE, 1984, BRIT J DERMATOL, V111, P609, DOI 10.1111/j.1365-2133.1984.tb06632.x; BENGTSSON NO, 1986, BRIT J CANCER, V54, P115, DOI 10.1038/bjc.1986.159; BIRCHFIELD RI, 1966, AM J DIS CHILD, V112, P561, DOI 10.1001/archpedi.1966.02090150105011; BONKOVSKY HL, 1993, GASTROENTEROLOGY, V105, P590, DOI 10.1016/0016-5085(93)90739-Y; BONKOWSKY HL, 1980, NEUROLOGY, V30, P588, DOI 10.1212/WNL.30.6.588; BRODIE MJ, 1977, BRIT J OBSTET GYNAEC, V84, P726, DOI 10.1111/j.1471-0528.1977.tb12480.x; BUTTERY JE, 1995, CLIN CHEM, V41, P1670; Deacon AC, 1998, ANN CLIN BIOCHEM, V35, P726, DOI 10.1177/000456329803500604; DEVERNEUIL H, 1995, J BIOENERG BIOMEMBR, V27, P239, DOI 10.1007/BF02110039; DISLER PB, 1989, ADVERSE DRUG REACT, V129, P484; DOVER SB, 1993, GASTROENTEROLOGY, V105, P500, DOI 10.1016/0016-5085(93)90726-S; Elder GH, 1998, SEMIN LIVER DIS, V18, P67, DOI 10.1055/s-2007-1007142; Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8; Elder GH, 1998, HEPATOLOGY, V27, P289, DOI 10.1002/hep.510270142; ELDER GH, 1990, ANN CLIN BIOCHEM, V27, P395, DOI 10.1177/000456329002700501; Elder GH, 1990, REC ADVDERMATOL, V8, P55; Fritsch C, 1997, J AM ACAD DERMATOL, V36, P594, DOI 10.1016/S0190-9622(97)70249-4; Hahn M, 1997, NEUROLOGY, V49, P97, DOI 10.1212/WNL.49.1.97; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; KAUPPINEN R, 1992, MEDICINE, V71, P1; KORDAC V, 1989, SEMIN HEMATOL, V26, P16; KRAUSS GL, 1995, NEUROLOGY, V45, P594, DOI 10.1212/WNL.45.3.594; LEE JS, 1991, P NATL ACAD SCI USA, V88, P10912, DOI 10.1073/pnas.88.23.10912; Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195; LIP GYH, 1991, BRIT MED J, V302, P507, DOI 10.1136/bmj.302.6775.507; LONG C, 1993, BRIT J DERMATOL, V129, P9, DOI 10.1111/j.1365-2133.1993.tb03303.x; MAGNUSSEN CR, 1975, NEUROLOGY, V25, P1121, DOI 10.1212/WNL.25.12.1121; MATHEWSROTH MM, 1993, ANN NY ACAD SCI, V691, P127, DOI 10.1111/j.1749-6632.1993.tb26164.x; McColl KE, 1996, OXFORD TXB MED, P1388; Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139; MONTEIRO HP, 1991, MOL CELL BIOCHEM, V103, P73; MUSTAJOKI P, 1993, ARCH INTERN MED, V153, P2004; POHFITZPATRICK MB, 1980, ARCH DERMATOL, V116, P543, DOI 10.1001/archderm.116.5.543; TATUM WO, 1995, NEUROLOGY, V45, P1216, DOI 10.1212/WNL.45.6.1216; THADANI H, 1997, J PSYCHIAT CASE REPO, V2, P29; TODD DJ, 1994, BRIT J DERMATOL, V131, P751, DOI 10.1111/j.1365-2133.1994.tb08577.x	36	113	122	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2000	320	7250					1647	1651		10.1136/bmj.320.7250.1647	http://dx.doi.org/10.1136/bmj.320.7250.1647			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856069	Green Published			2022-12-28	WOS:000087734200025
J	Lue, TF				Lue, TF			Drug therapy: Erectile dysfunction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VASOACTIVE INTESTINAL POLYPEPTIDE; DOUBLE-BLIND; TRANSURETHRAL ALPROSTADIL; INTRACAVERNOUS INJECTION; CORPUS CAVERNOSUM; PENILE ERECTION; IMPOTENT MEN; DEPRESSIVE SYMPTOMS; CIGARETTE-SMOKING; ORAL SILDENAFIL		Univ Calif San Francisco, Dept Urol, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lue, TF (corresponding author), Univ Calif San Francisco, Dept Urol, Sch Med, U-575, San Francisco, CA 94143 USA.	tlue@urol.ucsf.edu						AIZENBERG D, 1995, J CLIN PSYCHIAT, V56, P137; ANDERSSON KE, 1995, PHYSIOL REV, V75, P191, DOI 10.1152/physrev.1995.75.1.191; Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Arver S, 1996, J UROLOGY, V155, P1604, DOI 10.1016/S0022-5347(01)66141-X; BANCROFT J, 1983, ARCH SEX BEHAV, V12, P59, DOI 10.1007/BF01542116; BANYA Y, 1989, J UROLOGY, V142, P879, DOI 10.1016/S0022-5347(17)38935-8; BENET AE, 1995, UROL CLIN N AM, V22, P699; BENNETT AH, 1991, J UROLOGY, V146, P1564, DOI 10.1016/S0022-5347(17)38167-3; Canale D, 1996, INT J ANDROL, V19, P28, DOI 10.1111/j.1365-2605.1996.tb00430.x; Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0; Cheitlin, 1999, CIRCULATION, V100, P2389; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; Chew KK, 1997, INT J IMPOT RES, V9, P225, DOI 10.1038/sj.ijir.3900296; Christ G J, 1993, Int J Impot Res, V5, P77; CHRIST GJ, 1990, BRIT J PHARMACOL, V101, P375, DOI 10.1111/j.1476-5381.1990.tb12717.x; DETEJADA IS, 1989, NEW ENGL J MED, V320, P1025, DOI 10.1056/NEJM198904203201601; DETEJADA IS, 1989, J UROLOGY, V142, P1117, DOI 10.1016/S0022-5347(17)39009-2; Dinsmore WW, 1998, BRIT J UROL, V81, P437; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Ernst E, 1998, J UROLOGY, V159, P433, DOI 10.1016/S0022-5347(01)63942-9; FALLON B, 1995, UROL CLIN N AM, V22, P833; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; FOURNIER GR, 1987, J UROLOGY, V137, P163, DOI 10.1016/S0022-5347(17)43911-5; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Goldstein I, 1998, J UROLOGY, V159, P240; Gomaa A, 1996, BRIT MED J, V312, P1512, DOI 10.1136/bmj.312.7045.1512; Gondre M, 1998, J PHARMACOL EXP THER, V286, P635; Gueugniaud PY, 1998, NEW ENGL J MED, V339, P1595, DOI 10.1056/NEJM199811263392204; Gupta R, 1997, J UROLOGY, V157, P1681, DOI 10.1016/S0022-5347(01)64834-1; GWINUP G, 1988, ANN INTERN MED, V109, P162, DOI 10.7326/0003-4819-109-2-162; HEATON JPW, 1995, UROLOGY, V45, P200, DOI 10.1016/0090-4295(95)80005-0; Hong EK, 1999, INT J IMPOT RES, V11, pS15, DOI 10.1038/sj.ijir.3900466; HSIEH JT, 1989, INT J IMPOT RES, V1, P35; IGNARRO LJ, 1990, BIOCHEM BIOPH RES CO, V170, P843, DOI 10.1016/0006-291X(90)92168-Y; Italiano G, 1998, UROL RES, V26, P39, DOI 10.1007/s002400050021; Jeremy JY, 1997, BRIT J UROL, V79, P958, DOI 10.1046/j.1464-410X.1997.00206.x; JUENEMANN KP, 1987, J UROLOGY, V138, P438, DOI 10.1016/S0022-5347(17)43181-8; JUENEMANN KP, 1989, INT J IMPOT RES, V1, P71; KAISER FE, 1988, J AM GERIATR SOC, V36, P511, DOI 10.1111/j.1532-5415.1988.tb04021.x; KIELY EA, 1989, BRIT J UROL, V64, P191, DOI 10.1111/j.1464-410X.1989.tb05986.x; LANCE R, 1995, UROLOGY, V46, P117, DOI 10.1016/S0090-4295(99)80176-9; LEE LM, 1989, J UROLOGY, V141, P549, DOI 10.1016/S0022-5347(17)40889-5; LEVINE FJ, 1990, J UROLOGY, V144, P1147, DOI 10.1016/S0022-5347(17)39678-7; Lewis RW, 1998, J UROLOGY, V159, P237; LINET OI, 1994, CLIN INVESTIGATOR, V72, P139; LUE TF, 1990, WORLD J UROL, V8, P67, DOI 10.1007/BF01576350; Lue TF, 1988, CONT MANAGEMENT IMPO, P28; MASTERS WH, 1977, REFLECTIONS, V12, P31; Meinhardt W, 1997, INT J IMPOT RES, V9, P163, DOI 10.1038/sj.ijir.3900272; Meinhardt W, 1996, Int J Impot Res, V8, P5; MILLER NS, 1988, J SUBST ABUSE TREAT, V5, P171, DOI 10.1016/0740-5472(88)90006-2; Mirone V, 1996, BRIT J UROL, V77, P736, DOI 10.1046/j.1464-410X.1996.97722.x; MONTORSI F, 1994, UROLOGY, V44, P732, DOI 10.1016/S0090-4295(94)80216-5; MORALES A, 1994, J UROLOGY, V152, P1115, DOI 10.1016/S0022-5347(17)32517-X; Morales A, 1998, INT J IMPOT RES, V10, P69, DOI 10.1038/sj.ijir.3900354; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; Nogues M A, 1991, Funct Neurol, V6, P359; Padma-Nathan H, 1998, J UROLOGY, V159, P241; PadmaNathan H, 1997, NEW ENGL J MED, V336, P1, DOI 10.1056/NEJM199701023360101; Porst H, 1996, J UROLOGY, V155, P802, DOI 10.1016/S0022-5347(01)66315-8; Porst H, 1997, INT J IMPOT RES, V9, P187, DOI 10.1038/sj.ijir.3900318; Price DE, 1998, DIABETIC MED, V15, P821, DOI 10.1002/(SICI)1096-9136(199810)15:10<821::AID-DIA697>3.0.CO;2-P; RAJFER J, 1988, J UROLOGY, V140, P69, DOI 10.1016/S0022-5347(17)41489-3; ROSEN MP, 1991, J UROLOGY, V145, P759, DOI 10.1016/S0022-5347(17)38444-6; ROWLAND DL, 1989, ARCH SEX BEHAV, V18, P1, DOI 10.1007/BF01579287; Schiavi RC, 1997, ARCH SEX BEHAV, V26, P231, DOI 10.1023/A:1024518730222; Shabsigh R, 1998, UROLOGY, V52, P848, DOI 10.1016/S0090-4295(98)00292-1; STACKL W, 1988, J UROLOGY, V140, P66, DOI 10.1016/S0022-5347(17)41488-1; STIEF CG, 1988, J UROLOGY, V140, P1415, DOI 10.1016/S0022-5347(17)42059-3; Weiss J N, 1994, Int J Impot Res, V6, P171; Werthman P, 1997, UROLOGY, V50, P809, DOI 10.1016/S0090-4295(97)00448-2; Williams G, 1998, BRIT J UROL, V81, P889; WOLFE MM, 1979, NEW ENGL J MED, V300, P94; Zaher T. F., 1998, International Urology and Nephrology, V30, P193, DOI 10.1007/BF02550576; Zorgniotti A W, 1994, Int J Impot Res, V6, P37	75	994	1055	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1802	1813		10.1056/NEJM200006153422407	http://dx.doi.org/10.1056/NEJM200006153422407			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323PG	10853004				2022-12-28	WOS:000087573700007
J	Gross, M; Muller, DC; Nothofer, HG; Scherf, U; Neher, D; Brauchle, C; Meerholz, K				Gross, M; Muller, DC; Nothofer, HG; Scherf, U; Neher, D; Brauchle, C; Meerholz, K			Improving the performance of doped pi-conjugated polymers for use in organic light-emitting diodes	NATURE			English	Article							SINGLE-LAYER; ELECTRICAL CHARACTERISTICS; ELECTROLUMINESCENCE; EFFICIENCY; SPECTROSCOPY; ANODES	Organic light-emitting diodes (OLEDs) represent a promising technology for large, flexible, lightweight, flat-panel displays(1-3). Such devices consist of one or several semiconducting organic layer(s) sandwiched between two electrodes. When an electric field is applied, electrons are injected by the cathode into the lowest unoccupied molecular orbital of the adjacent molecules (simultaneously, holes are injected by the anode into the highest occupied molecular orbital). The two types of carriers migrate towards each other and a fraction of them recombine to form excitons, some of which decay radiatively to the ground state by spontaneous emission. Doped pi-conjugated polymer layers improve the injection of holes in OLED devices(4-9); this is thought to result from the more favourable work function of these injection layers compared with the more commonly used layer material (indium tin oxide). Here we demonstrate that by increasing the doping level of such polymers, the barrier to hole injection can be continuously reduced. The use of combinatorial devices allows us to quickly screen for the optimum doping level. We apply this concept in OLED devices with hole-limited electroluminescence (such as polyfluorene-based systems(10-12)), finding that it is possible to significantly reduce the operating voltage while improving the light output and efficiency.	Univ Munich, Inst Phys Chem, D-81377 Munich, Germany; Max Planck Inst Polymerforsch, D-55037 Mainz, Germany; Univ Potsdam, Inst Expt Phys, D-14469 Potsdam, Germany	University of Munich; Max Planck Society; University of Potsdam	Meerholz, K (corresponding author), Univ Munich, Inst Phys Chem, Butenandtstr 11, D-81377 Munich, Germany.		Meerholz, Klaus -/A-7819-2017; Scherf, Ullrich/G-1552-2012; Neher, Dieter/A-9334-2015	Meerholz, Klaus -/0000-0001-7450-4672; Scherf, Ullrich/0000-0001-8368-4919; 				Bard A.J., 2010, ELECTROCHEMICAL METH; Brown TM, 1999, APPL PHYS LETT, V75, P1679, DOI 10.1063/1.124789; Cao Y, 1997, SYNTHETIC MET, V87, P171, DOI 10.1016/S0379-6779(97)03823-X; Carter SA, 1997, APPL PHYS LETT, V70, P2067, DOI 10.1063/1.118953; DIETRICH M, 1991, SYNTHETIC MET, V41, P503, DOI 10.1016/0379-6779(91)91118-T; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; GAO J, 1996, SYNTHETIC MET, V82, P211; Grell M, 1999, ADV MATER, V11, P671, DOI 10.1002/(SICI)1521-4095(199906)11:8<671::AID-ADMA671>3.0.CO;2-E; Grice AW, 1998, APPL PHYS LETT, V73, P629, DOI 10.1063/1.121878; GUSTAFSSON G, 1992, NATURE, V357, P477, DOI 10.1038/357477a0; Heeger AJ, 1998, SOLID STATE COMMUN, V107, P673, DOI 10.1016/S0038-1098(98)00215-4; Janietz S, 1998, APPL PHYS LETT, V73, P2453, DOI 10.1063/1.122479; Kim JS, 1998, J APPL PHYS, V84, P6859, DOI 10.1063/1.368981; Malliaras GG, 1999, J APPL PHYS, V85, P7426, DOI 10.1063/1.369373; Malliaras GG, 1998, PHYS REV B, V58, P13411, DOI 10.1103/PhysRevB.58.R13411; Nuesch F, 1999, APPL PHYS LETT, V74, P880, DOI 10.1063/1.123397; Salbeck J, 1996, BER BUNSEN PHYS CHEM, V100, P1667, DOI 10.1002/bbpc.19961001002; Scott JC, 1997, SYNTHETIC MET, V85, P1197, DOI 10.1016/S0379-6779(97)80207-X; Skotheim T.J., 1986, HDB CONDUCTING POLYM; Xing KZ, 1997, SYNTHETIC MET, V89, P161, DOI 10.1016/S0379-6779(97)81212-X; YANG Y, 1994, APPL PHYS LETT, V64, P1245, DOI 10.1063/1.110853	21	541	551	8	308	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					661	665		10.1038/35015037	http://dx.doi.org/10.1038/35015037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864318				2022-12-28	WOS:000087465800040
J	Inzitari, D; Eliasziw, M; Gates, P; Sharpe, BL; Chan, RKT; Meldrum, HE; Barnett, HJM				Inzitari, D; Eliasziw, M; Gates, P; Sharpe, BL; Chan, RKT; Meldrum, HE; Barnett, HJM		N Amer Symptomatic Carotid Endar	The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM PROGNOSIS; MEDICARE BENEFICIARIES; NATURAL-HISTORY; ENDARTERECTOMY; GUIDELINES; TRIAL; APPROPRIATENESS; PERFORMANCE; ASSOCIATION; PREVENTION	Background: The causes of stroke in patients with asymptomatic carotid-artery stenosis have not been carefully studied. Information about causes might influence decisions about the use of carotid endarterectomy in such patients. Methods: We studied patients with unilateral symptomatic carotid-artery stenosis and asymptomatic contralateral stenosis from 1988 to 1997. The causes, severity, risk, and predictors of stroke in the territory of the asymptomatic artery were examined and quantified. Results: The risk of stroke at five years after study entry in a total of 1820 patients increased with the severity of stenosis. Among 1604 patients with stenosis of less than 60 percent of the luminal diameter, the risk of a first stroke was 8.0 percent (1.6 percent annually), as compared with 16.2 percent (3.2 percent annually) among 216 patients with 60 to 99 percent stenosis. In the group with 60 to 99 percent stenosis, the five-year risk of stroke in the territory of a large artery was 9.9 percent, that of lacunar stroke was 6.0 percent, and that of cardioembolic stroke 2.1 percent. Some patients had more than one stroke of more than one cause. In the territory of an asymptomatic occluded artery (as was identified in 86 patients), the annualized risk of stroke was 1.9 percent. Strokes with different causes had different risk factors. The risk factors for large-artery stroke were silent brain infarction, a history of diabetes, and a higher degree of stenosis; for cardioembolic stroke, a history of myocardial infarction or angina and hypertension; and for lacunar stroke, age of 75 years or older, hypertension, diabetes, and a higher degree of stenosis. Conclusions: The risk of stroke among patients with asymptomatic carotid-artery stenosis is relatively low. Forty-five percent of strokes in patients with asymptomatic stenosis of 60 to 99 percent are attributable to lacunes or cardioembolism. These observations have implications for the use of endarterectomy in asymptomatic patients. Without analysis of the risk of stroke according to cause, the absolute benefit associated with endarterectomy may be overestimated. (N Engl J Med 2000;342:1693-700.) (C) 2000, Massachusetts Medical Society.	Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada; Geelong Hosp, Dept Neurosci, Geelong, Vic, Australia; Univ Melbourne, Dept Med, Melbourne, Vic, Australia; SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA	University of Florence; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Geelong Hospital; University of Melbourne; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Barnett, HJM (corresponding author), John P Robarts Res Inst, 100 Perth Dr,POB 5015, London, ON N6A 5K8, Canada.		Inzitari, Domenico/AAH-8722-2020		NINDS NIH HHS [R01-NS-24456] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024456] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnett HJM, 2000, JAMA-J AM MED ASSOC, V283, P1429, DOI 10.1001/jama.283.11.1429; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; Barnett HJM, 1996, NEUROLOGY, V46, P603, DOI 10.1212/WNL.46.3.603; Biller J, 1998, STROKE, V29, P554, DOI 10.1161/01.STR.29.2.554; BOGOUSSLAVSKY J, 1986, NEUROLOGY, V36, P861, DOI 10.1212/WNL.36.6.861; CAPLAN LR, 1988, NEUROLOGY, V38, P791, DOI 10.1212/WNL.38.5.791; CHAMBERS BR, 1986, NEW ENGL J MED, V315, P860, DOI 10.1056/NEJM198610023151404; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; DIENER HC, 1991, STROKE, V22, P1229; ELLIS MR, 1992, EUR J VASCULAR SURG, V6, P172, DOI 10.1016/S0950-821X(05)80236-1; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Findlay JM, 1997, CAN MED ASSOC J, V157, P653; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; Frey JL, 1996, ANN NEUROL, V39, P405, DOI 10.1002/ana.410390322; GASECKI AP, 1995, J NEUROSURG, V83, P778, DOI 10.3171/jns.1995.83.5.0778; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; HALLIDAY AW, 1994, EUR J VASCULAR SURG, V8, P703; Hertzer NR, 1997, J VASC SURG, V26, P1, DOI 10.1016/S0741-5214(97)70139-3; Hertzer NR, 1996, J VASC SURG, V23, P167, DOI 10.1016/S0741-5214(05)80049-7; Hsia DC, 1998, STROKE, V29, P346, DOI 10.1161/01.STR.29.2.346; Inzitari D, 2000, NEUROLOGY, V54, P660, DOI 10.1212/WNL.54.3.660; Irvine CD, 1998, EUR J VASC ENDOVASC, V16, P245, DOI 10.1016/S1078-5884(98)80227-X; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; Kucey DS, 1998, J VASC SURG, V28, P1051, DOI 10.1016/S0741-5214(98)70031-X; Mackey AE, 1997, NEUROLOGY, V48, P896, DOI 10.1212/WNL.48.4.896; MADDEN KP, 1995, NEUROLOGY, V45, P1975, DOI 10.1212/WNL.45.11.1975; MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289; Morgenstern LB, 1997, NEUROLOGY, V48, P911, DOI 10.1212/WNL.48.4.911; NICOLAIDES AN, 1995, INT ANGIOL, V14, P21; NORRIS JW, 1991, STROKE, V22, P1485, DOI 10.1161/01.STR.22.12.1485; Perry JR, 1997, ARCH NEUROL-CHICAGO, V54, P25, DOI 10.1001/archneur.1997.00550130015009; ROTHWELL PM, 1995, LANCET, V345, P209; Rothwell PM, 2000, STROKE, V31, P622, DOI 10.1161/01.STR.31.3.622; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; Wong JH, 1997, STROKE, V28, P891, DOI 10.1161/01.STR.28.5.891; ZHU CZ, 1991, CAN J SURG, V34, P437	40	492	517	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1693	1700		10.1056/NEJM200006083422302	http://dx.doi.org/10.1056/NEJM200006083422302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841871				2022-12-28	WOS:000087449300002
J	Laubach, M; Wessberg, J; Nicolelis, MAL				Laubach, M; Wessberg, J; Nicolelis, MAL			Cortical ensemble activity increasingly predicts behaviour outcomes during learning of a motor task	NATURE			English	Article							SUPPLEMENTARY EYE FIELD; CONDITIONAL OCULOMOTOR ASSOCIATIONS; NEURONAL-ACTIVITY; MOVEMENT DIRECTION; CORTEX; ACQUISITION; POPULATION; OSCILLATIONS; INFORMATION; MONKEYS	When an animal learns to make movements in response to different stimuli, changes in activity in the motor cortex seem to accompany and underlie this learning(1-6). The precise nature of modifications in cortical motor areas during the initial stages of motor learning, however, is largely unknown. Here we address this issue by chronically recording from neuronal ensembles located in the rat motor cortex, throughout the period required for rats to learn a reaction-time task. Motor learning was demonstrated by a decrease in the variance of the rats' reaction times and an increase in the time the animals were able to wait for a trigger stimulus. These behavioural changes were correlated with a significant increase in our ability to predict the correct or incorrect outcome of single trials based on three measures of neuronal ensemble activity: average firing rate, temporal patterns of firing, and correlated firing. This increase in prediction indicates that an association between sensory cues and movement emerged in the motor cortex as the task was learned. Such modifications in cortical ensemble activity may be critical for the initial learning of motor tasks.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Laubach, M (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.			Laubach, Mark/0000-0002-2403-4497				ALMARIC M, 1987, J NEUROSCI, V7, P2129; BUCKHEIT JB, 1995, P SOC PHOTO-OPT INS, V2569, P540, DOI 10.1117/12.217608; Chen LL, 1997, J NEUROPHYSIOL, V78, P1166, DOI 10.1152/jn.1997.78.2.1166; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Efron B., 1994, INTRO BOOTSTRAP; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GERMAIN L, 1993, BRAIN RES, V611, P175, DOI 10.1016/0006-8993(93)91792-Q; GHAZANFAR AA, IN PRESS J NEUROSCI; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Kohonen T., 1997, SELF ORGANIZING MAPS; KRIPPENDORFF K, 1986, INFORMATION THEORY S; Laubach M, 1999, J NEUROSCI METH, V94, P141, DOI 10.1016/S0165-0270(99)00131-4; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; Maynard EM, 1999, J NEUROSCI, V19, P8083; MITZ AR, 1991, J NEUROSCI, V11, P1855; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Reyment R. A., 1993, APPL FACTOR ANAL NAT; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Seidemann E, 1996, J NEUROSCI, V16, P752; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; [No title captured]	29	207	217	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					567	571		10.1038/35014604	http://dx.doi.org/10.1038/35014604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850715				2022-12-28	WOS:000087449500050
J	Macilwain, C				Macilwain, C			Green light for plans to sell off US helium reserve	NATURE			English	News Item																			0	0	0	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					496	496		10.1038/35014757	http://dx.doi.org/10.1038/35014757			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850677	Bronze			2022-12-28	WOS:000087449500004
J	Bosch, X				Bosch, X			Molecular assay helps predict lymphoma outcome	LANCET			English	News Item																		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					473	473		10.1016/S0140-6736(00)82024-3	http://dx.doi.org/10.1016/S0140-6736(00)82024-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841137				2022-12-28	WOS:000085306800024
J	Piot, P				Piot, P			Global AIDS epidemic: Time to turn the tide	SCIENCE			English	Editorial Material								HIV/AIDS is catastrophic both from a public health perspective and in terms of its impact on economic and social stability in many of the most severely affected nations, including virtually all of southern Africa. A public health response alone is insufficient to address this devastating epidemic. Political Leadership at the highest Levels is needed to mobilize a multisectoral response to the impact of HIV/AIDS on educational systems, industry, agriculture, the military, and other sectors. With a few notable exceptions, political response was slow to mobilize in the early years of the epidemic, but response has dramatically improved in the past 18 months. The Joint United Nations Programme on HIV/AIDS (UNAIDS) is involved in ongoing efforts to encourage political Leaders to make a multisectoral response to the epidemic a major focus of their national plans.	Joint United Nations Programme HIV AIDS, Geneva 27, Switzerland		Piot, P (corresponding author), Joint United Nations Programme HIV AIDS, 20 Ave Appla, Geneva 27, Switzerland.							*UNAIDS, 2000, REP GLOB HIV AIDS EP	1	27	27	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2176	2178		10.1126/science.288.5474.2176	http://dx.doi.org/10.1126/science.288.5474.2176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864860				2022-12-28	WOS:000087782900049
J	Bell, MH				Bell, MH			Blood lines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3043	3044		10.1001/jama.283.23.3043	http://dx.doi.org/10.1001/jama.283.23.3043			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865280				2022-12-28	WOS:000087574900001
J	Herwaldt, BL; de Arroyave, KR; Roberts, JM; Juranek, DD				Herwaldt, BL; de Arroyave, KR; Roberts, JM; Juranek, DD			A multiyear prospective study of the risk factors for and incidence of diarrheal illness in a cohort of peace corps volunteers in Guatemala	ANNALS OF INTERNAL MEDICINE			English	Article							TRAVELERS DIARRHEA; DEVELOPING-COUNTRIES; FOOD-CONSUMPTION; UNITED-STATES; MEXICO; EPIDEMIOLOGY; PREVENTION; POPULATION; RESIDENTS; LOCATION	Background: Diarrheal illness is the most common medical disorder among travelers from developed to developing countries and is common among expatriate residents in developing countries. Objective: To assess the risk factors for and incidence of diarrheal illness among Americans living in a developing country. Design: Prospective longitudinal study. Setting: Rural Guatemala. Patients: Cohort of 36 Peace Corps volunteers. Measurements: Collection of daily dietary and symptom data for more than 2 years; identification by multivariate Poisson regression analyses of risk factors for clinically defined episodes of diarrheal illness. Results: The 36 Peace Corps volunteers in this study had 307 diarrheal episodes (median, 7 per person), which lasted a median of 4 days (range, 1 to 112) and a total of 10.1% of the 23 689 person-days in the study. The incidence density (episodes per person-year) was 4.7 for the study as a whole, 6.1 for the first 6-month period, 5.2 for the second 6-month period, and 3.6 thereafter. Statistically significant risk factors for diarrheal illness included drinking water whose source (for example, the tap) and, therefore, quality, was unknown to the person; eating food prepared by a Guatemalan friend or family; eating food at a small, working-class restaurant; eating fruit peeled by someone other than a Peace Corps volunteer; drinking an iced beverage; and eating ice cream, ice milk, or flavored ices. The relative risks comparing the presence of these exposures during the first 6-month period overseas with their absence during the second year of residence ranged from 1.90 to 2.67, and the summary attributable risk percentage (that is, the percentage of diarrheal episodes that could be ascribed to the exposures) was 75.4%. Exposures generally were riskier if they occurred during travel elsewhere in Guatemala rather than in the person's usual work area. Conclusions: Diarrheal illness of mild-to-moderate severity continued to occur throughout Peace Corps service but decreased in incidence as length of stay increased. Various dietary behaviors increased the risk for diarrheal illness, which suggests that avoidance of potentially risky foods and beverages is beneficial.	Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA 30341 USA; Peace Corps Med Off, Guatemala City, Guatemala	Centers for Disease Control & Prevention - USA	Herwaldt, BL (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis, 4770 Buford Highway NE,Mailstop F22, Atlanta, GA 30341 USA.	bxh4@cdc.gov						Ansdell VE, 1999, MED CLIN N AM, V83, P945; BERNARD KW, 1989, INT J EPIDEMIOL, V18, P220, DOI 10.1093/ije/18.1.220; BLASER MJ, 1986, REV INFECT DIS, V8, pS142; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; BRYANT HE, 1991, CAN J PUBLIC HEALTH, V82, P316; CHANG TW, 1978, ANN INTERN MED, V89, P428, DOI 10.7326/0003-4819-89-3-428_2; DUPONT HL, 1977, AM J EPIDEMIOL, V105, P37, DOI 10.1093/oxfordjournals.aje.a112353; ERICSSON CD, 1980, GASTROENTEROLOGY, V79, P812; Hoge CW, 1996, JAMA-J AM MED ASSOC, V275, P533, DOI 10.1001/jama.275.7.533; KOZICKI M, 1985, INT J EPIDEMIOL, V14, P169, DOI 10.1093/ije/14.1.169; LOEWENSTEIN MS, 1973, LANCET, V1, P529; Mattila, 1995, J Travel Med, V2, P77, DOI 10.1111/j.1708-8305.1995.tb00631.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MERSON MH, 1976, NEW ENGL J MED, V294, P1299, DOI 10.1056/NEJM197606102942401; MONTO AS, 1980, AM J EPIDEMIOL, V112, P323, DOI 10.1093/oxfordjournals.aje.a112998; PELTOLA H, 1997, TXB TRAVEL MED HLTH, P78; Shlim DR, 1999, CLIN INFECT DIS, V29, P613, DOI 10.1086/598642; STEFFEN R, 1986, REV INFECT DIS, V8, pS122; STEFFEN R, 1983, JAMA-J AM MED ASSOC, V249, P1176; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; TJOA WS, 1977, AM J EPIDEMIOL, V106, P61, DOI 10.1093/oxfordjournals.aje.a112433; VOLLET JJ, 1979, J MED VIROL, V4, P81, DOI 10.1002/jmv.1890040202; White GC, 1999, HDB CHLORINATION ALT, P331; WOOD LV, 1983, APPL ENVIRON MICROB, V46, P328, DOI 10.1128/AEM.46.2.328-332.1983	25	27	27	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					982	988		10.7326/0003-4819-132-12-200006200-00009	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858182				2022-12-28	WOS:000087670800008
J	Lyon, JG				Lyon, JG			The solar wind-magnetosphere-ionosphere system	SCIENCE			English	Review							COLLISIONLESS MAGNETIC RECONNECTION; RADIATION BELT FORMATION; 1997 CME EVENT; JANUARY 1997; GEOSYNCHRONOUS ORBIT; CLOUD EVENT; MARCH 24; SIMULATION; STORM; ACCELERATION	The solar wind, magnetosphere, and ionosphere form a single system driven by the transfer of energy and momentum from the solar wind to the magnetosphere and ionosphere. Variations in the solar wind can Lead to disruptions of space- and ground-based systems caused by enhanced currents flowing into the ionosphere and increased radiation in the near-Earth environment. The coupling between the solar wind and the magnetosphere is mediated and controlled by the magnetic field in the solar wind through the process of magnetic reconnection. Understanding of the global behavior of this system has improved markedly in the recent past from coordinated observations with a constellation of satellite and ground instruments.	Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA	Dartmouth College	Lyon, JG (corresponding author), Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA.							Baker D. N., 1994, EOS T AM GEOPHYS UN, V75; Baker DN, 1998, GEOPHYS RES LETT, V25, P2975, DOI 10.1029/98GL01134; Baker DN, 1998, J GEOPHYS RES-SPACE, V103, P17279, DOI 10.1029/97JA03329; BAKER DN, 1987, J ELECTROSTAT, V20, P3, DOI 10.1016/0304-3886(87)90082-9; BAKER DN, 1998, EOS T AGU, V79, P477, DOI [10.1029/98EO00359, DOI 10.1029/98E000359]; Baumjohann W., 1996, BASIC SPACE PLASMA P; BIRN J, IN PRESS J GEOPHYS R; Biskamp D, 1997, PHYS PLASMAS, V4, P1002, DOI 10.1063/1.872211; Buhler P, 1998, GEOPHYS RES LETT, V25, P2983, DOI 10.1029/98GL50338; Burlaga L, 1998, J GEOPHYS RES-SPACE, V103, P277, DOI 10.1029/97JA02768; BURLAGA LF, 1991, PHYSICS INNER HELIOS, V2, pCH6; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; Elkington SR, 1999, GEOPHYS RES LETT, V26, P3273, DOI 10.1029/1999GL003659; ELKINGTON SR, COMMUNICATION; Fedder JA, 1998, J GEOPHYS RES-SPACE, V103, P14799, DOI 10.1029/97JA03664; Fox NJ, 1998, GEOPHYS RES LETT, V25, P2461, DOI 10.1029/98GL01775; Germany GA, 1998, GEOPHYS RES LETT, V25, P3043, DOI 10.1029/98GL01220; Goodrich CC, 1998, GEOPHYS RES LETT, V25, P2537, DOI 10.1029/98GL01159; Henderson MG, 1997, GEOPHYS RES LETT, V24, P1167, DOI 10.1029/97GL01162; Hesse M, 1999, PHYS PLASMAS, V6, P1781, DOI 10.1063/1.873436; HESSE M, IN PRESS J GEOPHYS R; HUDSON MK, 1995, GEOPHYS RES LETT, V22, P291, DOI 10.1029/95GL00009; Hudson MK, 1999, GEOPHYS MONOGR SER, V109, P171; Hudson MK, 2000, ADV SPACE RES, V25, P2327, DOI 10.1016/S0273-1177(99)00518-9; Hudson MK, 1997, J GEOPHYS RES-SPACE, V102, P14087, DOI 10.1029/97JA03995; KUZNETZOVA M, IN PRESS J GEOPHYS R; LI XL, 1993, GEOPHYS RES LETT, V20, P2423, DOI 10.1029/93GL02701; Li XL, 1998, GEOPHYS RES LETT, V25, P2561, DOI 10.1029/98GL00036; Lu G, 1998, J GEOPHYS RES-SPACE, V103, P11685, DOI 10.1029/98JA00897; MA Z, IN PRESS J GEOPHYS R; Ma ZW, 1996, GEOPHYS RES LETT, V23, P1673, DOI 10.1029/96GL01600; MANDT ME, 1994, GEOPHYS RES LETT, V21, P73, DOI 10.1029/93GL03382; Nakamura M, 1998, GEOPHYS RES LETT, V25, P2529, DOI 10.1029/98GL00135; Ness W.N., 1964, NASA SPECIAL PUBLICA, P425; *OFF FED COORD, 1997, FCMP311997 OFF FED C; OTTO A, IN PRESS J GEOPHYS R; PARKER EN, 1957, J GEOPHYS RES, V62, P509, DOI 10.1029/JZ062i004p00509; PRITCHETT P, IN PRESS J GEOPHYS R; Raeder J, 1998, J GEOPHYS RES-SPACE, V103, P14787, DOI 10.1029/98JA00014; Reeves GD, 1998, J GEOPHYS RES-SPACE, V103, P17559, DOI 10.1029/97JA03236; Reeves GD, 1998, GEOPHYS RES LETT, V25, P3265, DOI 10.1029/98GL02509; Sanchez ER, 1998, GEOPHYS RES LETT, V25, P2597, DOI 10.1029/98GL00707; Sawyer Kathy, 1997, WASHINGTON POST 0705, pA1; Selesnick RS, 1998, GEOPHYS RES LETT, V25, P2553, DOI 10.1029/98GL00665; SHAY M, IN PRESS J GEOPHYS R; SHAY M, COMMUNICATION; Shay MA, 1998, GEOPHYS RES LETT, V25, P3759, DOI 10.1029/1998GL900036; Showstack R., 1998, EOS, V79, P601, DOI 10.1029/98EO00434; SPENCE H, COMMUNICATION; Sweet P. A., 1958, ELECTROMAGNETIC PHEN, P123; Thomsen MF, 1998, GEOPHYS RES LETT, V25, P2545, DOI 10.1029/98GL00514; Webb DF, 1998, GEOPHYS RES LETT, V25, P2469, DOI 10.1029/98GL00493; Winglee RM, 1997, J GEOPHYS RES-SPACE, V102, P26961, DOI 10.1029/97JA02461	53	58	66	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					1987	1991		10.1126/science.288.5473.1987	http://dx.doi.org/10.1126/science.288.5473.1987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856203				2022-12-28	WOS:000087687000036
J	Menou, K				Menou, K			Viscosity mechanisms in accretion disks	SCIENCE			English	Article							CLOSE BINARY-SYSTEMS; INSTABILITY; TRANSPORT; OUTBURSTS	The self-sustained turbulence that develops in magnetized accretion disks is suppressed in the weakly ionized, quiescent disks of close binary stars. Because accretion still proceeds during quiescence, another viscosity mechanism operates in these systems. An anticorrelation of the recurrence times of SU UMa dwarf novae with their mass ratio supports spiral waves or shockwaves tidally induced by the companion star as the main process responsible for accretion in the quiescent disks. Other weakly ionized gaseous disks in systems Lacking a massive companion must rely on yet another transport mechanism, or they could be essentially passive.	Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Princeton University	Menou, K (corresponding author), Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA.							Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; BALBUS SA, 1991, ASTROPHYS J, V376, P214, DOI 10.1086/170270; CANNIZZO JK, 1993, ADV SER ASTROPHYS CO, V9, P6; Fleming TP, 2000, ASTROPHYS J, V530, P464, DOI 10.1086/308338; Frankel Jonathan, 1992, ACCRETION POWER ASTR, P2; Gammie CF, 1998, ASTROPHYS J, V492, pL75, DOI 10.1086/311091; Hameury JM, 1998, MON NOT R ASTRON SOC, V298, P1048, DOI 10.1046/j.1365-8711.1998.01773.x; Hawley JF, 1996, ASTROPHYS J, V464, P690, DOI 10.1086/177356; KING AR, 1988, Q J ROY ASTRON SOC, V29, P1; King AR, 1996, ASTROPHYS J, V464, pL127, DOI 10.1086/310105; Lewin W. H. G., 1995, XRAY BINARIES; LIVIO M, 1991, ASTRON ASTROPHYS, V252, P189; Menou K, 2000, MON NOT R ASTRON SOC, V314, P498, DOI 10.1046/j.1365-8711.2000.03357.x; MEYER F, 1981, ASTRON ASTROPHYS, V104, pL10; PAPALOIZOU J, 1977, MON NOT R ASTRON SOC, V181, P441, DOI 10.1093/mnras/181.3.441; PRINGLE JE, 1981, ANNU REV ASTRON ASTR, V19, P137, DOI 10.1146/annurev.aa.19.090181.001033; Ritter H, 1998, ASTRON ASTROPHYS SUP, V129, P83, DOI 10.1051/aas:1998175; SAVONIJE GJ, 1994, MON NOT R ASTRON SOC, V268, P13, DOI 10.1093/mnras/268.1.13; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; SMAK J, 1993, ACTA ASTRONOM, V43, P101; Smak J., 1984, Acta Astronomica, V34, P161; Warner B, 2003, CATACLYSMIC VARIABLE	23	40	40	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2022	2024		10.1126/science.288.5473.2022	http://dx.doi.org/10.1126/science.288.5473.2022			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856210	Green Submitted			2022-12-28	WOS:000087687000043
J	Deichmann, U				Deichmann, U			An unholy alliance	NATURE			English	Editorial Material									Inst Genet, D-50931 Cologne, Germany	University of Cologne	Deichmann, U (corresponding author), Inst Genet, Weyertal 121, D-50931 Cologne, Germany.		Deichmann, Ute/W-6295-2019; Deichmann, Ute/F-3946-2012						0	3	3	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					739	739		10.1038/35015633	http://dx.doi.org/10.1038/35015633			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866177				2022-12-28	WOS:000087620600024
J	Gostin, LO				Gostin, LO			Public health law in a new century - Part II: Public health powers and limits	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The Constitution allocates public health powers among the federal government and the states, Federal public health powers include the authority to tax, spend, and regulate interstate commerce. These powers enable the federal government to raise revenues, allocate resources, economically penalize risk behavior, and broadly regulate in the public's interest. States have an inherent authority to protect, preserve, and promote the health, safety, morals, and general welfare of the people, termed police powers. Police powers enable states to preserve the public health in areas ranging from injury and disease prevention to sanitation, waste disposal, and environmental protection. The Rehnquist Court has emphasized the limits of federal powers and the primacy of states in public health issues affecting local concerns. Finally, the Constitution safeguards individual interests in autonomy, privacy, liberty, and property. The Supreme Court often defers to public health authorities in matters of public health, but engages in strict scrutiny if government interferes with fundamental freedoms or discriminates against a suspect class. Provided that they act justly and reasonably to avert a serious health threat, the Court should cede to agencies the power to act for the communal good.	Georgetown Univ, Ctr Law, Washington, DC 20001 USA; Johns Hopkins Univ, Program Law & Publ Hlth, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.							Burris Scott, 1989, Villanova Law Rev, V34, P933; EPSTEIN R, 1985, TAKINGS PRIVATE PROP; FRIED C, 1991, ORDER LAW ARGUING RE; Gostin LO, 2000, JAMA-J AM MED ASSOC, V283, P2837, DOI 10.1001/jama.283.21.2837; GOVE PB, 1986, WEBSTERS 3 NEW INT D, P1753; Hodge J G Jr, 1997, J Contemp Health Law Policy, V14, P93; Novak William J., 1996, PEOPLES WELFARE LAW; STODDARD TB, 1990, MILBANK Q, V68, P143, DOI 10.2307/3350179	8	26	26	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2979	2984		10.1001/jama.283.22.2979	http://dx.doi.org/10.1001/jama.283.22.2979			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	321XL	10865277				2022-12-28	WOS:000087480600039
J	Hu, FB; Stampfer, MJ; Colditz, GA; Ascherio, A; Rexrode, KM; Willett, WC; Manson, JE				Hu, FB; Stampfer, MJ; Colditz, GA; Ascherio, A; Rexrode, KM; Willett, WC; Manson, JE			Physical activity and risk of stroke in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; MIDDLE-AGED MEN; ACTIVITY QUESTIONNAIRE; ISCHEMIC STROKE; PREVENTION; EXERCISE; WALKING; MORTALITY; PROGRAM; WEIGHT	Context Persuasive evidence has demonstrated that increased physical activity is associated with substantial reduction in risk of coronary heart disease. However, the role of physical activity in the prevention of stroke is less well established. Objective To examine the association between physical activity and risk of total stroke and stroke subtypes in women. Design and Setting The Nurses' Health Study, a prospective cohort study of subjects residing in 11 US states. Subjects A total of 72 488 female nurses aged 40 to 65 years who did not have diagnosed cardiovascular disease or cancer at baseline in 1986 and who completed detailed physical activity questionnaires in 1986, 1988, and 1992. Main Outcome Measure Incident stroke occurring between baseline and June 1, 1994, compared among quintiles of physical activity level as measured by metabolic equivalent tasks (METs) in hours per week. Results During 8 years (560087 person-years) of follow-up, we documented 407 incident cases of stroke (258 ischemic strokes, 67 subarachnoid hemorrhages, 42 intracerebral hemorrhages, and 40 strokes of unknown type). In multivariate analyses controlling for age, body mass index, history of hypertension, and other covariates, increasing physical activity was strongly inversely associated with risk of total stroke. Relative risks (RRs) in the lowest to highest MET quintiles were 1.00, 0.98, 0.82, 0.74, and 0.66 (P for trend = .005). The inverse gradient was seen primarily for ischemic stroke (RRs across increasing MET quintiles, 1.00, 0.87, 0.83, 0.76, and 0.52; P for trend = .003). Physical activity was not significantly associated with subarachnoid hemorrhage or intracerebral hemorrhage. After multivariate adjustment, walking was associated with reduced risk of total stroke (RRs across increasing walking MET quintiles, 1.00, 0.76, 0.78, 0.70, and 0.66; P for trend = .01) and ischemic stroke (RRs across increasing walking MET quintiles, 1.00, 0.77, 0.75, 0.69, and 0.60; P for trend = .02). Brisk or striding walking pace was associated with lower risk of total and ischemic stroke compared with average or casual pace. Conclusion These data indicate that physical activity, including moderate-intensity exercise such as walking, is associated with substantial reduction in risk of total and ischemic stroke in a dose-response manner.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Div Prevent Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Lee, I-Min/ABD-5409-2021; Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009; Rexrode, Kathryn M/I-1177-2018; Kurth, Tobias/A-9243-2012	Colditz, Graham/0000-0002-7307-0291; Kurth, Tobias/0000-0001-7169-2620; Rexrode, Kathryn/0000-0003-3387-8429	NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL24074, HL34594] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT RD, 1994, AM J EPIDEMIOL, V139, P881, DOI 10.1093/oxfordjournals.aje.a117094; AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ANDERSON CS, 1993, MED J AUSTRALIA, V158, P85, DOI 10.5694/j.1326-5377.1993.tb137529.x; [Anonymous], 1996, JAMA, V276, P241; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; BLAIR SN, 1993, ANN INTERN MED, V119, P702, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00015; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DEVLIN JT, 1992, DIABETES CARE, V15, P1690, DOI 10.2337/diacare.15.11.1690; ELLEKJAER EF, 1992, STROKE, V23, P829, DOI 10.1161/01.STR.23.6.829; Gillum RF, 1996, AM J EPIDEMIOL, V143, P860, DOI 10.1093/oxfordjournals.aje.a008829; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; Henriksson J, 1995, J Cardiovasc Risk, V2, P303, DOI 10.1097/00043798-199508000-00004; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KIELY DK, 1994, AM J EPIDEMIOL, V140, P608, DOI 10.1093/oxfordjournals.aje.a117298; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lee IM, 1999, STROKE, V30, P1, DOI 10.1161/01.STR.30.1.1; LINDSTED KD, 1991, J CLIN EPIDEMIOL, V44, P355, DOI 10.1016/0895-4356(91)90074-J; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MANSON JE, 1994, AM J PREV MED, V10, P172, DOI 10.1016/S0749-3797(18)30615-9; MENOTTI A, 1990, INT J EPIDEMIOL, V19, P309, DOI 10.1093/ije/19.2.309; Paffenbarger R S Jr, 1972, Prev Med, V1, P522, DOI 10.1016/0091-7435(72)90034-5; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Walker AE, 1981, STROKE S1, V12, P13; WANNAMETHEE G, 1992, BRIT MED J, V304, P597, DOI 10.1136/bmj.304.6827.597; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; ZIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706	37	317	325	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2961	+		10.1001/jama.283.22.2961	http://dx.doi.org/10.1001/jama.283.22.2961			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865274	Bronze			2022-12-28	WOS:000087480600036
J	Richardson, C; Jasin, M				Richardson, C; Jasin, M			Frequent chromosomal translocations induced by DNA double-strand breaks	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; REPAIR; CELLS; ENDS; CHROMATIDS; MECHANISM; NEOPLASIA; DAMAGE; MODEL; SITE	The faithful repair of DNA damage such as chromosomal double-strand breaks (DSBs) is crucial for genomic integrity. Aberrant repair of these lesions can result in chromosomal rearrangements, including translocations, which are associated with numerous tumours(1,2). Models predict that some translocations arise from DSB-induced recombination in differentiating lymphoid cell types(3-5) or from aberrant repair of DNA damage induced by irradiation or other agents(6-8); however, a genetic system to study the aetiology of these events has been lacking. Here we use a mouse embryonic stem cell system to examine the role of DNA damage on the formation of translocations. We rnd that two DSBs, each on different chromosomes, are sufficient to promote frequent reciprocal translocations. The results are in striking contrast with interchromosomal repair of a single DSB in an analogous system in which translocations are not recovered. Thus, while interchromosomal DNA repair does not result in genome instability per se, the presence of two DSBs in a single cell can alter the spectrum of repair products that are recovered.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	m-jasin@ski.mskcc.org	Wilson, Matthew H/K-3193-2013					Andreasson P, 1998, LEUKEMIA, V12, P1411, DOI 10.1038/sj.leu.2401108; Beumer KJ, 1998, GENETICS, V150, P173; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Coleman AE, 1999, BLOOD, V93, P4442, DOI 10.1182/blood.V93.12.4442; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; Cooper DN, 1998, GENETIC BASIS HUMAN, P65; CORNFORTH MN, 1993, ADV RADIAT BIOL, V17, P423; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Ikeda H, 1994, Adv Pharmacol, V29A, P147; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; KADYK LC, 1992, GENETICS, V132, P387; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; LIN FL, 1984, MOL CELL BIOL, V4, P1020, DOI 10.1128/MCB.4.6.1020; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Moynahan ME, 1997, P NATL ACAD SCI USA, V94, P8988, DOI 10.1073/pnas.94.17.8988; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; TYCKO B, 1990, CANCER CELL-MON REV, V2, P1; Wang P, 1997, P NATL ACAD SCI USA, V94, P12018, DOI 10.1073/pnas.94.22.12018; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9	29	403	414	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					697	700		10.1038/35015097	http://dx.doi.org/10.1038/35015097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864328				2022-12-28	WOS:000087465800050
J	McAlister, FA; Straus, SE; Guyatt, GH; Haynes, RB				McAlister, FA; Straus, SE; Guyatt, GH; Haynes, RB		Evidence-Based Med Working Grp	Users' guides to the medical literature - XX. Integrating research evidence with the care of the individual patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL DECISION-MAKING; CORONARY HEART-DISEASE; CAROTID ENDARTERECTOMY; PATIENTS PREFERENCES; COST-EFFECTIVENESS; RANDOMIZED TRIALS; BREAST-CANCER; HELP ME; RISK; STROKE	Clinicians can use research results to determine optimal care for an individual patient by using a patient's baseline risk estimate, clinical prediction guidelines that quantitate an individual patient's potential for benefit, and published articles. We propose that when clinicians are determining the likelihood that treatment will prevent the target event (at the expense of adverse events) in a patient that they also incorporate the patient's values. The 3 main elements to joint clinical decision making are disclosure of information about the risks and benefits of therapeutic alternatives, exploration of the patient's values about both the therapy and potential outcomes, and the actual decision. In addressing the patient's risk of adverse events without treatment and risk of harm with therapy, clinicians must recognize that patients are rarely identical to the average study patient. Differences between study participants and patients in real-world practice tend to be quantitative (differences in degree of risk of the outcome or responsiveness to therapy) rather than qualitative (no risk or adverse response to therapy). The number needed to treat and number needed to harm can be used to generate patient-specific estimates relative to the risk of the outcome event, Clinicians must consider a patient's risk of adverse events from any intervention and incorporate the patient's values in clinical decision making by using information about the risks and benefits of therapeutic alternatives.	McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Mt Sinai Hosp Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada; Univ Alberta Hosp, Div Gen Internal Med, Edmonton, AB T6G 2B7, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Alberta	Guyatt, GH (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Room 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	sstraus@mtsinai.on.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341; Haynes, Robert Brian/0000-0002-1453-3196				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Bain DJ, 1998, BRIT J SURG, V85, P768; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Chassin MR, 1998, NEW ENGL J MED, V339, P1468, DOI 10.1056/NEJM199811123392010; Chatellier G, 1996, BRIT MED J, V312, P426; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Dans AL, 1998, JAMA-J AM MED ASSOC, V279, P545, DOI 10.1001/jama.279.7.545; DAVEYSMITH G, 1994, BRIT MED J, V308, P72; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; ELIASZIW M, 1994, STROKE, V25, P304, DOI 10.1161/01.STR.25.2.304; ELIASZIW M, 1995, STROKE, V26, P1747, DOI 10.1161/01.STR.26.10.1747; Elneihoum AM, 1998, STROKE, V29, P2114, DOI 10.1161/01.STR.29.10.2114; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Glasziou P, 1998, ACP J Club, V129, pA15; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; Guyatt GH, 1999, JAMA-J AM MED ASSOC, V281, P1836, DOI 10.1001/jama.281.19.1836; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Ioannidis JPA, 1998, AM J EPIDEMIOL, V148, P1117; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; LEVINE MN, 1992, ANN INTERN MED, V117, P53, DOI 10.7326/0003-4819-117-1-53; Lilford RJ, 1998, BMJ-BRIT MED J, V317, P405; Llewellyn-Thomas H A, 1997, Can J Nurs Res, V29, P45; LLEWELLYNTHOMAS HA, 1991, SOC SCI MED, V32, P35, DOI 10.1016/0277-9536(91)90124-U; Margalith I, 1997, SOC SCI MED, V45, P419, DOI 10.1016/S0277-9536(96)00357-7; Mazur DJ, 1997, J GEN INTERN MED, V12, P114, DOI 10.1046/j.1525-1497.1997.00016.x; McAlister FA, 1999, J AM GERIATR SOC, V47, P811, DOI 10.1111/j.1532-5415.1999.tb03837.x; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; NEASE RF, 1995, JAMA-J AM MED ASSOC, V273, P1185, DOI 10.1001/jama.273.15.1185; O'Connor A M, 1997, Can J Nurs Res, V29, P7; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; PEDERSEN TR, 1995, LANCET, V345, P1274; RICHARDSON WS, 1995, JAMA-J AM MED ASSOC, V273, P1610, DOI 10.1001/jama.273.20.1610; RIEGELMAN R, 1993, MED DECIS MAKING, V13, P247, DOI 10.1177/0272989X9301300312; Rothenbacher D, 1997, EUR J CANCER, V33, P1184, DOI 10.1016/S0959-8049(97)00034-8; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Rothwell PM, 1996, STROKE, V27, P260, DOI 10.1161/01.STR.27.2.260; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sackett D L, 1997, ACP J Club, V127, pA15; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Samsa GP, 1998, AM HEART J, V136, P703, DOI 10.1016/S0002-8703(98)70019-5; SAUVE JS, 1993, JAMA-J AM MED ASSOC, V270, P2843, DOI 10.1001/jama.270.23.2843; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; SCHULMAN BA, 1979, MED CARE, V17, P267, DOI 10.1097/00005650-197903000-00004; Sculpher M, 1998, HEALTH ECON, V7, P129; Sharp SJ, 1996, BRIT MED J, V313, P735; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Stiggelbout AM, 1997, CAN MED ASSOC J, V157, P383; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Szabo E, 1997, ARCH INTERN MED, V157, P1352, DOI 10.1001/archinte.157.12.1352; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Tu JV, 1998, NEW ENGL J MED, V339, P1441, DOI 10.1056/NEJM199811123392006; VICKERY DM, 1988, MED CARE, V26, P580, DOI 10.1097/00005650-198806000-00006; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; YUSUF S, 1990, STAT MED, V9, P73, DOI 10.1002/sim.4780090114; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	76	165	168	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2829	2836		10.1001/jama.283.21.2829	http://dx.doi.org/10.1001/jama.283.21.2829			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320BQ	10838653				2022-12-28	WOS:000087381500039
J	Grosskurth, H; Gray, R; Hayes, R; Mabey, D; Wawer, M				Grosskurth, H; Gray, R; Hayes, R; Mabey, D; Wawer, M			Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CONTROLLED TRIAL; RURAL TANZANIA; COMMUNITY TRIAL; RISK-FACTORS; AIDS-PREVENTION; SEX WORKERS; INFECTION; TRANSMISSION; FEMALE	Two randomised controlled trials of sexually transmitted disease (STD) treatment for the prevention of HIV-1 infection, in Mwanza, Tanzania, and Rakai, Uganda, unexpectedly produced contrasting results. A decrease in population HIV-1 incidence was associated with improved STD case management in Mwanza, but was not associated with STD mass treatment in Rakai. Some reductions in curable STDs were seen in both studies. These trials tested different interventions in different HIV-1 epidemic settings and used different evaluation methods; the divergent results may be complementary rather than contradictory. Possible explanations include: differences in stage of the HIV-1 epidemic, which can influence exposure to HIV-1 and the distribution of viral load in the infected population; potential differences in the prevalence of incurable STDs (such as genital herpes); perhaps greater importance of symptomatic than symptomless STDs for HIV-1 transmission; and possibly greater effectiveness of continuously available services than of intermittent mass treatment to control rapid STD reinfection. Implications of the trials for policy and future research agenda are discussed.	Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; Columbia Univ, Joseph L Mailman Sch Publ Hlth, New York, NY USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Columbia University	Grosskurth, H (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	Heiner.Grosskurth@ishtm.ac.uk		Hayes, Richard/0000-0002-1729-9892; Grosskurth, Heiner/0000-0001-9960-7280; Mabey, David/0000-0002-0031-8276				ATTAWELL K, 1999, KNOWLEDGE PRACTICE S; BALLARD R, 1998, WHO UNAIDS CONS OCT; Brugha R, 1999, SEX TRANSM INFECT, V75, P283, DOI 10.1136/sti.75.5.283; CAMERON DW, 1989, LANCET, V2, P403; Chen CY, 2000, SEX TRANSM DIS, V27, P21, DOI 10.1097/00007435-200001000-00005; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; GROSSKURTH H, 1995, AIDS, V9, P927, DOI 10.1097/00002030-199508000-00015; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; HAYES R, 1995, AIDS, V9, P919, DOI 10.1097/00002030-199508000-00014; HAYES R, 1995, LANCET, V346, P1159; Hayes R, 1997, GENITOURIN MED, V73, P432; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; LAGA M, 1998, WHO UNAIDS CONS OCT; Mayaud P, 1997, AIDS, V11, P1873, DOI 10.1097/00002030-199715000-00013; MERTENS TE, 1990, AIDS, V4, P57, DOI 10.1097/00002030-199001000-00008; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; ORROTH K, 2000, IN PRESS AIDS; PEPIN J, 1989, AIDS, V3, P3, DOI 10.1097/00002030-198903010-00002; PLUMMER FA, 1991, J INFECT DIS, V163, P233, DOI 10.1093/infdis/163.2.233; PLUMMER FA, 1998, WHO UNAIDS CONS OCT; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Robinson NJ, 1997, INT J EPIDEMIOL, V26, P180, DOI 10.1093/ije/26.1.180; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; *WHO, 1991, WHO TECHN REP SER, V810; *WHO, 1995, 951 WHO GPA STD; *WORLD BANK, 1993, WORLD DEV REP 1993 I	37	208	210	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1981	1987		10.1016/S0140-6736(00)02336-9	http://dx.doi.org/10.1016/S0140-6736(00)02336-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859054				2022-12-28	WOS:000087381900037
J	Paul, D				Paul, D			A double-edged sword	NATURE			English	Article									Univ Massachusetts, Dept Polit Sci, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston	Paul, D (corresponding author), Univ Massachusetts, Dept Polit Sci, 100 Morrissey Blvd, Boston, MA 02125 USA.			Paul, Diane/0000-0003-4053-0121					0	12	12	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					515	515		10.1038/35014676	http://dx.doi.org/10.1038/35014676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850693	Bronze			2022-12-28	WOS:000087449500027
J	Takada, S; Lis, JT; Zhou, S; Tjian, R				Takada, S; Lis, JT; Zhou, S; Tjian, R			A TRF1 : BRF complex directs Drosophila RNA polymerase III transcription	CELL			English	Article							TATA-BINDING PROTEIN; GENES; TBP; SEQUENCES; SPECIFICITY; INITIATION; SUBUNIT; CELLS; DNA; ACCURATE	It has been generally accepted that the TATA binding protein (TBP) is a universal mediator of transcription by RNA polymerase I, II, and III. Here we report that the TBP-related factor TRF1 rather than TBP is responsible for RNA polymerase III transcription in Drosophila. Immunoprecipitation and in vitro transcription assays using immunodepleted extracts supplemented with recombinant proteins reveals that a TRF1:BRF complex is required to reconstitute transcription of tRNA, 5S and U6 RNA genes. In vivo, the majority of TRF1 is complexed with BRF and these two proteins colocalize at many polytene chromosome sites containing RNA pol III genes. These data suggest that in Drosophila, TRF1 rather than TBP forms a complex with BRF that plays a major role in RNA pol III transcription.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Cornell Univ, Biochem Mol & Cell Biol Sect, Ithaca, NY 14853 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Cornell University	Tjian, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA.							BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; BURKE DJ, 1985, J BIOL CHEM, V260, P816; Clarke EM, 1996, J BIOL CHEM, V271, P22189, DOI 10.1074/jbc.271.36.22189; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; DAS G, 1987, J BIOL CHEM, V262, P1187; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; DINGERMANN T, 1983, J BIOL CHEM, V258, P395; DINGERMANN T, 1982, J BIOL CHEM, V257, P4738; GEIDUSCHEK EP, 1995, CURR OPIN CELL BIOL, V7, P344, DOI 10.1016/0955-0674(95)80089-1; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Harlow E., 1988, ANTIBODIES LAB MANUA; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Jensen RC, 1998, NUCLEIC ACIDS RES, V26, P616, DOI 10.1093/nar/26.2.616; JOHNSON DL, 1991, J BIOL CHEM, V266, P16037; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; LOFQUIST A, 1986, J BIOL CHEM, V261, P4600; MARTIN GJ, 1995, METHODS DETECT ADULT, V1, P1; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; SHARP S, 1984, NUCLEIC ACIDS RES, V12, P7617, DOI 10.1093/nar/12.20.7617; Shen YH, 1998, MOL CELL BIOL, V18, P1692, DOI 10.1128/MCB.18.3.1692; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; STRUHL K, 1994, SCIENCE, V263, P1103, DOI 10.1126/science.8108728; SUTCLIFFE JG, 1984, NATURE, V308, P237, DOI 10.1038/308237a0; TOWER J, 1988, MOL CELL BIOL, V8, P1001, DOI 10.1128/MCB.8.2.1001; Trivedi A, 1996, MOL CELL BIOL, V16, P6909; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Vilalta A, 1997, J BIOL CHEM, V272, P18087, DOI 10.1074/jbc.272.29.18087; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8606, DOI 10.1073/pnas.92.19.8606; WANG ZX, 1995, P NATL ACAD SCI USA, V92, P7026, DOI 10.1073/pnas.92.15.7026; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; WHITE RJ, 1995, MOL CELL BIOL, V15, P6653; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844	44	89	90	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					459	469		10.1016/S0092-8674(00)80857-0	http://dx.doi.org/10.1016/S0092-8674(00)80857-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850489	Bronze			2022-12-28	WOS:000087375400004
J	Schliwa, M				Schliwa, M			Cell biology - Centrioles go for a stroll	NATURE			English	Editorial Material									Univ Munich, Inst Cell Biol, D-80336 Munich, Germany	University of Munich	Schliwa, M (corresponding author), Univ Munich, Inst Cell Biol, Schillerstr 42, D-80336 Munich, Germany.							Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					292	292		10.1038/35012738	http://dx.doi.org/10.1038/35012738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10858106	Bronze			2022-12-28	WOS:000087085700028
J	Fisher, M; Raper, RF				Fisher, M; Raper, RF			Delay in stopping treatment can become unreasonable and unfair - Commentary	BRITISH MEDICAL JOURNAL			English	Article									Royal N Shore Hosp, Intens Therapy Unit, St Leonards, NSW 2065, Australia	Royal North Shore Hospital	Fisher, M (corresponding author), Royal N Shore Hosp, Intens Therapy Unit, St Leonards, NSW 2065, Australia.							ANNINI C, 1992, MINERVA ANESTHESIOL, V58, P1247; PARISI JE, 1982, NEW ENGL J MED, V306, P14, DOI 10.1056/NEJM198201073060104	2	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 6	2000	320	7244					1268	1268						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CF	10847729				2022-12-28	WOS:000086981400028
J	Hoffman, PC; Mauer, AM; Vokes, EE				Hoffman, PC; Mauer, AM; Vokes, EE			Lung cancer	LANCET			English	Review							SOUTHWEST-ONCOLOGY-GROUP; RANDOMIZED TRIAL; MULTICENTER TRIAL; FOLLOW-UP; PHASE-II; CELL; RADIOTHERAPY; CHEMOTHERAPY; IRRADIATION; CISPLATIN	Lung cancer remains a major worldwide health problem, accounting for more than a sixth of cancer deaths. The proportion of cancers that are adenocarcinomas is increasing in North America and to some degree in Europe, leading to a changing clinical picture characterised by early development of metastases. Newer diagnostic techniques have allowed for snore accurate tumour staging and treatment planning. In patients with non-small-cell cancer, surgical resection offers substantial cure rates in early-stage cases. Combined chemotherapy plus radiation therapy has clearly improved the treatment results for patients with locally advanced cancers, and patients with metastatic disease are now candidates for newer chemotherapy regimens with more favourable results than in the past. Small-cell lung cancer is highly responsive to chemotherapy, and recent advances In radiation therapy have improved the prospects for long survival. New techniques for screening, and innovative approaches to both local and systemic treatment offer hope for substantial progress against this disease in the near future.	Univ Chicago, Med Ctr, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center	Hoffman, PC (corresponding author), Univ Chicago, Med Ctr, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Larsen, Jill E/G-3787-2010; Gw, Safwan/ABG-4675-2020; Stojkovski, Igor/L-3236-2019; Fong, Kwun M/G-6369-2010; Huber, Rudolf M./L-2464-2019; Vokes, Everett/Q-2146-2019; Besse, Benjamin/V-1523-2019; Ozyigit, Gokhan/I-9471-2013; Stojkovski, Igor/N-2436-2018	Larsen, Jill E/0000-0001-7806-3931; Gw, Safwan/0000-0001-6764-1038; Huber, Rudolf M./0000-0001-7041-6368; Besse, Benjamin/0000-0001-5090-8189; Ozyigit, Gokhan/0000-0002-7497-4348; Stojkovski, Igor/0000-0002-5770-2578				ALBAIN KS, 1995, J CLIN ONCOL, V13, P1880, DOI 10.1200/JCO.1995.13.8.1880; ALBERTI W, 1995, BRIT MED J, V311, P899; ARRIAGADA R, 1995, JNCI-J NATL CANCER I, V87, P183, DOI 10.1093/jnci/87.3.183; Auperin A, 1999, NEW ENGL J MED, V341, P476, DOI 10.1056/NEJM199908123410703; BELANI CP, 1998, P AN M AM SOC CLIN, V17, pA455; BLEEHEN NM, 1989, BRIT J CANCER, V59, P584; Bonomi P, 1998, TAXANES IN LUNG CANCER THERAPY, P81; BUNN PA, 1987, ANN INTERN MED, V106, P655, DOI 10.7326/0003-4819-106-5-655; Burdett S, 1998, LANCET, V352, P257; Cardenal F, 1999, J CLIN ONCOL, V17, P12, DOI 10.1200/JCO.1999.17.1.12; Charloux A, 1997, LUNG CANCER, V16, P133, DOI 10.1016/S0169-5002(96)00623-X; Crino L, 1999, J CLIN ONCOL, V17, P2081, DOI 10.1200/JCO.1999.17.7.2081; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; Dillman RO, 1996, J NATL CANCER I, V88, P1210, DOI 10.1093/jnci/88.17.1210; FERGUSON MK, 1995, J THORAC CARDIOV SUR, V109, P275, DOI 10.1016/S0022-5223(95)70389-6; FERGUSON MK, 1986, J THORAC CARDIOV SUR, V91, P498; FOSSELLA FV, 1995, J CLIN ONCOL, V13, P645, DOI 10.1200/JCO.1995.13.3.645; FURUSE K, 1999, P AN M AM SOC CLIN, V18, pA458; GATZEMEIER U, 1998, P AN M AM SOC CLIN, V17, pA454; JAAKKIMAINEN L, 1990, J CLIN ONCOL, V8, P1301, DOI 10.1200/JCO.1990.8.8.1301; JOHNSON BE, 1990, J CLIN ONCOL, V8, P48, DOI 10.1200/JCO.1990.8.1.48; KELLER SM, 1999, P AN M AM SOC CLIN, V18, pA465; Komaki R, 1997, INT J RADIAT ONCOL, V39, P537, DOI 10.1016/S0360-3016(97)00365-9; LAD T, 1988, J CLIN ONCOL, V6, P9; LECHEVALIER T, 1994, J CLIN ONCOL, V12, P360, DOI 10.1200/JCO.1994.12.2.360; LECHEVALIER T, 1992, J NATL CANCER I, V84, P58; LEE JS, 1986, INT J RADIAT ONCOL, V12, P313, DOI 10.1016/0360-3016(86)90344-5; LIPPMAN SM, 1998, P AN M AM SOC CLIN, V17, pA456; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; LUKE WP, 1986, J THORAC CARDIOV SUR, V91, P53; MARTINI N, 1992, ANN THORAC SURG, V54, P460, DOI 10.1016/0003-4975(92)90435-7; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mentzer SJ, 1997, CHEST, V112, pS239, DOI 10.1378/chest.112.4_Supplement.239S; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; MURRAY N, 1993, J CLIN ONCOL, V11, P336, DOI 10.1200/JCO.1993.11.2.336; NOORDIJK EM, 1988, RADIOTHER ONCOL, V13, P83, DOI 10.1016/0167-8140(88)90029-1; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; SANDLER A, 1998, P AN M AM SOC CLIN, V17, pA454; Saunders CAB, 1999, ANN THORAC SURG, V67, P790, DOI 10.1016/S0003-4975(98)01257-0; Saunders M, 1997, LANCET, V350, P161, DOI 10.1016/S0140-6736(97)06305-8; SCHAAKEKONING C, 1992, NEW ENGL J MED, V326, P524, DOI 10.1056/NEJM199202203260805; Somerfield MR, 1997, J CLIN ONCOL, V15, P2996; Swisher SG, 1999, J NATL CANCER I, V91, P763, DOI 10.1093/jnci/91.9.763; Turrisi AT, 1999, NEW ENGL J MED, V340, P265, DOI 10.1056/NEJM199901283400403; VANSTEENKISTE J, 1994, EUR RESPIR J, V7, P265, DOI 10.1183/09031936.94.07020265; VOKES EE, 1999, P AN M AM SOC CLIN, V18, pA459; WEISENBURGER TH, 1986, NEW ENGL J MED, V315, P1377; *WHO, 1998, WORLD HLTH STAT ANN, pB632; Wozniak AJ, 1998, J CLIN ONCOL, V16, P2459, DOI 10.1200/JCO.1998.16.7.2459	50	592	625	2	74	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					479	485		10.1016/S0140-6736(00)82038-3	http://dx.doi.org/10.1016/S0140-6736(00)82038-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841143				2022-12-28	WOS:000085306800038
J	McCormack, J; Greenhalgh, T				McCormack, J; Greenhalgh, T			Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1W5, Canada; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London N19 3UA, England	University of British Columbia; University of London; University College London; UCL Medical School	McCormack, J (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1W5, Canada.	jmccorma@interchange.ubc.ca	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088; McCormack, James/0000-0002-7801-5515				COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Ewart RM, 1999, LANCET, V353, P1882, DOI 10.1016/S0140-6736(05)75087-X; GERSTEIN HC, 2000, ACP J CLUB      0328; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P480, DOI 10.1136/bmj.315.7106.480; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Janis IL, 1982, GROUPTHINK PSYCHOL S; Kerner W, 1998, LANCET, V352, P1934, DOI 10.1016/S0140-6736(05)60427-8; KLIMT CR, 1970, DIABETES, V19, P747; Nathan DM, 1998, LANCET, V352, P832, DOI 10.1016/S0140-6736(98)22937-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WINDELER J, 1995, BRIT MED J, V310, P454, DOI 10.1136/bmj.310.6977.454	12	88	89	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2000	320	7251					1720	1723		10.1136/bmj.320.7251.1720	http://dx.doi.org/10.1136/bmj.320.7251.1720			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864554	Green Published			2022-12-28	WOS:000087926400029
J	Plamping, D; Gordon, P; Pratt, J				Plamping, D; Gordon, P; Pratt, J			Modernising the NHS - Practical partnerships for health and local authorities	BRITISH MEDICAL JOURNAL			English	Article									London Sch Econ, Dept Operat Res, Urban Partnerships Grp, London WC2 2AE, England	University of London; London School Economics & Political Science	Plamping, D (corresponding author), London Sch Econ, Dept Operat Res, Urban Partnerships Grp, London WC2 2AE, England.							[Anonymous], 1996, CREATING COLLABORATI; AXELROD R, 1990, EVOLUTION COOPERATIO; Fisher R., 1983, GETTING YES; HIGGINS J, 1983, GOVT URBAN POVERTY P; Pratt J., 1998, PARTNERSHIP FIT PURP; Pratt J., 1999, WORKING WHOLE SYSTEM; [No title captured]	7	8	8	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1723	1725		10.1136/bmj.320.7251.1723	http://dx.doi.org/10.1136/bmj.320.7251.1723			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864555	Green Published			2022-12-28	WOS:000087926400030
J	Concato, J; Shah, N; Horwitz, RI				Concato, J; Shah, N; Horwitz, RI			Randomized, controlled trials, observational studies, and the hierarchy of research designs.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; CLINICAL-TRIALS; SCREENING MAMMOGRAPHY; HISTORICAL CONTROLS; BLOOD-PRESSURE; METAANALYSIS; EFFICACY; BIAS; CHOLESTEROL; QUALITY	Background: In the hierarchy of research designs, the results of randomized, controlled trials are considered to be evidence of the highest grade, whereas observational studies are viewed as having less validity because they reportedly overestimate treatment effects. We used published meta-analyses to identify randomized clinical trials and observational studies that examined the same clinical topics. We then compared the results of the original reports according to the type of research design. Methods: A search of the Medline data base for articles published in five major medical journals from 1991 to 1995 identified meta-analyses of randomized, controlled trials and meta-analyses of either cohort or case-control studies that assessed the same intervention. For each of five topics, summary estimates and 95 percent confidence intervals were calculated on the basis of data from the individual randomized, controlled trials and the individual observational studies. Results: For the five clinical topics and 99 reports evaluated, the average results of the observational studies were remarkably similar to those of the randomized, controlled trials. For example, analysis of 13 randomized, controlled trials of the effectiveness of bacille Calmette-Guerin vaccine in preventing active tuberculosis yielded a relative risk of 0.49 (95 percent confidence interval, 0.34 to 0.70) among vaccinated patients, as compared with an odds ratio of 0.50 (95 percent confidence interval, 0.39 to 0.65) from 10 case-control studies. In addition, the range of the point estimates for the effect of vaccination was wider for the randomized, controlled trials (0.20 to 1.56) than for the observational studies (0.17 to 0.84). Conclusions: The results of well-designed observational studies (with either a cohort or a case-control design) do not systematically overestimate the magnitude of the effects of treatment as compared with those in randomized, controlled trials on the same topic. (N Engl J Med 2000;342:1887-92.) (C)2000, Massachusetts Medical Society.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; W Haven Vet Affairs Med Ctr, Clin Epidemiol Unit, W Haven, CT USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Concato, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,SHM IE-61, New Haven, CT 06510 USA.		Rodríguez, Ferran A. A/H-4892-2011	Rodríguez, Ferran A. A/0000-0002-2280-8962; Shah, Nirav/0000-0003-2044-7865	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL074478] Funding Source: NIH RePORTER; NHLBI NIH HHS [F32 HL074478] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abel U, 1999, J CLIN EPIDEMIOL, V52, P487; Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; [Anonymous], 1948, BMJ-BRIT MED J, V2, P769; BYAR DP, 1976, NEW ENGL J MED, V295, P74, DOI 10.1056/NEJM197607082950204; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; CUMMINGS P, 1994, ANN INTERN MED, V120, P848, DOI 10.7326/0003-4819-120-10-199405150-00006; Demissie K, 1998, J CLIN EPIDEMIOL, V51, P81, DOI 10.1016/S0895-4356(97)00243-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FEINSTEIN AR, 1984, CIRCULATION, V70, P767, DOI 10.1161/01.CIR.70.5.767; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Guyatt GH, 1996, JAMA-J AM MED ASSOC, V275, P1232; Horn KD, 1998, QJM-MON J ASSOC PHYS, V91, P265, DOI 10.1093/qjmed/91.4.265; Horwitz R I, 1987, Am J Med, V82, P498, DOI 10.1016/0002-9343(87)90450-5; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; HORWITZ RI, 1979, AM J MED, V66, P556, DOI 10.1016/0002-9343(79)91164-1; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; McKee M, 1999, BMJ-BRIT MED J, V319, P312, DOI 10.1136/bmj.319.7205.312; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; SACKS HS, 1983, ARCH INTERN MED, V143, P753, DOI 10.1001/archinte.143.4.753; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; U.S. Preventive Services Task Force, 1996, GUID CLIN PREV SERV	32	2318	2360	5	177	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2000	342	25					1887	1892		10.1056/NEJM200006223422507	http://dx.doi.org/10.1056/NEJM200006223422507			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325YK	10861325	Green Accepted			2022-12-28	WOS:000087704700007
J	Berger, A				Berger, A			Antibodies can repair damaged myelin in model of MS	BRITISH MEDICAL JOURNAL			English	News Item																		2000, PROC NATL ACAD SCI, V97, P6820	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1622	1622						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856050				2022-12-28	WOS:000087734200009
J	Buffett, BA				Buffett, BA			Earth's core and the geodynamo	SCIENCE			English	Review							GRAVITATIONALLY POWERED DYNAMO; INNER-CORE; OUTER CORE; GEOMAGNETIC-FIELD; DIFFERENTIAL ROTATION; THERMAL EVOLUTION; MANTLE BOUNDARY; HETEROGENEOUS MANTLE; TERRESTRIAL PLANETS; MAGNETIC-FIELDS	Earth's magnetic field is generated by fluid motion in the liquid iron core. Details of how this occurs are now emerging from numerical simulations that achieve a serf-sustaining magnetic field. Early results predict a dominant dipole field outside the core, and some models even reproduce magnetic reversals. The simulations also show how different patterns of flow can produce similar external fields. Efforts to distinguish between the various possibilities appeal to observations of the time-dependent behavior of the field. important constraints will come from geological records of the magnetic field in the past.	Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Buffett, BA (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, 2219 Main Mall, Vancouver, BC V6T 1Z4, Canada.	buffett@eos.ubc.ca						Aurnou JM, 1996, GEOPHYS RES LETT, V23, P3401, DOI 10.1029/96GL03258; Bergman MI, 1997, NATURE, V389, P60, DOI 10.1038/37962; BLOXHAM J, 1991, REV GEOPHYS, V29, P97, DOI 10.1029/90RG02470; Bloxham J, 2000, PHILOS T R SOC A, V358, P1171, DOI 10.1098/rsta.2000.0579; Bloxham J, 2000, NATURE, V405, P63, DOI 10.1038/35011045; BLOXHAM J, 1987, NATURE, V325, P511, DOI 10.1038/325511a0; BRAGINSKII SI, 1963, DOKL AKAD NAUK SSSR+, V149, P1311; BRAGINSKY SI, 1990, GEOPHYS ASTRO FLUID, V55, P71, DOI 10.1080/03091929008203556; BRAGINSKY SI, 1995, GEOPHYS ASTRO FLUID, V79, P1, DOI 10.1080/03091929508228992; Buffet BA, 1996, GEOPHYS RES LETT, V23, P3803, DOI 10.1029/96GL03571; Buffett BA, 1996, GEOPHYS RES LETT, V23, P2279, DOI 10.1029/96GL02083; Buffett BA, 1996, J GEOPHYS RES-SOL EA, V101, P7989, DOI 10.1029/95JB03539; Buffett BA, 1996, GEOPHYS J INT, V125, P303, DOI 10.1111/j.1365-246X.1996.tb06552.x; BUFFETT BA, UNPUB; BUFFETT BA, 2000, MINERAL PHYSICS SEIS; BUSH JWM, 1995, J FLUID MECH, V282, P247, DOI 10.1017/S0022112095000139; Busse FH, 2000, ANNU REV FLUID MECH, V32, P383, DOI 10.1146/annurev.fluid.32.1.383; BUSSE FH, 1992, GEOPHYS ASTRO FLUID, V64, P135, DOI 10.1080/03091929208228087; Chabot NL, 1999, EARTH PLANET SC LETT, V172, P323, DOI 10.1016/S0012-821X(99)00208-3; Christensen U, 1998, GEOPHYS RES LETT, V25, P1565, DOI 10.1029/98GL00911; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; COX A, 1975, REV GEOPHYS, V13, P35, DOI 10.1029/RG013i003p00035; Creager KC, 1999, J GEOPHYS RES-SOL EA, V104, P23127, DOI 10.1029/1999JB900162; Creager KC, 1997, SCIENCE, V278, P1284, DOI 10.1126/science.278.5341.1284; de Wijs GA, 1998, NATURE, V392, P805, DOI 10.1038/33905; Fearn DR, 1998, REP PROG PHYS, V61, P175, DOI 10.1088/0034-4885/61/3/001; FEARN DR, 1994, GEOPHYS ASTRO FLUID, V77, P111, DOI 10.1080/03091929408203678; Flasar FM, 1973, J GEOPHYS RES, V78, P6101, DOI 10.1029/JB078i026p06101; Glatzmaier GA, 1996, SCIENCE, V274, P1887, DOI 10.1126/science.274.5294.1887; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; Glatzmaier GA, 1996, PHYSICA D, V97, P81, DOI 10.1016/0167-2789(96)00100-5; GLATZMAIER GA, 1995, PHYS EARTH PLANET IN, V91, P63, DOI 10.1016/0031-9201(95)03049-3; Grote E, 2000, PHYS EARTH PLANET IN, V117, P259, DOI 10.1016/S0031-9201(99)00101-6; GUBBINS D, 1979, GEOPHYS J ROY ASTR S, V59, P57, DOI 10.1111/j.1365-246X.1979.tb02553.x; GUBBINS D, 1987, NATURE, V325, P509, DOI 10.1038/325509a0; Halliday AN, 1999, GEOCHIM COSMOCHIM AC, V63, P4157, DOI 10.1016/S0016-7037(99)00315-4; HIDE R, 1967, SCIENCE, V157, P55, DOI 10.1126/science.157.3784.55; Hollerbach R, 1996, PHYS EARTH PLANET IN, V98, P163, DOI 10.1016/S0031-9201(96)03185-8; Holme R, 2000, PHYS EARTH PLANET IN, V117, P329, DOI 10.1016/S0031-9201(99)00105-3; Jault D, 1996, PHYS EARTH PLANET IN, V98, P187, DOI 10.1016/S0031-9201(96)03186-X; JAULT D, 1989, GEOPHYS ASTRO FLUID, V48, P273, DOI 10.1080/03091928908218533; JEANLOZ R, 1988, GEOPHYS RES LETT, V15, P72, DOI 10.1029/GL015i001p00072; JEANLOZ R, 1990, ANNU REV EARTH PL SC, V18, P357; JEPHCOAT A, 1987, NATURE, V325, P332, DOI 10.1038/325332a0; Johnson CL, 1997, GEOPHYS J INT, V131, P643, DOI 10.1111/j.1365-246X.1997.tb06604.x; Kageyama A, 1997, PHYS REV E, V55, P4617, DOI 10.1103/PhysRevE.55.4617; KARATO S, 1993, SCIENCE, V262, P1708, DOI 10.1126/science.262.5140.1708; Karato S, 1999, NATURE, V402, P871, DOI 10.1038/47235; Kelly P, 1997, GEOPHYS J INT, V128, P315, DOI 10.1111/j.1365-246X.1997.tb01557.x; Kennett BLN, 1998, GEOPHYS J INT, V132, P374, DOI 10.1046/j.1365-246x.1998.00451.x; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; Kuang WL, 1997, NATURE, V389, P371, DOI 10.1038/38712; Labrosse S, 1997, PHYS EARTH PLANET IN, V99, P1, DOI 10.1016/S0031-9201(96)03207-4; Laio A, 2000, SCIENCE, V287, P1027, DOI 10.1126/science.287.5455.1027; Langereis CG, 1997, GEOPHYS J INT, V129, P75, DOI 10.1111/j.1365-246X.1997.tb00938.x; Laske G, 1999, NATURE, V402, P66, DOI 10.1038/47011; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Lister JR, 1998, PHYS EARTH PLANET IN, V105, P5, DOI 10.1016/S0031-9201(97)00082-4; LISTER JR, 1995, PHYS EARTH PLANET IN, V91, P17, DOI 10.1016/0031-9201(95)03042-U; LOPER DE, 1978, GEOPHYS J ROY ASTR S, V54, P389, DOI 10.1111/j.1365-246X.1978.tb04265.x; LOPER DE, 1978, J GEOPHYS RES, V83, P5961, DOI 10.1029/JB083iB12p05961; LOPER DE, 1991, J GEOMAGN GEOELECTR, V43, P79, DOI 10.5636/jgg.43.79; Manga M, 1996, GEOPHYS RES LETT, V23, P3091, DOI 10.1029/96GL03021; MCELHINNY MW, 1980, J GEOPHYS RES, V85, P3523, DOI 10.1029/JB085iB07p03523; MCQUEEN RG, 1966, J GEOPHYS RES, V71, P1751, DOI 10.1029/JZ071i006p01751; McSweeney TJ, 1997, PHYS EARTH PLANET IN, V101, P131, DOI 10.1016/S0031-9201(96)03216-5; Merrill RT, 1999, REV GEOPHYS, V37, P201, DOI 10.1029/1998RG900004; MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; OLSON P, 1995, PHYS EARTH PLANET IN, V92, P109, DOI 10.1016/0031-9201(95)03065-5; Olson P, 1999, J GEOPHYS RES-SOL EA, V104, P10383, DOI 10.1029/1999JB900013; Olson P, 1996, PHILOS T R SOC A, V354, P1413, DOI 10.1098/rsta.1996.0055; OVERSBY VM, 1971, NATURE, V234, P463, DOI 10.1038/234463a0; Parker LJ, 1996, SCIENCE, V273, P95, DOI 10.1126/science.273.5271.95; PHILLIPS NA, 1963, REV GEOPHYS, V1, P123, DOI 10.1029/RG001i002p00123; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Righter K, 1997, PHYS EARTH PLANET IN, V100, P115, DOI 10.1016/S0031-9201(96)03235-9; ROBERTS PH, 1963, PHILOS T R SOC LON A, V263, P93; RUSSELL CT, 1993, J GEOPHYS RES-PLANET, V98, P18681, DOI 10.1029/93JE00981; Sakuraba A, 1999, PHYS EARTH PLANET IN, V111, P105, DOI 10.1016/S0031-9201(98)00150-2; Sarson GR, 1997, PHYS EARTH PLANET IN, V101, P13, DOI 10.1016/S0031-9201(96)03248-7; Sharrock DS, 1998, EARTH PLANETS SPACE, V50, P1013, DOI 10.1186/BF03352195; Singh SC, 2000, SCIENCE, V287, P2471, DOI 10.1126/science.287.5462.2471; SLEEP NH, 1990, J GEOPHYS RES-SOLID, V95, P6715, DOI 10.1029/JB095iB05p06715; Song XD, 1997, REV GEOPHYS, V35, P297, DOI 10.1029/97RG01285; Song XD, 1998, SCIENCE, V282, P924, DOI 10.1126/science.282.5390.924; Song XD, 2000, J GEOPHYS RES-SOL EA, V105, P623, DOI 10.1029/1999JB900341; Song XD, 1996, NATURE, V382, P221, DOI 10.1038/382221a0; Souriau A, 2000, PHYS EARTH PLANET IN, V118, P13, DOI 10.1016/S0031-9201(99)00131-4; Souriau A, 1998, GEOPHYS J INT, V134, pF1, DOI 10.1046/j.1365-246x.1998.00637.x; Steinle-Neumann G, 1999, PHYS REV B, V60, P791, DOI 10.1103/PhysRevB.60.791; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; Stevenson DJ, 2000, SCIENCE, V287, P997, DOI 10.1126/science.287.5455.997; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P24729, DOI 10.1029/97JB02125; STIXRUDE L, 1995, SCIENCE, V267, P1972, DOI 10.1126/science.267.5206.1972; STIXRUDE L, 1995, GEOPHYS RES LETT, V22, P125, DOI 10.1029/94GL02742; SU WJ, 1995, J GEOPHYS RES-SOL EA, V100, P9831, DOI 10.1029/95JB00746; Sumita I, 1999, SCIENCE, V286, P1547, DOI 10.1126/science.286.5444.1547; Sumita I, 1996, GEOPHYS J INT, V124, P502, DOI 10.1111/j.1365-246X.1996.tb07034.x; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; TAYLOR GI, 2000, PHYS TODAY, V53, P30; Tschauner O, 1999, NATURE, V398, P604, DOI 10.1038/19287; Vidale JE, 2000, NATURE, V404, P273, DOI 10.1038/35005059; Williams Q, 1997, PHYS EARTH PLANET IN, V100, P49, DOI 10.1016/S0031-9201(96)03231-1; Yoshida S, 1996, J GEOPHYS RES-SOL EA, V101, P28085, DOI 10.1029/96JB02700; Zatman S, 1997, NATURE, V388, P760, DOI 10.1038/41987; Zhang K, 1998, STUD GEOPHYS GEOD, V42, P247, DOI 10.1023/A:1023336216088; Zhang K, 1997, GEOPHYS RES LETT, V24, P2869, DOI 10.1029/97GL02955; Zhang K, 2000, GEOPHYS J INT, V140, pF1, DOI 10.1046/j.1365-246x.2000.00024.x; Zhang K, 1996, PHYS FLUIDS, V8, P1141, DOI 10.1063/1.868914	110	117	127	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2007	2012		10.1126/science.288.5473.2007	http://dx.doi.org/10.1126/science.288.5473.2007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856207				2022-12-28	WOS:000087687000040
J	Minkoff, H; Santoro, N				Minkoff, H; Santoro, N			Ethical considerations in the treatment of infertility in women with human immunodeficiency virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PELVIC INFLAMMATORY DISEASE; ANTIRETROVIRAL THERAPY; HIV-INFECTION; UNITED-STATES; TRANSMISSION; IMPACT; AIDS		Maimonides Hosp, Brooklyn, NY 11219 USA; Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Maimonides Medical Center; Yeshiva University; Albert Einstein College of Medicine	Minkoff, H (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.							American Society for Reproductive Medicine, 1993, FERTIL STERIL, V59, pS1; CARPENTER CC, 2000, JAMA-J AM MED ASSOC, V383, P381; CHERVENAK FA, 1992, CLIN OBSTET GYNECOL, V35, P709, DOI 10.1097/00003081-199212000-00003; Chirgwin KD, 1996, J ACQ IMMUN DEF SYND, V12, P489, DOI 10.1097/00042560-199608150-00008; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Grinspoon S, 1997, J CLIN ENDOCR METAB, V82, P3360; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; *INT PER HIV GROUP, 1915, NEW ENGL J MED, V340, P977; KAMENGA MC, 1995, AM J OBSTET GYNECOL, V172, P919, DOI 10.1016/0002-9378(95)90022-5; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; Kimani J, 1996, J INFECT DIS, V173, P1437, DOI 10.1093/infdis/173.6.1437; Lindegren ML, 1999, JAMA-J AM MED ASSOC, V282, P531, DOI 10.1001/jama.282.6.531; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Robertson JA., 1994, CHILDREN CHOICE FREE	17	45	45	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1748	1750		10.1056/NEJM200006083422312	http://dx.doi.org/10.1056/NEJM200006083422312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841881				2022-12-28	WOS:000087449300012
J	Cockcroft, CE; den Boer, BGW; Healy, JMS; Murray, JAH				Cockcroft, CE; den Boer, BGW; Healy, JMS; Murray, JAH			Cyclin D control of growth rate in plants	NATURE			English	Article							CELL-DIVISION; DEPENDENT KINASES; PHASE; COORDINATION; EXPRESSION; TRANSITION; SINAPIS; HOMOLOG; SYSTEM	The mechanisms by which plants modulate their growth rate in response to environmental and developmental conditions are unknown, but are presumed to involve specialized regions called meristems where cell division is concentrated(1-5), The possible role of cell division in influencing meristem activity and overall plant growth rate is controversial, with a prevailing view that cell division is secondary to higher order meristem controls(1,2,6,7). Here we show that a reduction in the length of the cell-cycle G1 phase and faster cell cycling occur when the rate of cell. division in transgenic tobacco plants is increased by the plant D-type cyclin CycD2 (ref. 8), The plants have normal cell and meristem sizes, but elevated overall growth rates, an increased rate of leaf initiation and accelerated development in all stages from seedling to maturity. We conclude that cell division is a principal determinant of meristem activity and overall growth rate, and propose that modulation of plant growth rate is achieved through regulation of G1.	Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England; Aventis Corp, B-9000 Ghent, Belgium	University of Cambridge	Murray, JAH (corresponding author), Univ Cambridge, Inst Biotechnol, Tennis Court Rd, Cambridge CB2 1QT, England.	j.murray@biotech.cam.ac.uk	Healy, Sandra J/D-5256-2013; Murray, James AH/D-3399-2009	Murray, James AH/0000-0002-2282-3839				BARLOW PW, 1994, LINNEAN SOC, P169; Bryant ja, 1985, CELL DIVISION CYCLE, P157; Clark SE, 1997, TRENDS CELL BIOL, V7, P454, DOI 10.1016/S0962-8924(97)01152-5; Clowes F. A. L., 1976, Cell division in higher plants., P253; Doerner P, 1996, NATURE, V380, P520, DOI 10.1038/380520a0; EVANS H. J., 1957, JOUR GENETICS, V55, P487, DOI 10.1007/BF02984066; Francis D, 1995, J EXP BOT, V46, P1887, DOI 10.1093/jxb/46.12.1887; FRANCIS D, 1988, SYM SOC EXP BIOL, V42, P181; Francis D, 1998, INHERENT VARIATION IN PLANT GROWTH, P5; GALLI M G, 1983, Plant Cell Reports, V2, P156, DOI 10.1007/BF00269343; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GONTHIER R, 1985, PLANTA, V165, P288, DOI 10.1007/BF00395053; GONTHIER R, 1987, PLANTA, V170, P55, DOI 10.1007/BF00392381; HAGEMANN W, 1992, INT J PLANT SCI, V153, pS38, DOI 10.1086/297062; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Kinsman EA, 1997, PLANT CELL ENVIRON, V20, P1309, DOI 10.1046/j.1365-3040.1997.d01-21.x; LYNDON RF, 1970, ANN BOT-LONDON, V34, P1; Lyndon RF, 1998, SHOOT APICAL MERISTE; Mironov V, 1999, PLANT CELL, V11, P509; Murray JAH, 1998, PORT PR R M, V10, P99; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PINES J, 1995, ADV CANCER RES, V66, P181, DOI 10.1016/S0065-230X(08)60254-7; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; RIOUKHAMLICHI C, IN PRESS MOL CELL BI; Setiady YY, 1996, PLANT CELL PHYSIOL, V37, P369, DOI 10.1093/oxfordjournals.pcp.a028955; SONI R, 1995, PLANT CELL, V7, P85, DOI 10.1105/tpc.7.1.85	30	253	283	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					575	579		10.1038/35014621	http://dx.doi.org/10.1038/35014621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850717				2022-12-28	WOS:000087449500052
J	Citterio, E; Vermeulen, W; Hoeijmakers, JHJ				Citterio, E; Vermeulen, W; Hoeijmakers, JHJ			Transcriptional healing	CELL			English	Review							NUCLEOTIDE EXCISION-REPAIR; COUPLED REPAIR; MOLECULAR MECHANISM; COCKAYNE-SYNDROME; RNA-POLYMERASE; DNA-REPAIR; DAMAGE		Erasmus Univ, Ctr Biomed Genet, MGC, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Ctr Biomed Genet, MGC, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands.		Hoeijmakers, Jan/AAX-6972-2021; Vermeulen, Wim/W-8708-2019	Vermeulen, Wim/0000-0003-3616-734X; Citterio, Elisabetta/0000-0003-2347-3495				Bootsma D., 1998, GENETIC BASIS HUMAN, P245; Constantinou A, 1999, J BIOL CHEM, V274, P5637, DOI 10.1074/jbc.274.9.5637; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; de Boer J, 1999, BIOCHIMIE, V81, P127, DOI 10.1016/S0300-9084(99)80045-5; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; HANAWALT P, 1999, ADV DNA DAMAGE REPAI; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; Leadon SA, 1999, AM J HUM GENET, V64, P1259, DOI 10.1086/302390; LEADON SA, 1993, P NATL ACAD SCI USA, V90, P10499, DOI 10.1073/pnas.90.22.10499; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ljungman M, 1996, ONCOGENE, V13, P823; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2	20	40	40	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					447	450		10.1016/S0092-8674(00)80854-5	http://dx.doi.org/10.1016/S0092-8674(00)80854-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850486	Bronze			2022-12-28	WOS:000087375400001
J	Boss, AP				Boss, AP			Star formation - Three's a crowd	NATURE			English	Editorial Material							BINARY		Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Boss, AP (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.							CLARKE CJ, 1991, MON NOT R ASTRON SOC, V249, P584, DOI 10.1093/mnras/249.4.584; Ghez AM, 1997, ASTROPHYS J, V481, P378, DOI 10.1086/304031; MATHIEU RD, 1994, ANNU REV ASTRON ASTR, V32, P465, DOI 10.1146/annurev.aa.32.090194.002341; Rodriguez LF, 1998, NATURE, V395, P355, DOI 10.1038/26421; SHU FH, 1987, ANNU REV ASTRON ASTR, V25, P23, DOI 10.1146/annurev.aa.25.090187.000323	5	3	3	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					405	407		10.1038/35013174	http://dx.doi.org/10.1038/35013174			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839520				2022-12-28	WOS:000087212000027
J	Nakayama, J; Klar, AJS; Grewal, SIS				Nakayama, J; Klar, AJS; Grewal, SIS			A chromodomain protein, Swi6, performs imprinting functions in fission yeast during mitosis and meiosis	CELL			English	Article							MATING-TYPE LOCI; EPIGENETIC INHERITANCE; SCHIZOSACCHAROMYCES-POMBE; DNA METHYLATION; CHROMOSOME SEGREGATION; HETEROCHROMATIN; CHROMATIN; DROSOPHILA; REPRESSION; DOMAINS	Inheritance of stable states of gene expression is essential for cellular differentiation. In fission yeast, an epigenetic imprint marking the mating-type (mat2/3) region contributes to inheritance of the silenced state, but the nature of the imprint is not known. We show that a chromodomain-containing Swi6 protein is a dosage-critical component involved in imprinting the mat locus. Transient overexpression of Swi6 alters the epigenetic imprint at the mat2/3 region and heritably converts the expressed state to the silenced state. The establishment and maintenance of the imprint are tightly coupled to the recruitment and the persistence of Swi6 at the mat2/3 region during mitosis as well as meiosis. Remarkably, Swi6 remains bound to the mat2/3 interval throughout the cell cycle and itself seems to be a component of the imprint. Our analyses suggest that the unit of inheritance at the mat2/3 locus comprises the DNA plus the associated Swi6 protein complex.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NCI, Frederick, MD 21702 USA	Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	grewal@cshl.org	Nakayama, Jun-ichi/C-6003-2011	Nakayama, Jun-ichi/0000-0002-5597-8239; Grewal, Shiv/0000-0002-4552-9261	NIGMS NIH HHS [R01 GM59772-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ainscough J. F. X., 1996, Epigenetic mechanisms of gene regulation., P173; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; ALLSHIRE RC, 1996, EPIGENETIC MECH GENE, P443; ANTEQUERA F, 1984, J BIOL CHEM, V259, P8033; Ayoub N, 1999, GENETICS, V152, P495; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; EGEL R, 1980, COLD SPRING HARB SYM, V45, P1003, DOI 10.1101/SQB.1981.045.01.116; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; EKWALL K, 1999, CHROMOSOME STRUCTURA, P47; ENGELKE U, 1987, CURR GENET, V12, P535, DOI 10.1007/BF00419563; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 1997, GENETICS, V146, P1221; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Klar AJS, 1998, CIBA F SYMP, V214, P87; Klein CB, 1997, MUTAT RES-REV MUTAT, V386, P163, DOI 10.1016/S1383-5742(96)00052-X; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Paro R, 1993, CURR OPIN CELL BIOL, V5, P999, DOI 10.1016/0955-0674(93)90084-4; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; Riggs A.D., 1996, EPIGENETIC MECH GENE, P231; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SINGH PB, 1994, J CELL SCI, V107, P2653; THON G, 1993, GENETICS, V134, P1045; THON G, 1992, GENETICS, V131, P287; Thon G, 1997, GENETICS, V145, P685; THON G, 1994, GENETICS, V138, P29; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; WRIGHT A, 1986, PLASMID, V15, P156, DOI 10.1016/0147-619X(86)90051-X	43	150	152	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					307	317		10.1016/S0092-8674(00)80840-5	http://dx.doi.org/10.1016/S0092-8674(00)80840-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847685	Bronze			2022-12-28	WOS:000086741900010
J	Nelson, DC; Lasswell, J; Rogg, LE; Cohen, MA; Bartel, B				Nelson, DC; Lasswell, J; Rogg, LE; Cohen, MA; Bartel, B			FKF1, a clock-controlled gene that regulates the transition to flowering in Arabidopsis	CELL			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; BLUE-LIGHT; HYPOCOTYL ELONGATION; MOLECULAR-BASES; F-BOX; PROTEIN; THALIANA; ENCODES; MUTANTS; PHYTOCHROME	Plant reproduction requires precise control of flowering in response to environmental cues. We isolated a late-flowering Arabidopsis mutant, fkf1, that is rescued by vernalization or gibberellin treatment. We positionally cloned FKF1, which encodes a novel protein with a PAS domain similar to the flavin-binding region of certain photoreceptors, an F box characteristic of proteins that direct ubiquitin-mediated degradation, and six kelch repeats predicted to fold into a beta propeller. FKF1 mRNA levels oscillate with a circadian rhythm, and deletion of FKF1 alters the waveform of rhythmic expression of two clock-controlled genes, implicating FKF1 in modulating the Arabidopsis circadian clock.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	Bartel, B (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.	bartel@rice.edu	Bartel, Bonnie/O-8119-2019; Bartel, Bonnie/D-3550-2011	Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X; Nelson, David/0000-0001-9792-5015	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054749] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29 GM054749-05, R29 GM054749-04, R29 GM54749] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Aukerman MJ, 1999, PLANT J, V18, P195, DOI 10.1046/j.1365-313X.1999.00442.x; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bagnall DJ, 1996, PLANTA, V200, P278, DOI 10.1007/BF00208319; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; BARTEL B, 1994, P NATL ACAD SCI USA, V91, P6649, DOI 10.1073/pnas.91.14.6649; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BOYLAN MT, 1991, P NATL ACAD SCI USA, V88, P10806, DOI 10.1073/pnas.88.23.10806; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Bruggemann E, 1996, PLANT J, V10, P755, DOI 10.1046/j.1365-313X.1996.10040755.x; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chon ML, 1999, PLANT CELL PHYSIOL, V40, P702, DOI 10.1093/oxfordjournals.pcp.a029596; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; DEHIO C, 1994, P NATL ACAD SCI USA, V91, P5538, DOI 10.1073/pnas.91.12.5538; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; ESKINS K, 1992, PHYSIOL PLANTARUM, V86, P439, DOI 10.1111/j.1399-3054.1992.tb01341.x; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Frechilla S, 1999, PLANT CELL PHYSIOL, V40, P949, DOI 10.1093/oxfordjournals.pcp.a029627; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; JEFFERSON RA, 1987, EMBO J, V6, P3901; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Mengiste T, 1997, PLANT J, V12, P945, DOI 10.1046/j.1365-313X.1997.12040945.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; MILLAR AJ, 1991, PLANT CELL, V3, P541, DOI 10.1105/tpc.3.5.541; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MINET M, 1992, PLANT J, V2, P417; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Natorff R, 1998, MOL GEN GENET, V257, P255, DOI 10.1007/s004380050646; Neff MM, 2000, GENE DEV, V14, P257; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; REDEI GP, 1962, GENETICS, V47, P443; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Samach A, 1999, PLANT J, V20, P433, DOI 10.1046/j.1365-313x.1999.00617.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; THOMPSON AH, 1995, CAN J PSYCHIAT, V40, P15, DOI 10.1177/070674379504000106; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	74	361	400	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					331	340		10.1016/S0092-8674(00)80842-9	http://dx.doi.org/10.1016/S0092-8674(00)80842-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847687	Bronze			2022-12-28	WOS:000086741900012
J	Pickup, J				Pickup, J			Sensitive glucose sensing in diabetes	LANCET			English	Editorial Material							BLOOD		Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Chem Pathol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Pickup, J (corresponding author), Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Chem Pathol, London SE1 9RT, England.							Garg SK, 1999, DIABETES CARE, V22, P1708, DOI 10.2337/diacare.22.10.1708; Mastrototaro J, 1998, DIABETES, V47, pA61; Pickup J, 1999, BRIT MED J, V319, P1289, DOI 10.1136/bmj.319.7220.1289; PICKUP JC, 1993, DIABETES CARE, V16, P535, DOI 10.2337/diacare.16.2.535; Rebrin K, 1999, AM J PHYSIOL-ENDOC M, V277, pE561, DOI 10.1152/ajpendo.1999.277.3.E561; Sternberg F, 1996, DIABETOLOGIA, V39, P609, DOI 10.1007/BF00403309; Tamada JA, 1999, JAMA-J AM MED ASSOC, V282, P1839, DOI 10.1001/jama.282.19.1839; TAMADA JA, 1995, NAT MED, V1, P1198, DOI 10.1038/nm1195-1198; ThomeDuret V, 1996, ANAL CHEM, V68, P3822, DOI 10.1021/ac960069i	9	26	27	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					426	427						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841120				2022-12-28	WOS:000085306800006
J	Raju, TNK				Raju, TNK			The Nobel chronicles	LANCET			English	Article									Univ Illinois, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Raju, TNK (corresponding author), Univ Illinois, Chicago, IL 60680 USA.								0	15	19	2	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 1	2000	356	9223					81	81		10.1016/S0140-6736(05)73417-6	http://dx.doi.org/10.1016/S0140-6736(05)73417-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XH	10859071				2022-12-28	WOS:000087933400062
J	Buss, N				Buss, N			Effect of ritonavir on saquinavir metabolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland	Roche Holding	Buss, N (corresponding author), F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland.							BUSS N, 1998, 5 C RETR OPP INF FEB; Carpenter CCJ, 2000, JAMA-J AM MED ASSOC, V283, P381, DOI 10.1001/jama.283.3.381; JORGA K, 1999, 39 INT C ANT AG CHEM	3	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2936	2937		10.1001/jama.283.22.2936	http://dx.doi.org/10.1001/jama.283.22.2936			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865270				2022-12-28	WOS:000087480600031
